MP:0000001	mammalian phenotype	7616	0	0	0	0	2.706765e-93
MP:0000003	abnormal adipose tissue morphology	635	0	9.245504e-262	6.441544e-211	0	4.022375e-07
MP:0000005	increased brown adipose tissue amount	39	5.717429e-99	6.380461e-08	5.888115e-11	3.753941e-34	0.9379495
MP:0000008	increased white adipose tissue amount	48	7.192286e-57	2.382074e-06	0.001499306	2.301176e-10	0.5821964
MP:0000010	abnormal abdominal fat pad morphology	184	6.396563e-279	1.869047e-66	4.342137e-101	1.84985e-157	0.007834507
MP:0000013	abnormal adipose tissue distribution	17	2.130197e-30	1.425446e-10	3.878439e-06	4.74556e-08	0.3349692
MP:0000015	abnormal ear pigmentation	24	1.385204e-17	6.219105e-07	2.901008e-12	4.150507e-13	0.1808163
MP:0000017	big ears	4	0.0001868204	0.00113984	0.01427997	2.8247e-07	0.1719951
MP:0000018	small ears	37	1.78289e-06	1.289332e-35	9.979238e-06	1.8214e-08	0.09008389
MP:0000019	thick ears	3	0.06230812	0.4674563	0.007447458	0.01057709	0.5044799
MP:0000020	scaly ears	2	0.1593789	0.003741736	1	0.7208989	0.4373913
MP:0000021	prominent ears	1	7.882348e-05	0.9443174	0.01250401	1.2427e-09	1
MP:0000022	abnormal ear shape	8	3.199375e-06	1.95341e-05	0.01303942	0.0006640652	0.6057138
MP:0000023	abnormal ear distance/ position	24	3.974679e-15	3.468384e-43	1.478861e-06	1.902034e-09	0.4626271
MP:0000024	lowered ear position	17	1.646577e-07	5.081e-31	0.0003163656	5.518158e-10	0.3764875
MP:0000025	otic hypertelorism	1	1.443946e-05	0.9629829	0.4415859	0.05873643	1
MP:0000026	abnormal inner ear morphology	253	1.491925e-163	2.423887e-180	3.646393e-27	6.543491e-68	0.001170791
MP:0000029	abnormal malleus morphology	36	2.573196e-06	1.776181e-65	5.965285e-06	3.426933e-20	0.02434717
MP:0000030	abnormal tympanic ring morphology	48	0.008377798	2.3973e-65	1.178026e-10	1.427282e-20	0.007526849
MP:0000031	abnormal cochlea morphology	212	5.64193e-140	1.021554e-135	1.280568e-20	1.424327e-59	0.00035619
MP:0000032	cochlear degeneration	56	3.001129e-47	6.745755e-18	2.417478e-18	1.730266e-16	0.000546588
MP:0000033	absent scala media	5	0.999964	0.01194027	0.9688644	0.9788997	0.8994167
MP:0000034	abnormal inner ear vestibule morphology	74	8.267747e-21	9.303781e-38	1.241047e-12	1.929239e-13	0.018231
MP:0000035	abnormal membranous labyrinth morphology	229	1.775067e-149	5.84271e-133	3.070563e-27	2.629207e-65	0.0005332078
MP:0000036	absent semicircular canals	15	0.9996354	3.151238e-12	0.6201851	0.000250875	0.9048177
MP:0000037	abnormal lateral semicircular canal morphology	26	0.2187524	1.021523e-20	0.9547469	0.5424465	0.3301982
MP:0000039	abnormal otic capsule morphology	22	0.9765108	3.93181e-50	0.1192747	0.0005498688	0.1602481
MP:0000040	absent middle ear ossicles	8	2.126199e-20	3.758529e-12	5.09971e-08	3.86659e-10	0.5299238
MP:0000041	absent endolymphatic duct	10	0.2210225	0.04291843	0.9383856	0.8018909	0.9900239
MP:0000042	abnormal organ of Corti morphology	171	6.008498e-154	8.412077e-91	1.357416e-25	3.031452e-67	0.0003595862
MP:0000043	organ of Corti degeneration	47	4.238308e-41	3.122699e-12	9.1675e-16	3.808364e-12	0.001930571
MP:0000044	absent organ of Corti	5	2.229979e-08	1.252759e-10	0.180194	0.0007917264	0.4434972
MP:0000045	abnormal hair cell morphology	170	8.410974e-146	3.237597e-86	2.743898e-25	1.245999e-63	0.000122994
MP:0000046	abnormal sulcus ampullaris morphology	3	0.9999942	5.504663e-08	0.0297223	0.1753119	0.5249455
MP:0000048	abnormal stria vascularis morphology	38	3.637179e-26	5.689597e-22	8.815605e-09	3.409247e-12	0.02328598
MP:0000049	abnormal middle ear morphology	89	2.986056e-12	1.266903e-126	2.279084e-13	1.137661e-34	0.07274219
MP:0000054	delayed ear emergence	5	0.04514567	0.1889526	0.9996343	0.06003268	0.9615514
MP:0000060	delayed bone ossification	117	5.503636e-119	1.050392e-123	2.200632e-31	2.64428e-48	0.06550623
MP:0000061	fragile skeleton	31	1.776896e-61	9.044422e-22	7.488519e-12	1.049619e-26	0.03830866
MP:0000062	increased bone mineral density	79	4.423417e-65	1.974046e-32	5.820352e-50	6.941325e-42	0.0001985538
MP:0000063	decreased bone mineral density	198	2.672316e-181	4.064411e-116	2.438653e-74	1.901826e-120	2.678973e-05
MP:0000064	failure of secondary bone resorption	5	7.279922e-11	2.066058e-10	0.001374906	1.3612e-05	0.1896428
MP:0000065	abnormal bone marrow cavity morphology	36	3.464175e-52	5.331726e-25	4.041753e-28	1.620717e-48	0.2804519
MP:0000066	osteoporosis	50	1.050723e-32	1.111768e-35	2.601636e-36	1.017413e-24	5.792006e-05
MP:0000067	osteopetrosis	40	1.140911e-38	1.031264e-25	1.108567e-47	1.0011e-48	0.002568314
MP:0000069	kyphoscoliosis	26	4.881806e-28	2.309367e-07	5.757744e-10	2.297916e-29	0.282566
MP:0000071	axial skeleton hypoplasia	7	7.902693e-08	0.2810161	0.02504675	0.004006093	0.0745421
MP:0000073	absent craniofacial bones	4	4.640158e-07	4.090206e-08	1.111012e-08	0.000126234	0.02638642
MP:0000074	abnormal neurocranium morphology	238	7.522719e-153	6.439132e-235	3.174133e-33	7.800295e-98	0.04610567
MP:0000075	absent neurocranium	4	5.723298e-11	7.430725e-15	0.03347739	6.011821e-18	0.6966405
MP:0000077	abnormal interparietal bone morphology	52	5.380027e-26	1.187944e-53	0.007958772	2.192727e-11	0.7644111
MP:0000078	abnormal supraoccipital bone morphology	32	2.133568e-32	2.354048e-46	2.484847e-07	3.620583e-17	0.5381289
MP:0000079	abnormal basioccipital bone morphology	31	2.45994e-47	7.905653e-42	1.57474e-07	6.350933e-27	0.7548663
MP:0000080	abnormal exoccipital bone morphology	15	4.640966e-49	6.516849e-13	4.050693e-08	2.505106e-24	0.9862731
MP:0000081	premature suture closure	13	0.9219636	5.495767e-71	1.367631e-07	3.537564e-07	0.1262588
MP:0000082	overlapping parietal bones	1	0.9889855	2.460237e-06	1	0.6923945	0.4662091
MP:0000083	ectopic cranial bone growth	4	0.7716578	0.01242894	0.5631385	4.65362e-05	0.2447849
MP:0000084	abnormal fontanelle morphology	26	1.553892e-12	1.316369e-31	0.0002560191	3.525177e-08	0.02077258
MP:0000085	large anterior fontanelle	8	4.952599e-07	2.137788e-08	0.00436668	0.01175856	0.05303232
MP:0000087	absent mandible	27	0.5933963	1.033018e-39	0.002170636	0.003659545	0.4273605
MP:0000088	short mandible	83	2.283268e-30	4.832318e-93	0.000262884	3.596435e-18	0.3993729
MP:0000090	absent premaxilla	11	0.9999519	3.560056e-07	0.9999712	0.2750147	0.05615329
MP:0000091	short premaxilla	15	2.753137e-08	1.109134e-12	0.08447525	1.055654e-13	0.2859218
MP:0000094	absent alveolar process	5	0.9999872	0.04351667	0.999998	0.9098372	0.6181864
MP:0000097	short maxilla	44	0.366168	4.696388e-43	9.053325e-05	4.511921e-16	0.01593514
MP:0000098	abnormal vomer bone morphology	9	0.001258972	0.01145457	0.9461029	2.418723e-05	0.9902498
MP:0000099	absent vomer bone	3	1.341137e-12	1.326597e-06	0.2000932	1.858223e-07	0.8011267
MP:0000100	abnormal ethmoidal bone morphology	9	8.615527e-11	0.06246952	0.00195259	9.930033e-08	0.4109218
MP:0000101	absent ethmoidal bone	2	0.4416131	0.03951723	0.001892534	0.1074365	0.7229391
MP:0000102	abnormal nasal bone morphology	66	4.752325e-86	1.251473e-74	1.209453e-08	7.534274e-35	0.2283122
MP:0000103	nasal bone hypoplasia	4	6.73573e-22	0.02763476	0.001636246	1.249102e-06	0.450766
MP:0000104	abnormal sphenoid bone morphology	84	1.858524e-28	1.656794e-140	1.343619e-12	3.277318e-41	0.1234317
MP:0000105	impaired ossification of basisphenoid bone	2	0.6367195	0.06787785	0.5182865	0.0005768571	0.2170321
MP:0000106	abnormal basisphenoid bone morphology	48	1.334264e-18	1.057323e-114	0.002043605	2.431427e-23	0.4426976
MP:0000107	abnormal frontal bone morphology	77	7.535113e-59	6.453321e-73	1.273439e-06	6.929624e-42	0.7169894
MP:0000108	midline facial cleft	23	4.245601e-36	1.614316e-24	3.411885e-17	2.352184e-31	0.8754852
MP:0000109	abnormal parietal bone morphology	63	1.166391e-75	1.071918e-56	8.66716e-07	4.858881e-36	0.9757487
MP:0000111	cleft palate	251	2.09167e-113	8.272552e-214	9.11929e-35	3.928044e-79	0.0008099002
MP:0000114	cleft chin	3	0.9976596	4.03429e-09	0.2228658	0.8160563	0.01225369
MP:0000116	abnormal tooth development	68	1.440489e-10	7.032208e-53	1.156902e-05	3.418972e-17	0.1139669
MP:0000117	absent tooth primordium	2	0.9421781	0.0002154314	0.1262126	0.3651406	0.3598147
MP:0000118	arrest of tooth development	9	0.9999954	6.702603e-09	0.9999543	0.7333887	0.6010102
MP:0000119	abnormal tooth eruption	30	7.648646e-17	1.944848e-25	2.462551e-28	3.457953e-24	0.225334
MP:0000120	malocclusion	43	1.618779e-61	7.756109e-39	8.405118e-16	2.475621e-20	0.9960227
MP:0000121	failure of tooth eruption	19	1.307474e-23	2.923759e-15	2.582807e-24	1.472556e-29	0.1009279
MP:0000122	accelerated tooth eruption	3	0.9604232	0.1237769	0.0002267779	0.4505208	0.1475685
MP:0000124	absent teeth	15	0.3178368	7.466954e-43	4.704869e-07	1.226252e-08	0.3066924
MP:0000125	absent incisors	30	3.151992e-08	3.506028e-53	1.645699e-08	7.986736e-18	1.487272e-05
MP:0000126	brittle teeth	6	0.993435	3.449548e-05	0.3010411	0.5046029	0.4287343
MP:0000127	degenerate molars	1	0.9993189	0.002140724	0.7705591	0.5785263	1
MP:0000128	growth retardation of molars	9	0.008410953	0.000917373	0.9034409	0.5606192	0.7226584
MP:0000129	ameloblast degeneration	3	9.495485e-05	0.0001433302	0.07154798	1.621062e-08	1
MP:0000130	abnormal trabecular bone morphology	245	2.353801e-224	2.061931e-115	4.33227e-108	6.076767e-159	3.949848e-08
MP:0000131	abnormal long bone epiphysis morphology	30	8.50427e-47	3.528652e-09	2.397543e-05	3.516792e-16	0.5889532
MP:0000132	thickened long bone epiphysis	4	1.564793e-08	0.7733858	0.02976253	8.188217e-11	0.432855
MP:0000133	abnormal long bone metaphysis morphology	42	8.516454e-39	8.374952e-28	1.784528e-12	8.471319e-35	0.06607334
MP:0000134	abnormal compact bone thickness	92	8.456679e-76	9.64097e-71	8.784539e-29	2.005189e-58	0.0001427575
MP:0000135	decreased compact bone thickness	67	2.412212e-50	9.218419e-62	2.050427e-21	7.605408e-48	0.003626231
MP:0000136	abnormal microglial cell morphology	73	6.132536e-155	1.3882e-15	1.365216e-38	1.210713e-89	0.02484434
MP:0000137	abnormal vertebrae morphology	361	0	2.053096e-256	4.748606e-58	6.557202e-146	0.07973902
MP:0000138	absent vertebrae	6	0.5754158	0.0001924556	0.4833909	0.9287098	0.7319762
MP:0000139	absent vertebral transverse processes	2	0.7635308	0.2074043	0.5791852	0.2442318	0.1785852
MP:0000140	absent vertebral pedicles	5	1.773527e-25	6.764146e-06	0.7167236	0.009359422	0.3416995
MP:0000141	abnormal vertebral body morphology	53	3.220417e-56	2.25617e-55	1.602466e-05	1.354377e-14	0.973277
MP:0000149	abnormal scapula morphology	54	1.608585e-13	3.222532e-65	0.00687406	4.544977e-07	0.1299997
MP:0000150	abnormal rib morphology	250	1.017332e-240	3.447472e-110	3.501761e-62	1.293312e-105	0.001722315
MP:0000151	absent ribs	9	0.0004013015	2.96095e-13	0.5096812	0.4754149	0.313006
MP:0000152	absent proximal rib	3	0.6432949	1.172059e-07	0.9711303	0.1919486	0.07510239
MP:0000153	rib bifurcation	30	1.21173e-33	2.344613e-20	6.777341e-12	1.028362e-21	0.6145984
MP:0000154	rib fusion	88	1.137297e-70	3.54978e-69	2.398597e-21	1.274277e-38	0.04204458
MP:0000155	asymmetric rib attachment	48	4.125792e-10	8.749907e-39	1.73273e-10	4.297763e-14	0.2555818
MP:0000157	abnormal sternum morphology	205	8.424618e-190	6.244012e-188	7.628548e-34	2.440942e-86	0.005117279
MP:0000158	absent sternum	10	0.01562272	1.186085e-23	0.2917804	0.004107951	0.09826834
MP:0000159	abnormal xiphoid process morphology	59	7.299236e-23	1.454467e-84	0.002237849	1.711933e-16	0.2651997
MP:0000160	kyphosis	192	8.787668e-267	2.105134e-74	1.278088e-42	7.464499e-87	0.03293806
MP:0000161	scoliosis	38	2.963248e-128	4.581187e-19	8.993216e-23	6.431078e-46	0.4952701
MP:0000162	lordosis	32	7.864398e-46	1.095162e-23	3.441771e-07	1.240758e-18	0.0984776
MP:0000163	abnormal cartilage morphology	345	5.095613e-202	0	3.292935e-75	2.472917e-174	0.01325178
MP:0000164	abnormal cartilage development	183	1.021061e-99	5.589718e-199	5.073234e-46	1.041173e-75	0.233503
MP:0000165	abnormal long bone hypertrophic chondrocyte zone	119	4.720846e-131	2.991125e-140	3.954759e-54	1.272157e-82	0.5559723
MP:0000166	abnormal chondrocyte morphology	95	9.106344e-56	8.62459e-116	4.575929e-21	8.723977e-41	0.002059294
MP:0000167	decreased chondrocyte number	18	5.108029e-10	1.089558e-36	4.964524e-06	1.826486e-12	0.5199966
MP:0000168	abnormal bone marrow development	11	8.102178e-09	2.971477e-08	1.177052e-10	1.380446e-11	0.0007974491
MP:0000172	abnormal bone marrow cell number	192	0	2.411283e-47	1.3643e-96	4.926271e-305	0.004944589
MP:0000175	absent bone marrow cell	18	9.527477e-39	1.497422e-06	6.905543e-17	2.835183e-34	0.1889217
MP:0000180	abnormal circulating cholesterol level	339	0	5.899613e-122	1.68064e-113	3.012922e-210	1.086969e-05
MP:0000181	abnormal circulating LDL cholesterol level	99	1.466334e-148	5.11265e-38	1.248713e-27	2.117485e-66	0.01170241
MP:0000182	increased circulating LDL cholesterol level	49	1.27472e-71	1.68181e-25	2.034131e-18	1.548204e-27	0.2900175
MP:0000183	decreased circulating LDL cholesterol level	56	5.669229e-90	2.069749e-19	2.178593e-15	2.971207e-46	0.02075156
MP:0000184	abnormal circulating HDL cholesterol level	123	4.239348e-83	1.954475e-63	1.632812e-47	7.547656e-66	0.0003125516
MP:0000186	decreased circulating HDL cholesterol level	82	1.225008e-65	2.829987e-36	5.462337e-39	1.438604e-44	0.001219019
MP:0000187	abnormal triglyceride level	361	0	2.482357e-154	7.188815e-132	3.325613e-269	0.000254556
MP:0000188	abnormal circulating glucose level	488	0	1.905592e-173	3.680902e-184	8.208357e-276	2.523095e-08
MP:0000189	hypoglycemia	111	9.561607e-158	8.25484e-76	4.348675e-39	8.708653e-67	0.002035785
MP:0000192	abnormal mineral level	269	0	2.462314e-74	5.238679e-95	5.240714e-203	0.01203833
MP:0000194	increased circulating calcium level	30	3.800843e-30	1.111495e-16	2.416668e-18	8.591975e-34	0.01830814
MP:0000195	decreased circulating calcium level	30	8.793581e-35	6.110013e-19	2.497472e-17	1.031893e-31	0.03836301
MP:0000198	decreased circulating phosphate level	22	1.311616e-20	7.020163e-17	1.288274e-06	2.155325e-15	0.06433101
MP:0000199	abnormal circulating serum albumin level	64	4.806712e-118	4.302151e-16	7.649976e-25	2.032604e-44	0.004030892
MP:0000202	abnormal circulating alkaline phosphatase level	112	9.450204e-129	8.55605e-63	2.480663e-46	6.589255e-74	0.000309178
MP:0000203	abnormal circulating aspartate transaminase level	91	4.446155e-180	1.860491e-60	1.1683e-39	3.020588e-86	0.09792004
MP:0000208	decreased hematocrit	188	0	3.1236e-56	6.694409e-81	5.379043e-248	0.03656463
MP:0000215	absent erythrocytes	6	1.303715e-33	0.4255179	0.004585209	3.477189e-16	0.2052151
MP:0000216	absent erythroid progenitor cell	6	1.835753e-18	0.6329024	0.001296389	1.099249e-11	0.2645408
MP:0000217	abnormal leukocyte cell number	1306	0	5.140239e-309	0	0	1.047727e-48
MP:0000218	increased leukocyte cell number	849	0	3.469935e-190	0	0	2.386551e-42
MP:0000219	increased neutrophil cell number	167	0	1.244823e-44	2.379546e-138	0	0.0001085441
MP:0000220	increased monocyte cell number	102	2.155611e-215	5.31252e-19	7.270309e-84	9.024595e-193	5.115108e-05
MP:0000221	decreased leukocyte cell number	980	0	1.420204e-213	0	0	2.966461e-33
MP:0000222	decreased neutrophil cell number	90	6.137325e-178	1.095786e-20	3.967732e-57	5.977371e-150	0.0001450755
MP:0000223	decreased monocyte cell number	51	1.797908e-91	2.092758e-12	1.722781e-58	2.240505e-101	0.02151051
MP:0000226	abnormal mean corpuscular volume	122	0	2.546193e-12	7.396386e-38	2.541499e-215	0.05725331
MP:0000228	abnormal thrombopoiesis	239	0	8.899852e-42	5.491558e-138	0	1.16223e-06
MP:0000229	abnormal megakaryocyte differentiation	23	1.325191e-99	0.0009170092	6.100929e-27	7.360911e-95	0.3694915
MP:0000230	abnormal systemic arterial blood pressure	218	4.823914e-143	2.208593e-121	3.320743e-65	1.014198e-96	4.933404e-05
MP:0000231	hypertension	52	1.733328e-60	9.375041e-32	1.924804e-08	3.94815e-22	0.0605331
MP:0000233	abnormal blood flow velocity	32	3.780568e-16	1.963102e-34	3.855199e-17	2.417773e-28	0.3185447
MP:0000238	absent pre-B cells	13	6.566071e-42	0.8943431	1.118426e-05	1.369657e-38	0.2872618
MP:0000239	absent common myeloid progenitor cells	15	2.08677e-34	2.913325e-10	1.018208e-17	1.13043e-33	0.256509
MP:0000240	extramedullary hematopoiesis	158	0	2.069161e-22	7.698843e-146	0	0.011088
MP:0000242	impaired fertilization	72	3.616426e-37	0.06583947	4.602171e-08	1.050437e-17	0.5512988
MP:0000243	myoclonus	34	8.565713e-29	1.968333e-35	8.631276e-17	9.329392e-16	0.05946279
MP:0000245	abnormal erythropoiesis	647	0	3.695598e-129	1.493943e-284	0	0.0007188962
MP:0000248	macrocytosis	21	8.843743e-87	0.02429456	1.496875e-09	5.366015e-75	0.2634815
MP:0000249	abnormal blood vessel physiology	299	0	2.65769e-143	2.158001e-181	2.390078e-269	0.0002893518
MP:0000250	abnormal vasoconstriction	53	1.405768e-23	9.153546e-19	7.574457e-14	3.807166e-18	0.7360925
MP:0000255	vasculature congestion	75	2.591329e-63	6.828713e-42	7.862232e-29	1.366069e-34	0.01555111
MP:0000256	echinocytosis	7	1.926132e-19	1.390408e-07	4.31158e-19	4.077248e-17	0.9186503
MP:0000259	abnormal vascular development	551	0	0	2.215149e-218	0	1.793543e-12
MP:0000260	abnormal angiogenesis	399	0	4.524755e-269	1.531477e-177	0	3.197771e-11
MP:0000262	poor arterial differentiation	7	0.0001118582	5.5575e-08	2.56063e-06	1.947162e-16	0.001556642
MP:0000263	absent organized vascular network	8	0.001213239	0.0004256397	0.005722841	0.01065527	0.02856449
MP:0000264	failure of vascular branching	10	5.848821e-26	0.007342988	6.152764e-11	1.931615e-06	1.500724e-06
MP:0000265	atretic vasculature	3	8.370654e-17	0.8816839	0.0007192782	4.080629e-10	1
MP:0000266	abnormal heart morphology	1082	0	0	3.467983e-272	0	2.35836e-16
MP:0000267	abnormal heart development	340	0	8.532611e-234	9.208248e-99	7.939936e-241	0.006014804
MP:0000269	abnormal heart looping	123	3.440505e-132	4.971867e-59	4.391707e-29	6.865111e-96	0.006781588
MP:0000270	abnormal heart tube morphology	88	1.672761e-86	3.113853e-94	2.094469e-11	1.018269e-29	0.1973198
MP:0000272	abnormal aorta morphology	188	3.695305e-144	2.043524e-141	1.448878e-58	2.028793e-119	2.211713e-05
MP:0000273	overriding aortic valve	35	6.039208e-72	2.850218e-51	2.007817e-20	1.054909e-33	0.926859
MP:0000274	enlarged heart	364	0	2.011428e-270	4.488723e-96	1.124896e-218	0.0001496379
MP:0000275	heart hyperplasia	9	4.484063e-26	1.069616e-15	2.610147e-21	2.479274e-28	0.6198495
MP:0000276	heart right ventricle hypertrophy	36	8.014625e-40	6.939283e-29	1.490879e-07	1.63558e-10	0.8627812
MP:0000277	abnormal heart shape	31	8.900853e-45	1.250842e-09	0.004203661	7.203248e-13	0.8438235
MP:0000278	abnormal myocardial fiber morphology	193	2.010099e-272	2.684985e-148	2.930146e-45	1.048762e-153	0.006088217
MP:0000279	ventricular hypoplasia	30	5.316347e-67	3.436219e-44	1.618105e-08	2.427972e-25	0.7815957
MP:0000280	thin ventricular wall	112	1.808519e-155	4.049977e-81	1.095796e-40	1.078765e-83	0.0009736764
MP:0000281	abnormal interventricular septum morphology	273	0	1.229236e-207	2.212557e-81	8.940876e-179	0.05084779
MP:0000282	abnormal interatrial septum morphology	93	1.910448e-75	4.347841e-58	6.700073e-05	1.33041e-24	0.7063675
MP:0000284	double outlet right ventricle	115	1.103141e-103	1.555132e-70	3.931801e-26	1.213838e-52	0.3130376
MP:0000285	abnormal heart valve morphology	129	4.214153e-175	1.481907e-113	3.623587e-31	1.260023e-59	0.04968278
MP:0000286	abnormal mitral valve morphology	37	5.948291e-19	5.606876e-63	5.29226e-07	1.009463e-13	0.03879579
MP:0000287	heart valve hypoplasia	2	0.9989528	3.153283e-08	0.9610434	0.4088053	0.4295862
MP:0000288	abnormal pericardium morphology	292	0	2.035783e-144	5.254678e-118	6.891122e-271	1.92515e-07
MP:0000291	enlarged pericardium	69	1.715594e-61	1.462923e-33	4.755458e-35	5.502782e-63	0.002435719
MP:0000292	distended pericardium	58	3.654413e-205	3.187166e-20	3.474497e-30	2.193912e-91	0.001955125
MP:0000293	absent myocardial trabeculae	26	3.712114e-41	9.639202e-11	9.785785e-07	1.143096e-17	0.2866952
MP:0000295	trabecula carnea hypoplasia	60	3.371459e-138	7.364253e-37	6.80098e-32	3.555293e-63	0.2161375
MP:0000296	absent trabeculae carneae	13	3.220638e-15	1.191223e-10	0.02352324	0.0005813041	0.4182577
MP:0000297	abnormal atrioventricular cushion morphology	78	2.981154e-70	6.829202e-64	3.123535e-42	1.62508e-45	0.08935459
MP:0000298	absent atrioventricular cushions	22	1.273436e-41	9.644592e-13	4.726675e-15	6.056976e-14	0.001163807
MP:0000299	failure of atrioventricular cushion closure	9	1.425571e-15	4.793203e-09	4.583384e-08	2.246662e-05	0.6014045
MP:0000300	thin atrioventricular cushion	1	7.098568e-08	0.08874424	0.3040263	0.004724677	1
MP:0000301	decreased atrioventricular cushion size	15	4.332278e-13	3.977653e-27	3.493466e-06	2.680259e-14	0.6646444
MP:0000304	abnormal cardiac stroke volume	19	6.606561e-42	7.662483e-08	0.07678485	1.168199e-13	0.9534095
MP:0000313	abnormal cell death	1268	0	0	0	0	1.600873e-11
MP:0000314	schistocytosis	11	1.175041e-16	0.6576445	0.0001960375	7.123968e-13	0.3036532
MP:0000315	hemoglobinuria	5	2.0071e-18	3.982701e-09	5.394374e-07	5.425685e-05	1
MP:0000316	cellular necrosis	8	5.374744e-05	0.01759776	0.02872338	0.0007118775	0.7502145
MP:0000321	increased bone marrow cell number	49	1.723619e-113	3.059498e-09	1.253287e-17	1.895824e-97	0.1470231
MP:0000322	increased granulocyte number	270	0	3.715313e-43	3.170072e-232	0	2.714717e-08
MP:0000324	increased mast cell number	13	2.077404e-25	0.00343249	2.181585e-19	6.893797e-07	0.006869288
MP:0000327	hemosiderinuria	1	9.511737e-06	1	0.09126677	0.2332583	1
MP:0000328	increased enterocyte cell number	2	1.867046e-06	1.811202e-06	0.003942865	9.679257e-05	0.6529765
MP:0000332	hemoglobinemia	3	5.323175e-15	0.9443191	0.1093714	0.002106149	1
MP:0000333	decreased bone marrow cell number	134	5.711114e-296	2.066845e-47	1.779945e-71	5.917343e-201	0.006767482
MP:0000334	decreased granulocyte number	166	4.94065645841247e-324	2.49263e-36	1.245981e-117	1.537081e-295	0.003017622
MP:0000336	decreased mast cell number	20	7.288279e-53	0.0001773927	4.026129e-23	5.277701e-45	0.05263609
MP:0000339	decreased enterocyte cell number	3	2.402821e-17	1.547177e-12	1.583142e-06	0.000170758	0.9455485
MP:0000341	abnormal bile color	2	8.158747e-10	0.003185288	0.9096861	0.4747664	0.771915
MP:0000343	altered response to myocardial infarction	84	2.208847e-113	1.848171e-37	1.850711e-62	1.464187e-91	0.0007711093
MP:0000344	absent Cajal-Retzius cell	4	2.541307e-39	2.803641e-09	1	4.075144e-06	0.9356747
MP:0000346	broad head	9	1.275787e-18	8.614064e-15	0.0001803721	0.004742782	0.009730828
MP:0000348	abnormal aerobic fitness	7	2.538904e-14	9.103889e-06	0.1150092	7.003662e-05	0.3036248
MP:0000350	abnormal cell proliferation	819	0	3.358174e-293	1.21098e-247	0	3.129238e-05
MP:0000351	increased cell proliferation	217	0	4.284005e-85	4.977192e-105	8.226512e-251	0.02907599
MP:0000352	decreased cell proliferation	423	0	1.426729e-142	9.441762e-125	0	0.007185372
MP:0000358	abnormal cell morphology	405	0	2.719391e-78	2.841759e-104	0	0.002406777
MP:0000359	abnormal mast cell morphology	45	1.889491e-88	7.868956e-08	6.518705e-46	2.272444e-78	0.01803783
MP:0000361	decreased mast cell protease storage	4	1.367959e-17	0.171246	0.00680243	1.656993e-05	0.6256382
MP:0000362	decreased mast cell histamine storage	3	6.468081e-23	0.02930335	1.786815e-05	4.12166e-19	0.9663826
MP:0000364	abnormal vascular regression	40	2.622274e-23	2.740614e-42	7.731102e-14	1.510882e-09	7.861345e-05
MP:0000367	abnormal coat/ hair morphology	490	0	1.499987e-193	3.697207e-129	1.63798e-262	3.680043e-10
MP:0000370	head blaze	3	0.3595836	0.018478	0.2450309	0.9930083	0.387109
MP:0000371	diluted coat color	67	2.429076e-53	4.764357e-46	8.050872e-24	1.490115e-38	0.002150374
MP:0000372	irregular coat pigmentation	23	0.8241717	0.0001198876	0.0003443941	0.07111487	0.01404598
MP:0000373	belly spot	32	2.023419e-15	2.62484e-18	4.090237e-11	2.540569e-14	0.0002591413
MP:0000376	folliculitis	4	0.009782245	0.9290025	0.00130424	0.04575475	0.1794504
MP:0000377	abnormal hair follicle morphology	191	2.80332847450323e-320	2.181253e-96	1.173516e-67	6.94783e-126	0.02741299
MP:0000378	absent hair follicles	10	9.687962e-06	1.526736e-06	0.3610913	0.9239654	0.7606016
MP:0000379	decreased hair follicle number	61	1.025581e-95	5.062635e-59	4.738266e-25	2.892132e-40	0.01393023
MP:0000380	small hair follicles	10	1.029365e-58	6.483099e-06	8.738921e-08	1.849659e-10	0.2196281
MP:0000381	enlarged hair follicles	5	2.761929e-07	0.02610113	0.0005232323	2.071547e-07	0.7521572
MP:0000382	underdeveloped hair follicles	28	1.062521e-73	4.724532e-08	1.676945e-24	3.422875e-36	0.01944925
MP:0000383	abnormal hair follicle orientation	28	2.204732e-24	2.77612e-34	6.097936e-09	3.588841e-18	0.6548976
MP:0000384	distorted hair follicle pattern	8	6.396918e-18	1.845244e-09	1.245402e-05	2.716433e-08	0.8529674
MP:0000385	distended hair follicles	2	0.002995474	0.001912447	0.1023953	0.01750964	1
MP:0000387	disorganized inner root sheath cells	2	7.839064e-16	0.0001937013	0.008496983	6.798045e-07	1
MP:0000388	absent hair follicle inner root sheath	5	1.982364e-22	0.04042011	0.2375178	1.298238e-13	0.999229
MP:0000389	disorganized outer root sheath cells	2	6.334485e-28	0.02928237	4.534639e-06	2.440935e-08	0.5500931
MP:0000392	accelerated hair follicle regression	5	5.656076e-05	4.463177e-05	0.00954388	6.359105e-07	0.04647598
MP:0000394	absent hair follicle melanin granules	6	0.1218028	0.0001903555	2.247609e-07	1.19882e-07	0.006968793
MP:0000396	increased curvature of hairs	9	7.986116e-13	8.242825e-05	5.062663e-05	0.00011066	0.2057285
MP:0000397	abnormal guard hair morphology	20	0.006983442	5.798871e-30	5.921364e-05	5.364054e-05	0.287762
MP:0000398	splitting of guard hairs	1	9.055697e-12	0.13798	0.638411	0.282793	1
MP:0000399	increased curvature of guard hairs	3	0.8979081	4.932254e-18	0.0004853561	0.1121542	0.7205595
MP:0000400	abnormal awl hair morphology	16	6.945144e-16	9.392781e-21	6.106727e-05	4.702443e-08	0.3278716
MP:0000401	increased curvature of awl hairs	1	0.1147406	2.325589e-08	0.0003157966	0.004004114	0.498173
MP:0000402	abnormal zigzag hair morphology	24	6.075115e-37	7.636872e-27	1.230946e-12	1.334291e-16	0.09284349
MP:0000403	increased curvature of zigzag hairs	2	0.01160971	1.206273e-07	0.0005756051	9.0852e-06	0.5327667
MP:0000404	decreased curvature of zigzag hairs	3	1.018818e-31	0.8740767	0.00104711	2.485958e-07	0.5556223
MP:0000405	abnormal auchene hair morphology	17	1.286647e-32	1.256537e-13	6.926276e-12	5.363462e-11	0.5607772
MP:0000406	increased curvature of auchene hairs	2	3.887503e-17	0.001519169	1.527002e-06	3.222807e-07	0.4295862
MP:0000408	absent duvet hair	2	1	0.05185435	0.9610434	0.922511	0.8468146
MP:0000410	waved hair	27	3.073513e-25	4.208518e-17	4.005322e-06	1.32393e-13	0.005687903
MP:0000411	shiny fur	5	0.9999997	0.629421	0.7729567	0.6275139	0.6664558
MP:0000412	excessive hair	1	6.969599e-05	1.792878e-06	0.7263645	0.003223239	0.6526259
MP:0000413	polyphalangy	10	1.818256e-09	6.351837e-21	5.275956e-06	3.766188e-06	0.7032146
MP:0000414	alopecia	134	9.436876e-112	1.281515e-82	3.114219e-25	4.298532e-63	0.06309598
MP:0000416	sparse hair	92	3.00341e-174	6.493361e-21	2.582375e-31	7.416894e-98	0.8798708
MP:0000417	short hair	20	8.366305e-21	4.863888e-11	1.608557e-11	1.039156e-10	0.3832805
MP:0000418	focal hair loss	37	6.661628e-40	4.306109e-08	3.074077e-09	1.945683e-13	0.005998802
MP:0000420	ruffled hair	28	1.850303e-43	5.830095e-11	5.720175e-19	1.468822e-33	0.01100515
MP:0000421	mottled coat	8	0.2855452	0.8666442	0.005269968	0.9995229	0.120025
MP:0000422	delayed hair appearance	24	2.032251e-42	6.406272e-32	6.609647e-07	4.52356e-11	0.5361465
MP:0000423	delayed hair regrowth	12	7.789388e-10	2.255715e-05	0.0001638028	0.06305414	0.2009568
MP:0000424	retarded hair growth	11	0.004504582	1.424576e-10	0.001372979	1.743932e-06	0.01983294
MP:0000425	loss of eyelid cilia	3	0.988172	2.992151e-09	0.5686417	0.5171693	0.2480912
MP:0000427	abnormal hair cycle	68	5.739042e-52	2.824173e-59	8.962458e-26	6.746403e-38	0.06794247
MP:0000428	abnormal craniofacial morphology	1006	0	0	1.371017e-230	0	2.737404e-08
MP:0000430	absent maxillary shelf	14	0.2127061	2.711896e-59	0.02534143	5.578536e-06	0.01252194
MP:0000431	absent palatine shelf	11	0.4277313	1.147815e-17	0.006850363	2.494611e-06	0.01015672
MP:0000432	abnormal head morphology	765	0	0	1.266472e-145	0	0.0002848919
MP:0000433	microcephaly	76	3.550572e-56	7.718419e-31	1.292329e-14	4.544275e-44	0.6574144
MP:0000434	megacephaly	20	8.756776e-27	5.562537e-10	0.1585514	3.277617e-08	0.9981351
MP:0000435	shortened head	35	4.314107e-16	5.926866e-64	0.001230055	9.957221e-09	0.1306423
MP:0000436	abnormal head movements	93	6.433046e-37	1.024974e-41	7.850768e-16	4.682653e-18	0.00136723
MP:0000438	abnormal cranium morphology	486	0	0	4.259321e-97	1.063282e-184	0.0001373146
MP:0000439	enlarged cranium	14	0.0003943217	7.26216e-08	0.008698904	0.1856597	0.905028
MP:0000440	domed cranium	79	4.182098e-137	1.22123e-60	1.106909e-21	1.867685e-44	0.4376626
MP:0000441	increased cranium width	12	2.005338e-33	9.561553e-12	0.3651805	6.104676e-16	0.1278333
MP:0000443	abnormal snout morphology	164	8.696264e-132	3.59558e-182	1.036313e-43	5.413111e-71	0.03354615
MP:0000445	short snout	120	2.798349e-128	5.834925e-100	2.252154e-26	4.397641e-53	0.1864499
MP:0000446	long snout	2	1.850557e-05	1.390832e-08	0.0003062078	0.005139207	0.9647485
MP:0000447	flattened snout	3	0.0003854717	1.730346e-05	3.427905e-06	0.01857028	0.08526369
MP:0000448	pointed snout	11	0.04837967	9.061156e-37	0.1181668	0.04439336	0.001587766
MP:0000449	broad nasal bridge	4	8.574033e-05	0.0004701091	0.000675994	0.2308383	0.2703801
MP:0000450	absent snout	2	0.8808993	0.03885668	0.1384174	0.06868826	0.02241576
MP:0000451	scaly muzzle	1	0.9996359	0.1057508	1	1	1
MP:0000452	abnormal mouth morphology	449	3.301373e-260	0	6.207486e-84	5.824622e-181	8.569698e-06
MP:0000453	absent mouth	2	0.9995664	0.8594071	0.9991345	0.9999948	0.9577542
MP:0000454	abnormal jaw morphology	248	7.243497e-126	8.879641e-240	5.439701e-43	2.039309e-86	0.0004731405
MP:0000455	abnormal maxilla morphology	124	6.755888e-40	5.551411e-162	1.593283e-08	6.966796e-37	0.0004928875
MP:0000457	maxilla hypoplasia	11	3.699566e-05	3.906542e-15	0.9390504	0.03383131	0.950754
MP:0000458	abnormal mandible morphology	171	1.204033e-71	5.062077e-164	1.308459e-22	1.203648e-56	0.1113376
MP:0000459	abnormal presacral vertebrae morphology	205	6.845833e-157	2.839179e-141	1.144953e-25	7.954176e-73	0.373204
MP:0000460	mandible hypoplasia	28	0.003512436	9.493362e-45	0.02006184	4.221254e-08	0.004895877
MP:0000461	decreased presacral vertebrae number	35	8.769053e-90	1.82112e-10	2.86623e-22	1.247988e-42	0.1938442
MP:0000462	abnormal digestive system morphology	875	0	0	4.546969e-205	0	1.035931e-09
MP:0000464	increased presacral vertebrae number	15	7.31167e-13	9.645891e-05	6.844289e-05	6.856786e-09	0.2754561
MP:0000465	gastrointestinal hemorrhage	53	7.797722e-64	4.681014e-22	8.27583e-31	7.067377e-41	0.003326444
MP:0000466	esophageal epithelium hyperplasia	4	4.552932e-12	3.363464e-06	0.09427314	0.251216	0.39487
MP:0000467	abnormal esophagus morphology	65	8.368014e-29	2.68118e-62	0.006932838	1.467507e-21	0.2145088
MP:0000468	abnormal esophageal epithelium morphology	21	2.828402e-09	6.344074e-15	0.2411855	0.008617078	0.4438736
MP:0000469	abnormal esophageal squamous epithelium morphology	3	1	2.251147e-20	0.935911	0.3353375	0.04958615
MP:0000470	abnormal stomach morphology	143	5.967552e-86	2.911075e-54	9.209707e-29	2.956916e-41	0.000411632
MP:0000471	abnormal stomach epithelium morphology	48	1.172008e-52	4.779642e-19	1.863568e-14	1.39633e-21	0.02848628
MP:0000472	abnormal stomach squamous epithelium morphology	4	0.01797088	7.638392e-06	0.1583131	0.001993884	0.2314725
MP:0000473	abnormal stomach glandular epithelium morphology	23	1.656996e-23	1.429857e-08	3.538553e-05	1.480455e-09	0.167092
MP:0000474	abnormal foregut morphology	32	1.253083e-16	4.027443e-27	0.00431585	7.93188e-09	0.5694863
MP:0000477	abnormal intestine morphology	405	0	5.798347e-246	2.276981e-138	1.726609e-266	0.0123702
MP:0000478	delayed intestine development	8	8.820716e-10	0.0005204025	0.0002027041	2.485506e-10	0.5755141
MP:0000479	abnormal enterocyte morphology	71	8.488556e-171	3.794996e-32	1.498537e-34	2.689755e-75	0.5433827
MP:0000480	increased rib number	46	9.389427e-17	3.342751e-27	1.311458e-07	2.230781e-10	0.226017
MP:0000481	abnormal enterocyte cell number	6	1.530681e-22	1.146407e-16	3.363288e-08	5.373409e-10	0.8993143
MP:0000482	long fibula	1	8.889783e-05	0.06501858	8.414704e-05	0.002685823	0.7669281
MP:0000484	abnormal pulmonary artery morphology	50	4.925615e-29	1.385102e-69	2.657359e-16	1.323786e-38	0.070191
MP:0000486	abnormal pulmonary trunk morphology	17	7.869099e-32	1.078479e-16	2.718533e-05	3.154981e-13	0.5365749
MP:0000487	absent enterocytes	2	1.608009e-21	0.0009473702	0.3541385	0.001595277	1
MP:0000488	abnormal intestinal epithelium morphology	222	0	3.367645e-96	6.385092e-85	2.017796e-210	0.0009255817
MP:0000489	abnormal large intestine morphology	165	3.54038e-137	3.685099e-99	9.6267e-56	9.16343e-82	0.06228738
MP:0000490	abnormal crypts of Lieberkuhn morphology	144	1.068259e-245	1.880857e-60	5.124802e-54	1.990828e-142	0.01622881
MP:0000491	crypts of Lieberkuhn abscesses	16	6.080388e-38	0.007309914	2.594934e-08	1.036605e-17	0.8327549
MP:0000492	abnormal rectum morphology	49	1.83405e-47	2.600688e-44	7.977622e-13	3.643064e-30	0.02937579
MP:0000493	rectal prolapse	35	4.212479e-60	6.392123e-12	4.545477e-18	2.408688e-36	0.006780561
MP:0000494	abnormal cecum morphology	28	2.671695e-44	7.164011e-17	3.394271e-14	9.24155e-14	0.388646
MP:0000495	abnormal colon morphology	98	2.183182e-86	1.929718e-42	3.80066e-38	3.134086e-38	0.02000005
MP:0000496	abnormal small intestine morphology	173	3.940913e-223	1.143044e-105	1.563678e-64	6.118324e-122	0.4985204
MP:0000497	abnormal small intestine placement	1	0.7338375	0.6948788	0.4218103	0.4306829	1
MP:0000498	absent jejunum	1	1.124237e-08	0.002087143	0.0020594	0.3766044	1
MP:0000500	small intestinal prolapse	1	0.9996953	0.04353317	0.054902	0.936322	0.498173
MP:0000501	abnormal digestive secretion	35	1.78193e-29	3.629264e-22	5.685603e-17	1.621476e-07	0.002993219
MP:0000503	excessive digestive secretion	4	7.929078e-16	0.0004397692	0.7716423	0.00228896	0.3837173
MP:0000504	excessive digestive mucosecretion	1	5.430506e-27	0.0002367784	1	0.0040418	1
MP:0000505	decreased digestive secretion	14	6.67699e-07	3.141255e-18	1.937688e-08	0.001970368	0.04061367
MP:0000506	decreased digestive mucosecretion	4	1.227724e-08	0.04158088	0.000104611	0.003464749	0.3695549
MP:0000507	absent digestive secretion	2	7.875113e-22	0.179908	6.930318e-07	0.01053648	0.4185695
MP:0000508	right-sided isomerism	18	0.002004678	0.8389937	0.002007143	0.0628608	0.01720355
MP:0000509	absent digestive mucosecretion	1	2.90366e-16	0.2639492	0.001369142	0.3434051	0.4410307
MP:0000510	remittent intestinal hemorrhage	1	0.9996953	0.04353317	0.054902	0.936322	0.498173
MP:0000511	abnormal intestinal mucosa morphology	190	1.456655e-302	1.77948e-67	7.917402e-74	6.662542e-191	0.0001677564
MP:0000512	intestinal ulcer	34	2.517171e-69	0.001303636	6.585619e-15	5.204625e-30	0.003440352
MP:0000516	abnormal renal/urinary system morphology	772	0	0	1.194477e-266	0	8.614295e-11
MP:0000519	hydronephrosis	98	1.040649e-12	6.506798e-74	2.951154e-07	3.795773e-20	0.01576039
MP:0000520	absent kidney	63	3.649987e-24	5.522105e-84	0.0002052145	6.168651e-11	0.9662766
MP:0000521	abnormal kidney cortex morphology	348	0	5.247863e-190	2.499545e-185	2.496843e-303	4.526191e-08
MP:0000522	kidney cortex cysts	39	1.993114e-22	9.208566e-23	1.565615e-05	2.041652e-09	0.1208298
MP:0000523	cortical renal glomerulopathies	174	1.426495e-308	1.369374e-40	9.662724e-154	7.551258e-253	8.150477e-09
MP:0000524	decreased renal tubule number	9	5.462596e-12	1.835945e-27	5.237166e-07	0.001868192	0.9324818
MP:0000525	renal tubular acidosis	10	3.691676e-09	4.217251e-10	0.3224484	9.975238e-07	0.0283966
MP:0000526	small inner medullary pyramid	3	2.511831e-05	4.98287e-08	1.466401e-08	2.874772e-06	0.4395558
MP:0000527	abnormal kidney development	108	1.780055e-42	2.43771e-143	8.812756e-19	2.1058e-27	0.1452318
MP:0000528	delayed kidney development	18	3.120549e-46	1.455177e-19	0.002104766	7.608501e-06	0.1873914
MP:0000530	abnormal kidney blood vessel morphology	91	1.419577e-62	4.353407e-56	7.387444e-53	4.365397e-59	0.001739349
MP:0000531	right pulmonary isomerism	17	0.0001513786	0.6970735	0.0007943061	0.03026088	0.009257826
MP:0000532	kidney vascular congestion	5	0.04897658	2.773832e-12	2.388666e-08	0.0001018742	0.002971183
MP:0000533	kidney hemorrhage	16	1.106977e-33	2.119238e-17	2.318947e-11	2.038005e-26	0.07769901
MP:0000534	abnormal ureter morphology	156	2.479229e-51	5.050022e-133	8.382906e-18	8.512112e-45	0.0007701975
MP:0000535	ureter urothelium hyperplasia	1	4.648326e-07	0.239489	8.350423e-06	9.572875e-05	1
MP:0000536	hydroureter	30	1.517062e-06	1.117098e-36	0.009193314	0.0005116569	0.9697154
MP:0000537	abnormal urethra morphology	19	1.42349e-05	1.58252e-63	0.000786621	0.0003462724	0.2408957
MP:0000538	abnormal urinary bladder morphology	58	3.558985e-19	1.134185e-38	1.33898e-07	2.183973e-10	0.7232655
MP:0000539	distended urinary bladder	22	0.9580412	0.0002407567	0.2935532	0.5259121	0.4022304
MP:0000540	abnormal urinary bladder urothelium morphology	17	1.141188e-24	6.705699e-12	0.001159934	0.0002728075	0.1031707
MP:0000542	left-sided isomerism	20	3.158681e-08	1.661949e-05	2.294887e-05	0.0004726127	0.6001069
MP:0000543	absent urinary bladder transitional epithelium	1	1	0.07022086	1	0.999381	0.2355317
MP:0000544	thin urinary bladder transitional epithelium	1	1	0.07022086	1	0.999381	0.2355317
MP:0000547	short limbs	117	1.312814e-61	1.114542e-80	3.986276e-09	4.957547e-37	0.009671429
MP:0000548	long limbs	4	7.924194e-16	3.092966e-11	0.1465558	0.01334715	0.06106199
MP:0000549	absent limbs	17	2.401924e-08	1.047359e-15	0.9230546	0.4327957	0.5780943
MP:0000550	abnormal forelimb morphology	183	1.883572e-37	2.818639e-176	4.785238e-15	1.35718e-36	3.974961e-06
MP:0000551	absent forelimb	5	0.9947378	3.085727e-11	1	0.999999	0.6474027
MP:0000552	abnormal radius morphology	81	0.0004905609	3.376369e-90	0.004813084	1.747118e-07	0.03335061
MP:0000553	absent radius	10	0.9767743	0.003359493	0.9908158	0.9685071	0.178409
MP:0000554	abnormal carpal bone morphology	43	0.3981121	9.899955e-44	0.07825126	0.0009282853	0.4474551
MP:0000555	absent carpal bone	7	0.1132986	3.976802e-22	0.01095932	0.04068168	0.3044498
MP:0000556	abnormal hindlimb morphology	284	1.405556e-117	1.792655e-204	1.103934e-33	1.292069e-91	2.758592e-05
MP:0000557	absent hindlimb	12	0.0002418246	1.496109e-09	0.9365372	0.8360988	0.4430943
MP:0000558	abnormal tibia morphology	136	3.640577e-44	3.166077e-95	2.863188e-11	8.662083e-42	0.02401814
MP:0000559	abnormal femur morphology	149	3.18845e-27	2.485574e-95	8.70065e-11	8.217921e-38	0.03869648
MP:0000561	adactyly	7	0.7122491	0.06259902	0.9999931	0.9999775	0.9494966
MP:0000562	polydactyly	117	2.178296e-21	1.191098e-90	0.0002925486	9.514569e-24	0.2514079
MP:0000564	syndactyly	112	1.302221e-17	7.248975e-96	8.375423e-11	1.614399e-17	0.2768343
MP:0000565	oligodactyly	49	2.587072e-14	3.460186e-57	3.860666e-06	4.993867e-07	0.2030858
MP:0000566	synostosis	16	0.7796102	3.009531e-14	0.9323283	0.9567763	0.92912
MP:0000567	truncation of digits	1	0.9379559	0.1876644	0.5480092	0.1801954	0.7998004
MP:0000568	ectopic digits	8	0.2826917	3.338741e-15	0.05508926	0.008763609	0.2507709
MP:0000569	abnormal digit pigmentation	2	0.1201781	0.1402262	0.006416312	0.06600888	0.0102831
MP:0000571	interdigital webbing	28	0.01336785	6.118662e-23	0.01380709	2.534831e-08	0.4360442
MP:0000572	abnormal autopod morphology	311	5.679966e-192	3.865457e-256	1.664043e-47	2.20037e-117	0.002953093
MP:0000573	enlarged hind paws	1	8.791204e-06	0.9402756	9.06648e-08	1.111959e-06	0.5952274
MP:0000574	abnormal foot pad morphology	21	2.154898e-31	2.913252e-56	1.185239e-17	1.088138e-21	0.939139
MP:0000575	dark foot pads	10	4.833717e-08	7.718537e-16	3.590759e-16	5.21624e-11	0.9884374
MP:0000576	clubfoot	9	0.02730106	1.202592e-07	0.4160579	0.5509087	0.7242749
MP:0000577	absent eccrine glands	2	0.8687046	0.8517933	0.642369	0.4200224	0.7529738
MP:0000578	ulcerated paws	7	2.765253e-17	2.403395e-20	0.001853744	1.288706e-05	0.9000786
MP:0000579	abnormal nail morphology	27	3.363833e-21	2.872957e-35	0.03502834	4.641468e-05	0.983401
MP:0000580	deformed nails	7	0.0005598135	0.05675118	0.0001165596	1.535348e-07	0.8711091
MP:0000582	toenail hyperkeratosis	1	2.407553e-08	3.36219e-07	0.3024312	0.134149	0.7771805
MP:0000583	long toenails	4	0.9957409	7.176197e-09	0.3280828	0.8905841	0.9679284
MP:0000585	kinked tail	115	2.259325e-137	1.406324e-95	2.399383e-30	8.849325e-58	0.3582328
MP:0000588	thick tail	10	4.67156e-24	1.605677e-15	8.191442e-10	3.738749e-12	0.0001267921
MP:0000589	thin tail	3	4.922581e-10	3.79015e-05	0.6681553	0.0002820333	0.7575501
MP:0000592	short tail	104	4.578508e-60	1.151229e-84	4.213498e-22	1.367579e-41	0.05474838
MP:0000596	abnormal liver development	59	3.904742e-87	1.094673e-43	2.0136e-21	3.647872e-63	0.4012953
MP:0000597	delayed hepatic development	11	7.690644e-35	7.604808e-07	0.0002022694	2.280164e-09	0.999888
MP:0000598	abnormal liver morphology	867	0	0	1.53160350210786e-322	0	6.44399e-09
MP:0000599	enlarged liver	213	1.147588e-285	8.913282e-103	4.714875e-73	4.135669e-140	0.003045203
MP:0000600	liver hypoplasia	64	1.768313e-191	6.444774e-13	1.538544e-21	7.541879e-107	0.0043618
MP:0000601	small liver	180	0	2.552617e-103	3.265851e-53	1.895402e-170	0.01489463
MP:0000602	enlarged liver sinusoidal spaces	17	1.159557e-68	1.440371e-05	6.730869e-12	8.220207e-23	0.0001965644
MP:0000603	pale liver	83	4.484498e-197	1.202706e-32	2.474792e-29	1.536218e-111	0.8092391
MP:0000604	amyloidosis	56	8.338881e-87	2.06038e-15	2.10468e-27	3.684596e-36	0.06538734
MP:0000606	decreased hepatocyte number	17	4.077529e-56	2.000013e-07	4.430496e-18	2.522685e-28	0.511691
MP:0000607	abnormal hepatocyte morphology	152	2.2974052531618e-321	1.981084e-52	7.340335e-45	4.052737e-133	0.06705197
MP:0000608	dissociated hepatocytes	7	4.858317e-08	0.2195173	0.000620824	0.0009124317	0.07409785
MP:0000609	abnormal liver physiology	357	0	3.653063e-148	1.562707e-189	0	0.0001099054
MP:0000610	cholestasis	15	2.858368e-37	8.736303e-06	5.301511e-09	3.881907e-16	0.6002951
MP:0000611	jaundice	24	1.048998e-42	8.968407e-23	4.633803e-07	1.486729e-21	0.2761306
MP:0000613	abnormal salivary gland morphology	63	1.054147e-34	3.541379e-52	5.165482e-13	5.858769e-27	1.084296e-06
MP:0000614	absent salivary gland	5	0.2883621	0.0001772325	0.06240141	0.4881314	0.000682465
MP:0000615	abnormal palatine gland morphology	3	0.8548564	2.140795e-08	0.9773139	0.1020883	0.92679
MP:0000616	decreased ductal branching in the palatine gland	1	3.85341e-06	0.9961259	0.8961866	0.02513093	1
MP:0000617	increased salivary gland mucosal cell number	1	3.85341e-06	0.9961259	0.8961866	0.02513093	1
MP:0000618	small salivary gland	8	1.357832e-07	0.01562427	0.04908815	0.05501599	0.1366282
MP:0000619	salivary gland epithelial hyperplasia	4	4.015692e-05	0.000151749	0.2623735	0.2067747	0.6928911
MP:0000620	narrow salivary ducts	1	3.85341e-06	0.9961259	0.8961866	0.02513093	1
MP:0000621	salivary adenocarcinoma	4	1.100405e-17	0.3948293	0.0001667775	1.532916e-05	0.7918992
MP:0000622	increased salivation	2	0.06891473	0.3881684	0.02410448	6.689384e-10	0.7563549
MP:0000623	decreased salivation	18	1.177339e-19	4.111666e-08	8.553206e-30	5.974839e-06	0.06662504
MP:0000624	xerostomia	1	0.9930732	6.509674e-13	2.163734e-12	0.936322	0.02789339
MP:0000627	abnormal mammary gland morphology	164	9.353987e-112	1.077098e-99	1.255376e-77	2.212496e-103	7.97216e-05
MP:0000628	abnormal mammary gland development	137	2.297504e-99	7.217197e-81	7.083856e-71	1.069388e-87	0.0001568108
MP:0000629	absent mammary gland	6	1	1.883704e-32	0.9998624	0.5162973	0.003315746
MP:0000630	mammary gland hyperplasia	18	6.743432e-15	3.167508e-15	1.061409e-12	3.209164e-10	0.1028373
MP:0000631	abnormal neuroendocrine gland morphology	132	1.506873e-85	8.509779e-75	4.184091e-28	4.992199e-63	0.4780099
MP:0000632	abnormal pineal gland morphology	1	1	2.652335e-09	0.770847	0.8595013	0.8122343
MP:0000633	abnormal pituitary gland morphology	110	2.699122e-90	1.667312e-61	1.192365e-23	2.084172e-62	0.2251278
MP:0000635	pituitary gland hyperplasia	6	0.959674	0.07857938	0.1519824	0.04788332	0.8137324
MP:0000636	enlarged pituitary gland	10	0.2050429	1.300954e-05	2.647299e-05	0.001122717	0.5952278
MP:0000639	abnormal adrenal gland morphology	97	2.918321e-49	1.133753e-60	8.693454e-21	2.641117e-54	0.03922782
MP:0000640	adrenal gland hypoplasia	5	1.714791e-06	0.1596704	0.001341526	0.1245697	0.002774904
MP:0000642	enlarged adrenal glands	20	2.056969e-22	2.073855e-16	1.137523e-09	2.473313e-15	0.6018453
MP:0000643	absent adrenal medulla	2	0.02515474	0.4880913	0.0001083019	0.602943	0.3713874
MP:0000644	dextrocardia	30	0.0003113769	0.001727465	0.1474421	0.2966145	0.04241174
MP:0000645	absent adrenergic chromaffin cells	2	1.774701e-06	0.59058	2.25479e-06	0.05600754	0.6277631
MP:0000646	enlarged adrenocortical cells	4	0.5395195	0.009768394	0.5267121	0.9985179	0.9876392
MP:0000647	abnormal sebaceous gland morphology	72	1.230986e-89	8.908314e-54	1.944176e-15	7.377657e-35	0.7076753
MP:0000648	absent sebaceous gland	9	5.304647e-64	0.002812772	4.580236e-09	2.494464e-20	0.9122324
MP:0000649	sebaceous gland atrophy	4	0.3572624	8.382873e-30	0.01821794	0.0001127466	0.8629331
MP:0000650	mesocardia	12	0.1230428	0.9964252	0.004257007	0.4531827	0.5839874
MP:0000652	enlarged sebaceous gland	24	8.356125e-23	1.867781e-06	3.710637e-08	9.327236e-12	0.7046744
MP:0000653	abnormal sex gland morphology	712	0	1.40874e-206	6.587973e-120	1.869597e-286	3.326508e-06
MP:0000659	prostate gland hyperplasia	9	5.169609e-18	0.1176822	0.01758432	0.01469126	0.3542816
MP:0000660	lateral prostate gland hypoplasia	1	3.85341e-06	0.9961259	0.8961866	0.02513093	1
MP:0000661	small prostate gland ventral lobe	6	0.7255369	0.9995874	0.9998678	0.5490388	0.8819686
MP:0000662	abnormal branching of the mammary ductal tree	51	8.234871e-66	4.300785e-16	3.215928e-21	1.4973e-34	0.005720598
MP:0000664	small prostate gland anterior lobe	8	0.6946069	0.8199783	0.5408586	0.8584559	0.1330325
MP:0000665	decreased ductal branching in the coagulating gland	2	1.622907e-06	0.9720606	0.9200242	0.007702258	1
MP:0000666	decreased prostate gland duct number	5	0.002852029	3.430688e-21	0.9924873	0.03077563	0.9278365
MP:0000671	bulbourethral gland hypoplasia	1	3.85341e-06	0.9961259	0.8961866	0.02513093	1
MP:0000674	abnormal sweat gland morphology	7	0.08602116	1.960023e-07	0.004256216	0.001173042	0.759379
MP:0000675	abnormal eccrine gland morphology	4	0.9997204	0.331674	0.5922829	0.2699494	0.713613
MP:0000676	abnormal water content	11	2.278363e-15	6.61537e-06	8.701136e-10	1.412777e-10	0.3808236
MP:0000678	abnormal parathyroid gland morphology	30	1.574261e-24	3.836377e-12	2.517097e-20	6.058734e-25	0.5233397
MP:0000679	increased percent water in carcass	3	6.580159e-07	0.0129278	0.4915373	0.01197679	1
MP:0000680	absent parathyroid glands	12	4.43085e-06	2.147257e-06	4.158247e-06	1.056421e-11	0.4833974
MP:0000681	abnormal thyroid gland morphology	57	3.833632e-53	4.16536e-25	1.08534e-15	8.102978e-46	0.06736472
MP:0000683	decreased percent water in carcass	2	3.367678e-21	0.1344097	1.993571e-07	2.955219e-09	1
MP:0000685	abnormal immune system morphology	1910	0	0	0	0	2.016899e-53
MP:0000687	small lymphoid organs	14	7.642059e-33	0.006351284	6.12043e-05	7.470395e-21	0.05701754
MP:0000688	lymphoid hyperplasia	23	5.2238e-77	0.002191671	7.418459e-23	2.696226e-43	0.005190409
MP:0000689	abnormal spleen morphology	830	0	1.126773e-134	0	0	4.499493e-22
MP:0000690	absent spleen	17	2.521245e-15	7.228199e-06	0.003586439	3.081916e-09	0.4017741
MP:0000691	enlarged spleen	442	0	1.373267e-65	0	0	4.217338e-09
MP:0000692	small spleen	238	1.720763e-261	1.321736e-53	1.452218e-110	3.612184e-215	3.070262e-13
MP:0000693	spleen hyperplasia	99	4.40917e-234	4.997523e-27	2.608289e-99	3.693679e-215	0.01645319
MP:0000694	spleen hypoplasia	128	3.607714e-170	2.004298e-17	2.522175e-72	1.267442e-135	3.99766e-12
MP:0000696	abnormal Peyer's patch morphology	87	9.887588e-113	7.360783e-28	3.417369e-104	9.073599e-171	6.924571e-09
MP:0000700	abnormal lymph node number	5	0.4838524	1.820557e-05	0.001273981	0.0003313126	0.1024486
MP:0000701	abnormal lymph node size	236	0	2.106027e-34	2.800084e-238	0	5.019978e-22
MP:0000702	enlarged lymph nodes	176	0	3.259013e-29	1.252863e-194	0	2.337576e-13
MP:0000703	abnormal thymus morphology	480	0	9.316019e-111	3.774981e-277	0	5.873059e-18
MP:0000704	abnormal thymus development	28	1.515423e-84	4.840086e-15	1.146831e-17	1.752395e-72	0.6913568
MP:0000705	athymia	18	9.286597e-14	1.475121e-15	1.943165e-08	5.583554e-15	0.1797264
MP:0000706	small thymus	300	0	5.704661e-75	2.703218e-153	0	4.799711e-11
MP:0000708	thymus hyperplasia	34	1.726241e-64	5.940093e-12	1.581635e-30	4.412748e-67	0.5322388
MP:0000709	enlarged thymus	70	2.191464e-129	1.723696e-13	3.228655e-47	4.899339e-137	0.003736949
MP:0000711	thymus cortex hypoplasia	19	3.099335e-42	9.858796e-08	2.189009e-22	5.208852e-53	0.5601881
MP:0000714	increased thymocyte number	39	3.033417e-51	2.576858e-08	1.526705e-44	7.604102e-101	0.0004607565
MP:0000715	decreased thymocyte number	162	0	1.461379e-19	2.291614e-116	4.42871e-307	6.097499e-11
MP:0000716	abnormal immune system cell morphology	1600	0	0	0	0	3.183874e-56
MP:0000717	abnormal lymphocyte cell number	1031	0	9.704675e-201	0	0	5.458088e-46
MP:0000726	absent lymphocyte	121	3.614484e-176	1.059793e-19	3.87031e-87	5.897829e-254	4.609335e-08
MP:0000727	absent CD8-positive T cells	25	4.427021e-43	0.00248609	1.004244e-17	3.547287e-40	0.6961128
MP:0000729	abnormal myogenesis	59	2.798406e-47	1.936458e-43	8.720606e-11	1.241983e-35	2.561547e-05
MP:0000730	increased satellite cell number	10	0.9996586	3.177513e-06	0.0001535182	0.0533583	0.256364
MP:0000731	increased collagen deposition in the muscles	4	0.554605	8.615464e-07	0.9446494	0.9635515	0.5060333
MP:0000733	abnormal muscle development	89	2.892217e-83	2.385682e-53	2.6381e-16	3.670786e-53	0.0001628085
MP:0000734	muscle hypoplasia	21	4.357879e-23	2.839518e-32	2.842473e-09	2.945902e-19	0.0007002811
MP:0000736	delayed muscle development	6	6.236926e-06	0.4115148	0.002117747	0.0007386759	0.8271459
MP:0000737	abnormal myotome development	24	2.490947e-07	1.552226e-20	0.4331952	5.826965e-07	0.02548982
MP:0000738	impaired muscle contractility	270	0	1.758116e-192	7.886179e-84	2.553393e-143	0.00273049
MP:0000740	impaired smooth muscle contractility	40	1.211082e-53	3.788878e-18	7.078308e-32	1.077589e-26	0.9819884
MP:0000741	impaired contractility of urinary bladder detrusor smooth muscle	2	0.3567917	0.9778492	0.0001813371	0.8451799	0.02120284
MP:0000742	impaired contractility of ileal smooth muscle	2	0.999993	0.996777	0.03798305	0.9999522	0.02120705
MP:0000743	muscle spasm	70	1.127628e-34	9.526374e-59	2.602639e-11	1.508536e-17	0.6829814
MP:0000745	tremors	260	4.651508e-210	2.450614e-137	4.137406e-32	1.993634e-136	0.02559799
MP:0000746	weakness	125	1.596075e-96	7.437902e-44	1.049556e-18	5.903714e-66	0.1491644
MP:0000747	muscle weakness	73	7.941263e-105	1.31114e-30	1.256712e-17	2.933864e-34	0.06081184
MP:0000748	progressive muscle weakness	30	6.57769e-40	3.34543e-06	1.930551e-13	4.265288e-17	0.03975346
MP:0000749	muscle degeneration	54	3.377733e-30	2.96094e-33	4.357533e-09	4.400166e-16	0.03390573
MP:0000750	abnormal muscle regeneration	59	1.978218e-41	8.396782e-28	4.030589e-28	4.784757e-38	0.002354485
MP:0000751	myopathy	45	4.528781e-29	1.408797e-39	2.172579e-06	4.578944e-05	0.4408115
MP:0000752	dystrophic muscle	42	1.423944e-09	1.423781e-16	0.01236169	1.272171e-12	0.7682217
MP:0000753	paralysis	129	7.42455e-144	2.266224e-49	2.908599e-37	4.666758e-78	0.03777153
MP:0000754	paresis	24	9.055951e-15	1.312692e-12	2.357336e-17	6.419773e-31	0.05593929
MP:0000755	hindlimb paralysis	83	2.694686e-87	1.382727e-31	1.290645e-19	3.617901e-48	0.246641
MP:0000756	forelimb paralysis	10	0.0007811654	1.000901e-09	0.002312777	7.375831e-10	0.4228066
MP:0000757	herniated abdominal wall	21	5.47499e-12	1.778921e-20	1.079527e-05	3.716436e-06	0.2499569
MP:0000759	abnormal skeletal muscle morphology	373	2.904351e-279	2.10599e-308	2.525448e-92	6.161184e-173	6.065654e-07
MP:0000761	thin diaphragm muscle	31	1.112711e-10	2.716527e-28	0.003660357	4.227664e-07	0.7501643
MP:0000762	abnormal tongue morphology	96	3.824073e-18	3.167281e-120	2.11058e-05	6.00563e-21	0.0669731
MP:0000763	abnormal filiform papillae morphology	6	0.9963136	2.79382e-06	0.8518243	0.9994298	0.874073
MP:0000764	abnormal tongue epithelium morphology	25	1.057703e-09	1.399063e-32	0.1734302	0.07629004	0.5161021
MP:0000765	abnormal tongue squamous epithelium morphology	3	0.9999993	0.004174639	0.3288299	0.6558809	0.06088744
MP:0000766	absent tongue squamous epithelium	1	1	0.07022086	1	0.999381	0.2355317
MP:0000767	abnormal smooth muscle morphology	139	6.979665e-69	5.500612e-102	5.917066e-37	7.422016e-105	0.04082991
MP:0000771	abnormal brain size	286	0	9.624662e-111	6.30259e-57	2.416117e-144	0.002266398
MP:0000774	decreased brain size	234	1.207936e-306	2.960947e-80	3.128184e-39	7.808199e-111	0.00767849
MP:0000776	abnormal inferior colliculus morphology	21	4.424172e-06	2.605789e-19	3.715304e-07	0.0001239829	0.9732331
MP:0000777	increased inferior colliculus size	5	0.001748888	0.0323977	0.1312107	0.1188636	0.8938104
MP:0000778	abnormal nervous system tract morphology	176	4.896615e-85	1.966243e-183	2.392866e-34	1.037926e-57	0.1011431
MP:0000780	abnormal corpus callosum morphology	119	2.363403e-78	5.308528e-139	1.053392e-34	2.719633e-40	0.1398775
MP:0000781	decreased corpus callosum size	40	1.565082e-37	3.687856e-51	1.291786e-09	3.334232e-11	0.151963
MP:0000783	abnormal forebrain morphology	885	0	0	1.579124e-156	0	9.709222e-09
MP:0000784	forebrain hypoplasia	27	1.416101e-39	1.124877e-06	3.082437e-08	1.447486e-25	0.0604986
MP:0000785	telencephalon hypoplasia	11	0.03088699	4.484453e-15	0.4457192	4.637241e-05	0.07594868
MP:0000786	abnormal embryonic neuroepithelial layer differentiation	18	1.036308e-61	0.003388826	0.07119779	1.867191e-10	0.947537
MP:0000787	abnormal telencephalon morphology	706	0	0	9.758743e-124	3.957363e-273	1.708363e-06
MP:0000788	abnormal cerebral cortex morphology	303	5.25563e-306	9.240313e-200	1.040601e-38	9.435043e-106	0.000589639
MP:0000789	thickened cerebral cortex	11	7.784114e-11	4.352708e-13	0.02894794	4.20204e-05	0.7939444
MP:0000790	abnormal stratification in cerebral cortex	42	3.817019e-39	9.398906e-48	1.30154e-06	0.0002137008	0.5352611
MP:0000791	delaminated cerebral cortex	3	0.6586373	1.759125e-10	6.89687e-07	0.08675753	0.4452268
MP:0000792	abnormal cortical marginal zone morphology	32	3.551086e-86	2.927949e-17	1.993274e-06	1.550295e-16	0.3619613
MP:0000794	abnormal parietal lobe morphology	38	9.8608e-17	9.878935e-38	0.0005716948	6.297511e-08	0.08580357
MP:0000798	abnormal frontal lobe morphology	15	2.967439e-54	1.007591e-15	1.746869e-09	1.24081e-13	0.5018571
MP:0000801	abnormal temporal lobe morphology	316	1.22659e-266	1.971006e-187	1.260576e-55	9.236261e-101	0.002571271
MP:0000804	abnormal occipital lobe morphology	14	1.787168e-08	2.957453e-07	0.9582648	6.092565e-05	0.7870858
MP:0000805	abnormal visual cortex morphology	12	1.696571e-05	8.284892e-06	0.9705319	0.0007429117	0.707203
MP:0000807	abnormal hippocampus morphology	310	6.339689e-255	5.536464e-182	2.423379e-52	1.352118e-96	0.002618982
MP:0000808	abnormal hippocampus development	30	1.911056e-07	3.102526e-48	0.002109492	3.213159e-08	0.5921775
MP:0000809	absent hippocampus	5	0.04950499	1.243355e-09	0.3039153	1.533181e-09	0.04416626
MP:0000811	hippocampal neuron degeneration	25	2.83451e-12	0.07644881	0.0106611	5.854477e-10	0.002575966
MP:0000812	abnormal dentate gyrus morphology	96	1.0084e-66	1.824427e-69	6.721885e-09	1.825813e-19	0.05601519
MP:0000813	abnormal hippocampus layer morphology	96	1.184874e-130	3.812713e-58	4.907319e-26	1.356623e-39	0.4177192
MP:0000814	absent dentate gyrus	14	0.9959363	1.825762e-54	0.9455157	0.006323048	0.3886505
MP:0000815	abnormal Ammon gyrus morphology	58	0.000159546	2.269951e-48	0.001129204	1.897173e-10	0.4169455
MP:0000818	abnormal amygdala morphology	10	0.00255212	0.004118299	0.001165826	0.001626246	0.3365925
MP:0000819	abnormal olfactory bulb morphology	146	5.292647e-36	4.04437e-96	5.826311e-10	1.435442e-30	0.008021371
MP:0000820	abnormal choroid plexus morphology	52	1.395594e-78	1.314075e-55	9.311597e-08	3.045181e-29	0.5817377
MP:0000821	choroid plexus hyperplasia	4	1.375557e-17	0.06030097	0.04144884	0.01506616	1
MP:0000822	abnormal brain ventricle morphology	232	2.829366e-307	1.081377e-172	4.273597e-38	5.46223e-112	0.01132666
MP:0000823	abnormal lateral ventricle morphology	138	2.748027e-188	1.515502e-103	8.582205e-16	1.268947e-66	0.0354904
MP:0000825	dilated lateral ventricles	57	1.206733e-121	8.231001e-19	5.348911e-07	4.503529e-26	0.2201327
MP:0000826	abnormal third ventricle morphology	64	3.496658e-116	3.093805e-33	2.07473e-07	3.959327e-30	0.9220672
MP:0000827	dilated third ventricle	25	1.366202e-56	2.121008e-11	0.01499741	1.360379e-22	0.8223091
MP:0000828	abnormal fourth ventricle morphology	26	2.062646e-12	4.952301e-60	0.009960081	3.738758e-07	0.966694
MP:0000829	dilated fourth ventricle	7	1.374226e-11	1.485784e-14	0.02113233	0.0005065995	0.3533466
MP:0000830	abnormal diencephalon morphology	271	4.973191e-268	5.480622e-153	5.642853e-42	2.922378e-123	0.2196915
MP:0000831	diencephalon hyperplasia	2	0.1109395	0.3234207	0.005358828	0.007664309	0.5361868
MP:0000832	abnormal thalamus morphology	66	5.08209e-30	1.031089e-40	0.2147164	3.590647e-11	0.2597027
MP:0000833	thalamus hyperplasia	1	0.1085885	0.7320917	0.3591456	0.09837502	1
MP:0000835	abnormal subthalamic nucleus morphology	1	0.01015258	0.999982	0.5651307	0.930891	0.8068106
MP:0000836	abnormal substantia nigra morphology	27	1.988495e-10	0.06681245	0.03764146	1.457051e-09	0.4549425
MP:0000837	abnormal hypothalamus morphology	39	2.191318e-13	1.930937e-19	1.210749e-05	4.105266e-08	0.7592762
MP:0000839	hypothalamus hyperplasia	1	0.1085885	0.7320917	0.3591456	0.09837502	1
MP:0000840	abnormal epithalamus morphology	7	0.2832851	0.002572012	2.632527e-05	5.785844e-05	0.7201523
MP:0000841	abnormal hindbrain morphology	464	0	0	7.254392e-80	5.176488e-192	0.001767933
MP:0000842	absent superior olivary complex	1	0.3285139	2.86898e-05	0.3651411	0.2022989	1
MP:0000843	absent facial nuclei	3	0.2123416	5.833833e-17	0.5421599	0.02042419	0.5989627
MP:0000844	abnormal pontine flexure morphology	1	7.098568e-08	0.08874424	0.3040263	0.004724677	1
MP:0000846	abnormal medulla oblongata morphology	29	3.235219e-20	1.609557e-51	0.1139178	1.404869e-07	0.383445
MP:0000847	abnormal metencephalon morphology	415	1.876604e-278	1.657503e-278	1.146976e-65	9.037752e-162	0.003269228
MP:0000848	abnormal pons morphology	45	1.812724e-26	7.393681e-45	0.0002191922	4.540641e-08	0.06940336
MP:0000849	abnormal cerebellum morphology	384	2.460351e-269	1.221428e-254	7.894126e-61	2.259434e-157	0.01593025
MP:0000850	absent cerebellum	14	0.0004577672	1.2426e-15	0.02082789	0.001610646	0.5586193
MP:0000851	cerebellum hypoplasia	23	2.779074e-15	1.089215e-22	0.002727331	3.769083e-09	0.4394593
MP:0000852	small cerebellum	132	1.519312e-62	1.318709e-111	1.172553e-10	1.663856e-32	0.2451782
MP:0000853	absent cerebellar foliation	14	1.53026e-09	1.353756e-25	0.342112	6.468244e-09	0.2106213
MP:0000854	abnormal cerebellum development	143	4.577787e-35	4.741751e-131	1.998602e-21	9.173735e-35	0.3051631
MP:0000856	abnormal cerebellar plate morphology	3	9.162084e-19	4.584376e-10	0.2162385	2.866811e-08	0.6645961
MP:0000857	abnormal cerebellar foliation	98	6.144709e-14	4.138737e-67	5.518895e-08	1.150691e-15	0.521335
MP:0000858	altered metastatic potential	112	2.785372e-162	9.389036e-43	3.576309e-72	3.675397e-133	1.016243e-07
MP:0000859	abnormal somatosensory cortex morphology	31	0.001840815	1.479639e-21	0.00285096	0.002358932	0.01261762
MP:0000860	abnormal primary somatosensory cortex morphology	18	1	1.601238e-25	0.8082407	0.7919921	0.02132596
MP:0000861	disorganized barrel cortex	8	1	5.823869e-05	0.978613	0.9995085	0.05386517
MP:0000862	absent barrels in primary somatosensory cortex	5	0.9631816	5.178741e-24	0.8521034	0.006259624	0.1995038
MP:0000863	abnormal secondary somatosensory cortex morphology	1	7.349229e-05	0.2528496	0.02445157	0.5758676	1
MP:0000864	abnormal cerebellum vermis morphology	47	4.897087e-43	3.864481e-24	1.124447e-08	1.479874e-18	0.05290699
MP:0000865	absent cerebellum vermis	5	0.07330016	1.367778e-18	0.00134452	0.013278	0.6114003
MP:0000866	cerebellum vermis hypoplasia	14	4.804623e-14	6.004533e-23	0.03493548	2.283234e-05	0.8375383
MP:0000867	abnormal cerebellum anterior vermis morphology	13	0.0005104076	4.710551e-15	0.6209321	0.0006608862	0.6210488
MP:0000868	decreased anterior vermis size	3	0.01346426	0.0003423874	0.1788722	0.06579035	0.9460675
MP:0000869	abnormal cerebellum posterior vermis morphology	9	0.002255369	1.126114e-06	0.189631	0.01608814	0.8362425
MP:0000870	absent cerebellum vermis lobule VIII	1	0.9993189	0.002140724	0.7705591	0.5785263	1
MP:0000871	absent cerebellum vermis lobule IX	1	0.9993189	0.002140724	0.7705591	0.5785263	1
MP:0000872	abnormal cerebellum external granule cell layer morphology	72	6.945506e-10	7.385594e-58	4.707128e-12	2.879567e-13	0.06585535
MP:0000873	thin external granule cell layer	23	0.0001571541	1.566274e-20	0.0001787378	1.00407e-11	0.4027403
MP:0000874	irregular external granule cell layer	1	0.9999736	0.9979726	1	0.3225972	0.498173
MP:0000875	abnormal cerebellar Purkinje cell layer	225	1.517239e-197	1.269685e-148	1.943856e-30	9.395718e-103	0.03589483
MP:0000876	Purkinje cell degeneration	67	5.04901e-126	2.30455e-23	3.837816e-11	8.974739e-55	0.1418356
MP:0000877	abnormal Purkinje cell morphology	203	9.59515e-194	8.934667e-127	1.575369e-26	1.304128e-99	0.01218624
MP:0000878	abnormal Purkinje cell number	76	1.777739e-53	4.861247e-58	0.001066891	1.377256e-25	0.4706875
MP:0000879	increased Purkinje cell number	4	0.9387464	2.52485e-27	0.8479345	0.8214503	0.3047213
MP:0000880	decreased Purkinje cell number	73	4.736114e-55	8.843411e-42	0.001040757	3.341957e-26	0.5665275
MP:0000884	delaminated Purkinje cell layer	7	0.1343332	0.01501029	0.8296209	0.2385676	0.8354742
MP:0000885	ectopic Purkinje cell	35	6.750885e-32	1.414034e-40	0.0001058381	8.093414e-15	0.06888633
MP:0000886	abnormal cerebellar granule layer	116	6.027541e-53	5.118517e-66	4.223691e-19	3.545097e-29	0.08996925
MP:0000887	delaminated cerebellar granule layer	3	0.9999982	0.1532389	0.6522533	0.7713709	0.4682546
MP:0000888	absent cerebellar granule layer	3	2.766567e-14	0.2128126	0.6914764	0.0149145	0.6426656
MP:0000889	abnormal cerebellar molecular layer	58	7.666216e-20	1.398756e-26	0.009185859	1.777177e-08	0.8844534
MP:0000890	thin cerebellar molecular layer	28	3.042669e-17	1.088055e-16	0.09015723	5.241596e-05	0.3691596
MP:0000897	abnormal midbrain morphology	135	2.512076e-127	6.708857e-45	5.42655e-26	3.309714e-46	0.3665962
MP:0000898	midbrain hyperplasia	4	0.6707916	0.00873598	0.561349	0.08978265	0.1823539
MP:0000899	abnormal corpora quadrigemina morphology	32	7.077685e-37	4.025805e-46	1.462132e-07	7.747949e-08	0.9863384
MP:0000900	decreased colliculi size	1	0.03298418	1.97567e-05	0.06324652	0.5687689	1
MP:0000904	abnormal superior colliculus morphology	16	1.418654e-41	7.659382e-28	0.006162288	2.677549e-07	0.996454
MP:0000905	increased superior colliculus size	3	9.588056e-08	0.4515934	0.05815383	0.009391483	0.985344
MP:0000906	abnormal trigeminal V mesencephalic nucleus morphology	8	0.0002214515	1.740996e-12	0.2488833	0.03300071	0.4380734
MP:0000907	small mesencephalic trigeminal nucleus	2	1	7.101093e-07	0.9997038	0.9967379	0.8468146
MP:0000908	absent mesencephalic trigeminal nucleus	1	0.9982283	0.0001120899	0.5785484	0.000666837	0.001711476
MP:0000909	abnormal facial motor nucleus morphology	16	1.64721e-08	1.412407e-32	6.745693e-06	0.001844645	0.008861489
MP:0000910	small facial motor nucleus	5	0.32138	9.020683e-09	0.9321471	0.2446146	0.9226376
MP:0000911	abnormal trigeminal motor nucleus morphology	3	0.002548654	0.6303801	0.9985259	0.5218614	1
MP:0000912	small trigeminal motor nucleus	1	2.312105e-10	2.041394e-06	0.7446295	0.00407449	1
MP:0000913	abnormal brain development	697	0	0	5.007686e-172	0	0.009165184
MP:0000914	exencephaly	247	0	4.615625e-215	4.572959e-75	7.189682e-188	0.7831272
MP:0000917	obstructive hydrocephaly	6	6.719959e-20	4.775178e-06	0.001215299	8.608347e-07	0.4923691
MP:0000919	cranioschisis	9	1.731368e-05	9.050955e-09	9.030655e-06	0.0005114108	0.1076797
MP:0000920	abnormal myelination	182	7.97037e-179	5.067774e-107	4.568699e-91	1.354715e-160	3.709778e-07
MP:0000921	demyelination	89	2.886423e-81	1.110253e-61	1.339193e-49	3.837505e-85	7.211337e-05
MP:0000923	abnormal roof plate morphology	13	5.689846e-12	7.67502e-10	0.008432746	9.830811e-08	0.6687893
MP:0000924	absent roof plate	2	0.9198402	0.01435745	0.499006	0.001015047	0.03173351
MP:0000925	abnormal floor plate morphology	48	2.78126e-30	1.455495e-26	2.655498e-12	6.161442e-23	0.004141985
MP:0000926	absent floor plate	22	4.097775e-05	7.122876e-08	0.05052076	9.990646e-11	0.0621112
MP:0000927	small floor plate	3	0.01261834	0.000307181	8.48918e-09	0.0003697641	0.07454064
MP:0000928	incomplete cephalic closure	52	1.328407e-42	3.874451e-73	2.304823e-20	2.439412e-40	0.0009616483
MP:0000929	open neural tube	244	7.115991e-270	2.24509e-179	3.100036e-46	8.732519e-154	0.3777318
MP:0000930	wavy neural tube	40	1.878349e-61	8.793103e-38	2.940953e-24	6.350279e-53	0.009391103
MP:0000932	absent notochord	19	2.828931e-11	1.8265e-06	0.0002643235	0.0001747459	0.292265
MP:0000933	abnormal rhombomere morphology	25	8.7684e-24	5.854925e-35	0.001817154	9.051575e-16	0.6029232
MP:0000934	abnormal telencephalon development	143	1.766944e-210	8.209079e-122	3.035937e-26	3.313971e-79	0.09687719
MP:0000935	abnormal folding of telencephalic vesicles	6	1.009897e-05	1.819645e-23	0.5843483	9.683254e-05	0.9656823
MP:0000936	small embryonic telencephalon	22	6.755001e-58	1.605037e-25	2.551691e-09	1.676782e-21	0.3954154
MP:0000937	abnormal motor neuron morphology	168	2.028107e-136	3.148082e-108	1.257412e-23	2.290349e-60	0.0828893
MP:0000938	motor neuron degeneration	37	8.197828e-63	3.129169e-15	2.127958e-07	7.150125e-34	0.02526088
MP:0000939	decreased motor neuron number	77	1.608698e-66	3.368849e-75	3.290159e-09	3.403979e-23	0.06786724
MP:0000940	abnormal motor neuron innervation pattern	42	3.271549e-23	5.183571e-12	0.002317765	6.388782e-05	0.4577559
MP:0000947	convulsive seizures	154	5.813518e-70	1.668565e-89	9.685806e-41	8.56045e-64	0.002444943
MP:0000948	nonconvulsive seizures	42	9.401684e-23	7.458926e-37	0.7498191	2.082359e-06	0.1708675
MP:0000950	abnormal seizure response to pharmacological agent	115	2.41133e-51	5.892592e-31	1.05657e-06	1.199961e-08	0.02570775
MP:0000951	sporadic seizures	30	6.90555e-38	5.263028e-15	0.05421778	3.156136e-15	0.1594803
MP:0000952	abnormal CNS glial cell morphology	264	0	7.3366e-91	3.576719e-65	3.98399e-180	0.0001997224
MP:0000953	abnormal oligodendrocyte morphology	47	3.9629e-73	2.427737e-22	2.826834e-34	8.428747e-37	0.03778746
MP:0000954	decreased oligodendrocyte progenitor number	11	7.840763e-15	8.71266e-13	1.048845e-10	2.552975e-15	0.001149727
MP:0000955	abnormal spinal cord morphology	301	1.14949700000003e-312	1.367364e-163	9.464434e-53	2.046069e-136	0.1311165
MP:0000956	decreased spinal cord size	12	1.014231e-22	2.70514e-07	2.837857e-08	0.0001504814	0.6469962
MP:0000958	peripheral nervous system degeneration	10	0.0003912897	8.118458e-41	2.249677e-08	1.443232e-10	0.000259144
MP:0000959	abnormal somatic sensory system morphology	620	0	5.3852060053159e-316	5.330779e-97	1.866157e-211	1.348415e-07
MP:0000960	abnormal sensory ganglion morphology	219	5.121074e-224	5.489989e-134	3.515739e-44	1.069675e-80	0.01599912
MP:0000961	abnormal dorsal root ganglion morphology	120	8.148405e-122	1.046104e-88	1.622248e-26	1.228891e-51	0.007328211
MP:0000962	disorganized dorsal root ganglion	8	0.4864183	4.646151e-12	0.04348895	3.396934e-09	0.006076586
MP:0000963	fused dorsal root ganglion	12	1.596902e-28	2.848107e-11	7.545314e-07	3.72891e-06	0.6312137
MP:0000964	small dorsal root ganglion	28	9.526304e-17	4.322571e-12	0.0006153595	7.260596e-10	0.7804419
MP:0000965	abnormal sensory neuron morphology	516	2.35157099895196e-315	1.917237e-249	3.464657e-80	5.390306e-164	2.549074e-06
MP:0000966	decreased sensory neuron number	169	9.245088e-116	2.441109e-71	2.119723e-24	1.423755e-43	0.007567102
MP:0000968	abnormal sensory neuron innervation pattern	100	1.138686e-37	2.538854e-67	1.029463e-09	1.496434e-24	0.05129784
MP:0000969	abnormal nociceptor morphology	3	0.3415704	0.5140052	0.9870163	0.1742931	0.8328142
MP:0000972	abnormal mechanoreceptor morphology	191	6.430658e-152	6.308137e-101	1.930883e-28	6.93154e-69	9.938445e-05
MP:0000973	abnormal cutaneous/subcutaneous mechanoreceptor morphology	7	0.9999988	2.073114e-16	0.8356279	0.9885549	0.4753175
MP:0000980	absent hair-down neurons	1	0.9996953	0.008215793	1	0.999381	0.8122343
MP:0000982	abnormal Meissner's corpuscle morphology	2	0.9999998	0.3545795	0.7015452	0.922511	0.2456392
MP:0000985	abnormal Merkel's receptor morphology	1	1	4.892357e-05	1	0.999381	0.8122343
MP:0000988	abnormal pacinian corpuscle morphology	4	0.9911242	1.106927e-06	0.5607501	0.8409703	0.2958349
MP:0000992	absent primary muscle spindle	1	3.604828e-08	0.008359882	1	1	1
MP:0000995	absent secondary muscle spindle	1	3.604828e-08	0.008359882	1	1	1
MP:0000996	partial loss of secondary muscle spindle	1	3.604828e-08	0.008359882	1	1	1
MP:0000997	abnormal joint capsule morphology	5	3.50063e-10	1.062323e-05	1.340692e-07	6.606388e-11	0.09171136
MP:0001000	absent golgi tendon organ	2	1	2.38669e-05	0.907263	0.9967379	0.6495497
MP:0001001	abnormal chemoreceptor morphology	38	0.003636225	7.379388e-07	0.5020275	8.695656e-09	0.2740312
MP:0001003	abnormal olfactory receptor morphology	4	1.643604e-15	0.9954941	6.149382e-06	1.190314e-11	0.9471821
MP:0001004	abnormal retinal photoreceptor morphology	154	4.737066e-172	1.879278e-22	2.313074e-36	1.523806e-59	0.002608843
MP:0001005	abnormal retinal rod cell morphology	57	2.493236e-70	3.766095e-10	4.812739e-20	8.860012e-24	0.1416005
MP:0001006	abnormal retinal cone cell morphology	47	3.22931e-13	3.607772e-10	3.378031e-07	1.24625e-10	0.04982939
MP:0001007	abnormal sympathetic system morphology	50	3.25632e-16	2.919569e-31	0.0004890334	7.289114e-11	0.008163888
MP:0001008	abnormal sympathetic ganglion morphology	42	1.083342e-20	2.134209e-21	0.007343555	1.293001e-11	0.02421111
MP:0001009	paravertebral ganglia hyperplasia	1	7.349229e-05	0.2528496	0.02445157	0.5758676	1
MP:0001010	prevertebral ganglia hyperplasia	1	7.349229e-05	0.2528496	0.02445157	0.5758676	1
MP:0001011	abnormal superior cervical ganglion morphology	30	7.733134e-22	5.362182e-15	0.05989198	2.696284e-11	0.04313054
MP:0001013	enlarged superior cervical ganglion	1	0.9508384	0.0005358713	0.054902	9.077317e-05	0.498173
MP:0001014	absent superior cervical ganglion	3	0.03848777	0.06688502	0.9988592	0.938846	0.8875498
MP:0001015	small superior cervical ganglion	15	2.716922e-08	1.060712e-10	0.8592255	0.05965543	0.2325542
MP:0001017	abnormal stellate ganglion morphology	7	0.03788755	4.086738e-06	0.9153318	0.3230749	0.09782732
MP:0001019	abnormal L4 dorsal root ganglion morphology	7	7.614554e-09	5.872184e-12	0.9586039	0.9007577	0.8796493
MP:0001021	small L4 dorsal root ganglion	6	3.960474e-06	1.359331e-12	0.9987949	0.9920135	0.8546421
MP:0001022	abnormal L5 dorsal root ganglion morphology	7	1.865255e-15	2.480672e-10	0.8223758	0.004819095	0.7965521
MP:0001023	L5 dorsal root ganglion hypertrophy	1	0.8325764	0.2062409	0.9587492	0.006767628	0.3776528
MP:0001024	small L5 dorsal root ganglion	3	2.223791e-05	1.117572e-05	0.9350506	0.5201358	0.6959741
MP:0001025	abnormal sympathetic neuron morphology	15	6.246873e-10	1.386146e-20	0.0001238939	3.071203e-08	0.07444048
MP:0001026	abnormal adrenergic neuron morphology	2	0.9989528	3.153283e-08	0.5642112	0.6149029	0.6495497
MP:0001033	abnormal parasympathetic system morphology	14	0.09697671	0.001958564	0.9606042	0.04012809	0.858312
MP:0001034	abnormal parasympathetic ganglion morphology	11	0.8354655	0.04116525	0.9946727	0.5710485	0.7103814
MP:0001035	abnormal submandibular ganglion morphology	3	0.6277172	0.9644251	0.8244981	0.9077597	0.07393192
MP:0001036	small submandibular ganglion	2	0.057404	0.6188981	0.3238895	0.2953928	0.006168257
MP:0001037	abnormal parasympathetic neuron morphology	2	0.0006831628	0.5964396	0.2214405	0.1161562	0.1450565
MP:0001038	abnormal cholinergic neuron morphology	11	0.1564527	2.237127e-12	0.7074396	0.1804087	0.2860713
MP:0001044	abnormal enteric nervous system morphology	35	8.56166e-41	1.328133e-28	9.015458e-07	1.267119e-06	0.2246231
MP:0001045	abnormal enteric ganglia morphology	15	2.341274e-06	1.162404e-17	0.04849108	0.0002547784	0.04291604
MP:0001046	abnormal enteric neuron morphology	27	3.229035e-16	5.692531e-38	2.722736e-05	4.671664e-05	0.479687
MP:0001047	abnormal enteric cholinergic neuron morphology	1	0.9005029	0.813613	1	0.746	1
MP:0001048	absent enteric neurons	8	0.1450336	4.255922e-13	0.2766673	0.01767365	0.1472275
MP:0001051	abnormal somatic motor system morphology	81	2.516277e-52	4.885055e-55	2.707752e-19	2.901821e-26	0.2306197
MP:0001052	abnormal innervation pattern to muscle	40	1.308469e-33	7.934837e-40	0.01882196	3.336208e-08	0.4972261
MP:0001053	abnormal neuromuscular synapse morphology	76	1.068639e-51	6.615113e-46	1.888794e-18	6.321496e-26	0.1332677
MP:0001054	failure of neuromuscular synapse presynaptic differentiation	6	0.412169	4.86791e-05	0.021742	0.02609088	0.7039136
MP:0001055	failure of neuromuscular synapse postsynaptic differentiation	5	6.259932e-05	0.004383399	0.0008724185	0.0003079687	0.8788108
MP:0001056	abnormal cranial nerve morphology	209	3.894592e-93	6.044217e-142	4.100348e-34	1.500956e-60	0.0005768706
MP:0001059	optic nerve atrophy	10	2.363364e-12	0.6162194	5.504159e-05	0.001510886	0.1147723
MP:0001061	abnormal oculomotor nerve morphology	13	1.586857e-06	6.346595e-13	6.781851e-15	5.327079e-07	0.3117192
MP:0001062	absent oculomotor nerve	5	5.570595e-05	3.704514e-11	1.113732e-09	0.002146633	0.5872683
MP:0001063	abnormal trochlear nerve morphology	14	0.009509214	1.736866e-08	1.11125e-13	0.0003344535	0.298633
MP:0001064	absent trochlear nerve	5	0.0001660866	5.736007e-08	1.249804e-13	0.0001146636	0.693793
MP:0001065	abnormal trigeminal nerve morphology	37	4.471758e-10	2.5794e-29	2.66336e-13	2.996708e-12	0.03153271
MP:0001066	absent trigeminal nerve	3	0.9999832	0.1860133	0.07326328	0.420516	0.3777268
MP:0001067	absent mandibular nerve	1	0.9930732	0.3150907	0.001040567	0.2108217	0.02789339
MP:0001068	abnormal mandibular nerve branching	5	0.01444613	7.783433e-05	2.0645e-06	0.003245844	0.01628514
MP:0001069	absent trigeminal nerve connections to hindbrain	2	0.1157127	0.06111021	0.00351385	0.3584303	0.04775866
MP:0001070	abnormal abducens nerve morphology	3	6.646645e-11	0.1649656	0.02321354	0.0002251324	0.6647319
MP:0001071	abnormal facial nerve morphology	28	2.752145e-19	5.492498e-35	5.366629e-14	1.437043e-08	0.003932878
MP:0001072	abnormal vestibulocochlear nerve morphology	19	1.743538e-06	9.589026e-22	0.03195679	0.2072705	0.5475607
MP:0001073	abnormal glossopharyngeal nerve morphology	22	6.481457e-10	5.592371e-29	7.054494e-07	2.10454e-09	0.2720862
MP:0001074	abnormal vagus nerve morphology	23	5.342905e-08	1.03178e-23	5.804943e-08	1.099601e-09	0.1124518
MP:0001075	abnormal accessory nerve morphology	4	1.421386e-05	0.1610587	0.6555205	0.007762865	0.8776965
MP:0001076	abnormal hypoglossal nerve morphology	15	6.116929e-20	4.237804e-14	2.055944e-07	5.110406e-09	0.1725915
MP:0001077	abnormal spinal nerve morphology	110	1.014537e-119	9.378601e-85	7.905875e-30	2.523504e-40	5.915816e-06
MP:0001078	abnormal phrenic nerve morphology	29	5.039151e-29	1.693034e-14	1.447162e-14	2.553612e-14	0.1299719
MP:0001079	absent phrenic nerve	1	0.913736	1.555618e-08	0.8814681	0.7435166	0.5844193
MP:0001080	defasiculated phrenic nerve	2	0.1157127	0.06111021	0.00351385	0.3584303	0.04775866
MP:0001081	abnormal cranial ganglia morphology	142	2.499671e-88	2.261248e-91	1.158862e-12	3.17247e-31	0.3980634
MP:0001082	abnormal geniculate ganglion morphology	21	0.07231017	2.041234e-08	0.3032121	0.2891688	0.7529269
MP:0001083	small geniculate ganglion	12	0.7822798	1.26225e-12	0.2372017	0.1070577	0.5929475
MP:0001084	abnormal petrosal ganglion morphology	17	0.8389074	1.174717e-09	0.839538	0.2382888	0.2435119
MP:0001085	small petrosal ganglion	12	0.6365173	1.457294e-13	0.7223442	0.08256157	0.09304869
MP:0001086	absent petrosal ganglion	4	1	0.9187501	0.794755	0.8619986	0.885617
MP:0001087	abnormal nodose ganglion morphology	13	0.8998301	3.329803e-11	0.7714756	0.1881273	0.2038119
MP:0001088	small nodose ganglion	11	0.3577478	2.4885e-09	0.8479184	0.1967434	0.1169674
MP:0001089	absent nodose ganglion	1	0.1508481	0.2276447	0.2321885	0.3815255	1
MP:0001092	abnormal trigeminal ganglion morphology	50	2.33138e-29	1.43602e-44	0.001481683	4.299541e-18	0.9831431
MP:0001093	small trigeminal ganglion	19	0.9977515	3.954788e-23	0.2130444	6.410939e-05	0.9152967
MP:0001095	enlarged trigeminal ganglion	2	4.38986e-17	0.6443396	1.070476e-08	2.394332e-09	1
MP:0001096	abnormal glossopharyngeal ganglion morphology	31	0.6305463	4.666253e-28	0.1399333	0.0006066952	0.7218117
MP:0001097	abnormal superior glossopharyngeal ganglion morphology	3	0.6147174	1.173455e-11	0.4747911	0.2121712	0.6779762
MP:0001098	small superior glossopharyngeal ganglion	1	0.3285139	2.86898e-05	0.3651411	0.2022989	1
MP:0001100	abnormal vagus ganglion morphology	27	3.838239e-06	2.409918e-26	0.00142983	0.00199872	0.4897
MP:0001101	abnormal superior vagus ganglion morphology	5	0.2840886	5.867512e-11	0.02885301	0.1784285	0.1828807
MP:0001102	small superior vagus ganglion	2	7.841881e-05	1.034001e-06	0.5340907	0.4049449	1
MP:0001106	abnormal Schwann cell morphology	48	2.00804e-21	2.454657e-38	1.974053e-07	4.126491e-18	0.2400302
MP:0001107	decreased Schwann cell number	15	0.003856493	1.297023e-12	0.061112	0.05005848	0.3811138
MP:0001108	absent Schwann cells	4	0.6308174	0.3402826	0.0538152	0.06653562	0.3555479
MP:0001109	absent Schwann cell precursors	3	7.513538e-20	0.03544184	0.0002430343	1.108132e-05	0.5841112
MP:0001116	small gonad	448	0	5.499173e-75	1.174973e-88	5.259837e-165	1.486707e-05
MP:0001117	absent gametes	169	9.010209e-235	4.408315e-32	1.454376e-36	3.090569e-87	0.001293593
MP:0001119	abnormal female reproductive system morphology	387	0	5.788483e-169	3.402803e-86	1.839707e-181	1.776805e-06
MP:0001120	abnormal uterus morphology	171	1.780738e-86	1.896475e-125	4.44263e-45	1.131417e-75	8.535229e-05
MP:0001121	uterus hypoplasia	19	7.716143e-06	1.107442e-17	2.265865e-05	2.207605e-06	0.4953624
MP:0001123	dilated uterus	12	0.04034102	2.4606e-05	2.964296e-10	0.003128441	0.001848456
MP:0001124	abnormal gametes	419	0	2.91356e-66	6.653761e-67	3.579553e-173	3.103035e-05
MP:0001125	abnormal oocyte morphology	96	1.470772e-135	4.04458e-10	1.733341e-19	2.455926e-39	0.001758427
MP:0001126	abnormal ovary morphology	270	1.240609e-217	7.975135e-80	2.006123e-38	7.175757e-93	5.060064e-05
MP:0001127	small ovary	122	6.716098e-98	3.072773e-21	7.91002e-19	3.07925e-29	0.001202506
MP:0001128	ovary hyperplasia	5	4.362021e-11	0.012651	0.1029907	0.08488834	0.192029
MP:0001129	impaired ovarian folliculogenesis	42	5.632491e-19	3.462958e-10	2.491356e-08	2.838498e-06	0.003981119
MP:0001130	abnormal ovarian folliculogenesis	95	2.557928e-47	4.595161e-20	2.515569e-25	4.084231e-23	0.008598522
MP:0001131	abnormal ovarian follicle morphology	190	1.477128e-159	1.028952e-43	3.438251e-35	1.358346e-62	3.960622e-07
MP:0001132	absent mature ovarian follicles	30	8.963504e-18	6.350772e-12	6.459971e-13	2.748145e-07	0.1790354
MP:0001133	impaired luteal cell differentiation	2	0.3270549	2.919392e-06	0.01011596	0.002528619	0.004397632
MP:0001134	absent corpus luteum	60	5.914614e-44	3.166853e-14	1.830084e-19	6.081191e-21	3.033646e-05
MP:0001135	abnormal uterine cervix morphology	13	8.001175e-06	5.703413e-08	0.004214164	0.007215364	0.007499447
MP:0001136	dilated uterine cervix	4	7.654968e-08	2.884364e-16	2.589101e-05	6.714757e-06	0.1983861
MP:0001137	abnormal uterine cervix epithelium morphology	4	3.700245e-08	0.04028582	0.4404184	0.6057629	0.330742
MP:0001138	abnormal uterine cervix squamous epithelium morphology	3	1.361412e-17	0.1711196	0.03756753	0.05450158	0.6255765
MP:0001139	abnormal vagina morphology	65	8.892477e-25	8.028746e-72	4.586516e-24	1.268414e-31	0.003409604
MP:0001140	abnormal vagina epithelium morphology	10	0.0003524266	5.608234e-07	0.0008218037	4.191152e-05	0.05729117
MP:0001142	abnormal vagina orifice morphology	40	9.172688e-16	7.299282e-55	1.427502e-21	1.694125e-16	0.004794933
MP:0001143	constricted vagina orifice	6	2.514867e-14	0.5836771	0.001738848	0.003306757	0.5832428
MP:0001144	vagina atresia	26	4.833324e-16	5.879593e-31	2.188984e-21	2.455928e-22	0.03055903
MP:0001146	abnormal testis morphology	542	0	6.253156e-139	4.349127e-91	4.135534e-217	0.0001583779
MP:0001147	small testis	407	0	1.976766e-67	4.151596e-71	3.0514e-146	1.00046e-05
MP:0001148	enlarged testis	68	1.120549e-31	4.396075e-32	5.302322e-18	1.112346e-16	0.3999989
MP:0001149	testicular hyperplasia	42	3.209663e-40	2.525589e-10	1.891198e-09	3.831305e-14	0.08853241
MP:0001152	Leydig cell hyperplasia	40	1.049764e-40	3.234704e-09	1.513638e-07	5.884152e-13	0.03891517
MP:0001153	small seminiferous tubules	84	1.108724e-89	4.323546e-14	2.364865e-21	4.51905e-50	0.07513918
MP:0001154	seminiferous tubule degeneration	80	7.446837e-108	2.131745e-18	7.472583e-16	2.774676e-52	0.4218578
MP:0001155	arrest of spermatogenesis	165	2.630275e-166	2.484288e-22	1.853241e-25	1.041029e-46	0.03663945
MP:0001156	abnormal spermatogenesis	541	0	4.123002e-104	1.154234e-99	3.837069e-233	3.060965e-05
MP:0001157	small seminal vesicle	53	1.554226e-53	4.741759e-08	1.43943e-05	1.128709e-14	0.05307161
MP:0001158	abnormal prostate gland morphology	73	1.826079e-77	4.146481e-34	2.885428e-08	1.049222e-28	0.2596783
MP:0001159	absent prostate gland	5	0.8910194	2.597457e-05	0.977078	0.6670339	0.06997764
MP:0001163	abnormal prostate gland anterior lobe morphology	19	0.002148258	1.386695e-09	0.01351653	6.417067e-09	0.1871823
MP:0001167	prostate gland epithelial hyperplasia	9	3.106132e-30	0.0002445989	3.581465e-08	9.96693e-17	0.3771083
MP:0001168	abnormal prostate gland epithelium morphology	24	7.720758e-55	3.40225e-06	1.520729e-08	4.770549e-24	0.3326312
MP:0001169	abnormal bulbourethral gland morphology	10	6.501542e-10	5.327092e-16	0.08442575	4.295286e-05	0.04534062
MP:0001170	bulbourethral gland hyperplasia	2	0.005587811	0.001255344	0.9942398	0.007900753	0.6263249
MP:0001175	abnormal lung morphology	543	0	0	1.391942e-178	0	0.002875036
MP:0001176	abnormal lung development	155	1.078585e-126	1.617396e-213	4.776685e-43	5.885269e-79	0.6483721
MP:0001177	atelectasis	107	8.237682e-83	7.021625e-94	9.95678e-43	1.33017e-69	0.05013068
MP:0001178	pulmonary hypoplasia	56	1.547909e-07	3.05656e-81	0.1725679	1.407433e-08	0.2566639
MP:0001179	thick pulmonary interalveolar septum	44	6.313235e-36	4.64009e-44	8.883971e-26	6.425035e-36	0.6937793
MP:0001181	absent lungs	10	0.9873087	8.66294e-23	0.9832383	0.9676357	0.3618081
MP:0001182	lung hemorrhage	51	7.358999e-55	1.869118e-50	1.672954e-07	6.385613e-38	0.01175191
MP:0001183	overexpanded pulmonary alveoli	40	1.318997e-40	1.096323e-34	7.937156e-23	4.092801e-40	0.9634441
MP:0001184	absent pulmonary alveoli	5	1.271293e-22	1.627449e-07	0.1369816	2.021887e-05	0.9336195
MP:0001186	pigmentation phenotype	360	1.26046599991476e-314	5.612188e-164	1.999944e-99	1.337404e-171	0.000138989
MP:0001188	hyperpigmentation	27	7.821586e-18	1.025136e-10	7.679078e-13	4.948484e-09	0.9099145
MP:0001189	absent skin pigmentation	8	0.07077559	3.066476e-07	0.1537065	0.03669074	0.08312143
MP:0001190	reddish skin	42	8.825528e-78	1.82059e-05	1.963991e-19	6.434039e-39	0.3008642
MP:0001191	abnormal skin condition	294	0	6.428748e-143	2.624823e-123	1.507296e-270	0.005480932
MP:0001192	scaly skin	68	1.218787e-159	3.379791e-15	6.373036e-39	6.094843e-52	0.3789308
MP:0001193	psoriasis	8	6.44452e-44	2.287601e-15	6.064877e-06	2.944732e-27	0.008529776
MP:0001194	dermatitis	86	4.37867e-132	2.16919e-18	1.952354e-55	2.003113e-99	0.0009665978
MP:0001195	flaky skin	27	0.006377105	9.277354e-25	9.397415e-15	2.891787e-11	0.7360463
MP:0001196	shiny skin	35	9.566921e-63	1.128954e-06	2.151425e-12	1.548195e-15	0.7879217
MP:0001197	oily skin	2	2.853206e-06	0.2377864	0.0005992672	0.2735226	0.01019838
MP:0001198	tight skin	16	1.213509e-19	0.0002710203	8.202011e-17	6.914188e-14	0.3165032
MP:0001199	thin skin	45	2.796411e-46	3.120544e-37	3.713759e-09	1.35275e-32	0.1870062
MP:0001200	thick skin	42	4.750902e-98	5.276299e-11	6.65384e-24	5.819044e-31	0.897253
MP:0001201	translucent skin	20	4.683938e-65	2.63005e-13	2.688856e-06	1.124108e-18	0.1028184
MP:0001202	skin photosensitivity	7	1.25053e-26	0.703481	0.0512203	1.328735e-09	0.7344707
MP:0001203	increased sensitivity to skin irradiation	11	2.168042e-23	0.04294697	3.200844e-06	6.39056e-22	0.9817279
MP:0001204	decreased sensitivity to skin irradiation	6	6.683276e-23	0.0001234178	1.368194e-08	3.907188e-25	0.2971403
MP:0001208	blistering	30	1.344177e-19	1.223441e-32	0.02491931	4.445602e-06	0.3931304
MP:0001209	spontaneous skin ulceration	40	4.624014e-105	2.765567e-17	1.276173e-26	2.614469e-47	0.4691641
MP:0001210	skin ridges	1	0.006032635	0.2305501	0.008981698	0.1282527	0.2355317
MP:0001211	wrinkled skin	33	9.822287e-62	2.56526e-05	4.257225e-11	8.798841e-21	0.4768653
MP:0001212	skin lesions	121	6.813892e-184	2.877099e-34	1.855652e-45	1.498151e-84	0.1263988
MP:0001213	abnormal skin cell number	8	1.375989e-26	0.003761545	6.194501e-08	9.383341e-14	0.4593396
MP:0001214	skin hyperplasia	5	4.014023e-14	0.0003607936	7.907422e-06	3.268082e-09	0.4129101
MP:0001215	skin hypoplasia	2	4.435e-07	0.2229724	0.7624037	0.0003909841	0.4466443
MP:0001216	abnormal epidermal layer morphology	313	0	9.167802e-139	3.318539e-144	7.157828e-248	0.003037859
MP:0001217	absent epidermis	2	0.9999999	0.1221963	1	0.9990792	0.3484813
MP:0001218	thin epidermis	43	1.935662e-53	9.279064e-40	1.267344e-17	2.08834e-22	0.06996507
MP:0001219	thick epidermis	97	1.590932e-212	1.416849e-61	1.675376e-64	8.385615e-85	0.14634
MP:0001220	epidermal necrosis	3	0.0002687765	0.0355198	4.494017e-05	9.934181e-07	0.6968545
MP:0001221	epidermal atrophy	5	1.506854e-05	5.948604e-22	0.02367403	0.1722229	0.7349902
MP:0001222	epidermal hyperplasia	89	7.277581e-203	2.05515e-43	1.600516e-39	3.694124e-98	0.09922738
MP:0001224	abnormal keratinocyte apoptosis	22	6.192625e-68	0.09394213	4.72496e-12	1.970686e-25	0.7734596
MP:0001230	epidermal desquamation	13	0.05362522	0.2499654	0.5465424	0.96462	0.7070504
MP:0001231	abnormal epidermis stratum basale morphology	48	2.012828e-63	4.126983e-41	2.911504e-30	1.845681e-32	0.1180504
MP:0001232	absent epidermis stratum basale	1	3.949584e-14	0.01182993	0.893487	6.777054e-08	1
MP:0001233	abnormal epidermis suprabasal layer morphology	22	5.8249e-72	5.185539e-11	3.844845e-12	2.913637e-20	0.03535425
MP:0001234	absent suprabasal layer	2	1.668217e-14	0.8007342	0.02481746	0.0002517069	1
MP:0001235	disorganized suprabasal layer	2	0.02427591	1.832982e-05	0.06762892	0.4231812	0.1530846
MP:0001236	abnormal epidermis stratum spinosum morphology	71	2.18251e-100	1.693191e-25	1.240121e-29	1.09403e-33	0.6479725
MP:0001237	enlarged spinous cells	3	7.235429e-11	7.433095e-08	0.1374247	0.05784791	1
MP:0001238	thin epidermis stratum spinosum	7	5.977785e-16	2.422725e-05	9.268082e-07	0.0001404013	0.02650147
MP:0001239	abnormal epidermis stratum granulosum morphology	66	3.656646e-84	1.605211e-46	1.150358e-30	6.965634e-48	0.3680403
MP:0001240	abnormal epidermis stratum corneum morphology	154	6.249267e-231	2.054575e-83	3.378691e-52	2.061553e-112	0.1632392
MP:0001241	absent epidermis stratum corneum	11	6.510323e-19	1.488292e-09	7.361118e-06	1.69967e-12	0.3784712
MP:0001242	hyperkeratosis	116	4.526204e-182	3.293065e-53	7.203756e-42	3.604524e-94	0.1638747
MP:0001243	abnormal dermal layer morphology	98	7.290712e-189	3.12992e-53	3.485149e-20	2.684636e-49	0.2028882
MP:0001244	thin dermal layer	25	3.215991e-21	2.327951e-32	0.09426502	2.28948e-06	0.09663327
MP:0001245	thick dermal layer	22	1.317581e-48	1.126037e-13	2.821401e-11	3.818601e-17	0.8095573
MP:0001246	mixed cellular infiltration to dermis	21	2.248259e-65	0.008358801	1.234262e-08	3.88761e-17	0.4967394
MP:0001247	dermal cysts	10	1.02204e-54	4.544543e-10	2.238697e-09	1.567255e-11	0.7966333
MP:0001255	decreased body height	20	1.854095e-31	1.241076e-17	5.778256e-17	4.210816e-17	0.8367785
MP:0001256	abnormal body length	242	0	4.586857e-142	4.743916e-60	5.663969e-129	0.01190881
MP:0001257	increased body length	37	1.299372e-18	9.413799e-27	1.39228e-12	2.211754e-08	0.1734214
MP:0001258	decreased body length	213	0	4.391939e-127	4.550136e-55	1.006968e-126	0.02770255
MP:0001259	abnormal body weight	1847	0	0	0	0	6.509967e-19
MP:0001260	increased body weight	272	1.069371e-169	9.358588e-49	2.90732e-57	4.318333e-94	0.00131895
MP:0001261	obese	83	1.737234e-63	2.734842e-15	2.530149e-16	6.391203e-26	0.09182003
MP:0001262	decreased body weight	1587	0	0	0	0	2.914077e-16
MP:0001263	weight loss	382	0	2.088846e-166	3.446766e-153	1.778337e-258	2.419148e-09
MP:0001264	increased body size	284	4.38571e-167	1.482915e-69	6.324218e-63	9.118776e-98	0.002118124
MP:0001265	decreased body size	2047	0	0	0	0	1.599066e-18
MP:0001267	enlarged chest	5	0.002995748	0.4183098	0.0001149263	0.01039878	0.9966843
MP:0001268	barrel chest	3	1	0.009879218	0.9823153	0.6698229	0.9354399
MP:0001270	distended abdomen	90	2.073364e-53	2.815197e-74	3.355656e-18	1.617675e-33	0.09137031
MP:0001272	increased metastatic potential	66	3.541862e-140	2.750542e-15	3.315194e-47	7.577464e-66	1.474787e-06
MP:0001273	decreased metastatic potential	50	1.019864e-39	9.123409e-35	7.052284e-32	2.254094e-92	0.007320029
MP:0001274	curly vibrissae	24	4.4309e-19	1.457858e-16	1.548091e-06	2.812688e-14	0.02134051
MP:0001278	kinked vibrissae	5	3.514088e-17	0.01323266	0.001193411	7.15113e-18	0.05051492
MP:0001279	wavy vibrissae	9	3.02357e-13	1.010347e-08	0.002210402	8.377631e-12	0.3025563
MP:0001280	loss of vibrissae	5	0.002195109	3.850956e-18	3.108691e-05	0.04036744	0.04946367
MP:0001281	increased vibrissae length	1	0.9412582	0.5246082	0.5526167	0.8958141	0.3343108
MP:0001282	short vibrissae	18	4.414568e-21	6.333453e-11	5.716564e-08	5.334775e-13	0.9945923
MP:0001283	sparse vibrissae	6	1.68871e-21	1.157132e-08	1.248015e-13	2.263005e-07	0.9728527
MP:0001284	absent vibrissae	27	3.839523e-13	1.596387e-14	4.162724e-06	0.04684704	0.05091643
MP:0001286	abnormal eye development	263	1.463447e-217	3.26608e-279	5.813897e-62	3.879929e-134	0.09134277
MP:0001288	abnormal lens induction	22	1.841362e-05	2.868757e-27	0.001285792	9.974678e-11	0.259074
MP:0001289	persistence of hyaloid vascular system	23	9.476105e-43	8.543229e-41	2.304873e-12	6.392384e-21	0.0005806848
MP:0001290	delayed eyelid opening	31	8.432607e-05	1.007154e-57	0.0001796925	1.606305e-06	0.1561498
MP:0001292	abnormal lens vesicle development	16	0.04053531	4.264995e-20	0.02458754	1.711562e-05	0.1620316
MP:0001293	anophthalmia	75	2.939517e-32	1.351025e-69	5.388523e-07	2.197905e-29	0.4506179
MP:0001296	macrophthalmia	11	0.000234233	1.525125e-16	9.22389e-08	1.708155e-07	0.01931899
MP:0001297	microphthalmia	153	2.094309e-119	6.477949e-180	7.609419e-24	8.987544e-76	0.3748835
MP:0001299	abnormal eye distance/ position	63	5.368307e-63	1.457118e-71	2.203734e-30	9.012111e-38	0.01613051
MP:0001300	ocular hypertelorism	24	2.834174e-42	1.754816e-37	2.850284e-19	4.62099e-15	0.1766207
MP:0001302	eyelids open at birth	81	2.958281e-51	4.28216e-105	8.165554e-18	9.395547e-30	0.02791429
MP:0001303	abnormal lens morphology	227	5.100097e-204	3.850468e-163	2.095524e-64	9.240501e-136	7.463224e-05
MP:0001304	cataracts	139	2.973355e-125	5.886937e-60	3.253855e-53	1.699103e-91	3.046786e-06
MP:0001306	small lens	52	2.415824e-41	6.770219e-34	1.932233e-07	9.172689e-22	0.1613032
MP:0001307	fused cornea and lens	7	0.5962455	3.817112e-14	0.009243532	0.0002834618	0.1834586
MP:0001308	abnormal lens polarity	6	9.796937e-12	1.825951e-06	5.305517e-11	0.0009035791	0.7498746
MP:0001309	hydropic eye lens fibers	3	0.01028851	0.4403675	0.01162861	5.035444e-05	0.5324138
MP:0001310	abnormal conjunctiva morphology	37	2.485617e-28	3.639749e-22	6.933922e-20	1.624511e-24	0.4771008
MP:0001312	abnormal cornea morphology	162	1.016281e-160	2.941315e-137	4.952984e-62	2.226506e-73	0.005735112
MP:0001313	increased incidence of corneal inflammation	16	2.144101e-67	9.887764e-15	2.507963e-19	5.253656e-31	0.6810867
MP:0001314	corneal opacity	70	9.351574e-59	3.443757e-48	2.967586e-21	1.562439e-23	0.1629023
MP:0001316	corneal scarring	5	2.246872e-26	6.229398e-11	2.73279e-09	0.002732341	0.7063934
MP:0001317	abnormal pupil morphology	59	7.961178e-22	3.40613e-41	1.160324e-17	1.761936e-20	0.03514959
MP:0001318	pupil opacity	1	0.1628608	0.03431722	0.002937057	0.1408839	0.2521755
MP:0001319	irregularly shaped pupil	10	0.9411298	6.195617e-24	0.4169216	0.09164346	0.6007119
MP:0001320	small pupils	4	0.9156208	0.0005555552	0.01229115	0.2720619	0.009069829
MP:0001322	abnormal iris morphology	113	4.327785e-33	1.649387e-81	3.242022e-36	2.123665e-35	0.009774503
MP:0001324	abnormal eye pigmentation	159	1.673643e-108	1.792686e-60	1.509277e-38	2.654991e-52	0.1322685
MP:0001325	abnormal retina morphology	523	0	6.096354e-286	9.519066e-136	2.401381e-253	0.0002600678
MP:0001326	retinal degeneration	95	2.067121e-121	7.717573e-32	2.547855e-28	1.580393e-56	0.003125298
MP:0001327	decreased retinal photoreceptor cell number	64	4.748712e-60	1.124586e-09	2.260546e-15	1.619225e-20	0.1180752
MP:0001328	disorganized retinal layers	14	8.122581e-18	1.743781e-16	5.6751e-05	0.002611942	0.3823222
MP:0001329	retina hyperplasia	9	0.8713363	1.182678e-18	0.0006527702	0.0001452902	0.6597817
MP:0001330	abnormal optic nerve morphology	102	8.251038e-41	2.112821e-61	1.681635e-10	3.328133e-27	0.01602255
MP:0001332	abnormal optic nerve innervation	12	0.09824552	0.0006038844	0.9876828	0.9423759	0.7760968
MP:0001333	absent optic nerve	14	1.030871e-09	5.891688e-11	0.1159847	8.127797e-06	0.03228819
MP:0001334	absent optic tract	2	0.1868463	0.01451986	0.813415	0.5906826	0.06709159
MP:0001337	dry eyes	13	8.580133e-30	9.019319e-24	5.975831e-25	5.661701e-12	0.1955019
MP:0001340	abnormal eyelid morphology	242	7.274324e-182	2.068893e-236	1.386706e-68	3.256763e-100	0.001340561
MP:0001341	absent eyelids	18	1.826043e-17	2.172696e-64	0.0002201694	0.1384552	0.1981924
MP:0001344	blepharoptosis	23	2.119102e-20	1.796994e-17	1.974472e-08	1.695424e-11	0.03001953
MP:0001345	meibomian gland atrophy	5	2.328837e-12	4.005503e-05	0.001679948	2.449478e-07	0.8975072
MP:0001346	abnormal lacrimal gland morphology	26	4.108863e-19	1.17684e-33	2.407675e-09	9.539427e-29	0.49634
MP:0001347	absent lacrimal glands	9	4.462474e-08	8.252337e-25	0.100374	2.48112e-11	0.8806449
MP:0001348	abnormal lacrimal gland physiology	19	7.63518e-11	6.249756e-32	2.348954e-24	1.847237e-21	0.2311954
MP:0001349	excessive tearing	6	1.043414e-07	3.371393e-13	0.1831689	0.00069827	0.9852925
MP:0001353	increased aggression towards mice	34	1.680779e-09	0.01234547	0.02590007	0.01026919	0.3508782
MP:0001354	increased aggression towards males	15	0.0007823937	0.003032937	0.003007203	0.0003188816	0.8254236
MP:0001355	submission towards male mice	3	7.987661e-32	0.003942877	1	1.501187e-05	0.7057445
MP:0001356	increased aggression towards females	5	0.9073804	0.02798671	0.1886778	0.7227987	0.3670684
MP:0001357	increased aggression toward humans	5	0.683419	0.06743782	0.3552297	0.0004424563	0.009587563
MP:0001360	abnormal social investigation	71	9.864443e-43	3.47076e-11	0.2439059	4.493599e-07	0.8957416
MP:0001361	social withdrawal	16	4.25305e-15	0.5675403	0.981164	0.004494272	0.8475032
MP:0001362	abnormal anxiety-related response	249	1.019024e-84	3.2129e-47	1.271391e-14	1.306762e-43	0.7662793
MP:0001363	increased anxiety-related response	165	1.935919e-47	4.392262e-34	2.201956e-06	7.353156e-23	0.5750529
MP:0001364	decreased anxiety-related response	98	7.425435e-37	2.135837e-20	2.823582e-13	8.76029e-18	0.395172
MP:0001375	abnormal mating preference	4	0.06346444	5.650621e-11	0.5627801	0.1796529	0.9605696
MP:0001376	abnormal mating receptivity	6	0.9996992	1.370029e-05	0.0003021312	0.02315762	0.008268995
MP:0001377	abnormal mating frequency	31	8.988827e-12	4.177198e-07	1.335391e-12	8.564529e-06	0.3239496
MP:0001378	abnormal ejaculation	11	0.003721142	0.00015535	0.1378155	0.01153727	0.3382876
MP:0001379	abnormal penile erection	13	2.403074e-26	3.598362e-06	7.528215e-14	0.0001057155	0.0759529
MP:0001380	reduced male mating frequency	19	6.694673e-13	0.0004548733	9.637391e-05	0.02490263	0.4095551
MP:0001382	abnormal nursing	39	3.350336e-20	7.506637e-47	1.104611e-11	1.612599e-16	0.004757341
MP:0001384	abnormal pup retrieval	19	0.0004238316	5.866618e-11	6.960094e-09	2.902145e-05	0.2645496
MP:0001385	pup cannibalization	20	3.029285e-08	8.792404e-21	2.654427e-07	0.00189239	0.4195384
MP:0001386	abnormal maternal nurturing	124	1.910079e-42	1.970669e-77	1.039064e-28	2.276745e-34	0.02443969
MP:0001388	abnormal stationary movement	186	4.381818e-120	5.918551e-76	2.689624e-22	7.338572e-59	0.001254846
MP:0001389	abnormal eye movement	4	0.04164319	0.9828754	0.8649382	0.2979238	0.9897715
MP:0001391	abnormal tail movements	32	2.563675e-34	1.237883e-17	7.825385e-12	8.974062e-16	0.05525413
MP:0001392	abnormal locomotor behavior	1229	0	0	5.595283e-206	0	3.058736e-05
MP:0001393	ataxia	290	1.76488e-218	1.16386e-173	6.681221e-47	1.734451e-112	0.1173214
MP:0001394	circling	108	8.687865e-65	9.337097e-64	3.082968e-08	2.483098e-26	0.2198482
MP:0001395	bidirectional circling	22	8.792051e-15	2.968037e-12	2.211321e-05	8.370133e-13	0.1696399
MP:0001396	unidirectional circling	11	2.034257e-13	9.494316e-10	0.176548	0.2495895	0.982563
MP:0001399	hyperactivity	329	1.231501e-228	1.898945e-92	1.464445e-35	2.373441e-83	0.6916406
MP:0001400	hyperresponsive	6	0.9998661	0.9999999	0.9999963	0.9986276	0.9095289
MP:0001401	jumpy	5	0.1812339	0.0001316822	0.7883581	0.9891899	0.9829127
MP:0001402	hypoactivity	387	1.123283e-255	1.030567e-208	1.565111e-79	1.736409e-135	0.0005889013
MP:0001404	no spontaneous movement	28	1.259897e-15	7.74912e-17	0.002766856	1.4543e-20	0.08850393
MP:0001405	impaired coordination	372	0	1.157883e-166	4.982717e-46	3.393546e-134	0.1144489
MP:0001406	abnormal gait	339	3.392314e-214	1.268699e-144	1.205072e-31	4.256658e-114	0.05104405
MP:0001407	short stride length	57	4.701107e-21	9.990878e-19	0.0002737683	7.779821e-15	0.3127072
MP:0001408	stereotypic behavior	176	4.497045e-123	2.022154e-67	1.337638e-17	3.452203e-48	0.3015378
MP:0001409	increased stereotypic behavior	28	1.358954e-23	8.048368e-08	0.01990096	7.987001e-07	0.6067534
MP:0001410	head bobbing	42	5.877276e-14	1.214067e-29	1.80266e-08	1.746049e-07	0.006810408
MP:0001411	spinning	11	4.869297e-12	2.7015e-18	5.109334e-07	6.493516e-08	0.04200426
MP:0001412	excessive scratching	18	4.65628e-11	0.105574	3.392568e-07	1.296516e-07	0.98902
MP:0001413	abnormal response to new environment	160	1.858397e-97	2.18741e-39	1.049435e-10	3.963117e-44	0.4023916
MP:0001415	increased exploration in new environment	34	6.145553e-08	6.107785e-08	0.9346441	0.01533345	0.7419813
MP:0001417	decreased exploration in new environment	91	7.062359e-46	7.370398e-29	6.376448e-08	3.26123e-23	0.8972323
MP:0001422	abnormal drinking behavior	129	2.581688e-126	3.086309e-39	1.141152e-28	3.129792e-49	0.01016346
MP:0001423	abnormal liquid preference	25	1.487029e-25	3.206155e-09	0.002275739	2.932672e-10	0.6717791
MP:0001425	abnormal alcohol consumption	27	1.365889e-09	0.0002622945	0.3462946	2.030987e-06	0.1901783
MP:0001426	polydipsia	33	6.224139e-38	8.724461e-37	4.240278e-21	4.659018e-20	0.1765759
MP:0001428	adipsia	4	4.776874e-10	0.6898241	0.354259	0.901142	0.6226596
MP:0001429	dehydration	95	4.849565e-93	2.850793e-56	1.781808e-14	3.918644e-38	0.619084
MP:0001431	abnormal eating behavior	504	0	1.235035e-219	3.22805e-106	1.409055e-199	0.1064219
MP:0001432	abnormal food preference	12	4.781981e-09	2.940763e-10	0.0159151	2.546626e-05	0.9634691
MP:0001433	polyphagia	61	4.991642e-77	4.136115e-19	1.140248e-23	1.170931e-20	0.6195605
MP:0001435	no suckling reflex	14	1.775047e-16	3.999094e-05	0.004736814	7.429776e-05	0.7796179
MP:0001436	abnormal suckling behavior	117	3.376116e-86	5.708517e-57	2.113358e-16	3.20461e-56	0.04636265
MP:0001437	no swallowing reflex	4	0.9808947	1.221195e-05	0.6946101	0.0008840195	0.9853115
MP:0001438	aphagia	128	1.71497e-100	2.548568e-78	9.743806e-14	2.181324e-32	0.3839221
MP:0001440	abnormal grooming behavior	91	5.177492e-24	2.984653e-11	4.187316e-16	4.714373e-15	0.740379
MP:0001441	increased grooming behavior	29	9.165306e-08	0.001356356	0.08181254	0.004604285	0.4058069
MP:0001442	decreased grooming behavior	23	3.164319e-10	8.871153e-10	1.230138e-05	4.688886e-07	0.2374746
MP:0001443	poor grooming	14	0.0001262483	0.2214068	2.84384e-15	0.009077956	0.1032919
MP:0001446	abnormal whisker trimming behavior	3	1.616132e-05	4.661827e-13	0.0001399148	0.0002796293	0.3143916
MP:0001447	abnormal nest building behavior	27	1.606166e-16	2.634621e-05	0.02360839	0.03164137	0.9103442
MP:0001448	abnormal huddling behavior	2	3.530392e-13	1	0.007415064	0.06812787	1
MP:0001454	abnormal cued conditioning behavior	96	4.175378e-47	7.017679e-34	4.739851e-06	8.023632e-21	0.8060858
MP:0001458	abnormal object recognition memory	58	6.903391e-89	8.570508e-32	0.0005179312	9.547068e-25	0.950809
MP:0001460	abnormal olfactory -discrimination memory	9	0.01024407	2.490211e-07	0.05728753	0.7108574	0.9858022
MP:0001462	abnormal avoidance learning behavior	73	3.791889e-11	2.557011e-16	0.0003110279	8.914544e-05	0.05013051
MP:0001463	abnormal spatial learning	204	1.739341e-126	3.344268e-39	6.687049e-10	8.441642e-29	0.3434621
MP:0001468	abnormal temporal memory	141	4.849087e-88	2.661168e-62	1.468764e-06	4.210946e-28	0.651342
MP:0001469	abnormal contextual conditioning behavior	119	7.969221e-60	1.985675e-53	3.143255e-05	8.874296e-20	0.7607424
MP:0001473	reduced long term potentiation	137	2.946164e-95	1.060519e-67	2.838773e-18	7.121722e-45	0.02688979
MP:0001475	reduced long term depression	38	5.298397e-28	2.718398e-16	0.07913921	1.3826e-05	0.2502112
MP:0001485	abnormal pinna reflex	51	3.468008e-43	9.365724e-48	1.238205e-15	1.202565e-22	7.169427e-05
MP:0001486	abnormal startle reflex	195	4.69427e-181	1.274708e-74	3.215179e-39	1.343052e-46	0.07228381
MP:0001488	increased startle reflex	84	4.551076e-120	2.22624e-32	8.701152e-15	5.60458e-21	0.9862654
MP:0001489	decreased startle reflex	73	1.957899e-29	4.065757e-35	4.889008e-08	4.123707e-06	0.05765451
MP:0001490	abnormal vibrissae reflex	5	0.1721398	1.025716e-16	0.04989038	0.04017241	0.4147653
MP:0001491	unresponsive to tactile stimuli	24	1.007789e-13	4.6227e-32	1.680645e-07	1.74279e-07	0.4211357
MP:0001492	abnormal pilomotor reflex	15	6.998451e-14	0.6826888	1.16008e-07	2.266354e-13	0.006803702
MP:0001496	audiogenic seizures	20	0.01608209	0.03429333	8.546763e-06	9.617973e-12	0.1459044
MP:0001499	abnormal kindling response	11	0.09069613	4.574755e-05	0.9242835	0.3623698	0.8957843
MP:0001500	reduced kindling response	3	0.9889981	0.006132682	0.9587161	0.9930083	0.5625908
MP:0001501	abnormal sleep pattern	48	8.139445e-27	6.129764e-14	9.424981e-10	1.866859e-24	0.4302977
MP:0001502	abnormal circadian rhythm	79	2.240935e-40	6.00237e-20	1.330439e-19	2.99733e-26	0.4287228
MP:0001504	abnormal posture	250	2.668792e-169	2.218085e-121	1.51141e-38	2.621023e-108	4.113896e-09
MP:0001505	hunched posture	107	1.019825e-54	1.28668e-41	1.307465e-16	1.212514e-65	2.268338e-05
MP:0001506	limp posture	6	0.03855296	0.6935002	0.4045764	0.3600741	0.4043384
MP:0001510	abnormal coat appearance	472	0	1.640418e-190	8.678797e-129	9.49998e-258	2.300659e-10
MP:0001511	disheveled coat	48	6.052724e-62	2.057683e-11	0.01402584	4.691413e-16	0.2769106
MP:0001512	trunk curl	17	5.125746e-38	0.08979443	1.281591e-12	1.457816e-19	0.04050272
MP:0001513	limb grasping	178	1.481416e-121	1.826264e-76	1.876894e-27	1.146357e-63	0.04318714
MP:0001515	abnormal grip strength	200	3.064994e-238	7.338163e-89	1.539625e-43	1.385428e-76	0.01585728
MP:0001516	abnormal motor coordination/ balance	729	0	0	7.506121e-90	7.879054e-249	0.03181919
MP:0001522	impaired swimming	71	1.077795e-24	9.819308e-42	7.920975e-10	4.449736e-19	0.003281918
MP:0001523	impaired righting response	110	2.108361e-63	1.223201e-64	4.559214e-15	5.039797e-38	0.1011944
MP:0001524	impaired limb coordination	66	7.494694e-39	2.256149e-44	0.01262866	1.155617e-12	0.07205389
MP:0001525	impaired balance	130	2.228346e-77	3.654646e-59	5.560662e-16	2.25866e-58	0.02017139
MP:0001526	abnormal placing response	16	4.097126e-08	5.172967e-36	0.6273753	0.05235112	0.4161062
MP:0001527	athetotic walking movements	5	0.9999952	7.922189e-12	0.9991427	0.3361165	0.9671554
MP:0001529	abnormal vocalization	37	3.186958e-36	6.232573e-13	1.369371e-06	6.95724e-10	0.9874779
MP:0001533	abnormal skeleton physiology	576	0	1.29546799857949e-315	2.837936e-206	0	2.530656e-13
MP:0001539	decreased caudal vertebrae number	30	1.193654e-57	1.926961e-14	8.667647e-17	1.247277e-28	0.6678186
MP:0001541	abnormal osteoclast physiology	72	6.190937e-104	1.833123e-20	1.054489e-51	1.54147e-112	0.0001607563
MP:0001542	abnormal bone strength	65	3.778486e-87	6.441418e-38	2.016451e-17	9.564868e-43	0.04045771
MP:0001544	abnormal cardiovascular system physiology	1308	0	0	0	0	1.67403e-19
MP:0001545	abnormal hematopoietic system physiology	395	0	3.819877e-56	1.419628e-256	0	5.829348e-08
MP:0001547	abnormal lipid level	774	0	4.846665e-301	2.078607e-244	0	2.058317e-08
MP:0001548	hyperlipidemia	20	2.87776e-36	9.918015e-12	4.031991e-14	5.455384e-13	0.09470145
MP:0001552	increased circulating triglyceride level	143	5.390935e-205	4.969395e-87	6.288588e-48	1.440741e-90	0.01499128
MP:0001553	abnormal circulating free fatty acids level	139	1.43794e-162	1.628226e-71	4.463795e-56	1.19046e-113	0.04090166
MP:0001554	increased circulating free fatty acid level	73	2.992633e-49	2.850703e-62	5.13992e-26	9.671018e-40	0.0853179
MP:0001556	increased circulating HDL cholesterol level	53	6.102941e-34	1.113243e-30	2.511707e-29	9.175543e-31	0.03546473
MP:0001559	hyperglycemia	117	1.99737e-98	7.812743e-30	1.421648e-45	1.225698e-61	0.04366326
MP:0001560	abnormal circulating insulin level	362	0	9.042484e-132	2.015851e-106	2.553244e-185	1.966306e-05
MP:0001562	abnormal circulating calcium level	68	7.181548e-48	4.732303e-30	2.689259e-42	1.047031e-59	0.003955269
MP:0001565	abnormal circulating phosphate level	46	1.329289e-44	6.788393e-32	9.003091e-16	8.979658e-26	0.04042178
MP:0001566	increased circulating phosphate level	26	1.975065e-19	4.436677e-14	6.071683e-09	2.928514e-10	0.006039652
MP:0001569	abnormal circulating bilirubin level	57	3.383023e-148	9.803842e-27	1.423856e-26	2.571188e-60	0.1198523
MP:0001570	abnormal circulating enzyme level	325	0	1.81319e-128	1.108144e-97	3.197287e-230	1.117645e-05
MP:0001573	abnormal circulating alanine transaminase level	126	4.824431e-292	1.205256e-44	2.457181e-52	2.271304e-124	0.002872926
MP:0001574	abnormal oxygen level	256	2.806487e-200	1.32475e-159	1.142293e-45	1.866961e-112	0.009914551
MP:0001575	cyanosis	227	3.598757e-180	1.051162e-157	5.444693e-33	4.666116e-95	0.005845404
MP:0001577	anemia	335	0	2.561275e-58	3.361257e-161	0	0.002260634
MP:0001585	hemolytic anemia	36	6.024938e-145	0.1714747	3.962632e-18	3.394064e-60	0.3570839
MP:0001586	abnormal erythrocyte cell number	244	0	1.181625e-56	4.087453e-122	0	0.0414861
MP:0001588	abnormal hemoglobin	252	0	6.923828e-55	6.022066e-108	0	0.6695955
MP:0001589	abnormal mean corpuscular hemoglobin	69	4.317338e-223	1.375566e-05	1.090498e-27	2.651737e-128	0.9183428
MP:0001596	hypotension	25	0.06155459	2.739658e-37	4.598163e-07	0.0003150327	0.002743477
MP:0001599	abnormal blood volume	10	1.871022e-28	1.118446e-08	0.001396047	1.715908e-13	0.995197
MP:0001601	abnormal myelopoiesis	124	0	8.225061e-17	1.781698e-99	6.85585e-279	0.0002018406
MP:0001602	impaired myelopoiesis	13	1.613198e-29	0.0003534171	5.392972e-08	5.819484e-20	0.1528011
MP:0001603	failure of myelopoiesis	3	0.06816353	2.059489e-08	2.45398e-05	2.289534e-15	0.01169444
MP:0001606	impaired hematopoiesis	46	1.806538e-131	3.689451e-06	1.437484e-20	1.839107e-79	0.5471716
MP:0001613	abnormal vasodilation	72	4.036181e-54	9.732448e-54	6.223242e-40	9.952387e-50	0.001842525
MP:0001614	abnormal blood vessel morphology	1066	0	0	0	0	8.309028e-19
MP:0001619	abnormal vascular permeability	61	9.799926e-72	3.667569e-17	5.959692e-31	7.538579e-50	0.4553574
MP:0001622	abnormal vasculogenesis	64	4.861558e-110	1.451141e-72	1.605038e-25	1.073127e-59	0.2283418
MP:0001625	cardiac hypertrophy	171	4.40129e-151	1.34249e-158	1.0228e-35	4.164419e-75	0.02457286
MP:0001627	abnormal cardiac output	37	1.003777e-65	1.085976e-39	0.003473358	1.316632e-13	0.3260076
MP:0001629	abnormal heart rate	181	8.007563e-133	1.910623e-104	5.885247e-50	2.038231e-60	2.286567e-05
MP:0001633	poor circulation	17	1.741156e-17	4.52038e-10	2.43577e-12	1.403055e-16	0.03228695
MP:0001634	internal hemorrhage	304	0	3.170761e-146	7.81314e-128	1.333423e-264	1.413025e-09
MP:0001636	irregular heartbeat	60	6.025826e-43	2.304042e-60	2.16815e-14	6.947097e-34	0.257635
MP:0001648	abnormal apoptosis	1105	0	7.99476200000167e-312	3.184039e-301	0	3.170844e-10
MP:0001649	abnormal symphysis menti morphology	1	0.9005029	3.503605e-18	0.3832671	0.4587774	0.498173
MP:0001650	abnormal seizure response to electrical stimulation	24	0.02285195	1.011698e-12	0.617604	0.0004738723	0.05910204
MP:0001651	necrosis	71	3.267545e-67	7.162059e-34	3.488076e-39	1.54394e-54	0.01608195
MP:0001652	colonic necrosis	4	0.2423782	3.045983e-06	0.1205037	0.001454067	0.9748997
MP:0001653	gastric necrosis	2	0.4611684	0.3867552	0.02105102	0.007773985	0.2277299
MP:0001654	hepatic necrosis	95	1.778378e-141	1.391595e-28	9.531068e-38	1.588704e-103	0.01696781
MP:0001655	multifocal hepatic necrosis	11	6.34097e-22	0.9858901	4.834097e-09	1.491588e-18	0.5765462
MP:0001656	focal hepatic necrosis	21	1.838198e-26	1.30738e-08	1.041603e-08	2.200855e-29	0.0002874126
MP:0001657	abnormal induced morbidity/mortality	544	0	2.238051e-119	8.373354e-202	0	7.305832e-25
MP:0001658	increased mortality induced by gamma-irradiation	31	2.201799e-61	2.98626e-05	2.472642e-09	1.738608e-12	0.7822709
MP:0001661	extended life span	36	0.000357101	7.335214e-06	1.308624e-08	6.873259e-13	0.01285563
MP:0001663	abnormal digestive system physiology	569	0	1.303598e-220	9.00669e-236	0	1.610532e-11
MP:0001664	abnormal digestion	109	2.440705e-78	7.57883e-77	1.451555e-28	4.987996e-34	5.479291e-06
MP:0001665	chronic diarrhea	6	0.002365482	0.9672325	2.654559e-05	0.3580199	0.02193312
MP:0001666	abnormal intestinal absorption	62	1.160722e-48	1.556937e-47	5.675043e-13	1.268134e-18	0.008494616
MP:0001667	abnormal carbohydrate absorption	6	0.03360837	7.963286e-21	0.4548565	0.09963994	0.4637527
MP:0001668	abnormal fructose absorption	1	0.0002057755	0.0339262	0.4158952	0.2575184	1
MP:0001669	abnormal glucose absorption	5	0.4733557	9.095467e-21	0.5291945	0.1479223	0.295638
MP:0001670	abnormal intestinal mineral absorption	10	1.226887e-17	0.03127866	1.724216e-06	1.251946e-12	0.1230202
MP:0001671	abnormal vitamin absorption	5	0.002032635	3.338992e-05	0.4012602	8.453891e-06	0.460682
MP:0001672	abnormal embryogenesis/ development	1550	0	0	0	0	2.449815e-10
MP:0001674	abnormal triploblastic development	235	0	9.187557e-225	8.181861e-64	3.024184e-106	0.2998621
MP:0001675	abnormal ectoderm development	93	7.127794e-111	1.164927e-120	3.709339e-19	8.757037e-38	0.2285844
MP:0001676	abnormal apical ectodermal ridge morphology	41	1.208396e-08	3.4809e-90	2.576035e-05	2.407438e-10	0.02084163
MP:0001677	absent apical ectodermal ridge	8	1.063563e-06	1.197376e-34	0.01965214	2.946398e-06	0.05931213
MP:0001678	thick apical ectodermal ridge	4	0.02830385	2.184744e-05	0.7781789	0.03840463	0.4824511
MP:0001679	thin apical ectodermal ridge	7	5.589259e-05	1.004207e-18	0.3626642	0.2843953	0.4203596
MP:0001680	abnormal mesoderm development	156	1.185601e-255	2.984093e-131	1.626578e-52	2.698014e-59	0.5489228
MP:0001683	absent mesoderm	62	1.084004e-161	6.063747e-34	2.96716e-33	2.679994e-32	0.3548018
MP:0001684	abnormal axial mesoderm	18	1.7571e-27	2.796781e-38	1.217661e-12	7.914459e-07	0.1835399
MP:0001685	abnormal endoderm development	57	1.247436e-45	4.023694e-52	3.331469e-12	8.143094e-14	0.2066541
MP:0001688	abnormal somite development	233	5.39953900000147e-312	4.82447e-131	9.268222e-49	1.568666e-137	0.02126111
MP:0001689	incomplete somite formation	56	9.464267e-56	3.731716e-48	1.387062e-12	2.296304e-42	0.1103704
MP:0001690	failure of somite differentiation	58	2.989213e-163	5.713161e-45	5.142559e-24	3.892901e-30	0.4193011
MP:0001691	abnormal somite shape	34	3.538943e-34	1.895818e-17	8.218757e-07	1.306092e-10	0.6335023
MP:0001693	failure of primitive streak formation	36	9.031932e-55	1.074173e-17	9.757066e-15	7.02653e-16	0.1529903
MP:0001694	failure to form egg cylinders	16	3.1448e-50	4.165537e-15	4.479845e-07	4.59223e-08	0.2163706
MP:0001695	abnormal gastrulation	434	0	9.274188e-289	4.265045e-112	9.645286e-256	0.04831745
MP:0001696	failure to gastrulate	47	5.873468e-166	8.369331e-32	6.068826e-24	2.548525e-36	0.274894
MP:0001697	abnormal embryo size	580	0	3.077229e-305	7.91843e-190	0	3.451092e-05
MP:0001698	decreased embryo size	571	0	4.963854e-295	2.479768e-183	0	7.596485e-05
MP:0001699	increased embryo size	9	0.001809922	6.530471e-15	6.194431e-08	6.714388e-05	0.08218133
MP:0001700	abnormal embryo turning	197	4.209301e-251	3.628667e-85	2.760008e-53	3.350936e-122	0.06123438
MP:0001701	incomplete embryo turning	77	8.172937e-86	3.146354e-51	4.074379e-26	7.424935e-57	0.00018468
MP:0001704	abnormal dorsal-ventral axis patterning	22	1.613071e-16	4.433665e-13	2.606272e-05	3.800829e-09	0.5934307
MP:0001705	abnormal proximal-distal axis patterning	14	6.111857e-21	4.992229e-15	9.871937e-11	3.144118e-05	0.0003973659
MP:0001706	abnormal left-right axis patterning	69	9.434927e-53	1.631707e-24	7.767336e-28	2.806055e-52	0.004686428
MP:0001710	absent amniotic folds	7	8.275536e-33	3.263014e-20	4.200445e-05	0.001540989	0.5415338
MP:0001711	abnormal placenta morphology	385	0	9.806996e-204	8.190903e-157	1.331211e-304	0.0001000978
MP:0001712	abnormal placenta development	184	1.377557e-238	2.276739e-98	1.199492e-56	1.010047e-95	0.004910517
MP:0001713	decreased trophoblast giant cell number	41	4.186011e-55	1.182818e-24	1.258579e-12	1.941216e-27	0.1085391
MP:0001714	absent trophoblast giant cells	10	1.086878e-11	0.0001998711	1.995478e-05	0.001475252	0.6700135
MP:0001715	placental labyrinth hypoplasia	15	2.098586e-27	5.349718e-18	1.912803e-14	4.469583e-28	0.3069794
MP:0001716	abnormal placenta labyrinth morphology	174	2.47032822920623e-323	4.131618e-118	1.049167e-85	3.890237e-156	0.005927124
MP:0001717	absent ectoplacental cone	9	1.523833e-22	6.022229e-07	0.1116173	6.501017e-07	0.5386312
MP:0001718	abnormal visceral yolk sac morphology	229	0	1.512986e-131	1.713791e-84	7.348812e-226	0.002034562
MP:0001719	absent vitelline blood vessels	74	1.143472e-99	1.417676e-50	6.523055e-35	1.109992e-65	0.2104931
MP:0001721	absent visceral yolk sac blood islands	17	2.104859e-43	1.768471e-10	7.829043e-16	4.616235e-35	0.1054521
MP:0001722	pale yolk sac	90	2.806568e-211	7.672816e-56	1.477275e-46	5.849305e-134	0.3329282
MP:0001723	disorganized yolk sac vascular plexus	23	6.088201e-25	5.773244e-46	5.743294e-17	4.038777e-18	0.3747944
MP:0001724	abnormal extraembryonic endoderm formation	18	1.448962e-19	7.561206e-06	0.0001616444	7.425162e-06	0.2078879
MP:0001725	abnormal umbilical cord morphology	25	6.387637e-06	2.632544e-35	1.527169e-10	4.914163e-11	0.001970201
MP:0001726	abnormal allantois morphology	105	9.057968e-117	8.507592e-90	1.348889e-34	7.250938e-58	0.02625814
MP:0001727	abnormal embryo implantation	59	6.018527e-46	2.123884e-29	3.231486e-28	1.893255e-33	0.003328563
MP:0001728	failure of embryo implantation	28	8.859737e-16	7.044024e-12	1.276272e-10	2.315335e-11	0.0003958083
MP:0001729	impaired embryo implantation	14	0.01912877	1.270927e-17	6.651279e-14	1.196042e-06	0.7432653
MP:0001730	embryonic growth arrest	281	0	3.930898e-100	4.645498e-67	6.311843e-199	0.08076249
MP:0001731	abnormal postnatal growth	903	0	0	3.59953e-293	0	2.853018e-05
MP:0001732	postnatal growth retardation	878	0	0	1.197364e-279	0	2.140851e-05
MP:0001739	abnormal adrenal gland secretion	22	5.956547e-20	9.858141e-15	3.396618e-06	1.111973e-25	0.9979449
MP:0001740	failure of adrenal epinephrine secretion	1	0.002180276	0.003512653	0.1329433	4.859985e-22	1
MP:0001742	absent circulating adrenaline	2	1.432839e-06	0.1449598	6.079957e-06	0.3151886	0.7124123
MP:0001743	absent circulating noradrenaline	1	6.380794e-07	0.001912207	0.3249752	0.3028271	1
MP:0001744	hypersecretion of corticosterone	5	0.0005205034	6.150993e-09	0.2153218	0.2567271	0.9554481
MP:0001745	increased circulating corticosterone level	49	3.920438e-50	5.077358e-16	9.959278e-08	4.361843e-13	0.6582405
MP:0001746	abnormal pituitary secretion	13	3.285398e-10	0.7266838	1.621049e-05	0.0009153984	0.06459843
MP:0001747	hypersecretion of adrenocorticotropin	1	0.9995148	0.9336549	1	0.6181946	0.702005
MP:0001748	increased circulating adrenocorticotropin level	15	0.01886907	0.0118707	0.7896172	0.9606908	0.8170723
MP:0001749	suppressed circulating follicle stimulating hormone level	6	2.229442e-17	0.0003388718	0.006216952	7.749219e-06	0.01025599
MP:0001750	increased circulating follicle stimulating hormone level	39	2.300929e-49	0.0001587101	1.625797e-07	6.692708e-15	0.0003646727
MP:0001751	increased circulating luteinizing hormone level	36	1.029799e-15	1.423111e-08	2.143976e-09	5.081752e-08	0.001123191
MP:0001752	abnormal hypothalamus secretion	11	2.163514e-07	9.019978e-14	0.5975838	0.02336989	0.8870343
MP:0001753	hypersecretion of corticotropin-releasing hormone	1	0.02261012	0.8829117	1.386651e-06	0.4587774	0.498173
MP:0001754	increased circulating corticotropin-releasing hormone level	1	0.00548645	0.06007696	0.08154684	0.2776689	1
MP:0001756	abnormal urination	136	1.619032e-131	2.442525e-73	3.49696e-37	4.371993e-60	5.335262e-05
MP:0001758	abnormal urine glucose level	30	2.582815e-20	5.332748e-13	4.945719e-10	1.840109e-16	0.3653365
MP:0001759	increased urine glucose level	27	2.221635e-23	3.234249e-10	7.340109e-09	5.415805e-15	0.5462041
MP:0001760	abnormal urine enzyme level	2	0.9716598	0.0008859613	0.000566924	0.0006551093	0.191062
MP:0001761	abnormal urination pattern	3	0.8547297	7.90311e-07	0.9946595	0.9792701	1
MP:0001762	polyuria	81	3.180881e-78	3.098922e-46	5.765395e-24	5.677865e-38	0.002729442
MP:0001764	abnormal homeostasis	2999	0	0	0	0	4.695994e-44
MP:0001765	abnormal ion homeostasis	357	0	5.277937e-112	1.923758e-136	2.975674e-237	5.753376e-05
MP:0001770	abnormal iron level	88	2.509225e-251	1.872089e-08	5.102363e-35	2.210862e-111	0.9235528
MP:0001771	abnormal circulating magnesium level	17	9.154158e-21	9.585437e-09	1.526751e-07	2.073087e-10	0.06950976
MP:0001775	abnormal selenium level	3	6.464196e-06	3.849095e-07	2.153446e-05	6.957721e-05	0.3967792
MP:0001776	abnormal circulating sodium level	46	1.031205e-48	1.491896e-19	4.964139e-09	1.71086e-13	0.1299236
MP:0001777	abnormal body temperature homeostasis	62	3.493035e-20	1.044789e-13	1.975935e-18	4.137124e-23	0.1308113
MP:0001778	abnormal brown adipose tissue amount	84	6.994238e-165	1.032939e-27	5.548547e-37	1.079471e-81	0.4470566
MP:0001780	decreased brown adipose tissue amount	47	5.569133e-78	1.134698e-24	8.651749e-30	1.635241e-62	0.2511181
MP:0001781	abnormal white adipose tissue amount	208	0	2.239283e-67	2.066974e-79	2.588115e-154	0.03713433
MP:0001783	decreased white adipose tissue amount	88	3.063352e-169	1.724904e-38	6.16117e-56	1.11059e-105	0.05533928
MP:0001784	abnormal fluid regulation	673	0	0	1.465144e-186	0	3.236624e-10
MP:0001785	edema	424	0	2.573645e-265	1.603762e-123	0	3.575022e-07
MP:0001786	skin edema	58	2.996689e-139	8.907975e-25	6.318231e-35	2.625175e-69	0.01236891
MP:0001787	pericardial edema	87	1.425904e-134	1.657706e-43	2.354286e-26	9.937818e-95	0.0005837524
MP:0001788	periorbital edema	4	2.57353e-23	1.125896e-09	2.883627e-07	3.205826e-08	0.9523511
MP:0001790	abnormal immune system physiology	2085	0	0	0	0	3.591981e-61
MP:0001792	impaired wound healing	47	6.439901e-54	2.891546e-24	4.825145e-27	1.814985e-69	0.001088112
MP:0001793	altered susceptibility to infection	554	0	2.472886e-78	9.920238e-272	0	6.912841e-30
MP:0001798	impaired macrophage phagocytosis	49	1.694444e-115	1.608804e-13	4.889142e-55	1.110007e-107	0.2045842
MP:0001800	abnormal humoral immune response	521	0	9.330543e-75	0	0	4.933112e-26
MP:0001802	arrested B cell differentiation	72	1.592416e-184	0.0004164329	5.596538e-59	8.316835e-198	0.0132429
MP:0001805	decreased IgG level	245	6.062144e-239	2.697997e-38	3.214844e-221	0	1.379398e-16
MP:0001806	decreased IgM level	113	2.258538e-110	2.435188e-23	2.985409e-89	1.967839e-181	3.375195e-07
MP:0001807	decreased IgA level	57	7.897969e-31	3.613058e-12	9.462622e-54	1.454935e-73	1.192837e-05
MP:0001819	abnormal immune cell physiology	1316	0	6.527825e-218	0	0	1.602018e-62
MP:0001823	thymus hypoplasia	184	0	1.08257e-35	5.842123e-123	0	5.039917e-12
MP:0001824	abnormal thymus involution	15	3.96973e-35	1.942225e-13	1.061865e-17	7.465092e-30	0.5373595
MP:0001825	arrested T cell differentiation	59	5.23501e-132	0.0002292661	2.686869e-59	1.378742e-119	8.419967e-13
MP:0001828	abnormal T cell activation	353	0	2.69888e-58	2.03716300220215e-315	0	4.597214e-34
MP:0001829	increased activated T cell number	34	1.275359e-60	2.77178e-15	3.615769e-37	1.27325e-43	0.00446113
MP:0001830	decreased activated T cell number	8	9.975896e-15	0.001033522	8.175857e-06	2.623432e-15	0.205576
MP:0001835	abnormal antigen presentation	68	1.970732e-57	0.6188071	2.26741e-59	2.416127e-93	0.00505473
MP:0001836	abnormal antigen presentation via MHC class I	13	7.203461e-26	0.9994027	0.0006540629	1.104504e-11	0.9299057
MP:0001837	defective assembly of class I molecules	4	0.003067116	0.9410929	0.1506975	2.702213e-16	1
MP:0001838	defective intracellular transport of class I molecules	2	0.1680289	0.769503	0.05073594	5.379297e-07	1
MP:0001839	abnormal level of surface class I molecules	11	1.524784e-22	0.9991696	0.0007313903	5.863985e-08	0.9178129
MP:0001840	increased level of surface class I molecules	1	0.0006000107	0.9999856	1	0.6062543	0.8122343
MP:0001841	decreased level of surface class I molecules	9	1.460848e-12	0.9682108	0.0006878105	7.438805e-08	0.9905673
MP:0001844	autoimmune response	372	0	3.262638e-65	0	0	9.719442e-24
MP:0001845	abnormal inflammatory response	1088	0	2.326716e-290	0	0	2.292056e-18
MP:0001846	increased inflammatory response	918	0	3.50855e-272	0	0	4.255448e-17
MP:0001847	brain inflammation	23	1.800656e-21	0.5532467	1.464501e-13	2.610345e-21	0.001198023
MP:0001849	ear inflammation	36	2.727792e-121	1.185486e-36	8.613422e-18	9.735583e-31	0.5106296
MP:0001850	increased susceptibility to otitis media	25	1.062255e-67	4.60128e-24	2.741825e-12	1.056217e-19	0.456481
MP:0001851	eye inflammation	67	7.984999e-119	1.95457e-34	1.85961e-53	1.191521e-67	0.03735388
MP:0001852	conjunctivitis	28	8.241659e-24	3.290171e-13	1.443029e-17	4.285167e-20	0.8283127
MP:0001853	heart inflammation	44	1.548648e-57	7.17011e-13	2.10228e-24	2.06872e-46	0.07724509
MP:0001854	atrial endocarditis	1	0.0007990111	1	0.03826761	1.460962e-06	1
MP:0001855	atrial thrombosis	22	2.91163e-22	4.937375e-06	0.001294098	1.901035e-10	0.001767517
MP:0001856	myocarditis	17	3.114153e-31	0.003821092	1.049831e-12	7.619506e-30	0.5150168
MP:0001857	pericarditis	2	9.279538e-06	1	0.06850427	3.255013e-08	1
MP:0001858	intestinal inflammation	185	1.327279e-236	1.001153e-19	4.867215e-94	9.502108e-158	7.041805e-05
MP:0001859	kidney inflammation	180	4.194289e-282	1.731149e-33	8.800303e-132	2.03286e-220	1.056527e-08
MP:0001860	liver inflammation	140	6.973169e-210	7.147203e-43	2.13331e-111	6.478773e-203	0.0004976731
MP:0001861	lung inflammation	186	3.56812e-199	5.61949e-52	1.682148e-117	2.852662e-226	0.0009427986
MP:0001862	interstitial pneumonia	21	5.818487e-33	2.70686e-08	1.332734e-21	1.604068e-36	0.2723764
MP:0001863	vascular inflammation	37	5.617922e-76	5.785533e-10	4.833834e-38	4.991532e-71	0.001639897
MP:0001864	vasculitis	30	4.303e-59	7.889392e-06	8.014465e-35	1.588746e-59	0.02716828
MP:0001866	nasal inflammation	13	9.196446e-30	1.760094e-08	0.02911325	7.76113e-10	0.2381332
MP:0001867	rhinitis	11	7.517795e-29	6.57108e-10	0.003341974	3.104535e-12	0.3709173
MP:0001868	ovary inflammation	4	1.826831e-09	0.001011155	0.04772668	0.004217884	0.267129
MP:0001869	pancreas inflammation	68	5.088464e-54	9.483747e-17	6.907469e-57	2.92177e-63	0.0002319404
MP:0001870	salivary gland inflammation	27	4.19818e-46	8.732727e-06	7.730131e-40	1.656455e-47	0.006719616
MP:0001872	sinus inflammation	9	4.184708e-53	0.01252247	3.386314e-08	1.285928e-05	0.5823198
MP:0001873	stomach inflammation	30	1.588617e-57	3.50513e-16	1.374321e-31	7.114987e-36	0.004319019
MP:0001874	acanthosis	45	6.668487e-50	6.557527e-11	1.980986e-17	6.763481e-24	0.6694694
MP:0001875	testis inflammation	3	0.9194542	0.3722244	0.0003977123	0.823142	0.5555045
MP:0001876	decreased inflammatory response	245	3.21157491766185e-319	1.667545e-24	6.689004e-216	2.14518708613763e-317	3.928899e-07
MP:0001879	abnormal lymphatic vessel morphology	46	2.672005e-43	3.60212e-33	4.614076e-39	2.858902e-47	0.004058565
MP:0001881	abnormal mammary gland physiology	94	4.879882e-136	6.951122e-33	1.792151e-58	3.224549e-69	0.2127287
MP:0001882	abnormal lactation	84	1.909389e-92	1.266064e-30	6.246939e-54	7.866745e-53	0.08770143
MP:0001883	mammary adenocarcinoma	49	1.59612e-84	9.831092e-17	4.255072e-26	2.705456e-52	0.2484836
MP:0001884	mammary gland alveolar hyperplasia	9	2.59088e-07	0.08329077	8.77406e-12	1.761935e-08	0.009916992
MP:0001885	mammary gland duct hyperplasia	8	7.218055e-10	1.459806e-06	5.367254e-08	7.68019e-06	0.08641952
MP:0001889	delayed brain development	9	4.574904e-25	9.677389e-07	3.732442e-10	1.05141e-06	0.9518283
MP:0001890	anencephaly	20	0.03787056	4.530982e-32	3.161115e-07	1.821816e-11	0.7845753
MP:0001891	hydroencephaly	119	6.362421e-193	5.386667e-96	1.256894e-39	4.382261e-77	0.1161621
MP:0001893	non-obstructive hydrocephaly	6	4.495019e-33	0.07885342	0.9915486	0.0001223672	0.8647073
MP:0001898	abnormal long term depression	85	2.046582e-40	1.133282e-34	0.002482843	1.408527e-11	0.4543588
MP:0001899	absent long term depression	32	6.445615e-07	1.234954e-13	3.70524e-05	5.123069e-05	0.4576171
MP:0001900	impaired synaptic plasticity	35	8.39187e-43	2.641585e-16	1.796277e-05	1.843682e-11	0.7820141
MP:0001901	absence of NMDA-mediated synaptic currents	3	0.001486073	0.1680653	0.7812953	0.8156191	0.8794322
MP:0001902	reduced NMDA-mediated synaptic currents	13	4.642125e-26	1.446884e-05	0.03014949	1.587394e-05	0.7819412
MP:0001905	abnormal dopamine level	87	2.424695e-25	6.099062e-11	7.853343e-05	9.672773e-18	0.3719751
MP:0001906	increased dopamine level	38	5.798275e-06	0.004859898	0.002533259	0.000208653	0.4909266
MP:0001908	abnormal somatosensory cortex physiology	5	0.8122907	1.185503e-10	0.3653737	0.555693	0.0006127629
MP:0001909	reduced NMDA receptor mediated synaptic activity in barrel cortex	3	0.02272651	0.0006515605	0.02991725	0.741822	0.02991736
MP:0001911	abnormal cerebrospinal fluid production	1	5.430506e-27	0.0002367784	1	0.0040418	1
MP:0001914	hemorrhage	535	0	1.58216e-295	8.944517e-198	0	1.034648e-12
MP:0001915	intracranial hemorrhage	106	2.560633e-270	3.142008e-53	1.561243e-38	1.133024e-114	0.006416693
MP:0001916	intracerebral hemorrhage	37	7.793635e-100	1.963568e-07	1.050108e-11	4.795765e-54	0.02367651
MP:0001917	intraventricular hemorrhage	19	9.912942e-98	0.02323649	0.0008391969	8.502808e-28	0.5186914
MP:0001919	abnormal reproductive system physiology	1383	0	0	0	0	2.560658e-11
MP:0001921	reduced fertility	557	0	2.427451e-238	1.807182e-94	1.215554e-227	0.004936206
MP:0001922	reduced male fertility	237	1.820618e-163	8.765594e-100	1.171342e-25	6.601713e-77	0.5907667
MP:0001923	reduced female fertility	260	4.402855e-187	8.506777e-85	5.073329e-56	1.33111e-113	0.0001672997
MP:0001924	infertility	719	0	4.142646e-205	1.132171e-141	1.000811e-271	0.001248842
MP:0001925	male infertility	499	0	6.990817e-83	7.31658e-77	4.404549e-160	0.04372412
MP:0001926	female infertility	287	2.57732999999985e-311	7.189499e-109	2.042643e-74	8.916989e-132	0.000109662
MP:0001927	abnormal estrous cycle	86	2.555747e-17	1.07999e-50	1.708034e-14	2.3328e-31	0.3386525
MP:0001928	abnormal ovulation	79	2.651655e-26	1.044745e-19	7.73008e-25	2.242173e-20	1.264192e-05
MP:0001929	abnormal gametogenesis	661	0	3.472249e-133	2.085485e-128	2.01447609074258e-317	1.353183e-08
MP:0001930	abnormal meiosis	167	8.312831e-198	2.845618e-22	1.315774e-24	8.39175e-75	0.01159456
MP:0001931	abnormal oogenesis	128	8.483032e-155	1.174015e-12	1.225975e-19	6.922971e-49	0.0001427922
MP:0001932	abnormal spermiogenesis	70	1.391495e-110	4.357812e-15	5.216092e-09	2.162629e-33	0.01491063
MP:0001933	abnormal litter size	323	1.116267e-266	3.132387e-106	3.188397e-94	5.549032e-127	1.199408e-05
MP:0001934	increased litter size	12	0.02537194	2.159835e-07	0.4825572	0.003701563	0.8560416
MP:0001935	decreased litter size	313	5.114611e-272	5.962459e-104	1.555712e-96	1.038308e-126	3.885403e-06
MP:0001937	abnormal sexual maturation	55	1.478803e-18	6.775399e-19	5.96345e-12	8.874401e-28	0.0472759
MP:0001938	delayed sexual maturation	30	1.046015e-21	6.412833e-18	0.0001818799	4.520365e-13	0.4308713
MP:0001939	secondary sex reversal	13	2.33723e-27	1.775918e-09	0.047903	0.0007697564	0.816913
MP:0001940	testis hypoplasia	29	3.235316e-24	3.449889e-06	0.04045788	6.236179e-18	0.1457854
MP:0001942	abnormal lung volume	33	9.380521e-47	8.652905e-05	3.425798e-10	2.282894e-13	0.3809013
MP:0001943	abnormal respiration	554	0	2.682719e-291	1.020555e-85	1.153156e-263	0.0002678272
MP:0001944	abnormal pancreas morphology	275	6.748345e-210	3.585914e-132	7.108966e-79	2.087415e-139	0.0001521263
MP:0001947	abnormal mucociliary clearance	10	9.324631e-34	0.2788937	0.00418877	7.65857e-07	0.6875637
MP:0001948	vesicoureteral reflux	3	0.8326312	2.01326e-05	0.9422147	0.980497	0.9745792
MP:0001950	abnormal respiratory sounds	6	4.72539e-31	0.1140622	6.334931e-06	1.103178e-08	0.614446
MP:0001951	abnormal breathing pattern	318	4.583813e-199	6.797354e-233	6.004799e-42	4.680437e-157	0.005409868
MP:0001952	increased airway responsiveness	16	2.279317e-32	0.8258342	5.002181e-20	1.772179e-15	0.00299456
MP:0001953	respiratory failure	170	4.016324e-97	1.450874e-133	3.325298e-17	3.166434e-67	0.01976968
MP:0001954	respiratory distress	231	4.12525e-146	1.958188e-230	3.4441e-34	9.627443e-121	0.000104893
MP:0001956	hypopnea	4	0.7534585	0.001219643	0.01998661	2.888096e-06	0.04924751
MP:0001957	apnea	23	3.339543e-11	0.004937229	8.617473e-06	1.255504e-09	0.02445849
MP:0001958	emphysema	45	1.683143e-25	1.123622e-38	6.63023e-15	6.825031e-23	0.2554316
MP:0001961	abnormal reflex	593	0	2.740424e-221	8.355826e-103	1.091584e-198	0.002768566
MP:0001963	abnormal hearing physiology	267	1.577902e-220	3.728382e-154	4.450998e-49	1.314868e-112	6.508879e-05
MP:0001967	deafness	91	6.224255e-76	2.774239e-49	2.730138e-19	2.752543e-23	0.001339516
MP:0001968	abnormal touch/ nociception	286	8.285198e-193	9.95676e-80	1.594642e-38	1.47472e-84	0.06070151
MP:0001970	abnormal pain threshold	224	4.443561e-157	1.595325e-45	2.648338e-29	6.13438e-59	0.03211892
MP:0001973	increased thermal nociceptive threshold	89	3.183057e-40	2.811803e-16	1.461768e-10	1.84956e-16	0.02822753
MP:0001980	abnormal chemically-elicited antinociception	30	3.897285e-21	0.0003699842	0.1475253	0.01587602	0.3976724
MP:0001981	increased chemically-elicited antinociception	6	0.9897096	0.05591056	0.2264786	0.3855973	0.2459466
MP:0001982	decreased chemically-elicited antinociception	22	3.389919e-27	0.001608744	0.3992053	0.07861296	0.5717885
MP:0001983	abnormal olfactory system physiology	47	9.91806e-35	3.655692e-24	3.864069e-09	1.574136e-17	0.1508568
MP:0001984	abnormal olfaction	39	1.594912e-38	1.877963e-18	2.746394e-08	1.842522e-17	0.3652081
MP:0001985	abnormal gustatory system physiology	19	4.71327e-10	0.03473392	0.04073485	0.07576507	0.6449933
MP:0001986	abnormal taste sensitivity	16	3.198261e-08	0.01936457	0.06833259	0.434425	0.7285227
MP:0001987	alcohol preference	11	0.002049053	1.036408e-08	0.006219871	0.000272577	0.05642634
MP:0001988	cocaine preference	1	0.0002996149	0.01993603	1	0.02080489	1
MP:0001993	abnormal blinking	8	2.475432e-05	1.076115e-34	0.06179392	0.001105888	0.2963297
MP:0001994	increased blinking frequency	4	0.02406767	1.928095e-24	0.8319652	0.1385163	0.4391408
MP:0001999	photosensitivity	10	2.682359e-12	0.201567	0.00997361	1.023466e-09	0.4121475
MP:0002001	blindness	23	3.280152e-32	1.36288e-08	2.947718e-10	4.432662e-23	0.006659324
MP:0002003	miotic pupils	5	4.682943e-06	0.2296228	0.2192031	0.05635102	0.7307765
MP:0002006	tumorigenesis	795	0	2.015585e-276	0	0	6.452354e-13
MP:0002007	increased cellular sensitivity to gamma-irradiation	49	4.153886e-129	2.98942e-06	0.0001567757	3.637549e-26	0.6420981
MP:0002009	preneoplasia	14	9.8737e-14	0.001189492	7.284413e-06	1.290906e-14	0.2855376
MP:0002013	increased pilomatricoma incidence	2	0.9656568	5.992933e-05	0.001571119	0.0001369971	0.6602112
MP:0002014	increased papilloma incidence	59	2.158403e-105	1.320133e-42	1.029985e-37	2.733208e-61	0.01581758
MP:0002015	epithelioid cysts	3	0.01454843	0.01905563	7.136476e-08	2.600762e-06	0.2301558
MP:0002016	ovary cysts	38	1.068858e-31	2.361417e-06	1.710193e-08	2.643379e-23	0.003270983
MP:0002018	malignant tumors	337	0	6.462874e-89	1.625749e-113	1.253971e-242	5.098669e-06
MP:0002019	abnormal tumor incidence	715	0	5.541345e-210	0	0	1.594628e-09
MP:0002020	increased tumor incidence	634	0	3.568315e-190	2.170058e-274	0	4.209579e-09
MP:0002021	increased incidence of induced tumors	138	4.394872e-205	1.017243e-58	1.446839e-72	5.646743e-157	0.03178986
MP:0002022	increased lymphoma incidence	221	0	5.69564e-54	1.271771e-81	5.045431e-285	0.08722926
MP:0002023	B cell derived lymphoma	72	1.571932e-166	1.209225e-11	2.668274e-45	2.589116e-106	0.04533292
MP:0002024	T cell derived lymphoma	98	6.922992e-253	5.959439e-15	1.526548e-50	1.841955e-120	0.0004504744
MP:0002026	leukemia	85	9.538357e-273	1.2931e-09	7.835126e-39	7.315898e-178	0.2391942
MP:0002027	lung adenocarcinoma	69	6.448674e-146	1.361612e-18	1.844375e-27	1.658812e-75	0.06251362
MP:0002030	increased neurofibrosarcoma incidence	6	1.488362e-14	0.004412344	6.905899e-06	2.5888e-05	0.4949272
MP:0002031	increased adrenal gland tumor incidence	16	8.113177e-40	7.886561e-05	1.240637e-06	2.712486e-24	0.6181611
MP:0002032	sarcoma	120	1.289315e-236	8.115175e-46	4.906082e-30	4.649052e-88	0.007247788
MP:0002033	malignant triton tumors	2	0.0001332467	0.3766772	0.008285265	0.05062536	1
MP:0002035	leiomyosarcoma	9	6.091653e-27	4.987366e-10	1.218838e-07	3.446292e-18	0.8342794
MP:0002036	rhabdomyosarcoma	15	3.361272e-17	1.590442e-20	0.0001091533	3.455862e-07	0.1662045
MP:0002037	increased fibrohistocytoma incidence	3	0.00157078	0.4029964	0.002479405	0.02090551	0.421107
MP:0002038	carcinoma	275	0	1.280233e-63	1.560757e-105	7.343941e-211	0.0003854558
MP:0002039	neuroblastoma	4	8.242863e-14	0.05466339	0.0001049422	4.575735e-05	0.4785887
MP:0002041	increased pituitary adenoma incidence	25	1.497444e-27	0.009098847	1.304493e-12	1.006966e-21	0.106883
MP:0002043	colonic hamartoma	1	0.7441549	0.4620382	0.02057629	0.1193049	1
MP:0002044	increased colonic adenoma incidence	18	1.065493e-24	0.00217841	3.200288e-09	1.3272e-15	0.3073897
MP:0002045	increased renal cystadenoma incidence	3	6.213928e-21	0.3372858	0.0001862529	0.01528481	0.5695086
MP:0002047	hepatic hemangioma	10	3.470683e-21	0.5162431	6.474059e-05	2.788267e-15	0.4370284
MP:0002048	increased lung adenoma incidence	50	1.093612e-133	1.409332e-13	1.19029e-19	2.092951e-64	0.597465
MP:0002049	extremity angiosarcoma	3	3.99054e-19	0.004626288	1.015358e-05	0.003452689	1
MP:0002050	pheochromocytoma	10	8.125945e-27	0.1174375	0.00625769	4.933304e-07	0.7332501
MP:0002051	skin papilloma	42	1.581798e-79	3.031327e-30	1.353949e-25	1.139399e-47	0.3625901
MP:0002052	decreased tumor incidence	179	0	5.879629e-49	1.27213e-113	1.33213e-219	0.001982657
MP:0002053	decreased incidence of induced tumors	95	2.640603e-131	1.058465e-27	3.556922e-52	4.955166e-98	0.08965732
MP:0002058	neonatal lethality	893	0	0	5.160057e-176	0	1.001366e-05
MP:0002059	abnormal seminal vesicle morphology	85	2.290959e-69	1.938097e-28	9.968207e-08	1.152524e-24	0.08932057
MP:0002060	abnormal skin morphology	789	0	6.31933399999259e-315	9.946794e-296	0	1.063735e-08
MP:0002061	abnormal aggression-related behavior	79	7.822759e-19	2.194883e-11	0.01843171	0.000111452	0.6531719
MP:0002062	abnormal associative learning	248	3.877401e-127	1.568969e-68	4.216159e-13	1.530239e-42	0.4330312
MP:0002063	abnormal learning/memory/conditioning	532	0	1.399491e-139	2.087649e-31	3.45066e-115	0.2072777
MP:0002064	seizures	339	5.651485e-202	1.451375e-142	5.287089e-42	1.450835e-95	0.05598348
MP:0002065	abnormal fear/anxiety-related behavior	280	1.326768e-77	3.890516e-56	4.87861e-20	1.469127e-39	0.5042794
MP:0002066	abnormal motor capabilities/coordination/movement	1772	0	0	0	0	5.245132e-08
MP:0002067	abnormal sensory capabilities/reflexes/nociception	752	0	1.9681e-246	3.851874e-118	6.179578e-244	0.0009599491
MP:0002068	abnormal parental behavior	159	8.045423e-53	2.643932e-78	1.461318e-33	8.490202e-41	0.003792567
MP:0002069	abnormal consumption behavior	574	0	1.140765e-244	2.831523e-127	1.829985e-245	0.02401023
MP:0002073	abnormal hair growth	264	6.623074e-263	8.638016e-125	2.50292e-65	5.018622e-148	0.001081368
MP:0002074	abnormal hair texture	52	1.783779e-32	2.952348e-20	1.893545e-26	3.034409e-25	0.06268784
MP:0002075	abnormal coat/hair pigmentation	173	3.393922e-159	1.081319e-70	6.210974e-56	2.375658e-91	5.35401e-06
MP:0002078	abnormal glucose homeostasis	742	0	4.690913e-264	2.574038e-264	0	1.021667e-10
MP:0002079	increased circulating insulin level	185	5.388521e-165	7.359969e-78	7.138571e-27	4.53412e-71	0.01071895
MP:0002080	prenatal lethality	2036	0	0	0	0	6.10224e-11
MP:0002081	perinatal lethality	1226	0	0	6.425541e-275	0	3.349177e-08
MP:0002082	postnatal lethality	1253	0	0	2.051505e-301	0	7.051124e-15
MP:0002083	premature death	1284	0	0	0	0	6.065695e-17
MP:0002084	abnormal developmental patterning	498	0	6.798123e-304	4.780658e-122	2.168973e-286	0.01450929
MP:0002085	abnormal embryonic tissue morphology	878	0	0	2.581326e-226	0	0.006061318
MP:0002086	abnormal extraembryonic tissue morphology	656	0	0	1.120915e-241	0	1.220305e-08
MP:0002088	abnormal embryonic growth/weight/body size	835	0	0	3.537095e-274	0	4.662826e-05
MP:0002089	abnormal postnatal growth/weight/body size	2513	0	0	0	0	1.950726e-23
MP:0002090	abnormal vision	62	2.683612e-33	9.189017e-37	8.271658e-13	1.229165e-21	0.002225121
MP:0002092	abnormal eye morphology	1114	0	0	0	0	1.422342e-13
MP:0002095	abnormal skin pigmentation	82	4.65232e-31	3.448857e-39	7.350155e-32	3.815575e-28	0.001535397
MP:0002098	abnormal vibrissa morphology	81	1.231078e-30	1.873709e-59	3.15837e-13	2.516437e-21	0.006270321
MP:0002100	abnormal tooth morphology	176	7.757485e-104	1.932707e-161	2.847608e-42	1.794984e-76	0.00114209
MP:0002102	abnormal ear morphology	407	1.128756e-218	6.91691904177745e-323	1.363511e-63	1.717956e-136	0.0002699661
MP:0002106	abnormal muscle physiology	830	0	0	6.167357e-264	0	2.895082e-06
MP:0002108	abnormal muscle morphology	833	0	0	4.806693e-207	0	3.047935e-08
MP:0002109	abnormal limb morphology	603	0	0	7.577342e-110	8.083613e-269	1.218724e-05
MP:0002110	abnormal digit morphology	257	8.57216e-130	1.245961e-214	6.545866e-29	2.728823e-82	0.00879932
MP:0002111	abnormal tail morphology	308	1.506764e-281	1.957707e-256	5.078728e-83	4.418714e-150	0.0008100433
MP:0002113	abnormal skeleton development	444	0	0	1.214526e-139	4.258898e-275	8.374394e-06
MP:0002114	abnormal axial skeleton morphology	889	0	0	9.411592e-210	0	3.537193e-06
MP:0002115	abnormal limb bone morphology	322	9.762108e-146	6.069584e-228	3.26996e-34	1.231887e-94	0.0005253953
MP:0002116	abnormal craniofacial bone morphology	503	0	0	3.131059e-105	6.295257e-204	0.0002532443
MP:0002118	abnormal lipid homeostasis	831	0	0	1.842657e-261	0	2.274991e-10
MP:0002123	abnormal hematopoiesis	1951	0	0	0	0	2.934818e-55
MP:0002127	abnormal cardiovascular system morphology	1601	0	0	0	0	6.282029e-24
MP:0002128	abnormal blood circulation	653	0	0	1.156658e-225	0	7.187192e-11
MP:0002132	abnormal respiratory system morphology	712	0	0	1.227408e-205	0	1.927588e-05
MP:0002133	abnormal respiratory system physiology	815	0	0	1.481704e-218	0	1.035928e-12
MP:0002135	abnormal kidney morphology	723	0	0	1.140538e-269	0	3.722815e-12
MP:0002136	abnormal kidney physiology	401	0	3.678012e-146	2.084808e-193	0	2.798968e-12
MP:0002138	abnormal hepatobiliary system morphology	881	0	0	0	0	8.650623e-09
MP:0002139	abnormal hepatobiliary system physiology	388	0	1.121162e-162	3.736886e-182	0	0.0001801869
MP:0002144	abnormal B cell differentiation	410	0	1.70199e-73	0	0	2.172029e-18
MP:0002145	abnormal T cell differentiation	589	0	7.04304e-96	0	0	2.902895e-35
MP:0002148	abnormal hypersensitivity reaction	155	2.9617e-176	6.876825e-14	2.74217e-169	3.141195e-213	1.069906e-09
MP:0002151	abnormal neural tube morphology/development	532	0	0	2.98082e-121	0	0.1126797
MP:0002152	abnormal brain morphology	1439	0	0	0	0	2.551802e-11
MP:0002160	abnormal reproductive system morphology	1019	0	5.92878775009496e-323	3.014036e-197	0	8.015841e-11
MP:0002161	abnormal fertility/fecundity	1216	0	0	4.636727e-262	0	1.797142e-06
MP:0002163	abnormal gland morphology	1339	0	0	0	0	9.23608e-16
MP:0002164	abnormal gland physiology	482	0	1.995175e-197	1.155454e-213	9.289232e-286	2.525529e-10
MP:0002166	altered tumor susceptibility	729	0	2.232572e-214	0	0	8.084491e-10
MP:0002168	other aberrant phenotype	132	1.589744e-106	8.112665e-81	1.835097e-55	2.742423e-59	0.0008962185
MP:0002169	no abnormal phenotype detected	1682	0	0	0	0	1.033616e-10
MP:0002174	abnormal gastrulation movements	10	6.068712e-20	5.72236e-06	2.305604e-08	9.047897e-07	0.1146327
MP:0002175	decreased brain weight	73	1.227537e-79	1.632427e-13	1.550856e-06	1.738878e-37	0.3926512
MP:0002176	increased brain weight	29	1.633041e-49	4.395223e-09	1.014122e-11	2.608643e-16	0.001454515
MP:0002177	abnormal outer ear morphology	127	1.671981e-53	6.253343e-115	1.239112e-33	6.89258e-58	0.03884209
MP:0002182	abnormal astrocyte morphology	153	1.175179e-252	5.199733e-52	1.88111e-24	6.536313e-102	0.02008035
MP:0002183	gliosis	167	0	4.751473e-42	9.190717e-64	1.495786e-144	0.03246434
MP:0002184	abnormal innervation	210	3.982996e-132	5.11285e-151	4.672198e-18	9.429488e-40	0.1614684
MP:0002187	abnormal fibula morphology	55	0.0007527369	5.75495e-66	0.00243595	5.602007e-06	0.0759438
MP:0002188	small heart	160	6.776076e-265	2.198335e-110	1.047897e-48	4.810795e-91	0.379516
MP:0002189	abnormal myocardial trabeculae morphology	143	3.253809e-272	1.512131e-84	8.299828e-61	1.183306e-122	0.08328897
MP:0002190	disorganized myocardium	39	1.996117e-73	3.597052e-44	1.619506e-14	1.50763e-43	0.374215
MP:0002191	abnormal artery morphology	436	0	6.65283e-264	1.510963e-164	0	2.375442e-12
MP:0002192	hydrops fetalis	83	1.219752e-185	1.378034e-54	1.069906e-29	3.120001e-96	0.01802372
MP:0002193	minimal clonic seizures	2	0.002337761	0.9996341	0.4249069	0.9316662	0.9219734
MP:0002194	maximal tonic hindlimb extension seizures	4	0.01168244	0.9972786	8.872461e-05	0.02796053	4.476603e-05
MP:0002196	absent corpus callosum	42	3.180013e-11	1.088051e-57	4.818657e-11	2.000221e-06	0.7380736
MP:0002199	abnormal brain commissure morphology	148	4.434305e-87	5.080198e-173	6.217834e-43	7.917047e-62	0.026084
MP:0002200	abnormal brain ventricle/choroid plexus morphology	301	0	4.596337e-215	2.428066e-71	2.632476e-170	0.001289476
MP:0002204	abnormal neurotransmitter level	89	2.650257e-65	8.667308e-39	0.262099	6.257006e-20	0.7388735
MP:0002206	abnormal CNS synaptic transmission	506	2.813665e-281	3.749302e-189	2.02868e-32	1.248095e-101	0.147588
MP:0002207	abnormal long term potentiation	209	1.273884e-153	3.560584e-68	5.362601e-14	1.425373e-49	0.2870927
MP:0002208	abnormal germ cell morphology	544	0	2.469005e-107	5.999721e-96	9.01732e-220	2.580402e-08
MP:0002209	decreased germ cell number	411	0	6.839812e-77	8.80495e-81	5.400041e-178	3.162586e-07
MP:0002210	abnormal sex determination	497	0	1.803691e-110	1.890615e-98	4.043783e-200	4.997742e-05
MP:0002211	abnormal primary sex determination	463	0	2.688837e-89	2.411423e-87	1.079675e-167	1.705257e-05
MP:0002212	abnormal secondary sex determination	76	1.782776e-39	4.359159e-31	3.716924e-13	2.906765e-33	0.2431915
MP:0002213	true hermaphroditism	6	6.736776e-13	0.009847513	3.08314e-05	0.007001071	0.9150428
MP:0002214	streak gonad	2	0.8747294	4.433075e-07	0.345913	0.9127658	0.2922405
MP:0002216	abnormal seminiferous tubule morphology	303	0	7.758982e-79	2.297805e-59	6.212047e-129	0.0002920075
MP:0002217	small lymph nodes	67	1.934539e-93	4.528869e-10	9.661805e-50	1.284576e-97	6.705575e-10
MP:0002218	increased lymph node number	1	0.02517156	0.04953377	0.02439757	0.07108977	1
MP:0002219	decreased lymph node number	4	0.6453305	5.121545e-05	0.004067843	0.0007771857	0.09442805
MP:0002220	large lymphoid organs	25	6.436098e-75	0.003921193	1.19944e-20	2.8151e-50	0.004673728
MP:0002221	abnormal lymph organ size	839	0	3.006351e-167	0	0	4.796819e-24
MP:0002223	lymphoid hypoplasia	13	1.252196e-36	0.002145007	0.0002868304	1.116782e-15	0.4380153
MP:0002224	abnormal spleen size	637	0	3.085627e-111	0	0	3.445272e-17
MP:0002227	abnormal spleen capsule morphology	2	1.399674e-05	0.8798453	0.04192725	0.2570214	1
MP:0002229	neurodegeneration	399	0	1.62353e-123	1.153654e-79	2.596763e-217	3.037464e-10
MP:0002230	abnormal primitive streak formation	67	1.719334e-109	2.55764e-40	1.015576e-28	9.390559e-34	0.1969268
MP:0002231	abnormal primitive streak morphology	134	6.516402e-206	8.120408e-82	3.475146e-54	3.03544e-68	0.1741505
MP:0002233	abnormal nose morphology	142	1.411397e-39	5.038977e-145	9.98768e-13	1.217071e-54	0.03474287
MP:0002234	abnormal pharynx morphology	20	1.44295e-06	2.079757e-08	0.3377906	3.774133e-05	0.7041722
MP:0002235	abnormal external nares morphology	9	0.9956626	1.057973e-20	0.4807192	0.2133343	0.3596734
MP:0002236	abnormal internal nares morphology	8	1.482764e-20	0.9462551	0.0002827813	9.657481e-12	0.7886929
MP:0002237	abnormal nasal cavity morphology	21	0.03145131	2.923393e-34	0.3098199	1.342676e-14	0.8426327
MP:0002238	abnormal nasal mucosa morphology	5	0.01477	0.1060961	0.4102076	0.05020584	0.5402248
MP:0002239	abnormal nasal septum morphology	44	1.471759e-13	7.580607e-72	8.766443e-08	1.743697e-17	0.9882047
MP:0002240	abnormal paranasal sinus morphology	6	7.209137e-06	0.1524144	0.008409075	1.515073e-05	0.5461637
MP:0002241	abnormal laryngeal mucosa goblet cell morphology	1	6.002391e-41	0.2451823	0.2392139	1.061889e-07	1
MP:0002243	abnormal vomeronasal organ morphology	12	0.00613799	1.566107e-16	0.01564882	9.294882e-07	0.8729303
MP:0002244	abnormal turbinate morphology	14	0.1076547	3.591096e-22	0.2794285	1.335264e-09	0.3385579
MP:0002247	abnormal maxillary sinus morphology	4	3.252284e-05	0.6609557	0.01072545	2.308999e-07	0.2132804
MP:0002249	abnormal larynx morphology	41	6.209017e-30	1.501173e-48	3.935757e-08	2.727743e-23	0.9770847
MP:0002251	abnormal nasopharynx morphology	6	1.101737e-09	1.48872e-12	0.03686296	2.361565e-10	0.1305952
MP:0002252	abnormal oropharynx morphology	5	6.936172e-06	1.013607e-05	1.047968e-07	9.060499e-06	0.9625531
MP:0002253	abnormal pharyngeal muscle morphology	2	0.003109821	0.6121243	0.9902655	0.2282571	0.8515102
MP:0002254	reproductive system inflammation	16	0.3116851	3.054231e-09	0.001688488	0.02102618	0.141893
MP:0002256	abnormal laryngeal cartilage morphology	34	4.53513e-13	4.753413e-41	0.03965492	3.795254e-14	0.8532636
MP:0002257	abnormal arytenoid cartilage morphology	5	0.8738516	0.2203188	0.6823411	0.001637075	0.843452
MP:0002258	abnormal cricoid cartilage morphology	17	9.870538e-07	4.804516e-16	0.2013451	3.754564e-05	0.9139241
MP:0002260	abnormal thyroid cartilage morphology	26	4.773589e-15	6.27464e-23	0.02112796	5.725547e-16	0.8734963
MP:0002263	abnormal laryngeal muscle morphology	3	2.915839e-14	6.822445e-05	0.0001440473	4.116631e-05	1
MP:0002264	abnormal bronchus morphology	43	8.237276e-07	3.282226e-52	2.594705e-06	1.083419e-13	0.1324831
MP:0002265	abnormal left major bronchus morphology	2	0.5754978	0.428909	0.05596795	8.884558e-07	0.3991433
MP:0002266	abnormal right major bronchus morphology	2	0.5754978	0.428909	0.05596795	8.884558e-07	0.3991433
MP:0002267	abnormal bronchiole morphology	45	2.634e-12	3.702923e-95	5.254915e-23	1.323727e-23	0.2416407
MP:0002268	abnormal terminal bronchiole morphology	14	0.0007029104	2.799333e-57	1.668724e-10	4.840259e-05	0.08281389
MP:0002269	muscular atrophy	127	3.475963e-136	7.179763e-89	8.400711e-30	5.418154e-48	0.1110802
MP:0002270	abnormal pulmonary alveolus morphology	210	1.157677e-264	4.445631e-203	6.222105e-95	4.340093e-169	0.4025222
MP:0002271	abnormal pulmonary alveolar duct morphology	17	1.222137e-05	6.756391e-06	1.953954e-10	1.460168e-06	0.1767309
MP:0002272	abnormal nervous system electrophysiology	288	3.919786e-85	1.590363e-108	1.792048e-23	1.296383e-47	0.1228172
MP:0002273	abnormal pulmonary alveolus epithelial cell morphology	77	3.138783e-43	1.677994e-100	2.931451e-48	9.377755e-60	0.8524964
MP:0002274	abnormal type I pneumocyte morphology	22	1.439563e-15	3.02387e-28	5.809656e-20	1.808154e-17	0.8178528
MP:0002275	abnormal type II pneumocyte morphology	64	5.437363e-28	4.061204e-63	7.431527e-36	1.569709e-46	0.9107867
MP:0002276	abnormal lung interstitium morphology	27	1.041453e-09	1.535048e-20	5.342446e-09	3.80915e-08	0.6086684
MP:0002277	abnormal respiratory mucosa morphology	26	2.512589e-07	2.669367e-08	0.002707768	8.05314e-09	0.1972001
MP:0002279	abnormal diaphragm morphology	78	4.83638e-26	1.602045e-68	2.24974e-12	4.436247e-25	0.1324879
MP:0002280	abnormal intercostal muscle morphology	13	0.1614075	2.403207e-18	0.4564688	0.02741251	0.05908734
MP:0002281	abnormal respiratory mucosa goblet cell morphology	17	4.945443e-10	2.745856e-09	0.0005277461	2.252774e-06	0.4887777
MP:0002282	abnormal trachea morphology	63	0.02656575	9.09056e-78	0.001509786	4.872588e-12	0.3737422
MP:0002284	abnormal tracheal smooth muscle morphology	3	0.0003988442	0.6513571	0.8302144	0.9990447	0.9473177
MP:0002285	abnormal tracheal ciliated epithelium morphology	9	6.867139e-12	8.952065e-10	5.446161e-09	0.01175897	0.7015511
MP:0002286	cryptorchism	34	7.538333e-08	2.394893e-26	0.1422829	3.854631e-06	0.09646365
MP:0002292	abnormal gestational length	14	0.02503035	2.229396e-16	5.410382e-06	6.12235e-06	0.04404788
MP:0002293	long gestation period	9	0.7857682	4.23713e-08	0.000198732	3.527188e-06	0.006830285
MP:0002294	short gestation period	4	1.414718e-06	1.11691e-12	0.003934533	0.4965848	0.9636208
MP:0002295	abnormal pulmonary circulation	69	2.95726e-67	5.065332e-77	9.61772e-17	1.11923e-45	0.0006303947
MP:0002296	aspiration	3	3.790102e-16	0.1074047	7.497097e-05	2.799078e-13	0.6686002
MP:0002304	abnormal total lung capacity	6	5.035728e-26	0.08196195	1.021262e-14	3.355597e-10	0.119541
MP:0002306	abnormal functional residual capacity	1	0.281202	0.1330011	0.6652537	0.7446288	0.4118376
MP:0002309	abnormal vital capacity	2	0.5177251	0.586636	0.666846	0.213167	1
MP:0002310	decreased susceptibility to hepatic steatosis	56	3.971844e-141	1.759778e-30	1.412524e-43	1.037659e-79	0.5692475
MP:0002313	abnormal tidal volume	13	1.226236e-19	5.559607e-06	0.2984291	9.844102e-05	0.6780102
MP:0002314	abnormal respiratory mechanics	72	1.820918e-41	2.027993e-38	1.032691e-22	9.816751e-27	0.329094
MP:0002316	anoxia	5	1.454545e-12	1.552533e-05	0.418459	0.000437247	0.8860008
MP:0002318	hypercapnia	3	0.7203011	0.3865842	1.24418e-06	0.06206054	0.02875791
MP:0002319	hyperoxia	6	0.3739714	0.5846006	0.1764527	0.1712298	0.9064655
MP:0002320	hyperventilation	1	0.0006596271	0.7381469	1	1	1
MP:0002321	hypoventilation	4	0.9987493	0.001401351	0.9880619	0.9844413	0.990647
MP:0002323	decreased susceptibility to hyperlipidemia	4	1.485222e-12	0.001459545	0.03717251	0.003305399	1
MP:0002324	abnormal alveolocapillary membrane morphology	3	7.318833e-07	0.4346206	6.292308e-08	2.264336e-06	0.5806516
MP:0002327	abnormal respiratory function	384	5.17464e-246	1.654061e-217	1.492113e-75	4.564664e-199	0.0002944157
MP:0002328	abnormal airway resistance	18	8.649561e-09	7.346686e-14	6.220676e-08	7.332797e-05	0.6459099
MP:0002329	abnormal blood gas level	6	0.01284507	0.0006568882	9.310174e-08	8.154748e-05	0.01695872
MP:0002330	abnormal bronchial provocation	49	4.556971e-46	0.5698683	3.009931e-42	1.582717e-46	0.0164055
MP:0002332	abnormal exercise endurance	52	1.006729e-59	1.453557e-44	1.508003e-15	2.282815e-33	0.1900254
MP:0002333	abnormal lung compliance	27	1.271204e-27	8.753517e-17	2.734921e-22	7.514345e-13	0.3217136
MP:0002334	abnormal airway responsiveness	48	1.220611e-49	0.3316282	1.274526e-44	2.545692e-49	0.008287375
MP:0002335	decreased airway responsiveness	25	1.284404e-25	0.3059567	4.94669e-29	1.211783e-30	0.01768854
MP:0002336	abnormal pulmonary gas exchange	2	0.2703331	0.2912	0.01764734	0.3533984	0.1857269
MP:0002338	abnormal pulmonary ventilation	22	5.289466e-09	2.76338e-07	0.1608406	0.0005670795	0.050776
MP:0002339	abnormal lymph node morphology	342	0	2.207105e-66	0	0	5.369609e-24
MP:0002340	abnormal axillary lymph node morphology	18	1.283923e-61	0.0006895237	1.722481e-15	1.095555e-48	0.2082018
MP:0002343	abnormal lymph node cortex morphology	61	3.578505e-85	4.462848e-20	4.05969e-64	3.50035e-106	9.348792e-10
MP:0002344	abnormal lymph node B cell domain morphology	53	9.890404e-67	3.362675e-17	1.99404e-65	5.118805e-91	1.508749e-10
MP:0002345	abnormal lymph node primary follicle morphology	11	0.0001035046	7.369944e-07	3.33793e-14	8.222863e-15	8.796709e-05
MP:0002346	abnormal lymph node secondary follicle morphology	31	4.408361e-48	0.0002663616	2.405529e-49	2.088793e-66	3.043216e-09
MP:0002347	abnormal lymph node T cell domain morphology	4	4.172068e-24	0.001985074	5.924805e-10	3.154688e-16	0.05972991
MP:0002348	abnormal lymph node medulla morphology	9	3.872609e-62	0.9577226	1.14905e-07	1.888808e-39	0.8542556
MP:0002349	abnormal afferent lymphatic vessel morphology	2	0.03882054	0.01389684	0.05325623	0.20543	1
MP:0002351	abnormal cervical lymph node morphology	22	5.430557e-31	8.182198e-06	4.178026e-22	1.314339e-45	0.00554286
MP:0002352	abnormal popliteal lymph node morphology	11	8.947433e-08	2.979044e-07	3.875774e-07	3.469297e-14	0.4704357
MP:0002353	abnormal inguinal lymph node morphology	22	5.287238e-81	0.02189159	6.796957e-20	8.786668e-72	0.2614057
MP:0002356	abnormal spleen red pulp morphology	136	0	1.988623e-12	6.375547e-130	3.42385797922819e-316	0.270938
MP:0002357	abnormal spleen white pulp morphology	315	0	6.064387e-48	3.8004679999885e-313	0	1.81128e-13
MP:0002358	abnormal spleen periarteriolar lymphoid sheath morphology	16	1.945817e-30	9.136181e-07	5.478515e-16	3.733627e-25	0.7046431
MP:0002359	abnormal spleen germinal center morphology	115	3.746596e-144	2.172262e-22	6.601668e-135	2.166225e-171	2.267542e-11
MP:0002360	abnormal spleen B cell corona morphology	4	0.2236754	1.825919e-05	2.226759e-19	0.001259516	0.004124483
MP:0002362	abnormal spleen marginal zone morphology	146	1.571769e-254	4.327229e-24	1.521963e-116	3.510226e-282	1.692358e-05
MP:0002363	abnormal spleen marginal sinus morphology	3	1.599214e-08	0.0001295901	0.0001501183	7.541781e-17	0.2292781
MP:0002364	abnormal thymus size	350	0	2.358874e-80	2.332185e-184	0	2.297105e-11
MP:0002367	abnormal thymus lobule morphology	94	1.493206e-152	1.355541e-33	3.237993e-65	1.422494e-155	1.689372e-05
MP:0002369	abnormal thymus subcapsular epithelium morphology	1	0.2623658	1.324959e-06	0.02326111	1.417257e-09	0.02789339
MP:0002371	abnormal thymus cortex morphology	48	1.888142e-76	1.306652e-33	1.002112e-40	8.322206e-103	0.008329292
MP:0002375	abnormal thymus medulla morphology	42	1.049712e-85	1.780786e-19	3.333769e-31	8.31279e-89	1.850008e-09
MP:0002376	abnormal dendritic cell physiology	149	3.321297e-197	2.076596e-22	3.157862e-152	5.98612e-211	2.580967e-13
MP:0002377	abnormal mucosa-associated lymphoid tissue morphology	3	2.426409e-11	3.537103e-05	3.796337e-09	2.286929e-12	0.3062209
MP:0002378	abnormal gut-associated lymphoid tissue morphology	90	6.795888e-126	3.49155e-29	2.606593e-108	9.542886e-176	4.250122e-08
MP:0002379	abnormal oropharyngeal lymphoid tissue morphology	1	0.9930732	1.84821e-07	0.0003157966	0.000666837	0.08911155
MP:0002389	abnormal Peyer's patch follicle morphology	28	1.594592e-62	3.280371e-18	6.5012e-35	2.57365e-86	0.02954107
MP:0002391	abnormal Peyer's patch germinal center morphology	15	1.585779e-27	1.202602e-10	6.910807e-19	6.150337e-41	0.2795563
MP:0002392	abnormal Peyer's patch T cell area morphology	10	1.058788e-39	0.0009176252	3.89286e-15	4.081625e-41	0.1092559
MP:0002396	abnormal hematopoietic system morphology/development	2175	0	0	0	0	1.287102e-54
MP:0002397	abnormal bone marrow morphology	46	7.893539e-127	1.280873e-38	9.455972e-38	7.705041e-73	0.423658
MP:0002398	abnormal bone marrow cell morphology/development	1142	0	1.829024e-165	0	0	5.364158e-46
MP:0002399	abnormal pluripotent precursor cell morphology/development	11	2.063132e-32	0.3229716	0.6350143	2.136362e-09	0.590213
MP:0002400	abnormal multipotent stem cell morphology	1	0.02517156	0.04953377	0.02439757	0.07108977	1
MP:0002401	abnormal lymphopoiesis	796	0	3.916077e-113	0	0	3.396638e-45
MP:0002403	abnormal pre-B cell morphology	120	0	2.166126e-13	6.378147e-93	6.323883e-263	0.1171135
MP:0002404	increased intestinal adenoma incidence	48	1.921852e-86	8.505538e-28	3.474819e-25	1.596174e-41	0.03982624
MP:0002405	respiratory system inflammation	217	3.421099e-242	1.387762e-57	1.420342e-127	4.226241e-239	7.85928e-05
MP:0002406	increased susceptibility to infection	459	0	1.00151e-73	1.837723e-226	0	3.069098e-28
MP:0002407	abnormal double-negative T cell morphology	166	0	3.851717e-37	3.621308e-127	6.464845e-288	2.626782e-14
MP:0002408	abnormal double-positive T cell morphology	221	0	2.358992e-45	1.783971e-169	0	7.214679e-17
MP:0002409	decreased susceptibility to infection	179	3.651029e-173	1.067291e-20	4.917044e-112	1.976947e-175	1.664608e-16
MP:0002410	decreased susceptibility to viral infection	53	1.687445e-88	5.133104e-07	7.656385e-48	1.933427e-76	4.563884e-11
MP:0002411	decreased susceptibility to bacterial infection	103	8.555421e-75	7.119113e-15	2.784866e-45	1.407326e-80	0.00241986
MP:0002412	increased susceptibility to bacterial infection	294	0	1.283488e-40	3.418004e-123	2.66241799999979e-311	3.716072e-16
MP:0002413	abnormal megakaryocyte progenitor cell morphology	278	0	4.599976e-46	4.491593e-160	0	1.246454e-06
MP:0002414	abnormal myeloblast morphology/development	865	0	4.345821e-123	0	0	2.138714e-45
MP:0002415	abnormal neutrophil differentiation	14	3.672789e-19	2.53581e-09	1.877876e-13	5.080567e-17	0.06267084
MP:0002416	abnormal proerythroblast morphology	65	2.460994e-179	9.971373e-07	2.6235e-22	4.005237e-148	0.02610327
MP:0002417	abnormal megakaryocyte morphology	270	0	2.627213e-44	1.118762e-153	0	4.456678e-07
MP:0002418	increased susceptibility to viral infection	111	1.066351e-148	1.798089e-12	6.017027e-71	6.678768e-127	9.027052e-18
MP:0002419	abnormal innate immunity	577	0	6.152209e-91	0	0	1.469065e-34
MP:0002420	abnormal adaptive immunity	1343	0	1.05665e-215	0	0	1.089112e-65
MP:0002421	abnormal cell-mediated immunity	1327	0	1.31629e-221	0	0	1.856117e-62
MP:0002422	abnormal basophil morphology	17	7.10328e-63	0.7596504	7.201765e-36	4.709051e-67	0.09119263
MP:0002423	abnormal mast cell physiology	65	3.74038e-130	0.001144955	3.705707e-59	4.341446e-118	8.867258e-08
MP:0002424	abnormal reticulocyte morphology	102	0	1.044462e-13	3.046722e-56	1.113983e-221	0.4653073
MP:0002425	altered susceptibility to autoimmune disorder	294	0	1.381453e-54	8.427519e-281	0	4.235154e-17
MP:0002427	disproportionate dwarf	58	1.086041e-83	5.557585e-31	2.155244e-27	2.184484e-31	0.1092857
MP:0002428	abnormal semicircular canal morphology	63	0.04489557	2.025503e-88	0.09431059	0.0003122381	0.2384163
MP:0002429	abnormal blood cell morphology/development	1970	0	0	0	0	5.404323e-56
MP:0002432	abnormal CD4-positive T cell morphology	415	0	1.915105e-79	0	0	1.235665e-22
MP:0002433	abnormal T-helper 1 cell morphology	48	5.667363e-55	8.687893e-09	4.762862e-59	3.09046e-78	0.0006360134
MP:0002434	abnormal T-helper 2 cell morphology	41	1.555582e-43	8.232164e-13	3.632024e-52	1.49126e-66	0.0005382628
MP:0002435	abnormal effector T cell morphology	519	0	7.135452e-93	0	0	5.230265e-30
MP:0002436	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	10	5.839923e-19	0.9910246	8.690138e-11	7.072888e-13	0.3751528
MP:0002439	abnormal plasma cell morphology	73	1.215505e-64	1.919848e-14	8.552311e-110	8.35479e-117	2.200705e-17
MP:0002440	abnormal memory B cell morphology	17	2.047141e-05	2.353863e-06	6.585871e-18	2.888344e-16	9.846393e-07
MP:0002441	abnormal granulocyte morphology	420	0	2.546872e-90	0	0	4.133181e-12
MP:0002442	abnormal leukocyte physiology	1292	0	3.383609e-217	0	0	5.458462e-64
MP:0002443	abnormal eosinophil differentiation	1	0.0003765114	2.479831e-05	0.0001127399	0.006727781	1
MP:0002444	abnormal T cell physiology	623	0	6.422925e-118	0	0	7.869082e-45
MP:0002445	abnormal mononuclear cell differentiation	802	0	6.591445e-115	0	0	5.940275e-45
MP:0002446	abnormal macrophage morphology	380	0	2.440648e-149	6.197336e-249	0	3.261104e-07
MP:0002447	abnormal erythrocyte morphology	597	0	2.716611e-135	8.746532e-266	0	0.0003101455
MP:0002450	abnormal lymph organ development	12	7.748246e-13	7.919772e-09	5.127189e-10	1.384022e-25	0.1064556
MP:0002451	abnormal macrophage physiology	385	0	1.600458e-77	2.019154e-300	0	3.537328e-12
MP:0002452	abnormal professional antigen presenting cell physiology	884	0	2.453832e-159	0	0	3.515986e-29
MP:0002453	abnormal B lymphocyte antigen presentation	26	1.297438e-14	0.3435415	1.060367e-30	1.812322e-19	0.1401848
MP:0002454	abnormal macrophage antigen presentation	11	2.996562e-15	0.4066266	1.404216e-22	1.507697e-08	0.0325154
MP:0002455	abnormal dendritic cell antigen presentation	34	1.6401e-22	0.6492012	1.105734e-26	3.483722e-63	0.05803563
MP:0002458	abnormal B cell number	508	0	6.62358e-94	0	0	1.0302e-24
MP:0002459	abnormal B cell physiology	586	0	6.166837e-83	0	0	5.478586e-27
MP:0002460	decreased immunoglobulin level	304	5.60626169648979e-319	2.971679e-51	1.291899e-263	0	1.499293e-18
MP:0002461	increased immunoglobulin level	288	0	8.128721e-34	4.01422408458263e-318	0	5.346943e-19
MP:0002462	abnormal granulocyte physiology	248	0	1.540591e-27	6.113603e-191	0	3.359478e-20
MP:0002463	abnormal neutrophil physiology	171	2.671769e-310	3.460887e-29	8.843011e-118	0	1.439491e-10
MP:0002464	abnormal basophil physiology	1	0.2711275	1	1	0.001537641	1
MP:0002465	abnormal eosinophil physiology	30	3.518101e-78	0.0008459467	1.110706e-39	5.921943e-65	0.001783973
MP:0002467	impaired neutrophil phagocytosis	12	3.0312e-60	0.2283516	0.0002252715	2.06822e-62	0.8746763
MP:0002471	abnormal complement pathway	24	2.418774e-47	0.01401852	4.360234e-19	2.381201e-16	0.05559192
MP:0002472	impaired complement alternative pathway	8	0.001070336	0.007022249	8.069956e-05	7.203682e-07	0.005897476
MP:0002473	impaired complement classical pathway	5	0.008107299	0.9819833	1.787558e-05	0.105102	0.5597774
MP:0002490	abnormal immunoglobulin level	481	0	1.64238e-67	0	0	1.493065e-26
MP:0002491	decreased IgD level	9	0.04118875	0.972514	1.410102e-06	1.724921e-06	1.326069e-06
MP:0002492	decreased IgE level	62	2.366172e-33	1.337205e-08	1.64681e-69	7.263199e-59	1.15505e-08
MP:0002493	increased IgG level	213	7.012346e-285	1.900182e-34	3.29854e-244	0	5.785264e-17
MP:0002494	increased IgM level	125	3.229251e-176	4.553175e-30	4.881687e-171	6.395716e-227	1.15148e-11
MP:0002495	increased IgA level	62	6.036278e-77	0.001040543	5.169569e-72	2.518686e-101	3.10282e-05
MP:0002496	increased IgD level	1	0.07127867	0.7812047	0.0108416	0.0001966662	1
MP:0002497	increased IgE level	79	6.945189e-156	1.186258e-06	1.368154e-104	6.994766e-125	7.956724e-06
MP:0002498	abnormal acute inflammation	303	0	7.031535e-29	1.938341e-270	0	8.512616e-12
MP:0002499	chronic inflammation	66	2.927838e-186	1.01205e-21	5.178955e-56	1.229315e-88	0.1555022
MP:0002500	granulomatous inflammation	35	2.524395e-70	1.357577e-17	9.906607e-37	5.571791e-42	0.160645
MP:0002503	abnormal histamine physiology	4	4.007914e-06	0.7001811	9.758241e-09	0.1584567	0.02981587
MP:0002531	abnormal type I hypersensitivity reaction	61	1.971711e-83	0.03019808	4.191217e-78	4.549581e-89	4.409843e-07
MP:0002533	abnormal type III hypersensitivity reaction	6	0.7246776	7.168309e-05	0.190967	3.448377e-08	0.815151
MP:0002534	abnormal type IV hypersensitivity reaction	91	8.661158e-95	7.516275e-17	5.223753e-97	2.900329e-128	0.0002465586
MP:0002543	brachyphalangia	18	0.8784494	5.350999e-19	0.6303623	0.9150991	0.9886108
MP:0002544	brachydactyly	30	0.0003450952	7.856649e-20	0.3723488	0.4562471	0.9174863
MP:0002546	mydriasis	17	0.8186855	0.008484624	0.006485615	0.004142808	0.03959037
MP:0002551	abnormal blood coagulation	244	0	2.296612e-39	4.027254e-124	2.808351e-271	2.344328e-11
MP:0002553	preference for addictive substance	13	2.166453e-06	1.254806e-10	0.006895906	2.467468e-05	0.1061755
MP:0002555	addiction	1	4.062106e-05	0.01271842	0.1789641	0.1281295	1
MP:0002556	abnormal cocaine consumption	3	0.4021698	0.01413062	0.8337768	0.2573404	0.8546025
MP:0002557	abnormal social/conspecific interaction	308	8.830358e-152	1.107147e-115	1.271341e-42	9.256264e-68	0.06644577
MP:0002558	abnormal circadian period	33	8.661008e-32	0.001683128	0.0002095834	1.199839e-16	0.3470131
MP:0002560	arrhythmic circadian persistence	11	0.02644613	1.073902e-06	1.144323e-05	8.336478e-06	0.1742711
MP:0002561	abnormal circadian phase	29	9.498932e-05	6.936746e-14	1.310385e-06	6.592099e-09	0.3642381
MP:0002562	prolonged circadian period	8	2.057713e-36	0.05631201	2.558115e-10	6.48821e-15	0.2192749
MP:0002563	shortened circadian period	27	4.085755e-20	0.001259896	0.2176815	3.606877e-10	0.7144507
MP:0002564	advanced circadian phase	8	0.02766373	1.111331e-07	0.5705368	3.594979e-07	0.5479476
MP:0002565	delayed circadian phase	9	0.0006012063	5.478513e-16	9.205428e-16	3.264673e-08	0.1477954
MP:0002566	abnormal sexual interaction	78	2.879649e-33	6.55525e-39	2.366012e-10	3.642607e-10	0.6649271
MP:0002570	alcohol aversion	6	5.926917e-06	0.9474571	0.2277279	0.0009409405	0.08572022
MP:0002572	abnormal emotion/affect behavior	456	1.279022e-214	8.742674e-109	5.423531e-37	1.255578e-114	0.2143796
MP:0002573	behavioral despair	32	8.238071e-44	1.044455e-10	0.0006070321	4.991758e-17	0.01824441
MP:0002574	increased vertical activity	48	2.580462e-24	3.725734e-09	0.0004683075	6.090888e-21	0.8342297
MP:0002575	increased circulating ketone body level	37	5.847673e-20	2.153391e-39	4.662341e-10	6.533627e-14	0.07038758
MP:0002576	abnormal enamel morphology	30	0.1273823	2.004764e-14	0.0791179	0.005778486	0.3113391
MP:0002577	reduced enamel thickness	7	0.6705446	0.5614484	0.003024061	0.05985274	0.1445214
MP:0002578	impaired ability to fire action potentials	16	0.9470647	1.382792e-17	0.9573378	0.9887011	0.200622
MP:0002579	disorganized secondary lens fibers	12	5.629295e-11	2.026436e-12	6.702014e-09	0.0001559245	0.0004810158
MP:0002580	duodenal lesions	4	0.02892308	0.0004632136	0.3977567	0.02847434	0.0824988
MP:0002581	abnormal ileum morphology	26	2.954951e-61	4.098453e-10	2.773799e-14	1.238949e-35	0.9231223
MP:0002582	disorganized extraembryonic tissue	23	6.295448e-79	1.485451e-05	1.554768e-12	1.023131e-26	0.6293355
MP:0002583	absent extraembryonic ectoderm	9	1.626135e-34	3.140418e-07	1.466384e-09	4.812836e-05	0.3771654
MP:0002584	small ectoplacental cone	17	2.736577e-31	0.0009062437	0.008974203	6.351121e-11	0.3787004
MP:0002586	abnormal platelet volume	34	1.200504e-119	0.0001677352	1.072063e-22	5.667601e-33	4.495576e-05
MP:0002590	increased mean corpuscular volume	64	8.741453e-198	2.955581e-09	4.09417e-19	1.288476e-96	0.002014766
MP:0002591	decreased mean corpuscular volume	61	1.252634e-205	0.001967964	9.437657e-18	2.167791e-127	0.6359463
MP:0002593	high mean erythrocyte cell number	5	1.836092e-11	0.407625	1.606579e-10	6.843183e-05	0.08683348
MP:0002594	low mean erythrocyte cell number	16	6.332467e-32	9.189972e-05	3.62537e-15	1.391808e-17	0.002802243
MP:0002596	abnormal hematocrit	227	0	2.121693e-70	7.721553e-95	2.267547e-282	0.01531992
MP:0002599	increased mean platelet volume	31	2.085804e-93	0.0002074912	1.115688e-20	1.84741e-31	0.01255184
MP:0002602	abnormal eosinophil cell number	104	2.209551e-144	1.024473e-10	3.605815e-121	1.892993e-167	0.0002062238
MP:0002606	increased basophil cell number	7	5.76996e-47	0.9882236	4.880613e-16	5.561711e-34	0.2723618
MP:0002607	decreased basophil cell number	12	2.62907e-33	0.2960105	3.272107e-27	2.261927e-34	0.1075258
MP:0002608	increased hematocrit	41	4.337458e-69	4.466525e-16	1.438629e-17	1.257772e-34	0.05057576
MP:0002619	abnormal lymphocyte morphology	1207	0	2.221888e-216	0	0	3.948022e-50
MP:0002620	abnormal monocyte morphology	156	3.28898e-305	1.845395e-28	3.393107e-134	1.446669e-278	2.584455e-06
MP:0002621	delayed neural tube closure	25	1.293985e-67	6.335933e-40	2.122312e-15	7.621017e-28	0.9974514
MP:0002622	abnormal cochlear hair cell morphology	163	3.802105e-144	1.687297e-86	5.951584e-27	5.833169e-67	0.0002410405
MP:0002623	abnormal vestibular hair cell morphology	40	4.01682e-12	5.450678e-23	3.679655e-12	1.260266e-05	0.0166154
MP:0002624	abnormal tricuspid valve morphology	25	9.586734e-33	2.625973e-37	2.139781e-05	9.062891e-19	0.8262928
MP:0002625	heart left ventricle hypertrophy	58	1.315905e-40	1.554617e-58	2.335902e-10	5.244902e-29	0.1157243
MP:0002626	increased heart rate	64	1.003065e-45	6.108675e-32	3.805928e-13	8.084808e-21	0.001874363
MP:0002627	teratoma	19	2.966483e-36	2.086444e-05	1.15422e-11	6.76614e-16	0.1279986
MP:0002628	hepatic steatosis	184	1.8748e-227	6.090622e-86	1.608697e-62	3.362931e-96	0.006838648
MP:0002629	hyperactivity elicited by ethanol administration	5	4.822366e-08	6.378385e-12	0.6926688	0.030017	0.9905267
MP:0002630	abnormal endocochlear potential	21	1.440296e-10	2.622363e-11	9.412799e-08	4.162936e-06	0.0982281
MP:0002631	abnormal epididymis morphology	92	2.101265e-74	9.237256e-35	1.895134e-09	6.036131e-33	2.348986e-05
MP:0002632	vestigial tail	9	2.767955e-08	7.577939e-15	0.3493172	0.006502195	0.4885103
MP:0002633	persistent truncus arteriosis	71	3.138301e-33	6.042699e-88	2.419178e-15	2.690968e-28	0.04798811
MP:0002634	abnormal sensorimotor gating	13	3.152895e-21	0.8127349	0.0007527578	5.699804e-20	0.5864322
MP:0002635	reduced sensorimotor gating	7	6.962304e-10	0.940264	0.03673917	9.659853e-07	0.4292477
MP:0002636	delayed vaginal opening	16	7.192891e-08	1.814181e-17	0.04555016	7.627838e-08	0.2231331
MP:0002637	small uterus	62	7.173748e-32	3.840759e-27	8.821322e-16	2.679226e-12	2.265644e-05
MP:0002638	abnormal pupillary reflex	23	1.953323e-09	3.199936e-06	0.001220407	5.092275e-06	0.03308493
MP:0002639	micrognathia	49	2.439165e-40	9.153819e-51	5.785162e-07	8.429091e-14	0.04223214
MP:0002640	reticulocytosis	87	1.742256e-278	2.173682e-09	8.529569e-47	5.744285e-195	0.7588243
MP:0002641	anisopoikilocytosis	19	2.594971e-107	0.4603079	7.956443e-09	8.881997e-38	0.2131363
MP:0002642	anisocytosis	46	1.13879e-116	0.002509133	4.988772e-22	1.706965e-64	0.5908519
MP:0002643	poikilocytosis	38	1.203723e-81	0.4324255	2.183744e-24	4.691615e-52	0.406661
MP:0002644	decreased circulating triglyceride level	157	9.45979e-248	4.584581e-66	1.113654e-72	1.763805e-142	0.006363591
MP:0002645	abnormal intestinal cholesterol absorption	14	6.560733e-09	4.827616e-05	0.000317825	0.008096168	0.1658737
MP:0002646	increased intestinal cholesterol absorption	3	0.9245109	6.333499e-07	0.05121608	6.932759e-05	0.8639162
MP:0002647	decreased intestinal cholesterol absorption	12	1.527389e-10	0.0002046381	0.0001049444	0.003371196	0.1032871
MP:0002648	delaminated enamel	1	0.9832667	0.8026146	0.9025295	0.1364499	0.2490182
MP:0002649	abnormal enamel rod pattern	4	0.7787972	4.771521e-12	0.3249369	0.05791681	0.03279693
MP:0002650	abnormal ameloblast morphology	21	0.1745424	7.706913e-18	0.8958459	0.1616119	0.3185614
MP:0002651	abnormal sciatic nerve morphology	42	5.43517e-41	9.086353e-45	5.776153e-11	2.542335e-13	0.0005729513
MP:0002652	thin myocardium	89	3.535151e-185	1.97156e-67	1.06065e-42	9.504569e-107	0.5169302
MP:0002653	abnormal ependyma morphology	27	1.968105e-80	2.15918e-20	5.331232e-09	4.326137e-19	0.4119714
MP:0002654	spongiform encephalopathy	15	6.20733e-11	3.572134e-11	0.06838561	0.0001374737	0.03630959
MP:0002655	abnormal keratinocyte morphology	73	1.208788e-145	8.548583e-73	2.67129e-43	2.575845e-61	0.03321718
MP:0002656	abnormal keratinocyte differentiation	31	2.512343e-37	2.800225e-50	1.495826e-12	6.247796e-14	0.008885179
MP:0002657	chondrodystrophy	26	1.474736e-25	1.185311e-29	4.110601e-11	2.572424e-11	0.195684
MP:0002658	abnormal liver regeneration	32	1.582552e-47	3.496759e-21	1.086896e-10	1.500541e-17	0.05994158
MP:0002659	pituitary gland hypoplasia	13	0.001883527	4.067059e-16	0.0008541185	1.746945e-13	0.1863618
MP:0002660	abnormal caput epididymis morphology	13	0.2274065	0.001854647	7.121298e-05	0.7238724	0.3417888
MP:0002661	abnormal corpus epididymis morphology	6	0.3379167	0.03710399	0.9118967	0.1930088	0.09568514
MP:0002662	abnormal cauda epididymis morphology	8	3.003983e-05	0.9984514	0.9943612	0.9972933	0.8220098
MP:0002663	failure to form blastocele	25	1.234989e-33	1.199023e-22	1.53876e-06	3.964808e-13	0.003527049
MP:0002664	decreased circulating adrenocorticotropin level	10	1.192263e-12	2.726042e-07	9.720409e-10	2.354563e-05	0.3521042
MP:0002665	decreased circulating corticosterone level	31	5.826928e-12	0.0002113502	1.560976e-06	6.772136e-05	0.6653277
MP:0002666	increased circulating aldosterone level	21	1.632087e-17	4.923398e-34	1.025087e-05	3.549603e-08	0.02844271
MP:0002667	decreased circulating aldosterone level	15	1.123384e-49	3.069343e-17	1.420779e-05	2.941659e-15	0.3820817
MP:0002668	abnormal circulating potassium level	43	2.001819e-22	2.737363e-37	0.0001067379	2.331285e-16	0.02564716
MP:0002669	abnormal scrotum morphology	7	0.1678431	6.875415e-05	0.4266164	0.008666433	0.215235
MP:0002670	absent scrotum	4	0.05577018	2.192694e-07	0.4647214	0.1420086	0.6723641
MP:0002671	belted	6	8.501374e-05	1.810963e-08	0.03356805	0.406314	0.6269729
MP:0002672	abnormal branchial arch artery morphology	55	6.953778e-56	6.599779e-40	1.634664e-29	1.454384e-74	0.001552642
MP:0002673	abnormal sperm number	348	0	5.217463e-55	1.558976e-63	1.706329e-170	6.272617e-05
MP:0002674	abnormal sperm motility	167	4.58604e-150	2.044577e-10	5.583326e-21	7.196e-45	0.2463082
MP:0002675	asthenozoospermia	145	2.182595e-148	3.282931e-09	1.619594e-19	5.002876e-40	0.1339446
MP:0002676	uterus hyperplasia	6	6.066559e-07	0.000978904	0.002082152	0.2872816	0.1811258
MP:0002678	increased follicle recruitment	3	0.1966925	0.9970368	0.710219	0.9752758	0.05161253
MP:0002679	abnormal corpus luteum morphology	100	4.009844e-62	2.110816e-31	3.115333e-26	2.580558e-34	1.809387e-06
MP:0002680	decreased corpora lutea number	28	1.662862e-27	4.41664e-07	3.487992e-09	2.957606e-10	0.006052203
MP:0002681	increased corpora lutea number	8	0.001680116	7.129597e-05	0.006645337	1.844755e-06	0.1662811
MP:0002682	decreased mature ovarian follicle number	60	4.876665e-62	4.573285e-10	1.646984e-11	5.283209e-23	0.002190102
MP:0002683	delayed fertility	19	0.01687652	2.056629e-05	1.81433e-05	8.236214e-12	0.01020446
MP:0002685	abnormal spermatogonia proliferation	18	9.468531e-39	0.06273066	5.631451e-14	6.720251e-16	0.1901836
MP:0002686	globozoospermia	34	2.424399e-46	0.002172325	0.0004393619	9.446707e-13	0.4930247
MP:0002687	oligozoospermia	205	7.043926e-185	5.201222e-36	3.340947e-37	1.183837e-87	0.002887331
MP:0002689	abnormal molar morphology	48	0.02816827	1.872088e-54	0.009972071	3.224109e-08	0.004174663
MP:0002690	akinesia	20	6.940212e-18	2.006616e-11	0.02815547	2.383467e-08	0.7345471
MP:0002691	small stomach	22	0.1233658	8.279371e-30	0.1061329	0.001363255	0.4993291
MP:0002693	abnormal pancreas physiology	246	1.308671e-223	4.948869e-120	2.941655e-114	2.449047e-143	1.543091e-10
MP:0002694	abnormal pancreas secretion	150	7.285719e-135	9.985607e-109	2.147999e-51	3.589072e-73	0.0003284075
MP:0002695	abnormal circulating glucagon level	37	1.563717e-24	7.288906e-19	1.759117e-10	1.172748e-16	0.006675896
MP:0002696	decreased circulating glucagon level	20	2.239613e-12	4.19894e-07	6.670817e-07	4.180489e-11	0.1623074
MP:0002697	abnormal eye size	171	3.368675e-153	2.819493e-177	1.075563e-26	7.97787e-90	0.08964406
MP:0002698	abnormal sclera morphology	11	2.002357e-19	1.094051e-11	0.0003322412	2.275682e-05	0.9637623
MP:0002699	abnormal vitreous body morphology	56	4.66804e-84	2.05192e-82	3.163638e-22	4.666009e-49	0.01842597
MP:0002700	opacity of vitreous body	6	0.4527825	0.00229171	0.3535062	0.0009339021	0.03465194
MP:0002702	decreased circulating free fatty acid level	76	9.146441e-151	1.803193e-39	3.505584e-42	7.455663e-88	0.1234578
MP:0002703	abnormal renal tubule morphology	248	1.493944e-251	3.632991e-178	7.424584e-82	6.218572e-127	0.009444501
MP:0002704	tubular nephritis	9	0.03705017	1.550509e-06	0.2523733	0.1203343	0.0008698528
MP:0002705	dilated renal tubules	113	1.843502e-88	3.665383e-96	2.201997e-31	1.288941e-34	0.03452821
MP:0002706	abnormal kidney size	293	1.497429e-186	2.278345e-245	2.791162e-62	3.772587e-98	0.1382257
MP:0002707	abnormal kidney weight	112	1.389822e-76	2.442216e-66	1.195974e-36	9.277533e-36	0.1340112
MP:0002708	nephrolithiasis	4	2.353269e-29	0.2662289	0.04158213	3.268788e-07	0.5936175
MP:0002710	increased glucagon secretion	6	0.984018	0.3229923	0.5232916	0.0861187	0.9358792
MP:0002711	decreased glucagon secretion	10	0.2687631	3.590634e-18	0.01432762	0.9608507	0.02520966
MP:0002712	increased circulating glucagon level	18	1.467163e-19	7.028768e-14	0.0003110656	7.055878e-09	0.003189344
MP:0002713	abnormal glycogen catabolism	12	5.022989e-23	1.415789e-05	3.311128e-12	1.602332e-19	0.7887248
MP:0002714	increased glycogen catabolism rate	3	7.479026e-21	0.5566743	0.01882252	2.039434e-12	1
MP:0002715	decreased glycogen catabolism rate	9	1.055887e-10	3.930969e-06	3.816242e-11	1.677012e-11	0.6465765
MP:0002716	small male preputial glands	7	0.9465564	3.199674e-13	0.252757	0.2832002	0.1231728
MP:0002717	abnormal male preputial gland morphology	14	5.201535e-06	1.375126e-09	0.103453	0.1072694	0.4150015
MP:0002718	abnormal inner cell mass morphology	80	8.912772e-233	4.144023e-31	3.646853e-18	2.872803e-46	0.09300358
MP:0002722	abnormal immune system organ morphology	1103	0	1.994742e-201	0	0	2.93976e-29
MP:0002723	abnormal immune serum protein physiology	986	0	7.52832e-149	0	0	3.692234e-45
MP:0002724	enhanced wound healing	24	9.586638e-22	1.823292e-23	9.47611e-29	6.355427e-27	0.01502504
MP:0002725	abnormal vein morphology	89	1.16577e-29	2.052476e-54	2.331345e-22	9.347625e-55	0.4792186
MP:0002726	abnormal pulmonary vein morphology	9	0.9923902	1.951121e-32	0.11864	0.00628677	0.6346131
MP:0002727	decreased circulating insulin level	213	4.579207e-266	6.687138e-97	3.873147e-95	3.348988e-141	0.0001217495
MP:0002728	absent tibia	9	0.9999956	0.1981496	0.9971587	0.999763	0.8957695
MP:0002729	abnormal inner ear canal morphology	66	0.009415069	1.329249e-99	0.09366468	1.47544e-05	0.2525881
MP:0002730	head shaking	20	4.147825e-28	1.233404e-08	1.577377e-07	1.69017e-17	0.1639278
MP:0002731	megacolon	25	2.367514e-25	2.898368e-25	2.381738e-06	3.75484e-12	0.3457347
MP:0002732	trichoepithelioma	1	1.138766e-08	1	0.4496234	0.02471883	1
MP:0002733	abnormal thermal nociception	142	4.105776e-74	8.487246e-35	1.082943e-20	2.174615e-32	0.205044
MP:0002734	abnormal mechanical nociception	16	2.69806e-12	0.1325585	0.01602487	1.272887e-07	0.1172486
MP:0002735	abnormal chemical nociception	41	3.543182e-17	3.123022e-06	0.08474678	0.00107475	0.803102
MP:0002736	abnormal nociception after inflammation	39	5.619503e-09	0.06173209	0.2985965	3.323888e-06	0.9117434
MP:0002738	hyperresponsive to tactile stimuli	13	0.02317007	2.779584e-05	0.0078733	1.281014e-08	0.2245093
MP:0002739	abnormal olfactory bulb development	56	0.004212313	3.03188e-23	6.762272e-05	7.547359e-07	0.004521724
MP:0002740	heart hypoplasia	28	5.292405e-44	6.761437e-28	1.669664e-07	1.864355e-19	0.9431633
MP:0002741	small olfactory bulb	55	1.346641e-13	6.808096e-32	0.06000137	1.115819e-12	0.0569298
MP:0002742	enlarged submandibular lymph nodes	7	9.780954e-29	0.01383225	2.517024e-13	4.024965e-06	0.3729226
MP:0002743	glomerulonephritis	110	4.661705e-227	4.144387e-12	3.90525e-118	9.639162e-191	2.096762e-09
MP:0002745	abnormal atrioventricular valve morphology	73	1.083439e-64	1.718144e-76	2.707763e-16	1.594959e-32	0.03276292
MP:0002746	abnormal semilunar valve morphology	67	1.829196e-87	2.696534e-67	1.798895e-08	5.451285e-28	0.8164435
MP:0002747	abnormal aortic valve morphology	50	1.396509e-27	3.908746e-73	5.076352e-07	4.835618e-16	0.7112532
MP:0002748	abnormal pulmonary valve morphology	39	1.216212e-45	2.681654e-46	0.0002653339	4.546828e-16	0.8979247
MP:0002750	exophthalmos	18	0.001581582	9.837105e-29	4.520527e-10	1.230996e-12	0.008601672
MP:0002751	abnormal autonomic nervous system morphology	81	1.346586e-41	5.295243e-56	3.278125e-09	4.205663e-18	0.01602815
MP:0002752	abnormal somatic nervous system morphology	811	0	0	7.567085e-131	1.178771e-273	1.551162e-08
MP:0002753	dilated heart left ventricle	93	1.02488e-71	2.595862e-110	4.82854e-16	1.070307e-49	0.002251391
MP:0002754	dilated heart right ventricle	58	6.383596e-33	1.737389e-77	1.6105e-06	8.775621e-33	0.02399967
MP:0002757	decreased vertical activity	120	2.77264e-104	1.760422e-32	1.339959e-20	2.071304e-41	0.03990939
MP:0002758	long tail	7	1.118936e-10	1.757961e-13	2.707893e-06	7.072222e-06	0.4254118
MP:0002759	abnormal caudal vertebrae morphology	72	5.341499e-52	2.521323e-72	1.38762e-07	3.508071e-29	0.937034
MP:0002761	abnormal hippocampal mossy fiber morphology	30	0.002453874	2.559274e-28	0.0003605698	4.695124e-05	0.1275469
MP:0002762	ectopic cerebellar granule cells	23	4.366138e-26	7.533566e-22	7.260547e-13	2.926085e-13	0.1223803
MP:0002763	ectopic Bergmann glia cells	6	1.463791e-13	1.359719e-06	0.0002237282	3.136871e-09	0.4831356
MP:0002764	short tibia	87	6.818714e-17	1.014258e-82	1.43773e-06	5.196382e-23	0.08222722
MP:0002765	short fibula	24	0.9477808	1.497364e-31	0.9999745	0.547355	0.03770132
MP:0002766	situs inversus	33	6.274133e-13	1.067966e-05	7.327415e-05	8.550585e-10	0.07423491
MP:0002767	situs ambiguus	7	0.9504127	8.003832e-19	0.587577	0.5032105	0.9052338
MP:0002768	small adrenal glands	21	5.194878e-23	1.326201e-16	2.695841e-09	5.500849e-09	0.02501522
MP:0002769	abnormal vas deferens morphology	26	3.287025e-17	5.972523e-23	0.3639786	2.705514e-08	0.843569
MP:0002770	absent bulbourethral gland	4	0.7941329	1.128473e-07	0.8584195	0.7737827	0.06524556
MP:0002771	absent prostate gland anterior lobe	3	1.159682e-09	1.422383e-15	0.04404402	7.898679e-05	0.9166523
MP:0002772	brachypodia	7	0.0001523651	7.549596e-06	6.34048e-05	1.006832e-07	0.4742467
MP:0002773	decreased circulating luteinizing hormone level	22	5.96332e-38	1.186426e-07	1.233176e-05	2.269938e-08	0.2301037
MP:0002774	small prostate gland	26	1.424197e-37	0.2745138	0.02059876	1.233509e-08	0.666477
MP:0002776	Sertoli cell hyperplasia	4	0.9999953	0.002343717	0.002697268	0.9950836	0.9531402
MP:0002777	absent ovarian follicles	40	3.090058e-57	3.086246e-08	4.300949e-08	3.437887e-10	0.002400241
MP:0002778	meroanencephaly	1	0.9999736	0.9998923	1	0.4587774	0.8122343
MP:0002779	abnormal sex gland secretion	22	1.636576e-09	6.63665e-16	0.02095914	0.005929172	0.3828518
MP:0002780	decreased circulating testosterone level	58	6.468595e-10	9.600913e-26	6.623333e-22	2.382063e-12	0.001241159
MP:0002781	increased circulating testosterone level	16	4.319867e-05	9.675302e-10	0.004666674	2.069879e-05	0.485681
MP:0002782	abnormal testes secretion	15	0.07002096	9.135736e-08	0.1278431	0.3260982	0.5744657
MP:0002783	abnormal ovarian secretion	8	0.2406133	8.112712e-10	0.5276036	0.2706119	0.05985771
MP:0002784	abnormal Sertoli cell morphology	58	1.687964e-18	6.027696e-11	6.231118e-13	2.193226e-19	0.02422007
MP:0002785	absent Leydig cells	6	0.9959766	1.301423e-09	0.9801338	0.7605097	0.2314155
MP:0002786	abnormal Leydig cell morphology	78	6.652483e-39	1.760796e-44	5.234284e-09	2.389794e-17	0.003806481
MP:0002787	pseudohermaphroditism	11	8.313599e-08	0.2093899	0.9370921	0.1726483	0.851431
MP:0002789	male pseudohermaphroditism	10	0.0004530475	0.4392805	0.9780704	0.4585498	0.9597385
MP:0002790	decreased circulating follicle stimulating hormone level	32	5.343907e-15	2.252488e-08	0.006643776	1.635627e-07	0.1219947
MP:0002791	steatorrhea	10	1.560275e-12	0.005829536	5.381503e-13	2.21044e-13	0.1204219
MP:0002792	abnormal retinal vasculature morphology	107	1.461123e-138	1.590249e-90	8.643827e-60	7.642545e-104	0.0001203116
MP:0002794	lenticonus	1	0.000127582	0.9103801	0.0008251902	0.04183991	1
MP:0002795	dilated cardiomyopathy	72	3.002726e-88	1.846184e-44	1.625998e-09	7.410116e-38	0.5643755
MP:0002796	impaired skin barrier function	72	4.14565e-65	1.80604e-20	6.90824e-18	1.070959e-27	0.216628
MP:0002797	increased thigmotaxis	57	1.093647e-09	4.943678e-22	0.0001805745	0.003104127	0.0127161
MP:0002798	abnormal active avoidance behavior	12	0.0002538117	0.04919603	2.400647e-06	0.2464356	0.2112592
MP:0002799	abnormal passive avoidance behavior	45	2.46999e-09	1.153147e-09	0.0009626091	7.375783e-05	0.04068057
MP:0002800	abnormal short term object recognition memory	6	0.2306185	0.9036881	0.9815125	0.00758772	0.6557649
MP:0002801	abnormal long term object recognition memory	27	1.86206e-45	4.647079e-31	1.415906e-05	6.339448e-15	0.4095901
MP:0002802	abnormal discrimination learning	24	2.757107e-17	0.003687731	0.09783894	0.3801318	0.4652924
MP:0002803	abnormal operant conditioning behavior	9	0.583075	0.8004081	0.676528	0.04081732	0.6249762
MP:0002804	abnormal motor learning	47	9.24953e-26	5.76362e-10	0.01233461	0.0001211572	0.763487
MP:0002805	abnormal conditioned taste aversion behavior	17	4.210798e-09	0.0008792369	0.2204469	3.161115e-06	0.4306102
MP:0002806	abnormal conditioned emotional response	1	1	0.9329748	1	1	1
MP:0002807	abnormal eye blink conditioning behavior	9	0.04980635	0.341098	0.9979154	0.9847885	0.9336418
MP:0002808	abnormal barbering behavior	3	0.9997095	1.226618e-07	0.997611	0.4345752	0.4420818
MP:0002809	increased spinal cord size	7	5.573724e-41	2.139832e-05	0.02493067	6.994717e-17	0.500925
MP:0002810	microcytic anemia	23	1.884484e-76	0.6324091	4.663346e-21	8.335354e-50	0.1092282
MP:0002811	macrocytic anemia	20	1.220808e-32	1.999763e-08	9.422678e-09	9.475542e-42	0.3985354
MP:0002812	spherocytosis	16	4.32794e-80	0.8524161	9.909074e-05	1.104082e-31	0.3236832
MP:0002813	microcytosis	22	2.043003e-84	0.6429248	7.700081e-12	1.02675e-43	0.2868587
MP:0002814	hyperchromasia	6	1.714266e-27	0.982823	3.630261e-06	6.53095e-18	0.1999574
MP:0002816	colitis	142	1.476846e-169	1.511908e-15	1.027299e-66	6.1792e-122	1.828576e-05
MP:0002817	abnormal tooth mineralization	9	0.1307178	6.057763e-12	0.00315912	0.007880033	0.54842
MP:0002818	abnormal dentin morphology	17	5.464231e-07	3.268883e-08	0.006344878	0.01189498	0.7851802
MP:0002819	abnormal pulp cavity morphology	6	3.936582e-05	4.916547e-12	0.07392243	0.004851555	0.6923124
MP:0002820	abnormal premaxilla morphology	40	4.525282e-08	7.020001e-53	0.1190902	5.248141e-10	0.06113809
MP:0002822	catalepsy	9	3.389948e-05	0.09500529	0.1166372	0.2353084	0.06391013
MP:0002823	abnormal rib development	32	4.542239e-22	3.038704e-17	3.857443e-05	3.781526e-16	0.567752
MP:0002824	abnormal chorioallantoic fusion	84	5.520492e-87	2.193993e-62	1.624876e-29	1.272396e-36	0.2543813
MP:0002825	abnormal notochord morphology	79	1.3796e-57	4.157651e-63	2.731842e-12	9.958232e-35	0.3559129
MP:0002826	tonic seizures	30	1.023899e-23	1.194711e-22	5.410722e-10	9.709597e-25	0.0005013221
MP:0002827	abnormal renal corpuscle morphology	322	0	3.968542e-182	6.06611e-191	8.959376e-300	1.536026e-07
MP:0002828	abnormal renal glomerular capsule morphology	107	2.793075e-99	2.731115e-102	1.564149e-46	4.638484e-79	0.01620055
MP:0002829	abnormal juxtaglomerular apparatus morphology	7	0.9819877	4.284914e-10	0.01007136	0.9424448	0.2396671
MP:0002830	gallstones	9	1.3091e-17	0.001587647	0.09389001	0.0003476894	0.01270584
MP:0002831	absent Peyer's patches	22	8.063842e-42	6.920671e-06	3.989959e-12	3.314104e-44	0.1135947
MP:0002832	coarse hair	7	0.2808468	0.0002518575	0.1145737	0.3988512	0.6298838
MP:0002833	increased heart weight	155	2.344791e-161	3.99395e-96	1.099376e-48	2.44649e-105	0.03675051
MP:0002834	decreased heart weight	64	2.148998e-91	8.99674e-52	3.447446e-21	1.757646e-34	0.1083205
MP:0002835	abnormal cranial suture morphology	55	1.269047e-58	4.773512e-63	7.731651e-16	1.087998e-39	0.05327597
MP:0002836	abnormal chorion morphology	47	2.921243e-90	1.207256e-31	4.595548e-17	3.970797e-35	0.02538822
MP:0002837	dystrophic cardiac calcinosis	13	1.667679e-10	0.006422722	0.3713355	2.461581e-13	0.9252718
MP:0002838	decreased susceptibility to dystrophic cardiac calcinosis	1	0.004680066	0.4410056	0.6286851	0.01795318	0.2194996
MP:0002839	increased susceptibility to dystrophic cardiac calcinosis	2	1.099089e-06	0.8188856	0.1968607	1.195338e-07	0.360594
MP:0002840	abnormal lens fiber morphology	53	5.705613e-39	4.753785e-37	2.314816e-46	1.824927e-31	2.52377e-08
MP:0002841	impaired skeletal muscle contractility	35	5.265344e-44	5.013502e-17	5.238054e-06	5.10111e-05	0.7508398
MP:0002842	increased systemic arterial blood pressure	136	1.470131e-112	6.658077e-61	1.453409e-34	2.753638e-64	0.0004841565
MP:0002843	decreased systemic arterial blood pressure	102	2.435384e-33	2.13578e-52	1.369929e-39	3.120359e-33	0.0002736057
MP:0002844	aortic hypertrophy	4	0.002117004	5.406038e-06	0.05813769	1.676448e-05	0.006217464
MP:0002845	abnormal aortic weight	1	0.1347306	0.3575849	0.3886625	0.3864508	0.0146412
MP:0002847	abnormal renal glomerular filtration rate	29	1.87236e-26	1.817868e-13	2.800175e-10	4.857933e-17	0.0002026762
MP:0002849	abnormal saccharin consumption	1	0.7927111	0.9428404	0.1876109	1	1
MP:0002850	saccharin preference	2	0.1665656	1.262594e-06	0.834116	0.9959077	1
MP:0002853	hyposulfatemia	2	0.9972778	0.4791884	0.8306143	0.8307925	1
MP:0002855	abnormal cochlear ganglion morphology	83	2.478853e-75	1.628529e-34	1.562603e-12	2.885145e-20	0.1749254
MP:0002856	abnormal vestibular ganglion morphology	29	0.002927383	1.89128e-13	0.00269222	0.0003452789	0.7691984
MP:0002857	cochlear ganglion degeneration	56	1.749684e-59	5.148873e-18	1.584164e-15	3.771566e-20	0.06219923
MP:0002858	abnormal posterior semicircular canal morphology	20	7.782545e-11	7.088648e-09	0.3829196	0.01823461	0.3770268
MP:0002859	abnormal inner ear canal fusion	3	1.219997e-11	1.125993e-05	0.02350995	1.019958e-06	0.9407034
MP:0002861	abnormal tail bud morphology	24	7.437808e-34	2.586818e-22	1.921852e-06	3.028461e-09	0.1677434
MP:0002862	altered righting response	128	7.959595e-56	2.139028e-69	6.18565e-12	1.695951e-36	0.1883585
MP:0002863	improved righting response	7	1.610284e-09	2.150612e-18	0.0431391	7.09914e-05	0.4656745
MP:0002864	abnormal ocular fundus morphology	536	0	7.852027e-295	1.239071e-141	2.861729e-266	0.0003444835
MP:0002865	increased growth rate	14	4.295985e-06	1.760972e-16	1.696611e-12	6.026787e-09	0.3402739
MP:0002869	increased anti-insulin autoantibody level	5	0.001220467	0.901387	0.2604554	1.43798e-12	0.6931924
MP:0002870	decreased anti-insulin autoantibody level	5	0.9999251	0.94636	0.2554673	0.02086545	0.004068475
MP:0002871	albuminuria	70	7.410112e-89	6.036543e-35	4.313899e-47	1.841917e-58	0.00648319
MP:0002872	polycythemia	16	4.499849e-14	7.363037e-06	2.058257e-24	2.403331e-15	0.3182467
MP:0002873	normal phenotype	1687	0	0	0	0	9.049806e-11
MP:0002874	decreased hemoglobin content	161	0	7.92399e-34	6.369592e-61	1.272468e-247	0.2248191
MP:0002875	decreased erythrocyte cell number	193	0	2.902177e-45	1.439234e-88	0	0.1665054
MP:0002876	abnormal thyroid physiology	26	8.68297e-16	7.186327e-11	5.724902e-07	4.077524e-15	0.185222
MP:0002877	abnormal melanocyte morphology	67	5.063375e-69	1.77055e-21	1.65092e-32	2.004332e-52	0.115611
MP:0002878	abnormal corticospinal tract morphology	16	0.2479424	3.143062e-18	0.9951388	0.592348	0.03851586
MP:0002879	increased cellular sensitivity to X-ray irradiation	6	1.054062e-46	0.937968	0.09597151	2.216222e-09	0.9416129
MP:0002880	opisthotonus	6	0.009733354	1.670883e-09	4.231774e-05	0.001031234	0.8289152
MP:0002881	long hair	5	0.8680667	8.415524e-05	0.001226526	0.4745191	0.002457076
MP:0002882	abnormal neuron morphology	1364	0	0	6.936003e-227	0	5.174645e-11
MP:0002883	chromatolysis	8	2.647771e-10	1.818199e-11	0.0005590651	5.486951e-07	0.1348904
MP:0002884	abnormal branchial arch morphology	153	8.315688e-177	9.704942e-98	5.557794e-75	8.471272e-138	0.002481228
MP:0002885	abnormal AMPA-mediated synaptic currents	29	6.372311e-14	1.968535e-13	0.6808881	0.07817246	0.9907785
MP:0002886	abnormal glutamate-mediated receptor currents	58	9.973248e-41	5.539755e-28	4.295058e-08	7.696481e-15	0.9303075
MP:0002887	decreased susceptibility to pharmacologically induced seizures	26	1.474886e-12	0.0001021882	0.1018788	0.08024421	0.714912
MP:0002888	abnormal NMDA-mediated synaptic currents	29	1.394965e-31	3.330872e-22	0.002343713	7.809214e-07	0.5046717
MP:0002891	increased insulin sensitivity	146	8.821747e-223	1.17775e-93	4.689331e-96	1.14388e-131	2.10264e-05
MP:0002892	decreased superior colliculus size	6	6.612887e-18	4.396486e-12	0.0006567156	4.491667e-06	0.997337
MP:0002893	ketoaciduria	11	1.440912e-12	7.519846e-16	0.0002228788	1.002544e-14	0.05312085
MP:0002894	abnormal otolith morphology	30	3.927306e-32	1.854717e-09	7.928933e-07	7.265711e-11	0.08799443
MP:0002895	abnormal otolithic membrane morphology	33	3.058826e-35	1.263157e-10	1.731137e-06	2.54754e-19	0.05695969
MP:0002896	abnormal bone mineralization	144	2.62336e-106	8.544976e-66	1.823096e-39	1.090109e-61	0.01536572
MP:0002897	blotchy skin	1	1	2.613672e-11	1	0.936322	1
MP:0002898	absent cartilage	8	0.9999634	4.370633e-05	0.9999937	0.9976587	0.8906445
MP:0002899	fatigue	48	1.071305e-42	6.151458e-51	1.275108e-09	6.106901e-23	0.4307554
MP:0002900	abnormal urine phosphate level	19	8.057059e-05	6.804048e-14	0.008077349	0.002178007	0.03776788
MP:0002901	increased urine phosphate level	15	3.566871e-10	1.520932e-05	0.003778242	0.000653421	0.09285713
MP:0002902	decreased urine phosphate level	4	0.9948293	3.150148e-11	0.3639547	0.3498911	0.1394758
MP:0002903	abnormal circulating parathyroid hormone level	26	2.074684e-12	2.821198e-22	1.549437e-10	3.868291e-13	0.3171577
MP:0002904	increased circulating parathyroid hormone level	20	9.228633e-08	2.793961e-22	4.437003e-10	7.287571e-07	0.7138756
MP:0002905	decreased circulating parathyroid hormone level	10	7.729276e-08	2.072479e-06	0.4481329	7.609209e-10	0.007617226
MP:0002906	increased susceptibility to pharmacologically induced seizures	91	1.272392e-38	1.380018e-26	4.658289e-06	3.97809e-07	0.01809818
MP:0002907	abnormal parturition	27	0.002864394	6.887907e-14	7.312204e-06	1.79022e-08	0.01220138
MP:0002908	delayed wound healing	58	2.78314e-47	1.501486e-43	1.354244e-23	6.577315e-56	0.006854799
MP:0002909	abnormal adrenal gland physiology	31	9.540959e-28	3.948499e-22	0.0005036892	3.058717e-16	0.9989531
MP:0002910	abnormal excitatory postsynaptic currents	118	8.544064e-36	5.79079e-63	0.02288528	2.854903e-14	0.5634707
MP:0002911	abnormal inhibitory postsynaptic potential	7	0.987584	0.01781261	0.107224	0.07811591	0.05841968
MP:0002912	abnormal excitatory postsynaptic potential	83	1.699324e-28	8.644441e-19	9.457238e-08	5.159081e-22	0.0001016256
MP:0002913	abnormal PNS synaptic transmission	38	1.427451e-23	1.467019e-30	7.815639e-14	5.346848e-16	0.3472099
MP:0002914	abnormal endplate potential	16	0.2224464	1.276975e-12	1.851953e-06	0.0007311229	0.2445582
MP:0002915	abnormal synaptic depression	111	8.825812e-66	6.65277e-48	0.003511628	1.042226e-16	0.8310353
MP:0002916	increased synaptic depression	17	5.977451e-10	0.0001833305	0.9807579	0.0002835543	0.9501333
MP:0002917	decreased synaptic depression	9	1.21483e-22	2.850372e-10	3.165928e-14	7.316693e-07	0.7074698
MP:0002918	abnormal paired-pulse facilitation	61	1.700078e-32	1.862488e-30	4.201312e-07	8.967535e-14	0.2149177
MP:0002919	enhanced paired-pulse facilitation	33	3.998708e-08	3.765792e-23	0.00541539	0.004764211	0.1682207
MP:0002920	decreased paired-pulse facilitation	26	1.166782e-34	1.527097e-12	8.25019e-06	5.867357e-18	0.6286404
MP:0002921	abnormal post-tetanic potentiation	21	7.999784e-34	0.1483763	0.001144992	1.127822e-06	0.9756474
MP:0002922	decreased post-tetanic potentiation	14	6.547032e-23	0.3865364	0.001313123	0.003074797	0.9110796
MP:0002923	increased post-tetanic potentiation	5	1.851659e-20	0.003249507	0.004844723	6.627234e-10	0.8160415
MP:0002924	delayed CNS synapse formation	3	0.9971637	0.2192616	0.9945582	0.237623	1
MP:0002925	abnormal cardiovascular development	752	0	0	1.028208e-279	0	5.506529e-12
MP:0002926	aganglionic megacolon	9	3.544076e-05	2.189671e-08	4.338252e-08	0.002098092	0.008989645
MP:0002928	abnormal bile duct morphology	42	1.316471e-68	1.356439e-32	4.230926e-24	3.518613e-45	0.242097
MP:0002929	abnormal bile duct development	18	1.743613e-09	1.114083e-15	1.450103e-07	1.350902e-18	0.6609869
MP:0002931	glutaricadicuria	1	1.303535e-05	0.5330962	1	0.6145544	1
MP:0002932	abnormal joint morphology	177	5.290777e-210	1.421434e-176	1.196559e-26	1.318724e-87	0.003918302
MP:0002933	joint inflammation	135	8.282122e-179	3.789264e-35	1.971936e-81	3.503567e-197	0.0004468911
MP:0002935	chronic joint inflammation	2	1.410386e-15	0.3012067	0.001539967	0.0356542	0.05218186
MP:0002936	joint swelling	11	2.910813e-11	0.0001897704	2.400414e-08	6.503517e-12	0.04823714
MP:0002938	white spotting	45	3.198582e-14	9.172288e-19	1.471486e-10	1.765992e-09	0.003497738
MP:0002939	head spot	8	0.03784847	1.277253e-06	0.0003081856	0.007216446	0.0006526811
MP:0002940	variable body spotting	15	0.09207501	4.160196e-08	2.227391e-05	0.06314688	0.0001377882
MP:0002941	increased circulating alanine transaminase level	94	6.264714e-198	4.142888e-33	3.806149e-38	6.022639e-77	0.003232892
MP:0002942	decreased circulating alanine transaminase level	30	2.47833e-95	1.243732e-10	1.476918e-11	4.423944e-42	0.1660708
MP:0002943	abnormal lactate dehydrogenase level	38	7.815337e-44	2.246304e-26	6.153069e-12	2.15033e-53	0.01987591
MP:0002944	increased lactate dehydrogenase level	27	1.031106e-47	1.460576e-25	1.793431e-08	9.005403e-45	0.2062781
MP:0002945	abnormal inhibitory postsynaptic currents	73	1.382277e-21	1.957158e-22	0.01239531	0.0004774202	0.7102146
MP:0002946	delayed axon outgrowth	4	0.9807454	1.03662e-14	0.04867754	0.4099924	0.3577284
MP:0002947	hemangioma	28	1.335819e-64	2.083516e-06	3.194909e-14	1.651779e-45	0.4761447
MP:0002948	abnormal neuron specification	18	3.706324e-08	2.248735e-05	0.7755182	0.0001339365	0.4112199
MP:0002950	abnormal neural crest cell migration	44	3.14968e-20	5.36661e-20	1.029194e-06	8.751397e-18	0.02818923
MP:0002951	small thyroid gland	19	1.949219e-07	1.014231e-06	1.178574e-05	1.676323e-15	0.07575569
MP:0002952	ventricular cardiomyopathy	5	0.1490464	0.4045174	0.596898	3.189525e-06	0.6950434
MP:0002953	thick ventricular wall	44	4.479333e-59	1.657682e-37	1.329842e-11	2.142272e-50	0.9833814
MP:0002955	increased compensatory renal growth	2	0.7255128	0.4330557	0.1690937	0.03561051	0.3260394
MP:0002957	intestinal adenocarcinoma	46	1.008269e-119	2.715684e-05	3.065147e-33	6.349413e-43	0.008237376
MP:0002958	aqueductal stenosis	2	5.273941e-19	0.0001094491	7.57485e-05	1.202511e-05	0.2996514
MP:0002959	increased urine microalbumin level	3	9.432314e-18	0.004887893	0.0001343391	1.32582e-05	1
MP:0002961	abnormal axon guidance	65	3.345472e-05	3.032415e-78	3.363374e-11	7.155041e-09	0.01833733
MP:0002962	increased urine protein level	148	2.335255e-192	1.336821e-50	1.540547e-94	2.962046e-164	0.003821115
MP:0002963	decreased urine protein level	11	1.061814e-10	0.08344932	0.001645336	0.03215752	0.4359722
MP:0002964	aortic elastic tissue lesions	4	0.0001865736	2.925286e-06	0.0004247854	0.0008770121	0.9462395
MP:0002965	increased circulating serum albumin level	13	5.410466e-05	8.845638e-11	0.002127002	0.04052792	0.1135203
MP:0002966	decreased circulating alkaline phosphatase level	25	1.318502e-40	1.558831e-33	4.243131e-06	5.92289e-11	0.01562078
MP:0002968	increased circulating alkaline phosphatase level	87	5.743636e-91	8.070736e-38	1.345177e-41	4.686669e-69	0.001546705
MP:0002969	impaired social transmission of food preference	7	4.609167e-13	0.0897913	0.02986939	0.4520989	0.7754597
MP:0002970	abnormal white adipose tissue morphology	245	0	9.219598e-84	1.544238e-103	1.033599e-201	0.07120868
MP:0002971	abnormal brown adipose tissue morphology	119	1.048917e-233	4.53628e-59	1.58685e-55	2.156018e-124	0.3407633
MP:0002972	abnormal cardiac muscle contractility	240	3.459943e-238	2.689318e-200	7.004974e-65	2.278342e-139	0.0001031804
MP:0002975	vascular smooth muscle hypertrophy	7	0.04390334	0.4457973	0.01429174	0.1141845	0.6946232
MP:0002976	vascular smooth muscle hypotrophy	4	0.9778806	2.009338e-18	0.006376004	0.008429839	0.98728
MP:0002978	absent otoliths	17	3.165153e-21	2.444711e-12	0.0001194263	9.125439e-09	0.2829113
MP:0002980	abnormal postural reflex	136	2.672706e-66	1.821525e-67	2.536912e-14	4.980611e-40	0.1885651
MP:0002981	increased liver weight	106	2.391911e-169	1.891108e-44	8.967952e-23	1.437075e-63	0.1341154
MP:0002982	abnormal primordial germ cell migration	10	0.2036385	3.076414e-28	9.947343e-05	0.02740883	0.1470881
MP:0002983	increased retinal ganglion cell number	11	0.2773644	0.1638251	4.669615e-06	9.16488e-07	0.00311214
MP:0002984	retina hypoplasia	17	6.066344e-18	2.584373e-09	4.826218e-06	8.491523e-22	0.1096147
MP:0002985	abnormal urine calcium level	32	0.0002350586	6.31483e-34	7.505548e-13	1.981816e-07	0.7909026
MP:0002986	decreased urine calcium level	7	0.7845583	3.084411e-26	0.001578845	0.001584046	0.4748225
MP:0002987	abnormal urine osmolality	70	7.295566e-65	5.149375e-48	1.196499e-24	6.539273e-28	0.0325446
MP:0002988	decreased urine osmolality	61	2.030973e-65	1.77653e-43	3.920932e-22	5.192776e-29	0.04451178
MP:0002989	small kidney	206	5.949316e-126	9.952899e-202	1.00543e-47	2.223999e-71	0.01939888
MP:0002990	short ureter	9	0.904878	2.589573e-05	0.997217	0.1908402	0.8805416
MP:0002992	abnormal sebaceous lipid secretion	4	5.012811e-05	0.1545253	0.0009651711	3.057179e-05	0.9807422
MP:0002993	arthritis	126	6.868536e-180	7.561011e-31	4.492366e-75	2.064637e-194	0.001608568
MP:0002995	primary sex reversal	19	7.264495e-26	7.687515e-17	0.003630956	1.494878e-08	0.7807542
MP:0002996	ovotestis	8	4.465621e-18	0.001814477	1.958735e-07	2.629109e-08	0.556137
MP:0002997	enlarged seminal vesicle	9	2.117448e-07	0.004852343	0.6793605	0.002409392	0.4096165
MP:0002998	abnormal bone remodeling	164	3.305537e-127	7.323767e-97	4.869116e-104	3.817664e-146	9.793906e-15
MP:0002999	abnormal bone healing	11	4.247363e-11	0.07925233	2.089525e-06	7.821873e-11	0.1636411
MP:0003005	abnormal hippocampal fimbria morphology	11	1.05012e-06	4.944461e-32	0.3311973	5.965246e-10	0.3341813
MP:0003006	abnormal hippocampal fornix morphology	4	5.855074e-06	3.051133e-05	0.1819236	3.897474e-10	0.9490653
MP:0003007	ectopic thymus	11	1.120901e-25	1.554206e-18	9.240469e-08	5.865308e-19	0.6202405
MP:0003008	enhanced long term potentiation	57	2.18472e-37	8.619955e-06	0.1484334	1.381306e-05	0.9811339
MP:0003009	abnormal cytokine secretion	615	0	1.031241e-88	0	0	5.423387e-40
MP:0003010	decreased mortality induced by ionizing radiation	7	6.824025e-10	1.08006e-08	3.738796e-05	1.352716e-15	0.5354356
MP:0003011	delayed dark adaptation	12	2.371918e-25	6.867788e-08	1.383455e-06	1.735998e-05	0.5508105
MP:0003014	abnormal kidney medulla morphology	62	2.257253e-27	2.32224e-38	3.996715e-09	1.324421e-18	0.003396842
MP:0003015	abnormal circulating bicarbonate level	14	1.159194e-15	1.075568e-09	0.02475485	1.131072e-10	0.4234793
MP:0003016	increased circulating bicarbonate level	3	0.002020579	0.02651392	0.2326238	0.0008433876	0.02275063
MP:0003017	decreased circulating bicarbonate level	11	8.3911e-14	6.956646e-09	0.03809072	2.006572e-08	0.8552058
MP:0003018	abnormal circulating chloride level	41	4.173413e-28	5.203529e-19	1.709248e-06	2.645008e-06	0.03313077
MP:0003019	increased circulating chloride level	21	6.39481e-18	1.76798e-10	0.632542	0.0351334	0.5610614
MP:0003020	decreased circulating chloride level	22	7.747699e-10	6.096113e-13	5.549071e-11	1.007022e-05	0.002275504
MP:0003021	abnormal coronary flow rate	9	7.809333e-05	7.907115e-13	0.03570969	2.270043e-12	0.7181058
MP:0003022	increased coronary flow rate	4	1.323249e-06	0.000320415	0.1116024	8.343916e-10	0.6675716
MP:0003023	decreased coronary flow rate	4	0.5449419	6.192042e-10	0.3083489	0.005460794	0.6081538
MP:0003024	coronary artery stenosis	1	0.9999736	0.1617153	1	1	1
MP:0003025	increased vasoconstriction	21	0.01179786	1.789997e-10	0.001728679	0.001308117	0.03904352
MP:0003026	decreased vasoconstriction	24	1.773579e-37	4.198283e-07	3.214894e-19	4.431015e-24	0.9979834
MP:0003027	abnormal blood pH regulation	31	4.978433e-09	2.241201e-12	0.09193361	2.186053e-08	0.7953949
MP:0003028	alkalosis	5	7.487638e-06	0.0002162757	0.8969277	0.209823	0.4318198
MP:0003029	alkalemia	2	0.9329137	0.8582557	0.751744	0.3598971	0.9249415
MP:0003030	acidemia	5	0.6507422	0.006921568	0.3464656	0.01258055	0.9935887
MP:0003031	acidosis	23	6.887632e-07	1.033252e-13	0.05145157	2.24863e-09	0.7382515
MP:0003032	hypocapnia	2	0.02441832	0.3101304	0.6252666	0.6964443	0.7349563
MP:0003033	abnormal pulmonary vascular resistance	4	7.534734e-20	0.2472014	1.538278e-06	3.448972e-05	0.05295047
MP:0003034	increased pulmonary vascular resistance	1	2.791306e-28	0.8659161	0.1587352	0.3396584	0.1888445
MP:0003035	decreased pulmonary vascular resistance	1	0.7228415	0.6495794	7.013772e-06	0.0003700546	0.04492429
MP:0003036	vertebral transformation	104	5.583657e-153	4.13509e-28	2.67672e-29	3.538064e-68	0.3466906
MP:0003037	increased myocardial infarction size	25	4.465643e-80	1.291643e-05	4.212945e-30	1.91266e-38	0.08927745
MP:0003038	decreased myocardial infarction size	27	1.555098e-97	3.073417e-18	4.376891e-23	2.75597e-75	0.8480584
MP:0003039	increased time of peak ischemic contracture	1	0.05629368	1	1	0.02975808	1
MP:0003043	hypoalgesia	143	7.875676e-110	4.375731e-27	6.337168e-22	3.625686e-31	0.004538219
MP:0003044	impaired basement membrane formation	13	3.448739e-07	3.462555e-24	5.851283e-06	4.96369e-06	0.2548908
MP:0003045	fibrosis	6	0.9809616	1.041064e-15	0.1048297	0.005385515	0.2365748
MP:0003046	liver cirrhosis	5	6.587402e-21	0.0001788271	0.001946975	0.001823782	0.5486058
MP:0003047	abnormal thoracic vertebrae morphology	109	1.465484e-71	4.982131e-87	4.625919e-19	7.34028e-45	0.3580656
MP:0003048	abnormal cervical vertebrae morphology	116	8.071316e-79	1.808583e-103	4.415569e-13	2.703917e-41	0.232716
MP:0003049	abnormal lumbar vertebrae morphology	112	1.686823e-131	9.474717e-43	1.359082e-19	4.201962e-61	0.9553474
MP:0003050	abnormal sacral vertebrae morphology	62	1.730669e-82	6.888449e-47	1.273528e-19	5.10527e-44	0.649098
MP:0003051	curly tail	58	1.110274e-102	7.026882e-58	7.307748e-13	7.087272e-35	0.2443616
MP:0003052	omphalocele	51	9.183324e-20	1.368901e-67	4.134928e-10	1.154738e-12	0.2711296
MP:0003053	delayed tooth eruption	9	0.001543632	1.589314e-14	6.414072e-10	1.236806e-06	0.2806318
MP:0003054	spina bifida	84	3.772731e-84	1.098191e-64	1.935878e-25	4.2749e-50	0.03376067
MP:0003055	abnormal long bone epiphyseal plate morphology	172	3.04871e-204	6.358e-179	3.908797e-68	1.193514e-121	0.6324989
MP:0003056	abnormal hyoid bone morphology	44	7.656558e-23	3.029508e-62	8.019465e-12	3.256784e-20	0.0667677
MP:0003057	abnormal epicardium morphology	20	1.557215e-29	4.961251e-12	2.894551e-12	3.224953e-15	0.6901935
MP:0003058	increased insulin secretion	37	1.698351e-60	4.147142e-34	1.961986e-18	8.85524e-28	0.003474999
MP:0003059	decreased insulin secretion	107	6.496199e-75	4.565288e-81	3.478045e-24	1.618435e-44	0.008836943
MP:0003060	increased aerobic running capacity	4	5.348289e-06	0.1464905	0.0070011	3.039345e-07	1
MP:0003061	decreased aerobic running capacity	3	2.482285e-05	2.025922e-06	0.005403661	0.002110779	0.9017553
MP:0003062	abnormal coping response	28	9.738053e-07	0.000658187	0.1523226	4.686218e-05	0.8087869
MP:0003063	increased coping response	17	0.006830885	1.143768e-05	0.05914714	0.0005099375	0.490572
MP:0003064	decreased coping response	9	2.297775e-07	0.5781349	0.5036907	0.008135896	0.9040865
MP:0003065	abnormal liver copper level	9	4.302459e-17	0.001430849	0.02541946	7.559214e-07	0.1738428
MP:0003066	increased liver copper level	5	4.885601e-24	0.6970684	0.02387349	1.717467e-05	0.7198989
MP:0003067	decreased liver copper level	4	1.573357e-09	0.009201719	0.5996145	0.002006101	0.06772875
MP:0003068	enlarged kidney	106	9.084117e-66	1.134748e-56	1.051974e-16	4.088389e-34	0.8410781
MP:0003069	abnormal superior semicircular canal morphology	19	0.0140325	1.499075e-09	0.973458	0.5368422	0.9794623
MP:0003070	increased vascular permeability	40	1.209961e-47	8.411984e-20	5.898976e-19	2.221286e-43	0.9122526
MP:0003071	decreased vascular permeability	17	6.155072e-16	0.1939431	5.356948e-14	9.207996e-10	0.07348552
MP:0003072	abnormal metatarsal bone morphology	34	0.003928627	8.445206e-45	0.02168829	3.619745e-08	0.7113811
MP:0003073	abnormal metacarpal bone morphology	41	0.009255037	3.256393e-110	0.521948	0.002810138	0.9870284
MP:0003074	absent metacarpal bones	3	0.004369621	9.277045e-26	0.001213207	0.001502178	0.218821
MP:0003075	altered response to CNS ischemic injury	76	1.657107e-82	5.921044e-22	7.997932e-50	3.715619e-58	0.1372686
MP:0003076	increased susceptibility to ischemic brain injury	35	7.167339e-20	6.469403e-12	1.269033e-21	8.669348e-27	0.5123795
MP:0003077	abnormal cell cycle	259	0	6.446413e-35	6.139562e-76	1.996432e-238	0.2599047
MP:0003078	aphakia	27	2.041566e-19	9.138046e-28	0.2195171	2.412672e-07	0.1292861
MP:0003080	increased natural killer cell mediated cytotoxicity	9	2.394238e-12	0.1553991	0.001165176	7.44994e-09	1.681256e-12
MP:0003081	abnormal soleus morphology	19	5.887709e-18	3.951198e-18	0.0002009161	1.647785e-11	0.6412932
MP:0003082	abnormal gastrocnemius morphology	19	0.3870452	3.945511e-09	0.001601792	0.001190035	0.01392789
MP:0003083	abnormal tibialis anterior morphology	18	2.096492e-17	1.948483e-11	4.511445e-05	9.859922e-11	0.6714613
MP:0003084	abnormal skeletal muscle fiber morphology	183	4.964984e-152	2.908573e-127	3.203353e-59	4.240516e-97	3.709081e-05
MP:0003085	abnormal egg cylinder morphology	40	9.723166e-97	1.115307e-27	3.918475e-11	4.063106e-17	0.006543567
MP:0003087	absent allantois	25	1.255479e-28	1.28569e-33	2.474141e-12	2.076552e-15	0.009519412
MP:0003088	abnormal prepulse inhibition	96	2.937042e-35	1.793829e-35	2.540727e-10	4.701691e-19	0.8200643
MP:0003089	decreased skin tensile strength	22	0.04507784	1.973806e-37	0.200362	0.01697417	0.04850778
MP:0003090	abnormal muscle precursor cell migration	9	0.3833874	1.090516e-16	0.0002345134	6.482465e-11	0.0001182106
MP:0003091	abnormal cell migration	465	0	2.742061e-224	6.48386e-208	0	4.308916e-15
MP:0003092	decreased corneal stroma thickness	10	0.8304578	3.600988e-22	0.4068737	0.4442022	0.1343142
MP:0003093	abnormal anterior stroma morphology	1	0.7248003	0.07022086	0.3832671	0.07280409	0.007418096
MP:0003094	abnormal posterior stroma morphology	3	0.9999978	5.245625e-14	0.9955784	0.9540362	0.1965113
MP:0003095	abnormal corneal stroma development	5	0.2539857	1.110134e-05	0.7169992	0.604511	0.497511
MP:0003096	increased corneal light-scattering	2	0.9999579	1.529667e-13	0.2124441	0.2174321	0.7495844
MP:0003097	abnormal tendon stiffness	7	4.852329e-17	1.540549e-16	0.05124027	0.0001930595	0.5762952
MP:0003098	decreased tendon stiffness	6	3.939452e-07	5.928948e-18	0.04628477	0.0008194905	0.4602567
MP:0003099	retinal detachment	13	1.593905e-15	2.866016e-21	0.001018287	1.596923e-07	0.08720283
MP:0003100	myopia	3	6.419683e-06	7.441795e-06	0.009143077	0.0002806504	0.973391
MP:0003101	high myopia	2	2.066172e-05	6.937903e-05	0.9007327	0.1145365	0.8887376
MP:0003102	sclera thinning	2	2.066172e-05	6.937903e-05	0.9007327	0.1145365	0.8887376
MP:0003103	liver degeneration	29	9.530674e-66	1.595616e-08	5.053564e-11	2.182769e-32	0.02487492
MP:0003104	acrania	8	0.005210997	1.355001e-14	0.0003776292	4.590452e-10	0.338635
MP:0003105	abnormal heart atrium morphology	192	4.269192e-187	7.121055e-137	5.57438e-26	1.214059e-92	0.01767908
MP:0003106	abnormal fear-related response	46	0.03206749	4.339099e-06	4.131615e-06	0.322409	0.04758512
MP:0003107	abnormal response to novelty	201	5.760915e-126	1.117448e-46	2.116019e-12	3.505872e-52	0.3185343
MP:0003108	short zygomatic bone	5	0.3121673	0.6708747	0.4694549	7.231275e-06	0.1919942
MP:0003109	short femur	102	1.006262e-21	4.828344e-76	2.021134e-06	1.648078e-22	0.319304
MP:0003110	absent malleus processus brevis	6	0.9999899	4.663259e-09	0.6838259	0.02773102	0.01891467
MP:0003111	abnormal cell nucleus morphology	145	2.47032822920623e-323	1.172865e-07	2.169328e-20	8.816828e-81	0.1545559
MP:0003112	enlarged parathyroid gland	5	0.190755	0.06611956	2.238815e-05	0.02181902	0.05168522
MP:0003114	pigmented parathyroid gland	1	0.9508384	0.5187106	0.1172219	0.07280409	0.02789339
MP:0003115	abnormal respiratory system development	175	1.213407e-141	1.488694e-236	2.077315e-47	3.195911e-102	0.5281564
MP:0003116	rickets	12	2.874368e-07	0.0006913914	4.46158e-07	1.259152e-05	0.05299137
MP:0003118	abnormal tracheal-bronchial branching morphogenesis	2	0.9988408	0.6541427	0.999989	0.9999986	0.9689102
MP:0003119	abnormal digestive system development	83	2.031704e-37	3.2203e-69	6.271115e-09	1.85661e-30	0.6951122
MP:0003120	abnormal tracheal cartilage morphology	32	0.9779811	2.149057e-54	0.2371662	0.001317807	0.4014352
MP:0003121	genetic imprinting	42	5.227387e-44	6.875805e-11	6.329178e-07	0.008410765	0.004070289
MP:0003122	maternal imprinting	22	1.244503e-18	1.212652e-20	1.5868e-09	0.02326203	0.0003938312
MP:0003123	paternal imprinting	13	2.4955e-20	0.1560904	0.02087202	0.005557382	0.1129044
MP:0003124	hypospadia	9	0.8567361	5.454895e-30	0.1759902	0.02661096	0.2188238
MP:0003125	abnormal septation of the cloaca	3	0.9999251	0.00103409	0.9914441	0.9892517	0.4146572
MP:0003126	abnormal external female genitalia morphology	19	0.1167618	4.072072e-35	0.08777825	0.6070891	0.5952254
MP:0003127	abnormal clitoris morphology	8	0.2426345	2.201901e-12	0.3866421	0.5141198	0.005954543
MP:0003128	splayed clitoris	1	0.1947878	7.316015e-05	0.1675448	0.5423956	1
MP:0003129	persistent cloaca	4	0.002134889	2.264039e-14	0.03509525	0.5359906	0.7658101
MP:0003130	anal atresia	11	0.9999966	4.375846e-18	0.9999999	0.9983172	0.9259176
MP:0003131	increased erythrocyte cell number	61	2.10693e-124	3.187052e-17	9.704789e-47	4.042711e-103	0.0551711
MP:0003132	increased pre-B cell number	33	4.261432e-64	0.02931473	7.088715e-45	6.353343e-89	0.1031241
MP:0003133	increased early pro-B cell number	4	1.852273e-33	0.156433	0.1084528	3.120883e-41	0.9050771
MP:0003134	increased late pro-B cell number	1	2.011627e-09	0.8960566	0.4572537	0.06602567	1
MP:0003135	increased erythroid progenitor cell number	41	9.844725e-90	0.02418884	1.586588e-40	1.036663e-86	0.006701914
MP:0003136	yellow coat color	15	1.53311e-08	0.01766418	0.005767981	0.0004030726	0.2653199
MP:0003137	abnormal impulse conducting system conduction	97	8.845648e-116	9.016509e-52	3.086204e-22	4.843842e-40	0.5198953
MP:0003138	absent tympanic ring	17	0.01725948	9.833707e-33	0.001628963	3.213662e-09	0.0113528
MP:0003139	patent ductus arteriosus	16	0.2053336	1.824973e-30	0.1122777	0.3095313	0.03672876
MP:0003140	dilated heart atrium	61	4.787157e-104	2.763506e-58	3.437539e-10	2.424881e-34	0.03404822
MP:0003141	cardiac fibrosis	157	1.86083e-147	2.29992e-84	2.564901e-30	1.444674e-84	0.003108322
MP:0003142	anotia	7	0.01427021	7.308294e-13	0.2179613	0.005778817	0.08230391
MP:0003143	enlarged otoliths	10	3.372369e-12	0.002554078	3.600256e-06	1.313598e-07	0.7859427
MP:0003144	decreased otolith number	8	1.995137e-12	1.933448e-06	0.001733658	5.360728e-10	0.6164024
MP:0003145	detached otolithic membrane	2	0.001318902	0.004891348	0.2663443	0.3869369	0.1051851
MP:0003146	absent cochlear ganglion	6	0.7066713	2.80157e-15	0.3780703	0.7442399	0.7596896
MP:0003147	absent cochlea	7	0.7883439	3.633112e-07	0.3794257	0.03240126	0.02493849
MP:0003148	decreased cochlear coiling	18	0.04752268	8.433003e-21	0.2499316	1.750764e-05	0.2361312
MP:0003149	abnormal tectorial membrane morphology	30	1.751243e-05	6.355602e-15	9.398494e-07	8.481911e-09	0.008971549
MP:0003150	detached tectorial membrane	7	0.0001579834	0.03987204	0.4005711	1.352977e-09	0.03220413
MP:0003151	absent tunnel of Corti	6	0.0001628218	2.123182e-11	0.4970308	0.5695383	0.8164303
MP:0003152	abnormal pillar cell differentiation	4	4.351654e-16	0.02814326	0.8830541	0.02465998	0.9851198
MP:0003153	early eyelid opening	8	0.01290258	6.801031e-24	0.0006299749	0.07937679	0.488775
MP:0003154	abnormal soft palate morphology	9	3.960637e-06	3.712011e-25	4.010917e-06	2.184876e-05	0.01260056
MP:0003155	abnormal telomere length	21	3.019602e-33	0.3854365	0.001394719	1.199094e-07	0.2305473
MP:0003156	abnormal leukocyte migration	153	1.685546e-221	4.335149e-49	7.896462e-137	6.195654e-272	1.388832e-14
MP:0003157	impaired muscle relaxation	17	3.882878e-19	0.2534015	3.766173e-13	4.253398e-09	0.3465572
MP:0003158	dysphagia	9	2.920124e-12	5.481668e-07	0.0542785	0.01268194	0.1255504
MP:0003159	abnormal esophageal smooth muscle morphology	5	0.7689503	7.665364e-09	0.5454705	1.71126e-07	0.5586734
MP:0003160	abnormal esophageal development	9	0.9999892	4.167194e-07	0.770706	0.0001098409	0.3950563
MP:0003161	absent lateral semicircular canal	16	0.4845752	6.620731e-13	0.959366	0.2629675	0.9607075
MP:0003162	decreased lateral semicircular canal size	12	0.09358074	3.201571e-09	0.6576385	0.001722634	0.3218823
MP:0003163	absent posterior semicircular canal	11	1.50291e-09	3.715157e-05	0.3422247	0.0001369512	0.6520352
MP:0003164	decreased posterior semicircular canal size	7	2.068962e-06	7.160634e-07	0.007744093	4.629633e-05	0.765371
MP:0003165	absent superior semicircular canal	5	8.443194e-09	0.001960279	0.7134767	0.02355954	0.3393053
MP:0003166	decreased superior semicircular canal size	7	0.008673645	1.334773e-06	0.03845411	0.001699261	0.7946563
MP:0003167	abnormal scala tympani morphology	3	0.9999759	0.820814	0.9977576	0.9781073	0.06550804
MP:0003168	abnormal scala vestibuli morphology	4	1.716598e-13	6.528742e-06	0.5065091	0.0008647153	0.7626515
MP:0003169	abnormal scala media morphology	196	3.844634e-150	2.388521e-109	8.26101e-22	4.103929e-56	0.005051743
MP:0003171	phenotypic reversion	11	3.040927e-13	0.01690993	3.140363e-10	1.817791e-16	0.2019966
MP:0003172	abnormal lysosome physiology	31	9.329697e-46	2.871549e-16	1.197864e-11	2.006117e-32	0.4692756
MP:0003173	decreased lysosomal enzyme secretion	6	3.911117e-23	0.1314048	3.327781e-07	2.984782e-05	0.8645201
MP:0003174	increased lysosomal enzyme secretion	4	4.89153e-07	0.000288546	0.09159473	0.00523869	0.8885094
MP:0003175	reversion by mitotic recombination	2	1.804567e-16	0.8221793	2.801339e-07	1.096856e-10	0.5854607
MP:0003176	reversion by viral sequence excision	2	0.0003880492	0.0008309846	0.1307218	0.6366413	0.8214476
MP:0003177	allodynia	12	1.15898e-06	9.675948e-09	0.258064	7.371242e-06	0.4631856
MP:0003178	left pulmonary isomerism	18	0.0002540815	3.116168e-07	0.002894806	0.0007739073	0.5785694
MP:0003179	decreased platelet cell number	145	0	5.816806e-30	8.362222e-87	1.015343e-292	0.09843801
MP:0003180	abnormal pulmonary endothelial cell surface	4	0.03740259	5.017384e-08	4.921052e-06	0.03544224	0.3042469
MP:0003182	decreased pulmonary endothelial cell surface	2	0.06782559	0.0002205628	4.963435e-06	0.1588241	0.2060372
MP:0003183	abnormal peptide metabolism	12	1.711445e-25	0.0001235469	1.16353e-11	2.934609e-14	1.591402e-05
MP:0003184	increased angiotensin I-converting enzyme activity	4	7.122348e-18	0.0003835866	6.81813e-09	3.871967e-10	4.703761e-05
MP:0003185	decreased angiotensin I-converting enzyme activity	1	0.02138692	0.007912932	1	0.0008812468	0.0004095485
MP:0003186	abnormal redox activity	105	2.999725e-114	1.39105e-17	1.140822e-37	1.169907e-61	0.000119657
MP:0003189	fused joints	122	2.119566e-131	2.516455e-140	1.120076e-19	2.626135e-53	0.06602687
MP:0003190	fused synovial joints	6	0.02526781	1.865296e-16	0.5085458	0.1693698	0.7601181
MP:0003191	abnormal cellular cholesterol metabolism	15	3.875627e-19	1.836737e-08	3.958647e-15	1.090006e-23	0.9917142
MP:0003192	increased cholesterol efflux	3	4.355851e-06	1.41412e-09	6.704196e-09	4.598203e-12	0.974753
MP:0003193	decreased cholesterol efflux	9	9.762203e-14	3.082059e-05	5.967549e-06	3.814165e-15	0.9789572
MP:0003194	abnormal frequency of paradoxical sleep	11	7.662968e-23	1.713707e-06	3.13022e-06	2.739447e-09	0.4251431
MP:0003195	calcinosis	7	0.8337964	0.003346214	0.07989713	0.1529084	0.002442811
MP:0003196	calcified skin	3	0.6492663	4.799022e-07	0.6953279	0.498606	0.2506185
MP:0003197	nephrocalcinosis	22	2.494432e-07	1.62692e-12	1.160868e-07	1.754376e-05	0.05664857
MP:0003198	calcified tendon	2	0.08548183	7.037444e-08	1.527002e-06	6.877223e-05	0.02120705
MP:0003199	calcified muscle	7	7.927834e-06	1.233978e-07	0.02867762	0.0001467881	0.5129672
MP:0003200	calcified joint	5	5.503269e-12	5.307633e-07	2.731469e-09	6.866713e-09	0.0188282
MP:0003201	extremity edema	8	5.1708e-17	3.247247e-05	0.01627202	3.665898e-09	0.3535719
MP:0003202	abnormal neuron apoptosis	242	0	8.88605e-38	3.74915e-57	4.360674e-143	1.805494e-05
MP:0003203	increased neuron apoptosis	166	1.590484e-260	2.109914e-23	1.456701e-32	1.573325e-111	0.0002463405
MP:0003204	decreased neuron apoptosis	81	4.26147e-106	2.981355e-09	3.82488e-25	1.237641e-40	0.01613504
MP:0003205	testicular atrophy	55	8.748831e-30	5.286297e-18	5.744848e-16	2.774187e-18	0.2715114
MP:0003207	decreased cellular sensitivity to gamma-irradiation	22	2.257032e-49	1.372474e-05	3.025501e-07	1.024183e-36	0.287852
MP:0003208	abnormal neuromere morphology	26	5.097191e-23	4.028198e-36	0.001000342	1.027557e-17	0.5048933
MP:0003209	abnormal pulmonary elastic fiber morphology	18	2.743261e-13	3.058614e-14	6.710381e-05	4.372415e-06	0.1812951
MP:0003211	abnormal aorta elastic fiber morphology	13	3.9916e-06	1.169228e-16	7.080979e-06	0.009537315	0.6261397
MP:0003212	increased susceptibility to age related obesity	22	1.01072e-05	2.670144e-06	0.2164879	0.1754041	0.03407849
MP:0003213	decreased susceptibility to age related obesity	9	2.765106e-05	0.0009277837	0.001538251	3.333278e-05	0.3959453
MP:0003214	neurofibrillary tangles	6	1.545633e-36	0.003645465	0.3512191	0.0009201675	0.7469143
MP:0003215	renal interstitial fibrosis	50	3.754962e-48	1.408173e-11	6.587079e-09	1.069558e-27	0.5957957
MP:0003216	absence seizures	37	8.211387e-23	9.738866e-25	0.9543704	9.181347e-05	0.05835149
MP:0003221	abnormal cardiomyocyte apoptosis	61	7.455047e-82	8.307128e-22	6.973513e-26	5.629392e-50	0.02796491
MP:0003222	increased cardiomyocyte apoptosis	48	1.202532e-70	4.005261e-19	1.864648e-24	8.278375e-36	0.000448652
MP:0003223	decreased cardiomyocyte apoptosis	13	1.134744e-36	0.003759763	3.199266e-05	1.436006e-24	0.9149808
MP:0003224	neuron degeneration	321	0	2.487949e-84	2.080571e-65	4.646252e-172	2.778506e-07
MP:0003225	axonal dystrophy	13	8.303022e-25	7.896887e-16	0.01191883	5.804793e-11	0.0523272
MP:0003226	absent modiolus	1	0.9930732	0.5187106	0.3832671	0.4587774	6.334363e-05
MP:0003227	abnormal vascular branching morphogenesis	40	4.338184e-119	2.977483e-26	1.185264e-34	5.286744e-84	0.01151466
MP:0003228	abnormal sinus venosus morphology	9	3.575196e-09	9.700562e-06	0.01201765	2.900138e-16	0.2826294
MP:0003229	abnormal vitelline vasculature morphology	217	0	3.460163e-141	3.45828e-93	1.449312e-176	0.001078774
MP:0003230	abnormal umbilical artery morphology	10	9.807236e-08	4.813057e-19	0.0001781116	1.004777e-08	0.5217265
MP:0003231	abnormal placenta vasculature	129	2.55762e-288	9.382728e-84	1.138093e-68	1.780697e-128	0.005890488
MP:0003232	abnormal forebrain development	211	7.940214e-250	9.790802e-229	5.889992e-46	1.826421e-117	0.02920822
MP:0003233	prolonged QT interval	24	9.228474e-40	3.057188e-14	9.814065e-10	1.143747e-13	0.08557142
MP:0003234	enhanced NMDA-mediated synaptic currents	7	0.03462562	3.033877e-11	0.1706978	0.05145644	0.3794442
MP:0003235	abnormal alisphenoid bone morphology	31	4.133834e-12	1.470876e-48	1.613608e-05	1.638544e-19	0.0974499
MP:0003236	abnormal lens capsule morphology	17	2.688016e-06	1.538906e-15	5.443583e-18	2.796413e-05	0.001206229
MP:0003237	abnormal lens epithelium morphology	29	1.275658e-34	3.48798e-51	2.74478e-21	5.394115e-15	0.003400639
MP:0003240	loss of hippocampal neurons	16	0.0006770634	2.601051e-08	0.005598286	0.000506002	0.05594561
MP:0003241	loss of cortex neurons	21	6.9491e-07	7.574182e-07	0.004494573	2.597501e-10	0.1149276
MP:0003242	loss of basal ganglia neurons	2	0.000616535	0.99668	0.0731044	0.003172175	0.2645916
MP:0003243	abnormal dopaminergic neuron morphology	45	1.017082e-10	2.926352e-10	0.007877978	1.230884e-05	0.8908417
MP:0003244	loss of dopaminergic neurons	21	0.000232827	0.001225547	0.2839028	0.01040882	0.6213693
MP:0003245	abnormal GABAergic neuron morphology	26	1.132978e-06	8.472618e-10	0.005410023	1.044524e-21	0.0003723168
MP:0003246	loss of GABAergic neurons	11	3.678271e-05	0.0003898307	0.2073277	4.800647e-15	0.0001336846
MP:0003247	abnormal glutaminergic neuron morphology	9	0.9988311	3.566593e-06	0.03461208	1.39712e-05	7.452385e-06
MP:0003248	loss of glutamate neurons	2	0.9950619	1.068776e-05	0.4003044	0.01748625	0.1071355
MP:0003250	absent gallbladder	5	1.999043e-05	0.008538818	4.314572e-12	1.463942e-07	0.05477679
MP:0003252	abnormal bile duct physiology	32	6.206958e-36	6.179969e-21	3.105838e-19	2.021856e-28	0.6769487
MP:0003253	dilated bile duct	8	1.613412e-06	1.041319e-10	0.09747773	0.00837546	0.9812697
MP:0003254	bile duct inflammation	6	6.950516e-11	0.2011181	3.277945e-05	4.548515e-06	0.4734257
MP:0003255	bile duct proliferation	8	0.006893085	4.480629e-07	0.002351475	0.000489932	0.07758045
MP:0003256	biliary cirrhosis	1	0.0004161656	0.5871406	0.01995751	0.1889281	0.08258879
MP:0003257	abnormal abdominal wall morphology	77	2.258657e-42	1.998044e-75	2.179307e-17	4.796349e-25	0.08526628
MP:0003262	intestinal/bowel diverticulum	1	0.01612643	0.0005676379	0.4579226	0.0915071	0.6437678
MP:0003266	biliary cyst	6	1.95329e-06	9.328038e-05	0.02397862	0.005577497	0.8525572
MP:0003267	constipation	2	0.9940374	4.571298e-05	0.907263	0.6149029	0.9647485
MP:0003268	chronic constipation	1	0.9005029	0.813613	1	0.746	1
MP:0003269	colon polyps	14	5.079905e-37	0.03362699	5.746228e-16	8.760891e-17	0.1382007
MP:0003270	intestinal obstruction	20	1.932434e-18	3.086167e-12	3.205823e-07	1.088474e-11	0.1204365
MP:0003271	abnormal duodenum morphology	38	2.397543e-13	1.261463e-14	0.00581553	1.532954e-08	0.9007347
MP:0003273	duodenal ulcer	1	0.9621678	0.003530956	0.3856569	0.06617561	0.726318
MP:0003276	esophageal atresia	7	0.991156	2.165122e-24	0.9977249	0.03405687	0.176049
MP:0003277	esophageal papilloma	5	8.603872e-16	5.209035e-05	3.413558e-06	1.92668e-05	0.5883284
MP:0003278	esophageal inflammation	2	0.0004488195	0.3014822	0.1389514	0.01301287	0.4186107
MP:0003279	aneurysm	48	1.873123e-35	8.999355e-72	5.946554e-22	9.220606e-46	0.2866062
MP:0003280	urinary incontinence	9	6.003862e-07	2.491951e-16	0.9532558	0.1226216	0.8889862
MP:0003281	fecal incontinence	1	0.9787641	6.665475e-19	0.2214331	0.3176153	0.4955633
MP:0003282	gastric ulcer	5	0.8665546	9.172431e-10	0.003894033	0.0001511987	0.1801126
MP:0003283	abnormal digestive organ placement	23	0.1059678	0.9298883	0.006952663	0.2753335	0.636549
MP:0003284	abnormal large intestine placement	1	1.937016e-10	1	0.0004733176	0.09934322	1
MP:0003285	gastric hypertrophy	5	4.17074e-06	1.31073e-06	3.603546e-08	0.014716	0.399784
MP:0003288	intestinal edema	17	3.442593e-38	0.004127364	1.37709e-17	6.847072e-26	0.0003448647
MP:0003289	abnormal intestinal peristalsis	23	2.262247e-15	2.036708e-39	0.0001699443	8.706952e-09	0.8146108
MP:0003290	intestinal hypoperistalsis	16	4.115677e-12	2.339992e-18	0.01745302	0.0001673488	0.5661449
MP:0003292	melena	10	2.999095e-38	0.1513371	1.737601e-05	4.331667e-08	0.0002431674
MP:0003293	rectal hemorrhage	17	2.809727e-16	0.0006743082	3.605208e-15	3.795648e-08	0.03303346
MP:0003299	gastric polyps	7	0.8530922	0.02552629	4.189719e-05	0.1184905	0.001177912
MP:0003300	gastrointestinal ulcer	41	1.116251e-57	4.816855e-11	5.791653e-16	6.904573e-29	0.005626855
MP:0003301	peptic ulcer	6	0.01702957	2.205964e-08	4.891426e-06	0.0002315392	0.1066985
MP:0003303	peritoneal inflammation	19	4.58411e-41	0.005555788	8.318147e-27	2.912597e-48	0.09997261
MP:0003304	large intestinal inflammation	152	2.2347e-176	9.428963e-17	5.355415e-75	1.725905e-133	3.102133e-05
MP:0003305	proctitis	3	3.077507e-16	0.5782184	4.640421e-05	2.726355e-27	0.8631676
MP:0003306	small intestinal inflammation	37	1.884584e-141	0.01343655	2.065781e-52	7.69306e-59	0.1360289
MP:0003307	pyloric stenosis	4	1.753691e-05	0.3737327	0.008160727	0.1092264	0.8753374
MP:0003308	abnormal cochlear sensory epithelium morphology	170	7.709346e-141	3.560926e-109	2.984596e-26	6.643856e-66	0.0007843504
MP:0003309	abnormal modiolus morphology	2	0.9993344	0.007930053	0.03579401	0.4154689	0.0005006983
MP:0003310	reduced modiolus	1	0.9884873	0.000211509	0.01405367	0.4750838	0.6420776
MP:0003311	aminoaciduria	23	2.289539e-21	3.079028e-12	4.259323e-05	0.001565763	0.1769427
MP:0003312	abnormal locomotor coordination	568	0	8.187142e-294	9.795158e-74	1.220914e-237	0.01237015
MP:0003313	abnormal locomotor activation	902	0	0	4.492765e-148	0	9.261778e-06
MP:0003314	dysmetria	4	7.353124e-08	0.7552258	0.09454566	1.70286e-09	1
MP:0003315	abnormal perineum morphology	25	0.002134636	9.687938e-45	0.004913428	0.0003090373	0.01072329
MP:0003316	perineal fistula	1	3.1199e-06	1.220147e-06	1	0.1510882	1
MP:0003320	rectovaginal fistula	1	1	0.07022086	1	0.999381	0.2355317
MP:0003321	tracheoesophageal fistula	18	0.9593278	9.793019e-19	0.995036	0.02601953	0.8796969
MP:0003324	increased liver adenoma incidence	20	2.619282e-38	8.117624e-17	2.823932e-10	1.622904e-11	0.2622964
MP:0003325	decreased liver function	8	3.236277e-32	3.394718e-08	0.07044659	3.531363e-08	0.3625803
MP:0003326	liver failure	13	1.359879e-25	2.027294e-07	0.0002253462	3.511305e-15	0.8100303
MP:0003327	liver cysts	10	1.393432e-23	0.3546334	0.01608474	3.452601e-05	0.7790668
MP:0003328	portal hypertension	1	4.306956e-08	0.173366	0.4733913	0.6854728	0.2852617
MP:0003329	amyloid beta deposits	43	1.961582e-90	5.70055e-13	4.40948e-21	1.983152e-30	0.03940166
MP:0003330	abnormal auditory tube	6	3.90275e-06	0.01904825	2.716598e-07	1.630675e-06	0.9806749
MP:0003331	hepatocellular carcinoma	73	1.886179e-165	5.065013e-28	2.677006e-15	1.190996e-48	0.2708388
MP:0003332	liver abscess	4	2.407163e-08	0.0007735575	2.641602e-07	8.454608e-15	0.07531092
MP:0003333	liver fibrosis	44	4.094246e-52	3.990018e-11	3.395514e-11	5.710698e-40	0.2272107
MP:0003334	pancreas fibrosis	9	7.105911e-17	0.003746868	0.004434137	0.03496303	0.08149424
MP:0003335	exocrine pancreatic insufficiency	8	5.007141e-27	0.7324232	0.02135702	1.947471e-07	0.004902675
MP:0003336	pancreas cysts	21	5.645483e-07	3.459193e-09	0.0006108147	2.971561e-05	0.8237052
MP:0003337	exocrine pancreas hyperplasia	2	0.2720937	0.6380109	0.003395504	0.3315031	1
MP:0003338	pancreas lipomatosis	3	1.144186e-14	0.5023882	0.00156993	0.0002105956	0.7128261
MP:0003339	decreased pancreatic beta cell number	52	7.745848e-14	5.220108e-22	1.828585e-16	4.862711e-17	9.426132e-05
MP:0003340	acute pancreas inflammation	2	0.04253087	0.548057	0.2071376	0.0327063	0.9016517
MP:0003341	chronic pancreas inflammation	1	0.3184871	0.06656323	1	0.009250224	1
MP:0003342	accessory spleen	5	8.00799e-17	0.9991675	0.001478332	0.5179925	0.04088394
MP:0003344	mammary gland hypoplasia	6	0.9153176	8.87761e-24	0.3900882	1.911716e-08	0.004298356
MP:0003345	decreased rib number	50	8.025899e-42	2.257093e-24	0.0001079072	3.801582e-07	0.5961437
MP:0003346	abnormal pectoral muscle morphology	3	0.9998655	0.04638993	0.0601631	0.02456917	0.002742561
MP:0003348	hypopituitarism	3	1.208845e-07	0.9999873	0.02003123	0.0005236464	0.3950343
MP:0003349	abnormal circulating renin level	26	6.569952e-42	2.111984e-19	0.004891444	2.36564e-11	0.001197488
MP:0003350	increased circulating levels of thyroid hormone	13	0.799904	0.0007512213	2.59739e-05	0.07434926	0.005859942
MP:0003351	decreased circulating levels of thyroid hormone	41	6.817102e-26	2.474116e-06	5.60422e-10	5.847862e-17	0.0004697541
MP:0003352	increased circulating renin level	17	5.764705e-20	5.77383e-13	8.589134e-06	1.715925e-08	0.0019095
MP:0003353	decreased circulating renin level	11	2.502494e-11	3.807518e-07	0.8560461	0.009404721	0.01689178
MP:0003354	astrocytosis	98	1.871837e-243	2.850114e-15	3.921431e-07	5.602106e-63	0.5611168
MP:0003355	decreased ovulation rate	29	6.488809e-09	1.607132e-12	3.511279e-13	1.82303e-12	0.008580865
MP:0003356	impaired luteinization	11	0.3057115	0.008485592	4.171688e-05	0.000139282	0.09045325
MP:0003357	impaired granulosa cell differentiation	13	2.821329e-10	1.150656e-09	4.713093e-09	9.286164e-05	0.5027447
MP:0003358	abnormal hypaxial muscle morphology	126	2.625612e-35	4.031476e-104	5.380552e-18	1.289863e-36	0.01547622
MP:0003359	hypaxial muscle hypoplasia	7	0.002120389	3.11132e-17	0.004783206	1.397746e-06	0.0002455891
MP:0003360	abnormal depression-related behavior	83	1.056656e-46	2.329549e-21	6.802835e-06	7.414515e-30	0.2479947
MP:0003361	abnormal circulating gonadotropin level	98	5.202022e-73	3.967456e-12	8.783523e-16	1.005875e-22	0.0004499053
MP:0003362	increased circulating gonadotropin level	60	1.405018e-38	1.711656e-07	2.967755e-08	5.969687e-11	0.0004997674
MP:0003363	decreased circulating gonadotropin level	51	1.165793e-31	2.304389e-08	5.439205e-08	1.613511e-11	0.08074641
MP:0003364	increased insulinoma incidence	4	8.99387e-16	0.02491117	0.9461927	0.01552226	0.8217728
MP:0003365	increased glucagonoma incidence	1	8.700358e-12	1	1	0.004668533	1
MP:0003366	abnormal circulating glucocorticoid level	78	5.418003e-64	7.955826e-17	3.114118e-12	1.474018e-16	0.8864268
MP:0003368	decreased circulating glucocorticoid level	32	1.583353e-18	0.0003337689	7.013188e-07	5.512491e-05	0.6070637
MP:0003369	abnormal circulating estrogen level	46	0.00174232	1.412993e-16	1.240423e-18	2.458869e-13	0.001488251
MP:0003370	increased circulating estrogen level	15	0.5762278	0.186551	0.01342612	0.2324686	0.00395616
MP:0003371	decreased circulating estrogen level	32	0.03567498	7.678047e-19	6.459607e-13	1.98375e-10	0.02629288
MP:0003377	late onset of menarche	1	0.9748396	0.01094389	1	0.4766529	1
MP:0003378	early sexual maturation	7	0.9999962	0.0002643585	0.08629037	0.9426798	0.005482251
MP:0003379	absent sexual maturation	4	7.729958e-15	0.004591695	0.06083673	0.05758273	0.2044104
MP:0003380	abnormal intestine regeneration	4	0.002083193	0.02539095	0.2332468	0.01603548	0.943405
MP:0003381	vitreal fibroplasia	4	0.7391013	1.072474e-09	0.02063865	0.1771984	0.6756845
MP:0003382	straub tail	3	6.747991e-21	0.7927875	0.03320094	5.84797e-09	0.03211105
MP:0003383	abnormal gluconeogenesis	51	4.857277e-48	8.749181e-34	2.004691e-39	4.18247e-43	0.009137772
MP:0003384	abnormal ventral body wall morphology	18	0.9875065	1.146394e-09	8.998099e-08	0.0004540719	0.009471636
MP:0003385	abnormal body wall morphology	95	2.759515e-36	2.794464e-88	6.762994e-23	2.50883e-35	0.04127693
MP:0003387	aorta coarctation	5	2.980023e-22	5.19954e-06	0.01289402	5.805639e-06	0.996384
MP:0003388	absent pericardium	2	0.7657562	0.08011368	0.1707346	0.02004807	0.6989466
MP:0003390	lymphedema	11	0.02138859	0.0001351042	6.560866e-12	1.608618e-09	0.1556809
MP:0003393	decreased cardiac output	26	2.315369e-35	5.673375e-46	0.08132476	0.002206994	0.09580789
MP:0003394	increased cardiac output	6	7.218728e-29	0.01947442	0.002291161	2.284355e-15	1
MP:0003395	abnormal subclavian artery morphology	44	3.234197e-20	3.639959e-63	1.946277e-25	1.403715e-24	0.03612618
MP:0003396	abnormal embryonic hematopoiesis	64	4.388919e-217	7.120689e-12	4.100622e-42	8.487433e-149	0.09009372
MP:0003397	increased muscle weight	11	0.06175842	6.81842e-18	0.0001600261	0.003313715	0.1200512
MP:0003398	increased skeletal muscle size	14	0.004925669	3.573184e-08	0.007621029	0.002657949	0.5585858
MP:0003400	kinked neural tube	59	1.051494e-76	5.743102e-24	1.14331e-18	7.282985e-26	0.2674819
MP:0003401	enlarged tail bud	3	2.734958e-15	0.2691267	0.002603742	0.04907398	0.7514693
MP:0003402	decreased liver weight	74	9.78772e-56	3.447349e-59	3.603366e-14	8.863963e-29	0.5752058
MP:0003403	absent placental labyrinth	27	1.261107e-33	7.035861e-47	1.843589e-09	4.16169e-15	0.7040008
MP:0003404	absent enamel	7	2.440413e-06	8.793532e-07	0.0002306673	0.0571105	0.6337709
MP:0003405	abnormal platelet shape	5	9.429369e-37	0.2675089	1.292586e-10	8.694893e-34	0.7434467
MP:0003406	failure of zygotic cell division	17	5.235783e-42	7.381788e-07	3.424238e-11	5.919729e-13	0.8495005
MP:0003407	abnormal central nervous system regeneration	10	8.626552e-69	2.632777e-14	4.849303e-21	2.52956e-29	0.3386028
MP:0003408	increased width of hypertrophic chondrocyte zone	37	6.303291e-49	4.805869e-23	3.731505e-24	2.557745e-33	0.1028621
MP:0003409	decreased width of hypertrophic chondrocyte zone	43	5.854865e-51	9.154922e-100	4.34932e-20	2.814255e-22	0.5846569
MP:0003410	abnormal artery development	137	1.206175e-153	2.689622e-98	3.548061e-69	1.730205e-170	0.000557822
MP:0003411	abnormal vein development	32	4.069719e-31	7.62016e-29	8.929633e-09	8.661614e-36	0.3627492
MP:0003412	abnormal afterhyperpolarization	14	0.054129	0.002889844	0.4477437	0.04129091	0.9228447
MP:0003413	hair follicle degeneration	23	6.989919e-110	1.506192e-17	1.564812e-11	6.707097e-35	0.9974296
MP:0003414	epidermal cyst	19	2.038037e-37	2.761048e-30	2.595018e-09	9.205619e-22	0.2759077
MP:0003415	priapism	9	2.127797e-19	5.139041e-09	7.668134e-11	6.839189e-05	0.05408573
MP:0003416	premature bone ossification	24	1.15252e-06	3.634929e-99	5.925843e-10	3.853328e-11	0.1740413
MP:0003417	premature endochondral bone ossification	7	0.9928804	1.860786e-19	0.3924831	0.3038764	0.04905366
MP:0003419	delayed endochondral bone ossification	52	2.72728e-62	5.531578e-64	2.40676e-15	1.375099e-22	0.1742701
MP:0003420	delayed intramembranous bone ossification	22	5.617582e-68	3.046162e-11	5.578875e-06	1.922038e-18	0.3904818
MP:0003421	abnormal thyroid gland development	14	2.735118e-07	7.867224e-11	0.05720228	2.158318e-10	0.1866574
MP:0003422	abnormal thrombolysis	9	0.861976	0.1213332	0.03740233	0.0133655	0.1000228
MP:0003423	reduced thrombolysis	4	0.001224645	0.03545962	0.1182083	2.707335e-05	0.4102409
MP:0003424	premature neuronal precursor differentiation	20	2.878792e-24	1.503259e-12	0.0002113909	0.0007519736	0.5923588
MP:0003425	abnormal optic vesicle formation	33	3.463813e-22	5.44972e-27	0.02882846	1.28455e-12	0.1641093
MP:0003426	pulmonary interstitial fibrosis	9	3.363201e-08	0.2654022	0.06150889	7.016106e-06	0.5998823
MP:0003427	parakeratosis	31	4.558944e-19	1.26851e-29	4.962691e-09	4.416078e-20	0.2358585
MP:0003429	insensitivity to growth hormone	2	0.9999987	2.38669e-05	0.7015452	0.9579386	0.8468146
MP:0003430	increased pancreatic islet cell adenoma incidence	5	1.977839e-16	0.006727822	0.4909602	0.02959665	0.8685132
MP:0003431	abnormal parathyroid gland physiology	6	0.0003005892	5.518943e-05	2.787315e-10	4.741894e-05	0.2214609
MP:0003432	increased activity of parathyroid	5	0.000178979	1.47025e-05	8.063913e-11	0.0003859175	0.3062053
MP:0003433	decreased activity of parathyroid	1	0.7973255	1	1	0.005819655	0.223714
MP:0003434	decreased susceptibility to induced choroidal neovascularization	11	6.276329e-15	0.0006690589	8.489683e-05	3.635638e-21	0.9861601
MP:0003435	herniated seminal vesicle	1	0.0005143265	0.03186208	0.1150078	7.567139e-06	0.6494361
MP:0003436	decreased susceptibility to induced arthritis	63	1.103181e-95	1.105749e-08	1.106521e-36	5.029426e-118	0.007107133
MP:0003437	abnormal carotid body morphology	4	0.999322	0.1548464	0.520049	0.009076651	0.9682988
MP:0003438	abnormal carotid body physiology	3	2.571302e-13	0.9254259	0.0277735	2.697263e-06	1
MP:0003439	abnormal glycerol level	35	1.613756e-30	1.740172e-12	1.766605e-12	3.326659e-15	0.0001287802
MP:0003441	increased glycerol level	17	8.915625e-27	2.254086e-06	4.789853e-07	1.13218e-08	0.0006136678
MP:0003442	decreased circulating glycerol level	18	5.180725e-19	5.559271e-06	2.78876e-10	5.259855e-09	0.06807423
MP:0003443	increased circulating glycerol level	13	1.678586e-10	0.004406448	7.35157e-07	8.848383e-06	0.001334113
MP:0003444	abnormal neurotransmitter uptake	7	1.005207e-16	2.627476e-08	0.102397	5.830133e-05	0.9381046
MP:0003445	sirenomelia	7	5.073867e-05	1.069006e-09	2.145092e-06	1.606703e-09	0.6430854
MP:0003446	renal hypoplasia	63	9.334059e-42	7.444169e-61	1.096322e-13	2.845681e-15	0.5093821
MP:0003447	decreased tumor growth/size	95	2.194332e-156	2.553896e-49	8.337893e-57	3.537881e-136	0.000211602
MP:0003448	altered tumor morphology	169	1.877428e-238	1.105575e-70	1.788015e-102	5.144508e-190	5.56893e-08
MP:0003449	abnormal intestinal goblet cell morphology	62	8.507635e-135	5.013071e-23	4.125674e-22	5.057856e-65	0.02600273
MP:0003450	enlarged pancreas	20	2.259942e-16	1.39312e-08	0.0003179893	5.367739e-07	0.3318819
MP:0003451	absent olfactory bulb	15	0.00010154	3.444967e-09	0.1004231	3.292678e-08	0.4046185
MP:0003452	abnormal parotid gland morphology	9	1.055991e-15	3.286575e-09	1.930281e-13	1.172935e-23	3.073832e-08
MP:0003453	abnormal keratinocyte physiology	90	3.212561e-194	9.434202e-35	3.882913e-47	2.246042e-70	0.2310448
MP:0003454	erythroderma	5	0.99424	0.5619211	0.001694498	6.762445e-05	0.0803557
MP:0003455	decreased susceptibility to induced retinal damage	1	0.3548049	0.05861242	0.1189244	0.2533789	0.5355122
MP:0003456	absent tail	16	1.482129e-06	4.213202e-05	1.945476e-05	9.593729e-07	0.1568374
MP:0003457	abnormal circulating ketone body level	51	6.133155e-37	5.776425e-60	1.555565e-13	7.304732e-21	0.1745773
MP:0003458	decreased circulating ketone body level	12	5.440186e-26	6.837079e-09	4.230929e-08	2.640716e-07	0.8530769
MP:0003459	increased fear-related response	11	0.6803681	0.9999788	0.008521968	0.8892535	0.003383714
MP:0003460	decreased fear-related response	37	0.04953304	2.226511e-11	0.0002738894	0.1744909	0.4679461
MP:0003461	abnormal response to novel object	49	2.371934e-11	2.472496e-07	0.1080238	0.0003417241	0.07225086
MP:0003462	abnormal response to novel odor	7	4.981648e-07	0.9925408	0.04251929	0.000635776	0.8300968
MP:0003463	abnormal single cell response	35	1.124433e-21	0.1777061	0.8423865	0.001212158	0.1141809
MP:0003464	abnormal single cell response threshold	3	2.94324e-19	0.4060114	0.06211661	0.002126867	0.1777519
MP:0003465	increased single cell response threshold	1	1.302273e-13	0.03548832	0.1538298	0.03598069	1
MP:0003466	decreased single cell response threshold	2	4.37279e-08	0.927123	0.1532498	0.01652379	0.03649641
MP:0003469	decreased single cell response intensity	2	0.01321673	0.2333921	0.3678279	0.00205844	0.3057597
MP:0003470	abnormal summary potential	3	1.360031e-25	0.5680658	0.3412056	5.531266e-05	0.7541649
MP:0003477	abnormal nerve fiber response	16	0.9988922	1.701774e-05	0.9674669	0.7539	0.2562047
MP:0003479	abnormal nerve fiber response intensity	3	0.8777066	1.537109e-06	0.9853355	0.8477636	0.4767934
MP:0003481	decreased nerve fiber response intensity	2	0.999993	0.02441939	1	0.9579386	0.4295862
MP:0003483	decreased nerve fiber response threshold	1	0.5442089	3.787123e-05	1	0.8084912	1
MP:0003484	abnormal channel response	29	0.01642711	5.35791e-15	0.04603934	0.0002973524	0.6881407
MP:0003486	abnormal channel response intensity	5	0.9775697	0.000298535	0.0001558566	0.01076075	0.04649211
MP:0003488	decreased channel response intensity	4	0.9970519	0.009382845	0.1271789	0.3160803	0.2832867
MP:0003489	increased channel response threshold	2	0.9999998	0.002542829	0.06993206	0.6149029	0.1225824
MP:0003491	abnormal voluntary movement	1317	0	0	2.779393e-231	0	1.84439e-05
MP:0003492	abnormal involuntary movement	736	0	9.087441e-297	1.462258e-121	1.060613e-294	0.004520747
MP:0003493	parathyroid gland hyperplasia	1	8.700358e-12	1	1	0.004668533	1
MP:0003494	parathyroid hypoplasia	6	1.178122e-22	3.136035e-10	3.339702e-09	1.699597e-14	0.9683676
MP:0003495	increased parathyroid adenoma incidence	1	8.700358e-12	1	1	0.004668533	1
MP:0003496	increased thyroid adenoma incidence	7	7.48139e-19	0.4147913	0.0002805299	8.805998e-11	0.3081548
MP:0003497	insensitivity to parathyroid hormone	1	7.64628e-09	0.6258174	0.9827874	0.001677676	0.2355317
MP:0003498	thyroid gland hyperplasia	7	9.824824e-05	0.7055777	0.0236986	7.119566e-08	0.1497263
MP:0003499	thyroid hypoplasia	3	0.0856171	2.747268e-05	0.08713129	4.730844e-05	0.2843126
MP:0003501	iodide oxidation defect	1	1	0.982939	0.6612904	0.2341186	1
MP:0003502	increased activity of thyroid	2	0.9986123	0.4936705	0.1203677	0.01944978	0.1439787
MP:0003503	decreased activity of thyroid	16	0.0001100135	8.678022e-11	4.056636e-05	8.743688e-09	0.334714
MP:0003504	thyroid inflammation	5	0.6234466	0.0194321	0.1250821	1.215237e-07	0.1353264
MP:0003505	increased prolactinoma incidence	3	4.253256e-22	0.999043	0.04490477	4.492895e-12	0.8880927
MP:0003507	abnormal ovary physiology	29	4.155191e-16	2.479449e-07	0.004327589	3.530213e-09	0.004781904
MP:0003508	abnormal circulating dihydrotestosterone level	3	0.9988934	0.107586	0.4434823	0.785279	0.5270077
MP:0003509	increased circulating dihydrotestosterone level	2	0.9716999	0.007361792	0.168512	0.7228541	0.3255105
MP:0003510	decreased circulating dihydrotestosterone level	1	1	0.9958755	1	0.7736162	1
MP:0003511	abnormal labium morphology	1	0.999459	0.7495598	0.8942425	0.9923504	0.07506315
MP:0003527	small vulva	2	0.06938307	8.105117e-11	1	0.9856651	1
MP:0003529	enlarged clitoris	4	0.9656471	0.1273587	0.8004651	0.9712801	0.004097412
MP:0003531	abnormal vagina development	4	0.645041	1.499358e-05	0.0001835824	0.1569851	0.01411507
MP:0003534	blind vagina	3	0.7642807	7.60775e-08	0.7735008	0.6260752	0.387109
MP:0003535	absent vagina	4	0.002606006	1.907804e-25	0.4018081	0.1772921	0.7222871
MP:0003537	hydrometrocolpos	5	5.327011e-06	0.0001654967	1.054101e-09	1.561334e-07	0.3884932
MP:0003540	imperforate hymen	1	0.5129706	0.0673791	1.146136e-07	0.6954157	0.6575066
MP:0003541	vaginal inflammation	2	1.059622e-05	8.106894e-09	0.5135486	0.01016035	0.785351
MP:0003542	abnormal vascular endothelial cell development	33	1.262055e-79	9.731548e-23	1.291925e-27	8.517031e-56	0.1006587
MP:0003543	abnormal vascular endothelial cell differentiation	8	1.324753e-07	2.953813e-23	4.98555e-12	1.458945e-07	0.3224124
MP:0003544	abnormal vascular endothelial cell migration	14	3.791236e-18	9.351902e-06	8.396286e-15	2.517182e-20	0.1797705
MP:0003545	increased alcohol consumption	12	0.001054503	1.140739e-12	0.001240606	3.741848e-05	0.3439772
MP:0003546	decreased alcohol consumption	12	4.891768e-11	0.8316656	0.1117567	2.589299e-06	0.03123905
MP:0003547	abnormal pulmonary pressure	12	2.232906e-26	0.09472527	0.0003036694	9.429969e-12	0.7583689
MP:0003548	pulmonary hypertension	10	1.981399e-22	0.06182903	0.0007322831	3.654869e-11	0.7347437
MP:0003550	short perineum	5	0.2311523	0.07159559	0.9998614	0.3551549	0.7073279
MP:0003553	abnormal foreskin morphology	4	4.777467e-09	0.01122176	0.04248957	0.004887101	0.4418785
MP:0003554	phimosis	1	1.015192e-16	0.9680676	9.016229e-09	0.03982747	1
MP:0003557	absent vas deferens	11	4.676281e-06	3.893325e-14	0.3174631	2.377402e-10	0.7487858
MP:0003558	absent uterus	8	0.01132962	9.652659e-14	0.0706373	6.604457e-09	0.7796469
MP:0003560	osteoarthritis	24	4.561443e-36	4.346593e-15	0.0006876264	5.75716e-11	0.102429
MP:0003561	rheumatoid arthritis	14	8.000494e-31	0.01352449	1.457174e-22	1.422807e-31	0.002180511
MP:0003562	abnormal pancreatic beta cell physiology	155	5.334768e-114	2.284371e-95	3.097712e-51	6.848121e-68	3.466714e-06
MP:0003563	abnormal pancreatic alpha cell physiology	18	0.7829322	7.488731e-16	0.02805769	0.7122091	0.102105
MP:0003564	abnormal insulin secretion	139	9.475289e-106	5.507407e-106	2.917229e-46	1.745505e-68	0.0001327358
MP:0003565	abnormal glucagon secretion	17	0.7281154	1.455509e-13	0.01661052	0.6673403	0.1381347
MP:0003566	abnormal cell adhesion	60	6.817394e-125	4.241044e-50	3.017896e-66	9.906784e-78	8.450571e-05
MP:0003567	abnormal fetal cardiomyocyte proliferation	47	1.359746e-67	6.525944e-34	2.334937e-14	9.318835e-51	0.02686074
MP:0003568	uterus atresia	1	1.124237e-08	0.002087143	0.0020594	0.3766044	1
MP:0003570	increased uterus leiomyoma incidence	6	3.419247e-09	0.1032948	0.05814905	1.180051e-05	0.4145402
MP:0003572	abnormal uterus development	12	8.300642e-13	1.384446e-11	5.449223e-05	0.01478986	0.06980026
MP:0003574	abnormal oviduct morphology	21	9.396898e-23	4.081083e-16	0.08494407	2.084893e-09	0.1573287
MP:0003575	absent oviduct	5	0.9811237	1.152651e-06	0.5057046	0.0001642279	0.4458016
MP:0003576	oviduct hypoplasia	1	0.001001089	0.04433443	1	0.1018567	0.4253707
MP:0003578	absent ovary	8	0.4579774	0.004662501	0.7742214	0.08647798	0.2519179
MP:0003579	ovarian carcinoma	10	0.1691436	0.002207243	1.271298e-10	0.0001001917	1.300597e-06
MP:0003580	increased fibroma incidence	9	8.755807e-13	0.0003369115	3.576493e-07	2.50185e-06	0.4566808
MP:0003582	abnormal ovary development	7	2.506016e-44	0.0008827339	0.8326244	0.00260813	0.5356157
MP:0003584	bifid ureter	4	0.03960337	1.127948e-14	0.6819988	0.6213285	0.9817294
MP:0003585	large ureter	7	0.1984872	0.0009687261	0.4928472	0.2791016	0.9373652
MP:0003586	dilated ureter	16	3.250595e-05	2.298743e-25	0.167437	0.001215764	0.4634323
MP:0003587	ureter obstruction	7	5.486278e-05	0.1639117	0.0102698	0.006641278	0.2022688
MP:0003588	ureter stenosis	3	0.3311437	3.197132e-06	0.1214274	0.188988	0.3780846
MP:0003589	abnormal ureter physiology	8	0.0007099712	8.235395e-21	0.006847515	0.01109867	0.4281628
MP:0003590	ureteral reflux	2	0.6726787	2.763902e-14	0.004709611	0.5179774	0.5265777
MP:0003591	urethra atresia	4	0.00578931	6.681574e-18	0.006843871	0.0109994	0.390201
MP:0003595	epididymal cyst	2	0.03880655	0.04488222	0.03449147	0.4074634	0.05544807
MP:0003596	epididymal inflammation	3	0.03327391	0.6094484	0.2770722	0.9957342	0.5544319
MP:0003597	increased epididymal cystadenoma incidence	2	0.0001388682	0.3806399	0.05855711	0.02501429	0.4095529
MP:0003599	large penis	1	0.9982283	0.6258174	0.054902	0.6062543	0.02789339
MP:0003600	ectopic kidney	11	0.9479563	0.0241958	0.7001314	0.05863387	0.2360841
MP:0003602	renal hamartoma	1	1.150047e-16	0.2762569	0.0001112282	0.04962712	1
MP:0003604	single kidney	46	4.875918e-10	6.392827e-52	0.0006167303	0.009271412	0.5200565
MP:0003605	fused kidneys	5	5.653883e-06	1.993209e-13	0.007175131	0.003906724	0.6245569
MP:0003606	kidney failure	64	1.003863e-92	1.14384e-28	2.237339e-20	4.183739e-53	0.1232519
MP:0003607	abnormal prostate gland physiology	18	2.605839e-30	0.4689048	4.547672e-05	8.443446e-08	0.5509175
MP:0003608	prostate gland inflammation	4	0.4919342	0.1177184	0.6501414	0.6173886	0.3821013
MP:0003609	small scrotum	2	0.9960713	0.3431397	0.5564539	0.02324835	0.3372771
MP:0003611	scrotum hypoplasia	1	0.9996953	0.3150907	0.770847	0.999381	0.2355317
MP:0003613	abnormal kidney medulla development	7	6.443896e-08	1.802826e-09	0.002027271	0.001331183	0.9792482
MP:0003617	urinary bladder hypoplasia	1	1	0.3642343	0.687584	0.06370262	1
MP:0003619	abnormal urine color	13	8.172798e-16	7.739476e-05	6.426764e-08	6.070595e-06	0.9818879
MP:0003620	oliguria	24	5.062906e-15	4.092477e-09	4.182114e-09	2.400641e-15	0.003440087
MP:0003622	ischuria	6	5.670012e-07	3.530392e-07	8.069679e-07	9.538429e-06	0.4834793
MP:0003624	anuria	8	2.733063e-39	0.1622706	9.839336e-06	2.863494e-05	0.6513609
MP:0003626	kidney medulla hypoplasia	8	0.8621583	0.0985048	0.914579	0.9857831	0.2580679
MP:0003627	abnormal leukocyte tethering or rolling	34	2.373638e-75	2.797623e-09	3.900741e-24	9.632325e-65	0.1870138
MP:0003628	abnormal leukocyte adhesion	40	1.485112e-69	1.181449e-06	1.584239e-18	1.256653e-88	0.01394051
MP:0003630	abnormal urothelium morphology	25	4.640214e-34	1.881019e-25	3.384898e-08	4.108611e-08	0.2046091
MP:0003631	nervous system phenotype	2813	0	0	0	0	3.646362e-21
MP:0003632	abnormal nervous system morphology	2293	0	0	0	0	5.883655e-16
MP:0003633	abnormal nervous system physiology	1731	0	0	1.14425603576833e-320	0	1.002376e-13
MP:0003634	abnormal glial cell morphology	347	0	5.922658e-150	9.792686e-97	6.168271e-232	0.0003282999
MP:0003635	abnormal synaptic transmission	589	8.85853599998058e-313	1.63255e-197	1.481325e-39	6.781831e-119	0.1021269
MP:0003637	cochlear ganglion hypoplasia	12	2.171845e-30	0.9704166	0.2498104	0.05667723	0.9410093
MP:0003638	abnormal response/metabolism to endogenous compounds	112	3.105452e-45	1.129529e-36	2.112043e-48	2.559881e-52	0.007674197
MP:0003639	abnormal response to vitamins	5	1.860395e-08	3.735548e-20	0.0005567887	9.516888e-12	0.8653826
MP:0003641	small lung	106	3.230249e-45	1.256028e-123	1.15489e-13	1.104107e-35	0.096365
MP:0003642	absent seminal vesicle	13	0.009781169	0.0001282849	0.6903201	0.0002482524	0.3963265
MP:0003643	spleen atrophy	22	1.18665e-33	1.621926e-10	5.507944e-08	1.150811e-17	0.1870788
MP:0003644	thymus atrophy	57	2.917551e-93	2.651968e-31	9.313424e-23	6.609983e-54	0.2433693
MP:0003645	increased pancreatic beta cell number	20	9.280811e-16	0.01246106	3.364634e-06	1.124423e-15	0.003029786
MP:0003646	muscle fatigue	17	2.156736e-32	3.692896e-16	0.03868964	0.001027873	0.2667006
MP:0003647	absent oligodendrocytes	7	0.0005196149	9.582717e-08	1.040277e-11	1.4042e-05	0.001402581
MP:0003648	abnormal radial glial cell morphology	32	3.450468e-18	4.751429e-31	1.684204e-08	1.869307e-19	0.1390897
MP:0003649	decreased heart right ventricle size	15	5.079384e-08	4.090885e-06	0.01376388	3.825104e-07	0.3667528
MP:0003651	abnormal axon outgrowth	68	3.450256e-40	2.245085e-91	2.827522e-06	5.622084e-12	0.8730857
MP:0003653	decreased skin turgor	7	0.0002642578	1.293468e-06	4.669437e-08	3.183875e-05	0.1385704
MP:0003655	absent pancreas	4	0.9791455	0.4680541	0.1611328	0.2204083	0.2337682
MP:0003656	abnormal erythrocyte physiology	52	5.083233e-158	0.6851703	7.546681e-14	1.078397e-104	0.9328963
MP:0003657	abnormal erythrocyte osmotic lysis	30	2.830784e-87	0.4754415	9.631027e-09	8.596238e-68	0.8312117
MP:0003658	abnormal capillary morphology	100	2.545382e-148	1.492639e-66	2.036312e-64	3.670722e-104	0.03844074
MP:0003659	abnormal lymph circulation	13	1.254805e-16	2.422748e-14	2.838108e-07	1.390889e-12	0.7304229
MP:0003660	chylothorax	4	0.00230468	5.109367e-16	6.516609e-09	4.703447e-06	0.7000266
MP:0003661	abnormal locus ceruleus morphology	11	0.987323	0.0522757	0.4047571	0.1491011	0.3406961
MP:0003662	abnormal long bone epiphyseal plate proliferative zone	64	5.492231e-48	6.315446e-82	3.673156e-13	3.193359e-27	0.8772005
MP:0003663	abnormal thermosensation	7	0.01565032	0.4588003	0.9989157	0.998361	0.9825518
MP:0003664	ocular pterygium	1	0.9412159	0.008757409	0.008673577	0.4305299	0.05490222
MP:0003665	endophthalmitis	1	0.9412159	0.008757409	0.008673577	0.4305299	0.05490222
MP:0003666	impaired sperm capacitation	37	3.532733e-21	0.1355543	5.811568e-05	2.57767e-12	0.9988028
MP:0003667	hemangiosarcoma	35	2.203345e-50	9.588561e-29	1.882174e-13	2.26659e-25	0.1765124
MP:0003668	abnormal periodontal ligament morphology	5	0.5468073	8.095355e-20	0.3735562	0.8759958	0.9637786
MP:0003669	periodontal ligament hypercellularity	1	1	4.023704e-07	1	1	0.7798993
MP:0003670	dilated renal glomerular capsule	10	2.702726e-14	2.091503e-14	0.233088	0.0001418883	0.3516157
MP:0003671	abnormal eyelid aperture	40	1.927056e-53	3.866713e-18	1.053084e-16	3.753113e-40	0.02241407
MP:0003672	abnormal ureter development	24	2.478052e-11	3.430463e-23	0.0005982127	0.0004469256	0.8627172
MP:0003674	oxidative stress	94	1.628483e-105	8.730451e-21	6.504701e-32	8.392511e-60	0.0001292766
MP:0003675	kidney cysts	136	5.732128e-92	1.096046e-102	7.822527e-25	2.457918e-46	0.6171
MP:0003677	abnormal ear lobe morphology	3	1.470364e-08	0.1296848	0.1021764	0.07973464	0.6569165
MP:0003679	ear lobe hypoplasia	2	5.859795e-09	0.07635929	0.1582817	0.07131583	0.7745168
MP:0003684	abnormal inferior olivary complex morphology	5	0.2206047	8.288056e-13	0.8497539	0.9924158	0.3176017
MP:0003685	abnormal cardiac ganglion morphology	1	0.1189998	0.9048957	0.9558322	0.8172051	0.7232245
MP:0003686	abnormal eye muscle morphology	11	0.3418962	4.159213e-20	0.5126209	0.0007407548	0.1347705
MP:0003687	abnormal intraocular muscle morphology	3	0.1483571	4.49986e-12	0.3382214	0.02884977	0.2403624
MP:0003690	abnormal glial cell physiology	85	3.892192e-99	2.669545e-27	8.118018e-35	3.488625e-62	0.0003059891
MP:0003691	abnormal microglial cell physiology	44	3.070239e-66	0.0004003221	1.986373e-31	3.602184e-50	0.003571093
MP:0003692	xanthoma	6	6.31694e-14	5.159228e-10	1.18211e-05	1.120321e-07	0.562854
MP:0003693	abnormal blastocyst hatching	37	2.073449e-80	4.000659e-05	2.029046e-07	1.773631e-23	0.2455702
MP:0003694	failure of blastocyst to hatch from the zona pellucida	32	5.065686e-72	0.005135806	2.871526e-08	2.139797e-20	0.1668677
MP:0003695	delayed blastocyst hatching from the zona pellucida	6	1.282428e-21	1.809553e-07	1.292638e-05	0.03059932	0.002169756
MP:0003696	abnormal zona pellucida morphology	13	0.000966066	0.005710972	0.3527356	4.109654e-06	0.7556994
MP:0003697	absent zona pellucida	4	0.3541786	0.0055831	0.008442811	0.03126331	0.803381
MP:0003698	abnormal male reproductive system physiology	754	0	4.354836e-169	2.298051e-106	8.644624e-260	0.002077907
MP:0003699	abnormal female reproductive system physiology	624	0	1.729741e-207	1.955815e-192	1.236032e-300	1.188583e-11
MP:0003700	abnormal oviduct transport	3	2.634676e-17	3.802889e-06	0.1133395	0.004112617	0.0838873
MP:0003701	elevated level of mitotic sister chromatid exchange	9	1.46638e-30	0.9787725	0.0006281319	4.462189e-05	0.6896924
MP:0003702	abnormal chromosome morphology	61	8.032887e-100	0.129477	8.905991e-09	2.22917e-27	0.03536092
MP:0003703	abnormal vestibulocochlear ganglion morphology	18	0.05148862	1.379331e-17	0.9393355	0.8417011	0.9381856
MP:0003704	abnormal hair follicle development	70	7.420104e-109	8.283101e-43	2.197599e-27	5.267603e-46	0.03835566
MP:0003705	abnormal hypodermis morphology	110	1.046967e-134	8.110428e-80	1.747086e-46	6.395343e-61	0.01037497
MP:0003706	abnormal cell nucleus count	13	3.719379e-24	0.0001173994	7.310563e-05	1.882686e-15	0.07470684
MP:0003707	increased cell nucleus count	12	6.675611e-25	0.04732853	0.0003529857	4.630376e-15	0.03894636
MP:0003708	binucleate	7	1.497355e-08	0.1853124	0.008998354	4.481048e-07	0.1151653
MP:0003710	abnormal physiological neovascularization	21	2.940704e-46	1.178524e-07	6.441765e-16	2.245392e-48	0.1738304
MP:0003711	pathological neovascularization	88	2.591442e-103	3.251346e-58	1.853493e-63	2.360745e-97	0.00385275
MP:0003714	absent platelets	2	0.2632229	0.5592197	0.9310576	3.736845e-06	0.6675308
MP:0003717	pallor	183	0	1.584799e-51	2.903908e-78	9.121444e-253	0.002885993
MP:0003718	maternal effect	60	1.142306e-89	8.062594e-17	5.634157e-09	2.500299e-34	0.07695632
MP:0003719	abnormal pericyte morphology	16	2.813538e-25	2.013653e-15	3.677007e-12	1.350795e-43	0.01597047
MP:0003720	abnormal neural tube closure	331	0	3.328159e-270	1.195992e-74	8.174827e-223	0.3510468
MP:0003721	increased tumor growth/size	64	4.260571e-62	1.66671e-23	3.456274e-68	4.969107e-68	6.614767e-07
MP:0003722	absent ureter	23	8.155209e-12	3.019557e-36	7.870298e-07	1.986708e-11	0.6444631
MP:0003723	abnormal long bone morphology	442	1.076854e-289	0	6.822208e-89	1.041332e-196	0.001058417
MP:0003724	increased susceptibility to induced arthritis	31	1.155177e-33	5.363579e-16	2.347235e-40	1.104456e-48	0.01005177
MP:0003725	increased autoantibody level	137	6.060646e-183	4.728802e-22	7.358034e-139	5.720252e-207	4.343095e-14
MP:0003726	decreased autoantibody level	22	1.55097e-06	0.275271	2.07338e-20	1.862167e-27	1.631552e-08
MP:0003727	abnormal retinal layer morphology	358	2.839546e-232	6.58236e-170	1.240358e-71	1.733729e-119	0.000297414
MP:0003728	abnormal retinal photoreceptor layer morphology	169	7.552696e-193	5.703136e-33	3.349916e-41	5.528161e-74	0.0001203038
MP:0003729	abnormal photoreceptor outer segment morphology	92	6.039216e-89	2.401261e-07	8.835628e-20	2.136162e-28	0.0006845032
MP:0003730	abnormal photoreceptor inner segment morphology	42	3.154983e-41	0.02072731	6.836632e-07	6.40812e-10	0.002961202
MP:0003731	abnormal retinal outer nuclear layer morphology	118	1.748927e-115	8.89492e-32	1.343011e-35	6.867411e-43	0.02919238
MP:0003732	abnormal retinal outer plexiform layer morphology	37	9.581462e-17	4.371419e-29	2.742123e-12	7.176433e-10	0.2771431
MP:0003733	abnormal retinal inner nuclear layer morphology	72	5.251955e-41	1.531499e-57	5.418591e-15	5.246812e-19	0.05132037
MP:0003734	abnormal retinal inner plexiform layer morphology	32	3.408205e-33	2.402524e-10	3.106804e-10	5.028616e-15	0.009907132
MP:0003735	cup-shaped ears	1	0.7834672	2.130744e-09	0.873847	2.306763e-06	1
MP:0003740	fusion of middle ear ossicles	4	0.8967753	0.002609525	0.4145442	0.1933137	0.5060522
MP:0003742	narrow head	3	8.691722e-09	3.396598e-06	5.780697e-13	1.579478e-05	0.9706262
MP:0003743	abnormal facial morphology	606	0	0	2.078674e-117	2.546139e-258	3.291602e-06
MP:0003744	abnormal orofacial morphology	452	9.957257e-258	0	8.316055e-84	6.467693e-179	1.049714e-05
MP:0003745	abnormal mucosal lining of the mouth	9	0.0003206263	3.175626e-09	4.912128e-05	0.5041549	0.04781993
MP:0003747	mouth mucosal ulceration	3	0.1904074	0.1655599	1	0.9990085	0.4675526
MP:0003750	increased mouth tumor incidence	19	1.965227e-42	5.889193e-20	5.683919e-17	5.195948e-17	0.341772
MP:0003751	oral leukoplakia	3	0.9064922	0.04668757	0.8805775	0.571416	0.875671
MP:0003752	oral papilloma	5	1.159398e-12	0.0006038943	9.400338e-07	0.0005181784	0.2895249
MP:0003755	abnormal palate morphology	280	2.546243e-107	1.468027e-231	6.8656e-34	3.482026e-90	0.0003975712
MP:0003756	abnormal hard palate morphology	64	1.184076e-09	1.404788e-67	3.416788e-08	1.202814e-12	0.005504041
MP:0003757	high palate	1	0.9604766	0.003232989	0.2056645	0.9965804	0.04166206
MP:0003760	short palate	5	0.9997097	1.667205e-23	0.9999118	0.447887	0.01942578
MP:0003761	arched palate	1	1	0.3150907	0.008981698	0.1282527	0.02789339
MP:0003762	abnormal immune organ physiology	179	2.384343e-242	1.793428e-28	1.929413e-141	2.205667e-264	3.249527e-09
MP:0003763	abnormal thymus physiology	104	7.23837e-185	2.748395e-24	1.893647e-86	1.332528e-150	1.515613e-07
MP:0003769	abnormal lip morphology	33	1.530386e-05	1.613002e-47	0.0005318943	2.584115e-12	0.1318824
MP:0003773	everted lip	1	1	0.9998923	0.9128654	1	1
MP:0003775	thin lip	2	7.873394e-12	0.8997667	0.3727636	0.005278264	0.04034779
MP:0003780	lip tumor	2	1.49427e-06	2.513139e-07	0.088033	0.004757882	0.4594215
MP:0003782	short lip	1	0.3357434	0.0002586375	0.6386467	0.007498427	0.2254903
MP:0003786	premature aging	58	1.051618e-53	7.859761e-13	5.624696e-07	3.037824e-19	0.004861877
MP:0003787	abnormal imprinting	18	3.519738e-43	0.04384927	0.001429718	0.02076122	0.05591229
MP:0003789	osteosarcoma	23	6.87118e-21	1.770059e-26	7.692413e-07	1.298617e-06	0.02574903
MP:0003790	absent CD4-positive T cells	22	3.97439e-27	0.002551581	8.660171e-18	1.493974e-46	0.01309655
MP:0003792	abnormal major salivary gland morphology	34	1.193704e-19	6.54641e-30	5.207815e-08	1.30282e-15	0.0002176269
MP:0003793	abnormal submandibular gland morphology	24	0.0008626767	3.380349e-32	0.0001729746	0.0002488169	0.005693413
MP:0003794	delayed somite formation	10	3.506211e-32	0.02676651	0.002767439	7.333074e-22	0.6622088
MP:0003795	abnormal bone structure	567	0	2.429926e-285	1.165005e-245	0	4.877289e-13
MP:0003797	abnormal compact bone morphology	136	1.239852e-96	7.441579e-77	2.174787e-37	1.330218e-73	4.433058e-07
MP:0003798	abnormal Harderian gland pigmentation	1	0.1902299	0.0008806795	0.6891663	2.5197e-06	0.08453146
MP:0003799	impaired macrophage chemotaxis	48	1.036748e-48	6.063924e-35	2.519845e-60	1.063089e-67	5.495567e-05
MP:0003800	monodactyly	8	0.0002638525	1.367666e-10	0.005625468	0.001614446	0.943048
MP:0003806	abnormal nucleotide metabolism	12	7.375778e-27	0.1254198	1.998603e-10	1.507079e-18	0.6357298
MP:0003807	camptodactyly	6	0.01604864	0.006989215	0.7803445	0.001542434	0.3931089
MP:0003808	increased atrioventricular cushion size	10	2.003947e-15	2.597953e-05	2.03752e-06	8.408883e-11	0.4877333
MP:0003809	abnormal hair shaft morphology	78	2.055011e-69	1.953685e-24	4.232899e-19	4.506068e-34	0.05012418
MP:0003810	abnormal hair cuticle	11	4.813683e-21	0.7940692	0.006849655	5.235468e-15	0.0423752
MP:0003811	abnormal hair cortex morphology	6	0.9026555	1.549667e-05	0.0227069	0.9194561	0.5968736
MP:0003812	abnormal hair medulla	11	1.507927e-10	2.862964e-10	5.899903e-05	1.391589e-10	0.4318655
MP:0003813	abnormal hair follicle dermal papilla morphology	5	6.185433e-06	0.03743918	0.08945871	3.407517e-13	0.4688243
MP:0003814	vascular smooth muscle cell hypoplasia	21	9.640436e-21	4.598888e-07	1.000881e-13	2.037237e-33	0.01737538
MP:0003815	hairless	13	4.134693e-10	0.2751212	0.0002158485	2.664372e-08	0.01422083
MP:0003816	abnormal pituitary gland development	32	8.612353e-09	7.557736e-24	4.151247e-05	2.77685e-11	0.9500439
MP:0003817	abnormal pituitary diverticulum morphology	27	0.0003977555	1.194832e-27	0.002391452	4.524674e-10	0.8604962
MP:0003818	abnormal eye muscle development	3	0.9992192	0.933951	0.9654194	0.9330817	0.663524
MP:0003819	increased left ventricle diastolic pressure	15	5.246225e-06	7.111612e-30	8.903854e-12	2.686994e-06	0.1692401
MP:0003820	increased left ventricle systolic pressure	10	1.59291e-05	1.9222e-27	9.558281e-05	0.0001793665	0.1384432
MP:0003821	decreased left ventricle diastolic pressure	4	0.001212468	0.0002950503	0.9991233	0.4050829	0.9448888
MP:0003822	decreased left ventricle systolic pressure	15	3.9231e-17	3.260888e-21	4.095028e-06	3.839859e-09	0.1458516
MP:0003823	increased left ventricle developed pressure	5	0.000666386	0.0005552579	0.2035348	0.0005286333	0.9350826
MP:0003824	decreased left ventricle developed pressure	3	1.092994e-05	7.525169e-12	0.1358002	1.021941e-05	0.9353062
MP:0003825	abnormal pillar cell morphology	18	4.97129e-21	1.326031e-10	0.4155498	5.432151e-13	0.5512886
MP:0003826	abnormal Mullerian duct morphology	18	3.96178e-29	3.569539e-52	0.0001025543	3.682562e-09	0.3587018
MP:0003827	abnormal Wolffian duct morphology	22	0.3156144	3.144014e-19	0.1593207	1.555682e-09	0.2272456
MP:0003828	pulmonary edema	39	5.447908e-64	8.937931e-27	9.459476e-19	2.392364e-40	0.04793053
MP:0003829	impaired febrile response	12	0.01240643	0.0002338633	2.04138e-13	0.01238981	0.004280565
MP:0003830	abnormal testis development	40	4.666136e-12	1.234813e-18	6.549819e-07	7.618922e-07	0.02136498
MP:0003833	decreased satellite cell number	12	0.2199206	4.463157e-22	3.149497e-06	0.0001492582	0.1073554
MP:0003834	abnormal adrenergic chromaffin cell morphology	5	8.586972e-11	0.1690559	8.96295e-06	0.001393641	0.8689351
MP:0003838	abnormal milk ejection	10	4.328529e-24	2.248711e-10	1.67346e-11	1.106388e-08	0.06312321
MP:0003839	abnormal insulin clearance	3	1.37558e-05	9.626324e-06	0.1755484	0.001462948	0.1167394
MP:0003840	abnormal coronal suture morphology	14	4.565069e-15	2.72814e-26	1.457784e-08	3.037359e-13	0.5446318
MP:0003841	abnormal lambdoidal suture morphology	5	0.00103864	1.365223e-29	0.4708149	0.0005113837	0.9815076
MP:0003842	abnormal metopic suture morphology	6	7.992685e-07	7.262671e-26	0.3548905	3.322633e-09	0.4151453
MP:0003843	abnormal sagittal suture morphology	14	1.504647e-40	4.993433e-24	7.209482e-06	1.406401e-09	0.5579343
MP:0003845	abnormal decidualization	17	0.1080007	1.909311e-13	0.01179775	0.2071998	0.01588969
MP:0003846	matted coat	6	0.2122261	2.678787e-07	3.703199e-05	6.027928e-06	0.4613072
MP:0003847	disorganized lens bow	1	2.438437e-07	1.324959e-06	0.054902	0.4587774	0.8122343
MP:0003848	brittle hair	8	9.196335e-08	0.6255288	0.1534116	0.1441333	0.7731491
MP:0003849	greasy coat	12	0.3620775	0.0007066074	0.0181773	0.9201623	0.0532337
MP:0003850	abnormal thymocyte activation	28	4.654946e-50	8.351407e-11	1.999608e-37	4.187238e-84	1.480385e-09
MP:0003851	skeletal muscle interstitial fibrosis	13	1.148572e-06	2.195301e-11	0.03273157	2.301551e-08	0.5554061
MP:0003852	skeletal muscle necrosis	35	0.0006263276	9.574089e-18	0.1077176	3.127305e-09	0.5174438
MP:0003853	dry skin	35	8.877549e-79	1.435496e-17	8.087822e-17	3.234979e-18	0.02682386
MP:0003854	abnormal forelimb stylopod morphology	95	4.075058e-18	1.490285e-67	0.0003392033	4.039845e-13	8.880632e-06
MP:0003855	abnormal forelimb zeugopod morphology	104	2.65822e-08	2.553318e-128	9.899932e-07	1.726153e-12	0.0006006781
MP:0003856	abnormal hindlimb stylopod morphology	153	9.955438e-27	3.390019e-98	2.55947e-12	4.452941e-38	0.02394039
MP:0003857	abnormal hindlimb zeugopod morphology	153	2.358991e-53	1.305934e-129	1.237427e-15	4.454829e-45	0.01192388
MP:0003858	enhanced coordination	28	5.603549e-22	0.0003126509	1.487248e-07	3.555779e-14	0.6802038
MP:0003859	abnormal Harderian gland physiology	2	0.9741619	0.1874788	0.3357974	0.2214209	0.9328323
MP:0003860	abnormal carbon dioxide level	7	0.004857413	0.248081	3.147296e-08	0.0008322886	0.1019352
MP:0003861	abnormal nervous system development	1091	0	0	1.075358e-235	0	3.126385e-05
MP:0003862	decreased aggression towards males	15	0.999351	0.02319452	0.9061189	0.9663512	0.9891362
MP:0003863	decreased aggression towards mice	26	0.01610801	0.001923598	0.2289662	0.7272317	0.9412436
MP:0003864	abnormal midbrain development	26	2.750201e-48	5.136865e-13	6.308973e-14	3.864538e-23	0.6864567
MP:0003865	lymph node inflammation	9	4.761506e-15	0.01576658	1.72652e-05	2.159787e-19	0.360702
MP:0003866	abnormal defecation	80	1.513038e-83	2.457144e-19	2.958475e-54	5.263687e-57	0.0002095107
MP:0003867	increased defecation amount	13	1.382175e-07	9.502576e-06	6.211961e-08	4.121304e-06	0.5338464
MP:0003868	abnormal feces composition	45	1.551459e-39	7.856537e-11	1.111006e-11	2.860978e-14	0.02188461
MP:0003869	ectopic cartilage	16	4.057199e-13	4.271397e-34	1.472341e-07	4.486733e-11	0.0223299
MP:0003870	decreased urine glucose level	3	0.7243198	0.0001238144	0.01359967	0.005502478	0.1564984
MP:0003871	abnormal myelin sheath morphology	69	2.097802e-114	2.574914e-39	2.890599e-14	1.19019e-48	0.06913157
MP:0003872	absent heart right ventricle	6	1.738383e-07	0.008179182	0.09709706	0.03013527	0.6586959
MP:0003873	branchial arch hypoplasia	16	3.50368e-34	4.720678e-10	2.387387e-13	9.96076e-14	0.1056949
MP:0003874	absent branchial arches	10	1.632969e-05	1.08019e-09	0.4293858	0.0006323942	0.7922911
MP:0003875	abnormal hair follicle regression	12	4.297154e-12	6.9711e-12	6.063972e-10	1.147998e-12	0.004220047
MP:0003877	abnormal serotonergic neuron morphology	11	6.278849e-05	4.40675e-10	0.01288764	0.0001914248	0.9820183
MP:0003878	abnormal ear physiology	311	6.536202e-293	7.373339e-179	2.559752e-63	1.541566e-135	0.0002938764
MP:0003879	abnormal hair cell physiology	37	6.898044e-93	2.241325e-08	1.903213e-10	4.654268e-23	0.1349489
MP:0003880	abnormal central pattern generator function	19	1.074781e-15	1.401669e-11	0.0005029212	1.745499e-07	0.02005424
MP:0003881	abnormal nephron morphology	442	0	4.607853e-261	4.375117e-208	0	1.440169e-08
MP:0003882	abnormal pulse pressure	3	1.065278e-08	2.911127e-10	0.4998102	0.004784503	0.2118002
MP:0003883	enlarged stomach	20	3.26209e-15	5.383596e-12	2.291251e-11	1.084703e-09	0.001133689
MP:0003884	decreased macrophage cell number	107	4.468993e-133	3.016401e-44	1.123621e-105	8.861761e-150	0.1967242
MP:0003885	abnormal rostral-caudal body axis extension	21	8.469937e-09	2.136808e-25	4.967154e-05	0.03227047	0.1882245
MP:0003886	abnormal embryonic epiblast morphology	61	3.693734e-75	1.379221e-48	4.228587e-26	1.006891e-25	0.01576145
MP:0003887	increased hepatocyte apoptosis	60	5.458202e-140	6.156022e-42	9.146415e-18	9.699163e-66	0.6255551
MP:0003888	liver hemorrhage	36	4.290407e-53	3.09318e-14	9.94384e-15	4.108579e-28	0.5124763
MP:0003889	enhanced sensorimotor gating	3	1.442115e-13	0.7474964	0.04024442	7.568433e-09	0.760499
MP:0003890	abnormal embryonic-extraembryonic boundary morphology	33	3.377541e-48	2.492657e-17	4.843735e-24	7.099426e-12	0.207313
MP:0003891	increased allantois apoptosis	4	0.007156181	0.4467064	0.5989305	0.03156471	0.5813237
MP:0003892	abnormal gastric gland morphology	32	2.390669e-44	7.066286e-19	1.34273e-14	5.99757e-23	9.074171e-06
MP:0003893	increased hepatocyte proliferation	27	2.160436e-60	4.494596e-24	1.809414e-10	1.516777e-29	0.336087
MP:0003894	abnormal Purkinje cell innervation	12	0.0001214227	8.040571e-30	0.06180774	0.6920045	0.01676445
MP:0003895	increased ectoderm apoptosis	8	2.646666e-30	0.05888013	3.873257e-09	4.470754e-12	0.1806345
MP:0003896	prolonged PR interval	33	2.933654e-17	2.264265e-26	5.895711e-06	2.420344e-08	0.1179282
MP:0003897	abnormal ST segment	10	7.526042e-11	8.326131e-13	4.953175e-08	0.001436861	0.2372748
MP:0003898	abnormal QRS complex	39	5.873101e-58	5.700603e-16	6.98925e-12	1.573714e-22	0.7078171
MP:0003899	abnormal QT interval	26	3.249224e-37	1.881121e-17	1.32281e-09	1.558062e-12	0.05823649
MP:0003900	shortened QT interval	2	0.2903136	0.05185435	0.4247468	0.7998565	0.2456392
MP:0003901	abnormal PR interval	35	2.327062e-14	4.202937e-28	5.856494e-06	1.056317e-07	0.03647324
MP:0003902	abnormal cell mass	2	1	0.7863065	0.4175001	0.008642672	0.7419941
MP:0003903	increased cell mass	1	1	0.4144202	0.03724176	0.0001221175	0.39958
MP:0003904	decreased cell mass	1	1	0.9177246	1	0.719701	1
MP:0003905	abnormal aorta elastin content	4	0.006759637	1.674873e-05	0.1036553	0.4252156	0.2577698
MP:0003907	decreased aorta elastin content	3	0.02044974	7.494805e-05	0.4481793	0.440152	0.1312555
MP:0003908	decreased stereotypic behavior	5	3.95028e-12	9.211833e-05	0.1070689	0.03784123	0.04873527
MP:0003913	increased heart right ventricle weight	5	6.800679e-07	0.01607869	0.1047542	8.823148e-07	0.7316016
MP:0003915	increased left ventricle weight	25	4.16129e-19	5.992711e-28	4.914481e-18	1.263745e-15	0.5193627
MP:0003916	decreased heart left ventricle weight	4	0.3296671	2.315828e-12	0.2355155	0.1361603	0.9562264
MP:0003917	increased kidney weight	63	1.520516e-43	5.537811e-19	1.203068e-15	3.349655e-19	0.5546504
MP:0003918	decreased kidney weight	51	2.471613e-37	1.214989e-48	1.843079e-22	5.675621e-24	0.1806865
MP:0003920	abnormal heart right ventricle morphology	151	5.96869e-129	5.051577e-134	3.437086e-21	8.5518e-68	0.1210543
MP:0003921	abnormal heart left ventricle morphology	242	5.236514e-169	5.899463e-239	9.337073e-56	1.629796e-115	0.0005041349
MP:0003922	abnormal heart right atrium morphology	26	3.747675e-33	6.603255e-52	0.3223333	4.747763e-18	0.1673022
MP:0003923	abnormal heart left atrium morphology	10	4.62877e-27	1.230131e-08	2.864766e-05	0.0001729182	0.8057694
MP:0003924	herniated diaphragm	23	0.6236936	9.478572e-17	0.04609715	4.113989e-07	0.04181987
MP:0003925	abnormal cellular glucose import	10	2.692304e-46	0.001281171	0.006313892	9.131519e-24	0.9055755
MP:0003926	impaired cellular glucose import	5	2.860779e-08	0.01025354	0.1331935	2.516177e-13	0.5345225
MP:0003927	enhanced cellular glucose import	2	1.675373e-18	0.5050892	0.001547075	9.115133e-06	1
MP:0003928	increased heart rate variability	6	0.005067054	0.002531441	4.485715e-05	3.026454e-05	8.040085e-05
MP:0003929	decreased heart rate variability	7	0.65887	0.0002244752	0.1180402	0.8704878	0.03269373
MP:0003930	abnormal tooth hard tissue morphology	40	4.204919e-08	1.735168e-21	7.964306e-06	3.72938e-10	0.5332688
MP:0003931	absent molars	7	0.6559125	2.172373e-06	0.8585626	0.0004062706	0.1118951
MP:0003932	abnormal molar crown morphology	18	0.0231201	8.087404e-08	0.9539304	0.0009241632	0.4174772
MP:0003933	abnormal cementum morphology	1	0.0002563497	0.002248265	0.02326111	0.03867134	0.8122343
MP:0003934	abnormal pancreas development	40	1.148532e-14	6.779782e-52	2.187859e-14	1.474306e-29	0.189794
MP:0003935	abnormal craniofacial development	351	8.006524e-267	1.455737e-307	8.89055e-75	1.297382e-188	0.0001231832
MP:0003936	abnormal reproductive system development	80	2.282393e-55	3.49258e-63	5.34943e-12	2.38075e-11	0.001807948
MP:0003938	abnormal ear development	61	4.683083e-20	1.647412e-67	1.593207e-11	1.739772e-22	0.1742572
MP:0003939	abnormal myotome morphology	8	0.9630357	8.664747e-11	0.999931	0.0463284	0.07242273
MP:0003940	abnormal dermatome morphology	1	0.001556825	0.180813	0.2083871	0.02983271	0.6181084
MP:0003941	abnormal skin development	24	4.350194e-06	4.703741e-10	2.706616e-07	4.768969e-06	0.08390021
MP:0003942	abnormal urinary system development	133	4.732798e-53	9.686268e-151	1.739481e-19	6.116455e-34	0.1220775
MP:0003943	abnormal hepatobiliary system development	72	7.981255e-99	4.936358e-56	1.019729e-28	2.381364e-80	0.4894505
MP:0003944	abnormal T cell subpopulation ratio	53	1.19326e-139	1.140571e-07	1.944931e-54	2.774897e-79	0.0002151992
MP:0003945	abnormal lymphocyte physiology	960	0	1.456798e-149	0	0	1.350599e-54
MP:0003946	renal necrosis	32	3.896239e-35	3.164067e-05	2.627552e-09	3.695915e-20	0.06947123
MP:0003947	abnormal cholesterol level	387	0	1.534487e-138	1.320535e-119	4.921521e-228	1.572104e-05
MP:0003948	abnormal gas homeostasis	496	0	5.96715e-255	2.016905e-146	5.716109e-300	0.00180752
MP:0003949	abnormal circulating lipid level	584	0	4.395856e-214	3.19576e-173	0	5.550859e-06
MP:0003950	abnormal plasma membrane morphology	13	1.051666e-21	2.137646e-05	1.099219e-08	2.246166e-13	0.9210723
MP:0003951	abnormal copper homeostasis	11	1.504381e-18	4.09093e-05	0.007733516	7.858243e-07	0.2532819
MP:0003952	abnormal copper level	10	8.776147e-19	0.0005798458	0.009039744	2.410509e-07	0.2221819
MP:0003953	abnormal hormone level	826	0	1.345137e-284	3.34076e-220	0	1.338654e-12
MP:0003954	abnormal Reichert's membrane morphology	16	3.173771e-21	3.242471e-26	3.229995e-15	7.790884e-22	0.2567621
MP:0003955	abnormal ultimobranchial body morphology	8	0.3805512	1.046402e-08	0.3284819	0.0004541312	0.3900136
MP:0003956	abnormal body size	2299	0	0	0	0	4.641267e-21
MP:0003957	abnormal nitric oxide homeostasis	40	5.819045e-27	4.425292e-32	6.482745e-30	2.598139e-31	0.0513062
MP:0003958	heart valve hyperplasia	7	6.379502e-10	0.0001201871	0.0007440152	9.467313e-05	0.01115452
MP:0003959	abnormal lean body mass	167	1.680728e-205	5.228315e-73	4.15415e-46	1.27498e-87	0.02262326
MP:0003960	increased lean body mass	71	1.801987e-107	1.294644e-29	3.998326e-19	8.094823e-35	0.11308
MP:0003961	decreased lean body mass	105	3.416333e-118	1.499356e-51	2.539692e-31	9.11154e-59	0.03572035
MP:0003962	abnormal adrenaline level	28	4.526714e-07	8.092061e-08	8.879123e-09	1.088992e-11	0.6310743
MP:0003963	abnormal corticosterone level	82	2.899305e-71	2.782923e-17	4.937406e-13	2.474738e-19	0.9106445
MP:0003964	abnormal noradrenaline level	53	1.073795e-21	9.63491e-13	1.193196e-06	8.835574e-15	0.2757348
MP:0003965	abnormal pituitary hormone level	196	1.203073e-79	3.827134e-27	1.329528e-30	4.985527e-35	0.0001845687
MP:0003966	abnormal adrenocorticotropin level	37	2.256154e-09	9.719114e-15	0.01882011	0.01357835	0.7052516
MP:0003967	abnormal follicle stimulating hormone level	79	7.754311e-50	5.304566e-09	1.476865e-09	2.647258e-18	5.719479e-05
MP:0003968	abnormal growth hormone level	58	8.412666e-32	2.339077e-12	3.999892e-12	7.246693e-17	0.2001467
MP:0003969	abnormal luteinizing hormone level	66	3.651482e-56	2.308108e-20	1.196748e-15	2.720687e-22	0.004952529
MP:0003970	abnormal prolactin level	29	7.444064e-05	7.271024e-08	7.173898e-06	0.0004628106	0.1788616
MP:0003971	abnormal thyroid-stimulating hormone level	32	3.984184e-09	9.371916e-05	3.782169e-09	9.535855e-10	0.16398
MP:0003972	decreased pituitary hormone level	101	1.048355e-48	1.028253e-19	5.574343e-22	2.410143e-20	0.003014847
MP:0003973	increased pituitary hormone level	120	2.595061e-37	8.333403e-16	1.133408e-15	1.018949e-16	0.002245208
MP:0003974	abnormal endocardium morphology	28	1.090337e-59	3.08993e-13	6.08858e-35	3.108469e-28	0.04754371
MP:0003975	increased circulating VLDL triglyceride level	10	2.660131e-12	1.207389e-17	2.485781e-10	9.587079e-07	0.5060083
MP:0003976	decreased circulating VLDL triglyceride level	13	3.140491e-15	8.411849e-10	1.654116e-06	1.654895e-06	0.02771384
MP:0003977	abnormal circulating carnitine level	9	2.670532e-18	0.05666119	0.0004758156	2.868959e-06	0.04017575
MP:0003978	decreased circulating carnitine level	4	2.849738e-18	0.04415949	0.04313004	5.346956e-06	0.7659187
MP:0003979	increased circulating carnitine level	6	2.060988e-06	0.055266	0.008020861	0.001809931	0.01118041
MP:0003980	increased circulating phospholipid level	11	1.358479e-12	3.689322e-11	7.018935e-20	1.353687e-14	0.007221458
MP:0003981	decreased circulating phospholipid level	3	0.01916695	3.416356e-11	0.009841154	1.589284e-07	0.304297
MP:0003982	increased cholesterol level	225	6.503467e-233	3.321e-78	7.72144e-68	2.564158e-102	0.0003806635
MP:0003983	decreased cholesterol level	212	0	4.139435e-92	1.71367e-90	3.399335e-176	0.004756403
MP:0003984	embryonic growth retardation	499	0	3.152376e-272	8.09707e-168	0	0.2909546
MP:0003985	renal fibrosis	78	4.997907e-80	7.11482e-28	4.033385e-23	5.292834e-51	0.1003183
MP:0003986	small cochlear ganglion	17	1.978286e-16	0.04191598	0.5488859	0.1996917	0.852344
MP:0003987	small vestibular ganglion	14	0.2565392	3.894731e-09	0.5091487	0.06518791	0.946618
MP:0003988	disorganized embryonic tissue	34	1.30822e-74	9.714185e-32	1.201386e-06	2.452499e-10	0.1560211
MP:0003989	abnormal barrel cortex morphology	17	0.9999999	1.095933e-22	0.8775052	0.7283092	0.03217389
MP:0003990	decreased neurotransmitter release	35	1.23895e-38	1.560971e-39	0.1364848	4.374485e-14	0.3737558
MP:0003991	arteriosclerosis	107	3.365889e-70	3.337992e-36	1.317682e-69	4.348539e-99	9.401891e-05
MP:0003992	increased mortality induced by ionizing radiation	46	6.865382e-94	9.281248e-11	5.629213e-13	8.637103e-20	0.8531434
MP:0003993	abnormal ventral spinal root morphology	22	5.184865e-39	1.430017e-28	8.470526e-05	2.004397e-13	0.01432927
MP:0003994	abnormal dorsal spinal root morphology	10	2.696204e-23	6.11184e-21	3.72015e-08	2.850634e-11	0.06322584
MP:0003995	abnormal uterine artery morphology	3	0.0006787	0.4484606	0.02445918	0.001157457	0.04117674
MP:0003996	clonic seizures	18	6.920108e-09	3.086725e-13	2.886777e-05	0.031075	0.5158613
MP:0003997	tonic-clonic seizures	67	3.77715e-28	2.307385e-20	7.912505e-13	2.529863e-21	0.00553517
MP:0003998	decreased thermal nociceptive threshold	47	5.187009e-19	8.673622e-17	1.703815e-09	1.084379e-17	0.8757464
MP:0003999	enhanced passive avoidance behavior	2	6.564487e-05	0.2250921	2.550606e-09	0.01173873	0.0003235824
MP:0004000	impaired passive avoidance behavior	26	0.8078264	1.890036e-06	0.07517999	0.7279252	0.2948779
MP:0004001	decreased hepatocyte proliferation	30	4.319003e-66	1.679585e-24	2.096711e-13	1.450214e-27	0.4467754
MP:0004002	abnormal jejunum morphology	14	1.041888e-10	1.570921e-09	2.122947e-08	2.745624e-09	0.7153262
MP:0004003	abnormal vascular endothelial cell physiology	49	6.098608e-97	2.997714e-32	5.77137e-39	1.068202e-77	0.3433876
MP:0004004	patent ductus venosus	3	0.0002034453	0.9088077	0.1078695	0.1845313	0.2646734
MP:0004005	impaired contractility of intestinal smooth muscle	3	0.9786386	0.6030049	0.04347413	0.9846018	0.03481924
MP:0004006	impaired contractility of jejunal smooth muscle	1	0.01612643	0.0005676379	0.4579226	0.0915071	0.6437678
MP:0004007	abnormal lung vasculature morphology	93	1.690645e-47	4.608365e-54	2.826494e-16	1.25652e-20	0.1830683
MP:0004008	abnormal GABA-mediated receptor currents	18	0.8647694	0.999558	0.9784771	0.989857	0.9975442
MP:0004011	decreased diastolic filling velocity	3	0.9999999	0.009757767	0.9540779	0.997788	0.5316498
MP:0004014	abnormal uterine environment	35	3.494253e-09	1.945679e-22	1.324457e-06	2.714265e-08	0.001032797
MP:0004015	abnormal oviduct environment	1	0.9999736	0.008215793	0.5785484	0.8595013	0.8122343
MP:0004016	decreased bone mass	90	3.300435e-76	3.739791e-51	3.174702e-40	5.779497e-55	1.798897e-09
MP:0004017	duplex kidney	16	2.350127e-06	3.297783e-15	0.8841655	0.001562699	0.8095124
MP:0004018	abnormal galactose homeostasis	1	1	1	1	0.3054447	1
MP:0004019	abnormal vitamin homeostasis	61	1.712042e-08	1.054764e-50	1.148622e-08	1.776533e-13	0.0001162546
MP:0004020	polyhydramnios	4	0.05828919	0.2025204	0.7149165	0.9816253	0.4296159
MP:0004021	abnormal rod electrophysiology	87	3.574969e-56	2.132235e-29	2.222467e-18	1.406852e-18	0.008246622
MP:0004022	abnormal cone electrophysiology	71	2.428959e-36	5.405742e-12	1.887848e-08	5.918244e-10	0.2725753
MP:0004023	abnormal chromosome number	71	1.730377e-184	2.470022e-05	2.624418e-11	2.932448e-51	0.4785795
MP:0004024	aneuploidy	52	1.221139e-139	0.002083776	7.250197e-10	6.333394e-32	0.4441479
MP:0004025	polyploidy	25	1.946329e-72	1.316988e-08	2.036686e-08	4.358854e-27	0.3165282
MP:0004027	trisomy	2	0.8203977	0.4170668	0.9927828	0.4083391	1
MP:0004028	chromosome breakage	65	1.018956e-104	0.01350771	4.807765e-14	1.266195e-28	0.3793854
MP:0004029	spontaneous chromosome breakage	29	2.21318e-49	0.009572902	0.0001892154	8.305243e-10	0.3352824
MP:0004030	induced chromosome breakage	21	2.706211e-33	0.06239913	0.0002194638	6.93741e-08	0.6527763
MP:0004031	insulitis	28	2.298957e-09	7.28427e-10	2.872376e-30	7.685252e-26	3.402042e-05
MP:0004032	abnormal interventricular groove morphology	9	1.245809e-09	4.087656e-28	0.000743069	2.21766e-10	0.8747605
MP:0004033	supernumerary teeth	11	0.6925295	4.175523e-05	0.05874285	6.174111e-05	0.03959264
MP:0004034	belly blaze	1	2.496788e-08	0.5187106	2.368458e-05	0.3225972	0.2355317
MP:0004035	abnormal sublingual gland morphology	10	1.004759e-26	4.457855e-11	6.241861e-05	7.378051e-18	0.6617353
MP:0004036	abnormal muscle relaxation	56	5.609675e-63	7.45012e-26	6.47011e-33	1.767495e-38	0.1657048
MP:0004037	increased muscle relaxation	4	0.8048861	6.765643e-05	0.3624142	0.8237085	0.2051457
MP:0004038	lymphangiectasis	9	6.84114e-08	1.937776e-05	2.571295e-12	9.520194e-17	0.0007894371
MP:0004039	abnormal cardiac cell glucose uptake	14	1.482219e-07	3.969776e-08	2.430696e-13	8.228654e-19	0.01841566
MP:0004040	altered susceptibility to kidney reperfusion injury	26	8.110944e-25	1.538761e-10	3.359046e-20	9.630453e-39	0.1148141
MP:0004041	increased susceptibility to kidney reperfusion injury	5	4.080961e-28	0.3634886	0.002462373	5.338334e-14	0.3149224
MP:0004042	decreased susceptibility to kidney reperfusion injury	22	6.767894e-17	3.965423e-10	1.368196e-20	7.464285e-34	0.1041677
MP:0004043	abnormal pH regulation	36	1.147287e-14	5.624117e-12	0.09188761	1.377223e-06	0.5768538
MP:0004044	aortic dissection	10	2.488746e-24	1.225889e-06	0.04897637	0.0001693894	0.9843289
MP:0004045	abnormal cell cycle checkpoint function	55	7.422792e-151	2.143225e-07	6.724607e-33	2.519919e-54	0.6755662
MP:0004046	abnormal mitosis	114	1.53032e-309	1.363342e-09	2.20684e-25	2.910485e-78	0.03966967
MP:0004047	abnormal milk composition	22	6.796478e-20	1.635228e-05	5.324168e-15	2.866036e-19	0.9114459
MP:0004049	acute promyelocytic leukemia	8	1.191637e-30	0.02742861	1.199679e-09	8.997424e-15	0.1864715
MP:0004053	abnormal synchondrosis	7	3.375451e-44	8.044896e-08	0.02571778	3.520049e-07	0.9032307
MP:0004054	abnormal periocular mesenchyme morphology	4	0.9981864	0.003534168	0.3796195	0.8430263	0.3456226
MP:0004055	atrium hypoplasia	7	6.92141e-09	1.872308e-26	0.9861708	0.02279038	0.8049716
MP:0004056	abnormal myocardium compact layer morphology	61	8.219826e-163	1.936641e-21	8.053783e-26	2.453075e-51	0.3148811
MP:0004057	thin myocardium compact layer	42	1.052416e-131	9.952068e-22	4.444311e-16	4.886714e-36	0.1264819
MP:0004058	abnormal ventricle papillary muscle morphology	4	2.983476e-30	8.62775e-07	0.0001260554	5.91069e-08	1
MP:0004061	papillary muscle hypoplasia	1	0.0003250823	0.516914	1	0.0001440613	1
MP:0004062	dilated heart right atrium	7	9.501787e-43	8.686594e-08	0.01689482	2.602425e-08	0.6935745
MP:0004063	dilated heart left atrium	4	1.23431e-05	0.01360976	0.3482907	0.002633928	0.2752777
MP:0004064	decreased susceptibility to induced muscular atrophy	1	0.6889969	0.01511426	0.2349303	0.812425	1
MP:0004065	increased susceptibility to induced muscular atrophy	1	0.9852308	4.709394e-07	0.4261413	0.8071025	0.6253179
MP:0004066	abnormal primitive node morphology	55	1.528118e-60	9.263172e-21	3.119914e-20	1.923726e-18	0.5284459
MP:0004067	abnormal trabecula carnea morphology	88	1.385597e-151	2.749107e-68	2.290762e-34	1.713565e-64	0.4659642
MP:0004068	dilated dorsal aorta	18	1.635792e-38	1.413441e-11	1.430289e-06	4.179397e-36	0.629339
MP:0004069	abnormal muscle spindle morphology	19	4.078647e-16	2.298205e-17	0.002614393	1.232617e-06	0.600937
MP:0004070	abnormal P wave	18	3.534447e-34	3.268301e-14	0.0007038047	2.842798e-13	0.160848
MP:0004071	prolonged P wave	13	2.985269e-26	2.881962e-11	0.173768	3.147477e-07	0.3516287
MP:0004072	abnormal frontal plane axis	2	0.001472602	9.131696e-07	0.001573577	9.217369e-06	0.1159336
MP:0004073	caudal body truncation	56	1.598435e-74	2.412744e-21	2.495124e-17	1.061347e-27	0.008517952
MP:0004074	abnormal Schwann cell precursor morphology	7	8.990702e-19	0.06632058	9.997719e-05	3.42779e-06	0.1471131
MP:0004075	decreased Schwann cell precursor number	5	9.633609e-17	0.007735341	3.873079e-06	9.402549e-05	0.1309554
MP:0004076	abnormal vitelline vascular remodeling	74	4.381996e-133	4.255664e-45	1.325382e-37	8.249482e-66	0.1292809
MP:0004077	abnormal striatum morphology	78	4.88628e-36	2.390917e-21	2.600572e-06	1.784519e-20	0.07015792
MP:0004079	abnormal putamen morphology	2	0.0321372	0.9990372	1	0.03561021	0.5925187
MP:0004080	abnormal nucleus accumbens morphology	3	0.5500948	8.198955e-06	0.7892884	0.005825607	0.3996233
MP:0004081	abnormal globus pallidus morphology	5	1.312775e-07	0.003430806	0.05133463	0.004005562	0.8237735
MP:0004082	abnormal habenula morphology	4	0.03357001	0.1876966	9.509597e-06	0.03915084	0.5103358
MP:0004083	polysyndactyly	17	0.1181237	3.387833e-13	0.0005325273	0.0004375805	0.9301264
MP:0004084	abnormal cardiac muscle relaxation	31	3.135175e-46	7.107915e-19	3.52835e-19	1.804854e-29	0.3672035
MP:0004085	abnormal heartbeat	227	2.788333e-181	6.299491e-137	1.231946e-57	1.329632e-90	0.0002942137
MP:0004086	absent heartbeat	21	2.258911e-58	1.548655e-10	8.444695e-07	1.024286e-31	0.01690433
MP:0004087	abnormal muscle fiber morphology	358	0	5.605261e-275	1.036491e-100	1.357604e-247	5.103514e-05
MP:0004088	abnormal sarcoplasmic reticulum morphology	11	3.112518e-13	0.5901823	0.3724691	0.5813671	0.7320887
MP:0004089	dilated sarcoplasmic reticulum	5	1.477496e-10	0.9789306	0.3167302	0.2407005	0.728511
MP:0004090	abnormal sarcomere morphology	54	2.217365e-90	9.953145e-39	2.504701e-31	2.038385e-37	0.1290862
MP:0004091	abnormal Z lines	23	2.432306e-31	9.875529e-13	5.876101e-19	1.546746e-18	0.04003762
MP:0004092	absent Z lines	3	0.04211881	0.2671952	1.991242e-05	0.005894633	0.05815364
MP:0004093	diffuse Z lines	1	0.4844345	0.07022086	0.008981698	3.121819e-05	0.8122343
MP:0004094	abnormal M lines	2	0.006488375	8.659955e-05	0.6877209	0.1154706	0.908323
MP:0004095	ocular distichiasis	1	0.02517156	0.04953377	0.02439757	0.07108977	1
MP:0004096	abnormal midbrain-hindbrain boundary development	12	3.141909e-08	1.096901e-18	0.02292287	1.8763e-05	0.9894922
MP:0004097	abnormal cerebellar cortex morphology	306	1.947776e-197	1.280736e-199	9.14621e-46	7.900107e-120	0.03057438
MP:0004098	abnormal cerebellar granule cell morphology	63	1.060635e-41	1.252506e-42	1.072199e-14	1.012691e-18	0.1663606
MP:0004100	abnormal spinal cord interneuron morphology	40	4.060194e-15	7.803521e-34	0.02277344	2.253545e-12	0.1526428
MP:0004101	abnormal brain interneuron morphology	33	0.8148732	0.00320768	0.315716	0.1728262	0.001590881
MP:0004102	abnormal dorsal striatum morphology	12	1.040015e-12	0.9997209	0.1457787	6.147765e-05	0.7784436
MP:0004103	abnormal ventral striatum morphology	11	0.01056413	7.053977e-05	0.4157427	0.001057046	0.4296818
MP:0004105	corneal abrasion	2	2.241481e-06	0.1065014	0.0710962	0.006741781	0.8298349
MP:0004106	lymphatic vessel hyperplasia	6	0.001036602	0.0007699987	6.266074e-11	7.477304e-09	0.753809
MP:0004107	abnormal thoracic duct morphology	1	0.02517156	0.04953377	0.02439757	0.07108977	1
MP:0004109	abnormal Sertoli cell development	21	0.9600873	4.492961e-07	0.009170464	0.3616788	0.09450907
MP:0004110	transposition of great arteries	47	3.285513e-51	3.536218e-12	7.267494e-19	4.051939e-15	0.01757259
MP:0004111	abnormal coronary artery morphology	30	1.052915e-49	1.143163e-06	2.017026e-15	9.945818e-16	0.3912405
MP:0004112	abnormal arteriole morphology	6	3.095689e-13	1.929328e-13	1.386455e-08	1.897639e-13	0.40938
MP:0004113	abnormal aortic arch morphology	90	2.736335e-34	2.780827e-76	5.224235e-22	6.26091e-37	0.0006112121
MP:0004114	abnormal atrioventricular node morphology	3	7.358055e-05	0.0009367144	0.005736544	6.557782e-07	0.009007554
MP:0004115	abnormal sinoatrial node morphology	6	0.06922775	3.157871e-08	0.6689478	1.453845e-05	0.1484554
MP:0004116	abnormal atrioventricular bundle conduction	3	0.9996349	1.016395e-11	0.7735008	0.8893293	0.5625908
MP:0004117	abnormal atrioventricular bundle morphology	4	0.1372676	7.576667e-33	0.7935137	0.009358456	0.4050365
MP:0004119	hypokalemia	11	1.068139e-10	6.113231e-26	0.9491981	0.006338563	0.3018961
MP:0004120	cardiac ischemia	4	0.00101787	1.919938e-09	0.0002448555	0.1284712	0.3007286
MP:0004121	abnormal sarcolemma morphology	14	0.004330488	7.754363e-08	0.3396865	0.01709213	0.8949309
MP:0004122	abnormal sinus arrhythmia	17	0.1591221	3.639818e-21	0.0003775197	0.02608468	5.116727e-05
MP:0004123	abnormal impulse conducting system morphology	12	0.01523464	2.249678e-29	0.1970188	1.378798e-07	0.006188097
MP:0004124	abnormal Purkinje fiber morphology	2	0.0001146626	0.8069018	0.07550909	0.02281646	0.007162857
MP:0004125	abnormal venule morphology	3	3.086232e-11	1.071532e-07	2.323045e-11	2.417036e-18	0.8774411
MP:0004126	thin hypodermis	8	1.303305e-34	2.630664e-19	7.634412e-06	1.358329e-05	0.9984289
MP:0004127	thick hypodermis	2	0.9769552	0.002960307	0.5752356	0.9863669	0.04368017
MP:0004129	abnormal respiratory quotient	96	4.529503e-160	2.297097e-38	4.723977e-63	3.131864e-106	0.008123158
MP:0004130	abnormal muscle cell glucose uptake	62	1.611273e-44	5.073891e-53	1.366707e-42	1.165874e-66	0.001742224
MP:0004131	abnormal embryonic cilium morphology	34	5.875305e-28	1.422024e-09	1.967521e-10	5.936035e-16	0.3087349
MP:0004132	absent embryonic cilia	17	1.573157e-22	0.001320472	6.720827e-13	1.723276e-15	0.2498919
MP:0004133	heterotaxia	56	1.723582e-22	2.919402e-10	3.203601e-09	5.806028e-13	0.1115855
MP:0004134	abnormal chest morphology	38	7.392843e-41	2.608079e-24	2.332912e-06	8.340263e-19	0.8529196
MP:0004135	abnormal mammary gland embryonic development	11	1	5.764322e-53	0.9943689	4.607096e-05	0.001053603
MP:0004136	abnormal tongue muscle morphology	14	0.7881276	1.373294e-14	0.4830405	4.05905e-07	0.03899918
MP:0004137	abnormal gastric surface mucous cell morphology	5	0.2077993	0.4156613	0.08118283	0.9515127	0.5740103
MP:0004138	abnormal mucous neck cell morphology	5	0.5227093	1.642928e-12	0.0003981211	0.009886428	0.007469048
MP:0004139	abnormal gastric parietal cell morphology	26	3.901083e-31	4.566709e-19	6.51178e-17	4.288776e-17	9.752144e-05
MP:0004140	abnormal chief cell morphology	12	4.250139e-36	1.967719e-10	1.274285e-07	1.687518e-08	6.752275e-06
MP:0004141	abnormal enteroendocrine cell morphology	17	5.524043e-28	1.182954e-11	2.547357e-14	4.280934e-12	0.1584416
MP:0004142	abnormal muscle tone	70	1.474108e-26	1.623961e-31	2.595803e-11	1.442457e-23	0.2972796
MP:0004143	muscle hypertonia	19	0.0006459818	2.426629e-06	0.0003796235	3.115195e-05	0.167078
MP:0004144	hypotonia	22	4.346008e-06	0.0001886956	7.697073e-07	5.216669e-12	0.102304
MP:0004145	abnormal muscle electrophysiology	19	6.588881e-10	1.220588e-11	0.327628	0.0004804456	0.6371715
MP:0004147	increased porphyrin level	15	5.252237e-31	0.4099083	0.05710231	1.109455e-11	0.2156088
MP:0004148	increased compact bone thickness	25	2.005684e-19	7.573976e-12	9.64359e-07	8.746823e-08	0.001379923
MP:0004149	increased bone strength	17	1.839649e-37	4.407488e-05	3.857578e-07	2.460928e-12	0.1736588
MP:0004150	absent caveolae	3	0.1633455	0.03813027	0.06385259	0.1021456	0.6783287
MP:0004151	decreased circulating iron level	23	4.817674e-43	2.060621e-08	1.979109e-14	4.266131e-21	0.345951
MP:0004152	abnormal circulating iron level	43	3.20558e-119	1.220167e-08	4.173244e-19	4.863715e-47	0.4457788
MP:0004153	increased renal tubule apoptosis	20	4.04932e-16	0.0002218467	0.0004378144	0.001722325	0.9981922
MP:0004154	renal tubular necrosis	20	2.300541e-24	0.00514058	0.0002253136	1.570403e-06	0.04554159
MP:0004155	decreased susceptibility to induced pancreatitis	4	2.752042e-07	0.5735032	0.09873197	7.729988e-05	0.222239
MP:0004156	abnormal QT variability	2	0.8085903	5.759248e-06	0.3678136	0.8480794	0.2270054
MP:0004157	interrupted aortic arch	37	2.491851e-25	2.69972e-23	4.027422e-15	4.822481e-27	0.4140458
MP:0004158	right aortic arch	41	1.882213e-10	1.910728e-07	7.961524e-13	2.858796e-16	0.0339609
MP:0004159	double aortic arch	10	0.0001113678	6.255636e-10	3.795145e-09	0.01671502	0.00716293
MP:0004160	retroesophageal right subclavian artery	28	0.001304918	5.871042e-58	1.374096e-12	3.878363e-12	0.06855665
MP:0004161	cervical aortic arch	5	8.197735e-13	0.002312989	0.001343856	2.765294e-06	0.2257936
MP:0004162	abnormal mammillary body morphology	3	0.993791	0.04842657	0.5595045	0.3003492	0.876842
MP:0004163	abnormal adenohypophysis morphology	64	2.82758e-51	2.619784e-41	2.124905e-15	1.282104e-26	0.4086502
MP:0004164	abnormal neurohypophysis morphology	11	0.9973108	3.647909e-10	0.05705354	0.1869148	0.1264779
MP:0004165	abnormal lateral geniculate nucleus morphology	10	3.224089e-09	0.3575224	9.532708e-05	2.005017e-10	0.01778816
MP:0004166	abnormal limbic system morphology	351	6.710026e-243	1.06408e-203	3.550444e-51	5.88125e-99	0.004825155
MP:0004167	abnormal cingulate gyrus morphology	4	0.9948751	1.380858e-25	0.1962278	0.5291939	0.3769236
MP:0004169	abnormal fornicate gyrus morphology	11	0.0005515334	9.142207e-19	0.4120228	0.003982634	0.4877219
MP:0004170	abnormal orbitofrontal cortex morphology	2	0.9979929	0.001912184	0.3875848	0.9146897	0.2328022
MP:0004171	abnormal pallium development	5	0.003968388	7.124224e-07	0.3379885	1.193253e-13	0.07114841
MP:0004173	abnormal intervertebral disk morphology	42	3.568113e-09	1.406389e-47	0.00152842	1.238317e-05	0.8264983
MP:0004174	abnormal spine curvature	277	0	5.245733e-98	2.132863e-82	1.908801e-151	0.01796593
MP:0004175	telangiectases	4	1.145726e-21	6.484309e-05	0.0005028293	2.088223e-06	0.9692776
MP:0004176	ear telangiectases	1	9.985309e-12	0.8073913	0.1367272	0.0001516415	1
MP:0004177	tail telangiectases	1	9.985309e-12	0.8073913	0.1367272	0.0001516415	1
MP:0004178	neck telangiectases	1	9.985309e-12	0.8073913	0.1367272	0.0001516415	1
MP:0004179	transmission ratio distortion	32	1.732603e-102	1.852376e-07	1.158973e-13	3.445076e-42	0.5937824
MP:0004180	failure of initiation of embryo turning	61	9.044766e-96	4.931273e-20	6.673422e-16	2.782862e-35	0.6538827
MP:0004181	abnormal carotid artery morphology	31	1.194755e-20	2.600694e-16	8.70852e-07	1.272778e-20	0.002474359
MP:0004182	abnormal spermiation	16	2.082348e-27	5.373359e-07	3.599463e-05	2.144201e-06	0.3299468
MP:0004183	abnormal sympathetic nervous system physiology	27	5.370134e-08	0.0001050187	0.0001400314	0.00057486	0.08353044
MP:0004184	abnormal baroreceptor physiology	12	6.960396e-08	0.2124726	0.01550559	0.08200774	0.9753498
MP:0004185	abnormal adipocyte glucose uptake	32	6.56579e-36	1.511453e-15	8.646669e-28	8.414022e-46	0.1954671
MP:0004186	abnormal area postrema morphology	2	0.9542224	0.6877028	0.4131572	0.5557938	0.9195824
MP:0004187	cardia bifida	19	1.658498e-10	8.625381e-24	0.06672784	6.002621e-08	0.5881177
MP:0004188	delayed embryo turning	19	4.985621e-49	1.2462e-11	3.240607e-14	1.104883e-32	0.8013895
MP:0004189	abnormal alveolar process morphology	19	0.04979085	0.01937997	0.0001217206	3.473914e-05	0.06938659
MP:0004190	abnormal direction of embryo turning	17	8.554286e-17	0.01546401	0.3260925	8.107193e-12	0.005700327
MP:0004191	neuronal intranuclear inclusions	14	6.021784e-53	0.9843988	0.0003936184	3.962475e-17	0.8090825
MP:0004192	abnormal kidney pyramid morphology	30	1.94387e-16	3.762323e-22	1.881038e-09	5.301089e-12	0.007055699
MP:0004193	abnormal kidney papilla morphology	27	2.074757e-15	7.044756e-19	9.474265e-07	1.234391e-08	0.008835974
MP:0004194	abnormal kidney pelvis morphology	118	2.183253e-20	4.472015e-83	3.683583e-10	4.037807e-28	0.002232921
MP:0004195	abnormal kidney calyx morphology	13	0.9999616	0.0008043107	0.503604	0.7470493	0.005438438
MP:0004196	abnormal prenatal growth/weight/body size	993	0	0	2.04640500010204e-314	0	8.275499e-08
MP:0004197	abnormal fetal growth/weight/body size	251	0	1.292502e-151	2.905088e-73	2.43931e-165	0.0001018047
MP:0004198	abnormal fetal size	195	0	1.200402e-117	3.648608e-56	2.164834e-127	0.003375282
MP:0004199	increased fetal size	10	5.163006e-16	8.067951e-11	7.244465e-07	6.434123e-16	0.1160962
MP:0004200	decreased fetal size	186	1.48219693752374e-323	8.525391e-116	2.55308e-55	5.395499e-118	0.008013278
MP:0004201	fetal growth retardation	86	4.2762e-198	1.71824e-42	1.591105e-26	1.475937e-48	0.06633863
MP:0004202	pulmonary hyperplasia	10	8.131732e-08	3.956663e-09	8.138892e-12	9.068301e-23	0.3689636
MP:0004203	abnormal cranial flexure morphology	6	5.041127e-11	0.8454338	8.763446e-05	2.65225e-10	0.6181778
MP:0004204	absent stapes	15	3.420835e-09	4.702071e-22	0.0438311	4.16302e-12	0.03830194
MP:0004205	absent hyoid bone	4	4.681577e-17	2.069057e-05	4.71058e-05	0.0001474001	0.05851159
MP:0004206	abnormal dermomyotome development	14	2.061133e-17	1.125422e-07	0.9892993	1.896762e-05	0.1323868
MP:0004207	squamous cell carcinoma	52	2.939144e-91	8.180885e-38	5.70585e-31	2.691829e-43	0.02547455
MP:0004208	basal cell carcinoma	5	3.517825e-21	1.066064e-06	5.472404e-05	1.208723e-05	0.909575
MP:0004209	abnormal sweet taste sensitivity	7	1.462504e-07	0.1120777	0.0005884317	0.01421654	0.1551209
MP:0004210	abnormal bitter taste sensitivity	6	5.663985e-10	1.670714e-06	0.05252334	0.003950781	0.859552
MP:0004211	abnormal sour taste sensitivity	1	2.877874e-15	1	1	0.03223879	1
MP:0004212	abnormal salty taste sensitivity	1	2.877874e-15	1	1	0.03223879	1
MP:0004213	abnormal umami taste sensitivity	6	4.182922e-23	0.6203764	0.0002512371	0.1008311	0.4180174
MP:0004214	abnormal long bone diaphysis morphology	24	4.077412e-23	2.689793e-24	3.927711e-16	1.834225e-19	0.2134372
MP:0004215	abnormal myocardial fiber physiology	135	2.23134e-110	6.202331e-91	3.554042e-27	5.610457e-68	0.0148839
MP:0004216	salt-resistant hypertension	3	0.9739763	0.5561705	0.7822207	0.1496654	0.5059465
MP:0004217	salt-sensitive hypertension	7	0.01650995	4.960786e-16	4.48793e-05	0.02290673	0.06162407
MP:0004218	meiotic nondisjunction during M1 phase	2	1	0.9999998	0.9091311	0.8653748	0.8944163
MP:0004220	abnormal peripheral nervous system regeneration	12	2.22132e-10	1.501986e-14	0.01575244	0.0009622378	0.2479183
MP:0004221	abnormal iridocorneal angle	23	5.667658e-14	7.889527e-32	7.414646e-09	4.695257e-12	0.1484518
MP:0004222	iris synechia	23	3.135516e-08	3.156482e-29	3.315747e-14	4.6881e-07	0.0683189
MP:0004223	hypoplastic trabecular meshwork	6	0.8185671	5.669727e-18	0.007132114	0.08540189	0.783475
MP:0004224	absent trabecular meshwork	5	0.2995356	8.92307e-12	0.6225147	0.008398607	0.4804111
MP:0004225	patent foramen ovale	5	0.3043073	2.306243e-12	0.1826369	0.2499273	0.2153125
MP:0004226	absent Schlemm's canal	6	0.9998465	4.340984e-07	0.7209888	0.7006596	0.2185748
MP:0004227	increased cellular sensitivity to ionizing radiation	76	8.580538e-187	2.317323e-09	2.257675e-06	4.300987e-42	0.9174816
MP:0004228	decreased cellular sensitivity to ionizing radiation	33	3.31878e-35	3.748604e-09	1.77226e-07	3.071025e-30	0.3544889
MP:0004229	abnormal embryonic erythropoiesis	34	8.632143e-100	2.119901e-06	2.047265e-18	5.411926e-78	0.5760799
MP:0004230	abnormal embryonic erythrocyte morphology	12	3.779475e-25	0.0001397005	6.545237e-05	6.023299e-13	0.9356982
MP:0004231	abnormal calcium ion homeostasis	107	8.661715e-73	1.234279e-38	7.206335e-69	1.431906e-91	0.009744189
MP:0004232	decreased muscle weight	32	2.794414e-12	1.280288e-36	1.469548e-05	0.0466752	0.26237
MP:0004233	abnormal muscle weight	41	1.752353e-14	7.327495e-46	3.110592e-09	0.000319746	0.1573767
MP:0004234	abnormal masticatory muscle morphology	8	0.1755925	5.378896e-05	0.5738611	0.0003401531	0.9937756
MP:0004235	abnormal masseter muscle morphology	6	0.04598449	0.0004040487	0.2655424	0.02324619	0.997165
MP:0004236	absent masseter muscle	4	0.5008767	0.2213385	0.9999657	0.5949124	0.985492
MP:0004237	abnormal pterygoid muscle morphology	5	0.6803105	0.09578421	0.9999941	0.2161396	0.9929729
MP:0004238	absent pterygoid muscle	4	0.5008767	0.2213385	0.9999657	0.5949124	0.985492
MP:0004239	abnormal temporalis muscle morphology	3	0.8608019	0.1323598	0.998525	0.7447326	0.9317256
MP:0004240	absent temporalis muscle	2	0.9991472	0.1930624	1	0.8991425	0.9075206
MP:0004241	acantholysis	4	0.9966557	0.002886736	0.9961292	0.9297868	0.9807191
MP:0004242	abnormal plasmacytoid dendritic cell morphology	19	1.468571e-15	4.007632e-08	1.786913e-18	5.809989e-32	3.047203e-05
MP:0004243	abnormal motor nerve collateral sprouting	7	1.61724e-07	5.135703e-20	0.001074539	2.666471e-08	0.167625
MP:0004244	abnormal spontaneous abortion rate	12	0.9962965	2.029122e-16	9.231288e-06	0.001120255	0.5615851
MP:0004245	genital hemorrhage	23	9.595841e-30	0.0006616116	2.094141e-09	3.432535e-21	0.03109314
MP:0004246	abnormal extensor digitorum longus morphology	8	1.41922e-16	0.001646635	7.840032e-06	1.675382e-05	0.09834738
MP:0004247	small pancreas	44	1.823217e-29	1.670701e-60	7.978121e-11	2.518542e-30	0.07521206
MP:0004248	abnormal epaxial muscle morphology	9	0.1481451	7.968522e-07	0.7433249	0.006210244	0.006773568
MP:0004249	abnormal crista ampullaris morphology	31	0.0001469475	4.326311e-20	0.7723181	4.843811e-05	0.7492554
MP:0004250	tau protein deposits	10	0.003601796	0.001865957	0.2881714	0.02833052	0.1661245
MP:0004251	failure of heart looping	49	4.462736e-50	7.309161e-34	9.896616e-14	2.701487e-35	0.05672123
MP:0004252	abnormal direction of heart looping	45	5.492496e-45	2.551069e-12	7.435841e-21	4.360189e-34	0.02881405
MP:0004253	bifid atrial appendage	1	0.9996953	8.52348e-06	0.2246218	0.746	0.08911155
MP:0004254	cerebral amyloid angiopathy	4	2.799841e-07	7.669547e-06	3.500049e-08	1.67337e-23	0.9557099
MP:0004255	abnormal spongiotrophoblast layer morphology	65	5.780689e-141	4.134565e-44	1.132045e-23	9.686555e-58	0.8628939
MP:0004256	abnormal maternal decidual layer morphology	28	1.381532e-40	5.504679e-08	6.329296e-11	1.505577e-32	0.006109492
MP:0004257	abnormal placenta weight	31	9.907717e-73	8.364847e-36	7.591266e-16	1.862517e-22	0.7272563
MP:0004258	abnormal placenta size	80	1.561431e-161	1.520648e-43	3.403838e-31	3.053218e-88	0.1350171
MP:0004259	small placenta	66	4.657842e-148	4.496213e-34	1.818275e-28	9.339904e-63	0.2627064
MP:0004260	enlarged placenta	19	1.244868e-22	3.498076e-18	3.493144e-07	1.958456e-15	0.03015886
MP:0004261	abnormal embryonic neuroepithelium morphology	113	5.736905e-216	6.186035e-58	7.869629e-19	7.649576e-74	0.9047821
MP:0004262	abnormal physical strength	315	0	8.701345e-132	9.948611e-67	2.161715e-147	0.005987762
MP:0004263	abnormal limb posture	34	9.089361e-29	4.754021e-31	0.04544604	1.517391e-08	0.2730112
MP:0004264	abnormal extraembryonic tissue physiology	42	1.325626e-84	7.201509e-17	8.000706e-12	1.310969e-26	0.3141722
MP:0004265	abnormal placental transport	10	5.057667e-54	0.0005976082	0.0001848125	6.756805e-20	0.5515211
MP:0004266	pale placenta	13	4.863466e-12	2.28546e-12	2.276691e-10	3.032414e-17	0.08672407
MP:0004267	abnormal optic tract morphology	14	1.259279e-05	1.424747e-24	0.5661434	0.01399539	0.6644371
MP:0004268	abnormal optic stalk morphology	17	3.346905e-12	2.908241e-09	0.165396	7.90149e-06	0.5396423
MP:0004269	abnormal optic cup morphology	19	2.273232e-14	1.298064e-09	0.9182641	5.368342e-07	0.2712035
MP:0004270	analgesia	28	1.42682e-15	8.685715e-33	3.642696e-08	9.085699e-09	0.4623287
MP:0004272	abnormal basement membrane morphology	41	4.96591e-27	1.614487e-49	4.09955e-13	8.137793e-17	0.1748523
MP:0004273	abnormal basal lamina morphology	5	0.7980969	3.028893e-12	0.3687006	0.1354084	0.3383045
MP:0004274	abnormal embryonic/fetal subventricular zone morphology	55	3.207215e-44	2.139812e-42	2.261766e-06	2.212613e-20	0.480599
MP:0004275	abnormal postnatal subventricular zone morphology	35	3.548937e-05	2.080805e-05	0.08709694	0.0002462397	0.01275331
MP:0004276	abnormal medial ganglionic eminence morphology	9	0.998782	2.129557e-16	0.9705277	0.4532588	0.8343934
MP:0004277	abnormal lateral ganglionic eminence morphology	20	9.336165e-05	4.620864e-28	0.5573567	0.001808568	0.8656342
MP:0004279	abnormal rostral migratory stream morphology	31	0.0460678	1.245369e-13	0.0005045475	3.155072e-05	0.05167724
MP:0004281	abnormal hypoglossal nucleus morphology	2	9.942718e-05	0.04765713	0.5235973	0.8267424	0.2197807
MP:0004282	retrognathia	4	0.1637735	1.159874e-10	0.9900662	0.0003128204	0.345808
MP:0004283	absent corneal endothelium	4	0.7489138	0.002369017	0.8164052	0.03084067	0.6221961
MP:0004284	abnormal Descemet membrane	7	2.795383e-13	2.925914e-08	0.8986398	0.01635077	0.2577695
MP:0004285	absent Descemet membrane	3	2.054509e-05	8.692554e-08	0.4079768	0.002839178	0.1686542
MP:0004286	abnormal internal auditory canal morphology	1	0.9996953	0.9655247	1	1	1
MP:0004287	abnormal spiral limbus morphology	7	0.9014417	0.0004963156	0.9592324	0.9518915	0.7098006
MP:0004288	abnormal spiral ligament morphology	17	1.000954e-05	0.154947	0.4365926	0.8673242	0.7966069
MP:0004289	abnormal bony labyrinth	10	0.04549482	0.03944831	0.3088769	0.2743035	0.2951168
MP:0004290	abnormal stapes footplate morphology	3	0.03111109	0.8966099	0.1693262	0.3757025	0.9601726
MP:0004292	abnormal spiral ligament fibrocyte morphology	13	0.06349845	0.166677	0.5825741	0.9664859	0.9370646
MP:0004293	abnormal type I spiral ligament fibrocytes	5	0.06636509	0.8034319	0.9935588	0.8596524	0.6844789
MP:0004294	abnormal type II spiral ligament fibrocytes	5	0.973212	0.02051651	0.03784493	0.9069973	0.1642246
MP:0004296	abnormal type IV spiral ligament fibrocytes	7	0.9854316	0.1332194	0.06492167	0.9169393	0.7651026
MP:0004297	abnormal proprioceptive neuron morphology	17	1.383043e-07	4.868486e-20	0.005716239	0.0001732085	0.2304133
MP:0004298	vestibular ganglion degeneration	6	0.01653707	1.120716e-05	0.361864	0.0115623	0.3538487
MP:0004299	absent vestibular ganglion	1	0.9999736	0.6258174	0.2246218	0.6062543	0.2355317
MP:0004300	abnormal organ of Corti supporting cell morphology	42	1.3536e-34	2.128032e-27	2.091772e-10	2.094168e-23	0.06253407
MP:0004301	absent organ of Corti supporting cells	6	0.05876011	2.583227e-10	0.0001118655	0.29836	0.2094331
MP:0004302	abnormal Deiters cell morphology	8	4.753906e-11	1.181718e-09	0.1983368	2.210207e-10	0.1251676
MP:0004303	abnormal Hensen cell morphology	2	0.9961909	0.9974108	1	0.9873864	0.9219734
MP:0004304	absent spiral limbus	1	0.9410154	1.850401e-07	1	0.08626867	0.3339505
MP:0004305	abnormal Rosenthal canal morphology	3	0.2903334	8.166985e-07	0.7858819	0.005528187	0.6191741
MP:0004306	small Rosenthal canal	1	0.1781519	0.4128127	0.770847	0.2108217	0.8122343
MP:0004307	absent Rosenthal canal	1	0.9410154	1.850401e-07	1	0.08626867	0.3339505
MP:0004308	abnormal basilar membrane morphology	3	0.0004135114	0.01376469	0.03690575	0.1003822	0.5095959
MP:0004309	absent otic vesicle	3	1.338536e-15	0.8311495	0.1806867	0.04073711	0.0767244
MP:0004310	small otic vesicle	17	2.882151e-06	9.937382e-25	0.04422654	5.796889e-08	0.3563284
MP:0004311	otic vesicle hypoplasia	4	0.02073643	0.2913236	0.9822808	0.01352356	0.7327786
MP:0004312	absent pillar cells	6	1.144081e-11	7.022496e-11	0.8740559	0.4786303	0.9428868
MP:0004313	absent vestibulocochlear ganglion	4	0.03917603	0.870388	0.991147	0.9783724	0.4441765
MP:0004314	absent inner ear vestibule	8	0.9835889	0.03001046	0.609781	0.006366163	0.04278992
MP:0004315	absent vestibular saccule	11	0.9618201	1.895494e-06	0.9580486	0.4523728	0.9944724
MP:0004316	enlarged vestibular saccule	2	0.978134	0.08345766	0.656803	0.668432	3.15775e-05
MP:0004317	small vestibular saccule	6	0.9974056	1.400445e-13	0.8862581	0.2211999	0.07090033
MP:0004318	absent incus	8	2.187395e-08	1.504526e-12	0.01826832	1.184507e-10	0.3077517
MP:0004319	absent malleus	4	3.258935e-07	1.066995e-11	0.06134627	0.0001540759	0.2768795
MP:0004320	split sternum	25	9.649003e-25	2.291782e-73	0.002062709	6.462578e-12	0.7118643
MP:0004321	short sternum	43	4.99772e-19	4.291145e-54	2.520611e-07	4.512258e-12	0.1540039
MP:0004322	abnormal sternebra morphology	60	7.183401e-16	5.991606e-95	7.371963e-08	3.957263e-18	0.8407503
MP:0004323	sternum hypoplasia	6	0.7880584	4.664531e-25	0.9626394	0.03396461	0.7474559
MP:0004324	vestibular hair cell degeneration	15	1.59172e-19	2.117803e-08	2.461046e-13	2.938228e-10	0.001005321
MP:0004325	absent vestibular hair cells	7	0.9994059	2.318688e-09	0.9998969	0.7272428	0.9727323
MP:0004326	abnormal vestibular hair cell number	19	7.408007e-05	5.859547e-14	0.008899979	0.003678852	0.2806641
MP:0004327	increased vestibular hair cell number	5	1.119602e-18	0.003480177	5.032985e-17	9.608508e-10	0.03072133
MP:0004328	decreased vestibular hair cell number	14	0.9307754	1.73681e-12	0.9999073	0.7966283	0.7215774
MP:0004329	vestibular saccular degeneration	5	2.390078e-06	4.139353e-06	0.00102388	0.06495747	0.4188337
MP:0004330	abnormal vestibular saccular macula morphology	22	3.057805e-15	8.975195e-11	7.76519e-06	4.288303e-10	0.07057624
MP:0004331	vestibular saccular macula degeneration	14	6.19847e-11	0.0001089532	2.159013e-08	1.447659e-11	0.01991024
MP:0004332	utricular degeneration	2	0.2465824	0.8875583	1	0.4016432	1
MP:0004333	abnormal utricular macula morphology	21	1.203378e-11	1.049033e-22	0.02501316	1.305589e-06	0.2914753
MP:0004334	utricular macular degeneration	9	1.656658e-05	9.286252e-18	0.0005948541	0.006450317	0.2605236
MP:0004335	enlarged utricle	2	0.9974142	0.2019454	0.6904559	0.07226725	0.0008545025
MP:0004336	small utricle	5	0.9995694	2.760607e-17	0.993261	0.09726221	0.9200863
MP:0004337	clavicle hypoplasia	6	0.1670207	5.713885e-10	0.9249408	0.007170942	0.2715262
MP:0004338	small clavicle	9	0.002741335	2.221513e-10	0.9666935	0.0004161291	0.04572772
MP:0004339	absent clavicle	7	0.009993197	1.51886e-09	0.9372317	0.00399824	0.1866049
MP:0004340	short scapula	10	3.496306e-12	0.2491009	0.004238728	9.149353e-05	0.06517463
MP:0004341	absent scapula	1	0.9930732	8.577734e-11	0.9128654	0.8595013	0.498173
MP:0004342	scapular bone foramen	10	5.924687e-09	2.544095e-15	0.02906153	0.001036102	0.4451851
MP:0004343	small scapula	25	6.277991e-07	2.426326e-54	0.1327607	0.0001305104	0.2731506
MP:0004344	scapular bone hypoplasia	3	0.9700028	2.952002e-16	0.2450309	0.5420006	0.06921919
MP:0004345	abnormal acromion morphology	9	0.9952587	1.550458e-25	0.9956322	0.003000491	0.5044185
MP:0004346	absent acromion	2	0.9998838	4.758456e-16	0.907263	0.8701658	0.8468146
MP:0004347	abnormal scapular spine morphology	8	0.9192636	1.889522e-21	0.9944848	0.5795591	0.4692974
MP:0004348	long femur	9	8.409271e-08	0.008928143	0.2681372	0.0005376322	0.1980177
MP:0004349	absent femur	4	0.9834667	0.01574384	0.09174777	0.07038464	0.8636745
MP:0004350	long humerus	3	8.665854e-07	5.261854e-05	0.9201926	0.001308487	0.5644376
MP:0004351	short humerus	54	4.047495e-05	2.388467e-65	0.03328598	4.713808e-06	0.01265493
MP:0004352	absent humerus	2	0.9961909	0.9586564	1	0.1659431	0.04547414
MP:0004353	abnormal deltoid tuberosity morphology	30	3.787542e-16	1.005422e-19	0.1060193	1.703962e-06	0.2016717
MP:0004354	absent deltoid tuberosity	18	3.043277e-19	1.140994e-11	0.05678413	0.001315602	0.6673924
MP:0004355	short radius	49	0.5970939	6.793233e-88	0.8898135	0.05979768	0.6262696
MP:0004356	radius hypoplasia	3	0.0009669137	6.141674e-06	0.004638317	0.6062999	0.3730342
MP:0004357	long tibia	13	7.880539e-29	1.230604e-06	0.1083454	1.542879e-14	0.4233124
MP:0004358	bowed tibia	20	6.130643e-07	1.751621e-32	0.7175857	0.007812373	0.7709365
MP:0004359	short ulna	53	0.04054701	8.805459e-72	0.05809359	3.615964e-06	0.02240168
MP:0004360	absent ulna	9	0.01413747	5.715903e-11	0.963395	0.5192615	0.2493209
MP:0004361	bowed ulna	14	0.0001151087	3.207124e-35	0.0004293882	0.0004811745	0.3830429
MP:0004362	cochlear hair cell degeneration	80	1.171845e-85	8.164488e-40	3.717115e-18	1.68174e-32	0.0005666044
MP:0004363	stria vascularis degeneration	13	2.042668e-06	8.093903e-07	0.0003168708	1.384791e-05	0.0188384
MP:0004364	thin stria vascularis	8	5.779709e-26	3.707608e-06	2.12211e-08	4.91393e-09	0.0003186843
MP:0004365	abnormal strial basal cell morphology	4	1.316819e-07	5.432631e-06	0.003146486	0.2278526	0.1526959
MP:0004366	abnormal strial marginal cell morphology	9	0.1542852	1.018658e-09	0.003345998	0.06627825	0.3392151
MP:0004367	abnormal strial intermediate cell morphology	8	0.8901523	0.04333752	0.0001757665	0.1535857	0.0406052
MP:0004368	abnormal stria vascularis vasculature morphology	9	0.6699986	1.021866e-07	0.00476738	0.01639464	0.1749906
MP:0004369	absent utricle	9	0.761875	7.17698e-06	0.9712265	0.5204743	0.9984937
MP:0004370	long ulna	1	3.119091e-20	0.000894568	0.4338476	0.001968514	1
MP:0004371	bowed femur	3	9.526998e-21	0.000480348	0.0003164859	2.454621e-11	0.2958422
MP:0004372	bowed fibula	9	0.03633883	9.329554e-14	0.006918194	0.08224541	0.9337079
MP:0004373	bowed humerus	6	9.071535e-30	0.0002068268	2.343831e-06	1.375783e-09	0.5336354
MP:0004374	bowed radius	20	2.338093e-10	7.901735e-35	2.123093e-05	9.132672e-08	0.3110251
MP:0004375	enlarged frontal bone	2	0.001092489	0.9858056	0.04521271	0.964198	1
MP:0004376	absent frontal bone	8	2.930848e-15	1.113273e-17	3.92553e-08	1.379945e-21	0.5581001
MP:0004377	small frontal bone	14	0.6416956	7.781959e-47	0.964624	0.004739637	0.5515796
MP:0004378	frontal bone foramen	6	0.99712	0.01399791	0.9379777	0.01431456	0.8346489
MP:0004379	wide frontal bone	4	2.523996e-16	0.6405178	0.0001033591	0.1450554	0.9138517
MP:0004380	short frontal bone	8	1.278222e-39	0.01595932	0.002260312	5.862418e-24	0.7390866
MP:0004381	abnormal hair follicle melanocyte morphology	29	1.518763e-26	3.744873e-12	6.237395e-21	7.395153e-23	0.08659433
MP:0004382	abnormal hair follicle melanogenesis	4	0.8583975	0.9968687	0.0003835974	0.9975361	0.2915572
MP:0004383	absent interparietal bone	10	3.073925e-34	3.433524e-13	0.0006550869	1.437619e-19	0.9061236
MP:0004384	small interparietal bone	21	0.02562336	5.960927e-24	0.05422679	0.0004024483	0.009581415
MP:0004385	interparietal bone hypoplasia	4	0.2826858	0.0148477	0.05703623	0.05297284	0.007627793
MP:0004386	enlarged interparietal bone	6	2.701309e-25	0.06344267	0.1219709	0.008408946	0.9956764
MP:0004387	abnormal prechordal plate morphology	11	1.695033e-47	0.4153373	2.539715e-07	2.237394e-15	0.9174819
MP:0004388	absent prechordal plate	5	3.89297e-35	0.0815688	1.414016e-09	5.364977e-11	1
MP:0004389	abnormal respiratory bronchiole morphology	8	1.58808e-07	5.069068e-08	3.5522e-05	4.340811e-12	0.8691408
MP:0004390	abnormal bronchoalveolar duct junction morphology	3	4.447967e-11	0.002306514	0.00078694	1.683561e-13	0.7280471
MP:0004391	abnormal respiratory conducting tube morphology	91	1.939258e-14	2.236153e-125	2.701907e-31	1.785418e-43	0.01763034
MP:0004392	abnormal CD8-positive T cell physiology	113	2.48629e-129	9.483684e-10	3.499026e-99	4.8109e-240	3.416365e-14
MP:0004393	abnormal cochlear inner hair cell morphology	110	8.455918e-91	4.962962e-44	1.753404e-27	3.362292e-46	0.01070236
MP:0004394	abnormal cochlear inner hair cell number	30	9.361742e-29	6.146943e-22	1.201705e-16	5.190878e-23	0.5349856
MP:0004395	increased cochlear inner hair cell number	17	1.264864e-10	2.52302e-19	1.853973e-11	9.366133e-21	0.4335978
MP:0004396	decreased cochlear inner hair cell number	16	2.152293e-22	1.00842e-05	5.160616e-07	2.482153e-08	0.3467694
MP:0004397	absent cochlear inner hair cells	5	0.1044642	0.002622168	0.946824	0.6238058	0.9983624
MP:0004398	cochlear inner hair cell degeneration	46	1.528105e-19	6.411905e-20	6.769581e-09	6.943744e-13	0.004300745
MP:0004399	abnormal cochlear outer hair cell morphology	134	2.2253e-141	1.090929e-62	8.193312e-27	4.640465e-56	0.000222978
MP:0004400	abnormal cochlear outer hair cell number	44	5.26272e-37	3.737786e-15	1.2198e-20	3.942875e-27	0.01267456
MP:0004401	increased cochlear outer hair cell number	19	1.575033e-23	7.219511e-20	1.051101e-15	8.922984e-30	0.1420365
MP:0004402	decreased cochlear outer hair cell number	29	1.069001e-11	0.001002133	1.065503e-11	4.281215e-06	0.01211112
MP:0004403	absent cochlear outer hair cells	10	0.00947806	9.22231e-07	0.2351046	0.06282046	0.9025687
MP:0004404	cochlear outer hair cell degeneration	65	9.470601e-83	1.0559e-29	4.337153e-17	1.117751e-33	0.0003687027
MP:0004405	absent cochlear hair cells	21	0.0001976125	5.178587e-19	0.7886667	0.3445223	0.8750468
MP:0004406	abnormal cochlear hair cell number	63	1.525697e-45	2.543861e-32	2.746476e-15	2.427162e-26	0.01543924
MP:0004407	increased cochlear hair cell number	28	3.190515e-27	2.303604e-26	7.097734e-19	4.272269e-38	0.2212475
MP:0004408	decreased cochlear hair cell number	45	4.017743e-28	3.668392e-16	2.958554e-08	5.928359e-09	0.01097124
MP:0004409	abnormal crista ampullaris neuroepithelium morphology	12	5.812011e-14	2.549894e-06	0.06866329	1.301534e-09	0.9014587
MP:0004410	absent endocochlear potential	8	0.1960085	2.892493e-08	3.17698e-05	0.2293777	0.003400464
MP:0004411	decreased endocochlear potential	15	6.850005e-08	3.203034e-06	0.0002378736	0.0008132193	0.5631436
MP:0004412	abnormal cochlear microphonics	13	1.643125e-31	0.003257877	3.263429e-06	2.262875e-08	0.2756532
MP:0004413	absent cochlear microphonics	7	2.518175e-46	0.3114689	0.0003173536	1.953564e-13	0.8976887
MP:0004414	decreased cochlear microphonics	5	0.6219145	0.05127958	0.02902405	0.6187146	0.1054325
MP:0004415	abnormal cochlear nerve compound action potential	21	7.663383e-25	3.025602e-25	5.980197e-16	8.597741e-20	0.134292
MP:0004416	absent cochlear nerve compound action potential	4	0.0001074091	7.226635e-14	0.8580843	6.60485e-06	0.5640884
MP:0004417	decreased cochlear nerve compound action potential	11	1.842523e-12	1.260002e-18	4.426779e-09	6.739988e-11	0.6475332
MP:0004418	small parietal bone	19	2.238639e-05	1.062259e-26	0.4375696	0.0007139378	0.4661174
MP:0004419	absent parietal bone	10	1.170841e-06	1.387592e-09	0.1587152	1.996965e-07	0.6404697
MP:0004420	parietal bone hypoplasia	4	0.05326476	0.3507731	0.001036214	0.1461902	0.1433142
MP:0004421	enlarged parietal bone	5	9.028762e-18	0.1102217	0.7226911	1.505667e-13	0.996595
MP:0004422	small temporal bone	9	0.07371469	1.281476e-12	0.890826	2.430925e-08	0.7611491
MP:0004423	abnormal squamosal bone morphology	33	1.57837e-06	3.372578e-53	0.4975845	4.554922e-06	0.3710486
MP:0004424	temporal bone hypoplasia	4	1.068369e-05	9.185896e-13	0.7040823	1.41359e-05	0.9858432
MP:0004425	abnormal otolith organ morphology	59	3.103873e-16	3.192707e-29	6.949961e-09	1.938329e-13	0.03498406
MP:0004427	abnormal vestibular labyrinth morphology	84	2.461275e-25	2.234498e-53	1.416555e-14	6.478868e-21	0.01879952
MP:0004428	abnormal type I vestibular cell	4	0.9999992	2.969735e-05	0.8340728	0.9985754	0.6008951
MP:0004430	abnormal Claudius cell morphology	4	0.01467094	0.001623954	0.8119632	0.009914976	0.03106654
MP:0004431	abnormal hair cell mechanoelectric transduction	10	1.244768e-18	0.1380818	0.1960423	0.06076117	0.08113497
MP:0004432	abnormal cochlear hair cell physiology	31	3.409959e-99	1.356054e-08	1.496829e-11	1.181032e-22	0.1574143
MP:0004433	abnormal cochlear inner hair cell physiology	11	3.265226e-17	7.796447e-14	2.201239e-06	8.839922e-05	0.03353776
MP:0004434	abnormal cochlear outer hair cell physiology	21	1.827385e-79	0.003402839	2.495919e-10	2.385012e-22	0.3415811
MP:0004436	absent cochlear outer hair cell electromotility	1	0.3231497	0.1655967	1	0.9984616	0.7692535
MP:0004437	decreased cochlear outer hair cell electromotility	3	0.9500362	0.2365083	0.6057835	0.3686202	0.2693712
MP:0004438	abnormal vestibular hair cell physiology	4	0.0456782	0.004804536	0.001913782	0.03742657	0.3411001
MP:0004439	absent Meckel's cartilage	10	0.00238127	1.560281e-28	0.08941403	0.002772994	0.1773645
MP:0004440	absent occipital bone	2	0.04483932	0.005017322	0.8164985	0.002251641	0.03179002
MP:0004441	small occipital bone	5	2.16552e-18	3.49498e-11	0.0025905	8.879952e-09	0.1860682
MP:0004442	occipital bone foramen	1	0.9991011	0.9383899	0.9999864	0.9999998	0.9665249
MP:0004443	absent supraoccipital bone	10	5.205982e-11	1.934517e-37	4.441576e-05	1.400748e-07	0.8234477
MP:0004444	small supraoccipital bone	6	0.9505508	9.597321e-06	0.8312368	0.1023258	0.8720192
MP:0004445	small exoccipital bone	6	0.3106301	6.758701e-10	0.002304731	1.038774e-08	0.7126112
MP:0004446	split exoccipital bone	2	0.00139495	0.7566308	1	5.723219e-10	1
MP:0004447	small basioccipital bone	7	4.873889e-09	1.450279e-08	0.001009056	1.416396e-14	0.1149407
MP:0004448	abnormal presphenoid bone morphology	34	7.477857e-17	6.630881e-45	4.675632e-05	1.838616e-24	0.9495755
MP:0004449	absent presphenoid bone	12	0.004944681	4.326345e-31	0.03482315	5.02111e-08	0.6603988
MP:0004450	presphenoid bone hypoplasia	4	2.152996e-05	1.402933e-09	0.3055974	0.0008946756	0.485347
MP:0004451	short presphenoid bone	3	6.254467e-06	1.750671e-25	0.1007327	0.06901953	0.9231386
MP:0004452	abnormal pterygoid process morphology	28	0.005896295	5.459061e-57	0.0002440731	8.048047e-10	0.2434938
MP:0004453	abnormal pterygoid bone morphology	14	0.01817793	3.015849e-48	0.0001062905	2.285829e-06	0.3867349
MP:0004454	absent pterygoid process	3	0.1071033	6.765506e-09	1	3.785554e-06	0.02426564
MP:0004455	pterygoid bone hypoplasia	2	0.01880316	7.017499e-24	0.2361014	0.1613376	0.09786582
MP:0004456	small pterygoid bone	6	9.750843e-05	1.959814e-33	9.101593e-05	9.340602e-05	0.1189792
MP:0004457	abnormal orbitosphenoid bone morphology	6	0.6738342	2.255756e-07	0.3845619	0.002840891	0.8733308
MP:0004458	absent alisphenoid bone	7	0.7228692	3.215776e-34	0.1559393	0.01133372	0.002511881
MP:0004459	small alisphenoid bone	15	2.392051e-20	1.30228e-39	0.1884374	3.193598e-10	0.08833494
MP:0004460	alisphenoid bone hypoplasia	4	1.355701e-05	5.893043e-24	0.05122686	0.0001902664	0.02367768
MP:0004461	basisphenoid bone hypoplasia	2	0.0067768	9.126498e-07	0.03104723	8.449677e-05	0.7402578
MP:0004462	small basisphenoid bone	15	1.813823e-09	1.667591e-40	6.436207e-05	1.618655e-14	0.2480304
MP:0004463	basisphenoid bone foramen	11	0.9997676	4.422008e-61	0.03683413	0.01538074	0.6995483
MP:0004464	absent strial basal cell tight junctions	1	0.01921518	4.921825e-05	0.8188202	0.670413	0.7238742
MP:0004465	degeneration of organ of Corti supporting cells	13	0.009780593	2.298366e-06	2.518827e-08	0.0001195932	0.09196642
MP:0004466	short cochlear outer hair cells	5	4.085124e-06	0.2587106	0.3469406	0.2535792	0.1901754
MP:0004467	absent zygomatic bone	10	0.9880165	1.811843e-41	0.07428548	0.0002961747	0.006883296
MP:0004468	small zygomatic bone	10	0.7525733	6.358134e-06	0.003722551	0.0001996202	0.01139366
MP:0004469	abnormal zygomatic arch morphology	15	3.487757e-05	3.684803e-48	0.03607352	2.69804e-07	0.2975345
MP:0004470	small nasal bone	46	9.325952e-107	8.340736e-67	9.395493e-10	1.46688e-45	0.4113284
MP:0004471	short nasal bone	33	2.716662e-77	1.854505e-57	4.184892e-07	6.923782e-36	0.6854749
MP:0004472	broad nasal bone	5	0.005561289	2.032607e-11	0.182213	0.01329557	0.638973
MP:0004473	absent nasal bone	7	0.9931956	0.5564313	0.8180996	0.9405616	0.8867221
MP:0004474	enlarged nasal bone	1	0.9311788	0.8769263	0.8444373	0.9976356	1
MP:0004475	palatine bone hypoplasia	3	5.327563e-07	6.763979e-08	0.02143642	7.88873e-12	0.7668747
MP:0004476	absent palatine bone	5	5.604134e-05	0.2040709	0.9757681	8.598776e-07	0.877062
MP:0004477	turbinate hypoplasia	3	0.0122272	0.08186056	0.4011355	0.007390232	0.962205
MP:0004478	testicular teratoma	7	2.650288e-15	3.467882e-06	0.001872675	0.0002832863	0.1821039
MP:0004479	abnormal oval window morphology	5	0.9973758	1.42362e-21	0.763403	0.6719357	0.01328986
MP:0004480	abnormal round window morphology	4	3.338265e-08	1.228539e-10	6.146227e-08	1.551981e-10	0.2135578
MP:0004481	abnormal conjunctival epithelium morphology	5	0.1603347	0.001417644	0.004158847	4.746911e-11	0.7884178
MP:0004482	abnormal interdental cell morphology	3	0.9727612	4.563249e-07	0.4083621	0.2943964	0.4189268
MP:0004483	absent interdental cells	1	0.9410154	1.850401e-07	1	0.08626867	0.3339505
MP:0004484	altered response of heart to induced stress	79	9.789373e-49	1.124721e-91	1.962915e-28	2.255382e-41	0.05264302
MP:0004485	increased response of heart to induced stress	38	1.852418e-30	2.419873e-75	1.95431e-08	4.476469e-23	0.006586963
MP:0004486	decreased response of heart to induced stress	28	5.299494e-07	1.134511e-31	8.739726e-21	3.334498e-11	0.9102224
MP:0004487	type I spiral ligament fibrocyte degeneration	3	0.004658085	0.4011258	0.9718957	0.7818868	0.6866165
MP:0004488	type II spiral ligament fibrocyte degeneration	2	0.158332	0.160135	0.7959437	0.2418141	0.06091575
MP:0004489	type III spiral ligament fibrocyte degeneration	1	1.932602e-12	0.589273	0.3591456	0.01795318	1
MP:0004490	type IV spiral ligament fibrocyte degeneration	5	0.9007881	0.8166212	0.9391959	0.8877308	0.9333215
MP:0004491	abnormal orientation of outer hair cell stereociliary bundles	26	3.56866e-25	2.967094e-16	1.059816e-05	4.157785e-05	0.2210369
MP:0004492	abnormal orientation of inner hair cell stereociliary bundles	18	8.765412e-07	1.10436e-11	1.798209e-06	2.308507e-05	0.4862871
MP:0004493	dilated cochlea	3	5.010459e-10	1.682571e-11	0.62151	0.1581809	0.683319
MP:0004494	abnormal synaptic glutamate release	16	0.0002668394	3.390952e-12	0.9955667	1.116895e-05	0.5807524
MP:0004495	decreased synaptic glutamate release	10	0.2030797	9.738877e-08	0.9999878	0.7389081	0.8779973
MP:0004496	abnormal organ of Corti supporting cell number	12	1.018994e-15	6.121476e-12	2.16637e-07	2.773648e-09	0.06775494
MP:0004497	decreased organ of Corti supporting cell number	10	4.08301e-08	5.660104e-12	3.383433e-05	0.0008480096	0.145501
MP:0004498	increased organ of Corti supporting cell number	2	3.323504e-13	0.1255924	0.0003559888	8.108067e-12	0.1286599
MP:0004499	increased incidence of tumors by chemical induction	107	6.966445e-143	2.449614e-56	4.598241e-58	2.19276e-121	0.03308512
MP:0004500	increased incidence of tumors by ionizing radiation induction	18	2.826142e-43	2.071823e-06	6.885424e-16	2.339874e-19	0.6448012
MP:0004501	increased incidence of tumors by UV-induction	11	2.063688e-39	0.1190577	1.595614e-05	1.078291e-16	0.6230701
MP:0004502	decreased incidence of tumors by chemical induction	76	5.32923e-119	3.894816e-17	1.537135e-41	5.332575e-87	0.0627643
MP:0004503	decreased incidence of tumors by ionizing radiation induction	4	0.0003809221	0.8224069	0.002134567	0.001733436	1
MP:0004504	decreased incidence of tumors by UV induction	5	0.006470613	0.9991881	7.286061e-05	2.253761e-05	0.0197119
MP:0004505	decreased renal glomerulus number	48	2.620258e-50	1.947362e-92	1.07649e-18	9.585917e-12	0.2578786
MP:0004506	abnormal pubis morphology	23	0.9999973	5.228615e-58	0.9999691	0.9464917	0.5564187
MP:0004507	abnormal ischium morphology	11	0.2199867	2.660502e-15	0.7987442	0.8517299	0.9452814
MP:0004508	abnormal pectoral girdle bone morphology	233	1.853309e-182	1.234084e-204	4.853525e-31	3.263669e-89	0.0008272233
MP:0004509	abnormal pelvic girdle bone morphology	62	3.42533e-06	1.60456e-95	0.001626335	6.698858e-06	0.03298905
MP:0004510	myositis	26	6.471775e-30	6.423651e-20	1.711931e-07	1.867407e-16	0.940605
MP:0004512	anosmia	5	0.5126063	0.06275448	0.5533372	0.4593049	0.8347142
MP:0004514	dystocia	4	1.604622e-14	0.9328406	0.1108807	1.230046e-06	1
MP:0004515	abnormal vestibular hair cell stereociliary bundle morphology	18	7.929935e-13	4.082208e-05	1.476458e-09	2.064559e-05	0.000386928
MP:0004516	fused vestibular hair cell stereocilia	2	6.737945e-05	0.02220498	0.004021059	0.1070922	0.1196448
MP:0004517	decreased vestibular hair cell stereocilia number	4	2.555037e-12	0.3502679	0.005828178	0.04263104	0.3183011
MP:0004518	absent vestibular hair cell stereocilia	5	0.3597363	5.559435e-14	0.001024279	0.09790614	0.4337673
MP:0004519	thin vestibular hair cell stereocilia	1	0.9999736	0.9843364	0.008981698	0.8595013	0.08911155
MP:0004521	abnormal cochlear hair cell stereociliary bundle morphology	70	2.82038e-86	6.386507e-26	8.945339e-25	2.913983e-28	7.796305e-05
MP:0004522	abnormal orientation of cochlear hair cell stereociliary bundles	39	3.425899e-28	8.609279e-18	5.078148e-06	4.871256e-08	0.09248463
MP:0004523	decreased cochlear hair cell stereocilia number	16	5.241699e-32	0.4599931	0.000136774	5.945938e-10	0.1884373
MP:0004524	short cochlear hair cell stereocilia	13	1.146115e-24	0.595569	4.932684e-08	7.559634e-12	0.03077083
MP:0004525	thin cochlear hair cell stereocilia	2	0.4971818	0.9842279	0.02740139	6.660399e-06	0.1439288
MP:0004526	absent cochlear hair cell stereocilia	2	0.005758267	0.5014854	0.8375987	0.04642528	0.8496797
MP:0004527	abnormal outer hair cell stereociliary bundle morphology	52	3.648898e-67	4.373149e-22	2.53222e-19	2.132092e-17	0.01125082
MP:0004528	fused outer hair cell stereocilia	5	8.989529e-22	3.442264e-05	0.0003739931	1.454226e-06	0.1990346
MP:0004529	decreased outer hair cell stereocilia number	12	3.077201e-27	0.166385	1.935284e-05	1.888743e-07	0.3786799
MP:0004530	absent outer hair cell stereocilia	7	9.886334e-23	6.924964e-05	4.987081e-14	1.853728e-08	0.09538431
MP:0004531	short outer hair cell stereocilia	6	9.127933e-19	0.05978382	0.001441232	0.0142354	0.1139984
MP:0004532	abnormal inner hair cell stereociliary bundle morphology	35	1.634164e-45	2.367838e-10	3.949647e-18	6.018343e-19	0.05049366
MP:0004533	fused inner hair cell stereocilia	7	1.478629e-17	2.397764e-05	0.03741357	8.334927e-05	0.1501892
MP:0004534	decreased inner hair cell stereocilia number	8	3.779212e-20	0.432572	0.001050089	0.000821592	0.08308007
MP:0004535	absent inner hair cell stereocilia	1	0.1781519	0.4128127	0.770847	0.2108217	0.8122343
MP:0004536	short inner hair cell stereocilia	7	5.535189e-24	0.6501453	1.835515e-13	1.199821e-05	0.008874357
MP:0004537	abnormal palatine shelf morphology	28	0.008755986	2.135981e-37	0.03597391	9.964948e-06	0.3176812
MP:0004538	abnormal maxillary shelf morphology	32	0.06696447	8.919919e-62	0.00234261	6.349882e-05	0.03036547
MP:0004539	absent maxilla	14	0.6426602	3.169221e-28	0.001295205	0.05775075	0.119839
MP:0004540	small maxilla	56	0.002478404	1.284821e-56	0.0003122657	9.637405e-19	0.04342865
MP:0004541	absent auditory tube	2	0.9302741	0.3113517	0.001749582	0.6702061	1
MP:0004542	impaired acrosome reaction	28	2.802056e-21	0.2938642	5.140344e-07	9.558681e-16	0.9996751
MP:0004543	abnormal sperm physiology	197	1.94282e-149	3.922186e-06	5.662118e-21	3.198701e-45	0.2388148
MP:0004544	absent esophagus	3	0.9982669	1.996905e-14	0.9674845	0.1989571	0.6705411
MP:0004545	enlarged esophagus	13	8.261835e-32	1.521387e-26	0.005930233	1.944924e-09	0.5007088
MP:0004546	esophagus hyperplasia	5	1.925612e-44	0.01694389	0.06777498	5.42336e-11	0.3825568
MP:0004547	esophageal ulcer	1	0.9621678	0.003530956	0.3856569	0.06617561	0.726318
MP:0004548	dilated esophagus	7	0.9746662	8.28014e-14	0.06986237	3.017875e-08	0.3766766
MP:0004549	small trachea	8	6.992419e-05	4.355269e-07	0.9270986	1.768496e-12	0.7330079
MP:0004550	short trachea	4	0.005450094	0.001596516	0.7100233	5.073192e-07	0.7357895
MP:0004551	decreased tracheal cartilage ring number	8	0.9963144	2.886183e-14	0.4632132	0.4839249	0.9382036
MP:0004552	fused tracheal cartilage rings	3	0.002756908	9.039589e-25	0.9824021	0.004146554	0.9148821
MP:0004553	absent tracheal cartilage rings	5	0.9929291	0.2713937	0.9346957	0.4491664	0.6065218
MP:0004554	small pharynx	9	0.005421234	0.0003704099	0.7358677	0.0124506	0.2277616
MP:0004555	pharynx hypoplasia	5	2.75996e-08	0.1148735	0.4947702	0.00870974	0.2758901
MP:0004556	enlarged allantois	17	1.490984e-28	9.04311e-19	1.076891e-05	1.157792e-07	0.4675953
MP:0004557	dilated allantois	9	1.211259e-12	2.572195e-15	8.856591e-18	2.168476e-08	0.544307
MP:0004558	delayed allantois development	4	0.4474036	0.01817869	1.425647e-06	0.04480898	2.580154e-06
MP:0004559	small allantois	9	1.620524e-08	3.899701e-05	0.02650567	0.3972535	0.6829502
MP:0004560	abnormal chorionic plate morphology	13	2.045611e-27	1.038127e-13	1.817349e-11	9.045743e-22	0.5719968
MP:0004561	absent facial nerve	4	0.8876254	6.949789e-10	0.6718894	0.209437	0.8829842
MP:0004562	abnormal inner hair cell synaptic ribbon morphology	6	2.414164e-20	6.091269e-13	5.037169e-05	0.0236505	0.02638893
MP:0004563	absent active-zone-anchored inner hair cell synaptic ribbon	2	4.827504e-17	5.280307e-07	4.2641e-07	0.1410988	0.8499636
MP:0004564	enlarged myocardial fiber	55	5.395173e-68	7.197207e-46	6.109043e-22	3.536764e-37	0.08051736
MP:0004565	small myocardial fiber	20	2.574094e-37	5.433988e-13	2.148073e-09	1.585804e-23	0.0001460702
MP:0004566	myocardial fiber degeneration	33	9.911165e-25	4.339336e-37	2.644652e-09	7.926544e-25	0.659935
MP:0004567	decreased myocardial fiber number	19	1.110598e-19	5.997658e-07	1.18005e-10	5.727817e-24	0.05109965
MP:0004568	fusion of glossopharyngeal and vagus nerve	12	3.084248e-06	1.375327e-16	0.006992354	1.255139e-10	0.3592189
MP:0004569	glossopharyngeal nerve hypoplasia	2	5.859795e-09	0.07635929	0.1582817	0.07131583	0.7745168
MP:0004570	absent glossopharyngeal nerve	1	0.7834672	2.130744e-09	0.873847	2.306763e-06	1
MP:0004572	fusion of basioccipital and basisphenoid bone	5	1.009171e-14	3.575759e-05	0.0170449	0.0008197247	0.6047897
MP:0004573	absent limb buds	12	0.00599323	5.340554e-11	0.0005766541	0.006756296	0.007258284
MP:0004574	broad limb buds	11	6.765717e-09	8.390762e-09	3.809586e-08	5.579542e-12	0.06378884
MP:0004575	small limb buds	16	8.551981e-06	1.301955e-16	0.1041984	5.89166e-06	0.1896793
MP:0004576	abnormal foot plate morphology	9	8.365321e-06	6.346955e-05	0.1084178	0.1752694	0.9579143
MP:0004577	abnormal cochlear hair cell inter-stereocilial links morphology	8	3.926248e-16	0.9772658	0.003136565	0.116879	0.5478765
MP:0004578	abnormal cochlear hair bundle tip links morphology	6	2.496176e-10	0.9797526	0.03900671	0.3975252	0.3872897
MP:0004582	absent cochlear hair bundle ankle links	2	9.6833e-08	0.7136009	0.01312665	0.04262224	0.8707234
MP:0004585	absent vestibular hair bundle shaft connectors	1	0.9982283	0.5187106	1	0.977917	0.2355317
MP:0004586	pillar cell degeneration	6	1.321079e-28	0.0005453457	0.1275811	1.249902e-10	0.6886637
MP:0004587	decreased cellular sensitivity to X-ray irradiation	2	0.9063148	0.112247	0.09396435	0.01182121	0.2932854
MP:0004588	abnormal vestibular hair cell development	1	0.1781519	0.4128127	0.770847	0.2108217	0.8122343
MP:0004589	abnormal cochlear hair cell development	10	3.229785e-16	6.077593e-08	9.856603e-08	2.362834e-05	0.1754034
MP:0004590	absent Deiters cells	1	0.1781519	0.4128127	0.770847	0.2108217	0.8122343
MP:0004591	enlarged tectorial membrane	8	0.01528422	1.45431e-12	0.002854506	0.0009106302	0.1237312
MP:0004592	small mandible	118	3.664999e-40	5.955485e-130	3.799969e-10	3.212598e-36	0.09995728
MP:0004593	long mandible	1	0.09504113	0.05576737	0.01920915	0.5191141	1
MP:0004594	abnormal mandibular coronoid process morphology	18	0.1812095	1.285021e-23	0.3187321	1.289562e-05	0.8931562
MP:0004595	abnormal mandibular condyloid process morphology	19	4.060987e-10	4.891736e-30	0.00191151	9.971228e-12	0.5480413
MP:0004596	abnormal mandibular angle morphology	13	0.7161085	1.063541e-48	0.007826064	0.0005459355	0.4922555
MP:0004597	increased susceptibility to noise-induced hearing loss	12	5.329018e-45	5.059058e-14	0.001399158	2.733905e-09	0.9457501
MP:0004598	abnormal cochlear basement membrane morphology	2	2.200794e-08	0.4257713	0.1013101	7.858827e-05	0.5728157
MP:0004599	abnormal vertebral arch morphology	99	1.383508e-50	7.376509e-94	1.547581e-17	6.674156e-63	0.109612
MP:0004600	abnormal vertebral transverse process morphology	12	0.004770836	1.400393e-05	0.01112549	1.980755e-06	0.3989254
MP:0004601	abnormal vertebral spinous process morphology	17	9.969998e-11	8.300108e-32	0.0008690827	5.927968e-13	0.5928739
MP:0004602	abnormal vertebral articular process morphology	3	0.2145729	0.9870107	0.1774935	0.000154724	0.04247152
MP:0004603	absent vertebral arch	7	0.03095774	6.099846e-18	0.003904729	0.03315648	0.03425123
MP:0004604	abnormal vertebral pedicle morphology	11	7.722092e-22	3.874618e-08	0.417276	0.0003305835	0.5351551
MP:0004605	abnormal vertebral lamina morphology	6	1.790943e-32	0.05946615	0.01587356	0.0009326349	0.9064119
MP:0004606	absent vertebral spinous process	4	0.3216218	3.040725e-40	0.8771964	0.03541583	0.7853029
MP:0004607	abnormal cervical atlas morphology	47	5.27108e-40	8.46035e-29	6.304083e-14	1.064209e-25	0.08438739
MP:0004608	abnormal cervical axis morphology	43	1.626195e-13	3.435336e-33	1.038782e-07	2.587279e-14	0.8203464
MP:0004609	vertebral fusion	109	7.75163e-132	2.503331e-133	5.936164e-18	1.052356e-50	0.3117281
MP:0004610	small vertebrae	15	0.0782005	7.776159e-13	0.002391045	0.009477111	0.2435274
MP:0004611	increased susceptibility to ototoxicity-induced hearing loss	2	0.8886271	0.0002352991	0.9039712	0.01441996	0.007764571
MP:0004612	fusion of vertebral bodies	8	1.137681e-21	6.967709e-09	2.278148e-08	9.852974e-11	0.8634562
MP:0004613	fusion of vertebral arches	23	5.452078e-07	3.028708e-33	4.398852e-07	9.597994e-19	0.004747002
MP:0004614	caudal vertebral transformation	7	2.958013e-09	0.05319722	0.05939286	4.213329e-09	0.562206
MP:0004615	cervical vertebral transformation	45	1.16419e-77	7.478429e-29	7.408102e-15	1.131153e-33	0.6132444
MP:0004616	lumbar vertebral transformation	47	9.943635e-58	7.856174e-06	1.655146e-13	3.380098e-37	0.4146491
MP:0004617	sacral vertebral transformation	20	1.058364e-16	5.1839e-05	1.307215e-09	6.091407e-17	0.3514773
MP:0004618	thoracic vertebral transformation	53	8.376879e-62	2.215723e-19	8.109976e-22	2.008407e-42	0.1460096
MP:0004619	caudal vertebral fusion	17	7.438216e-29	5.030498e-44	0.01466355	3.185705e-10	0.8273836
MP:0004620	cervical vertebral fusion	45	8.046727e-39	1.303486e-38	2.110753e-08	2.165273e-16	0.06147918
MP:0004621	lumbar vertebral fusion	15	4.444607e-21	2.700953e-19	0.2012975	0.005895401	0.9999995
MP:0004622	sacral vertebral fusion	12	5.161912e-19	5.856508e-42	8.446395e-05	0.01238471	0.9509348
MP:0004623	thoracic vertebral fusion	13	1.500573e-07	1.680605e-18	8.205308e-05	0.0001280321	0.9572744
MP:0004624	abnormal thoracic cage morphology	341	4.96490599081539e-316	4.511638e-238	1.292337e-64	4.643321e-148	0.006686917
MP:0004625	abnormal rib attachment	96	3.068309e-71	8.481523e-54	1.432094e-23	1.261412e-39	0.0185382
MP:0004626	vertebral compression	4	0.677795	0.8654684	0.1110226	3.726231e-06	0.8400679
MP:0004627	abnormal trochanter morphology	5	0.04330908	0.0004597678	0.003757663	0.005179953	0.200027
MP:0004628	Deiters cell degeneration	2	0.999993	0.01621216	0.9610434	0.922511	0.4295862
MP:0004630	spiral modiolar artery stenosis	1	0.06074024	1	0.005161348	1	1
MP:0004631	abnormal auditory cortex morphology	5	5.235087e-11	6.308017e-07	3.05023e-05	3.0691e-05	0.4212936
MP:0004632	abnormal cochlear OHC efferent innervation pattern	10	8.189949e-25	0.9103952	0.00230777	5.432415e-09	0.7840598
MP:0004633	abnormal cochlear IHC efferent innervation pattern	7	3.10421e-21	0.000105246	0.02098055	2.160531e-07	0.3094303
MP:0004634	short metacarpal bones	15	0.999585	1.385611e-18	0.6949555	0.989091	0.9664051
MP:0004635	short metatarsal bones	9	0.9999205	2.530989e-18	0.3382487	0.6268196	0.7469008
MP:0004636	decreased metacarpal bone number	1	0.1268335	0.009487859	0.09991104	0.3542238	0.8318286
MP:0004637	metacarpal bone hypoplasia	1	0.9930732	2.275922e-12	1	0.8595013	1
MP:0004638	elongated metacarpal bones	2	0.5314519	0.0001026519	0.7388764	0.4622368	0.8032525
MP:0004639	fused metacarpal bones	7	2.81572e-06	1.031151e-10	0.9910576	0.0003433367	0.9619034
MP:0004640	decreased metatarsal bone number	1	0.1268335	0.009487859	0.09991104	0.3542238	0.8318286
MP:0004641	elongated metatarsal bones	3	0.4759046	0.0001551552	0.2222219	0.2506329	0.7728856
MP:0004642	fused metatarsal bones	8	0.02392417	9.224827e-05	0.01057867	0.001601508	0.418401
MP:0004643	abnormal vertebrae number	67	9.672097e-113	6.008718e-23	1.426965e-28	1.890646e-52	0.2208724
MP:0004644	increased vertebrae number	30	3.034125e-70	0.01256137	5.067941e-15	1.553452e-37	0.1606777
MP:0004645	decreased vertebrae number	59	4.614284e-115	7.419202e-23	2.837126e-29	3.839713e-55	0.2841812
MP:0004646	decreased cervical vertebrae number	2	5.789219e-12	1.661139e-06	0.01962757	1.11241e-07	0.5753447
MP:0004647	decreased lumbar vertebrae number	24	1.234292e-96	0.007020194	5.61772e-16	1.00255e-50	0.4458964
MP:0004648	decreased thoracic vertebrae number	11	3.109131e-15	3.815958e-06	1.281031e-06	0.0003752415	0.5134222
MP:0004649	decreased sacral vertebrae number	2	0.5050704	0.5321434	0.2805021	0.2599155	0.8865093
MP:0004650	increased lumbar vertebrae number	5	5.69692e-07	0.5415047	0.1451138	0.01276445	0.4257334
MP:0004651	increased thoracic vertebrae number	12	4.0007e-09	2.058941e-05	5.406308e-05	1.203538e-07	0.182997
MP:0004652	small caudal vertebrae	7	0.009286444	1.426131e-10	0.1208812	3.317821e-05	0.2012385
MP:0004653	absent caudal vertebrae	10	0.004276726	6.007546e-11	0.5364204	0.004404976	0.1830418
MP:0004654	absent lumbar vertebrae	3	0.485813	0.4468379	0.2029646	0.2261416	0.9003143
MP:0004656	absent sacral vertebrae	9	0.002186063	0.5863393	0.1297187	0.006997676	0.1528206
MP:0004657	small sacral vertebrae	3	0.06441388	1.168459e-09	0.9288783	0.6593965	0.5704189
MP:0004658	abnormal ventral tubercle of atlas morphology	5	0.9916234	0.9846016	0.9721315	0.9894363	0.9739959
MP:0004659	abnormal odontoid process morphology	18	1.075927e-05	0.0003015596	0.0004536197	4.355075e-06	0.9054487
MP:0004660	absent thyroid follicular cells	1	0.07017688	6.639017e-08	0.1172219	0.00904338	0.2355317
MP:0004662	abnormal thyroid diverticulum morphology	1	0.07017688	6.639017e-08	0.1172219	0.00904338	0.2355317
MP:0004664	delayed inner ear development	6	0.9834308	1.823888e-11	0.0009155724	2.712064e-05	0.04451811
MP:0004665	abnormal stapedial artery morphology	9	0.0088158	1.58393e-09	7.147682e-05	2.497882e-15	0.1167248
MP:0004666	absent stapedial artery	7	0.02741696	1.163687e-08	8.593824e-06	4.324678e-13	0.05458148
MP:0004667	vertebral body hypoplasia	4	0.1782179	1.571511e-08	0.4441126	0.1287628	0.7887475
MP:0004668	absent vertebral body	4	0.3205194	0.8161058	0.008073459	6.684239e-05	0.4506293
MP:0004669	enlarged vertebral body	4	2.605975e-43	1.074909e-06	0.1494783	0.0005598279	0.9568633
MP:0004670	small vertebral body	16	1.635958e-10	1.566415e-27	0.611498	1.807395e-08	0.8635959
MP:0004671	long ribs	2	6.648447e-13	0.08345672	0.1647593	0.01913847	1
MP:0004672	short ribs	30	4.43575e-17	2.892526e-34	9.708963e-15	6.740346e-08	0.02655352
MP:0004673	splayed ribs	5	0.911572	0.8001158	0.004166874	0.1913509	0.3971693
MP:0004674	thin ribs	8	4.850595e-07	8.629073e-07	0.00626958	2.970322e-11	0.5861883
MP:0004675	rib fractures	4	2.013516e-10	7.278203e-06	1.722148e-05	4.750145e-08	0.8766074
MP:0004676	wide ribs	3	0.4386637	0.03875216	0.9979366	7.015984e-06	0.9216045
MP:0004677	truncated ribs	6	7.801968e-08	0.04269966	0.2148819	3.551381e-05	0.1929652
MP:0004678	split xiphoid process	18	0.2530917	8.553501e-46	0.01858706	0.03953588	0.1176455
MP:0004679	xiphoid process foramen	5	6.586594e-15	2.469783e-17	0.0003123828	0.0007811358	0.6898222
MP:0004680	small xiphoid process	8	0.2949791	3.164531e-07	0.8898181	2.793672e-06	0.9858383
MP:0004681	intervertebral disk hypoplasia	1	1.597063e-05	0.2305501	0.2246218	0.01927655	0.8122343
MP:0004682	small intervertebral disk	2	0.05857821	0.7834646	0.5642112	0.2323022	0.9647485
MP:0004683	absent intervertebral disk	8	0.1611712	2.949848e-11	0.02477876	0.001558285	0.8230763
MP:0004684	intervertebral disk degeneration	6	7.619662e-08	2.054353e-09	0.9315499	0.2319805	0.6595691
MP:0004685	calcified intervertebral disk	4	0.004285947	1.472018e-11	5.178372e-06	0.0001559458	0.07260869
MP:0004686	decreased length of long bones	234	8.84023e-98	6.604858e-208	4.292422e-34	1.287865e-87	0.02409128
MP:0004687	split vertebrae	6	4.8934e-05	1.579487e-17	1.022603e-05	0.009049164	0.8857593
MP:0004688	absent ilium	2	0.003977422	5.607336e-19	0.05444356	0.1487129	1
MP:0004689	small ischium	2	0.01804825	0.4895618	0.03270123	0.03774883	0.2134564
MP:0004690	ischium hypoplasia	1	0.0005013046	0.9991832	0.302561	0.005851364	0.02900782
MP:0004691	absent pubis	5	0.9976524	3.055941e-31	0.9999981	0.6909744	0.9441651
MP:0004692	small pubis	7	0.3919052	1.349184e-12	0.9161879	0.1160769	0.6015357
MP:0004693	pubis hypoplasia	1	0.0005013046	0.9991832	0.302561	0.005851364	0.02900782
MP:0004694	absent patella	8	0.1005946	1.158316e-17	4.26927e-05	0.02994774	0.9969651
MP:0004695	increased length of long bones	27	5.758572e-23	5.496577e-12	0.003090732	5.117449e-12	0.4379114
MP:0004696	abnormal thyroid follicle morphology	22	2.473566e-17	1.99756e-06	2.756794e-12	5.924799e-16	0.3331607
MP:0004697	abnormal thyroid follicular cell morphology	9	7.9417e-11	1.780588e-05	1.305099e-08	1.338331e-07	0.8466554
MP:0004698	abnormal thyroid parafollicular C-cell morphology	1	0.08360925	1.6807e-06	1.623503e-06	0.0004033383	1
MP:0004699	unilateral deafness	3	0.9990641	0.2518576	0.4213368	0.004770602	0.04170774
MP:0004700	abnormal circulating insulin-like growth factor I level	64	1.684402e-61	2.889777e-24	2.478128e-29	8.871394e-25	0.04550482
MP:0004701	decreased circulating insulin-like growth factor I level	57	1.308126e-47	1.810567e-25	3.078469e-25	3.468759e-24	0.03742901
MP:0004702	increased circulating insulin-like growth factor I level	9	2.153323e-14	5.120081e-07	1.512956e-09	4.338825e-07	0.5984193
MP:0004703	abnormal vertebral column morphology	565	0	9.607305e-296	1.422833e-124	2.048632e-267	0.01077325
MP:0004704	short vertebral column	20	3.721481e-09	3.981746e-07	0.03057645	6.269289e-05	0.5453692
MP:0004705	elongated vertebral body	2	4.511245e-11	1.148135e-05	0.5951356	0.04229822	0.7282617
MP:0004706	short vertebral body	5	1.378552e-35	1.559172e-14	0.4627218	2.515322e-13	0.5392871
MP:0004707	enlarged lumbar vertebrae	1	0.09504113	0.05576737	0.01920915	0.5191141	1
MP:0004708	short lumbar vertebrae	4	4.123464e-12	5.010075e-08	0.4307054	0.4376509	0.8723948
MP:0004709	cervical vertebrae degeneration	1	0.7248003	4.892357e-05	0.3832671	0.6062543	0.08911155
MP:0004710	small notochord	4	0.9959567	5.553405e-06	0.9776263	0.04190689	1
MP:0004711	persistence of notochord tissue	6	5.668372e-11	1.519526e-10	0.2004562	5.151471e-10	0.7518678
MP:0004712	notochord degeneration	7	0.0006164694	0.3870688	0.003521798	0.005041941	0.3625894
MP:0004713	split notochord	9	1.211364e-08	0.0001514644	0.003294795	4.620656e-09	0.6089842
MP:0004714	truncated notochord	5	3.829139e-15	2.92349e-07	0.3922989	4.056938e-05	0.9612064
MP:0004715	absent vestibulocochlear nerve	1	0.3285139	2.86898e-05	0.3651411	0.2022989	1
MP:0004716	abnormal cochlear nerve morphology	12	6.204178e-06	5.03136e-19	0.3902132	0.5872424	0.9240331
MP:0004717	absent cochlear nerve	2	0.2688661	1.443624e-12	0.5884893	0.6917592	0.9226854
MP:0004718	abnormal vestibular nerve morphology	5	0.003036301	1.522684e-06	0.3809836	0.06159283	0.9822215
MP:0004719	absent vestibular nerve	1	0.3285139	2.86898e-05	0.3651411	0.2022989	1
MP:0004720	abnormal platelet morphology	235	0	2.921035e-42	2.083957e-139	0	4.528213e-07
MP:0004721	abnormal platelet dense granule morphology	29	1.738258e-41	0.04639222	1.146904e-20	3.769731e-43	8.395428e-05
MP:0004722	abnormal platelet dense granule number	15	9.367871e-27	0.013866	2.844548e-10	8.164788e-22	0.07751449
MP:0004725	decreased platelet serotonin level	17	1.817867e-17	0.004417212	2.82195e-13	1.03661e-11	0.001335485
MP:0004726	abnormal nasal capsule morphology	28	0.976801	4.238439e-114	0.5187122	4.449127e-08	0.5675004
MP:0004727	absent epididymis	8	0.007410151	1.770063e-11	0.6527733	0.002300544	0.6020757
MP:0004728	abnormal efferent ductules of testis morphology	12	0.01624513	1.291313e-11	0.01570276	0.0002949899	0.4569288
MP:0004729	absent efferent ductules of testis	3	0.2970123	2.729479e-14	0.2450309	0.0004097367	0.5625908
MP:0004730	abnormal circulating gastrin level	10	1.62696e-06	2.178794e-16	0.008245738	0.003424547	0.157558
MP:0004731	increased circulating gastrin level	8	0.00484387	7.576657e-12	0.02978457	0.007223063	0.04751289
MP:0004732	decreased circulating gastrin level	2	5.963224e-06	3.678259e-06	0.08184703	0.1357257	0.9144081
MP:0004733	abnormal thoracic cavity morphology	21	3.608362e-16	4.489423e-17	0.0001382025	4.691687e-13	0.2775309
MP:0004734	small thoracic cavity	12	2.371738e-14	5.797075e-08	0.003582504	1.119062e-07	0.08218034
MP:0004735	enlarged thoracic cavity	2	0.008522864	1.657113e-05	0.06408699	0.2400852	0.8227702
MP:0004736	abnormal distortion product otoacoustic emission	50	4.04991e-36	1.584152e-14	0.01655724	1.111559e-10	0.05589588
MP:0004737	absent distortion product otoacoustic emissions	28	3.078225e-34	1.11886e-11	0.0007815835	4.483679e-05	0.1118853
MP:0004738	abnormal auditory brainstem response	200	4.012858e-202	3.424604e-99	7.211162e-45	2.928196e-90	0.0001219689
MP:0004739	conductive hearing loss	12	0.9799684	1.317137e-21	0.2016998	4.941576e-06	0.3764398
MP:0004740	sensorineural hearing loss	32	2.270737e-30	5.498171e-15	0.8121118	3.620198e-07	0.7333801
MP:0004742	abnormal vestibular system physiology	55	1.978626e-31	1.488065e-10	7.393845e-11	4.848265e-18	0.2640015
MP:0004746	abnormal cochlear IHC afferent innervation pattern	9	0.1958178	0.01789034	0.9631281	0.2143897	0.4582262
MP:0004747	abnormal cochlear OHC afferent innervation pattern	2	1	8.596338e-05	0.9997038	0.9967379	0.8468146
MP:0004748	increased susceptibility to age-related hearing loss	24	1.232032e-83	3.60415e-20	1.075043e-07	1.348965e-22	0.9247946
MP:0004749	nonsyndromic hearing loss	4	2.158913e-12	0.2110409	0.04520615	0.005213643	0.1792001
MP:0004750	syndromic hearing loss	3	0.9999162	9.660222e-09	0.5368038	0.005563167	0.7257844
MP:0004751	increased length of allograft survival	27	1.09644e-07	3.411592e-18	1.838673e-30	7.417417e-24	0.0007135727
MP:0004752	decreased length of allograft survival	6	0.0004747687	0.9118493	8.678771e-12	5.188105e-11	0.0002978627
MP:0004753	abnormal miniature excitatory postsynaptic currents	87	3.133502e-107	5.228236e-44	0.005471486	1.410967e-15	0.7386415
MP:0004754	abnormal kidney collecting duct morphology	60	5.612321e-40	2.708168e-59	6.747076e-09	7.32547e-16	0.0008213106
MP:0004755	abnormal loop of Henle morphology	13	3.80429e-31	3.923598e-27	1.390623e-05	1.051231e-05	0.7760388
MP:0004756	abnormal proximal convoluted tubule morphology	88	1.875647e-102	4.795068e-76	2.581135e-31	2.104169e-50	0.8413311
MP:0004757	abnormal distal convoluted tubule morphology	18	6.803547e-09	3.461863e-46	0.003772286	6.927486e-11	0.2123376
MP:0004758	absent strial marginal cells	2	0.9918765	0.0001599398	1	0.9957348	0.8360376
MP:0004759	decreased mitotic index	13	1.377643e-61	0.07718678	2.262201e-08	1.511807e-19	0.4116512
MP:0004760	increased mitotic index	14	1.763609e-24	0.05039779	1.936026e-06	1.855266e-21	0.07658471
MP:0004761	increased susceptibility to induced pancreatitis	8	4.308252e-15	4.310714e-06	2.970537e-05	2.29789e-06	0.3206297
MP:0004762	increased anti-double stranded DNA antibody level	86	7.735142e-124	5.053535e-16	1.038735e-103	1.901834e-132	1.190112e-08
MP:0004767	increased cochlear nerve compound action potential	2	6.444976e-07	0.2679435	0.2698451	0.2273794	0.7150747
MP:0004768	abnormal axonal transport	26	4.601342e-104	8.966887e-08	2.549775e-09	4.989496e-32	0.3508582
MP:0004769	abnormal synaptic vesicle morphology	43	1.817064e-18	2.631762e-25	0.004716515	1.537692e-07	0.399234
MP:0004770	abnormal synaptic vesicle recycling	17	9.582691e-16	0.0001225967	0.0004346155	2.22065e-13	0.2262538
MP:0004771	increased anti-single stranded DNA antibody level	25	3.452175e-39	6.980101e-30	3.139834e-43	4.084542e-31	0.007458685
MP:0004772	abnormal bile secretion	12	0.5633546	5.359175e-22	7.217969e-05	3.604682e-05	0.7768715
MP:0004773	abnormal bile composition	21	0.04468574	8.39669e-15	0.002266694	0.119628	0.2801219
MP:0004774	abnormal bile salt level	27	2.961766e-09	5.994487e-24	1.378192e-07	1.09214e-05	0.1647725
MP:0004775	abnormal vestibular dark cell morphology	3	1.180306e-06	3.648482e-21	0.01182378	0.005164875	0.5728927
MP:0004776	vestibular dark cell degeneration	1	8.384018e-15	0.01355167	0.5068093	0.000188385	1
MP:0004777	abnormal phospholipid level	44	1.843014e-34	2.160465e-32	3.966894e-41	6.059604e-41	0.02885196
MP:0004778	increased macrophage derived foam cell number	15	2.904025e-41	1.582655e-09	1.743451e-14	1.801459e-13	0.9885792
MP:0004780	abnormal surfactant secretion	40	3.883314e-24	5.113494e-21	3.446979e-30	4.02246e-29	0.5545492
MP:0004781	abnormal surfactant composition	7	3.147096e-07	0.2510889	0.001113176	9.43964e-06	0.5767693
MP:0004782	abnormal surfactant physiology	48	9.394861e-36	2.296607e-17	5.168726e-32	2.73783e-38	0.6696028
MP:0004783	abnormal cardinal vein morphology	30	2.225168e-33	5.963046e-24	3.905928e-08	3.953909e-33	0.4058001
MP:0004784	abnormal anterior cardinal vein morphology	12	2.732208e-11	2.504944e-38	4.166412e-05	1.681576e-15	0.8613091
MP:0004785	abnormal posterior cardinal vein morphology	1	0.9559403	9.429755e-16	1	0.08927696	1
MP:0004786	abnormal common cardinal vein morphology	3	0.3728556	0.0009063314	0.1448209	0.002425762	0.530076
MP:0004787	abnormal dorsal aorta morphology	91	1.122143e-110	7.72841e-56	1.482883e-45	3.333339e-124	0.002580061
MP:0004788	abnormal auditory cortex tonotopy	1	1.674908e-05	0.1855036	2.23003e-06	0.005985958	0.2145426
MP:0004789	increased bile salt level	14	0.001189819	7.597201e-08	0.003034979	0.1491638	0.9410305
MP:0004790	absent upper incisors	4	0.01357856	1.620573e-32	0.4377439	0.005041353	0.03474612
MP:0004791	absent lower incisors	8	1.700236e-08	0.009638589	4.84742e-05	1.445153e-12	0.02830316
MP:0004792	abnormal synaptic vesicle number	36	6.370739e-10	8.322197e-26	0.02823332	1.467116e-05	0.2376844
MP:0004793	abnormal synaptic vesicle clustering	7	0.001243095	1.300385e-15	0.09911416	0.2079247	0.04151197
MP:0004794	increased anti-nuclear antigen antibody level	115	3.75903e-188	6.748941e-24	3.428216e-121	9.427125e-187	2.725099e-10
MP:0004795	decreased anti-nuclear antigen antibody level	9	4.659976e-08	0.8368393	1.713012e-24	1.579251e-25	0.01639778
MP:0004796	increased anti-histone antibody level	15	3.392331e-24	1.377685e-15	3.345528e-45	4.702985e-36	0.2626059
MP:0004797	increased anti-erythrocyte antigen antibody level	3	0.01650322	0.0008913067	0.0002883082	0.00235236	0.6787676
MP:0004798	decreased anti-double stranded DNA antibody level	6	0.1653022	0.8338055	1.930274e-14	3.262059e-07	0.008356482
MP:0004799	increased susceptibility to experimental autoimmune encephalomyelitis	69	7.570765e-48	2.227158e-15	1.905186e-68	1.324284e-79	9.086616e-08
MP:0004800	decreased susceptibility to experimental autoimmune encephalomyelitis	86	9.22374e-78	2.678771e-15	1.424585e-95	1.962243e-136	4.346232e-05
MP:0004801	increased susceptibility to systemic lupus erythematosus	25	2.063171e-51	0.01108387	1.375944e-34	3.690035e-62	1.973256e-05
MP:0004802	decreased susceptibility to systemic lupus erythematosus	14	4.967615e-05	0.02081384	2.054845e-33	6.759714e-22	7.595595e-06
MP:0004803	increased susceptibility to autoimmune diabetes	41	1.54722e-10	5.155563e-11	8.931067e-46	9.886547e-53	7.744475e-05
MP:0004804	decreased susceptibility to autoimmune diabetes	45	3.711295e-31	2.191203e-07	1.131422e-47	1.797383e-52	4.51562e-06
MP:0004805	absent oocytes	24	1.285979e-25	0.02660006	3.094314e-08	1.152515e-05	0.002478355
MP:0004806	absent germ cells	180	9.75594e-211	3.016075e-34	1.863049e-38	1.168506e-83	2.058895e-05
MP:0004807	abnormal paired-pulse inhibition	8	2.38602e-13	0.005813159	0.9931977	0.305494	0.9497832
MP:0004808	abnormal hematopoietic stem cell morphology	134	0	1.734478e-22	5.479987e-66	3.667212e-242	0.1290845
MP:0004809	increased hematopoietic stem cell number	55	3.527711e-183	4.278121e-07	4.968517e-34	6.772943e-119	0.02059772
MP:0004810	decreased hematopoietic stem cell number	78	6.119727e-217	6.827412e-12	2.494689e-47	1.734572e-149	0.03294733
MP:0004811	abnormal neuron physiology	587	0	1.469348e-194	1.055298e-111	1.649584e-276	0.0001656934
MP:0004812	abnormal linear vestibular evoked potential	29	7.213614e-33	0.01785132	0.01632407	1.54789e-12	0.9602248
MP:0004813	absent linear vestibular evoked potential	19	3.176128e-30	0.003435459	0.009646212	1.534659e-17	0.889042
MP:0004814	reduced linear vestibular evoked potential	14	1.813032e-18	0.0591826	0.04405721	5.196042e-11	0.8482948
MP:0004815	abnormal somatic hypermutation frequency	16	1.083758e-06	3.683013e-13	2.671504e-07	1.258571e-07	0.02391947
MP:0004816	abnormal class switch recombination	87	2.853962e-123	2.496333e-21	1.572862e-69	9.581276e-112	0.0003104255
MP:0004817	abnormal skeletal muscle mass	127	7.875183e-125	1.210253e-93	1.958974e-21	1.634507e-41	0.03153541
MP:0004818	increased skeletal muscle mass	21	4.838256e-10	3.18372e-07	0.04562982	0.01147737	0.7790603
MP:0004819	decreased skeletal muscle mass	112	3.597809e-125	1.29889e-93	9.455804e-20	3.138679e-41	0.02029846
MP:0004820	abnormal urine potassium level	34	2.630399e-11	1.028831e-33	7.356906e-10	8.646143e-11	0.0001503674
MP:0004821	increased susceptibility to experimental autoimmune uveoretinitis	4	0.02345977	0.004721111	1.837098e-12	5.583581e-13	0.05146667
MP:0004822	decreased susceptibility to experimental autoimmune uveoretinitis	6	0.0003032444	1.868317e-06	2.0063e-25	3.143472e-10	0.003668698
MP:0004823	increased susceptibility to experimental autoimmune myasthenia gravis	2	1.351337e-10	0.9996236	0.001368607	0.008133118	0.4410055
MP:0004824	decreased susceptibility to experimental autoimmune myasthenia gravis	4	0.4553867	0.7763102	1.508921e-11	3.764054e-13	0.1052701
MP:0004827	increased susceptibility to autoimmune hemolytic anemia	3	0.0003147404	0.2291784	3.455341e-10	0.009714814	0.2792512
MP:0004828	decreased susceptibility to autoimmune hemolytic anemia	4	1.025275e-21	0.02755454	0.1280626	6.634502e-08	0.4218188
MP:0004829	increased anti-chromatin antibody level	15	9.499136e-10	1.183933e-09	4.471778e-15	3.129813e-22	0.1267778
MP:0004830	short incisors	15	0.0001632759	6.85979e-20	0.02403312	2.8246e-06	0.07406971
MP:0004831	long incisors	10	5.243979e-09	5.134328e-45	4.361009e-06	1.687019e-07	0.714783
MP:0004832	enlarged ovary	19	4.582454e-23	0.008530149	6.018516e-05	1.58584e-12	0.09017056
MP:0004833	ovary atrophy	15	9.941707e-07	0.0005279608	0.929038	0.2654233	0.01266837
MP:0004834	ovary hemorrhage	15	2.130497e-13	0.03602538	0.002445393	5.924059e-10	0.05345413
MP:0004835	abnormal miniature endplate potential	30	6.021445e-20	1.127005e-24	1.03335e-12	1.180768e-13	0.1988879
MP:0004836	abnormal synaptic acetylcholine release	6	0.7758184	0.0001883413	0.8949929	0.2292535	0.6555439
MP:0004837	abnormal neural fold formation	33	1.276139e-67	7.084422e-37	3.832057e-11	5.079747e-30	0.04078937
MP:0004838	abnormal neural fold elevation formation	15	1.122856e-34	2.613676e-17	0.00814198	9.014375e-08	0.1118
MP:0004839	bile duct hyperplasia	8	6.080617e-30	1.197456e-12	0.0009508976	9.561185e-18	0.9994356
MP:0004840	increased Deiters cell number	4	2.734263e-10	3.570274e-10	0.03484971	2.63978e-09	0.05663224
MP:0004841	abnormal small intestine crypts of Lieberkuhn morphology	67	1.171125e-130	1.14357e-42	6.802306e-26	7.38272e-75	0.1732232
MP:0004842	abnormal large intestine crypts of Lieberkuhn morphology	41	6.167347e-48	3.545391e-17	1.281191e-06	8.815632e-18	0.001000475
MP:0004843	abnormal Paneth cell morphology	32	7.099832e-88	7.777094e-26	2.117046e-17	1.448853e-32	0.2844795
MP:0004844	abnormal vestibuloocular reflex	13	0.2928327	0.7947555	0.777059	0.1210701	0.6509483
MP:0004845	absent vestibuloocular reflex	2	6.944209e-06	0.1295953	0.8043594	0.2558211	1
MP:0004846	absent skeletal muscle	7	0.5150156	0.001726428	0.9927734	0.2064425	0.08544164
MP:0004847	abnormal liver weight	176	3.557394e-219	5.18899e-92	6.1919e-35	2.310824e-94	0.2231942
MP:0004848	abnormal liver size	379	0	3.269538e-188	3.215942e-113	2.950509e-307	0.0002214516
MP:0004849	abnormal testis size	441	0	2.247663e-89	3.726167e-80	2.764044e-157	6.239984e-05
MP:0004850	abnormal testis weight	243	3.478826e-210	4.255447e-34	9.743388e-50	6.487353e-78	0.007115024
MP:0004851	increased testis weight	18	0.6314529	5.842685e-15	1.812229e-07	0.08256727	0.9215082
MP:0004852	decreased testis weight	224	3.613305e-221	4.716403e-23	2.071992e-42	4.598261e-79	0.001492691
MP:0004853	abnormal ovary size	138	2.219893e-108	5.126857e-27	5.211554e-19	6.874757e-40	0.0006421701
MP:0004854	abnormal ovary weight	36	1.197323e-20	0.01536223	0.03633595	0.0003147192	0.04394415
MP:0004855	increased ovary weight	6	0.1525311	0.001942759	0.04628878	0.008954029	0.1078745
MP:0004856	decreased ovary weight	31	1.386944e-23	0.1439091	0.09575964	0.003598878	0.1158319
MP:0004857	abnormal heart weight	211	5.233133e-239	1.512129e-142	8.682444e-69	1.378844e-138	0.04402428
MP:0004858	abnormal nervous system regeneration	22	8.128871e-58	6.965474e-22	2.915838e-19	4.190442e-23	0.02342165
MP:0004859	abnormal synaptic plasticity	51	1.368859e-50	2.201177e-22	5.169738e-06	4.721772e-15	0.641925
MP:0004860	dilated kidney collecting duct	32	1.51172e-17	3.096735e-28	5.659754e-05	1.383065e-05	0.3334455
MP:0004861	abnormal Raphe nucleus morphology	4	1.278712e-05	5.854523e-14	0.2094788	0.0007779703	0.9544231
MP:0004862	small scala tympani	2	0.995608	0.4256802	0.9987467	0.9995408	0.5188203
MP:0004863	thin spiral ligament	1	0.672827	0.02064353	0.9271712	0.8540202	0.09530803
MP:0004864	spiral ligament degeneration	3	0.0002385365	0.5431458	0.4398783	0.3762102	0.07142952
MP:0004867	decreased platelet calcium level	8	1.071632e-18	0.9900601	6.319428e-09	1.145504e-23	0.4122746
MP:0004868	endometrial carcinoma	8	1.427895e-07	6.715183e-09	3.48998e-14	1.131958e-08	0.02074203
MP:0004869	frontal bone hypoplasia	2	0.9985304	2.695076e-07	0.9436852	0.03594398	1
MP:0004870	small premaxilla	20	8.298275e-13	2.457571e-18	0.05188503	9.769528e-11	0.580732
MP:0004871	premaxilla hypoplasia	5	0.0002489723	3.549136e-12	0.4211441	0.02937514	0.992293
MP:0004872	absent nasal septum	9	1.129863e-13	2.829537e-29	0.00716461	2.611246e-08	0.9993971
MP:0004873	absent turbinates	3	0.9409791	1.917179e-08	0.5311498	1.475034e-10	0.314691
MP:0004874	abnormal timing of postnatal eyelid opening	62	1.33391e-31	2.28093e-77	1.452842e-09	3.467729e-18	0.6092035
MP:0004875	increased mean systemic arterial blood pressure	39	1.145703e-49	7.156986e-15	1.405934e-16	2.588659e-33	0.03312413
MP:0004876	decreased mean systemic arterial blood pressure	30	0.0004600292	3.423153e-10	1.953032e-06	1.865901e-07	0.7519154
MP:0004877	abnormal systemic vascular resistance	6	0.0002496816	1.048328e-09	0.1828941	0.0001061289	0.4418463
MP:0004878	increased systemic vascular resistance	3	0.7227797	1.036141e-11	0.460082	0.5854732	0.1923897
MP:0004879	decreased systemic vascular resistance	2	0.0001879374	0.3720414	0.04548344	1.964053e-06	1
MP:0004880	lung cysts	5	1	0.5692338	0.9290374	0.9999999	0.3233369
MP:0004881	abnormal lung size	158	5.296719e-93	3.505445e-162	2.343863e-40	2.416231e-76	0.0443868
MP:0004882	enlarged lung	50	9.670681e-45	1.037105e-67	2.651553e-32	1.511648e-46	0.0523391
MP:0004883	abnormal vascular wound healing	54	7.645208e-38	4.569641e-48	1.090666e-49	3.61308e-41	0.04808104
MP:0004884	abnormal testis physiology	26	3.298587e-16	9.349847e-15	8.18198e-08	0.0006236811	0.2913903
MP:0004885	abnormal endolymph	25	3.663365e-09	1.454967e-30	4.539154e-08	2.632866e-05	0.1033071
MP:0004887	decreased endolymph production	2	0.3477979	3.640045e-12	0.8653411	0.7907487	0.7229391
MP:0004888	abnormal perilymph	1	1.749942e-06	0.5042393	1	0.05790084	1
MP:0004889	increased energy expenditure	138	0	3.491236e-51	2.715323e-63	5.234061e-133	0.2504276
MP:0004890	decreased energy expenditure	65	1.208583e-44	1.690289e-09	9.259958e-09	1.101436e-21	0.283911
MP:0004891	abnormal adiponectin level	62	1.699647e-86	1.683437e-28	3.94376e-45	2.471372e-58	0.4061201
MP:0004892	increased adiponectin level	29	5.307624e-55	1.607176e-19	9.951496e-29	1.57871e-41	0.829738
MP:0004893	decreased adiponectin level	35	8.143325e-32	3.718116e-15	3.447742e-22	2.02573e-23	0.06051038
MP:0004894	uterus atrophy	12	0.002028315	0.0003485065	0.0002525547	0.1286502	0.0318042
MP:0004895	vagina atrophy	3	0.9990217	0.9897236	0.3527375	0.6185224	0.004768297
MP:0004896	abnormal endometrium morphology	47	8.380995e-21	4.982492e-44	1.466053e-19	6.009763e-14	3.308451e-05
MP:0004897	otosclerosis	2	0.9951532	0.1674314	0.2189756	0.7797621	0.5953486
MP:0004898	uterine hemorrhage	7	1.669025e-06	0.001196241	2.546356e-06	2.91291e-10	0.02478029
MP:0004899	absent squamosal bone	7	0.1686177	6.522366e-36	0.04172933	0.0548125	0.07813012
MP:0004900	absent zygomatic arch	5	0.0001019157	1.466848e-09	0.8734715	0.1133522	0.07721406
MP:0004901	decreased male germ cell number	362	0	6.797249e-53	2.671312e-67	5.07475e-154	5.699518e-05
MP:0004902	abnormal uterus size	88	1.191836e-43	1.235984e-63	8.028356e-21	2.581549e-20	0.0001282421
MP:0004903	abnormal uterus weight	34	2.931719e-19	4.791897e-25	0.0003078219	7.188591e-08	0.0119857
MP:0004904	increased uterus weight	15	0.9994705	1.850542e-17	0.0136887	0.06804403	0.02532214
MP:0004905	decreased uterus weight	21	7.726808e-22	3.03638e-05	0.0013188	4.618458e-05	0.002953633
MP:0004906	enlarged uterus	29	0.0002890468	1.683572e-35	2.961435e-08	4.956827e-06	0.04064987
MP:0004907	abnormal seminal vesicle size	61	6.417004e-62	1.616716e-07	5.482003e-05	1.591246e-17	0.04219925
MP:0004908	abnormal seminal vesicle weight	34	3.302998e-15	0.01440074	0.04200054	2.540772e-09	0.1161233
MP:0004909	increased seminal vesicle weight	7	0.5838835	0.002118034	0.8018291	0.2659172	0.4716372
MP:0004910	decreased seminal vesicle weight	28	1.241328e-16	0.01343841	0.01606859	3.587768e-09	0.1371076
MP:0004911	absent mandibular condyloid process	5	2.615874e-05	3.210407e-05	7.231865e-06	0.01802895	0.09835675
MP:0004912	absent mandibular coronoid process	10	0.7405192	6.156861e-07	0.8886843	0.07139823	0.7513699
MP:0004913	absent mandibular angle	7	0.0005662705	7.600069e-16	1.615765e-07	2.273504e-08	0.2137359
MP:0004914	absent ultimobranchial body	3	0.1054839	0.1407731	0.997304	0.02014271	0.3966691
MP:0004915	abnormal Reichert's cartilage morphology	4	0.1640129	0.002221718	0.9469376	0.006845213	0.7827602
MP:0004916	absent Reichert cartilage	2	4.176246e-06	0.9935889	0.9564328	2.166311e-05	0.8675752
MP:0004917	abnormal T cell selection	48	2.221465e-34	1.168275e-13	1.825301e-52	2.753038e-80	1.14076e-15
MP:0004918	abnormal negative T cell selection	23	1.243998e-08	0.0001295193	6.584803e-29	2.671236e-25	1.909106e-09
MP:0004919	abnormal positive T cell selection	34	3.25048e-43	2.689554e-09	1.097887e-30	1.633527e-71	2.638151e-12
MP:0004920	increased placenta weight	11	1.296133e-09	1.226137e-17	0.006984812	0.0008161214	0.3775299
MP:0004921	decreased placenta weight	23	6.499966e-92	4.232982e-26	6.041128e-18	1.336155e-23	0.8248442
MP:0004922	abnormal common crus morphology	10	2.144965e-09	1.246336e-10	0.0002166494	4.403817e-07	0.1113159
MP:0004923	absent common crus	4	8.747024e-14	3.60193e-05	0.01459996	8.129595e-05	0.9602656
MP:0004924	abnormal behavior	2474	0	0	0	0	8.84491e-14
MP:0004925	decreased susceptibility to noise-induced hearing loss	3	0.002857614	0.0006730514	1.623884e-06	0.003005637	0.9117639
MP:0004926	abnormal epididymis size	44	3.048672e-27	2.868572e-10	0.001246835	3.190916e-12	0.001064908
MP:0004927	abnormal epididymis weight	30	1.258073e-18	1.577633e-06	0.07657197	2.999346e-07	0.04427773
MP:0004928	increased epididymis weight	6	0.3480154	7.906784e-09	0.8232429	0.0002853012	0.01514839
MP:0004929	decreased epididymis weight	24	6.013594e-21	0.01068317	0.02728654	6.192861e-05	0.2328342
MP:0004930	small epididymis	38	1.50199e-29	6.658545e-06	0.0002412043	9.530165e-10	0.008457045
MP:0004932	epididymis hypoplasia	3	0.7355726	0.008506051	0.08031966	0.2753491	0.5844071
MP:0004933	abnormal epididymis epithelium morphology	23	6.892407e-14	9.167451e-22	6.903937e-10	9.861595e-06	0.003916745
MP:0004934	epididymis epithelium degeneration	6	0.2808076	9.611561e-06	3.077619e-06	0.06354669	0.5837198
MP:0004936	impaired branching involved in ureteric bud morphogenesis	54	8.056401e-22	3.210359e-84	3.547332e-12	4.89474e-18	0.03507553
MP:0004937	dilated heart	222	2.380585e-273	6.139129e-171	1.355721e-40	2.654072e-126	0.0004722545
MP:0004938	dilated vasculature	32	8.232881e-46	1.024135e-32	1.041702e-17	6.345374e-34	0.3017097
MP:0004939	abnormal B cell morphology	606	0	5.652017e-126	0	0	3.378851e-27
MP:0004940	abnormal B-1 B cell morphology	102	2.153244e-128	6.61617e-11	7.715432e-91	8.258939e-215	2.415013e-09
MP:0004941	abnormal regulatory T cell morphology	84	4.838844e-75	8.937457e-17	8.570611e-92	2.906652e-108	1.064768e-13
MP:0004942	abnormal B cell selection	7	7.307779e-13	0.9000527	1.893998e-14	4.840212e-19	0.02964753
MP:0004944	abnormal B cell negative selection	5	1.439314e-09	0.9653023	6.097393e-08	8.024649e-10	0.07576683
MP:0004945	abnormal bone resorption	56	1.42531e-46	5.676001e-39	1.164451e-77	4.091622e-60	3.228206e-09
MP:0004946	abnormal regulatory T cell physiology	32	1.965052e-46	5.299135e-09	5.627447e-49	4.718884e-58	4.199021e-05
MP:0004947	skin inflammation	123	1.619339e-188	2.700828e-38	3.55507e-78	8.009228e-133	0.0001085781
MP:0004948	abnormal neuronal precursor proliferation	82	1.234687e-107	1.59334e-52	1.361232e-05	5.136204e-34	0.267759
MP:0004949	absent neuronal precursor cells	3	0.0009697675	0.9798906	1	8.093117e-10	0.8581537
MP:0004950	abnormal brain vasculature morphology	54	3.638854e-90	2.842271e-36	1.413825e-43	2.158847e-57	0.01160051
MP:0004951	abnormal spleen weight	186	5.281537e-244	1.546613e-40	6.44367e-122	2.353715e-259	0.001253247
MP:0004952	increased spleen weight	128	8.012844e-266	7.451342e-12	1.68394e-87	3.02334e-224	0.02482857
MP:0004953	decreased spleen weight	66	7.434082e-20	6.045602e-37	5.64542e-43	3.041145e-53	0.00293924
MP:0004954	abnormal thymus weight	49	5.438568e-68	6.33119e-21	1.081243e-39	1.019864e-63	0.01846178
MP:0004955	increased thymus weight	13	4.607883e-12	0.0004355974	1.449092e-14	3.08958e-30	0.1510276
MP:0004956	decreased thymus weight	36	1.022077e-58	5.808857e-19	4.733264e-27	4.568117e-37	0.03905627
MP:0004957	abnormal blastocyst morphology	198	0	3.408328e-78	2.552226e-45	7.091133e-125	0.01153311
MP:0004958	enlarged prostate gland	15	3.209842e-10	1.97448e-09	0.1721004	0.001431974	0.5382153
MP:0004959	abnormal prostate gland size	37	1.539291e-45	4.628642e-08	0.01318278	1.715606e-08	0.6549219
MP:0004960	abnormal prostate gland weight	16	3.851797e-14	2.118308e-11	0.5257976	1.162938e-05	0.8985313
MP:0004961	increased prostate gland weight	8	0.5264183	1.297947e-13	0.7602866	0.7272935	0.4599616
MP:0004962	decreased prostate gland weight	10	3.620799e-20	0.5908812	0.3612029	1.17569e-08	0.9416058
MP:0004963	abnormal blastocoele morphology	28	4.118201e-48	1.286745e-25	1.435993e-06	1.185235e-17	0.005162131
MP:0004964	absent inner cell mass	18	3.394998e-63	0.0003792458	1.659339e-05	2.089155e-07	0.02331084
MP:0004965	inner cell mass degeneration	33	6.213705e-129	2.388569e-13	4.376782e-07	4.923266e-18	0.2959239
MP:0004966	abnormal inner cell mass proliferation	62	1.125401e-111	6.781522e-10	2.527288e-17	2.069892e-19	0.5874067
MP:0004967	abnormal kidney epithelium morphology	55	2.089778e-57	2.293051e-19	8.707213e-14	5.218834e-23	0.3129633
MP:0004968	kidney epithelium hyperplasia	1	5.277725e-08	0.8495794	1	0.01470256	1
MP:0004969	pale kidney	40	1.171666e-70	3.795491e-21	5.896356e-39	1.026681e-72	0.08366818
MP:0004970	kidney atrophy	62	2.903257e-33	2.124913e-15	2.918211e-06	1.738779e-17	0.03825456
MP:0004971	dermal hyperplasia	6	1.075753e-26	0.0001253473	1.466876e-05	5.299066e-09	0.880532
MP:0004972	abnormal regulatory T cell number	75	5.940428e-76	7.078653e-18	1.032033e-81	2.755839e-105	7.45798e-16
MP:0004973	increased regulatory T cell number	33	1.104643e-27	4.653894e-10	7.202506e-49	9.519217e-42	4.941574e-06
MP:0004974	decreased regulatory T cell number	48	2.692037e-47	5.0552e-12	1.057873e-64	3.636329e-58	4.313656e-15
MP:0004975	absent regulatory T cells	2	0.7565095	0.4082436	0.1844726	0.6013636	0.0007977188
MP:0004976	abnormal B-1 B cell number	101	9.309684e-129	1.241153e-10	9.604531e-91	4.375761e-214	1.801077e-09
MP:0004977	increased B-1 B cell number	30	2.669819e-21	0.000220824	1.005105e-10	2.476778e-32	0.002059965
MP:0004978	decreased B-1 B cell number	76	3.510376e-109	4.516383e-06	7.12492e-78	3.100783e-185	1.069365e-08
MP:0004979	abnormal neuronal precursor cell number	60	9.79007e-55	1.188641e-22	0.01658141	2.011523e-21	0.4392914
MP:0004980	increased neuronal precursor cell number	22	5.25214e-29	3.3075e-09	0.009081955	2.651394e-06	0.7899528
MP:0004981	decreased neuronal precursor cell number	35	1.959358e-21	9.850127e-12	0.9920922	4.090757e-06	0.641567
MP:0004982	abnormal osteoclast morphology	160	1.71232e-147	3.648235e-71	1.600719e-118	9.105216e-177	7.384152e-10
MP:0004983	abnormal osteoclast cell number	112	2.681551e-131	1.618153e-50	2.304361e-77	7.301874e-138	0.0003892197
MP:0004984	increased osteoclast cell number	62	2.082052e-52	6.314234e-31	1.084192e-33	2.000554e-74	1.405664e-05
MP:0004985	decreased osteoclast cell number	56	8.716258e-93	6.25417e-28	9.183105e-57	2.523604e-75	0.0688078
MP:0004986	abnormal osteoblast morphology	123	1.682701e-103	2.271802e-130	7.613276e-58	5.211357e-60	0.01111691
MP:0004987	abnormal osteoblast cell number	69	1.553952e-51	2.629124e-74	3.532447e-48	3.966611e-39	5.572517e-05
MP:0004988	increased osteoblast cell number	35	6.577055e-19	8.645447e-48	1.277218e-23	3.74315e-26	0.01701152
MP:0004989	decreased osteoblast cell number	39	3.194503e-31	5.928751e-50	2.729256e-28	1.893579e-17	8.994082e-05
MP:0004990	abnormal ciliary ganglion morphology	3	0.4634288	0.1806753	0.9779985	0.3664606	1
MP:0004991	decreased bone strength	21	9.910555e-07	7.281434e-25	1.501482e-05	1.551475e-11	0.4130623
MP:0004992	increased bone resorption	25	1.750858e-19	4.935854e-15	6.018716e-44	3.405856e-28	3.033081e-05
MP:0004993	decreased bone resorption	26	9.981955e-21	2.465181e-18	1.084205e-34	6.677404e-30	2.232767e-05
MP:0004994	abnormal brain wave pattern	59	2.778664e-51	5.464037e-21	5.710151e-11	1.181302e-17	0.6517375
MP:0004996	abnormal CNS synapse formation	29	1.263772e-06	6.217845e-09	0.6549908	0.003724804	0.9703015
MP:0004997	increased CNS synapse formation	2	0.3238409	0.04121295	0.4770267	4.860957e-05	0.7694619
MP:0004998	decreased CNS synapse formation	20	7.548861e-07	3.359414e-08	0.9848712	0.1725258	0.9446449
MP:0004999	abnormal blood-inner ear barrier function	2	0.9999975	0.994384	0.9586556	0.9465042	0.005131435
MP:0005000	abnormal immune tolerance	382	0	3.44779e-64	0	0	4.506853e-23
MP:0005002	abnormal T cell clonal deletion	9	0.0303874	0.002532173	5.167536e-20	5.655082e-06	6.024431e-07
MP:0005004	abnormal lymphocyte anergy	11	6.424402e-06	0.0102277	4.899258e-15	2.796818e-15	0.3905101
MP:0005005	abnormal self tolerance	374	0	4.501951e-67	0	0	1.363847e-23
MP:0005006	abnormal osteoblast physiology	66	1.119595e-52	5.020219e-57	1.226028e-28	5.330498e-36	1.182597e-05
MP:0005010	abnormal CD8-positive T cell morphology	331	0	2.893849e-49	6.36266e-237	0	1.500721e-25
MP:0005011	increased eosinophil cell number	69	7.109176e-105	1.010364e-05	1.909089e-71	8.874325e-115	6.462009e-05
MP:0005012	decreased eosinophil cell number	44	1.024573e-74	1.819958e-05	1.303806e-60	1.369579e-76	0.3685055
MP:0005013	increased lymphocyte cell number	583	0	3.775021e-104	0	0	3.599919e-40
MP:0005014	increased B cell number	248	0	1.50767e-42	8.414297e-235	0	2.063412e-20
MP:0005015	increased T cell number	403	0	7.863919e-94	0	0	4.664767e-27
MP:0005016	decreased lymphocyte cell number	813	0	9.749477e-158	0	0	4.5434e-36
MP:0005017	decreased B cell number	407	0	2.7532e-78	0	0	3.773628e-19
MP:0005018	decreased T cell number	553	0	2.645292e-105	0	0	6.27474e-31
MP:0005019	abnormal early pro-B cell	7	1.902195e-43	0.2653664	0.03735644	1.621183e-46	0.9755836
MP:0005020	abnormal late pro-B cell	10	1.238429e-19	0.9136444	7.525652e-07	8.715921e-19	0.9504234
MP:0005022	abnormal immature B cell morphology	199	0	1.124629e-37	1.100083e-176	0	8.656809e-05
MP:0005023	abnormal wound healing	171	5.398288e-148	1.203155e-115	2.264844e-112	2.504825e-159	5.764209e-05
MP:0005025	abnormal response to infection	592	0	1.905154e-79	3.298442e-306	0	4.693395e-32
MP:0005026	decreased susceptibility to parasitic infection	37	4.068401e-15	0.003583262	3.693567e-39	1.652486e-38	7.072698e-11
MP:0005027	increased susceptibility to parasitic infection	107	1.861176e-109	1.766794e-21	2.480866e-108	2.848342e-169	6.677231e-09
MP:0005028	abnormal trophectoderm morphology	121	1.718242e-190	6.855787e-74	8.215901e-23	5.166846e-65	0.1321513
MP:0005029	abnormal amnion morphology	42	2.68693e-124	9.005513e-35	4.979135e-15	8.35259e-24	0.1169436
MP:0005030	absent amnion	24	4.333929e-71	1.145679e-11	1.599007e-13	6.68143e-15	0.002100242
MP:0005031	abnormal trophoblast layer morphology	154	1.788551e-294	2.109041e-71	1.155292e-46	1.136015e-121	0.1939564
MP:0005032	abnormal ectoplacental cone morphology	40	6.477398e-67	3.010235e-09	0.001521371	2.949535e-18	0.0656493
MP:0005033	abnormal trophoblast giant cells	86	1.778502e-137	1.639882e-63	4.187811e-20	4.298897e-56	0.4704027
MP:0005034	abnormal anus morphology	25	0.01808661	3.175811e-24	0.5571232	0.07768332	0.9234655
MP:0005035	perianal ulceration	4	1.053777e-09	0.01955303	0.01081563	0.0007741101	0.5047952
MP:0005036	diarrhea	50	7.82198e-68	0.02463266	3.454478e-38	3.652571e-34	2.494766e-07
MP:0005039	hypoxia	34	5.798152e-27	7.128261e-12	6.004163e-18	4.959544e-23	0.5877598
MP:0005040	abnormal MHC II cell surface expression on macrophages	8	0.0001316038	0.4068794	9.082759e-20	0.0001965902	0.01076131
MP:0005041	abnormal antigen presentation via MHC class II	25	1.334678e-13	0.3485592	3.173772e-30	3.534709e-18	0.1180881
MP:0005042	abnormal level of surface class II molecules	23	6.035703e-07	0.2109963	3.471917e-29	2.89197e-13	0.1187017
MP:0005043	defective assembly of class II molecules	2	0.007010176	0.0004668673	0.2550554	2.619889e-07	1
MP:0005044	sepsis	18	8.485118e-27	1.437908e-05	6.113371e-20	4.791643e-25	0.0775782
MP:0005046	absent spleen white pulp	9	1.532181e-30	2.703899e-07	1.925002e-10	4.32803e-25	0.8816777
MP:0005048	thrombosis	103	9.484742e-126	3.252931e-30	4.713958e-55	2.17126e-85	3.463587e-07
MP:0005058	abnormal lysosome morphology	32	5.426477e-67	0.01701623	1.488896e-14	3.703999e-32	0.7497273
MP:0005059	lysosomal protein accumulation	12	3.165643e-31	0.003872209	0.002375734	4.904428e-26	0.5173148
MP:0005060	accumulation of giant lysosomes in kidney/renal tubule cells	9	3.063577e-29	0.05035972	1.688399e-05	1.005696e-16	0.9699074
MP:0005061	abnormal eosinophil morphology	107	4.490407e-165	3.842948e-09	2.816218e-122	6.788561e-186	0.0004123569
MP:0005065	abnormal neutrophil morphology	260	0	8.397756e-80	2.384551e-195	0	3.448554e-08
MP:0005068	abnormal NK cell morphology	128	1.827807e-178	1.014128e-14	8.023894e-90	2.124684e-234	6.82447e-15
MP:0005070	impaired natural killer cell mediated cytotoxicity	58	1.09157e-50	4.18396e-06	1.933662e-66	5.147661e-114	1.774625e-20
MP:0005071	enlarged hair follicle melanin granules	3	0.9767146	0.01615259	0.0004100003	0.3863323	0.2071785
MP:0005072	abnormal hair follicle melanin granule morphology	17	2.242345e-06	1.347375e-08	9.935281e-11	4.490165e-08	0.06401191
MP:0005074	impaired granulocyte bactericidal activity	10	4.790127e-31	0.0007992673	2.7149e-13	6.393165e-36	0.1122311
MP:0005075	abnormal melanosome morphology	41	2.118793e-23	2.921795e-09	1.427056e-18	5.511168e-20	0.03061233
MP:0005076	abnormal cell differentiation	1291	0	0	0	0	8.081451e-42
MP:0005077	abnormal melanogenesis	10	8.01843e-10	0.1746175	5.187186e-13	0.009493439	0.1203077
MP:0005078	abnormal cytotoxic T cell physiology	82	2.921122e-96	1.953346e-06	2.722696e-71	2.734594e-165	5.384237e-12
MP:0005079	defective cytotoxic T cell cytolysis	47	1.430247e-55	0.007388238	3.368082e-38	5.396587e-94	2.479477e-07
MP:0005081	abnormal dermis reticular layer morphology	4	6.344953e-05	0.01835496	0.004766183	0.003948521	1
MP:0005083	abnormal biliary tract morphology	66	4.791353e-86	8.350859e-42	1.854637e-32	1.252366e-55	0.02550216
MP:0005084	abnormal gallbladder morphology	26	1.315611e-12	5.431463e-26	3.830928e-11	4.007831e-18	0.3240827
MP:0005085	abnormal gallbladder physiology	36	2.018385e-05	2.508652e-23	8.81827e-06	0.04231686	0.5701514
MP:0005087	decreased acute inflammation	181	1.134148e-194	7.990734e-18	5.774391e-191	3.084781e-238	7.873807e-08
MP:0005088	increased acute inflammation	131	1.463129e-183	2.138536e-15	9.783068e-92	5.284077e-151	3.405345e-07
MP:0005089	decreased double-negative T cell number	69	4.346016e-126	1.598213e-12	1.473203e-55	7.604077e-117	2.242399e-09
MP:0005090	increased double-negative T cell number	106	2.157318e-224	1.936988e-25	3.865142e-76	5.462591e-182	4.282935e-10
MP:0005091	increased double-positive T cell number	52	1.018869e-108	1.533139e-06	1.5083e-28	1.942835e-67	1.746895e-06
MP:0005092	decreased double-positive T cell number	182	0	1.27777e-37	1.342918e-137	0	1.164486e-14
MP:0005093	decreased B cell proliferation	106	2.494383e-190	6.744468e-12	6.617899e-92	7.166961e-237	1.791911e-07
MP:0005094	abnormal T cell proliferation	323	0	2.394799e-43	3.084519e-279	0	3.733967e-34
MP:0005095	decreased T cell proliferation	202	1.92086e-239	5.578554e-31	1.465901e-175	0	1.366454e-31
MP:0005096	erythroblastosis	6	2.549754e-14	0.001910029	5.939549e-06	2.5504e-15	0.0005079597
MP:0005097	polychromatophilia	31	6.861185e-107	0.0004532993	5.516521e-30	2.561525e-72	0.09211275
MP:0005098	abnormal choroid morphology	52	1.019268e-33	1.234431e-21	3.08124e-20	4.225915e-41	0.2692559
MP:0005099	abnormal ciliary body morphology	23	0.00156246	3.172009e-56	6.700804e-08	1.129591e-07	0.2833104
MP:0005100	abnormal choroid pigmentation	20	1.147255e-07	0.0001362495	3.234357e-11	5.8752e-11	0.04535872
MP:0005101	abnormal ciliary body pigmentation	4	0.7170477	0.0002287053	0.01918296	0.1961697	0.3639753
MP:0005102	abnormal iris pigmentation	16	0.01111939	0.01767397	3.792415e-06	9.230023e-09	0.2045329
MP:0005103	abnormal retinal pigmentation	64	1.641024e-25	5.609229e-15	3.598643e-13	1.220621e-14	0.1262256
MP:0005104	abnormal tarsal bone morphology	42	2.548468e-17	4.369998e-27	2.055379e-07	2.145779e-06	0.3396314
MP:0005105	abnormal middle ear ossicle morphology	60	4.678386e-17	2.389952e-93	6.300585e-14	2.454456e-33	0.4124442
MP:0005106	abnormal incus morphology	31	1.541054e-13	3.241013e-30	1.203753e-09	8.307766e-25	0.2049128
MP:0005107	abnormal stapes morphology	36	8.409128e-16	6.01504e-37	6.625845e-09	3.298492e-26	0.05497184
MP:0005108	abnormal ulna morphology	82	9.873308e-10	2.825863e-105	2.932999e-06	8.134709e-12	3.866195e-05
MP:0005109	abnormal talus morphology	10	3.770305e-14	0.2115825	0.007596222	0.001088223	0.7105465
MP:0005110	absent talus	2	0.8606514	0.9763662	0.1396633	0.001132465	0.03321572
MP:0005111	hyperdipsia	2	1.450881e-05	0.006579776	0.7323465	0.6909143	1
MP:0005112	abnormal spinal cord ventral horn morphology	21	2.298408e-57	5.100921e-05	0.01418609	5.304827e-06	0.4808078
MP:0005113	decreased spinal cord ventral horn cell number	3	1.628867e-33	1.52432e-06	0.264026	0.05520484	0.4847944
MP:0005114	premature hair loss	21	0.001038677	8.671103e-14	7.654451e-10	2.283917e-08	0.2663033
MP:0005116	abnormal circulating pituitary hormone level	166	1.24881e-77	6.461737e-23	4.71865e-29	2.459027e-32	4.328542e-05
MP:0005117	increased circulating pituitary hormone level	104	2.805978e-33	4.670623e-15	8.10792e-15	3.108895e-14	0.0008364712
MP:0005118	decreased circulating pituitary hormone level	86	1.167579e-42	1.789216e-17	2.67267e-18	2.530876e-19	0.001770385
MP:0005119	decreased circulating thyroid-stimulating hormone level	8	5.696749e-06	0.05947976	6.2517e-05	3.115438e-05	0.0152547
MP:0005120	decreased circulating growth hormone level	24	1.180807e-05	3.533399e-06	0.02438372	3.945764e-05	0.05539806
MP:0005121	decreased circulating prolactin level	15	7.69155e-11	0.1105006	1.879234e-10	0.0002830081	0.3080797
MP:0005122	increased circulating thyroid-stimulating hormone level	18	0.1603837	0.006326594	2.18064e-09	5.736836e-06	0.1223316
MP:0005123	increased circulating growth hormone level	16	2.268128e-11	2.867313e-15	4.760006e-05	1.258621e-06	0.4677569
MP:0005124	increased circulating prolactin level	9	0.9335928	0.002113387	0.7970546	0.8421673	0.4183095
MP:0005128	decreased adrenocorticotropin level	15	1.570505e-12	1.394889e-11	1.535615e-06	1.274888e-05	0.1251359
MP:0005129	increased adrenocorticotropin level	21	0.05105327	2.123683e-06	0.6854115	0.9026992	0.88384
MP:0005130	decreased follicle stimulating hormone level	40	3.264663e-11	1.138368e-05	0.007000817	3.670403e-06	0.1424371
MP:0005131	increased follicle stimulating hormone level	41	9.283948e-47	8.088708e-05	2.894816e-08	2.245186e-14	0.0001828244
MP:0005132	decreased luteinizing hormone level	31	1.35361e-43	4.623488e-11	1.158661e-06	1.382567e-13	0.1143105
MP:0005133	increased luteinizing hormone level	38	1.043288e-15	5.698483e-11	2.45966e-12	1.481616e-10	0.001417147
MP:0005134	decreased thyroid-stimulating hormone level	15	7.477276e-14	2.104473e-05	8.725007e-05	1.919744e-06	0.2884327
MP:0005135	increased thyroid-stimulating hormone level	21	0.06566985	0.1080247	2.618639e-07	7.66021e-06	0.03325983
MP:0005136	decreased growth hormone level	37	1.841572e-15	1.342774e-08	2.168662e-07	1.491261e-08	0.0436912
MP:0005137	increased growth hormone level	21	1.667064e-09	2.08552e-08	0.001121831	0.0003796306	0.7969138
MP:0005138	decreased prolactin level	20	1.239487e-08	5.38618e-06	6.293061e-09	1.563361e-06	0.1783975
MP:0005139	increased prolactin level	10	0.01434864	0.007501867	0.6825747	0.2659436	0.5237151
MP:0005140	decreased cardiac muscle contractility	201	4.42347e-224	1.58215e-179	1.532849e-55	2.134337e-120	1.020299e-05
MP:0005141	liver hyperplasia	12	5.349837e-21	4.287405e-09	1.635982e-07	1.344219e-16	0.6790626
MP:0005144	abnormal circulating VLDL cholesterol level	51	5.596925e-52	7.494756e-39	3.533017e-22	4.663007e-39	0.002896425
MP:0005145	increased circulating VLDL cholesterol level	28	2.216091e-42	8.472416e-25	8.531997e-18	2.464315e-16	0.02352195
MP:0005146	decreased circulating VLDL cholesterol level	27	7.336759e-29	3.398727e-16	1.157584e-09	2.340958e-30	0.08772989
MP:0005147	prostate gland hypoplasia	4	4.197325e-10	0.289825	0.3787072	0.5632939	0.445752
MP:0005148	seminal vesicle hypoplasia	6	0.0001036258	0.2714119	0.1299754	0.7060103	0.004433436
MP:0005149	abnormal gubernaculum morphology	5	0.916521	0.330571	0.9880604	0.2502868	0.4338944
MP:0005150	cachexia	142	9.676609e-223	8.722451e-65	2.55883e-60	9.169167e-125	0.001729957
MP:0005151	diffuse hepatic necrosis	2	0.9999877	0.005437205	1	0.9853747	1
MP:0005152	pancytopenia	20	3.333037e-52	4.653459e-06	9.190456e-14	1.056485e-46	0.424918
MP:0005153	abnormal B cell proliferation	168	0	2.117009e-21	1.625302e-153	0	1.76246e-10
MP:0005154	increased B cell proliferation	68	4.538888e-175	7.296361e-10	3.238841e-66	5.04613e-173	3.313828e-05
MP:0005155	herniated intestine	7	0.001289637	6.531789e-07	0.8451474	0.7778434	0.9178049
MP:0005156	bradykinesia	45	5.284697e-52	4.093985e-09	0.1046168	9.898511e-25	0.4289795
MP:0005157	holoprosencephaly	47	3.277143e-16	1.209722e-54	6.07531e-07	2.771755e-24	0.1943361
MP:0005158	ovary hypoplasia	8	6.118684e-13	7.820013e-10	0.0003018725	4.826058e-05	0.6602538
MP:0005159	azoospermia	159	1.849186e-260	1.142289e-30	3.241237e-35	4.441639e-88	0.01040912
MP:0005161	hematuria	13	3.074893e-35	1.096027e-10	1.740723e-06	4.958883e-20	0.993434
MP:0005162	carpoptosis	5	2.066362e-09	0.001812007	0.008481312	0.0001315769	0.821624
MP:0005163	cyclopia	19	0.001329026	3.278153e-18	0.3744232	0.002846442	0.1975024
MP:0005164	abnormal response to injury	467	0	8.79477e-269	7.152653e-245	0	1.977146e-12
MP:0005165	increased susceptibility to injury	129	5.767439e-116	1.88468e-94	7.24893e-65	5.591834e-89	0.0005486149
MP:0005166	decreased susceptibility to injury	137	7.445936e-135	2.394388e-60	1.719719e-99	1.330056e-95	7.918992e-05
MP:0005167	abnormal blood-brain barrier function	29	1.189405e-46	3.364397e-18	1.840348e-29	1.062307e-24	0.01680951
MP:0005168	abnormal female meiosis	56	1.273631e-106	3.890403e-09	0.000124	1.017884e-33	0.2471453
MP:0005169	abnormal male meiosis	142	1.538546e-158	7.79476e-15	4.288983e-22	4.620641e-56	0.02581844
MP:0005170	cleft lip	24	0.0474938	6.430727e-43	5.535542e-05	4.091255e-08	0.1476284
MP:0005171	absent coat pigmentation	15	0.07006739	1.208327e-10	3.055004e-07	0.003656057	2.512931e-06
MP:0005172	decreased eye pigmentation	22	1.074178e-14	0.07450184	3.370363e-10	1.779992e-07	0.03767828
MP:0005174	abnormal tail pigmentation	29	7.208139e-09	3.741544e-14	3.544841e-25	2.17352e-10	0.005191345
MP:0005175	non-pigmented tail tip	6	0.02661751	1.591966e-12	2.071682e-09	0.002575062	0.0009472027
MP:0005176	eyelids fail to open	25	4.67297e-26	3.441773e-10	0.0005556942	1.769118e-13	0.9462942
MP:0005178	increased circulating cholesterol level	193	5.914525e-223	6.206705e-71	1.149248e-63	3.925349e-95	0.0005950783
MP:0005179	decreased circulating cholesterol level	185	2.004296e-298	3.780395e-72	3.776696e-76	1.658507e-141	0.002058342
MP:0005180	abnormal circulating testosterone level	72	4.008648e-22	3.611259e-36	3.337051e-24	7.110234e-22	0.01049778
MP:0005181	decreased circulating estradiol level	29	0.01336965	8.937021e-21	1.801773e-11	4.522971e-10	0.0175364
MP:0005182	increased circulating estradiol level	14	0.5365293	0.3218933	0.01817733	0.3432132	0.01421974
MP:0005183	abnormal circulating estradiol level	41	5.898784e-05	2.006498e-18	7.024832e-14	6.479395e-12	0.003668559
MP:0005184	abnormal circulating progesterone level	43	8.144978e-10	1.119339e-34	7.740788e-18	3.711053e-15	0.004815842
MP:0005185	decreased circulating progesterone level	34	0.002867951	3.963106e-33	3.904479e-18	1.464543e-09	0.02573628
MP:0005186	increased circulating progesterone level	12	5.384467e-14	0.0002057713	0.05456533	9.806183e-08	0.05939736
MP:0005187	abnormal penis morphology	26	4.036697e-21	1.94931e-13	7.795952e-05	0.007184594	0.1404722
MP:0005188	small penis	8	0.9357956	0.1802186	0.9352398	0.5408395	0.05280782
MP:0005189	abnormal anogenital distance	17	0.3754474	1.364878e-18	0.623352	0.3018606	0.1526137
MP:0005190	osteomyelitis	7	1.367242e-11	0.0002526463	8.751158e-30	1.235169e-22	0.1532456
MP:0005191	head tilt	39	6.75305e-52	2.668021e-08	2.39438e-16	4.613005e-15	0.006459491
MP:0005192	increased motor neuron number	17	0.8381597	2.09769e-08	0.06797316	2.590286e-06	0.4763161
MP:0005193	abnormal anterior eye segment morphology	416	0	3.877702e-237	2.503832e-139	1.146803e-218	2.080584e-07
MP:0005194	abnormal anterior uvea morphology	121	1.168137e-30	4.001172e-100	9.400223e-34	9.196156e-34	0.006311996
MP:0005195	abnormal posterior eye segment morphology	580	0	0	1.003633e-154	7.53433311675942e-318	2.234311e-05
MP:0005197	abnormal uvea morphology	162	1.025204e-67	1.526369e-117	7.221952e-51	1.166687e-65	0.008030453
MP:0005199	abnormal iris pigment epithelium	7	0.9963739	0.002503532	0.0009757403	0.04925066	0.7497481
MP:0005200	abnormal eye pigment epithelium morphology	137	2.345028e-80	1.31294e-59	3.19421e-27	1.876865e-44	0.172032
MP:0005201	abnormal retinal pigment epithelium morphology	128	6.852968e-77	1.318542e-52	1.976887e-23	3.180813e-44	0.2252822
MP:0005202	lethargy	114	5.75694e-126	3.484587e-68	2.364513e-26	1.682989e-80	0.0002517838
MP:0005203	abnormal trabecular meshwork morphology	14	0.154389	1.594591e-26	0.001911072	0.00256939	0.7046968
MP:0005204	abnormal canal of Schlemm morphology	12	0.2386517	1.708498e-14	0.000662364	0.01736251	0.4403998
MP:0005205	abnormal eye anterior chamber morphology	32	1.74036e-18	9.311028e-35	1.097498e-13	3.604475e-14	0.06900045
MP:0005206	abnormal aqueous humor	2	0.9999942	0.773287	0.9787426	0.9974432	0.9532186
MP:0005208	abnormal iris stroma morphology	15	0.5430563	1.730546e-25	4.099799e-06	1.578076e-06	0.3270872
MP:0005210	disorganized stomach mucosa	3	2.489997e-09	0.04206055	9.611554e-06	2.173716e-09	0.4617639
MP:0005211	increased stomach mucosa thickness	8	1.30938e-48	5.788722e-06	3.907063e-12	6.685275e-19	0.05388745
MP:0005213	gastric metaplasia	5	0.9991266	0.04389012	0.9995537	0.9998711	0.523344
MP:0005214	regional gastric metaplasia	1	0.003720784	0.533213	0.03099087	0.0001310726	0.6150913
MP:0005215	abnormal pancreatic islet morphology	195	2.022467e-174	3.663966e-94	9.053985e-63	6.59153e-118	0.000504899
MP:0005216	abnormal pancreatic alpha cell morphology	42	0.009217601	8.067211e-23	3.422301e-06	2.205429e-07	1.322959e-05
MP:0005217	abnormal pancreatic beta cell morphology	128	1.794471e-75	8.012848e-70	9.238828e-35	8.558446e-48	0.004934662
MP:0005218	abnormal pancreatic delta cell morphology	18	0.9565112	5.059797e-15	0.06692541	0.03459932	0.105069
MP:0005220	abnormal exocrine pancreas morphology	70	3.69166e-54	5.83011e-44	1.987493e-22	6.122583e-43	0.04136322
MP:0005221	abnormal rostral-caudal axis patterning	137	1.153398e-167	1.663216e-67	1.358069e-34	2.444928e-68	0.02084989
MP:0005222	abnormal somite size	50	6.513548e-38	3.934861e-41	1.789611e-08	1.351889e-18	0.7957641
MP:0005223	abnormal dorsal-ventral polarity of the somites	16	8.364224e-42	4.98142e-10	0.003902491	3.564109e-09	0.9858825
MP:0005224	abnormal left-right axis symmetry of the somites	7	0.001354944	3.02462e-13	0.07609126	8.53291e-06	0.03127528
MP:0005225	abnormal vertebrae development	67	2.768023e-48	8.280835e-89	0.0002759197	7.948778e-21	0.9758701
MP:0005226	abnormal vertebral arch development	24	2.968286e-15	2.536931e-07	9.678226e-08	3.030667e-16	0.8198313
MP:0005227	abnormal vertebral body development	9	0.04810835	7.764012e-10	0.00123132	1.890261e-09	0.4269967
MP:0005229	abnormal intervertebral disk development	11	0.00106739	2.541994e-16	0.0009761379	0.2185042	0.7532237
MP:0005230	ectrodactyly	8	7.44647e-07	7.295715e-06	0.02536396	0.005682827	0.904806
MP:0005231	abnormal brachial lymph node morphology	11	5.320809e-21	1.503287e-05	8.30283e-11	5.235467e-25	0.003952249
MP:0005232	abnormal mesenteric lymph node morphology	49	4.917509e-60	9.378143e-07	1.162439e-43	3.118666e-63	0.0031615
MP:0005236	abnormal olfactory nerve morphology	19	0.927053	6.375909e-24	0.9846378	0.01809435	0.5819488
MP:0005237	abnormal olfactory tract morphology	8	9.253449e-09	0.0001390485	0.01066762	0.0002965393	0.9798095
MP:0005238	increased brain size	59	4.905552e-66	1.016291e-33	1.875862e-15	4.973949e-29	0.09483748
MP:0005239	abnormal Bruch membrane morphology	13	1.544753e-05	2.107026e-14	0.0003077803	1.744654e-07	0.2055852
MP:0005240	abnormal amacrine cell morphology	39	3.41598e-11	4.928838e-19	0.00270684	1.251196e-05	0.06664075
MP:0005241	abnormal retinal ganglion layer morphology	108	3.978292e-44	4.368363e-60	1.370429e-22	7.978809e-39	0.00901762
MP:0005242	cryptophthalmos	5	0.1762428	6.545724e-13	0.9867053	0.9983236	0.9597366
MP:0005243	hemothorax	9	0.00502865	6.414307e-08	6.015388e-08	0.0006886818	0.0005787424
MP:0005244	hemopericardium	50	7.701832e-102	1.546818e-15	2.918558e-40	1.683946e-62	0.0001161386
MP:0005245	hemarthrosis	1	0.351847	0.000146906	1	1	1
MP:0005247	abnormal extraocular muscle morphology	7	0.9999975	3.967335e-07	0.8120344	0.1752477	0.3946161
MP:0005248	abnormal Harderian gland morphology	18	4.725442e-15	5.931886e-15	2.829804e-07	1.848789e-09	0.1817229
MP:0005249	abnormal palatine bone morphology	43	6.419725e-10	2.39572e-44	0.0001545049	1.871797e-18	0.4198023
MP:0005250	Sertoli cell hypoplasia	9	0.3990525	0.003791362	0.9998561	0.7571304	0.2880251
MP:0005251	blepharitis	18	2.323068e-22	3.706297e-06	4.164555e-25	1.811463e-12	0.5675546
MP:0005252	abnormal meibomian gland morphology	18	6.219358e-11	5.019329e-25	0.00162026	4.951047e-09	0.3669601
MP:0005253	abnormal eye physiology	394	3.852851e-300	9.146477e-163	5.355917e-83	3.160214e-172	3.754643e-05
MP:0005257	abnormal intraocular pressure	21	1.892985e-17	1.432583e-07	2.174937e-05	1.362394e-11	0.01890695
MP:0005258	ocular hypertension	11	1.873609e-15	4.615477e-10	6.941184e-05	2.597189e-09	0.005823895
MP:0005260	ocular hypotension	5	1.068651e-13	0.02669111	0.002105046	1.533762e-09	0.297729
MP:0005261	aniridia	3	0.9942274	5.983375e-07	0.1277115	0.1319222	0.01535074
MP:0005262	coloboma	31	1.152246e-24	1.805526e-53	4.002457e-19	1.560538e-20	0.5347191
MP:0005263	ectopia lentis	2	3.698101e-10	0.8026477	7.225559e-06	0.0001413477	1
MP:0005264	glomerulosclerosis	74	2.292917e-59	9.537646e-37	2.830767e-51	2.174503e-72	0.00555998
MP:0005265	abnormal blood urea nitrogen level	156	7.128183e-116	1.407862e-77	9.146549e-76	1.785769e-82	0.0006147508
MP:0005266	abnormal metabolism	553	0	8.096646e-179	3.874875e-167	0	2.987264e-09
MP:0005267	abnormal olfactory cortex morphology	20	4.01352e-05	1.073837e-20	0.07649083	8.14167e-06	0.4139941
MP:0005269	abnormal occipital bone morphology	79	1.790394e-102	1.53146e-90	1.027395e-07	3.83736e-33	0.773848
MP:0005270	abnormal zygomatic bone morphology	33	0.0001804883	7.993129e-50	2.371985e-06	1.432887e-07	0.0769607
MP:0005271	abnormal lacrimal bone morphology	4	0.212419	2.73952e-14	0.995997	4.314178e-05	0.09860225
MP:0005272	abnormal temporal bone morphology	56	8.429082e-12	2.554486e-72	0.6565131	8.566423e-12	0.1557378
MP:0005274	abnormal viscerocranium morphology	312	1.438248e-192	1.785455e-266	7.035231e-55	8.504614e-116	0.002386946
MP:0005275	abnormal skin tensile strength	26	0.0004718069	2.674134e-41	0.09093459	0.05344442	0.05825992
MP:0005277	abnormal brainstem morphology	214	1.353816e-166	4.562269e-133	3.374176e-32	6.942986e-66	0.1314366
MP:0005278	abnormal cholesterol homeostasis	394	0	4.878243e-140	5.223042e-118	6.796169e-226	1.213194e-05
MP:0005279	narcolepsy	3	0.9830027	0.0001488661	0.7978581	0.3642996	0.2276008
MP:0005280	abnormal fatty acid level	192	1.7578e-213	4.999407e-104	1.279781e-86	1.95605e-166	0.04966497
MP:0005281	increased fatty acid level	99	7.042778e-68	1.390861e-72	9.906324e-42	6.510507e-59	0.01753155
MP:0005282	decreased fatty acid level	109	5.738511e-168	1.985389e-63	2.130721e-58	3.435091e-125	0.07719428
MP:0005283	increased unsaturated fatty acid level	3	0.09086622	0.09404619	0.02887126	0.50233	0.09925727
MP:0005284	increased saturated fatty acid level	2	0.1561651	0.02026233	0.106338	2.161715e-05	0.804023
MP:0005285	decreased unsaturated fatty acid level	5	1.93643e-05	1.127195e-07	0.008140923	1.326331e-07	0.9885601
MP:0005286	decreased saturated fatty acid level	3	1.73324e-16	0.1118646	9.020032e-05	0.2191187	0.8486377
MP:0005287	narrow eye opening	28	1.148718e-29	2.559181e-16	6.297402e-13	9.073782e-19	0.06038177
MP:0005288	abnormal oxygen consumption	165	1.789543e-239	2.032976e-45	4.399046e-51	2.922724e-91	0.1786221
MP:0005289	increased oxygen consumption	107	3.723741e-184	2.444478e-27	8.387199e-33	1.553559e-72	0.7783696
MP:0005290	decreased oxygen consumption	62	1.488101e-49	5.825913e-30	1.172196e-17	3.15256e-21	0.06899797
MP:0005291	abnormal glucose tolerance	362	0	1.965625e-188	7.625806e-164	2.106304e-214	6.305573e-09
MP:0005292	improved glucose tolerance	153	1.457148e-271	8.188328e-118	8.232214e-87	1.393282e-119	5.652187e-05
MP:0005293	impaired glucose tolerance	234	3.526403e-261	3.967201e-98	1.01941e-103	1.463086e-139	1.351942e-05
MP:0005294	abnormal heart ventricle morphology	558	0	0	2.775656e-147	0	8.578106e-06
MP:0005296	abnormal humerus morphology	89	4.158863e-19	5.370631e-64	0.005178133	4.546905e-13	4.3005e-05
MP:0005297	spina bifida occulta	14	2.396969e-07	0.001972601	0.0004296763	1.218723e-08	0.5921847
MP:0005298	abnormal clavicle morphology	26	0.002722396	4.241455e-46	0.9950146	0.0007206443	0.2279579
MP:0005299	abnormal eye posterior chamber morphology	6	3.261367e-11	1.996755e-10	0.0001359136	2.03337e-07	0.1078493
MP:0005300	abnormal corneal stroma morphology	41	1.389535e-38	3.297885e-75	6.740889e-10	1.533889e-12	0.1449975
MP:0005301	abnormal corneal endothelium morphology	14	5.271973e-09	5.790973e-16	0.9022279	0.0004654163	0.657053
MP:0005302	neurogenic bladder	4	8.064998e-07	0.892729	0.7961119	0.000411067	0.789012
MP:0005304	cystic bulbourethral gland	1	0.9410154	1.850401e-07	1	0.08626867	0.3339505
MP:0005305	prostate gland anterior lobe hyperplasia	2	0.005587811	0.001255344	0.9942398	0.007900753	0.6263249
MP:0005306	abnormal phalanx morphology	80	6.23442e-43	3.138306e-82	2.906842e-11	4.707375e-17	0.4879068
MP:0005307	head tossing	28	8.958651e-12	1.309328e-30	0.00785991	0.0005174808	0.1590618
MP:0005309	increased circulating ammonia level	16	5.506712e-19	3.466192e-09	0.0009966474	3.707989e-08	0.569791
MP:0005310	abnormal salivary gland physiology	48	2.489135e-57	4.903994e-09	5.740039e-53	1.325616e-45	0.0005927232
MP:0005311	abnormal circulating amino acid level	174	1.620434e-202	3.089602e-89	2.632296e-66	1.637802e-105	3.378268e-05
MP:0005312	pericardial effusion	132	1.081542e-212	8.425857e-80	1.498915e-60	1.147244e-125	6.373193e-06
MP:0005313	absent adrenal gland	8	0.5423007	9.029774e-14	0.01314361	0.04487904	0.2637323
MP:0005314	absent thyroid gland	7	0.6269616	4.697136e-19	0.9698607	0.01671677	0.001306898
MP:0005315	absent pituitary gland	9	0.04583429	1.780562e-31	0.9993144	0.0008098638	0.0467027
MP:0005316	abnormal response to tactile stimuli	104	9.352172e-103	4.663343e-40	7.133329e-25	7.816113e-39	0.07675277
MP:0005317	increased triglyceride level	203	8.477318e-274	5.042094e-112	1.868346e-76	4.875052e-141	0.0008014621
MP:0005318	decreased triglyceride level	206	0	2.620401e-97	1.456161e-101	3.907602e-186	0.006184923
MP:0005319	abnormal enzyme/ coenzyme level	388	0	1.837213e-137	5.556684e-110	4.305711e-266	8.52264e-06
MP:0005321	abnormal neopterin level	2	6.363496e-06	1	0.2101336	3.730094e-11	0.47712
MP:0005322	abnormal serotonin level	70	8.049165e-29	1.660639e-25	1.63774e-11	1.387945e-23	0.3962387
MP:0005323	dystonia	23	8.263182e-14	8.778139e-40	0.1660343	2.461283e-10	0.4854086
MP:0005324	ascites	37	9.371306e-107	4.984807e-06	1.158791e-17	7.046664e-64	0.02494964
MP:0005325	abnormal renal glomerulus morphology	298	0	1.985446e-146	9.099091e-192	6.577269e-292	1.649736e-07
MP:0005326	abnormal podocyte morphology	68	9.221436e-111	6.38486e-51	1.538479e-44	4.975196e-77	0.01605743
MP:0005327	abnormal mesangial cell morphology	49	3.166582e-79	1.86659e-16	6.127075e-49	1.084479e-79	0.04518083
MP:0005328	abnormal circulating creatinine level	104	3.974236e-137	2.34038e-43	4.002676e-67	2.448291e-84	5.625231e-05
MP:0005329	abnormal myocardium layer morphology	401	0	1.369779e-268	4.273264e-117	0	4.712392e-05
MP:0005330	cardiomyopathy	116	6.2311e-102	6.572979e-87	8.955631e-11	6.404066e-68	0.02901255
MP:0005331	insulin resistance	134	1.984198e-137	3.528104e-70	4.196548e-43	1.018235e-97	0.02362226
MP:0005332	abnormal amino acid level	217	4.025888e-216	4.657735e-117	3.960368e-66	6.0465e-108	3.437339e-05
MP:0005333	decreased heart rate	117	2.411333e-82	5.015326e-86	1.921267e-37	1.957343e-46	0.000276103
MP:0005334	abnormal fat pad morphology	224	2.766031e-282	1.402472e-87	1.462133e-119	7.686447e-180	0.001747181
MP:0005335	abnormal gonadal fat pad morphology	70	6.111274e-132	1.726827e-37	4.354843e-54	4.589159e-55	0.003095401
MP:0005336	abnormal inguinal fat pad morphology	46	2.239918e-49	2.778894e-24	1.838049e-34	1.434425e-59	0.7848592
MP:0005337	abnormal retroperitoneal fat pad morphology	35	4.83467e-22	1.900807e-19	9.769699e-14	1.123238e-20	0.5888211
MP:0005338	atherosclerotic lesions	102	7.793749e-65	6.603244e-31	8.274069e-74	2.334491e-93	1.087099e-05
MP:0005339	increased susceptibility to atherosclerosis	26	4.783039e-29	1.940302e-05	1.753221e-15	1.399762e-15	0.01976815
MP:0005340	altered susceptibility to atherosclerosis	70	9.510696e-63	1.943095e-26	9.04398e-63	1.274534e-66	0.0007727209
MP:0005341	decreased susceptibility to atherosclerosis	43	4.430493e-30	3.652755e-23	1.130659e-49	7.143324e-47	0.002991827
MP:0005342	abnormal intestinal lipid absorption	28	1.02162e-15	1.386579e-15	1.935079e-06	3.475875e-08	0.4998351
MP:0005343	increased circulating aspartate transaminase level	75	8.592596e-124	3.462687e-40	1.093107e-36	1.856435e-71	0.08580808
MP:0005344	increased circulating bilirubin level	53	1.314611e-152	2.006114e-21	1.547728e-24	4.556533e-61	0.149596
MP:0005345	abnormal circulating corticosterone level	77	3.165041e-55	3.424867e-17	6.826115e-12	1.740416e-16	0.9071489
MP:0005346	abnormal circulating aldosterone level	34	1.524467e-50	5.416784e-50	1.545934e-11	1.795102e-21	0.02134859
MP:0005348	increased T cell proliferation	131	2.935032e-272	1.27988e-16	9.439734e-113	1.546511e-308	1.319024e-09
MP:0005350	increased susceptibility to autoimmune disorder	164	1.250485e-190	6.011795e-31	4.382312e-173	5.76455e-237	1.191104e-13
MP:0005351	decreased susceptibility to autoimmune disorder	180	1.10062e-181	2.071146e-28	1.685833e-172	7.052381e-267	2.312833e-12
MP:0005352	small cranium	29	4.601833e-10	7.058977e-33	1.211902e-17	5.579277e-14	0.4848062
MP:0005353	abnormal patella morphology	21	0.2183623	2.494812e-19	0.001777393	0.00532464	0.8333612
MP:0005354	abnormal ilium morphology	9	2.19635e-05	3.592283e-48	0.01360774	0.003231719	0.9930588
MP:0005355	enlarged thyroid gland	10	0.03289269	0.4616326	0.001981669	4.501568e-06	0.3723506
MP:0005356	positive geotaxis	7	0.9799342	3.297164e-12	0.202559	0.5891942	0.1475607
MP:0005357	novel environmental response-related retropulsion	4	2.92223e-15	6.570109e-15	2.61847e-07	2.329617e-05	0.3528952
MP:0005358	abnormal incisor morphology	92	6.368039e-33	1.57512e-128	1.391251e-17	2.936814e-32	5.627804e-05
MP:0005359	growth retardation of incisors	9	0.07158719	3.887374e-05	0.9392158	0.9236941	0.1934861
MP:0005360	urolithiasis	19	1.638983e-22	2.429144e-05	0.02030154	0.09982238	0.8617932
MP:0005361	small pituitary gland	32	3.823387e-31	7.054349e-22	2.04728e-12	6.665097e-31	0.1074258
MP:0005362	abnormal Langerhans cell physiology	17	3.167294e-19	0.0008178802	4.840898e-22	2.773691e-27	3.808798e-05
MP:0005363	decreased susceptibility to prion infection	3	4.153344e-05	0.0004379956	0.3902709	0.001291151	0.1563416
MP:0005364	increased susceptibility to prion infection	2	0.9453002	0.6319923	0.0136887	0.2060842	1.081239e-05
MP:0005365	abnormal bile salt homeostasis	36	1.04131e-18	1.351728e-23	1.724924e-07	1.638677e-09	0.447616
MP:0005366	variegated coat color	10	0.01035114	0.4225861	1.59056e-06	0.6897784	0.01463266
MP:0005367	renal/urinary system phenotype	1014	0	0	0	0	1.959663e-16
MP:0005369	muscle phenotype	1225	0	0	0	0	4.07288e-09
MP:0005370	liver/biliary system phenotype	994	0	0	0	0	1.564938e-10
MP:0005371	limbs/digits/tail phenotype	769	0	0	9.096299e-168	0	9.213077e-07
MP:0005375	adipose tissue phenotype	645	0	4.143873e-264	1.603439e-218	0	6.654376e-07
MP:0005376	homeostasis/metabolism phenotype	3469	0	0	0	0	2.529357e-46
MP:0005377	hearing/vestibular/ear phenotype	522	0	0	4.113579e-91	1.541208e-203	0.0004066561
MP:0005378	growth/size phenotype	3149	0	0	0	0	4.614673e-29
MP:0005379	endocrine/exocrine gland phenotype	1475	0	0	0	0	9.121259e-19
MP:0005381	digestive/alimentary phenotype	1139	0	0	1.223926e-306	0	1.257965e-15
MP:0005384	cellular phenotype	3086	0	0	0	0	4.573199e-56
MP:0005385	cardiovascular system phenotype	2029	0	0	0	0	3.164015e-31
MP:0005387	immune system phenotype	2697	0	0	0	0	3.421438e-66
MP:0005388	respiratory system phenotype	1144	0	0	0	0	1.082558e-14
MP:0005389	reproductive system phenotype	1598	0	0	0	0	3.414718e-13
MP:0005390	skeleton phenotype	1471	0	0	0	0	2.905703e-13
MP:0005391	vision/eye phenotype	1190	0	0	0	0	3.871166e-14
MP:0005394	taste/olfaction phenotype	121	2.033611e-35	1.808313e-53	2.28713e-08	2.041537e-28	0.04341111
MP:0005395	other phenotype	277	0	2.355375e-102	4.952359e-98	2.25197e-151	5.511803e-05
MP:0005397	hematopoietic system phenotype	2240	0	0	0	0	1.620604e-54
MP:0005398	decreased susceptibility to fungal infection	6	1.749537e-19	4.112529e-10	3.616626e-05	6.015083e-13	0.2490278
MP:0005399	increased susceptibility to fungal infection	25	8.004558e-24	0.002005967	4.315796e-25	1.93307e-31	0.00338793
MP:0005400	abnormal vitamin level	52	6.054144e-09	5.459101e-43	1.877356e-09	7.033186e-11	1.323398e-06
MP:0005401	abnormal fat-soluble vitamin level	39	1.00526e-05	2.020854e-41	2.162313e-11	3.627653e-09	2.677106e-05
MP:0005402	abnormal action potential	105	2.152448e-27	3.442722e-86	1.972576e-10	6.248433e-23	0.03453642
MP:0005403	abnormal nerve conduction	64	1.796918e-14	3.471469e-65	9.259059e-10	2.202658e-11	0.003390554
MP:0005404	abnormal axon morphology	185	2.954772e-190	4.290571e-116	2.361076e-27	1.998654e-133	0.003775697
MP:0005405	axon degeneration	71	1.761253e-93	2.820403e-27	8.38075e-20	9.138577e-37	2.53389e-08
MP:0005406	abnormal heart size	491	0	0	1.647845e-130	1.00282e-304	0.0007064188
MP:0005407	hyperalgesia	63	1.302745e-14	1.897687e-16	8.228965e-06	1.879336e-15	0.8614229
MP:0005408	hypopigmentation	51	1.387889e-48	9.755031e-17	1.046065e-14	3.922256e-22	0.001835462
MP:0005409	darkened coat color	18	2.364242e-13	0.01605581	8.86494e-08	1.541761e-14	0.5083739
MP:0005410	abnormal fertilization	101	9.715789e-50	0.0004252075	3.463901e-15	1.066181e-28	0.5839402
MP:0005411	delayed fertilization	5	0.0002767202	0.2183406	0.1171346	0.001064407	0.9293444
MP:0005412	vascular stenosis	30	1.41055e-32	3.846386e-33	8.390562e-06	1.814067e-26	0.663806
MP:0005413	vascular restenosis	2	0.5834768	0.009375164	7.876047e-06	7.678912e-07	0.07686817
MP:0005415	intrahepatic cholestasis	9	2.455013e-28	9.976968e-05	4.047742e-09	1.35326e-05	0.1735652
MP:0005416	abnormal circulating protein level	670	0	9.499305e-155	1.250815e-262	0	3.200219e-18
MP:0005418	abnormal circulating hormone level	725	0	2.88316e-254	3.583404e-226	0	1.551709e-13
MP:0005419	decreased circulating serum albumin level	46	2.182931e-122	5.197518e-07	7.338169e-22	1.527498e-41	0.002619025
MP:0005421	loose skin	18	1.704402e-31	2.854458e-22	0.9547716	0.002378335	0.8822089
MP:0005422	osteosclerosis	11	1.683736e-05	1.449175e-12	1.752628e-09	2.234838e-20	0.01150764
MP:0005423	abnormal somatic nervous system physiology	65	2.97721e-95	2.51385e-11	3.890688e-11	1.314149e-24	0.1658171
MP:0005424	jerky movement	19	8.709151e-43	8.703623e-07	7.929797e-06	4.13127e-22	0.7334015
MP:0005425	increased macrophage cell number	152	1.853306e-202	3.450787e-68	1.000122e-96	2.98771e-181	0.002551643
MP:0005426	tachypnea	16	9.018707e-43	0.05266922	3.682819e-07	2.997387e-24	0.4289133
MP:0005430	absent fibula	11	0.923577	0.01379514	0.2544308	0.9598846	0.6644521
MP:0005431	decreased oocyte number	66	9.826006e-96	1.063275e-10	3.945553e-11	4.551639e-22	0.0070256
MP:0005432	abnormal pro-B cell morphology	102	1.690174e-285	2.770212e-12	7.266363e-58	3.469923e-191	0.01464213
MP:0005433	absent early pro-B cells	2	1.505904e-05	1	0.2404325	2.563683e-12	1
MP:0005434	absent late pro-B cells	4	0.01500803	0.8041631	0.0034877	2.836737e-10	1
MP:0005435	hemoperitoneum	22	3.37235e-32	1.213532e-13	1.793444e-07	5.012052e-21	0.009708483
MP:0005437	abnormal glycogen level	112	1.012806e-80	4.790351e-115	7.454224e-23	2.710638e-54	0.00606049
MP:0005438	abnormal glycogen homeostasis	126	9.573355e-94	1.368841e-108	7.037581e-35	9.065847e-68	0.004847645
MP:0005439	decreased glycogen level	61	6.20177e-26	6.660125e-71	9.864187e-13	4.832068e-30	0.00376798
MP:0005440	increased glycogen level	56	1.467174e-56	3.216e-51	5.904779e-13	1.58079e-27	0.2678797
MP:0005441	increased urine calcium level	26	0.01812099	2.294285e-20	3.074489e-08	6.026089e-05	0.7659254
MP:0005443	abnormal ethanol metabolism	2	0.7338173	1.736736e-16	0.9062954	0.4306615	0.2549831
MP:0005444	abnormal retinol metabolism	4	0.1114863	1.004437e-17	0.8124107	0.4951443	4.41583e-10
MP:0005445	abnormal neurotransmitter secretion	76	1.618996e-63	9.519949e-35	0.5326056	3.436669e-14	0.6166968
MP:0005447	abnormal synaptic norepinephrine release	5	1.510249e-13	0.1082692	0.0418732	0.004100135	0.2392821
MP:0005448	abnormal energy balance	217	0	3.408611e-56	3.731741e-71	1.488098e-149	0.1812625
MP:0005449	abnormal food intake	365	2.701064e-290	7.441676e-142	1.501804e-63	2.586371e-112	0.05503787
MP:0005450	abnormal energy expenditure	208	0	3.917345e-58	6.208619e-67	3.912277e-146	0.2385614
MP:0005451	abnormal body composition	12	1.906907e-14	3.675555e-06	1.087648e-08	4.114211e-09	0.3203448
MP:0005452	abnormal adipose tissue amount	527	0	2.169799e-207	4.261229e-163	2.362986e-276	6.208879e-06
MP:0005455	increased susceptibility to weight gain	99	6.078805e-50	2.607968e-22	2.325688e-07	7.841348e-25	0.006550971
MP:0005457	abnormal percent body fat	141	6.348604e-145	2.724968e-40	4.525438e-34	1.558429e-64	0.06050565
MP:0005458	increased percent body fat	57	1.394676e-16	1.955938e-14	1.824323e-08	8.279899e-11	0.1801665
MP:0005459	decreased percent body fat	87	1.652502e-179	3.215452e-35	1.2824e-35	1.26043e-73	0.2227529
MP:0005460	abnormal leukopoiesis	872	0	2.170008e-123	0	0	1.107533e-45
MP:0005461	abnormal dendritic cell morphology	105	2.744996e-207	1.076273e-49	9.413144e-121	3.922099e-158	1.855177e-07
MP:0005462	abnormal mast cell differentiation	5	2.263417e-15	0.3428354	1.091209e-14	7.251399e-05	0.2491456
MP:0005463	abnormal CD4-positive T cell physiology	170	1.2498e-254	5.390075e-47	1.097351e-178	2.927832e-291	8.228995e-07
MP:0005464	abnormal platelet physiology	109	2.299977e-236	3.245305e-08	9.50401e-88	2.766323e-216	0.0001543533
MP:0005465	abnormal T-helper 1 physiology	54	1.72038e-137	5.586366e-27	3.042287e-59	2.27213e-106	0.1199957
MP:0005466	abnormal T-helper 2 physiology	64	6.229135e-118	2.588217e-14	7.855655e-89	2.007226e-109	2.235876e-05
MP:0005468	abnormal thyroid hormone level	58	1.550961e-30	6.518495e-17	2.351966e-15	2.499324e-18	0.0008038168
MP:0005469	abnormal thyroxine level	51	8.669691e-26	8.850804e-14	4.769167e-16	7.479478e-15	0.001151724
MP:0005471	decreased thyroxine level	44	1.002251e-23	1.540102e-14	6.182062e-11	2.564057e-15	0.006652747
MP:0005472	abnormal triiodothyronine level	29	0.3029486	7.753205e-17	2.461926e-08	0.02952542	0.0002916793
MP:0005473	decreased triiodothyronine level	19	0.895027	4.842181e-10	0.0006714036	0.1412977	0.005277187
MP:0005474	increased triiodothyronine level	13	0.5097482	9.072162e-06	0.0002308385	0.04738673	0.001656169
MP:0005475	abnormal circulating thyroxine level	44	5.641214e-27	2.926728e-07	3.689767e-15	1.307188e-15	8.242434e-05
MP:0005476	abnormal circulating triiodothyronine level	24	0.4111528	4.377298e-16	6.240024e-09	0.019745	2.572963e-05
MP:0005477	increased circulating thyroxine level	8	0.1653755	0.3710627	2.312048e-08	0.04271876	0.01024326
MP:0005478	decreased circulating thyroxine level	38	2.042244e-26	8.163652e-08	7.931471e-10	1.420201e-16	0.0006584112
MP:0005479	decreased circulating triiodothyronine level	14	0.6631739	1.864634e-11	3.556214e-05	0.04593294	0.0004530946
MP:0005480	increased circulating triiodothyronine level	12	0.5720654	7.473574e-06	1.075421e-05	0.02710261	0.005091817
MP:0005481	chronic myelocytic leukemia	18	6.707416e-51	0.1082404	9.024294e-05	7.850346e-46	0.1589855
MP:0005488	bronchial epithelial hyperplasia	9	4.392379e-06	2.81588e-15	0.000214685	1.093817e-09	0.210887
MP:0005489	vascular smooth muscle cell hyperplasia	14	1.22738e-22	1.185242e-16	1.835806e-05	4.205515e-07	0.01750719
MP:0005490	increased Clara cell number	3	0.3137916	5.206176e-07	0.04186119	0.1796322	0.02283092
MP:0005491	pancreatic islet hyperplasia	39	8.982811e-86	6.186753e-29	1.236956e-17	6.138971e-24	0.2568302
MP:0005492	exocrine pancreas hypoplasia	5	0.9999775	2.993223e-16	0.5149666	0.2919377	0.02508206
MP:0005493	stomach epithelial hyperplasia	11	0.002224847	0.0003149773	0.5368224	0.009143728	0.8313616
MP:0005494	esophagogastric junction metaplasia	2	0.9999998	7.037444e-08	0.9610434	0.9967379	0.02120705
MP:0005497	optic nerve cupping	3	6.815193e-11	3.660051e-06	0.001198325	1.751661e-08	0.007533612
MP:0005498	hyporesponsive to tactile stimuli	47	6.889784e-65	2.875063e-09	4.968651e-13	3.340834e-13	0.08318072
MP:0005499	abnormal olfactory system morphology	66	1.881998e-13	2.704872e-25	0.001024574	9.317805e-22	0.05216199
MP:0005501	abnormal skin physiology	299	0	1.496663e-116	2.790075e-146	6.188439e-240	1.959756e-06
MP:0005502	abnormal renal/urinary system physiology	639	0	5.578425e-295	2.485039e-263	0	2.324094e-17
MP:0005503	abnormal tendon morphology	32	5.497549e-06	6.882082e-73	0.01064045	0.01040957	0.5376489
MP:0005504	abnormal ligament morphology	39	0.0002328235	3.214289e-30	0.01125764	0.1641963	0.3361024
MP:0005505	increased platelet cell number	59	4.204828e-119	1.263351e-14	8.800668e-32	1.746227e-62	0.002487316
MP:0005507	tail dragging	6	2.011947e-09	1.281098e-14	5.156392e-08	0.004344481	0.004278137
MP:0005508	abnormal skeleton morphology	1368	0	0	0	0	1.21214e-11
MP:0005515	uveitis	3	6.917188e-07	0.1507095	0.06899489	0.0001744059	1
MP:0005517	decreased liver regeneration	24	4.368482e-42	3.074947e-21	5.115041e-07	6.873326e-15	0.4896744
MP:0005518	abnormal pancreas regeneration	2	0.3297632	0.579312	0.5392481	0.839726	0.5248096
MP:0005520	decreased pancreas regeneration	1	1	0.487912	1	1	0.4268201
MP:0005521	abnormal circulating atrial natriuretic factor level	7	6.219247e-16	2.215014e-06	0.04681944	6.564848e-06	0.9646646
MP:0005522	increased circulating atrial natriuretic factor	6	2.413458e-23	3.546099e-08	0.01560797	3.948032e-07	0.8829416
MP:0005523	decreased circulating atrial natriuretic factor	1	0.9996953	0.7264086	0.770847	0.6062543	1
MP:0005524	abnormal renal plasma flow rate	9	0.002161002	2.316465e-15	0.002598002	0.2326765	0.5118394
MP:0005525	increased renal plasma flow rate	4	1.491215e-07	0.003462901	0.1057984	0.1459432	0.03095031
MP:0005526	decreased renal plasma flow rate	5	0.9849569	1.883425e-06	0.6452813	0.4045397	0.7921362
MP:0005527	increased renal glomerular filtration rate	7	1.989708e-15	0.1449045	6.552466e-06	0.001782841	0.04397777
MP:0005528	decreased renal glomerular filtration rate	18	3.167333e-11	6.022651e-08	0.001600439	4.995787e-13	0.004905075
MP:0005529	abnormal renal vascular resistance	7	0.4142238	0.4908054	0.02518963	0.02410539	0.05427855
MP:0005530	decreased renal vascular resistance	2	0.3885441	0.9820946	0.08061746	0.1737688	0.02328605
MP:0005531	increased renal vascular resistance	4	0.2053421	0.1793762	0.4168886	0.3392145	0.5445261
MP:0005532	abnormal vascular resistance	18	9.30236e-18	0.0003400086	2.054466e-09	1.447496e-07	0.02811974
MP:0005533	increased body temperature	33	1.26596e-104	2.487142e-15	2.877753e-31	4.42108e-78	0.9513256
MP:0005534	decreased body temperature	86	2.025617e-81	5.228088e-27	4.457064e-21	4.843717e-49	0.03677057
MP:0005535	abnormal body temperature	117	2.316052e-165	8.245249e-33	2.981953e-43	4.850383e-106	0.2539883
MP:0005536	Leydig cell hypoplasia	26	1.749781e-12	2.396505e-17	0.002903486	6.821793e-06	0.03090157
MP:0005537	abnormal cerebral aqueduct morphology	19	4.180623e-20	3.541992e-08	0.04112969	4.181011e-09	0.988105
MP:0005540	decreased urine albumin level	2	0.001426784	0.16717	0.1496372	0.5333269	0.1069603
MP:0005541	abnormal iris stromal pigmentation	1	0.9794862	0.00437481	0.02326111	3.121819e-05	0.02789339
MP:0005542	corneal vascularization	34	2.406808e-32	1.271634e-25	3.097058e-23	1.07979e-42	0.02541976
MP:0005543	decreased cornea thickness	18	0.002596453	1.607883e-30	1.845662e-05	0.0001238731	0.4914838
MP:0005544	corneal deposits	5	3.542284e-30	5.635321e-08	1.800223e-08	1.066149e-09	0.9911305
MP:0005545	abnormal lens development	69	2.332547e-65	6.516557e-70	1.150844e-24	1.33284e-31	0.001911817
MP:0005546	choroidal neovascularization	17	3.146097e-20	1.180501e-05	4.823611e-11	3.128449e-33	0.7690658
MP:0005547	abnormal Muller cell morphology	18	7.534644e-12	0.0001627352	0.1935691	0.0002500298	0.24247
MP:0005548	retinal pigment epithelium atrophy	10	0.002456993	1.035746e-27	6.331303e-06	0.2316605	0.6082264
MP:0005549	retinal pigment epithelium hyperplasia	10	7.483366e-08	5.823527e-13	4.268915e-05	1.128219e-06	0.4903331
MP:0005551	abnormal eye electrophysiology	190	7.392116e-103	3.523573e-53	1.18361e-22	1.353248e-38	1.795931e-05
MP:0005553	increased circulating creatinine level	70	8.406539e-95	7.39366e-34	2.909311e-35	1.72805e-51	0.001226727
MP:0005554	decreased circulating creatinine level	33	3.611493e-49	3.129009e-09	7.947613e-33	1.436679e-43	0.009377234
MP:0005556	abnormal kidney clearance	35	1.53155e-38	3.244956e-16	3.066255e-11	4.426973e-22	0.002564528
MP:0005557	increased creatinine clearance	3	0.09482908	0.001138951	0.08209161	0.6142457	0.6005887
MP:0005558	decreased creatinine clearance	25	6.818043e-21	4.289832e-09	6.114299e-06	2.400241e-18	0.009050109
MP:0005559	increased circulating glucose level	246	7.930286e-278	1.496393e-69	1.529461e-90	4.505766e-142	0.0001515975
MP:0005560	decreased circulating glucose level	284	1.009994e-307	3.208771e-153	2.120163e-112	1.684259e-164	1.720969e-05
MP:0005561	increased mean corpuscular hemoglobin	17	2.594671e-44	3.520372e-08	1.880502e-14	5.375809e-34	0.6939649
MP:0005562	decreased mean corpuscular hemoglobin	49	4.296155e-170	0.04233622	2.198185e-16	3.896222e-96	0.8751774
MP:0005563	abnormal hemoglobin content	205	0	8.328153e-50	9.759119e-83	2.82291e-297	0.427937
MP:0005564	increased hemoglobin content	35	1.666031e-53	8.265277e-22	5.51582e-29	5.551709e-31	0.6467409
MP:0005565	increased blood urea nitrogen level	135	1.09355e-69	1.777358e-73	4.066313e-54	5.074857e-53	0.001039021
MP:0005566	decreased blood urea nitrogen level	23	1.907633e-52	4.705294e-09	2.26453e-28	2.631062e-25	0.2351157
MP:0005567	decreased circulating total protein level	33	4.290131e-112	9.822819e-07	1.265981e-15	6.004772e-32	0.1065961
MP:0005568	increased circulating total protein level	8	0.4587697	0.007581884	0.4753489	0.6557034	0.08465451
MP:0005571	decreased lactate dehydrogenase level	11	0.003951966	0.0005633424	4.866462e-05	3.782194e-11	0.01030697
MP:0005572	abnormal pulmonary respiratory rate	52	2.773562e-32	0.000306928	0.0001237709	2.796937e-20	0.8290245
MP:0005573	increased pulmonary respiratory rate	31	6.350929e-37	0.00122642	0.007263192	1.442464e-21	0.7315927
MP:0005574	decreased pulmonary respiratory rate	18	0.002757532	0.2274805	0.0004884001	0.0006032255	0.3934775
MP:0005575	increased pulmonary ventilation	7	2.116943e-08	0.2856886	0.9996846	0.3574627	0.5913083
MP:0005576	decreased pulmonary ventilation	13	0.1381779	2.91245e-07	0.8099021	0.002824428	0.8486637
MP:0005577	uterus prolapse	2	1.469842e-06	0.0002134896	0.2663777	0.004893776	0.9180321
MP:0005578	teratozoospermia	156	6.154276e-132	1.712576e-08	5.180151e-13	3.166781e-38	0.08523146
MP:0005579	absent outer ear	16	0.000412772	2.753836e-28	0.0003504683	0.0006196181	0.1173677
MP:0005580	periinsulitis	5	0.001027169	3.119086e-05	3.402586e-07	9.450288e-05	0.130252
MP:0005581	abnormal renin activity	22	9.107903e-17	0.002327621	1.153947e-15	7.850629e-11	8.996443e-06
MP:0005582	increased renin activity	14	4.646862e-19	3.064322e-05	3.7539e-13	1.286576e-08	0.0007254336
MP:0005583	decreased renin activity	5	0.8834043	0.08821478	6.039156e-08	0.004082603	0.05937802
MP:0005584	abnormal enzyme/coenzyme activity	195	1.082103e-179	8.118339e-76	1.421035e-59	5.666184e-115	4.649992e-13
MP:0005585	increased tidal volume	7	2.723798e-07	0.1371579	0.9955828	0.3777145	0.5382755
MP:0005586	decreased tidal volume	7	9.27088e-15	1.17913e-06	0.007167192	3.14313e-08	0.7837631
MP:0005587	abnormal Meckel's cartilage morphology	45	1.175534e-08	1.230091e-73	0.005811042	6.066702e-11	0.7938831
MP:0005590	increased vasodilation	23	2.510489e-37	5.518839e-11	1.220073e-05	1.863018e-09	0.06349271
MP:0005591	decreased vasodilation	27	4.218627e-05	3.655728e-07	1.239573e-20	8.519191e-23	2.488828e-06
MP:0005592	abnormal vascular smooth muscle morphology	97	8.186131e-77	9.610792e-75	2.136863e-42	1.159021e-105	0.01932621
MP:0005595	abnormal vascular smooth muscle physiology	128	1.455604e-115	5.076333e-71	5.723561e-63	1.075562e-85	0.181851
MP:0005596	increased susceptibility to type I hypersensitivity reaction	28	1.107838e-32	3.902276e-07	2.336967e-34	3.915212e-33	0.02497389
MP:0005597	decreased susceptibility to type I hypersensitivity reaction	32	2.316432e-49	0.9601667	2.102441e-42	1.991019e-54	2.76428e-06
MP:0005598	decreased ventricle muscle contractility	96	1.931151e-98	1.335166e-79	1.674874e-15	1.188041e-55	0.0004792011
MP:0005599	increased cardiac muscle contractility	37	2.959651e-25	1.396178e-18	1.166096e-12	7.812104e-27	0.5849068
MP:0005600	increased ventricle muscle contractility	11	3.12647e-11	1.136924e-08	0.0001270616	7.007369e-13	0.6088616
MP:0005601	increased angiogenesis	26	6.915331e-15	1.873385e-32	9.417721e-16	1.841691e-22	0.6523935
MP:0005602	decreased angiogenesis	88	1.481038e-85	7.41071e-51	2.758613e-47	1.728165e-88	0.02525303
MP:0005603	neuron hypertrophy	5	4.568227e-16	0.02995499	5.441836e-07	2.989402e-07	0.6980028
MP:0005604	hyperekplexia	5	0.9991902	0.05348087	0.4280024	0.8402637	0.006357574
MP:0005605	increased bone mass	83	1.540437e-66	1.069452e-40	2.067641e-73	4.564852e-66	0.0004346126
MP:0005606	increased bleeding time	76	4.476126e-92	3.273916e-09	3.073712e-45	1.854189e-73	0.001040692
MP:0005607	decreased bleeding time	12	3.417811e-25	0.00126593	0.002568914	4.328815e-13	0.1445919
MP:0005608	cardiac interstitial fibrosis	56	2.046293e-46	5.900179e-17	1.973147e-10	2.670878e-24	0.262061
MP:0005609	abnormal circulating antidiuretic hormone level	9	5.952468e-24	9.107514e-10	2.250317e-10	4.454888e-10	0.001079294
MP:0005610	increased circulating antidiuretic hormone level	5	1.552428e-16	4.436851e-06	8.189081e-07	1.972571e-06	0.0003196863
MP:0005611	decreased circulating antidiuretic hormone level	2	1.922652e-12	0.004347409	0.001193111	0.0005791063	0.2824011
MP:0005612	decreased susceptibility to type II hypersensitivity reaction	2	0.00264718	0.001884652	0.7975357	4.329352e-06	0.346802
MP:0005614	decreased susceptibility to type III hypersensitivity reaction	4	0.3308723	1.906771e-05	0.09696414	1.602924e-08	0.6506597
MP:0005615	increased susceptibility to type III hypersensitivity reaction	2	0.9999959	0.8404427	0.8350909	0.9054511	0.9101486
MP:0005616	decreased susceptibility to type IV hypersensitivity reaction	59	9.919364e-57	5.095193e-14	2.752074e-68	1.675513e-82	0.0001454715
MP:0005617	increased susceptibility to type IV hypersensitivity reaction	27	2.807238e-11	0.009121674	3.443851e-25	7.585515e-28	0.0137473
MP:0005618	decreased urine potassium level	16	0.7271754	3.410641e-11	0.0007360789	0.0001264158	0.001540142
MP:0005619	increased urine potassium level	18	4.290102e-18	2.422381e-25	5.243511e-07	1.030997e-06	0.01507792
MP:0005620	abnormal muscle contractility	342	6.29637699999988e-311	3.26719e-237	6.974633e-90	5.899864e-164	0.004769942
MP:0005621	abnormal cell physiology	3003	0	0	0	0	1.197375e-57
MP:0005623	abnormal meninges morphology	24	9.432575e-18	2.420332e-37	8.43661e-16	2.985018e-25	0.5639437
MP:0005626	decreased plasma anion gap	1	0.4844345	2.613672e-11	0.001040567	0.004004114	0.08911155
MP:0005627	increased circulating potassium level	22	0.0004771692	4.008876e-08	0.0002708879	4.31563e-06	0.04449231
MP:0005628	decreased circulating potassium level	23	6.731046e-24	3.132066e-28	0.3245357	4.265245e-10	0.03348405
MP:0005629	abnormal lung weight	60	2.848884e-33	8.978867e-85	1.129697e-28	3.488148e-40	0.2592175
MP:0005630	increased lung weight	30	7.316602e-23	4.674196e-28	5.732933e-27	2.699115e-18	0.02715712
MP:0005631	decreased lung weight	24	6.539816e-14	1.196237e-31	1.960608e-08	1.951713e-25	0.8631308
MP:0005632	decreased circulating aspartate transaminase level	18	6.501303e-59	6.778877e-22	8.662552e-05	6.52712e-19	0.4980268
MP:0005633	increased circulating sodium level	19	1.753267e-39	0.01985551	0.00502842	2.408483e-08	0.3244843
MP:0005634	decreased circulating sodium level	27	7.670148e-14	2.70862e-13	1.348035e-06	2.396262e-06	0.09897846
MP:0005635	decreased circulating bilirubin level	3	2.67932e-05	0.001734565	0.0002871183	0.002688298	0.5357357
MP:0005636	abnormal mineral homeostasis	284	0	1.59022e-73	2.194875e-98	2.310291e-202	0.0140874
MP:0005637	abnormal iron homeostasis	92	3.242295e-266	4.374372e-08	1.85696e-34	2.139008e-109	0.9363812
MP:0005638	hemochromatosis	6	1.203478e-12	0.02451797	0.0194917	1.21247e-07	0.6497525
MP:0005639	hemosiderosis	14	1.541017e-44	0.3224422	1.137161e-08	3.481021e-27	0.05957444
MP:0005640	abnormal mean corpuscular hemoglobin concentration	55	9.293506e-189	6.115497e-11	2.231282e-21	1.832896e-68	0.3248556
MP:0005641	increased mean corpuscular hemoglobin concentration	22	5.872493e-91	6.916999e-07	1.330471e-09	1.589284e-16	0.1584167
MP:0005642	decreased mean corpuscular hemoglobin concentration	34	5.65438e-92	2.054296e-08	9.002323e-12	2.308663e-51	0.5327976
MP:0005643	decreased dopamine level	45	3.544991e-14	0.09110857	0.2162658	1.13645e-07	0.674073
MP:0005644	agonadal	9	0.230717	0.006162602	0.5561847	0.0878141	0.2966504
MP:0005645	abnormal hypothalamus physiology	22	8.357333e-22	1.518173e-13	0.01152998	0.003990961	0.8621447
MP:0005646	abnormal pituitary gland physiology	23	1.417358e-09	0.09069426	5.962687e-05	0.01423822	0.09155033
MP:0005647	abnormal sex gland physiology	69	3.620758e-94	7.972171e-14	2.213091e-14	1.423184e-26	0.07779805
MP:0005648	heart right ventricle degeneration	1	9.239027e-05	0.4064491	0.4922175	6.001268e-06	1
MP:0005649	spleen neoplasm	2	0.008694706	0.7276569	0.3756033	2.616088e-05	0.3650909
MP:0005650	abnormal limb bud morphology	94	2.565369e-20	8.620841e-96	7.971897e-09	7.956529e-15	0.03581898
MP:0005651	abnormal gonad rudiment morphology	2	1.053608e-05	6.405133e-09	0.4523499	0.392521	0.02585734
MP:0005652	sex reversal	30	1.064082e-40	1.704636e-23	2.565788e-05	1.941515e-09	0.5154559
MP:0005653	phototoxicity	2	3.917651e-07	0.472697	0.8464932	0.4045951	0.7043807
MP:0005654	porphyria	4	1.690841e-11	0.001961256	0.9975564	0.05249646	0.9663522
MP:0005655	increased aggression	41	7.934321e-14	0.0002546505	0.01889268	0.00392401	0.3674713
MP:0005656	decreased aggression	43	1.366735e-06	1.677787e-08	0.1173426	0.04300322	0.7319902
MP:0005657	abnormal neural plate morphology	37	1.264418e-64	7.240622e-39	1.715023e-13	1.770036e-50	0.4095675
MP:0005658	increased susceptibility to diet-induced obesity	45	2.194797e-13	1.954896e-09	0.00546229	3.190096e-12	0.08430422
MP:0005659	decreased susceptibility to diet-induced obesity	100	1.731291e-280	4.503304e-58	5.085339e-69	1.763746e-126	0.4661729
MP:0005660	abnormal circulating adrenaline level	19	3.90884e-07	1.993544e-07	6.937949e-11	3.234185e-13	0.1285798
MP:0005661	decreased circulating adrenaline level	10	0.9818865	8.584326e-05	0.001548722	5.885962e-06	0.6004466
MP:0005662	increased circulating adrenaline level	7	6.980636e-15	0.0006292116	2.092768e-06	1.947348e-10	0.01327507
MP:0005663	abnormal circulating noradrenaline level	22	4.653216e-19	3.771809e-18	1.079495e-08	3.81908e-17	0.05822458
MP:0005664	decreased circulating noradrenaline level	9	8.377166e-05	5.2162e-14	3.851396e-10	2.7399e-07	0.03426929
MP:0005665	increased circulating noradrenaline level	9	3.878637e-16	1.618629e-09	0.008808328	8.233832e-06	0.08209427
MP:0005666	abnormal adipose tissue physiology	73	3.816244e-101	2.050899e-28	5.637897e-47	1.019592e-95	0.02872623
MP:0005667	abnormal circulating leptin level	196	1.598737e-234	1.349303e-45	6.620939e-77	8.453494e-136	0.0724146
MP:0005668	decreased circulating leptin level	95	3.100788e-198	1.409331e-21	1.246808e-47	4.08404e-120	0.4567591
MP:0005669	increased circulating leptin level	110	9.469924e-71	1.678725e-35	3.820316e-37	7.545765e-42	0.03583534
MP:0005670	abnormal white adipose tissue physiology	16	3.500163e-62	3.951949e-18	1.045829e-19	3.98677e-29	0.5604535
MP:0005671	abnormal response to transplant	66	1.190161e-33	7.926182e-17	1.544259e-65	2.930668e-80	1.104087e-09
MP:0005672	increased susceptibility to graft versus host disease	2	0.8622434	0.9591744	0.001250414	7.585927e-10	0.0009273974
MP:0005673	decreased susceptibility to graft versus host disease	5	0.0005058832	2.590821e-05	1.179147e-11	0.0003562392	0.08320254
MP:0005675	small gallbladder	1	0.0366095	0.2143463	0.2387744	0.8159662	1
MP:0006000	abnormal corneal epithelium morphology	41	2.929949e-34	3.425177e-44	3.63453e-13	7.727604e-13	0.05416253
MP:0006001	abnormal intestinal transit time	16	5.704661e-14	0.06321813	0.02071508	0.002083372	0.1834371
MP:0006002	abnormal small intestinal transit time	3	2.358361e-06	0.003680192	0.2022418	0.08707786	0.4952542
MP:0006003	abnormal large intestinal transit time	4	0.0003439169	0.9871634	0.9999677	0.9936593	0.2935907
MP:0006006	increased sensory neuron number	56	3.533651e-34	4.751952e-39	2.758046e-28	5.884771e-48	0.002231211
MP:0006007	abnormal basal ganglion morphology	114	1.554838e-52	2.86969e-21	9.401815e-09	1.146465e-29	0.02698987
MP:0006009	abnormal neuronal migration	124	5.037808e-76	1.467527e-91	7.667567e-29	4.006857e-34	0.01331807
MP:0006010	absent strial intermediate cells	3	0.04426414	0.04842657	2.568814e-09	0.004192414	0.002076881
MP:0006011	abnormal endolymphatic duct morphology	32	0.04488063	1.293113e-34	0.006673	0.0005939372	0.1665428
MP:0006012	dilated endolymphatic duct	10	0.07314397	1.762235e-13	0.9005771	0.1506012	0.1375265
MP:0006013	absent endolymphatic sac	2	5.933276e-23	0.0074805	0.008510937	0.01811695	1
MP:0006014	dilated endolymphatic sac	5	0.9669499	6.05472e-06	0.0136634	0.5846592	0.005411931
MP:0006015	dilated lateral semicircular canal	1	0.9930732	0.5187106	0.3832671	0.4587774	6.334363e-05
MP:0006016	dilated posterior semicircular canal	1	0.9930732	0.5187106	0.3832671	0.4587774	6.334363e-05
MP:0006018	abnormal tympanic membrane morphology	9	0.9961214	1.575756e-09	0.01608119	0.001114341	0.14967
MP:0006019	absent tympanic membrane	2	0.9455226	6.001265e-05	0.3133026	0.2079411	0.02801569
MP:0006020	decreased tympanic ring size	21	0.9535754	2.862834e-18	0.02545266	9.762629e-06	0.2668965
MP:0006021	abnormal Reissner membrane morphology	13	3.58198e-07	0.0005591712	0.04784383	0.005031697	0.09605332
MP:0006023	detached Reissner membrane	2	0.9680567	0.3968981	0.8639222	0.8752678	1
MP:0006024	collapsed Reissner membrane	7	7.954959e-07	7.089455e-05	0.007670627	0.001898381	0.1944767
MP:0006025	distended Reissner membrane	4	0.9999942	0.556193	0.7691924	0.9615003	0.08943822
MP:0006026	dilated terminal bronchiole tubes	4	0.07904383	4.138804e-26	1.802969e-08	0.002778943	0.300016
MP:0006027	impaired lung alveolus development	42	3.436028e-39	4.263203e-71	1.221158e-23	1.294368e-28	0.668263
MP:0006029	abnormal sclerotome morphology	24	2.260504e-42	1.112415e-20	0.1495388	1.808099e-12	0.6578305
MP:0006030	abnormal otic vesicle development	28	1.320451e-12	1.453416e-23	0.0003840131	7.12361e-09	0.508227
MP:0006031	abnormal branchial pouch morphology	18	0.009238376	5.523989e-14	0.2200119	2.625073e-06	0.1939014
MP:0006032	abnormal ureteric bud morphology	70	1.267358e-22	7.129028e-84	7.019963e-11	6.695307e-22	0.01958639
MP:0006033	abnormal external auditory canal morphology	16	9.868529e-09	1.445475e-18	3.352148e-08	6.209323e-14	0.2725692
MP:0006035	abnormal mitochondrion morphology	111	2.093817e-146	1.183124e-30	3.456875e-22	4.266099e-82	0.01031276
MP:0006036	abnormal mitochondrial physiology	122	2.411416e-126	7.863564e-16	5.225501e-21	9.205599e-55	0.09484722
MP:0006037	abnormal mitochondrial proliferation	14	2.911444e-09	0.0123143	0.005728127	2.037341e-07	0.7120841
MP:0006038	increased mitochondrial proliferation	10	3.089481e-09	0.003492486	0.004062167	1.830016e-05	0.760573
MP:0006039	decreased mitochondrial proliferation	4	0.1122617	0.7239246	0.4434618	0.001492638	0.5372301
MP:0006042	increased apoptosis	717	0	3.81696e-223	3.137818e-194	0	9.051012e-07
MP:0006043	decreased apoptosis	238	0	8.713728e-54	6.628065e-128	2.300729e-283	8.069029e-07
MP:0006044	tricuspid valve regurgitation	1	0.283985	0.9951921	0.9351501	0.2341714	1
MP:0006045	mitral valve regurgitation	4	0.0971346	0.001845373	0.3672924	0.07928916	0.007529964
MP:0006046	atrioventricular valve regurgitation	8	0.5140443	7.008355e-12	0.04060381	0.02174644	0.1044003
MP:0006047	aortic valve regurgitation	6	0.0001069087	8.956168e-24	0.06933426	0.255949	0.990623
MP:0006048	pulmonary valve regurgitation	2	0.9999987	5.887861e-18	1	0.9967379	1
MP:0006049	semilunar valve regurgitation	11	0.6493346	1.960409e-27	0.07657683	0.169126	0.1972885
MP:0006050	pulmonary fibrosis	38	1.686155e-36	5.463026e-24	1.3777e-21	1.919629e-49	0.0551881
MP:0006051	brainstem hemorrhage	3	2.977593e-07	0.7690667	0.006449739	0.0001829013	0.02976054
MP:0006052	cerebellum hemorrhage	4	1.020629e-11	0.9400175	1.86734e-05	8.527961e-08	0.1015661
MP:0006054	spinal hemorrhage	21	3.624178e-80	5.316326e-14	1.467217e-12	1.709909e-33	0.02561928
MP:0006055	abnormal vascular endothelial cell morphology	69	3.41874e-99	8.981619e-48	3.172749e-37	1.750347e-95	0.01608779
MP:0006056	increased vascular endothelial cell number	13	1.856064e-14	4.315193e-14	7.848104e-07	4.111621e-26	0.4934281
MP:0006057	decreased vascular endothelial cell number	10	5.437066e-35	6.927774e-05	1.441633e-14	1.275235e-09	0.01920866
MP:0006058	decreased cerebral infarction size	32	2.177302e-48	1.602429e-11	1.461956e-30	6.695185e-19	0.07559163
MP:0006059	decreased susceptibility to ischemic brain injury	41	2.693317e-55	3.491278e-11	2.253713e-28	6.44448e-25	0.1138371
MP:0006060	increased cerebral infarction size	27	1.764433e-20	1.412001e-12	8.075728e-20	1.17697e-31	0.767381
MP:0006061	right atrial isomerism	8	0.0009978424	0.8798353	5.244917e-05	0.02605402	0.578791
MP:0006062	abnormal vena cava morphology	24	0.0004546295	0.1703185	3.059601e-06	8.426243e-07	0.3109717
MP:0006063	abnormal inferior vena cava morphology	16	7.078258e-06	0.584538	2.968624e-10	5.294415e-07	0.5330516
MP:0006064	abnormal superior vena cava morphology	4	0.9594673	0.167978	0.8211681	0.2127865	0.6267176
MP:0006065	abnormal heart position or orientation	43	1.011806e-09	2.032429e-06	0.000948494	1.18645e-06	0.03243489
MP:0006066	decreased clearance of atrial thrombosis	2	0.6381622	0.003294834	0.9766316	0.6772204	1
MP:0006068	abnormal horizontal cell morphology	21	0.00443596	1.810833e-13	8.74516e-06	0.0007349695	0.002670445
MP:0006069	abnormal retinal neuronal layer morphology	293	1.452505e-207	2.437314e-131	9.921468e-69	3.977124e-111	0.0001362884
MP:0006070	increased retinal photoreceptor cell number	5	1.405798e-22	5.776893e-11	0.2425095	0.001179866	0.4929224
MP:0006071	abnormal retinal progenitor cell morphology	10	5.109382e-19	1.001388e-08	0.003538488	1.646033e-05	0.7149409
MP:0006072	abnormal retinal apoptosis	48	1.944893e-33	1.086922e-14	2.519324e-05	2.531927e-25	0.009999288
MP:0006073	abnormal retinal bipolar cell morphology	43	6.199821e-07	2.241894e-21	0.0006306524	0.0003387047	0.3441283
MP:0006074	abnormal retinal rod bipolar cell morphology	19	0.3186765	1.801341e-06	0.175966	0.2269356	0.2588417
MP:0006075	abnormal retinal cone bipolar cell morphology	5	0.9750227	0.8447755	0.459704	0.5420597	0.4668827
MP:0006076	abnormal circulating homocysteine level	9	1.078291e-12	5.21586e-12	0.2708234	0.0007108909	0.912188
MP:0006077	inguinal hernia	1	1	0.3150907	0.9128654	0.999381	1
MP:0006078	abnormal nipple morphology	11	0.01648414	0.002931121	0.3836429	0.0007091733	0.3147512
MP:0006080	CNS ischemia	6	1.176162e-10	9.106126e-05	0.0001476185	6.426996e-13	0.7879272
MP:0006082	CNS inflammation	41	3.01772e-57	0.03338065	1.629791e-27	8.327544e-57	1.56487e-05
MP:0006083	abnormal blood vessel elastic tissue morphology	26	2.462612e-11	1.786113e-23	1.4392e-07	9.65653e-12	0.8017259
MP:0006084	abnormal circulating phospholipid level	17	9.091918e-19	1.93895e-18	1.714011e-22	2.1047e-24	0.009353411
MP:0006085	myocardial necrosis	28	5.600727e-31	7.025219e-21	0.0002237488	6.199924e-24	0.1080616
MP:0006086	decreased body mass index	17	2.077577e-40	1.260749e-05	1.847137e-10	1.108725e-12	0.4515896
MP:0006087	increased body mass index	12	3.276628e-45	2.770019e-05	9.491554e-15	2.866582e-18	0.4123878
MP:0006088	abnormal blood-cerebrospinal fluid barrier function	2	7.026415e-06	0.0003097479	1.275511e-10	1.194329e-11	0.2161857
MP:0006089	abnormal vestibular saccule morphology	52	1.13614e-11	1.379711e-25	9.977217e-08	1.351558e-12	0.02382271
MP:0006090	abnormal utricle morphology	48	4.49196e-18	4.525729e-31	1.017891e-05	1.056678e-12	0.3376259
MP:0006092	abnormal olfactory sensory neuron morphology	34	4.755655e-05	1.025418e-06	0.5088246	1.679947e-07	0.1195482
MP:0006093	arteriovenous malformation	7	2.041131e-05	2.682821e-15	0.0002151172	3.087869e-10	0.3531732
MP:0006094	increased fat cell size	57	1.168425e-78	1.149241e-36	1.565552e-29	1.447823e-45	0.5919112
MP:0006095	absent amacrine cells	4	0.238508	0.09463474	0.002321257	0.001219897	0.3655253
MP:0006096	absent retinal bipolar cells	4	0.003357795	0.04541025	0.0154439	8.097894e-05	0.08350464
MP:0006097	abnormal cerebellar lobule formation	18	0.3273594	0.003400142	0.8625757	0.2117409	0.8758588
MP:0006098	absent cerebellar lobules	6	0.6078798	0.1684753	0.9877589	0.6178911	0.9816363
MP:0006099	thin cerebellar granule layer	13	1.170005e-08	1.633852e-10	0.1773178	0.001118348	0.3732739
MP:0006100	abnormal tegmentum morphology	8	1.324194e-10	0.9977794	0.001453934	4.373771e-05	0.9952842
MP:0006101	absent tegmentum	3	0.9983061	0.3147315	0.671862	0.4571326	0.9601571
MP:0006102	decreased tegmentum size	1	1.482291e-19	1	1.548381e-06	2.291223e-10	1
MP:0006104	abnormal tectum morphology	40	7.780223e-36	7.239517e-45	1.585514e-08	1.885535e-12	0.8346128
MP:0006105	small tectum	8	3.310092e-11	1.588974e-13	0.0404724	0.0001581132	0.9985788
MP:0006106	absent tectum	6	0.9443601	2.399696e-07	0.4391687	0.5022644	0.9845222
MP:0006107	abnormal fetal atrioventricular canal morphology	84	2.705854e-81	2.324144e-62	1.286612e-38	5.88863e-50	0.2224236
MP:0006108	abnormal hindbrain development	185	3.648074e-70	7.540887e-177	3.888878e-27	1.31447e-51	0.2041824
MP:0006109	fibrillation	9	0.005668619	3.041068e-12	0.03576024	0.05857147	0.03524431
MP:0006110	ventricular fibrillation	5	0.2231619	5.443801e-12	0.0004010087	0.1550639	0.09538265
MP:0006111	abnormal coronary circulation	14	6.738232e-05	7.230779e-18	0.001601176	3.759975e-08	0.6699013
MP:0006113	abnormal heart septum morphology	310	0	1.10468e-224	2.661884e-76	9.68023e-169	0.07147275
MP:0006116	calcified aortic valve	5	0.9232958	3.067231e-28	0.0002993943	0.2274901	0.7214939
MP:0006117	aortic valve stenosis	14	7.321873e-11	2.975675e-21	2.096914e-07	4.374103e-09	0.3159125
MP:0006119	mitral valve atresia	1	2.426927e-21	4.892357e-05	5.900599e-06	0.01927655	1
MP:0006120	mitral valve prolapse	3	6.710757e-06	0.003768339	0.00140649	0.05294578	0.4489378
MP:0006121	calcified mitral valve	2	0.9973716	1.869882e-20	1	0.9967379	1
MP:0006122	mitral valve stenosis	2	2.13259e-10	2.58335e-09	4.164232e-05	0.1125639	0.4295862
MP:0006123	tricuspid valve atresia	7	9.880473e-15	0.7659182	0.08716537	7.174948e-06	0.9993077
MP:0006124	tricuspid valve stenosis	2	0.000337964	0.865814	0.3235002	0.01333477	0.8528306
MP:0006126	abnormal outflow tract development	127	3.069455e-98	7.079363e-133	5.927743e-37	2.263984e-69	0.2907136
MP:0006128	pulmonary valve stenosis	13	0.01489447	5.469584e-24	0.01650846	1.225303e-07	0.8988475
MP:0006130	pulmonary valve atresia	4	8.925039e-10	0.3069334	0.7102247	0.003576961	0.7882619
MP:0006133	calcified artery	13	0.2127205	1.19346e-14	2.198042e-09	0.00421916	0.004368851
MP:0006134	artery occlusion	4	1.960243e-50	0.238273	4.177225e-05	4.069907e-06	0.6954136
MP:0006135	artery stenosis	25	4.362133e-34	2.731001e-28	0.001939495	5.970314e-13	0.9231279
MP:0006137	venoocclusion	4	0.8157213	0.1429715	0.9843099	0.8732476	0.5046803
MP:0006138	congestive heart failure	87	3.595205e-110	5.438877e-94	1.091701e-26	2.939476e-47	0.5578257
MP:0006141	abnormal atrioventricular node conduction	48	1.961024e-56	2.436669e-31	1.270549e-15	1.234938e-19	0.1384826
MP:0006142	abnormal sinoatrial node conduction	33	1.159044e-38	5.546256e-23	0.0006604323	4.466327e-16	0.002769704
MP:0006143	increased systemic arterial diastolic blood pressure	37	6.966413e-36	2.082574e-08	0.1272764	1.130191e-15	0.07932759
MP:0006144	increased systemic arterial systolic blood pressure	71	3.336331e-46	2.461351e-37	3.795138e-14	1.648685e-28	0.04212705
MP:0006149	decreased visual acuity	2	2.844769e-06	0.7142579	0.09788319	0.4476311	0.6302052
MP:0006156	abnormal visual pursuit	2	0.1507942	0.6114653	0.8696867	0.07248986	0.8688789
MP:0006159	ocular albinism	5	0.9999421	0.4139824	0.6973123	0.2260285	0.2566023
MP:0006162	thick eyelids	1	1	1	1	0.009515328	1
MP:0006164	ectropion	1	0.9621678	0.003530956	0.3856569	0.06617561	0.726318
MP:0006165	entropion	1	0.9712669	5.117882e-16	1	0.9709588	0.4721274
MP:0006167	eyelid edema	4	0.002817766	0.06760801	2.077912e-05	1.241824e-09	0.9675004
MP:0006173	abnormal myeloid dendritic cell morphology	33	2.534921e-71	4.705365e-27	1.242072e-58	1.353727e-46	0.5972809
MP:0006185	retinal hemorrhage	5	0.03342926	2.199234e-17	5.407238e-08	0.00133783	0.080547
MP:0006186	retinal fibrosis	1	0.002328637	4.828191e-05	0.3393116	1.248626e-10	0.3411677
MP:0006187	retinal deposits	7	2.396012e-05	2.533558e-05	5.267885e-05	4.502438e-10	0.01226052
MP:0006188	calcified retina	1	0.004680066	0.4410056	0.6286851	0.01795318	0.2194996
MP:0006190	retinal ischemia	2	0.9998838	0.9462814	0.9610434	0.9795184	0.9647485
MP:0006194	keratoconjunctivitis	4	3.007936e-10	5.430097e-14	5.082341e-10	0.001220856	0.1499218
MP:0006197	ocular hypotelorism	8	0.9576023	1.094922e-31	0.003759565	4.073461e-05	0.5009368
MP:0006198	enophthalmos	10	0.01705668	9.60029e-13	0.03637004	0.02231496	0.4539935
MP:0006200	vitreous body deposition	6	0.02725463	0.0006258351	0.4239315	0.1759366	0.8548651
MP:0006201	vitreous body inflammation	2	0.2126235	1.298477e-08	0.3197831	0.03915629	0.007101007
MP:0006203	eye hemorrhage	9	0.5947482	2.497773e-37	2.135131e-06	0.006809859	0.1669574
MP:0006204	embryonic lethality before implantation	157	0	6.800254e-29	1.773077e-35	2.176217e-112	0.2528622
MP:0006205	embryonic lethality between implantation and somite formation	297	0	1.245816e-125	1.719812e-102	2.208696e-194	0.004987802
MP:0006206	embryonic lethality between somite formation and embryo turning	115	2.730904e-252	4.049816e-34	3.388615e-44	4.816719e-73	0.006233113
MP:0006207	embryonic lethality during organogenesis	883	0	0	1.948993e-308	0	1.731156e-06
MP:0006208	lethality throughout fetal growth and development	462	0	1.57686880844855e-317	3.786671e-160	0	0.000383344
MP:0006210	abnormal orbit size	7	0.05892411	9.662541e-34	0.001598	7.233573e-08	0.6821935
MP:0006211	small orbits	3	0.9173011	0.02172367	0.04717601	0.0002283496	0.2455021
MP:0006212	large orbits	1	1.387666e-07	0.003146579	2.105504e-07	2.135908e-05	1
MP:0006213	shallow orbits	2	0.4354153	6.29503e-25	0.62921	0.0005757882	0.8924728
MP:0006219	optic nerve degeneration	10	0.8990453	3.367072e-06	0.7706365	9.730899e-05	0.003240667
MP:0006221	optic nerve hypoplasia	13	6.457769e-13	9.191744e-12	0.01519726	2.459911e-06	0.1042333
MP:0006222	optic neuropathy	2	0.0003279526	0.9405443	0.7808673	0.0008106836	0.8177087
MP:0006223	optic nerve swelling	1	0.7450657	0.002712665	0.2337084	0.3879905	0.7408718
MP:0006225	ocular rupture	1	1	0.02825557	1	1	0.1279522
MP:0006226	iris hypoplasia	13	0.001794392	7.104184e-18	0.01572723	2.446657e-06	0.6847887
MP:0006228	iris atrophy	2	0.9911904	0.8868423	0.07656321	0.5858042	1
MP:0006230	iris stroma hypoplasia	6	0.0005152702	3.254852e-19	0.002322268	0.007214773	0.9973782
MP:0006236	absent meibomian glands	7	0.03871561	6.298364e-09	0.02923667	0.02730954	0.2313964
MP:0006237	abnormal choroid vasculature morphology	20	2.046926e-22	8.642801e-12	1.074365e-09	1.751294e-31	0.9323987
MP:0006238	abnormal choriocapillaris morphology	4	0.0004157887	0.03346771	0.0003852519	0.01143013	0.1649932
MP:0006240	anisocoria	1	0.9930732	0.7264086	0.5785484	0.4587774	0.8122343
MP:0006241	abnormal placement of pupils	11	0.004945406	6.70746e-18	0.168403	1.335351e-10	0.4323525
MP:0006243	impaired pupillary reflex	16	1.522396e-05	0.00145786	0.1484187	1.726467e-06	0.08724716
MP:0006249	phthisis bulbi	1	5.372047e-08	0.03059762	0.08195776	0.301498	0.1264603
MP:0006250	abnormal line of Schwalbe morphology	2	0.998923	0.001445681	0.9866005	0.3622569	1
MP:0006253	clinodactyly	4	0.9199923	0.008355013	0.8697338	0.1006274	0.8150663
MP:0006254	thin cerebral cortex	87	2.767021e-89	1.468033e-46	5.570095e-07	4.521694e-22	0.1171456
MP:0006256	abnormal gustatory papillae morphology	8	0.146893	3.712305e-28	0.5649424	0.146802	0.8511459
MP:0006257	abnormal fungiform papillae morphology	6	0.5039084	2.457682e-22	0.4009659	0.1589605	0.8133073
MP:0006258	abnormal circumvallate papillae morphology	3	0.6420394	2.502131e-09	0.9628456	0.621416	0.830426
MP:0006260	abnormal gustatory papillae taste bud morphology	3	1.314219e-05	2.893138e-10	0.822081	0.3429334	0.9785922
MP:0006261	annular pancreas	5	0.5567073	0.5172031	0.9386136	0.9499825	0.8408691
MP:0006262	testis tumor	28	8.005294e-23	7.415578e-18	1.232089e-08	4.120672e-14	0.1088431
MP:0006263	decreased systemic arterial diastolic blood pressure	14	0.0009878617	9.154028e-08	0.0002136551	0.01667068	0.009255461
MP:0006264	decreased systemic arterial systolic blood pressure	47	3.209776e-17	2.902945e-44	3.260175e-14	4.530817e-13	0.05370197
MP:0006265	increased pulse pressure	2	1.823513e-18	0.001989654	0.4860467	1.817681e-05	1
MP:0006266	decreased pulse pressure	1	0.9982283	7.948647e-09	0.5785484	0.8595013	0.02789339
MP:0006267	abnormal intercalated disc morphology	18	6.559023e-19	8.915094e-19	2.305481e-05	3.101533e-12	0.3055037
MP:0006268	absent cardiac desmosomes	1	0.001536245	0.008753536	0.08153932	0.0001244073	1
MP:0006269	abnormal mammary gland growth during pregnancy	49	1.068866e-63	4.852046e-15	7.593284e-60	4.956289e-33	0.007418973
MP:0006270	abnormal mammary gland growth during lactation	28	7.384069e-40	6.395535e-07	2.502907e-33	7.052123e-29	0.5950262
MP:0006271	abnormal involution of the mammary gland	23	3.496671e-39	5.761302e-18	7.933454e-14	4.041963e-38	0.640986
MP:0006272	abnormal urine organic anion level	4	3.498517e-05	0.002759107	8.107899e-10	0.0004137877	0.0693747
MP:0006273	abnormal urine organic cation level	2	0.02031614	0.004803908	3.200512e-05	5.207674e-05	0.1690623
MP:0006274	abnormal urine sodium level	52	6.51913e-31	4.361896e-32	6.520234e-15	3.493287e-20	0.003786627
MP:0006276	abnormal autonomic nervous system physiology	52	1.645454e-21	1.310344e-07	0.001327314	5.280042e-07	0.09650509
MP:0006277	abnormal parasympathetic nervous system physiology	14	6.104536e-13	3.053568e-07	0.2323371	0.001309088	0.1734059
MP:0006278	aortic aneurysm	23	1.549256e-14	4.208887e-21	3.894286e-18	4.452973e-12	0.003142527
MP:0006279	abnormal limb development	150	2.701007e-51	1.575584e-143	1.040491e-12	5.091566e-27	0.003324029
MP:0006280	abnormal digit development	36	4.882414e-11	4.817244e-24	0.0006611696	0.0001987237	0.3446776
MP:0006281	abnormal tail development	36	1.277232e-33	1.726438e-55	3.751265e-11	1.307859e-17	0.03539893
MP:0006282	abnormal spinal cord dorsal horn morphology	17	2.890459e-34	1.843831e-05	0.001990715	2.46426e-22	0.8389578
MP:0006283	medulloblastoma	23	6.323389e-18	7.118154e-23	2.175226e-07	4.95428e-11	0.04078418
MP:0006284	absent hypaxial muscle	5	0.9557278	4.549311e-06	0.2085783	4.61889e-07	0.01325327
MP:0006285	absent inner ear	7	2.241879e-07	0.4053104	0.2795513	0.008190709	0.0771288
MP:0006286	inner ear hypoplasia	6	0.03448596	0.0004028292	0.05170615	0.001845873	0.735453
MP:0006287	inner ear cysts	5	0.9995018	1.242463e-21	0.3973227	0.005912963	0.02092286
MP:0006288	small otic capsule	13	0.01360141	2.286596e-31	0.9931076	0.001291491	0.1458883
MP:0006289	otic capsule hypoplasia	4	0.1399982	0.01148844	0.9996406	0.01289515	1
MP:0006290	proboscis	9	0.9620662	1.727218e-25	0.8611996	0.94876	0.4675316
MP:0006291	aprosencephaly	2	0.9958621	0.3113517	0.9867843	0.7963496	0.531581
MP:0006292	abnormal nasal placode morphology	17	0.003335252	1.584537e-24	0.000102094	7.022203e-05	0.2169061
MP:0006293	absent nasal placodes	10	0.3968098	5.302463e-08	0.3134335	0.0005473086	0.09269117
MP:0006294	absent optic vesicle	12	0.5738707	9.131917e-16	0.01655624	9.254318e-06	0.7665694
MP:0006295	absent sclerotome	5	0.9832536	0.314825	0.7539093	0.5864041	0.6920891
MP:0006296	arachnodactyly	1	0.7781911	0.002215278	0.7385187	0.6986688	0.4698013
MP:0006298	abnormal platelet activation	78	3.275683e-153	8.870246e-09	1.275656e-68	8.339884e-142	0.0001476243
MP:0006299	abnormal latent inhibition of conditioning behavior	6	0.0005439062	0.7205046	0.9794423	0.03482177	0.8973395
MP:0006300	abnormal entorhinal cortex morphology	7	6.302095e-09	0.01536748	0.699861	0.0004144404	0.6342155
MP:0006301	abnormal mesenchyme morphology	25	4.326983e-48	5.244389e-15	1.217568e-05	5.398861e-21	0.05395807
MP:0006302	abnormal ectomesenchyme morphology	2	2.615192e-10	0.9784849	0.4315526	0.2635788	0.5296162
MP:0006303	abnormal retinal nerve fiber layer morphology	15	3.301763e-30	1.091931e-08	0.00416243	2.53517e-11	0.1071178
MP:0006305	abnormal optic eminence morphology	5	1.748652e-23	2.411127e-05	3.408174e-07	1.448331e-13	0.8162273
MP:0006306	abnormal nasal pit morphology	7	0.004068551	0.0003271029	0.9746168	0.0003432073	0.5523613
MP:0006307	abnormal seminiferous tubule size	88	3.650835e-88	3.468702e-13	5.844687e-23	1.384126e-50	0.02406338
MP:0006308	enlarged seminiferous tubules	5	5.295391e-05	0.9780402	0.01645797	0.02525003	0.1746888
MP:0006309	decreased retinal ganglion cell number	33	6.068473e-24	4.768119e-23	1.351194e-06	9.083408e-23	0.1966307
MP:0006310	retinoblastoma	4	7.161959e-10	0.3646184	0.0001647434	1.747371e-07	0.04805613
MP:0006315	abnormal urine protein level	157	7.964952e-207	8.6009e-52	1.96388e-98	9.520802e-165	0.004712821
MP:0006316	increased urine sodium level	23	6.314243e-14	3.484725e-18	0.1502748	8.397389e-05	0.2199297
MP:0006317	decreased urine sodium level	30	2.019701e-19	6.516664e-17	7.841234e-13	2.769442e-18	0.001224256
MP:0006319	abnormal epididymal fat pad morphology	80	1.370851e-120	1.01261e-38	2.145995e-42	3.212417e-83	0.03261201
MP:0006320	abnormal interscapular fat pad morphology	23	4.735453e-26	1.445842e-23	1.837523e-17	5.550041e-26	0.6523987
MP:0006321	increased myocardial fiber number	3	7.231831e-17	0.01366371	9.809741e-05	3.340265e-22	0.8420101
MP:0006322	abnormal perichondrium morphology	7	0.09803215	1.502502e-11	0.005696704	0.4397582	0.2928399
MP:0006323	abnormal extraembryonic mesoderm development	5	3.660922e-08	2.081099e-05	0.9740899	0.003625889	0.6952589
MP:0006324	abnormal cochlear nerve fiber response	1	0.9930732	8.52348e-06	1	0.999381	1
MP:0006325	impaired hearing	161	2.095684e-152	2.123443e-108	6.622219e-30	1.442082e-63	0.02073754
MP:0006326	conductive hearing impairment	14	0.06293099	1.609383e-18	0.1052498	2.346244e-08	0.4174331
MP:0006330	syndromic hearing impairment	4	0.9182284	2.489836e-11	0.1852173	0.002026054	0.5274936
MP:0006331	abnormal patterning of the organ of Corti	4	8.235819e-11	0.002466899	0.3282897	0.2425945	0.9225022
MP:0006332	abnormal cochlear potential	14	2.647456e-28	0.006344689	2.218842e-05	4.750892e-07	0.364861
MP:0006333	abnormal cochlear nucleus morphology	10	0.9956652	8.494616e-11	0.8266065	0.512828	0.7351577
MP:0006334	abnormal susceptibility to hearing loss	36	2.864607e-90	2.626502e-25	4.302428e-10	4.288303e-26	0.9230748
MP:0006335	abnormal hearing electrophysiology	215	3.148294e-195	1.619258e-114	1.132057e-46	1.288747e-93	0.0002412317
MP:0006336	abnormal otoacoustic response	51	6.976303e-40	9.994633e-14	0.01053423	4.690982e-11	0.06767568
MP:0006337	abnormal first branchial arch morphology	57	6.859582e-32	1.979281e-43	7.150271e-19	2.555807e-41	0.007910048
MP:0006338	abnormal second branchial arch morphology	38	5.695849e-28	2.784726e-40	7.388293e-21	2.64551e-29	8.445006e-05
MP:0006339	abnormal third branchial arch morphology	25	2.300291e-21	1.273466e-41	1.116051e-19	1.640161e-16	0.01112741
MP:0006340	abnormal fourth branchial arch morphology	27	9.914266e-37	1.780961e-22	8.252361e-22	2.086903e-24	0.03970662
MP:0006341	small first branchial arch	21	6.290829e-19	3.691509e-12	3.441555e-10	2.609727e-18	0.3309456
MP:0006342	absent first branchial arch	3	6.130409e-11	0.3250136	1.375041e-06	1.609822e-19	0.6590202
MP:0006343	enlarged first branchial arch	4	0.9999963	6.857439e-09	0.001418687	0.6369338	0.1394758
MP:0006344	small second branchial arch	17	2.501849e-21	2.989417e-11	3.17097e-09	1.674857e-11	0.0202421
MP:0006345	absent second branchial arch	16	1.270739e-06	3.8449e-15	2.803732e-06	1.054629e-16	0.04768918
MP:0006346	small branchial arch	53	1.768375e-78	1.285711e-35	6.562971e-36	7.628678e-35	0.1358275
MP:0006349	decreased circulating copper level	4	2.872475e-16	0.5870486	0.02653774	5.178115e-06	0.1403419
MP:0006350	increased circulating copper level	1	1.472905e-08	0.2067193	1	0.009235061	0.5432698
MP:0006353	increased glycosylated hemoglobin level	4	0.06859451	0.01341518	0.1525395	0.1114084	0.5460331
MP:0006354	abnormal fourth branchial arch artery morphology	24	4.276043e-30	4.252818e-22	3.001431e-23	5.029986e-25	0.0361327
MP:0006355	abnormal sixth branchial arch artery morphology	21	7.395664e-22	5.4492e-27	1.250522e-10	7.452547e-20	0.06680723
MP:0006356	abnormal third branchial arch artery morphology	18	3.782904e-24	1.84489e-34	4.558214e-16	3.713364e-11	0.07639328
MP:0006357	abnormal circulating mineral level	217	5.553907e-250	3.816273e-72	6.06468e-78	3.03892e-142	0.0007928385
MP:0006358	absent pinna reflex	44	1.901867e-57	3.827881e-23	1.320557e-16	1.19331e-25	4.966426e-06
MP:0006359	absent startle reflex	27	5.921993e-26	1.87125e-25	5.261691e-25	6.990773e-17	0.0006341668
MP:0006361	abnormal female germ cell morphology	98	1.380054e-132	5.91918e-10	9.755572e-21	2.92419e-42	0.002194894
MP:0006362	abnormal male germ cell morphology	476	0	2.843611e-88	3.79642e-80	2.185201e-176	2.947216e-05
MP:0006363	absent auchene hairs	5	0.3142253	0.0005930557	0.5692339	0.01317648	0.9639785
MP:0006364	absent awl hair	1	0.0001662143	0.05462013	0.01152454	3.794434e-09	1
MP:0006365	absent guard hair	7	0.9917013	0.00010407	0.05627587	0.005798466	0.7930142
MP:0006366	absent zigzag hairs	5	0.9969928	0.001106728	0.0554184	0.005112821	0.8171473
MP:0006367	absent sweat gland	2	0.9999462	0.01541364	0.9531865	0.9880215	1
MP:0006369	supernumerary incisors	5	0.602326	0.5319261	0.8681399	0.06219959	0.05820024
MP:0006370	abnormal phaeomelanin content	5	0.2681306	0.9059079	0.2155211	0.8338093	0.8486331
MP:0006371	absent phaeomelanin	1	0.9999736	0.9999856	1	0.9948082	1
MP:0006372	impaired placental function	7	3.211953e-20	9.320719e-08	0.0007401417	7.158911e-06	0.3656287
MP:0006373	abnormal circulating angiotensinogen level	8	0.0005693485	0.0006358935	2.514566e-07	3.784235e-05	0.003980533
MP:0006375	increased circulating angiotensinogen level	4	1.382212e-09	0.0004837372	1.04214e-08	0.0006583193	0.4276594
MP:0006376	decreased circulating angiotensinogen level	4	0.04932011	2.787596e-06	0.2311955	0.01325384	0.00217825
MP:0006377	abnormal vestibulocollic reflex	1	0.9795671	0.04749024	1	0.384922	1
MP:0006378	abnormal spermatogonia morphology	32	1.68132e-20	7.239679e-08	2.848165e-07	0.0002115074	0.1030531
MP:0006379	abnormal spermatocyte morphology	58	1.212215e-51	6.677864e-14	3.195767e-10	1.382372e-16	0.1636214
MP:0006380	abnormal spermatid morphology	116	3.970034e-134	2.074112e-24	1.907941e-07	6.823004e-29	0.03198917
MP:0006382	abnormal lung epithelium morphology	124	2.719256e-65	3.011199e-138	1.149061e-74	5.936476e-85	0.3069937
MP:0006384	enhanced cochlear frequency tuning	1	0.2916111	1.9614e-12	0.9365713	0.3867296	0.678748
MP:0006386	absent somites	44	1.344193e-99	1.117068e-38	1.29891e-23	8.000263e-22	0.4912387
MP:0006387	abnormal T cell number	710	0	7.313828e-152	0	0	1.579771e-36
MP:0006388	abnormal auditory summating potential	1	4.888273e-10	0.6335184	0.004639409	0.001009487	0.6483615
MP:0006391	abnormal vestibular endolymph ionic homeostasis	4	0.5051737	3.387913e-24	0.01886734	0.489057	0.2200203
MP:0006392	abnormal nucleus pulposus morphology	6	0.999975	0.007486423	0.2080155	0.5371476	0.5885685
MP:0006393	absent nucleus pulposus	3	0.9977415	0.001854542	0.7550308	0.9982673	0.9571167
MP:0006394	abnormal vertebral epiphyseal plate morphology	7	1.213625e-11	1.733622e-07	0.0001830324	1.403299e-08	0.9021908
MP:0006395	abnormal epiphyseal plate morphology	187	7.259214e-200	1.329666e-192	8.268705e-75	1.638766e-122	0.6746696
MP:0006396	decreased long bone epiphyseal plate size	32	2.535682e-56	2.295992e-14	2.902129e-13	3.695091e-18	0.003877366
MP:0006397	disorganized long bone epiphyseal plate	29	1.054037e-64	1.936631e-05	1.713445e-18	1.815694e-15	0.009601537
MP:0006398	increased long bone epiphyseal plate size	25	8.216495e-30	1.569425e-41	1.699865e-20	5.015472e-17	0.1341331
MP:0006399	abnormal long bone epiphyseal ossification zone morphology	13	7.108561e-24	0.0001183526	1.879229e-13	4.159931e-12	0.9325556
MP:0006400	decreased molar number	11	0.5946499	1.34268e-29	0.0003981528	0.0003836966	0.8956216
MP:0006401	absent male preputial gland	4	0.1550847	0.3150411	0.09603608	0.2197562	0.7929241
MP:0006402	small molars	12	0.8192452	5.115279e-22	0.1598432	0.5923537	0.01500186
MP:0006403	abnormal cochlear endolymph ionic homeostasis	4	0.8264978	0.01110304	0.3595052	0.8588476	0.5225471
MP:0006404	abnormal lumbar dorsal root ganglion morphology	16	5.199478e-08	3.10438e-15	0.4767018	0.002156942	0.2069369
MP:0006405	abnormal L3 dorsal root ganglion morphology	1	0.3538544	0.1354254	0.0009355242	0.001279064	0.03447261
MP:0006408	dorsal root ganglion hypoplasia	4	0.8767356	1.613702e-05	0.9999956	0.8515663	1
MP:0006409	vestibular ganglion hypoplasia	5	4.837726e-09	0.5772425	0.3692869	0.002205911	0.5587307
MP:0006410	abnormal common myeloid progenitor cell morphology	126	1.168698e-299	1.378822e-22	1.190932e-76	4.743469e-218	0.01735932
MP:0006411	upturned snout	7	7.892825e-62	1.063494e-05	0.008285953	3.641808e-09	0.1578269
MP:0006412	abnormal T cell apoptosis	136	2.990996e-232	3.455993e-38	5.465423e-91	2.082125e-221	5.596982e-09
MP:0006413	increased T cell apoptosis	94	8.339936e-157	2.064489e-21	6.559452e-54	1.059324e-123	2.426328e-05
MP:0006414	decreased T cell apoptosis	42	1.535405e-64	1.265414e-18	6.579925e-50	4.732014e-96	1.547291e-08
MP:0006415	absent testes	6	0.02923076	0.006596678	0.2356327	0.003127007	0.3535864
MP:0006416	abnormal rete testis morphology	10	1.576557e-08	0.01214028	7.563362e-09	7.776992e-07	0.5394915
MP:0006417	rete testis obstruction	2	0.1799238	0.1919116	0.01550429	0.7211338	1
MP:0006418	abnormal testis cord formation	15	1.449772e-08	2.336348e-21	0.001802414	1.269958e-07	0.3247599
MP:0006419	disorganized testis cords	4	0.9999911	0.3275388	0.8565389	0.3325182	0.04178632
MP:0006420	abnormal peritubular myoid cell morphology	4	0.9999719	0.999689	1	0.9524245	0.8482922
MP:0006421	decreased number of peritubular myoid cells	3	0.98277	0.941834	1	0.6858544	0.9518451
MP:0006422	mammary adenoacanthoma	1	0.004017566	0.6327778	0.0693156	0.08035383	0.3273782
MP:0006423	dilated rete testis	7	7.93917e-09	0.0009566891	6.279638e-09	4.69458e-08	0.6301543
MP:0006424	absent testis cords	5	1.550335e-08	3.033802e-23	0.0004541358	1.592943e-06	0.9699928
MP:0006425	absent Mullerian ducts	5	1.520428e-12	0.0001033281	0.1499056	4.213963e-09	0.877593
MP:0006426	Mullerian duct degeneration	2	0.2025404	3.990386e-11	0.4330081	0.7982357	0.9235834
MP:0006427	ectopic Leydig cells	1	1	0.9961208	1	1	1
MP:0006428	ectopic Sertoli cells	3	0.5756216	7.512503e-07	0.1801165	0.2055424	0.5076027
MP:0006429	abnormal hyaline cartilage morphology	21	2.531187e-41	5.399175e-18	7.168315e-07	2.392834e-22	0.2306301
MP:0006431	abnormal fibrocartilage morphology	1	0.9999065	0.9818493	0.8717927	0.3273484	0.01727618
MP:0006432	abnormal costal cartilage morphology	7	1.272773e-06	1.863653e-28	6.872939e-05	1.164116e-05	0.3141357
MP:0006433	abnormal articular cartilage morphology	15	5.480016e-32	1.537095e-08	8.407576e-05	5.674977e-17	0.08558432
MP:0008000	increased ovary tumor incidence	41	7.763025e-45	3.766478e-11	1.023013e-17	4.342954e-29	0.000182774
MP:0008001	hypochlorhydria	5	0.4491399	2.433684e-08	0.007348635	0.2877459	0.0590465
MP:0008002	hyperchlorhydria	2	0.9939832	0.8365937	0.003214372	0.8764586	0.05772106
MP:0008003	achlorhydria	5	1.010386e-16	0.003345997	0.002950088	1.304301e-05	1
MP:0008004	abnormal stomach pH	16	4.98274e-06	2.263746e-06	0.009025685	0.003308943	0.3856552
MP:0008006	increased stomach pH	13	1.510923e-14	5.548082e-14	4.166778e-09	5.299252e-10	0.1824843
MP:0008007	abnormal cellular replicative senescence	76	1.034035e-194	4.250088e-08	2.264533e-08	2.440094e-77	0.6941938
MP:0008008	early cellular replicative senescence	66	1.801459e-163	7.639375e-10	1.601416e-07	3.211678e-66	0.6632563
MP:0008009	delayed cellular replicative senescence	11	7.214345e-40	0.9703052	2.75226e-06	2.124884e-16	0.7244275
MP:0008010	gastric adenocarcinoma	3	1.733882e-11	0.4931294	0.06993763	7.392901e-07	1
MP:0008011	intestine polyps	28	1.010569e-67	1.00894e-07	2.158903e-16	5.002429e-22	0.1038186
MP:0008012	duodenum polyps	1	0.3921766	0.7062961	0.0003264373	0.0114093	0.1319432
MP:0008013	cecum polyps	1	0.7441549	0.4620382	0.02057629	0.1193049	1
MP:0008014	increased lung tumor incidence	125	1.45735e-291	5.021678e-31	3.209978e-49	1.081121e-132	0.0001229972
MP:0008018	increased facial tumor incidence	5	6.236714e-17	3.536663e-15	0.006991443	5.118774e-07	0.03594042
MP:0008019	increased liver tumor incidence	113	1.167436e-244	7.33961e-37	4.104099e-27	1.458071e-81	0.1553985
MP:0008020	abnormal dermal mast cell morphology	1	0.8246961	0.001116201	0.001040567	0.00904338	0.2355317
MP:0008021	blastoma	32	3.42544e-24	2.020091e-19	5.29982e-08	1.007416e-12	0.06615914
MP:0008022	dilated heart ventricle	132	2.019527e-111	1.262494e-135	1.685542e-19	5.057807e-74	0.0008617932
MP:0008023	abnormal styloid process morphology	12	0.4842478	2.225339e-30	0.05213349	1.813152e-07	0.04310085
MP:0008024	absent lymph nodes	19	1.245634e-32	0.0002062278	7.415594e-17	2.027022e-42	0.5081627
MP:0008025	brain vacuoles	23	2.465077e-11	0.02317204	0.01725217	2.760151e-07	0.00133725
MP:0008026	abnormal brain white matter morphology	187	2.297269e-123	7.92907e-182	5.844891e-44	2.105776e-89	0.02271514
MP:0008027	abnormal spinal cord white matter morphology	32	4.526635e-32	1.728859e-33	1.00667e-18	2.541677e-18	0.7661115
MP:0008028	pregnancy-related premature death	23	9.465024e-08	0.0001471324	8.783088e-16	3.48654e-18	0.05363847
MP:0008029	abnormal paraxial mesoderm morphology	38	3.051184e-58	2.39951e-22	5.508526e-11	1.755197e-11	0.3513892
MP:0008030	abnormal Cajal-Retzius cell morphology	15	1.567781e-73	2.087792e-08	6.26895e-06	4.990677e-12	0.4283408
MP:0008031	decreased Cajal-Retzius cell number	8	1.118326e-64	0.0002312263	0.6061117	0.0009414811	0.6271144
MP:0008032	abnormal lipolysis	29	5.977588e-39	2.598654e-16	3.089463e-38	2.587387e-38	0.01583988
MP:0008033	impaired lipolysis	16	2.974231e-35	1.821093e-15	4.351676e-25	1.424603e-26	0.5055472
MP:0008034	enhanced lipolysis	15	2.111989e-05	1.386851e-07	1.452065e-13	1.233887e-14	0.002977973
MP:0008035	behavioral arrest	4	9.171999e-47	3.246668e-05	0.0372539	7.741587e-09	0.7060777
MP:0008037	abnormal T cell morphology	881	0	1.378163e-157	0	0	1.701015e-40
MP:0008038	abnormal NK T cell number	60	5.688443e-54	1.285981e-06	5.904473e-59	7.855919e-94	5.130867e-06
MP:0008039	increased NK T cell number	16	1.095617e-32	0.0001355942	2.946745e-21	1.998428e-32	0.01535378
MP:0008040	decreased NK T cell number	43	3.555671e-29	0.004920449	5.324359e-34	1.481034e-63	0.0001673653
MP:0008041	absent NK T cells	6	1.148215e-07	0.0609668	0.0005151392	6.273499e-05	0.1772898
MP:0008042	abnormal NK T cell physiology	19	0.1329105	0.1216842	3.475481e-05	6.073326e-13	0.000377621
MP:0008043	abnormal NK cell number	109	2.160949e-156	3.24235e-17	3.302877e-75	1.782686e-205	3.058475e-11
MP:0008044	increased NK cell number	39	2.280059e-54	1.463421e-06	1.585316e-30	6.878106e-66	1.087943e-13
MP:0008045	decreased NK cell number	76	4.053388e-110	9.888486e-13	1.9225e-50	1.598971e-155	4.086352e-05
MP:0008046	absent NK cells	9	1.864715e-13	0.01746067	0.0004171874	5.381463e-28	0.002339026
MP:0008047	absent uterine NK cells	4	0.02422939	0.7870992	0.1432626	1.192812e-07	0.03762579
MP:0008048	abnormal memory T cell number	73	8.744118e-69	1.781163e-28	3.52352e-90	1.00603e-120	2.114239e-22
MP:0008049	increased memory T cell number	43	1.496951e-48	2.130469e-18	4.942938e-65	1.457241e-93	2.197943e-15
MP:0008050	decreased memory T cell number	30	5.85733e-21	1.373995e-11	4.766658e-28	8.243181e-35	6.096792e-09
MP:0008051	abnormal memory T cell physiology	13	3.260792e-21	1.81894e-06	1.948476e-08	2.774102e-38	0.2956787
MP:0008052	abnormal serous gland morphology	3	0.1482318	1.021086e-06	0.5593766	0.5418267	0.5625089
MP:0008053	abnormal NK cell differentiation	16	1.498517e-26	2.624694e-05	2.20289e-13	7.254998e-52	4.127802e-06
MP:0008054	abnormal uterine NK cell morphology	19	8.106391e-20	0.6400026	6.040209e-11	4.211681e-26	0.0007803963
MP:0008055	increased urine osmolality	9	0.1323482	5.529057e-06	0.02807092	0.807195	0.1206535
MP:0008056	abnormal retinal ganglion cell morphology	82	5.762368e-46	8.76053e-53	4.941549e-23	1.059622e-36	0.02536305
MP:0008057	abnormal DNA replication	19	2.497849e-27	0.0005521993	1.15e-08	2.569861e-21	0.02649768
MP:0008058	abnormal DNA repair	91	1.613211e-200	0.002320624	4.959754e-13	1.675575e-71	0.9421221
MP:0008059	abnormal podocyte foot process morphology	56	4.772324e-90	4.129048e-40	3.178855e-33	3.844113e-47	0.02958126
MP:0008060	abnormal podocyte slit diaphragm morphology	11	3.933784e-36	1.086662e-11	2.055955e-10	4.322755e-14	0.5306197
MP:0008061	absent podocyte slit diaphragm	7	9.214265e-29	2.240636e-08	0.004566387	2.068851e-07	0.6757388
MP:0008062	abnormal podocyte slit junction morphology	13	1.653669e-32	1.623281e-20	8.45816e-09	8.804303e-15	0.6325385
MP:0008063	increased otic epithelium apoptosis	1	0.9999736	0.6258174	0.2246218	0.6062543	0.2355317
MP:0008064	decreased otic epithelium proliferation	2	0.9995751	0.112258	0.07522649	0.006251134	0.09001936
MP:0008065	short endolymphatic duct	6	0.001821378	3.309641e-08	0.2893599	0.0009987289	0.1048487
MP:0008066	small endolymphatic duct	11	8.075199e-07	3.247422e-23	0.002078599	1.469897e-05	0.3521362
MP:0008067	retinal ganglion cell degeneration	17	2.058988e-17	1.641394e-05	3.912927e-09	3.579102e-14	0.1901277
MP:0008068	absent retinal ganglion cell	3	3.304313e-11	0.06509308	0.001146843	2.681834e-07	0.005137946
MP:0008069	abnormal joint mobility	15	0.2911875	2.062573e-28	0.006328592	0.005697803	0.2060892
MP:0008070	absent T cells	59	1.142716e-81	3.552558e-06	2.335041e-32	1.413936e-110	5.714296e-07
MP:0008071	absent B cells	72	1.819386e-123	1.858246e-13	1.876309e-55	5.631826e-189	0.008430233
MP:0008073	abnormal CD4-positive T cell number	354	0	6.853444e-60	6.170022e-260	0	1.121489e-18
MP:0008074	increased CD4-positive T cell number	152	2.334084e-236	2.379239e-22	2.887859e-142	1.770791e-261	1.081869e-10
MP:0008075	decreased CD4-positive T cell number	244	0	5.225365e-44	1.557605e-165	0	1.406853e-10
MP:0008076	abnormal CD4-positive T cell differentiation	80	7.211647e-125	1.935571e-13	1.834108e-110	8.680966e-157	3.264694e-07
MP:0008077	abnormal CD8-positive T cell number	296	0	9.493953e-40	2.56272e-229	0	3.14361e-23
MP:0008078	increased CD8-positive T cell number	121	3.40216e-218	9.622878e-14	4.42405e-118	5.243191e-230	5.513637e-13
MP:0008079	decreased CD8-positive T cell number	210	0	1.663852e-36	6.252797e-142	0	1.892377e-19
MP:0008080	abnormal CD8-positive T cell differentiation	23	3.025678e-71	0.06066653	1.268079e-17	1.191466e-50	1.231402e-09
MP:0008081	abnormal single-positive T cell number	439	0	1.757231e-73	1.93673733169769e-320	0	3.14825e-22
MP:0008082	increased single-positive T cell number	222	0	1.690817e-39	5.764601e-187	0	3.166213e-12
MP:0008083	decreased single-positive T cell number	314	0	9.310464e-50	1.330674e-210	0	3.255555e-16
MP:0008084	absent single-positive T cells	34	4.878998e-51	0.01865314	1.578437e-17	2.660402e-63	0.0494893
MP:0008085	abnormal T-helper 1 cell number	17	3.114455e-12	0.02686894	1.207767e-10	5.753467e-29	0.0691798
MP:0008086	increased T-helper 1 cell number	14	1.342281e-06	0.04430504	8.440056e-09	1.115368e-18	0.06850235
MP:0008087	decreased T helper 1 cell number	3	1.16474e-09	0.2005159	0.002605962	8.831317e-14	0.484154
MP:0008088	abnormal T-helper 1 cell differentiation	30	1.099603e-54	3.472657e-08	4.46078e-50	1.264772e-59	0.01327455
MP:0008089	abnormal T-helper 2 cell number	15	3.095104e-18	0.0001054736	3.481282e-17	7.211366e-28	0.4578325
MP:0008090	increased T-helper 2 cell number	7	2.346269e-08	0.0002166594	1.538697e-13	2.638463e-14	0.6322415
MP:0008091	decreased T-helper 2 cell number	8	5.634501e-12	0.0648666	1.360846e-05	1.833771e-15	0.3494327
MP:0008092	abnormal T-helper 2 cell differentiation	22	1.685998e-25	2.353207e-09	2.297397e-31	1.445945e-37	0.0001839522
MP:0008093	abnormal memory B cell number	10	1.151684e-08	0.0002074835	2.736763e-12	5.586277e-15	0.002137725
MP:0008094	absent memory B cells	3	6.37041e-07	0.0003167343	0.002623623	6.59408e-13	0.02909432
MP:0008095	abnormal memory B cell differentiation	4	0.9053125	0.8287425	0.1041315	0.5173156	0.00123258
MP:0008096	abnormal plasma cell number	62	5.885117e-48	1.478932e-16	3.038674e-97	9.963287e-99	2.256789e-18
MP:0008097	increased plasma cell number	38	2.04157e-24	1.181025e-09	7.93818e-45	2.842119e-47	2.626536e-10
MP:0008098	decreased plasma cell number	28	8.024527e-13	1.683735e-09	1.842559e-57	1.2602e-41	6.025063e-13
MP:0008099	abnormal plasma cell differentiation	8	1.787568e-11	0.01651931	9.059215e-11	4.371647e-16	0.852288
MP:0008100	absent plasma cells	7	1.175392e-08	4.742978e-14	1.734925e-20	5.364452e-16	0.003096623
MP:0008101	lymph node hypoplasia	43	9.020742e-33	3.042319e-08	1.600126e-29	2.096161e-52	1.261256e-07
MP:0008102	lymph node hyperplasia	38	1.018192e-74	1.104893e-11	1.196892e-85	1.809498e-77	0.006712285
MP:0008103	amacrine cell degeneration	2	3.37807e-06	0.9236931	1	0.08867959	0.1522499
MP:0008104	abnormal amacrine cell number	22	0.06941784	2.909455e-06	0.06606458	0.0001696619	0.3785023
MP:0008105	increased amacrine cell number	7	0.6102889	0.00959516	0.07970677	0.0003704011	0.229966
MP:0008106	decreased amacrine cell number	18	0.06803124	9.95572e-06	0.4589072	0.01055171	0.6133292
MP:0008107	absent horizontal cells	3	0.5131295	2.395541e-06	0.3425797	0.01735593	0.6152403
MP:0008108	abnormal small intestinal villus morphology	51	2.188742e-110	2.552761e-22	1.681572e-16	1.366274e-43	0.9070408
MP:0008109	abnormal small intestinal microvillus morphology	9	4.675289e-30	0.001174862	0.002779078	1.18779e-09	0.7005902
MP:0008111	abnormal granulocyte differentiation	37	6.717014e-156	4.04672e-05	4.397117e-35	5.568635e-99	0.002627724
MP:0008112	abnormal monocyte differentiation	9	1.632378e-47	0.16231	7.578523e-20	5.793752e-30	0.1465303
MP:0008113	abnormal macrophage differentiation	7	2.406374e-39	0.002884971	2.343836e-11	7.772734e-35	0.002339922
MP:0008114	abnormal Kupffer cell morphology	16	5.670208e-36	1.623052e-21	7.612206e-14	1.171541e-16	0.7992289
MP:0008115	abnormal dendritic cell differentiation	19	6.470897e-73	0.001377524	8.539324e-38	2.812295e-35	0.003242853
MP:0008117	abnormal Langerhans cell morphology	17	1.89997e-48	1.589619e-20	1.547043e-37	2.107745e-17	0.8742767
MP:0008118	absent Langerhans cell	7	7.243162e-52	2.870876e-11	5.613009e-23	1.066863e-12	0.9787827
MP:0008119	decreased Langerhans cell number	12	6.587725e-43	1.195055e-13	1.194851e-34	2.148249e-19	0.8664739
MP:0008120	abnormal myeloid dendritic cell number	23	2.369096e-55	3.532354e-20	5.338341e-54	7.733366e-41	0.6947055
MP:0008121	increased myeloid dendritic cell number	3	0.01729371	1.016237e-07	1.298962e-16	3.352009e-07	0.01217512
MP:0008122	decreased myeloid dendritic cell number	20	8.234216e-58	1.354945e-14	9.744337e-40	2.334602e-35	0.9779778
MP:0008123	abnormal plasmacytoid dendritic cell number	17	5.205853e-15	3.517262e-08	5.104795e-18	2.079281e-31	2.314904e-05
MP:0008124	decreased plasmacytoid dendritic cell number	10	3.190181e-24	0.05086122	2.987884e-05	4.053375e-23	0.07916358
MP:0008125	abnormal dendritic cell number	77	1.081009e-155	2.381112e-31	1.947435e-94	5.401011e-145	1.657518e-05
MP:0008126	increased dendritic cell number	24	3.483712e-76	3.114555e-13	7.137787e-44	1.89769e-51	0.01663743
MP:0008127	decreased dendritic cell number	53	2.409867e-113	6.648931e-23	8.699494e-62	6.047943e-91	0.02692047
MP:0008128	abnormal brain internal capsule morphology	26	1.419049e-08	2.379471e-14	0.2435709	4.540074e-12	0.00623213
MP:0008129	absent brain internal capsule	12	1.586472e-11	7.600761e-12	0.3577494	2.674227e-09	0.5171248
MP:0008130	abnormal pituitary intermediate lobe morphology	13	2.192864e-41	2.542305e-15	7.943144e-19	2.761131e-17	0.6145401
MP:0008131	abnormal Peyer's patch number	24	1.104004e-38	5.362372e-13	7.80855e-27	2.731612e-42	0.05055874
MP:0008132	increased Peyer's patch number	1	0.6020248	0.001102027	0.3374342	0.0004438524	1
MP:0008133	decreased Peyer's patch number	23	2.852779e-39	9.975683e-12	7.653811e-27	4.099887e-40	0.04071358
MP:0008134	abnormal Peyer's patch size	45	7.07052e-45	1.27991e-15	6.543724e-69	4.259372e-66	0.0001224182
MP:0008135	small Peyer's patches	34	2.623579e-39	1.284369e-07	2.29054e-55	8.465929e-51	5.787406e-05
MP:0008136	enlarged Peyer's patches	12	1.263235e-07	2.160238e-12	2.191599e-15	1.669771e-17	0.4113477
MP:0008137	absent podocytes	4	6.102772e-15	2.330961e-10	3.807604e-08	3.456769e-28	0.5625218
MP:0008138	absent podocyte foot process	6	7.471936e-29	4.76908e-14	0.0005489671	0.0001847983	0.5841708
MP:0008139	fused podocyte foot processes	19	3.406121e-29	5.194573e-18	1.542969e-19	1.207216e-32	0.1971331
MP:0008140	podocyte foot process effacement	38	2.50484e-68	6.374738e-22	9.672308e-24	3.104311e-32	0.06660594
MP:0008141	decreased small intestinal microvillus size	3	0.0004168638	0.770589	0.1065776	1.833018e-05	0.1944088
MP:0008142	decreased small intestinal villus size	20	9.062208e-30	6.937649e-06	2.925306e-06	1.197465e-13	0.7876842
MP:0008143	abnormal dendrite morphology	141	6.456831e-151	9.591691e-83	9.169088e-10	1.753895e-59	0.9888732
MP:0008146	asymmetric rib-sternum attachment	39	7.716374e-06	3.953912e-27	2.117943e-11	2.816565e-11	0.2975642
MP:0008147	asymmetric rib-vertebral column attachment	1	0.197791	0.0001286407	0.8201069	0.06486874	0.04217139
MP:0008148	abnormal rib-sternum attachment	74	5.341105e-48	3.646577e-43	3.117328e-26	1.114972e-31	0.01353255
MP:0008149	abnormal rib-vertebral column attachment	9	4.546581e-38	0.001788962	4.844836e-05	0.0004631405	0.494466
MP:0008150	decreased diameter of long bones	20	2.899384e-18	6.043428e-22	1.866335e-05	5.042634e-15	0.02006824
MP:0008151	increased diameter of long bones	41	9.330512e-41	1.556612e-18	7.783371e-12	2.248434e-25	0.6842672
MP:0008152	decreased diameter of femur	14	4.855057e-09	2.578265e-20	2.210924e-06	2.954599e-14	0.02831102
MP:0008154	decreased diameter of humerus	2	0.9669814	3.759502e-05	0.9530372	0.6676795	0.4043757
MP:0008155	decreased diameter of radius	2	0.005072936	0.07724303	0.4966757	0.02634189	0.6656319
MP:0008156	decreased diameter of tibia	5	1.360056e-16	0.09875693	5.298533e-05	2.317736e-08	0.4173723
MP:0008157	decreased diameter of ulna	1	0.001089546	0.004160079	0.3520102	0.5457299	1
MP:0008158	increased diameter of femur	12	6.111646e-13	0.0008716206	0.5075723	1.746222e-07	0.5388084
MP:0008159	increased diameter of fibula	4	0.1182777	0.1471677	0.02545988	0.00148684	0.8787647
MP:0008160	increased diameter of humerus	8	2.373122e-05	4.094367e-14	0.2489461	3.982598e-07	0.5223926
MP:0008161	increased diameter of radius	8	0.1800669	7.080257e-12	0.006891542	7.922322e-05	0.6689334
MP:0008162	increased diameter of tibia	6	5.224866e-05	0.0006395398	1.0653e-05	7.431592e-13	0.6394769
MP:0008163	increased diameter of ulna	8	0.1800669	7.080257e-12	0.006891542	7.922322e-05	0.6689334
MP:0008164	abnormal B-1a B cell morphology	48	1.388448e-44	0.6156241	8.150581e-44	3.603241e-96	3.988169e-06
MP:0008165	abnormal B-1b B cell morphology	15	4.065834e-23	6.013406e-05	6.414973e-05	3.943446e-39	0.3023346
MP:0008166	abnormal B-2 B cell morphology	25	1.772411e-68	0.00145657	7.665898e-23	2.24757e-82	0.135315
MP:0008167	increased B-1a cell number	8	1.441702e-13	0.9964767	3.588295e-08	4.489136e-10	0.113176
MP:0008168	decreased B-1a cell number	41	2.098847e-33	0.2327226	1.90997e-37	3.086033e-89	9.760565e-06
MP:0008169	increased B-1b cell number	7	2.89678e-10	3.182799e-15	0.05704865	1.863509e-20	0.8311145
MP:0008170	decreased B-1b cell number	8	1.380952e-14	0.9748059	0.0002167767	5.720763e-21	0.1296387
MP:0008171	abnormal mature B cell morphology	307	0	2.500424e-54	1.293985e-306	0	1.534993e-26
MP:0008172	abnormal follicular B cell morphology	88	1.82978e-188	1.124972e-17	3.597182e-84	5.551826e-206	0.0002076877
MP:0008173	increased follicular B cell number	28	4.052202e-82	5.709192e-13	6.053435e-40	8.871219e-61	0.4641977
MP:0008174	decreased follicular B cell number	70	3.919186e-120	7.400004e-14	1.236722e-49	3.211903e-160	9.548321e-05
MP:0008175	absent follicular B cells	4	0.04664405	0.9312258	0.2111726	0.434946	0.9667286
MP:0008176	abnormal germinal center B cell morphology	57	7.217044e-82	2.909321e-10	6.167834e-71	6.235076e-89	4.489858e-05
MP:0008177	increased germinal center B cell number	27	1.313808e-45	0.002879926	1.753204e-49	3.299003e-46	0.0001518312
MP:0008178	decreased germinal center B cell number	35	4.324563e-37	4.558039e-09	3.097423e-40	3.401652e-49	0.01596382
MP:0008179	absent germinal center B cells	7	0.006371887	2.134463e-07	1.748781e-11	1.371789e-19	0.1536748
MP:0008180	abnormal marginal zone B cell morphology	122	1.014229e-269	6.568262e-23	4.316859e-109	6.121183e-275	3.477094e-05
MP:0008181	increased marginal zone B cell number	39	6.913546e-106	0.0002938129	1.235066e-50	9.516972e-77	0.08412604
MP:0008182	decreased marginal zone B cell number	92	5.131073e-189	1.003991e-19	4.072831e-64	1.105617e-220	6.079522e-05
MP:0008183	absent marginal zone B cells	18	7.148629e-54	0.001149826	1.205165e-06	4.393014e-52	0.02870463
MP:0008185	decreased naive B cell number	2	3.656523e-05	0.02323987	0.05289329	6.392198e-16	0.7460698
MP:0008186	increased pro-B cell number	40	8.946267e-99	2.490679e-06	7.058545e-15	3.205015e-93	0.4263545
MP:0008187	absent pro-B cells	6	1.370758e-37	0.9995776	0.0007328871	1.810881e-30	0.9839711
MP:0008188	abnormal transitional stage B cell morphology	71	2.668167e-182	6.627229e-15	2.642405e-82	1.958017e-180	0.0173869
MP:0008189	increased transitional stage B cell number	32	3.131066e-89	4.129355e-12	3.144646e-57	3.981681e-79	0.0287718
MP:0008190	decreased transitional stage B cell number	51	4.9219e-106	3.755441e-13	5.134779e-45	8.245621e-105	0.02220205
MP:0008191	abnormal follicular B cell physiology	4	0.07658048	0.0004660959	2.325548e-11	3.077466e-21	0.004198816
MP:0008192	abnormal germinal center B cell physiology	13	8.318892e-11	3.580851e-10	2.136705e-17	8.471821e-14	0.1044498
MP:0008193	abnormal marginal zone B cell physiology	9	5.708808e-11	1.199414e-05	3.034264e-06	6.285185e-19	0.06295893
MP:0008194	abnormal memory B cell physiology	4	4.91073e-07	7.013982e-05	4.811401e-05	8.036607e-11	0.9171468
MP:0008195	abnormal professional antigen presenting cell morphology	664	0	5.815069e-208	0	0	6.726228e-26
MP:0008196	abnormal follicular dendritic cell morphology	12	0.0001753697	1.051937e-05	4.765358e-05	4.612123e-28	0.1756009
MP:0008197	abnormal follicular dendritic cell physiology	3	0.000594602	0.07140711	0.001718359	2.500936e-07	0.1050885
MP:0008198	abnormal follicular dendritic cell antigen presentation	2	0.003077784	0.07283929	0.001083419	9.670905e-05	0.09030176
MP:0008200	decreased follicular dendritic cell number	11	0.0004480192	3.809074e-05	0.0004321411	1.117869e-23	0.2118763
MP:0008201	absent follicular dendritic cells	8	6.284828e-08	0.003743236	0.0003339205	3.966307e-23	0.6895336
MP:0008202	absent B-1 B cells	13	1.238844e-18	0.03826418	1.665491e-19	2.09447e-46	0.458103
MP:0008203	absent B-1a cells	10	1.311096e-07	0.5269924	1.046335e-12	2.545672e-31	0.3957514
MP:0008204	absent B-1b cells	1	0.3680741	0.7838021	0.1241651	0.001294639	1
MP:0008205	absent B-2 B cells	2	0.1299339	0.8337676	0.006925579	0.006232326	0.095146
MP:0008206	increased B-2 B cell number	9	1.341432e-22	0.5776883	8.3778e-16	2.397435e-47	0.08336504
MP:0008207	decreased B-2 B cell number	17	8.562483e-48	0.0001680085	3.755945e-10	1.671955e-39	0.4228204
MP:0008208	decreased pro-B cell number	59	3.13536e-178	7.207912e-10	1.060349e-28	2.292498e-136	0.04524677
MP:0008209	decreased pre-B cell number	95	1.360848e-288	7.611845e-13	2.435968e-60	7.697879e-200	0.2654016
MP:0008210	increased mature B cell number	140	1.859129e-214	1.837814e-22	1.54275e-137	3.705989e-209	3.308493e-11
MP:0008211	decreased mature B cell number	237	0	9.477305e-51	3.060508e-240	0	3.290214e-22
MP:0008212	absent mature B cells	56	2.018122e-71	4.720778e-14	3.697702e-48	1.633729e-130	0.001106956
MP:0008213	absent immature B cells	18	2.300549e-39	0.9396087	7.413109e-11	2.190673e-43	0.3840275
MP:0008214	increased immature B cell number	74	5.439555e-124	2.006697e-16	2.613325e-90	1.434109e-138	9.631038e-05
MP:0008215	decreased immature B cell number	152	0	2.893653e-33	6.704067e-134	1.27260400001039e-313	0.0004055806
MP:0008216	absent transitional stage B cells	1	1.3519e-05	0.2679713	0.09839766	0.0004753164	1
MP:0008217	abnormal B cell activation	185	0	1.182038e-23	1.60479e-167	0	7.841808e-14
MP:0008218	delayed emergence of vibrissae	2	0.01788883	0.7443348	0.04412129	0.009097537	0.2392903
MP:0008219	abnormal dorsal telencephalic commissure morphology	123	7.531385e-81	9.11597e-150	1.842759e-36	4.00925e-48	0.1673199
MP:0008221	abnormal hippocampal commissure morphology	32	0.001155453	4.591913e-71	1.140235e-07	1.9631e-06	0.8199209
MP:0008222	decreased hippocampal commissure size	6	4.155758e-07	5.132107e-13	0.001124902	0.1020792	0.9919373
MP:0008223	absent hippocampal commissure	17	0.0003976202	7.820894e-31	0.00251944	0.5707886	0.4045752
MP:0008225	abnormal anterior commissure morphology	54	1.315314e-19	2.416052e-90	1.163589e-14	4.190684e-31	0.4855182
MP:0008226	decreased anterior commissure size	17	0.01135021	2.309912e-31	0.005583575	1.014362e-05	0.3745861
MP:0008227	absent anterior commissure	24	9.982025e-11	1.335442e-29	2.027233e-05	3.865828e-08	0.3337714
MP:0008228	increased anterior commissure size	1	4.380283e-05	0.8232011	0.6041197	2.328197e-07	1
MP:0008232	abnormal cingulum morphology	2	2.286002e-12	0.9997806	0.04111595	0.02561936	1
MP:0008233	abnormal pro-B cell differentiation	11	3.404617e-19	0.3767113	2.768974e-23	7.447821e-15	0.008482475
MP:0008234	absent spleen marginal zone	11	1.826715e-09	0.06841117	0.0002759402	1.263892e-22	0.9388811
MP:0008235	increased susceptibility to neuronal excitotoxicity	38	7.215461e-58	0.8915566	9.654779e-17	2.935423e-31	0.0348054
MP:0008236	decreased susceptibility to neuronal excitotoxicity	33	7.653287e-36	0.005056961	2.327334e-12	3.276721e-11	0.1374634
MP:0008237	abnormal ventral coat pigmentation	6	0.0002274834	6.995544e-10	6.430254e-08	0.3607069	0.00697076
MP:0008238	abnormal dorsoventral coat patterning	4	0.7944744	0.00870079	0.09922935	0.2882784	0.1163519
MP:0008240	abnormal spleen marginal zone macrophage morphology	9	5.144422e-36	0.1136236	0.0005068376	2.493238e-25	0.5940062
MP:0008241	abnormal metallophilic macrophage morphology	7	3.555034e-13	0.04510298	0.001351156	4.556098e-16	0.9701979
MP:0008242	abnormal perivascular macrophage morphology	2	4.919733e-09	8.489795e-05	2.090579e-06	1.077653e-08	1
MP:0008243	abnormal macrophage derived foam cell morphology	20	4.236939e-44	7.473993e-12	1.401168e-18	3.641832e-23	0.7474092
MP:0008244	abnormal peritoneal macrophage morphology	6	2.094488e-07	4.856106e-07	4.765386e-08	0.0003214513	0.1240354
MP:0008245	abnormal alveolar macrophage morphology	12	0.0005061795	1.695364e-10	9.080076e-08	4.908001e-12	0.05296624
MP:0008246	abnormal leukocyte morphology	1588	0	0	0	0	4.924544e-55
MP:0008247	abnormal mononuclear cell morphology	1436	0	2.31617974770376e-320	0	0	1.443948e-55
MP:0008248	abnormal mononuclear phagocyte morphology	489	0	1.080755e-177	0	0	1.00996e-09
MP:0008249	abnormal common lymphocyte progenitor cell morphology	23	1.011999e-42	2.85613e-12	3.470979e-08	3.532854e-47	0.01542209
MP:0008250	abnormal myeloid leukocyte morphology	732	0	1.615744e-226	0	0	1.588702e-14
MP:0008251	abnormal phagocyte morphology	617	0	2.351234e-223	0	0	1.007406e-12
MP:0008253	absent megakaryocytes	5	1.275856e-07	0.1910744	0.7136812	2.173256e-06	0.5608058
MP:0008254	increased megakaryocyte cell number	42	7.910625e-135	1.001407e-07	3.25742e-47	6.271734e-94	0.003515998
MP:0008255	decreased megakaryocyte cell number	24	9.262119e-47	2.364466e-08	4.901081e-10	8.302689e-72	0.09480834
MP:0008256	abnormal myometrium morphology	24	6.175706e-11	1.484829e-20	0.000110736	0.0003117125	0.001114233
MP:0008257	thin myometrium	11	1.063549e-08	1.753931e-08	0.0751136	0.2556278	0.0002028873
MP:0008258	thin endometrium	8	0.01100641	7.02433e-05	0.0001638803	0.003021342	0.37366
MP:0008259	abnormal optic disc morphology	13	0.04702079	1.525293e-16	0.03467972	0.005261027	0.8772141
MP:0008260	abnormal autophagy	45	1.115237e-50	0.005164007	9.990317e-10	8.389277e-16	0.1740347
MP:0008261	arrest of male meiosis	104	9.932277e-104	9.149283e-11	4.190383e-14	1.128903e-29	0.02872627
MP:0008262	abnormal hippocampus region morphology	53	0.30503	1.07555e-53	0.02510974	9.801725e-10	0.4902403
MP:0008263	abnormal hippocampus CA1 region morphology	25	0.2441794	6.789238e-32	1.96303e-05	7.678838e-05	0.4537825
MP:0008264	absent hippocampus CA1 region	2	3.803025e-09	2.351127e-16	0.004048857	0.02545599	0.5237618
MP:0008265	abnormal hippocampus CA2 region morphology	9	0.8381894	2.358428e-13	0.992024	0.8467055	0.9471021
MP:0008266	absent hippocampus CA2 region	2	3.803025e-09	2.351127e-16	0.004048857	0.02545599	0.5237618
MP:0008267	abnormal hippocampus CA3 region morphology	24	0.004285431	6.67904e-22	0.5672403	0.01207232	0.8015047
MP:0008268	absent hippocampus CA3 region	2	3.803025e-09	2.351127e-16	0.004048857	0.02545599	0.5237618
MP:0008269	abnormal hippocampus CA4 region morphology	3	0.9996986	5.96865e-05	0.3753698	0.4678261	0.0764312
MP:0008271	abnormal bone ossification	358	2.181127e-242	3.804886e-241	5.884411e-97	5.704845e-140	1.767558e-06
MP:0008272	abnormal endochondral bone ossification	114	2.174526e-79	8.542661e-112	1.782282e-24	6.923435e-35	0.001485743
MP:0008273	abnormal intramembranous bone ossification	41	3.759171e-37	3.153319e-41	1.462946e-10	8.565444e-24	0.3480759
MP:0008274	failure of bone ossification	17	3.148838e-18	2.511792e-29	8.3967e-05	3.667265e-14	0.5723884
MP:0008275	failure of endochondral bone ossification	9	0.0009389574	8.776924e-20	0.5011805	4.161581e-07	0.6580672
MP:0008276	failure of intramembranous bone ossification	2	0.9999688	0.3545795	0.9610434	0.8701658	1
MP:0008277	abnormal sternum ossification	45	3.106078e-26	2.723412e-33	1.860827e-06	6.079861e-12	0.001361837
MP:0008278	failure of sternum ossification	5	4.642844e-34	0.0001261626	0.7618918	7.340955e-10	0.670411
MP:0008279	arrest of spermiogenesis	11	4.147383e-35	0.0004769613	0.1435239	1.787437e-06	0.6292683
MP:0008280	abnormal male germ cell apoptosis	123	1.216615e-153	4.172891e-10	8.341262e-18	3.066312e-49	0.005620799
MP:0008281	abnormal hippocampus size	46	5.750843e-36	2.567774e-21	2.026482e-15	1.377176e-25	0.6788607
MP:0008282	enlarged hippocampus	8	0.02132053	0.0001442758	1.901768e-06	4.282391e-07	0.1039209
MP:0008283	small hippocampus	38	1.921685e-36	2.474532e-18	2.796353e-11	3.617672e-20	0.7057353
MP:0008284	abnormal hippocampus pyramidal cell layer	76	5.925522e-107	4.680338e-34	1.552475e-23	1.673441e-26	0.326229
MP:0008285	abnormal hippocampus granule cell layer	16	4.956986e-24	2.250606e-11	0.01656653	0.009435597	0.2398963
MP:0008286	abnormal hippocampus molecular cell layer	2	4.769143e-48	0.3717734	0.00609107	1.52442e-06	1
MP:0008287	abnormal subiculum morphology	2	1.203021e-11	0.6637963	0.001447032	6.177061e-08	0.2939499
MP:0008288	abnormal adrenal cortex morphology	45	9.74445e-17	5.884337e-16	1.382977e-06	9.695603e-21	0.1944826
MP:0008289	abnormal adrenal medulla morphology	23	1.414646e-29	8.790324e-14	1.182496e-08	8.569698e-21	0.1303488
MP:0008291	abnormal adrenocortical cell morphology	8	0.1397267	3.701033e-05	0.2890765	0.2992526	0.8145305
MP:0008292	enlarged adrenocortical cell nuclei	1	0.02261012	0.8829117	1.386651e-06	0.4587774	0.498173
MP:0008293	abnormal zona glomerulosa morphology	4	4.339398e-10	1.323578e-12	1.883792e-08	0.001145667	0.03122095
MP:0008294	abnormal zona fasciculata morphology	15	3.899945e-31	2.176655e-15	3.16562e-06	9.518136e-14	0.177418
MP:0008295	abnormal zona reticularis morphology	6	1.945057e-05	0.01458721	6.564987e-08	4.827484e-12	0.6453573
MP:0008296	abnormal x-zone morphology	6	0.02087446	0.1055692	0.0119402	0.1144648	0.07401033
MP:0008297	retention of the x-zone	5	0.0270076	0.4458285	0.4755653	0.04265977	0.2737634
MP:0008298	adrenergic chromaffin cell hyperplasia	1	0.1189998	0.9048957	0.9558322	0.8172051	0.7232245
MP:0008299	adrenal cortical hyperplasia	6	1.758483e-07	0.1805677	0.04468566	0.08914926	0.8804539
MP:0008301	adrenal medulla hyperplasia	7	3.027494e-20	0.0001315752	0.0002868338	1.349848e-17	0.09582121
MP:0008302	thin adrenal cortex	4	0.853975	0.8530251	0.2165591	0.9986768	0.941459
MP:0008304	abnormal organ of Corti supporting cell differentiation	5	3.122781e-09	8.161319e-06	0.7629212	0.006309173	0.9972069
MP:0008306	abnormal organ of Corti supporting cell proliferation	1	2.380432e-12	0.05091295	0.000980152	4.741761e-05	0.03514669
MP:0008307	short scala media	4	0.9994914	1.389193e-19	0.9703957	0.4228485	0.9291845
MP:0008308	small scala media	8	0.002210298	2.701408e-32	0.8132244	0.00980816	0.8588615
MP:0008309	dilated scala media	3	2.34929e-18	3.106226e-07	0.3337404	0.5271286	0.5050689
MP:0008312	abnormal sympathetic postganglionic fiber morphology	3	4.991881e-05	0.9712784	0.584976	0.8618942	0.04190045
MP:0008313	abnormal parasympathetic postganglionic fiber morphology	3	0.0004414415	0.8190269	0.5479416	0.2943759	0.2367809
MP:0008314	abnormal pterygopalatine ganglion morphology	5	0.9797517	0.2724615	0.9445357	0.6273307	0.5340516
MP:0008315	abnormal otic ganglion morphology	3	0.0004162937	0.002692114	0.3009627	0.02599976	0.04915831
MP:0008316	abnormal prevertebral ganglion morphology	3	5.169545e-09	0.3644319	0.1724545	0.2175346	0.9446676
MP:0008317	abnormal paravertebral ganglion morphology	35	9.307551e-23	1.568145e-15	0.06453635	4.226134e-10	0.05824937
MP:0008320	absent adenohypophysis	6	0.07291579	6.292218e-13	0.9278099	0.3747011	0.04842788
MP:0008321	small adenohypophysis	21	1.129321e-43	3.444035e-11	2.038433e-08	4.499307e-24	0.8969324
MP:0008322	abnormal somatotroph morphology	22	5.09978e-24	9.070653e-34	1.622147e-05	9.139007e-06	0.9245964
MP:0008323	abnormal lactotroph morphology	15	1.899422e-25	1.161309e-10	3.348563e-07	1.461637e-08	0.3242794
MP:0008324	abnormal melanotroph morphology	2	0.000314482	0.847046	0.8657124	0.6632659	1
MP:0008325	abnormal gonadotroph morphology	16	1.749493e-15	9.19968e-14	9.535623e-09	0.04491016	0.4491902
MP:0008326	abnormal thyrotroph morphology	13	1.793276e-12	1.033358e-10	6.425367e-06	0.1522881	0.1000444
MP:0008327	abnormal corticotroph morphology	10	5.375636e-10	0.006702171	2.681326e-07	8.364044e-05	0.2969724
MP:0008328	increased somatotroph cell number	3	0.0003218948	1.330734e-14	2.713708e-05	0.009787146	0.8026238
MP:0008329	decreased somatotroph cell number	16	4.370255e-32	2.873597e-21	8.150625e-05	1.075821e-06	0.7699131
MP:0008330	absent somatotrophs	4	1.749513e-14	0.002010228	1.946063e-07	0.01693232	0.02342778
MP:0008331	increased lactotroph cell number	1	0.9641574	0.6405233	1	0.9790362	1
MP:0008332	decreased lactotroph cell number	13	1.200309e-33	1.420219e-11	4.103986e-08	2.046066e-09	0.2321163
MP:0008333	absent lactotrophs	5	2.795785e-23	6.845699e-10	6.302632e-06	9.696851e-05	0.04836967
MP:0008334	increased gonadotroph cell number	2	0.9999987	0.8378865	0.1210609	0.9795184	0.05398354
MP:0008335	decreased gonadotroph cell number	12	6.745824e-29	2.102025e-11	6.104142e-13	0.0007566986	0.5280523
MP:0008336	absent gonadotrophs	3	0.8581376	0.4984148	0.2612522	0.1888996	0.4018665
MP:0008337	increased thyrotroph cell number	5	0.9996403	1.513815e-05	0.4852063	0.8718653	0.03295655
MP:0008338	decreased thyrotroph cell number	8	2.533043e-26	9.482228e-07	4.414991e-08	0.01585867	0.5294939
MP:0008339	absent thyrotrophs	2	2.832994e-23	6.055899e-07	2.291657e-06	0.0008466307	0.2989967
MP:0008340	increased corticotroph cell number	1	6.594091e-10	2.325589e-08	2.368458e-05	0.03867134	0.2355317
MP:0008341	decreased corticotroph cell number	3	2.227262e-10	0.01696369	2.292645e-08	0.006883925	0.6315652
MP:0008343	abnormal gamma-delta T cell morphology	69	3.523642e-107	6.436479e-22	2.50038e-51	9.172156e-121	1.317749e-08
MP:0008344	abnormal mature gamma-delta T cell morphology	29	4.957866e-18	0.000477457	3.40173e-19	1.870129e-54	3.693926e-07
MP:0008345	abnormal gamma-delta T cell number	60	5.744779e-95	2.04579e-22	1.218175e-47	2.823391e-118	3.381375e-08
MP:0008346	increased gamma-delta T cell number	20	4.854785e-31	3.258452e-17	1.138212e-09	3.746587e-40	1.131113e-05
MP:0008347	decreased gamma-delta T cell number	44	1.694985e-70	9.983338e-05	3.637146e-42	8.072746e-79	4.53698e-05
MP:0008348	absent gamma-delta T cells	13	3.171383e-20	0.01687257	2.347344e-08	4.674676e-15	0.001951172
MP:0008349	abnormal gamma-delta intraepithelial T cell morphology	24	2.332194e-14	0.0002424143	1.5527e-14	5.48909e-48	2.441646e-05
MP:0008350	increased gamma-delta intraepithelial T cell number	2	0.02919839	0.3396019	0.05116462	0.003664215	0.7433584
MP:0008351	decreased gamma-delta intraepithelial T cell number	18	7.252769e-15	0.1364165	3.786407e-12	5.229367e-50	4.535007e-06
MP:0008352	absent gamma-delta intraepithelial T cell	3	2.284732e-05	0.01752872	0.03367984	2.555103e-13	0.008739257
MP:0008353	increased mature gamma-delta T cell number	5	1.01429e-08	0.0254415	5.392596e-07	9.266057e-09	0.04176151
MP:0008354	decreased mature gamma-delta T cell number	21	2.840282e-17	0.104628	8.951335e-15	2.081797e-51	1.24845e-06
MP:0008355	absent mature gamma-delta T cells	5	4.31982e-08	0.06063999	8.772008e-06	6.14913e-12	0.001601132
MP:0008356	abnormal gamma-delta T cell differentiation	6	1.729039e-15	0.0707164	3.329249e-05	5.619523e-14	7.743471e-05
MP:0008361	abnormal CD8-positive, gamma-delta intraepithelial T cell morphology	4	0.1831526	0.1742739	0.01419411	3.255915e-05	0.1229814
MP:0008363	decreased CD8-positive, gamma-delta intraepithelial T cell number	3	0.4885533	0.6910753	0.01128196	0.0001002884	0.1315343
MP:0008365	adenohypophysis hypoplasia	8	8.587763e-38	0.8784377	6.763001e-07	9.164806e-12	0.5182821
MP:0008366	enlarged adenohypophysis	5	0.05036546	0.008794859	0.007094669	0.001052652	0.4925866
MP:0008367	absent pituitary intermediate lobe	4	2.516364e-14	8.315443e-13	2.062612e-06	0.0002736812	0.7760013
MP:0008368	small pituitary intermediate lobe	3	2.414322e-17	0.01056343	2.535599e-11	9.016588e-10	0.3019902
MP:0008369	pituitary intermediate lobe hypoplasia	1	8.113349e-08	0.999883	0.1307005	4.653431e-05	1
MP:0008371	pituitary intermediate lobe hyperplasia	5	3.34666e-18	0.2253333	0.04296609	2.199735e-07	0.5048639
MP:0008372	small malleus	8	0.002671399	1.569665e-08	0.5939913	1.260301e-06	0.2894937
MP:0008373	short malleus	1	0.9889855	2.460237e-06	1	0.6923945	0.4662091
MP:0008374	abnormal malleus manubrium morphology	8	0.7457622	5.375499e-38	0.4651425	0.001445663	0.007680424
MP:0008375	short malleus manubrium	3	0.0495171	2.732333e-25	0.4195831	0.03583956	0.06328191
MP:0008376	small malleus manubrium	4	0.09764891	6.377247e-25	0.5796025	0.003786993	0.05455273
MP:0008377	absent malleus manubrium	3	0.9976944	2.755794e-10	0.7706649	0.08643436	0.03110122
MP:0008378	small malleus processus brevis	3	0.9368995	0.003844887	1	0.0006561743	0.7514152
MP:0008379	absent malleus head	2	0.9960101	1.590264e-06	1	0.1465195	0.668577
MP:0008380	abnormal gonial bone morphology	15	0.1260156	1.959724e-25	0.0001073005	2.133e-09	0.01190184
MP:0008381	absent gonial bone	6	0.3007489	2.148479e-17	9.786281e-05	8.5319e-05	0.01162898
MP:0008382	gonial bone hypoplasia	5	0.6542875	7.643158e-11	5.263534e-07	1.759499e-06	0.007536621
MP:0008383	enlarged gonial bone	2	8.503663e-05	0.003995782	1	0.8835941	1
MP:0008384	absent nasal capsule	4	0.4133395	8.49551e-20	0.9074786	0.1949464	0.9973205
MP:0008385	absent basisphenoid bone	3	0.2079034	3.206413e-11	0.9737445	0.0001988026	0.2445261
MP:0008386	absent styloid process	3	0.0149482	4.784773e-10	1	0.00912315	0.9017553
MP:0008387	hypochromic anemia	23	1.633058e-76	0.319932	4.455988e-23	1.810875e-50	0.2131337
MP:0008388	hypochromic microcytic anemia	13	1.875835e-45	0.9556622	1.809183e-14	5.945816e-29	0.04770166
MP:0008389	hypochromic macrocytic anemia	3	6.700952e-11	1.147747e-08	3.622934e-09	2.695065e-07	0.9383055
MP:0008390	abnormal primordial germ cell proliferation	11	7.650998e-11	0.0005130631	4.455557e-05	0.02626877	8.666897e-06
MP:0008391	abnormal primordial germ cell morphology	34	1.082409e-26	1.944065e-25	6.190201e-09	8.358025e-21	9.989183e-06
MP:0008392	decreased primordial germ cell number	31	1.531217e-17	7.55474e-27	1.100876e-06	6.480739e-18	1.457669e-05
MP:0008393	absent primordial germ cells	10	0.418562	4.209794e-12	4.795759e-05	0.00450054	0.01713886
MP:0008395	abnormal osteoblast differentiation	56	1.373838e-60	5.536956e-79	2.876417e-23	1.290634e-30	0.4785307
MP:0008396	abnormal osteoclast differentiation	89	7.968447e-93	1.183872e-60	1.506819e-83	2.129262e-125	1.432479e-06
MP:0008397	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	11	4.060323e-05	0.04084604	2.768172e-25	2.425347e-13	0.5859206
MP:0008399	abnormal alpha-beta intraepithelial T cell morphology	17	0.001055387	0.06322814	1.80793e-15	5.846683e-23	1.744242e-07
MP:0008400	abnormal CD4-positive, alpha-beta intraepithelial T cell morphology	3	0.02360444	0.1003205	3.110533e-05	4.077713e-09	0.002475873
MP:0008401	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	8	0.08877195	0.2243022	1.779657e-07	0.000674844	0.0002447393
MP:0008402	increased cellular sensitivity to alkylating agents	17	1.530774e-42	0.007660879	2.852925e-08	1.010584e-20	0.57813
MP:0008403	decreased cellular sensitivity to alkylating agents	2	0.7288638	0.8355215	0.150702	0.2485944	0.6829304
MP:0008404	increased cellular sensitivity to methylmethanesulfonate	5	1.688987e-20	0.09228048	2.599263e-05	5.287823e-11	0.991117
MP:0008405	decreased cellular sensitivity to methylmethanesulfonate	1	0.08453678	0.7389251	1	0.161631	1
MP:0008406	increased cellular sensitivity to hydrogen peroxide	20	1.405708e-16	8.160028e-15	0.07509736	7.744532e-16	0.3653321
MP:0008407	decreased cellular sensitivity to hydrogen peroxide	4	2.154557e-18	0.001827867	1.196874e-14	2.517071e-07	0.06020284
MP:0008409	increased cellular sensitivity to hydroxyurea	5	2.47516e-20	0.4321653	0.003907855	6.807129e-07	0.695934
MP:0008410	increased cellular sensitivity to ultraviolet irradiation	29	2.883128e-83	0.5142898	1.115107e-09	1.770382e-26	0.6485123
MP:0008411	decreased cellular sensitivity to ultraviolet irradiation	14	7.276279e-44	0.2016555	7.065521e-11	2.616458e-35	0.4969424
MP:0008412	increased cellular sensitivity to oxidative stress	35	1.838764e-40	5.574943e-12	1.331156e-05	2.59215e-20	0.266661
MP:0008413	decreased cellular sensitivity to oxidative stress	6	1.164816e-20	0.009593223	1.657708e-16	8.036979e-10	0.06198464
MP:0008414	abnormal spatial reference memory	55	5.816729e-44	4.711942e-22	0.0004549226	1.405308e-10	0.9234245
MP:0008415	abnormal neurite morphology	336	5.092578e-303	3.54002e-207	2.54019e-35	4.322917e-176	0.2930195
MP:0008417	decreased somatotroph cell size	1	0.00033877	0.000890264	0.1855545	0.003092038	0.5999221
MP:0008418	abnormal cutaneous elastic fiber morphology	5	0.0473852	4.660714e-09	0.003044411	4.985428e-05	0.8097894
MP:0008419	abnormal cutaneous microfibril morphology	1	0.09504113	0.05576737	0.01920915	0.5191141	1
MP:0008423	decreased lactotroph cell size	1	0.9641574	0.6405233	1	0.9790362	1
MP:0008427	decreased corticotroph cell size	1	0.9996953	0.2305501	0.1172219	0.07280409	0.498173
MP:0008428	abnormal spatial working memory	60	1.623861e-44	1.55439e-14	0.08771527	3.761831e-11	0.5905109
MP:0008429	absent parotid gland	1	0.8677464	0.02575601	0.1255062	0.0002215952	0.1633613
MP:0008430	short squamosal bone	4	0.03576192	1.462949e-12	0.8562542	0.0001073157	0.4727417
MP:0008431	abnormal short term spatial reference memory	7	8.476249e-26	0.1824279	0.1344541	0.0648355	0.2701761
MP:0008432	abnormal long term spatial reference memory	24	2.415421e-71	5.116954e-12	7.993041e-05	4.586105e-09	0.9339704
MP:0008437	absent somatotroph secretory granules	1	0.00033877	0.000890264	0.1855545	0.003092038	0.5999221
MP:0008438	abnormal cutaneous collagen fibril morphology	22	6.951904e-09	1.659801e-29	0.03127797	0.0003249326	0.04869677
MP:0008439	abnormal cortical plate morphology	38	1.046901e-110	7.873825e-32	3.040982e-08	1.348971e-24	0.001003761
MP:0008440	abnormal subplate morphology	9	3.256584e-34	5.582981e-09	0.05430565	0.03037381	0.2269864
MP:0008441	thin cortical plate	12	2.780833e-38	9.044314e-05	0.3654281	0.0001773095	0.001802617
MP:0008442	disorganized cortical plate	4	1.955902e-39	0.1276964	0.001681305	0.000271906	0.01530445
MP:0008443	absent subplate	4	0.8488786	4.77192e-10	0.5339003	0.9376244	0.1712494
MP:0008444	retinal cone cell degeneration	16	0.8600272	0.992104	0.9520124	0.4435794	0.4145442
MP:0008445	increased retinal cone cell number	3	1.115771e-11	0.002345161	0.6571057	0.0008705449	0.2014029
MP:0008446	decreased retinal cone cell number	24	1.280473e-08	3.959675e-10	0.0002873075	2.373635e-09	0.06181609
MP:0008447	absent retinal cone cells	2	0.0112076	8.474827e-06	0.1125337	1.729986e-06	0.05102805
MP:0008448	abnormal retinal cone cell inner segment morphology	2	3.158597e-11	0.1069115	0.1181184	0.02139068	1
MP:0008449	abnormal retinal cone cell outer segment morphology	7	0.2807176	0.8658793	0.1044731	0.02301795	0.9878988
MP:0008450	retinal photoreceptor degeneration	72	8.170139e-38	7.329993e-09	6.339449e-18	7.014138e-29	0.001568009
MP:0008451	retinal rod cell degeneration	18	3.973014e-07	0.0009212418	0.0006040835	1.502251e-05	0.6007087
MP:0008453	decreased retinal rod cell number	16	5.416928e-57	6.009278e-07	2.816748e-10	1.548603e-23	0.02315706
MP:0008454	absent retinal rod cells	7	2.766164e-12	6.408039e-07	0.008300887	4.063422e-08	0.08507587
MP:0008455	abnormal retinal rod cell inner segment morphology	3	8.500652e-13	0.62813	0.03136454	0.0004840209	0.8717293
MP:0008456	abnormal retinal rod cell outer segment morphology	23	2.562228e-21	0.2570193	0.003516815	7.48819e-06	0.4412189
MP:0008457	abnormal cortical intermediate zone morphology	8	2.556805e-14	4.937363e-08	8.598338e-05	6.277105e-11	0.003088524
MP:0008458	abnormal cortical ventricular zone morphology	24	1.612362e-23	1.782393e-17	0.0001265638	5.894898e-09	0.004995412
MP:0008459	abnormal circulating pancreatic peptide level	3	0.999957	0.04542319	0.9951066	0.9978146	0.8950949
MP:0008460	absent dorsal root ganglion	3	0.0009871434	0.00113468	0.0005654199	2.336107e-05	0.02287171
MP:0008461	left atrial isomerism	5	0.1958935	0.9979101	0.1461064	0.4926436	0.2213651
MP:0008462	abnormal medium spiny neuron morphology	10	2.509237e-06	0.07411753	0.05458203	0.009346263	0.70863
MP:0008463	abnormal peripheral lymph node morphology	47	4.040242e-112	1.173184e-07	2.557198e-36	3.313138e-80	0.02759171
MP:0008464	absent peripheral lymph nodes	6	4.009172e-05	1.094859e-07	3.903464e-09	0.001185876	0.04002033
MP:0008465	absent mesenteric lymph nodes	9	0.4542615	0.001572805	9.263429e-05	4.422701e-05	0.8747401
MP:0008466	enlarged mesenteric lymph nodes	19	4.50982e-35	2.714475e-06	2.871434e-29	8.731436e-33	0.000493512
MP:0008467	absent proprioceptive neurons	3	0.9959217	1.537525e-09	1	0.4507611	0.9373372
MP:0008468	absent muscle spindles	7	2.328257e-28	5.617706e-10	2.133757e-06	5.470408e-05	0.7752238
MP:0008469	abnormal protein level	770	0	1.986653e-184	0	0	1.889134e-19
MP:0008470	abnormal spleen B cell follicle morphology	164	2.016791e-249	3.882937e-36	2.561833e-195	1.144364e-258	4.798213e-11
MP:0008471	abnormal spleen primary B follicle morphology	8	1.70742e-29	0.005565053	4.556891e-14	4.791805e-38	0.9689071
MP:0008472	abnormal spleen secondary B follicle morphology	118	8.815259e-157	1.131082e-20	2.626316e-146	1.053626e-179	6.924874e-12
MP:0008473	abnormal spleen follicular dendritic cell network	5	0.0001273744	0.9412504	0.1280058	2.301587e-09	1
MP:0008474	absent spleen germinal center	31	8.672768e-32	2.644564e-05	4.984858e-37	9.051602e-61	3.474518e-07
MP:0008475	intermingled spleen red and white pulp	23	4.347584e-44	0.9868196	0.0006906648	1.851463e-55	0.743237
MP:0008476	increased spleen red pulp amount	65	2.391655e-256	1.27605e-05	1.151306e-62	3.199139e-176	0.9924538
MP:0008477	decreased spleen red pulp amount	15	2.40729e-37	0.9843639	3.501708e-14	2.92872e-44	0.7843064
MP:0008478	increased spleen white pulp amount	29	1.658798e-54	0.0670077	7.998879e-37	1.07103e-71	0.3162151
MP:0008479	decreased spleen white pulp amount	37	8.52392e-90	0.6711099	1.880598e-34	5.010431e-66	0.2057066
MP:0008480	absent eye pigmentation	8	0.9879849	0.02056747	0.8106892	0.07020986	0.4697737
MP:0008481	increased spleen germinal center number	26	5.222226e-11	1.420155e-08	4.908321e-32	1.185835e-22	5.53079e-05
MP:0008482	decreased spleen germinal center number	32	3.43575e-45	6.877766e-05	2.10835e-30	1.087361e-37	0.00885459
MP:0008483	increased spleen germinal center size	14	1.272504e-26	0.001838298	1.053643e-18	3.227547e-35	0.2885333
MP:0008484	decreased spleen germinal center size	31	5.540682e-32	0.0005164447	1.765364e-22	1.430893e-45	0.004264226
MP:0008485	increased muscle spindle number	3	0.5513376	0.005993052	0.3945644	0.08448646	0.6161187
MP:0008486	decreased muscle spindle number	13	8.027841e-21	1.127307e-17	0.001254366	5.254849e-06	0.8370038
MP:0008487	abnormal mesonephros morphology	35	2.65258e-08	6.341721e-44	0.01124896	1.232025e-07	0.141042
MP:0008488	abnormal semicircular canal ampulla morphology	36	0.01279796	2.514389e-31	0.661099	0.000134013	0.463889
MP:0008489	slow postnatal weight gain	166	2.356791e-164	2.614298e-72	7.127417e-57	3.341297e-72	0.07117118
MP:0008490	enlarged dorsal root ganglion	1	0.004017566	0.6327778	0.0693156	0.08035383	0.3273782
MP:0008492	dorsal root ganglion degeneration	2	1.367698e-05	0.02400728	0.6488104	0.004043541	0.1606733
MP:0008493	alpha-synuclein inclusion body	7	5.520494e-34	0.4383822	0.0004214085	0.006975376	0.4684164
MP:0008494	absence of all nails	2	0.05857821	1.847871e-10	0.907263	0.7132888	0.9647485
MP:0008495	decreased IgG1 level	140	3.172754e-129	7.857769e-24	5.759656e-145	3.147979e-196	2.385696e-13
MP:0008496	decreased IgG2a level	87	3.009795e-45	2.08649e-17	3.688133e-95	6.328003e-123	4.896273e-15
MP:0008497	decreased IgG2b level	66	1.079495e-28	3.312003e-16	6.61273e-63	1.775524e-83	7.539387e-12
MP:0008498	decreased IgG3 level	91	1.974676e-74	2.278915e-19	1.322519e-72	2.264387e-135	1.201754e-13
MP:0008499	increased IgG1 level	97	3.974575e-134	2.803498e-22	6.18362e-125	5.804077e-149	1.5091e-09
MP:0008500	increased IgG2a level	77	1.030418e-67	3.802469e-07	3.291853e-77	1.620157e-104	1.235007e-06
MP:0008501	increased IgG2b level	46	4.630927e-94	0.0356306	3.893075e-52	3.259628e-46	0.0004056623
MP:0008502	increased IgG3 level	37	5.342805e-39	7.248187e-10	1.220305e-42	6.699094e-59	0.0002559884
MP:0008503	abnormal spinal cord grey matter morphology	209	3.164127e-194	4.900393e-127	1.295995e-29	8.769354e-93	0.03191577
MP:0008504	abnormal adrenal chromaffin cell morphology	12	2.375822e-15	9.436479e-10	7.084996e-09	2.998507e-10	0.8611977
MP:0008505	absent adrenal chromaffin cells	1	4.03986e-06	7.235587e-19	0.0104198	0.00265009	1
MP:0008507	thin retinal ganglion layer	15	1.611622e-10	1.403801e-05	0.1973959	8.091328e-07	0.1139009
MP:0008508	thick retinal ganglion layer	4	0.9493818	0.4489246	0.001517644	0.2024458	0.194643
MP:0008509	disorganized retinal ganglion layer	8	0.0001564545	0.03315147	0.0003085885	0.0421525	0.03989951
MP:0008510	absent retinal ganglion layer	2	0.009619625	0.121278	0.09812352	0.04333676	0.1860557
MP:0008511	thin retinal inner nuclear layer	37	1.036123e-14	1.145425e-17	1.17885e-12	2.129507e-22	0.0741312
MP:0008512	disorganized retinal inner nuclear layer	13	5.579773e-45	9.638102e-17	7.418558e-07	9.784325e-09	0.06815431
MP:0008513	thin retinal inner plexiform layer	13	5.938211e-17	0.07088113	3.06107e-07	7.883926e-12	0.06020889
MP:0008514	absent retinal inner plexiform layer	4	0.0467283	0.1247036	0.01313062	0.003376695	0.2274025
MP:0008515	thin retinal outer nuclear layer	82	1.808784e-78	7.947613e-12	3.506657e-28	1.180758e-40	0.04732476
MP:0008516	disorganized retinal outer nuclear layer	15	1.337266e-29	1.456588e-16	0.001067173	2.52534e-05	0.7301715
MP:0008517	thick retinal outer nuclear layer	2	6.362831e-08	0.6093727	0.008346032	0.004731185	0.05388631
MP:0008518	retinal outer nuclear layer degeneration	24	1.228903e-21	0.0001458198	4.573067e-11	2.119428e-06	0.3333608
MP:0008519	thin retinal outer plexiform layer	17	3.023539e-05	8.658479e-18	0.0001596428	5.646233e-06	0.2918413
MP:0008520	disorganized retinal outer plexiform layer	8	0.001214345	0.01512832	0.0003979875	0.01961254	0.9033372
MP:0008521	abnormal Bowman membrane	1	0.7248003	0.07022086	0.3832671	0.07280409	0.007418096
MP:0008522	abnormal lymph node germinal center morphology	29	1.153697e-33	0.0001183559	3.812677e-45	5.268098e-59	5.709796e-10
MP:0008523	absent lymph node germinal center	13	4.776598e-06	0.2388721	1.549932e-24	1.554457e-20	2.41058e-10
MP:0008524	increased plasmacytoid dendritic cell number	10	0.01852917	4.283109e-09	1.238684e-12	8.109382e-13	7.893456e-06
MP:0008525	decreased cranium height	34	1.025538e-22	2.434297e-48	1.079023e-08	1.889377e-16	0.000208721
MP:0008526	decreased cranium width	7	5.184646e-19	0.009689636	0.02769818	1.941396e-11	0.5652092
MP:0008527	embryonic lethality at implantation	26	5.407532e-46	8.161162e-09	2.532544e-08	8.58556e-10	0.0835981
MP:0008528	polycystic kidney	40	3.802884e-19	1.78858e-23	9.125778e-06	4.932201e-09	0.7078738
MP:0008529	enlarged optic nerve	1	0.2470631	0.07840333	0.4838158	0.001516576	1
MP:0008530	abnormal rostral-caudal patterning of the somites	11	8.038595e-24	1.545023e-06	0.05333708	0.0009128466	0.6701379
MP:0008531	increased chemical nociceptive threshold	28	2.83702e-19	0.005154784	0.01343672	0.0005857024	0.2600012
MP:0008532	decreased chemical nociceptive threshold	10	0.04849329	4.851552e-07	0.7678472	0.6121402	0.99799
MP:0008533	abnormal anterior visceral endoderm morphology	20	4.102446e-27	5.39851e-14	5.050415e-12	2.250952e-11	0.06550635
MP:0008534	enlarged fourth ventricle	7	0.8793953	3.426079e-48	0.9350413	0.08031536	0.5105461
MP:0008535	enlarged lateral ventricles	70	7.241137e-99	4.68067e-75	2.944881e-07	6.508439e-40	0.188614
MP:0008536	enlarged third ventricle	21	3.363837e-37	6.597908e-14	0.0003535078	1.866657e-08	0.6519045
MP:0008537	increased susceptibility to induced colitis	80	6.314721e-71	1.166072e-17	2.373514e-28	3.253342e-63	1.98319e-05
MP:0008538	decreased zigzag hair amount	6	2.927117e-08	0.9467641	0.1502029	0.03037386	0.5528917
MP:0008539	decreased susceptibility to induced colitis	27	1.114022e-29	0.001524515	1.057752e-29	1.22055e-52	0.0009452253
MP:0008540	abnormal cerebrum morphology	520	0	4.94065645841247e-324	7.114033e-94	3.141316e-177	5.16745e-05
MP:0008541	leukostasis	1	0.7248003	1.324959e-06	0.0003157966	0.0002520314	0.8122343
MP:0008542	enlarged cervical lymph nodes	8	1.012197e-19	0.005745313	3.71923e-13	2.056153e-26	0.000635494
MP:0008543	atrial fibrillation	4	0.00178332	0.008156575	0.9736104	0.1232064	0.1305308
MP:0008544	impaired olfaction	17	1.717197e-27	2.58225e-18	0.02525027	6.47593e-07	0.3316693
MP:0008545	absent sperm flagellum	15	4.064117e-31	0.001949382	0.001744556	9.570579e-09	0.3324274
MP:0008546	abnormal vesicle-mediated transport	13	1.018968e-22	0.002919953	2.80075e-07	6.825136e-06	0.007089878
MP:0008547	abnormal neocortex morphology	39	4.560502e-40	3.090436e-24	0.04425419	3.255108e-11	0.2133938
MP:0008548	abnormal circulating interferon level	85	3.23453e-104	0.0007674554	4.531616e-58	7.141093e-150	2.803765e-06
MP:0008549	abnormal circulating interferon-alpha level	15	1.19839e-09	0.4660717	7.366024e-06	6.503823e-15	0.02224216
MP:0008550	abnormal circulating interferon-beta level	10	4.050753e-17	0.04150176	0.000672268	7.8849e-15	0.0821315
MP:0008551	abnormal circulating interferon-gamma level	70	3.743591e-100	3.394241e-05	2.432548e-53	4.990769e-141	3.461583e-05
MP:0008552	abnormal circulating tumor necrosis factor level	123	1.858488e-221	1.094924e-18	1.955215e-65	8.905716e-213	0.01505626
MP:0008553	increased circulating tumor necrosis factor level	79	1.831516e-170	9.265233e-15	2.462822e-55	4.979141e-179	0.1067215
MP:0008554	decreased circulating tumor necrosis factor level	45	2.172458e-54	1.075563e-07	1.215254e-16	2.782212e-60	0.02301149
MP:0008555	abnormal interferon secretion	306	0	2.181213e-29	1.542922e-254	0	4.909357e-34
MP:0008556	abnormal tumor necrosis factor secretion	207	0	6.228605e-38	5.025177e-167	0	1.607147e-12
MP:0008557	abnormal interferon-alpha secretion	23	5.834305e-61	0.2518639	3.245114e-23	2.287888e-56	0.01188389
MP:0008558	abnormal interferon-beta secretion	26	7.605679e-71	0.0009110435	9.810905e-27	2.910259e-58	0.1557212
MP:0008559	abnormal interferon-gamma secretion	273	6.378396e-270	1.791809e-33	2.545741e-217	0	8.207325e-33
MP:0008560	increased tumor necrosis factor secretion	104	9.677891e-205	8.822058e-22	3.431251e-95	2.4449e-205	1.694148e-06
MP:0008561	decreased tumor necrosis factor secretion	113	2.171327e-138	7.297792e-19	2.353316e-78	2.31363e-178	6.670744e-09
MP:0008562	increased interferon-alpha secretion	3	1.680683e-06	0.1615028	7.401483e-06	6.755575e-05	0.08586815
MP:0008563	decreased interferon-alpha secretion	22	3.709216e-64	0.2735379	3.009932e-18	2.650437e-58	0.05220148
MP:0008564	increased interferon-beta secretion	6	1.952035e-34	0.04155302	0.2434749	1.198626e-07	1
MP:0008565	decreased interferon-beta secretion	21	2.761427e-51	0.001304567	2.084085e-26	8.328436e-53	0.1003951
MP:0008566	increased interferon-gamma secretion	130	4.58189e-110	3.554781e-13	3.540579e-106	6.750665e-186	3.738168e-17
MP:0008567	decreased interferon-gamma secretion	165	1.427692e-195	6.716338e-22	3.086734e-154	9.642306e-237	5.533164e-27
MP:0008568	abnormal interleukin secretion	456	0	1.112238e-73	0	0	5.541647e-31
MP:0008569	lethality at weaning	100	2.390434e-62	7.925978e-29	2.077311e-13	2.720327e-43	0.1628033
MP:0008570	lipidosis	7	8.183284e-31	0.0002918845	1.438335e-09	2.606202e-16	0.2666504
MP:0008571	abnormal synaptic bouton morphology	12	4.486094e-24	0.08650885	1.663029e-09	2.752752e-12	2.387382e-06
MP:0008572	abnormal Purkinje cell dendrite morphology	53	2.015607e-43	2.857432e-25	0.0003341816	4.424911e-24	0.8848525
MP:0008573	increased circulating interferon-alpha level	5	0.01227032	0.0007141523	0.2872374	0.0001472942	0.4560427
MP:0008574	decreased circulating interferon-alpha level	11	4.006008e-07	0.999674	1.563728e-06	4.442054e-11	0.03075405
MP:0008575	increased circulating interferon-beta level	1	9.798127e-06	1	0.06939772	3.468392e-08	1
MP:0008576	decreased circulating interferon-beta level	8	1.013406e-10	0.2615943	0.001285517	4.450967e-11	0.02126409
MP:0008577	increased circulating interferon-gamma level	42	1.893643e-91	7.418876e-05	2.676891e-31	2.489052e-106	0.002077499
MP:0008578	decreased circulating interferon-gamma level	31	3.771658e-21	0.004330203	3.289954e-29	2.335067e-39	0.0191633
MP:0008579	abnormal Purkinje cell differentiation	6	0.8601646	0.0001906966	0.4040146	0.2140014	0.5887044
MP:0008580	photoreceptor inner segment degeneration	5	1.467084e-39	0.9965715	3.672786e-07	8.347949e-07	0.4978329
MP:0008581	disorganized photoreceptor inner segment	5	4.831574e-17	0.03836904	0.01315971	0.0002726933	0.1812251
MP:0008582	short photoreceptor inner segment	17	2.138041e-07	0.994955	0.05406571	0.08937533	0.07530805
MP:0008583	absent photoreceptor inner segment	6	1.282203e-06	0.3163358	9.420973e-05	0.276232	0.1747607
MP:0008584	photoreceptor outer segment degeneration	16	1.508114e-17	0.09404299	1.949515e-06	0.0001274547	0.6516786
MP:0008585	absent photoreceptor outer segment	19	3.978226e-35	0.0004004913	6.148495e-09	3.551454e-12	0.06135602
MP:0008586	disorganized photoreceptor outer segment	18	7.113189e-25	0.001750777	1.884783e-08	7.289545e-08	0.6919237
MP:0008587	short photoreceptor outer segment	38	3.395979e-29	0.01040079	5.933771e-07	3.711358e-06	0.1362526
MP:0008588	abnormal circulating interleukin level	211	1.971611e-274	1.5628e-13	5.591987e-141	2.106983e-256	8.492271e-11
MP:0008589	abnormal circulating interleukin-1 level	53	4.047231e-45	7.889799e-09	5.830269e-43	3.713048e-87	0.001773538
MP:0008590	abnormal circulating interleukin-10 level	27	6.435624e-51	0.03374054	1.137033e-13	2.619373e-42	0.0003126587
MP:0008591	increased circulating interleukin-1 level	1	7.280735e-07	0.02594287	0.003181986	1.458904e-15	1
MP:0008592	decreased circulating interleukin-1 level	2	0.6102036	0.04572186	0.231873	0.01610108	0.2675309
MP:0008593	increased circulating interleukin-10 level	20	9.158412e-29	0.01587564	7.123481e-08	6.609916e-26	0.0001565561
MP:0008594	decreased circulating interleukin-10 level	7	1.825093e-38	0.5987249	1.470973e-06	2.961525e-13	0.3383536
MP:0008595	abnormal circulating interleukin-6 level	125	1.257779e-255	2.511403e-13	1.473276e-87	1.436776e-189	9.261217e-07
MP:0008596	increased circulating interleukin-6 level	77	4.032414e-168	7.256905e-05	3.739438e-58	7.941488e-143	3.201179e-05
MP:0008597	decreased circulating interleukin-6 level	52	8.380695e-77	1.053038e-13	1.331855e-35	2.149579e-44	4.998886e-05
MP:0008598	abnormal circulating interleukin-2 level	14	3.015345e-25	0.008406023	2.117456e-11	2.424547e-53	0.4578405
MP:0008599	increased circulating interleukin-2 level	9	1.642614e-12	0.004545923	0.0005581376	3.789293e-34	0.683074
MP:0008600	decreased circulating interleukin-2 level	5	6.590944e-15	0.3151837	3.317732e-10	5.160335e-21	0.2862128
MP:0008601	abnormal circulating interleukin-4 level	27	1.441888e-08	0.00694903	7.204952e-24	1.605768e-24	0.1685608
MP:0008602	increased circulating interleukin-4 level	11	6.742031e-14	0.0225013	8.370949e-05	1.994138e-22	0.9178093
MP:0008603	decreased circulating interleukin-4 level	15	0.216386	0.09738484	5.043255e-21	1.15899e-06	0.02997166
MP:0008607	abnormal circulating interleukin-13 level	7	0.001549094	0.9355282	5.742553e-08	1.165141e-06	0.9972804
MP:0008608	increased circulating interleukin-13 level	3	0.0005120919	0.007176614	0.0002823679	1.383329e-11	1
MP:0008609	decreased circulating interleukin-13 level	4	0.101344	0.9999573	3.011133e-05	0.2581301	0.9857968
MP:0008613	abnormal circulating interleukin-17 level	14	2.866759e-10	0.002874757	1.667814e-07	1.968741e-18	0.1171601
MP:0008614	increased circulating interleukin-17 level	13	5.747584e-11	0.002206848	5.374902e-07	2.06392e-18	0.5421533
MP:0008615	decreased circulating interleukin-17 level	2	0.9858898	0.977065	2.730413e-06	0.3765806	0.009397553
MP:0008616	abnormal circulating interleukin-12 level	31	1.116442e-54	0.9049127	1.903765e-14	2.03666e-47	7.13574e-06
MP:0008617	increased circulating interleukin-12 level	19	9.557997e-22	0.6469881	1.745049e-06	2.225726e-25	0.0007696831
MP:0008618	decreased circulating interleukin-12 level	10	4.329795e-22	0.9518377	8.963336e-09	1.395473e-23	0.01352073
MP:0008623	increased circulating interleukin-3 level	7	0.06869384	0.08846106	0.00583958	3.2431e-20	0.8688559
MP:0008625	abnormal circulating interleukin-5 level	12	0.07948365	0.2926625	4.443786e-10	9.228339e-21	0.8614636
MP:0008626	increased circulating interleukin-5 level	10	0.04190754	0.1937703	0.0001062126	5.679745e-17	0.9713276
MP:0008627	decreased circulating interleukin-5 level	1	0.9794862	0.9329748	6.505246e-08	0.004004114	0.2355317
MP:0008629	increased circulating interleukin-9 level	1	0.05031546	0.03625118	0.4099752	7.626888e-06	1
MP:0008632	increased circulating interleukin-16 level	1	0.7615658	0.005696871	1.054181e-05	0.1644294	0.6360803
MP:0008634	abnormal circulating interleukin-18 level	18	6.431272e-06	0.002766099	6.713136e-12	4.23755e-12	0.003918118
MP:0008635	increased circulating interleukin-18 level	11	0.01626112	0.1573591	8.606447e-09	3.135798e-10	0.0005414591
MP:0008636	decreased circulating interleukin-18 level	10	0.09599348	9.321979e-06	6.683689e-09	0.003342973	0.452386
MP:0008637	abnormal circulating interleukin-1 alpha level	14	0.0005752654	0.9485229	1.327916e-05	2.0397e-18	1.841719e-05
MP:0008638	increased circulating interleukin-1 alpha level	7	4.800553e-07	0.2109267	0.003145186	5.556125e-21	0.0001074435
MP:0008639	decreased circulating interleukin-1 alpha level	7	0.8263708	0.9998486	0.0008408308	0.01390937	0.02714271
MP:0008640	abnormal circulating interleukin-1 beta level	45	2.206692e-40	2.693235e-09	1.323284e-43	8.514804e-73	0.03592857
MP:0008641	increased circulating interleukin-1 beta level	28	2.77728e-34	4.558723e-07	2.071681e-22	4.477376e-63	0.1555187
MP:0008642	decreased circulating interleukin-1 beta level	19	9.733113e-11	7.470229e-05	4.009083e-25	1.008551e-20	0.142638
MP:0008644	increased circulating interleukin-12a level	2	3.32536e-19	0.572092	0.01880226	0.03003802	0.02423172
MP:0008646	abnormal circulating interleukin-12b level	19	1.810694e-44	0.4217957	1.718214e-19	1.651019e-27	0.007941572
MP:0008647	increased circulating interleukin-12b level	8	5.726005e-18	0.1528858	3.254443e-10	0.0001402613	0.1263973
MP:0008648	decreased circulating interleukin-12b level	11	3.866807e-20	0.8403342	6.433962e-09	2.440232e-19	0.02897073
MP:0008650	abnormal interleukin-1 secretion	75	1.557289e-67	6.390977e-11	4.465571e-57	3.492558e-91	1.61444e-05
MP:0008651	increased interleukin-1 secretion	2	0.03901955	0.01053232	0.1965883	1.559397e-08	1
MP:0008652	decreased interleukin-1 secretion	2	0.02756838	0.001599687	0.06338365	1.535136e-08	0.4137194
MP:0008653	abnormal interleukin-1 alpha secretion	12	0.9933367	0.6107048	0.003222922	0.5098918	2.127112e-05
MP:0008654	increased interleukin-1 alpha secretion	5	0.6196344	0.9866732	0.002129665	0.2819215	4.356156e-05
MP:0008655	decreased interleukin-1 alpha secretion	7	0.9985342	0.1474544	0.1286914	0.7033618	0.02493519
MP:0008656	abnormal interleukin-1 beta secretion	71	1.305116e-70	9.799914e-09	7.354247e-58	3.256172e-89	3.528778e-06
MP:0008657	increased interleukin-1 beta secretion	39	2.973524e-71	0.001550484	9.668375e-30	4.899603e-69	2.642712e-07
MP:0008658	decreased interleukin-1 beta secretion	33	2.387954e-07	2.962872e-06	4.347781e-31	1.585501e-24	0.01652975
MP:0008659	abnormal interleukin-10 secretion	89	2.777165e-134	6.237687e-14	2.758345e-84	6.932856e-113	1.161673e-12
MP:0008660	increased interleukin-10 secretion	46	3.434521e-39	4.207139e-11	1.928943e-46	4.245023e-46	8.789666e-11
MP:0008661	decreased interleukin-10 secretion	51	4.477084e-97	4.03795e-07	9.389399e-60	1.104779e-70	2.798936e-08
MP:0008662	abnormal interleukin-12 secretion	67	2.886957e-154	0.0003780755	4.669891e-78	7.032389e-117	0.0001329889
MP:0008663	increased interleukin-12 secretion	28	3.159633e-58	0.8491998	5.063347e-29	1.932724e-30	0.01023986
MP:0008664	decreased interleukin-12 secretion	36	1.814471e-81	5.886655e-07	4.808361e-48	5.022769e-84	0.0009604499
MP:0008666	increased interleukin-12a secretion	3	8.019682e-23	0.8126542	0.0003633983	2.071821e-07	0.07262803
MP:0008668	abnormal interleukin-12b secretion	32	4.461747e-77	0.001892696	2.044677e-27	1.743891e-80	7.429349e-05
MP:0008669	increased interleukin-12b secretion	16	2.438078e-46	0.09062212	3.429332e-19	1.723538e-40	0.0006598676
MP:0008670	decreased interleukin-12b secretion	19	8.412268e-44	0.001828373	4.281147e-19	1.325099e-56	0.03745426
MP:0008671	abnormal interleukin-13 secretion	62	4.798308e-83	1.510668e-10	1.273806e-47	1.132306e-54	0.04795997
MP:0008672	increased interleukin-13 secretion	34	1.489359e-38	0.07372937	9.438383e-30	1.2996e-24	3.740641e-05
MP:0008673	decreased interleukin-13 secretion	29	9.669794e-40	1.241341e-11	2.659981e-22	2.151647e-28	0.9856832
MP:0008676	decreased interleukin-15 secretion	1	0.12743	1	1	0.00103102	1
MP:0008680	abnormal interleukin-17 secretion	74	3.483713e-62	3.225724e-17	4.126328e-64	1.367628e-68	1.792563e-09
MP:0008681	increased interleukin-17 secretion	47	4.443223e-28	6.803614e-11	7.891143e-34	1.595592e-34	3.464827e-09
MP:0008682	decreased interleukin-17 secretion	29	4.280719e-62	6.596196e-08	2.958387e-34	1.509447e-44	0.03562802
MP:0008683	abnormal interleukin-18 secretion	9	0.0006470325	0.203997	0.0003598108	0.001450022	0.05649459
MP:0008684	increased interleukin-18 secretion	3	4.04963e-05	0.1867192	1.804101e-05	0.002813075	0.1369068
MP:0008685	decreased interleukin-18 secretion	6	0.3476188	0.414635	0.3907617	0.08897693	0.1606808
MP:0008686	abnormal interleukin-2 secretion	131	7.295915e-115	3.146557e-31	5.372352e-152	2.931154e-229	7.329889e-19
MP:0008687	increased interleukin-2 secretion	51	1.181205e-44	2.518612e-06	1.719641e-48	1.00769e-92	0.0004102631
MP:0008688	decreased interleukin-2 secretion	80	3.592206e-70	4.570093e-30	4.471579e-106	5.208194e-140	2.374033e-18
MP:0008689	abnormal interleukin-23 secretion	10	1.2921e-09	1.264845e-10	1.800775e-07	1.625737e-14	0.00468768
MP:0008690	increased interleukin-23 secretion	6	0.01244609	8.910731e-14	3.739023e-06	1.64488e-11	0.01311439
MP:0008691	decreased interleukin-23 secretion	4	2.265582e-14	0.9353188	0.01092749	0.0001541399	0.1240123
MP:0008695	abnormal interleukin-3 secretion	4	6.717637e-10	0.9255848	2.401534e-05	0.001422106	0.3478935
MP:0008696	increased interleukin-3 secretion	1	3.373587e-08	0.8931558	0.02903747	3.560287e-05	1
MP:0008697	decreased interleukin-3 secretion	3	2.620848e-05	0.8848022	0.0002111504	0.114925	0.2749031
MP:0008698	abnormal interleukin-4 secretion	140	2.966393e-93	3.124843e-27	7.525791e-161	3.640145e-164	5.70588e-18
MP:0008699	increased interleukin-4 secretion	70	7.152868e-58	2.791835e-06	4.046125e-65	2.532874e-73	1.774418e-07
MP:0008700	decreased interleukin-4 secretion	78	1.123166e-40	1.611788e-29	8.005299e-99	2.950051e-107	7.308826e-12
MP:0008701	abnormal interleukin-5 secretion	56	1.013384e-54	7.320121e-11	6.938157e-58	1.954499e-50	0.001056422
MP:0008702	increased interleukin-5 secretion	30	2.788744e-29	9.96804e-08	5.686877e-33	4.92536e-20	0.001217748
MP:0008703	decreased interleukin-5 secretion	30	4.864035e-22	1.439363e-06	8.736824e-33	4.096383e-29	0.04238498
MP:0008704	abnormal interleukin-6 secretion	155	5.22584e-264	1.031181e-16	1.623194e-143	3.8285e-240	6.411445e-09
MP:0008705	increased interleukin-6 secretion	78	2.767862e-178	4.603135e-07	1.232983e-61	9.505384e-157	1.396354e-06
MP:0008706	decreased interleukin-6 secretion	78	5.900165e-86	3.015797e-14	1.986227e-80	4.493583e-94	0.0001936652
MP:0008710	abnormal interleukin-9 secretion	10	4.528009e-28	0.006783705	1.068609e-16	2.433359e-22	0.3569333
MP:0008711	increased interleukin-9 secretion	2	0.9236484	0.7769882	0.006386165	0.9346119	0.1525406
MP:0008712	decreased interleukin-9 secretion	8	1.044902e-32	0.002009404	3.095108e-15	4.200686e-26	0.5714802
MP:0008713	abnormal cytokine level	376	0	3.16092e-38	7.178759e-228	0	5.441659e-16
MP:0008714	lung carcinoma	89	3.681712e-208	4.587469e-20	4.815138e-34	7.173163e-92	0.0001225133
MP:0008715	lung small cell carcinoma	5	7.473292e-06	0.6513222	9.65744e-06	3.502665e-07	0.007505619
MP:0008716	lung non-small cell carcinoma	76	4.57589e-176	1.237406e-17	4.879885e-30	9.600187e-84	0.006427274
MP:0008717	lung squamous cell carcinoma	2	2.166812e-06	0.3171147	0.02345381	0.03904958	0.4989579
MP:0008719	impaired neutrophil recruitment	61	2.908491e-123	5.198868e-20	7.738119e-65	3.248843e-133	5.337112e-05
MP:0008720	impaired neutrophil chemotaxis	54	6.540511e-75	1.197408e-05	2.830104e-21	3.833422e-111	5.542602e-06
MP:0008721	abnormal chemokine level	62	2.011669e-17	2.910616e-23	4.542899e-52	2.141096e-76	1.756138e-07
MP:0008722	abnormal chemokine secretion	51	5.056086e-45	1.573308e-15	2.118498e-38	8.426628e-89	0.009752933
MP:0008723	impaired eosinophil recruitment	20	1.5108e-44	0.007944001	9.463895e-26	3.183037e-32	0.006283433
MP:0008724	impaired eosinophil chemotaxis	2	0.03663403	0.9039092	5.153338e-06	0.0002746821	0.04132146
MP:0008725	enlarged heart atrium	30	2.143973e-19	4.136403e-41	1.976265e-07	4.058729e-23	0.1641102
MP:0008726	enlarged heart left atrium	1	0.9930732	0.7264086	0.5785484	0.4587774	0.8122343
MP:0008727	enlarged heart right atrium	8	1.882158e-08	3.726156e-15	0.9694178	1.472225e-05	0.6726985
MP:0008728	increased memory B cell number	1	0.004017566	0.6327778	0.0693156	0.08035383	0.3273782
MP:0008729	decreased memory B cell number	4	1.643067e-08	0.001179501	0.000664339	2.563733e-14	0.006911346
MP:0008730	fused phalanges	20	1.013806e-32	1.104069e-16	2.271314e-05	8.179643e-06	0.7496518
MP:0008731	abnormal hair shaft melanin granule morphology	14	0.188115	7.056319e-08	3.448146e-07	4.682883e-07	0.08653379
MP:0008732	reduced hair shaft melanin granule number	4	0.03034737	0.5290625	0.001462862	0.09558474	0.6340918
MP:0008733	abnormal hair shaft melanin granule distribution	6	0.7678118	0.0009436785	0.00784194	0.2137399	0.4481618
MP:0008734	decreased susceptibility to endotoxin shock	75	1.884947e-89	6.52887e-17	5.08845e-85	5.172291e-73	0.2015753
MP:0008735	increased susceptibility to endotoxin shock	65	6.068142e-164	4.730474e-09	6.632881e-41	3.165875e-86	1.230203e-05
MP:0008736	micromelia	5	0.009277252	0.2520946	0.5202253	0.3254156	0.8645261
MP:0008737	abnormal spleen physiology	84	2.907591e-72	2.181226e-10	7.482892e-65	2.813728e-128	0.0005603024
MP:0008738	abnormal liver iron level	40	2.27995e-96	0.0001114016	9.246373e-18	5.925801e-57	0.781613
MP:0008739	abnormal spleen iron level	31	6.392762e-78	0.03984746	1.60577e-11	2.458991e-60	0.221665
MP:0008740	abnormal intestinal iron level	7	0.9661089	0.004553306	0.5032333	0.1757758	0.3220266
MP:0008741	abnormal heart iron level	6	1.135804e-18	0.004401775	0.03882992	6.727163e-10	0.6516814
MP:0008742	abnormal kidney iron level	13	1.735464e-63	0.4390443	0.0002858153	1.019759e-24	0.2874211
MP:0008743	decreased liver iron level	10	1.714575e-13	0.0006135741	4.743843e-07	3.522151e-18	0.5814417
MP:0008746	abnormal peripheral B cell anergy	2	0.003250101	0.7893313	0.05101793	0.04274122	0.3939778
MP:0008747	abnormal T cell anergy	6	0.09692698	0.05965446	5.231367e-13	3.787717e-05	0.4581217
MP:0008749	abnormal peripheral T cell anergy	2	0.9787475	0.8167601	0.6596921	0.4456461	0.5208893
MP:0008750	abnormal interferon level	107	9.328621e-164	0.004682096	2.168183e-92	2.521053e-172	1.275196e-08
MP:0008751	abnormal interleukin level	252	0	2.328411e-16	1.454326e-164	9.10254e-278	1.254595e-12
MP:0008752	abnormal tumor necrosis factor level	167	6.674561e-273	1.02381e-25	6.536294e-92	2.524702e-236	0.005752668
MP:0008753	abnormal osteocyte morphology	12	1.216647e-15	4.374932e-15	3.744298e-10	2.834248e-08	0.05548947
MP:0008754	abnormal T cell receptor V(D)J recombination	17	5.229164e-11	4.829468e-16	0.0002014335	2.229479e-07	0.02917799
MP:0008755	abnormal immunoglobulin V(D)J recombination	19	3.726152e-67	0.09422485	4.047589e-07	6.481677e-35	0.4039845
MP:0008756	abnormal T cell receptor alpha chain V-J recombination	1	0.3193886	0.8500084	0.1675448	0.9793148	1
MP:0008757	abnormal T cell receptor gamma chain V-J recombination	1	7.215978e-08	0.0004375086	0.0003241782	0.01593879	0.5768159
MP:0008758	abnormal T cell receptor beta chain V(D)J recombination	9	4.540183e-07	0.0004595028	0.002300474	0.0003562466	0.06322249
MP:0008759	abnormal T cell receptor delta chain V(D)J recombination	4	4.029854e-09	0.0008500172	9.807554e-05	0.03541598	0.1948721
MP:0008760	abnormal immunoglobulin heavy chain V(D)J recombination	13	1.118814e-51	0.9288433	7.017648e-06	2.531649e-30	0.9660372
MP:0008761	abnormal immunoglobulin light chain V-J recombination	5	3.118715e-27	0.4190507	2.62393e-06	1.018892e-05	0.8589709
MP:0008762	embryonic lethality	1560	0	0	0	0	3.828786e-06
MP:0008763	abnormal mast cell degranulation	27	6.227161e-78	0.3287087	1.554205e-31	4.870804e-61	0.0007277795
MP:0008764	increased mast cell degranulation	12	3.480343e-40	0.08281548	2.860096e-15	8.559097e-18	0.03251431
MP:0008765	decreased mast cell degranulation	12	5.052127e-36	0.8055464	3.078139e-21	1.837654e-22	0.002296528
MP:0008766	abnormal B cell receptor editing	1	0.9918224	0.198886	0.2742174	0.3513614	0.6637307
MP:0008767	abnormal hair medullary septa cells	1	0.7830758	0.2494395	0.00122974	0.3138227	1
MP:0008768	abnormal hair medulla air spaces	1	7.047607e-06	1	0.1758434	1.429486e-05	1
MP:0008769	abnormal plasmacytoid dendritic cell physiology	11	1.680045e-17	0.6586447	2.961241e-12	2.48325e-16	0.0512936
MP:0008770	decreased survivor rate	213	1.315206e-243	1.012353e-124	7.366976e-74	4.064913e-116	0.001204904
MP:0008771	elongated vertebral column	1	0.7781911	0.002215278	0.7385187	0.6986688	0.4698013
MP:0008772	increased heart ventricle size	172	2.27173e-121	7.250806e-194	2.741197e-27	7.187626e-85	0.05494677
MP:0008775	abnormal heart ventricle pressure	57	4.485402e-34	1.547725e-52	1.432885e-13	1.445369e-24	0.4111229
MP:0008776	increased right ventricle peak pressure	1	0.123141	0.1318879	1	0.5444861	1
MP:0008778	abnormal lymphangiogenesis	12	7.992206e-08	6.290051e-06	8.124211e-13	7.051593e-11	0.6868465
MP:0008779	abnormal maternal behavior	130	4.167233e-43	1.780586e-79	3.444137e-32	2.048281e-38	0.006856744
MP:0008780	increased pancreatic acinar cell carcinoma incidence	6	1.084384e-55	0.002588086	0.02390607	6.013678e-11	0.1339048
MP:0008781	abnormal B cell apoptosis	65	1.461872e-136	7.803584e-08	4.918936e-54	1.204519e-165	0.005173578
MP:0008782	increased B cell apoptosis	42	8.632647e-94	0.08739181	1.168199e-21	1.132808e-110	0.02428699
MP:0008783	decreased B cell apoptosis	20	7.784015e-33	2.620409e-08	4.732525e-39	7.370831e-53	0.003624997
MP:0008784	craniorachischisis	20	9.113816e-19	7.899931e-46	2.255645e-13	3.318439e-11	0.8253869
MP:0008785	abnormal sternal manubrium morphology	6	0.9061722	6.088396e-37	0.999525	0.07804862	0.9181632
MP:0008786	abnormal hindgut morphology	10	5.521193e-07	1.212774e-11	0.2298489	0.08507577	0.2718858
MP:0008787	abnormal tailgut morphology	2	1.343961e-05	6.226591e-08	0.9090422	0.006681901	0.8943554
MP:0008788	abnormal fetal cardiomyocyte morphology	24	1.039786e-23	1.832417e-44	0.0003635674	1.858919e-13	0.4418992
MP:0008789	abnormal olfactory epithelium morphology	53	3.617068e-08	1.317656e-15	0.2031405	3.59752e-20	0.06830151
MP:0008791	decreased NK cell degranulation	5	8.010899e-11	0.005659443	1.350296e-12	1.884719e-19	0.01766421
MP:0008794	increased lens epithelium apoptosis	8	6.205897e-18	1.215199e-24	1.92621e-07	0.0007078626	0.07543356
MP:0008796	increased lens fiber apoptosis	4	1.566115e-16	2.472028e-09	1.145984e-07	0.0003107321	0.07555991
MP:0008797	facial cleft	37	1.777315e-47	2.201062e-71	3.128713e-33	4.789089e-47	0.6038792
MP:0008798	lateral facial cleft	1	0.8246961	0.008215793	0.001040567	0.3225972	0.498173
MP:0008799	oblique facial cleft	1	0.002521238	0.1425808	3.855737e-06	0.02233877	1
MP:0008800	increased small intestinal crypt cell apoptosis	8	1.412612e-31	0.131638	0.005254892	4.441468e-17	0.5786195
MP:0008801	abnormal erythroid progenitor cell morphology	100	1.05418786853147e-319	1.104555e-06	5.015193e-71	1.690929e-223	0.02474464
MP:0008802	abnormal intestinal smooth muscle morphology	8	1.523735e-15	1.125348e-06	0.1454082	1.975021e-05	0.9931859
MP:0008803	abnormal placental labyrinth vasculature morphology	92	8.144095e-247	3.923941e-57	4.173779e-51	5.313703e-97	0.006529098
MP:0008804	abnormal circulating amylase level	46	4.777378e-116	3.49975e-12	2.288197e-06	5.917947e-37	0.05881775
MP:0008805	decreased circulating amylase level	38	2.019894e-125	1.043656e-08	7.430027e-05	5.832295e-37	0.2181379
MP:0008806	increased circulating amylase level	7	0.05239122	6.480491e-06	0.009615123	0.01138961	0.05558077
MP:0008807	increased liver iron level	34	2.936688e-101	0.00252663	8.21533e-15	2.607553e-57	0.6532649
MP:0008808	decreased spleen iron level	17	2.362131e-61	0.07861169	2.427934e-14	2.634657e-45	0.2005962
MP:0008809	increased spleen iron level	17	1.607492e-21	0.1257831	0.01406751	6.861419e-20	0.2567106
MP:0008810	increased circulating iron level	19	3.761041e-83	0.03794739	1.616289e-07	6.02319e-29	0.5588524
MP:0008811	abnormal brain iron level	5	2.977444e-06	2.298036e-07	0.411288	5.54277e-05	0.4208333
MP:0008813	decreased common myeloid progenitor cell number	55	2.412208e-144	7.061643e-25	1.758828e-37	1.738067e-87	0.09333634
MP:0008814	decreased nerve conduction velocity	39	4.156781e-18	1.716532e-39	4.246176e-13	3.228132e-11	0.001506974
MP:0008816	petechiae	7	9.92543e-24	8.379573e-06	2.798237e-05	5.405071e-15	0.07033116
MP:0008817	hematoma	20	1.25836e-28	8.913936e-13	0.003851233	3.703534e-09	0.8085124
MP:0008818	abnormal interfrontal bone morphology	3	0.05109796	2.99016e-10	0.5658606	0.2227025	0.2424641
MP:0008819	abnormal mastication	1	1.387666e-07	0.003146579	2.105504e-07	2.135908e-05	1
MP:0008820	abnormal blood uric acid level	15	2.100822e-07	4.864281e-08	0.01026199	8.62295e-05	0.03587946
MP:0008821	increased blood uric acid level	13	5.793373e-10	1.177405e-06	0.5393756	6.267373e-05	0.1314403
MP:0008822	decreased blood uric acid level	4	0.2824476	0.006432765	2.764828e-06	0.01124831	0.01925947
MP:0008823	abnormal interventricular septum membranous part morphology	54	6.56936e-75	1.501858e-67	7.738108e-10	7.760021e-23	0.01679917
MP:0008824	absent interventricular septum membranous part	1	0.283985	0.9951921	0.9351501	0.2341714	1
MP:0008825	abnormal cardiac epithelial to mesenchymal transition	27	3.517066e-30	5.741224e-25	1.126061e-06	2.436546e-14	0.660739
MP:0008826	abnormal splenic cell ratio	58	3.376822e-159	5.651646e-17	9.518524e-55	1.424266e-142	0.0007156378
MP:0008827	abnormal thymus cell ratio	24	4.051539e-94	5.794337e-06	5.845764e-17	6.574953e-52	0.02035032
MP:0008828	abnormal lymph node cell ratio	31	2.014849e-54	2.406099e-16	6.45487e-42	9.014501e-65	0.0004206388
MP:0008830	abnormal nucleolus morphology	3	0.0002626454	0.01604654	0.07253706	8.546135e-07	0.2637515
MP:0008831	abnormal insulin-like growth factor I level	65	1.113982e-59	6.059233e-23	1.639393e-33	4.103315e-25	0.03091238
MP:0008832	hemivertebra	3	2.932433e-14	4.468729e-14	0.001285166	0.001686245	0.8325293
MP:0008834	abnormal melanosome transport	1	0.1902299	0.0008806795	0.6891663	2.5197e-06	0.08453146
MP:0008835	abnormal intercellular signaling peptide or protein level	384	0	8.351368e-37	2.312911e-245	0	1.908894e-16
MP:0008836	abnormal transforming growth factor beta level	11	1.270698e-09	0.3542132	9.403589e-25	2.392241e-25	0.01633926
MP:0008837	increased transforming growth factor level	5	2.929603e-05	0.9888203	2.518074e-14	5.072562e-23	0.6570573
MP:0008838	decreased transforming growth factor level	7	0.0033171	0.1967974	5.166281e-09	0.000449059	0.013891
MP:0008839	absent acrosome	6	1.311688e-25	0.8692586	0.6644667	4.366744e-09	0.1221524
MP:0008840	abnormal spike wave discharge	22	2.682269e-30	1.116741e-21	0.5406886	0.001183954	0.002014523
MP:0008841	ruptured lens capsule	12	9.156504e-08	9.525053e-14	2.590625e-11	0.0002322141	0.00136227
MP:0008842	lipofuscinosis	10	4.37618e-14	0.4270116	3.269338e-09	2.755702e-17	0.2016048
MP:0008843	absent subcutaneous adipose tissue	19	2.716064e-05	8.667884e-22	4.200163e-06	1.355696e-23	0.02831972
MP:0008844	decreased subcutaneous adipose tissue amount	77	2.205655e-118	1.163692e-46	1.140686e-32	2.348597e-45	0.1443881
MP:0008845	abnormal paraventricular hypothalamic nucleus morphology	3	0.8836435	0.0001143856	0.03478835	0.2260141	0.04373056
MP:0008846	abnormal supraoptic nucleus morphology	3	0.02661559	9.192932e-05	0.06417864	0.1879313	0.03177075
MP:0008847	abnormal suprachiasmatic nucleus morphology	5	0.0001518701	0.1241259	0.3681854	0.0009413104	0.9498245
MP:0008850	increased hemoglobin concentration distribution width	8	7.938669e-23	0.8325872	4.614833e-07	1.846355e-35	0.9074851
MP:0008852	retinal neovascularization	37	4.945179e-52	6.239257e-30	9.419981e-29	3.421864e-30	0.01320151
MP:0008853	decreased abdominal adipose tissue amount	17	9.10242e-26	4.020823e-05	9.153474e-10	2.049906e-07	0.125515
MP:0008854	bleb	8	0.9999823	1.434102e-16	0.8409892	0.6928874	0.670724
MP:0008855	eye bleb	1	0.8246961	0.008215793	0.9827874	0.746	1
MP:0008856	fetal bleb	5	0.4183874	3.938231e-07	0.3510108	0.01630684	0.5542871
MP:0008857	myelencephalic blebs	1	0.9999736	5.014296e-07	1	0.999381	0.2355317
MP:0008858	abnormal hair cycle anagen phase	19	3.216165e-33	4.443321e-14	1.08335e-11	2.348833e-18	0.08165245
MP:0008859	abnormal hair cycle catagen phase	11	6.609431e-19	8.381656e-09	0.00219665	0.003764094	0.02878817
MP:0008860	abnormal hair cycle telogen phase	5	5.349267e-26	5.197335e-14	3.022791e-05	0.05307462	0.2677539
MP:0008861	abnormal hair shedding	5	0.003453741	7.099799e-31	0.007016337	1.299084e-06	0.02884903
MP:0008862	asymmetric snout	5	2.668971e-29	9.221403e-05	5.181018e-07	7.0067e-05	0.7993173
MP:0008863	craniofacial asymmetry	1	0.3382129	1.394423e-05	6.101e-06	0.01718481	0.187638
MP:0008864	abnormal intestinal secretion	2	1	0.2500734	0.0003429166	0.8052669	0.1336222
MP:0008866	chromosomal instability	115	8.767345e-171	7.924338e-06	6.531179e-13	1.962786e-48	0.3304422
MP:0008868	abnormal granulosa cell morphology	28	4.492533e-13	2.018839e-13	7.573298e-14	4.459869e-10	0.110651
MP:0008869	anovulation	24	5.109619e-19	5.031495e-11	1.232049e-10	1.036487e-06	0.001114755
MP:0008870	increased mature ovarian follicle number	3	0.9999362	0.999998	0.5139448	0.9416189	0.1051254
MP:0008871	abnormal ovarian follicle number	113	2.530489e-130	7.976017e-25	7.613014e-22	5.978871e-37	0.0001131406
MP:0008872	abnormal physiological response to xenobiotic	557	0	1.2273e-120	3.898772e-177	0	2.562637e-06
MP:0008873	increased physiological sensitivity to xenobiotic	238	1.699775e-272	1.68181e-57	1.141594e-85	7.023457e-180	1.271067e-05
MP:0008874	decreased physiological sensitivity to xenobiotic	256	3.066352e-296	1.445589e-42	2.609615e-89	3.587377e-163	0.09778165
MP:0008875	abnormal xenobiotic pharmacokinetics	31	4.992921e-12	4.853712e-16	8.490283e-05	1.709594e-13	0.3659313
MP:0008876	decreased uterine NK cell number	9	3.224301e-06	0.7228741	0.0379451	3.388168e-14	0.09706898
MP:0008877	abnormal DNA methylation	41	1.832591e-107	0.0008232185	1.988802e-09	3.497353e-12	0.1213834
MP:0008878	abnormal DNA methylation during gametogenesis	7	2.570579e-15	0.4381588	0.01628505	0.4012423	0.6801549
MP:0008879	submandibular gland inflammation	3	0.006516503	2.850527e-05	7.499043e-17	0.1935512	2.557906e-06
MP:0008880	lacrimal gland inflammation	12	0.001465298	1.163738e-24	1.343236e-26	5.627163e-18	0.02187635
MP:0008881	absent Harderian gland	6	0.0002978682	0.0002566344	0.0001677397	0.1733866	0.8200609
MP:0008882	abnormal enterocyte physiology	58	5.012289e-91	3.017004e-17	3.869759e-32	1.44803e-49	0.01592445
MP:0008883	abnormal enterocyte proliferation	38	9.586869e-76	1.555922e-09	2.904031e-26	8.258079e-34	0.01550366
MP:0008884	abnormal enterocyte apoptosis	27	7.707472e-50	4.792341e-14	1.576252e-15	1.808229e-17	0.008954245
MP:0008885	increased enterocyte apoptosis	21	6.709102e-45	5.304334e-07	6.62059e-12	1.431591e-12	0.002859303
MP:0008886	abnormal PML bodies	1	0.002521238	0.1425808	3.855737e-06	0.02233877	1
MP:0008888	abnormal Cajal body morphology	2	1.022426e-06	0.1906703	0.5896209	0.001431218	1
MP:0008890	abnormal nuclear lamina morphology	2	1.33626e-09	0.8791574	0.001464071	4.10318e-10	0.8924728
MP:0008891	decreased hepatocyte apoptosis	9	1.056976e-22	1.078193e-06	0.3499891	2.746402e-07	0.5837815
MP:0008892	abnormal sperm flagellum morphology	101	1.796374e-89	3.524681e-06	3.15756e-13	3.722762e-25	0.1553514
MP:0008893	detached sperm flagellum	14	3.378701e-08	0.01148191	5.260504e-06	1.020532e-08	0.5794454
MP:0008894	abnormal intraepithelial T cell morphology	29	8.388404e-21	1.190924e-05	4.907474e-18	5.789677e-49	1.009957e-05
MP:0008895	abnormal intraepithelial T cell number	24	3.512333e-23	0.005006771	1.198361e-15	8.879878e-51	6.992617e-06
MP:0008896	increased IgG2c level	8	4.898161e-08	2.913724e-11	1.622303e-15	1.673514e-05	0.09695759
MP:0008897	decreased IgG2c level	7	0.7360355	0.002297232	2.164159e-16	6.41728e-06	0.1043118
MP:0008898	abnormal acrosome morphology	55	6.341941e-61	0.4756562	0.0001463523	5.185655e-10	0.3447996
MP:0008899	plush coat	2	0.9997781	2.589386e-11	0.1344622	0.8909671	0.8729475
MP:0008900	abnormal uterine fat pad morphology	5	1.130106e-31	3.441783e-05	5.832905e-06	3.60128e-08	0.9535442
MP:0008901	absent epididymal fat pad	1	0.4481452	0.1018857	0.8735623	0.3245534	0.5732228
MP:0008902	abnormal renal fat pad morphology	14	2.159117e-05	0.1203334	0.001094315	2.34392e-08	0.1555636
MP:0008903	abnormal mesenteric fat pad morphology	22	7.220963e-29	7.404579e-06	6.933499e-25	1.306436e-13	0.7118724
MP:0008904	abnormal mammary fat pad morphology	7	0.7011076	0.009249626	0.07565003	0.0005174929	0.03715581
MP:0008906	abnormal parametrial fat pad morphology	9	0.4349057	0.006197127	1.725326e-08	7.016232e-07	0.2176449
MP:0008907	decreased total fat pad weight	15	1.421318e-06	9.97336e-08	0.001381523	6.550118e-05	0.8686195
MP:0008908	increased total fat pad weight	18	0.217296	9.63992e-08	4.95582e-05	0.01097173	0.0150464
MP:0008911	induced hyperactivity	31	6.534884e-13	1.126871e-21	0.0003121897	3.674861e-07	0.500098
MP:0008912	nervous	1	0.9794862	0.9938493	0.9128654	0.999381	0.498173
MP:0008913	weaving	4	0.9700753	0.9929603	0.9996274	0.8925782	0.7962542
MP:0008914	enlarged cerebellum	5	0.05875932	0.0004930693	0.02773468	0.001326955	0.9536651
MP:0008915	fused carpal bones	16	0.8658254	3.851471e-17	2.133906e-06	3.379422e-07	0.07922233
MP:0008916	abnormal astrocyte physiology	23	5.510483e-30	1.774198e-10	1.136367e-06	2.668304e-22	0.7398726
MP:0008917	abnormal oligodendrocyte physiology	16	8.944987e-17	5.633381e-18	1.807764e-05	6.558496e-06	0.02028583
MP:0008918	microgliosis	39	6.785229e-104	1.697815e-07	1.221413e-18	7.555565e-42	0.0452936
MP:0008919	fused tarsal bones	15	0.3137859	1.668002e-19	0.3807196	0.1037605	0.2571803
MP:0008921	increased neurotransmitter release	4	0.9708144	0.0004770236	0.7922071	0.01839617	0.8421917
MP:0008922	abnormal cervical rib	1	0.3131326	0.9828982	6.370743e-06	0.8272477	0.0437684
MP:0008923	thoracoschisis	1	0.9508384	2.652335e-09	0.3832671	0.3225972	0.8122343
MP:0008924	decreased cerebellar granule cell number	15	9.607637e-16	4.348714e-10	0.04807642	9.27017e-14	0.6934813
MP:0008925	increased cerebellar granule cell number	2	0.7224081	0.0009316445	0.005711582	0.8319487	0.7322204
MP:0008926	abnormal anterior definitive endoderm morphology	8	4.004824e-14	1.191399e-06	0.0004413975	1.458186e-05	0.007836944
MP:0008929	abnormal central medial nucleus morphology	1	0.8246961	0.9998923	0.3832671	0.8595013	0.007418096
MP:0008932	abnormal embryonic tissue physiology	104	6.648601e-110	2.019377e-37	1.069219e-27	2.547539e-48	0.02075456
MP:0008933	abnormal embryonic cilium physiology	10	0.01300504	6.029926e-08	0.02194527	0.04232202	0.1886887
MP:0008934	absent choroid plexus	15	3.476717e-15	2.965383e-16	0.0003423971	2.747888e-10	0.2224825
MP:0008935	decreased mean platelet volume	2	1.913994e-07	0.04679567	0.002704778	0.002937903	2.449509e-07
MP:0008936	abnormal pituitary gland size	41	6.452424e-31	6.890075e-26	2.723283e-16	1.675919e-33	0.2344003
MP:0008937	abnormal pituitary gland weight	5	0.3718693	0.006991039	0.9934843	0.1829032	1
MP:0008938	decreased pituitary gland weight	2	0.06062988	8.956386e-06	0.9853224	0.6876005	1
MP:0008939	increased pituitary gland weight	3	0.8796432	0.8511989	0.9431782	0.06672054	1
MP:0008940	delayed balanopreputial separation	1	0.9999736	1.84821e-07	1	0.9948082	1
MP:0008941	reticulocytopenia	12	2.093963e-27	2.351771e-08	0.03598364	3.246682e-30	0.5036256
MP:0008942	abnormal induced cell death	209	0	3.64328e-42	4.135293e-57	8.642325e-179	0.009907971
MP:0008943	increased sensitivity to induced cell death	151	2.311402e-274	1.678956e-20	1.777228e-18	4.020051e-104	0.04499185
MP:0008944	decreased sensitivity to induced cell death	74	1.070144e-131	7.270431e-26	1.799808e-51	1.517166e-90	0.1394263
MP:0008945	hyperchromic macrocytic anemia	1	0.1116055	0.4218286	0.6214038	0.009528175	1
MP:0008946	abnormal neuron number	443	0	6.102576e-222	1.650693e-60	5.6578e-149	5.99187e-05
MP:0008947	increased neuron number	94	2.61324e-26	2.182294e-78	4.310594e-24	6.005979e-47	0.01881798
MP:0008948	decreased neuron number	394	0	8.705523e-178	1.398626e-41	6.993383e-117	0.0005468197
MP:0008949	increased Cajal-Retzius cell number	4	5.932434e-05	1.967916e-13	6.887778e-06	0.002828722	0.827498
MP:0008950	ventricular tachycardia	13	7.776462e-06	7.94483e-16	0.0001730679	0.0006345106	0.1849469
MP:0008951	long radius	2	1.902477e-12	2.88437e-05	0.5386989	2.972145e-06	0.4383037
MP:0008953	abnormal pancreatic somatostatin secretion	3	0.9999989	0.2113518	0.9999724	0.9985745	0.4338267
MP:0008954	abnormal cellular hemoglobin content	8	2.39046e-40	0.9999585	0.09739199	8.539656e-14	0.03960639
MP:0008955	increased cellular hemoglobin content	2	4.687599e-10	0.7566675	0.8887372	0.0009022408	0.5951089
MP:0008956	decreased cellular hemoglobin content	6	2.875877e-32	0.9999736	0.04763287	1.52929e-11	0.03349281
MP:0008957	abnormal placenta junctional zone morphology	66	4.238771e-147	8.900057e-47	3.299522e-23	2.220501e-58	0.8828483
MP:0008958	abnormal trophoblast glycogen cell morphology	9	1.871187e-39	0.0007827887	6.5904e-14	5.328722e-13	0.91715
MP:0008959	abnormal spongiotrophoblast cell morphology	14	1.862754e-35	1.100305e-08	3.284171e-07	1.49289e-16	0.2039956
MP:0008960	abnormal axon pruning	8	0.1174672	2.358452e-38	0.00306834	0.4523858	0.8992608
MP:0008961	abnormal basal metabolism	34	4.270747e-34	1.810184e-05	2.275834e-17	1.190004e-23	0.002233014
MP:0008962	abnormal carbon dioxide production	57	4.922937e-99	6.463863e-09	5.126325e-15	7.518852e-39	0.1952347
MP:0008963	increased carbon dioxide production	42	1.055753e-91	0.0001997043	7.779439e-09	1.049736e-27	0.525512
MP:0008964	decreased carbon dioxide production	16	9.429972e-21	4.643343e-10	1.825377e-13	1.016379e-22	0.1532804
MP:0008965	increased basal metabolism	19	7.446107e-32	0.04330888	5.125715e-13	5.031654e-17	0.001082008
MP:0008966	abnormal chiasmata formation	10	4.650267e-09	0.9699966	0.4516998	0.5928578	0.9793302
MP:0008967	absent chiasmata formation	2	0.9236869	0.8561562	1	0.3722959	0.5233913
MP:0008968	abnormal lacrimal apparatus morphology	30	9.905058e-19	1.053723e-39	3.132234e-11	3.0353e-26	0.6189797
MP:0008969	abnormal nasolacrimal duct morphology	5	0.4383985	4.302762e-09	0.01797056	0.3442649	0.9554754
MP:0008970	choanal atresia	2	0.9995695	0.9981676	0.9064392	0.9622061	1
MP:0008971	abnormal ethmoturbinate morphology	4	0.9269051	0.04170858	0.1953046	0.06930862	0.505569
MP:0008972	ethmoturbinate hypoplasia	3	0.8783303	0.09430941	0.08212079	0.4008178	0.600632
MP:0008973	decreased erythroid progenitor cell number	60	1.038764e-232	0.0001315903	1.89975e-43	7.857721e-155	0.3267886
MP:0008974	proportional dwarf	23	0.001055978	6.395123e-19	3.372374e-07	1.580544e-05	0.1857313
MP:0008975	delayed male fertility	6	1	0.01997787	0.619447	0.9967852	0.1028109
MP:0008976	delayed female fertility	11	0.00020021	1.563709e-11	3.951783e-05	4.728333e-09	0.06688093
MP:0008977	abnormal vagina size	9	0.990554	0.6294718	0.06462102	0.007563235	0.02453747
MP:0008978	abnormal vagina weight	3	0.9999173	0.8015723	0.6920654	0.4954838	0.07036787
MP:0008980	decreased vagina weight	1	1	0.9843364	0.9128654	0.999381	0.02789339
MP:0008983	small vagina	7	0.9839911	0.7753088	0.08290068	0.05976309	0.0162181
MP:0008984	vagina hypoplasia	2	0.3897644	0.1195832	0.04206855	0.2113325	0.3710149
MP:0008985	hemimelia	3	0.0885074	0.2153444	0.9313415	0.9976818	0.8642901
MP:0008986	abnormal liver parenchyma morphology	190	0	2.092284e-85	2.92436e-60	1.225965e-177	0.1218711
MP:0008987	abnormal liver lobule morphology	180	0	6.355526e-73	1.519551e-59	9.132156e-168	0.05677007
MP:0008988	abnormal liver perisinusoidal space morphology	2	4.009811e-12	0.4022364	0.001693181	1.04219e-15	0.7302943
MP:0008989	abnormal liver sinusoid morphology	44	6.778608e-162	5.323495e-17	6.98081e-31	1.431911e-60	0.04115537
MP:0008990	abnormal Ito cell morphology	1	0.0372398	0.7666928	0.1169512	7.108931e-08	0.3857199
MP:0008991	abnormal bile canaliculus morphology	6	0.0002407457	0.003132701	0.008932886	0.009866379	0.2637156
MP:0008992	abnormal portal lobule morphology	5	2.526753e-09	1.084611e-15	0.2077517	0.0187721	0.3868128
MP:0008993	abnormal portal triad morphology	4	2.729748e-06	4.784769e-11	0.6506346	0.02365456	0.5476001
MP:0008994	early vaginal opening	3	0.9999701	0.3873001	0.06551881	0.9578827	0.01234911
MP:0008995	early reproductive senescence	22	0.008208121	1.035808e-07	0.0004753211	2.640862e-07	0.005923236
MP:0008996	abnormal blood osmolality	17	3.291581e-58	1.116553e-06	1.076471e-05	1.320944e-13	0.9777271
MP:0008997	increased blood osmolality	16	6.763951e-50	1.429763e-08	0.0002735943	1.294137e-12	0.9776758
MP:0008998	decreased blood osmolality	1	4.917769e-25	0.01217779	0.003833254	1.17357e-06	1
MP:0008999	absent anus	4	0.9999954	4.756562e-13	0.5437554	0.4722987	0.8969256
MP:0009001	absent hallux	1	1	0.3642343	0.687584	0.06370262	1
MP:0009003	abnormal vibrissa number	8	0.9832043	1.187251e-29	0.9630986	0.6678448	0.9762051
MP:0009004	progressive hair loss	13	3.191895e-26	2.747368e-22	1.01448e-07	1.895112e-37	0.8276035
MP:0009005	abnormal sesamoid bone of gastrocnemius morphology	4	0.1230921	2.919403e-06	0.0002020575	0.01683887	0.9018953
MP:0009006	prolonged estrous cycle	31	0.0007198598	9.795001e-33	3.530865e-08	1.953189e-16	0.7302568
MP:0009007	short estrous cycle	5	4.449272e-13	0.03983013	0.8317638	2.287324e-05	0.7459589
MP:0009008	delayed estrous cycle	7	0.994055	2.357087e-06	0.9999431	0.3637117	0.9451501
MP:0009009	absent estrous cycle	25	7.678313e-14	0.3386663	1.140842e-08	9.443261e-09	0.02075394
MP:0009010	abnormal diestrus	27	0.003713631	1.107395e-38	2.750343e-09	9.756181e-07	0.2311684
MP:0009011	prolonged diestrus	21	0.2523879	6.408025e-30	2.069337e-09	0.0003237844	0.2535263
MP:0009012	short diestrus	4	1.772545e-08	3.608478e-06	0.9431463	0.004025749	0.3779948
MP:0009013	abnormal proestrus	11	0.897324	1.081141e-15	0.1504906	0.003221223	0.3513279
MP:0009014	prolonged proestrus	6	0.9998448	6.130582e-11	0.9088103	0.6199191	0.5438009
MP:0009015	short proestrus	3	0.0408312	0.09163141	0.5915197	0.003215918	0.0466956
MP:0009016	abnormal estrus	22	0.4340286	1.153858e-19	0.9503036	0.1577944	0.2777154
MP:0009017	prolonged estrus	10	0.9968003	0.0001646291	0.8427814	0.02654151	0.8436472
MP:0009018	short estrus	4	0.4575615	4.09721e-14	0.4726305	0.3526424	0.4298098
MP:0009019	abnormal metestrus	8	0.4812988	5.4968e-14	0.6100408	0.1160068	0.9307435
MP:0009020	prolonged metestrus	5	0.4006851	3.057761e-11	0.2106031	0.007285137	1
MP:0009021	absent estrus	7	1.681e-05	5.23846e-11	0.8606333	0.1431915	0.223212
MP:0009022	abnormal brain meninges morphology	14	0.02633852	9.042646e-40	3.749334e-10	2.911555e-22	0.8163985
MP:0009023	abnormal spinal cord meninges morphology	2	0.04857763	0.6593541	0.0001913402	0.0001307576	0.02290371
MP:0009025	abnormal brain dura mater morphology	3	0.01012112	0.0007286181	4.617403e-09	4.645704e-09	0.9251793
MP:0009026	abnormal brain pia mater morphology	7	0.3343759	7.137306e-39	8.586989e-05	8.429194e-07	0.2310783
MP:0009027	abnormal subarachnoid space morphology	6	0.005238249	2.059756e-09	0.0001179889	1.569957e-07	0.4371889
MP:0009037	abnormal subarachnoid space development	2	0.866988	0.9905248	0.1443198	0.5219143	0.8298349
MP:0009038	decreased inferior colliculus size	11	0.02954513	7.137622e-14	0.0001824958	0.004294844	0.8605431
MP:0009039	absent inferior colliculus	8	0.0005542715	4.479794e-14	2.549283e-06	0.03219559	0.9339656
MP:0009040	absent superior colliculus	2	0.3770347	0.0001961476	0.1390134	0.2423554	0.9362376
MP:0009041	absent colliculi	2	0.3770347	0.0001961476	0.1390134	0.2423554	0.9362376
MP:0009043	increased pancreas adenoma incidence	9	1.208862e-41	0.0004568777	0.01234797	3.164559e-07	0.157026
MP:0009045	muscle tetany	1	0.001782329	0.9757942	0.00634996	0.0002044427	1
MP:0009046	muscle twitch	71	7.946815e-34	1.32401e-58	9.997816e-13	3.110262e-17	0.5435583
MP:0009047	short metestrus	1	0.01728365	0.8595563	0.464109	0.1823463	0.08820478
MP:0009048	enlarged tectum	7	6.740611e-10	7.184287e-09	0.9058729	2.045501e-07	0.9761753
MP:0009049	abnormal hallux morphology	4	0.102852	8.628483e-07	0.3814251	0.1188251	0.9368277
MP:0009050	dilated proximal convoluted tubules	28	1.80586e-18	1.688158e-41	4.41959e-07	1.908968e-11	0.897509
MP:0009051	dilated distal convoluted tubules	9	0.004296166	2.504062e-26	0.05507289	4.829966e-05	0.3773101
MP:0009052	anal stenosis	2	0.9723282	2.699623e-20	1	0.7428453	0.9314033
MP:0009053	abnormal anal canal morphology	28	0.0217916	2.025991e-23	0.3830106	0.003471246	0.8977057
MP:0009054	absent anal canal	2	0.5754978	0.428909	0.05596795	8.884558e-07	0.3991433
MP:0009055	abnormal internal anal sphincter morphology	2	0.1268335	0.009487859	0.09991104	0.3542238	0.8318286
MP:0009056	abnormal interleukin-21 secretion	7	2.238685e-05	0.005979924	1.723968e-15	5.559079e-16	0.287422
MP:0009057	increased interleukin-21 secretion	2	0.0009587032	0.001757158	1.271941e-06	1.599877e-08	0.8137631
MP:0009058	decreased interleukin-21 secretion	5	0.003184711	0.1910953	1.940983e-10	2.912241e-09	0.1381851
MP:0009062	impaired lectin complement pathway	4	3.020992e-36	0.01938318	0.06066087	0.003657468	0.6956783
MP:0009063	abnormal oviduct size	11	8.542262e-14	1.120138e-10	0.6362347	0.0003102863	0.2428005
MP:0009064	oviduct atrophy	1	9.401544e-20	0.8593011	1	0.08907121	1
MP:0009066	decreased oviduct weight	2	0.5682683	0.9998701	1	0.5847007	0.6225284
MP:0009069	dilated oviduct	2	4.946016e-06	1.698114e-05	0.0956434	8.645713e-07	0.2505474
MP:0009070	small oviduct	9	1.250786e-09	3.813759e-07	0.8917854	0.1423366	0.3700611
MP:0009071	short oviduct	4	1.70265e-07	7.072492e-11	0.4550016	0.06912637	0.1388928
MP:0009072	absent cranial vagina	5	0.03815946	0.01347744	0.1354324	5.155903e-12	0.5277764
MP:0009073	absent Wolffian ducts	4	0.6270975	0.7648944	0.8242452	0.05259945	0.1487558
MP:0009074	Wolffian duct degeneration	3	0.5063572	1.387613e-10	0.3386243	0.01000848	0.9247613
MP:0009075	rudimentary Wolffian ducts	5	0.02235309	1.566716e-06	0.7076177	0.0002034713	0.9943018
MP:0009076	rudimentary Mullerian ducts	5	0.04554017	3.257218e-08	0.08643913	0.0001055362	0.7576723
MP:0009078	adrenal gland hyperplasia	3	1.579532e-10	0.009990292	0.06298249	1.06133e-05	0.05700873
MP:0009080	uterus inflammation	2	0.9995825	0.004319244	0.02031747	0.000379577	0.03679406
MP:0009081	thin uterus	10	3.911825e-06	0.3351629	0.1614496	0.4365585	0.07258825
MP:0009082	uterus cysts	9	0.9999997	0.04539824	0.2698209	0.5255544	0.08692825
MP:0009083	uterus hypertrophy	1	0.001551689	1	0.3721935	0.0002489135	1
MP:0009084	blind uterus	2	0.005834455	1.384235e-15	0.1965883	0.3143715	0.9647485
MP:0009085	abnormal uterine horn morphology	18	2.540396e-09	2.676852e-35	0.0007383074	3.562084e-08	0.1215336
MP:0009087	dilated uterine horn	3	0.09018367	4.21769e-09	1.233358e-05	2.789704e-09	0.6929786
MP:0009088	thin uterine horn	5	0.1201586	0.01084291	0.1274222	0.9191196	0.0246914
MP:0009089	short uterine horn	5	1.937904e-10	2.863074e-13	0.06534059	0.001139465	0.6113773
MP:0009090	myometrium hypoplasia	3	0.9987592	1.482029e-07	0.0007094714	0.3303265	0.1918308
MP:0009091	endometrium hypoplasia	5	0.001568857	6.97821e-09	7.387396e-06	0.09075318	0.1785017
MP:0009092	endometrium hyperplasia	14	2.263634e-06	8.462714e-08	9.889188e-11	4.321357e-05	0.005801625
MP:0009093	oocyte degeneration	8	4.488421e-07	0.05854653	0.1710183	0.02580843	0.4897655
MP:0009094	abnormal endometrial gland morphology	28	0.001524238	8.628016e-42	6.845257e-14	2.647137e-06	2.663129e-05
MP:0009095	abnormal endometrial gland number	23	0.000246036	2.215824e-41	7.359227e-11	2.691163e-07	0.01864832
MP:0009096	decreased endometrial gland number	12	0.08649002	2.727957e-21	0.0004369426	0.01019945	0.0874703
MP:0009097	absent endometrial glands	9	0.3715392	2.734563e-05	0.0009201065	0.00880678	0.01638914
MP:0009098	anovaginal fistula	1	0.6082244	1.379083e-09	1	0.457831	0.6346409
MP:0009099	abnormal uterine NK cell physiology	2	0.9883288	0.9941661	1.386425e-07	1.253429e-06	2.81616e-05
MP:0009100	abnormal clitoris size	6	0.1215591	0.04335175	0.4371148	0.4994776	0.0166564
MP:0009101	clitoris hypoplasia	2	7.834221e-05	0.1006574	0.1210609	0.01663619	0.6495497
MP:0009102	abnormal glans penis morphology	15	2.00728e-05	1.335101e-09	0.1106257	0.06279799	0.4598316
MP:0009104	small penile bone	1	1	0.3642343	0.687584	0.06370262	1
MP:0009105	penis prolapse	1	2.407553e-08	3.36219e-07	0.3024312	0.134149	0.7771805
MP:0009106	abnormal pancreas size	62	7.156606e-47	1.245045e-64	1.080743e-13	2.088916e-33	0.06521764
MP:0009107	abnormal pancreas weight	21	1.425289e-15	7.111643e-07	0.004125281	8.934315e-08	0.0492556
MP:0009108	increased pancreas weight	12	6.687327e-05	0.002943834	0.6155814	0.01275446	0.05369352
MP:0009109	decreased pancreas weight	9	1.299017e-14	1.358323e-05	1.420752e-05	4.264437e-08	0.2981221
MP:0009110	pancreas hyperplasia	5	4.18495e-06	8.733703e-07	2.567085e-09	2.921269e-05	0.9446268
MP:0009111	pancreas hypoplasia	16	0.0003876424	2.183526e-23	0.0008323581	0.0002193815	0.03195845
MP:0009112	abnormal pancreatic beta cell mass	44	7.840303e-23	4.272526e-57	4.324901e-18	1.243872e-18	0.316758
MP:0009113	increased pancreatic beta cell mass	19	2.855288e-20	2.51328e-20	2.732919e-08	1.131565e-08	0.5694147
MP:0009114	decreased pancreatic beta cell mass	30	2.665922e-09	3.438025e-45	3.840053e-11	4.243882e-13	0.1940209
MP:0009115	abnormal fat cell morphology	155	1.518929e-263	5.923114e-111	1.072472e-97	1.501071e-159	0.2785988
MP:0009116	abnormal brown fat cell morphology	38	5.897912e-38	9.701242e-55	3.113066e-29	1.819907e-51	0.2545175
MP:0009117	abnormal white fat cell morphology	66	5.467463e-109	1.168853e-57	3.932679e-49	2.477028e-78	0.3026399
MP:0009118	increased white fat cell size	19	3.731904e-13	2.244507e-22	2.759948e-09	2.177732e-11	0.8307282
MP:0009119	increased brown fat cell size	5	0.002850237	1.360196e-12	1.531345e-13	1.94053e-09	0.5003471
MP:0009120	abnormal white fat cell lipid droplet size	6	0.004248321	1.248378e-08	3.138325e-17	0.002842982	9.139827e-05
MP:0009121	increased white fat cell lipid droplet size	1	2.181582e-07	0.9179921	0.2201241	0.2325797	0.01129889
MP:0009122	decreased white fat cell lipid droplet size	5	0.475078	4.830975e-11	3.348043e-18	0.004012453	0.001569027
MP:0009123	abnormal brown fat cell lipid droplet size	17	5.721382e-18	3.159753e-32	3.220223e-12	6.788098e-24	0.2361204
MP:0009124	increased brown fat cell lipid droplet size	7	0.01433062	4.664033e-16	0.01200175	4.87269e-05	0.2727137
MP:0009125	decreased brown fat cell lipid droplet size	11	1.154408e-17	1.379837e-22	1.068556e-14	8.857365e-25	0.4375198
MP:0009126	abnormal brown fat cell number	7	1.504646e-15	1.290426e-11	2.686546e-07	6.30958e-21	0.9068771
MP:0009127	increased brown fat cell number	3	4.526491e-18	1.724561e-05	2.581719e-05	8.302986e-16	0.8498502
MP:0009128	decreased brown fat cell number	4	0.01768188	8.136474e-08	0.001592817	2.04316e-07	0.8461845
MP:0009129	abnormal white fat cell number	19	1.080311e-39	1.346648e-21	2.213664e-18	4.670927e-31	0.8411855
MP:0009130	increased white fat cell number	8	1.067595e-08	1.326517e-05	2.810929e-09	1.234943e-13	0.8121389
MP:0009131	decreased white fat cell number	11	1.211791e-36	1.24157e-19	9.150549e-11	2.360518e-19	0.7401126
MP:0009132	abnormal white fat cell size	50	2.843349e-85	1.5856e-42	3.309007e-34	3.314857e-53	0.6393331
MP:0009133	decreased white fat cell size	32	5.166018e-81	3.983665e-27	1.377578e-28	2.358512e-49	0.5128215
MP:0009134	abnormal brown fat lipid droplet number	6	4.375738e-14	3.633967e-06	4.05971e-15	3.058539e-24	0.6921589
MP:0009135	abnormal brown fat cell size	12	1.001537e-14	1.334849e-18	9.697821e-22	1.661574e-22	0.58907
MP:0009136	decreased brown fat cell size	7	1.005571e-13	1.09303e-08	1.33322e-10	9.351143e-15	0.6536291
MP:0009137	decreased brown fat lipid droplet number	5	0.003959763	3.379016e-07	2.714768e-10	2.239645e-17	0.5415801
MP:0009139	failure of Mullerian duct regression	5	7.852315e-10	3.145694e-24	0.08300143	0.4631809	0.3110789
MP:0009140	dilated efferent ductules of testis	6	0.1122419	0.0612079	0.09378335	0.0380033	0.1159407
MP:0009141	increased prepulse inhibition	15	0.007925892	0.00913372	0.2799211	0.5196738	0.5541644
MP:0009142	decreased prepulse inhibition	69	2.573213e-42	2.636024e-22	1.184975e-08	1.948425e-22	0.8500629
MP:0009143	abnormal pancreatic duct morphology	21	2.546775e-10	4.466471e-19	7.736897e-05	9.45966e-07	0.6637677
MP:0009144	dilated pancreatic duct	10	6.18957e-05	1.168117e-06	0.01040102	0.3196153	0.9703781
MP:0009145	abnormal pancreatic acinus morphology	48	1.863801e-63	8.846928e-22	1.544149e-24	6.741806e-42	0.09855075
MP:0009146	abnormal pancreatic acinar cell morphology	41	8.619158e-31	7.334515e-14	1.108685e-13	1.29948e-23	0.1080852
MP:0009148	pancreas necrosis	3	0.0001567701	0.2295354	0.1444155	1.198841e-06	0.2052217
MP:0009149	decreased pancreatic acinar cell number	7	0.03867072	0.0005231722	0.0567636	0.0002514964	0.1469229
MP:0009150	pancreatic acinar cell atrophy	3	0.9611719	0.9007018	0.9999327	0.9998722	1
MP:0009151	pancreatic ductal adenocarcinoma	10	2.286464e-20	0.01341512	2.619216e-12	3.359993e-20	0.1223411
MP:0009152	pancreatic intraepithelial neoplasia	9	2.028857e-20	0.0002850903	2.592984e-10	6.720083e-13	0.1447846
MP:0009153	increased pancreas tumor incidence	28	2.193596e-77	1.497227e-09	4.092089e-17	1.531468e-36	0.1077793
MP:0009154	pancreatic acinar hypoplasia	7	3.843537e-08	7.374094e-05	5.44834e-06	5.49356e-05	0.1094894
MP:0009155	pancreatic acinar hyperplasia	1	9.097838e-27	0.1418406	0.1036869	6.944042e-05	0.0198158
MP:0009156	absent pancreatic acini	1	0.9943421	0.6501645	0.4664204	0.03041319	0.4242651
MP:0009157	ectopic pancreatic acinar cells	1	0.0001130836	0.6829657	0.08649913	0.1217147	1
MP:0009158	absent pancreatic acinar cells	1	7.280735e-07	0.4128127	0.3832671	0.000666837	0.498173
MP:0009159	increased pancreatic acinar cell number	5	0.006002255	3.191311e-22	0.0006663239	6.438719e-06	0.3036465
MP:0009160	abnormal pancreatic acinar cell zymogen granule morphology	17	8.991033e-27	6.958191e-06	6.973618e-14	2.514517e-17	0.011763
MP:0009161	pancreatic acinar cell zymogen granule accumulation	9	1.858697e-11	1.01849e-05	6.650292e-17	2.496082e-11	0.4773402
MP:0009162	absent pancreatic acinar cell zymogen granule	2	0.001416736	0.8519688	1	0.002639619	1
MP:0009163	absent pancreatic duct	2	0.5860755	0.005288537	0.4535888	0.4910861	0.2693502
MP:0009164	exocrine pancreas atrophy	4	0.000805731	0.001244252	0.0007020331	1.750171e-05	0.04103922
MP:0009165	abnormal endocrine pancreas morphology	196	7.144459e-171	3.614102e-98	2.907622e-61	7.673421e-118	0.0006185058
MP:0009166	abnormal pancreatic islet number	25	8.696175e-26	1.53144e-19	5.720694e-08	2.389035e-33	0.1523938
MP:0009167	increased pancreatic islet number	10	0.000331669	1.329628e-13	0.3362084	0.0005804908	0.09093551
MP:0009168	decreased pancreatic islet number	15	7.557094e-27	3.103641e-08	1.069583e-10	6.415921e-37	0.4805728
MP:0009169	pancreatic islet hypoplasia	5	0.7102427	0.0001345192	0.04271674	0.03890701	0.3562541
MP:0009170	abnormal pancreatic islet size	96	1.671913e-88	1.432041e-41	1.633871e-17	5.083501e-40	0.1313711
MP:0009171	enlarged pancreatic islets	54	3.567168e-111	4.075178e-27	3.900468e-16	1.230578e-36	0.3213629
MP:0009172	small pancreatic islets	47	6.462419e-08	2.553471e-23	1.980723e-07	5.292865e-10	0.1521908
MP:0009173	absent pancreatic islets	5	0.7823823	1.099291e-10	0.0002881748	0.004469556	0.0332055
MP:0009174	absent pancreatic beta cells	9	0.4745512	8.119623e-08	0.4248259	0.001924271	0.004166991
MP:0009175	abnormal pancreatic beta cell differentiation	13	0.001598535	7.329114e-12	1.932668e-06	0.0002394329	0.432747
MP:0009176	increased pancreatic alpha cell number	17	8.295408e-13	2.198572e-08	4.427894e-06	4.876133e-09	0.3306275
MP:0009177	decreased pancreatic alpha cell number	20	0.9566545	7.433392e-08	0.0001431924	0.0002106848	1.140711e-05
MP:0009178	absent pancreatic alpha cells	7	0.9081963	0.001842268	0.4534287	0.008416975	0.01892074
MP:0009179	abnormal pancreatic alpha cell differentiation	4	0.7510588	2.347994e-06	0.007064038	1.307236e-06	0.1684167
MP:0009180	increased pancreatic delta cell number	5	0.2732004	0.8875166	0.3094914	0.8306626	0.1929996
MP:0009181	decreased pancreatic delta cell number	10	0.9999874	4.840404e-20	0.3071345	0.6053438	0.09625911
MP:0009182	absent pancreatic delta cells	1	0.4443596	0.402448	1	0.5128482	1
MP:0009183	abnormal pancreatic delta cell differentiation	1	0.05558193	0.001417341	0.06539782	7.496451e-07	1
MP:0009184	abnormal PP cell morphology	7	0.06320395	1.085635e-08	0.01035057	0.004775926	0.5069004
MP:0009185	increased PP cell number	2	0.9974564	0.002021512	0.002673794	0.2009202	0.05258501
MP:0009186	decreased PP cell number	5	0.1079808	7.989806e-08	0.0337865	0.2755752	0.2536869
MP:0009187	absent PP cells	1	0.9996953	0.0001120899	0.001040567	0.2108217	0.007418096
MP:0009188	abnormal PP cell differentiation	1	0.05558193	0.001417341	0.06539782	7.496451e-07	1
MP:0009189	abnormal pancreatic epsilon cell morphology	7	0.9999942	1.868738e-09	0.156233	0.1026427	0.1506693
MP:0009190	increased pancreatic epsilon cell number	2	0.9947867	0.7378492	0.7161429	0.8521013	0.4495395
MP:0009191	decreased pancreatic epsilon cell number	3	1	4.49986e-12	0.2450309	0.7057417	0.03245028
MP:0009193	abnormal pancreatic epsilon cell differentiation	1	0.05558193	0.001417341	0.06539782	7.496451e-07	1
MP:0009195	abnormal PP cell physiology	1	0.8623914	0.0001085632	0.9068003	0.804589	0.2558011
MP:0009198	abnormal male genitalia morphology	634	0	2.356115e-175	7.465277e-100	1.073648e-241	0.0004148537
MP:0009199	abnormal external male genitalia morphology	42	9.984102e-19	5.43713e-36	0.00293302	0.01363444	0.6111285
MP:0009200	enlarged external male genitalia	1	0.9982283	0.6258174	0.054902	0.6062543	0.02789339
MP:0009201	external male genitalia atrophy	2	0.9940374	1.390832e-08	0.9875208	0.9997463	0.6495497
MP:0009202	small external male genitalia	4	4.085061e-05	1.379529e-07	0.8987789	0.9977758	0.5302896
MP:0009203	external male genitalia hypoplasia	1	2.807586e-12	0.1679736	0.239867	0.5584877	0.3957897
MP:0009204	absent external male genitalia	4	1	0.005106775	0.9999997	0.9999998	0.9915525
MP:0009205	abnormal internal male genitalia morphology	618	0	2.001781e-166	1.367541e-99	7.185664e-254	0.0001046429
MP:0009206	absent internal male genitalia	1	0.9005029	0.04353317	0.3832671	3.121819e-05	0.8122343
MP:0009207	internal male genitalia hypoplasia	2	9.208762e-16	0.2129485	0.1400662	0.5125679	0.5239876
MP:0009208	abnormal female genitalia morphology	384	2.10521371692955e-320	1.272741e-168	1.139617e-83	1.30587e-180	3.377877e-06
MP:0009209	abnormal internal female genitalia morphology	377	0	3.884708e-165	2.396412e-88	2.409663e-188	1.553011e-07
MP:0009210	absent internal female genitalia	1	0.9005029	0.04353317	0.3832671	3.121819e-05	0.8122343
MP:0009211	absent external female genitalia	3	0.9999965	6.664376e-05	0.9999933	0.9999973	0.9970965
MP:0009212	vulva atrophy	1	0.7248003	7.794395e-12	1	0.977917	1
MP:0009213	absent male inguinal canal	2	0.9869791	0.0006553843	0.9294142	0.03025014	0.8313579
MP:0009214	vas deferens hypoplasia	2	0.9992637	0.1965405	0.6521095	0.9610328	0.27991
MP:0009215	absent uterine horn	2	0.08548183	3.977175e-15	0.2988579	0.1649415	0.4295862
MP:0009216	abnormal peritoneum morphology	7	7.759212e-18	7.017812e-08	1.120139e-07	2.349567e-14	0.3472752
MP:0009218	absent peritoneal vaginal process	1	0.14785	0.2234687	1	0.0825431	1
MP:0009219	prostate intraepithelial neoplasia	23	1.18447e-56	1.342623e-08	1.711304e-14	1.327266e-27	0.2402723
MP:0009220	prostate gland adenocarcinoma	16	6.985124e-35	0.3933624	4.986773e-07	9.134274e-14	0.108727
MP:0009221	uterus adenomyosis	4	0.1318319	0.4714598	0.6184475	0.8064531	0.07688236
MP:0009222	uterus tumor	21	3.955007e-19	4.582641e-06	4.438855e-12	1.072118e-12	0.0360164
MP:0009223	increased uterus carcinoma incidence	1	0.004017566	0.6327778	0.0693156	0.08035383	0.3273782
MP:0009224	absent endometrium	1	0.07017688	6.639017e-08	0.1172219	0.00904338	0.2355317
MP:0009226	small uterine cervix	3	0.9865557	0.9883239	0.7902475	0.2890906	0.0005255579
MP:0009227	uterine cervix hypoplasia	1	1	0.3642343	0.687584	0.06370262	1
MP:0009228	uterine cervix inflammation	1	1	0.07022086	1	0.999381	0.2355317
MP:0009229	abnormal median eminence morphology	3	0.03024399	0.2736049	0.00411145	0.01206062	0.2512189
MP:0009230	abnormal sperm head morphology	90	1.006842e-86	8.795519e-05	4.070345e-05	1.244472e-18	0.9225758
MP:0009231	detached acrosome	14	1.981775e-06	0.9990032	0.1843175	0.6792299	0.54816
MP:0009232	abnormal sperm nucleus morphology	21	8.530248e-46	0.5601471	0.9786821	0.0002794143	0.8204732
MP:0009233	enlarged sperm head	6	2.496848e-08	0.9646913	0.6898449	0.3333137	0.1548893
MP:0009234	absent sperm head	6	1.525351e-13	0.01452748	9.268232e-06	0.001875804	0.9824456
MP:0009235	small sperm head	2	0.3713769	3.55181e-11	0.8040458	0.7882684	0.8983059
MP:0009236	pinhead sperm	2	0.3012951	0.907836	0.001528668	0.2166682	1
MP:0009237	kinked sperm flagellum	22	8.686792e-08	0.9963994	7.855768e-06	0.0005096444	0.08979813
MP:0009238	coiled sperm flagellum	21	1.49697e-08	0.06108207	0.01310941	2.032547e-05	0.4531395
MP:0009239	short sperm flagellum	11	7.840766e-11	2.632904e-05	0.002942451	3.978241e-05	0.5213683
MP:0009240	elongated sperm flagellum	2	0.9985265	0.9949461	0.7827402	0.2285063	0.8187364
MP:0009241	thick sperm flagellum	1	0.9331273	8.211513e-09	1	0.5649656	0.3489379
MP:0009242	thin sperm flagellum	2	0.0009497241	0.5574507	0.03402773	0.0005130353	1
MP:0009243	hairpin sperm flagellum	15	0.3444052	0.07231874	0.008792317	0.04691465	0.2948336
MP:0009244	abnormal acid-activated cation-mediated receptor currents	2	0.09300609	0.9846966	1	0.7828712	1
MP:0009246	pale spleen	5	1.717194e-21	0.213436	4.175654e-08	3.247638e-12	0.02815378
MP:0009247	meteorism	23	1.234167e-18	3.851346e-31	0.0001811365	3.358172e-05	0.6805167
MP:0009248	small caput epididymis	4	0.7869006	0.3001431	0.1252752	0.8535716	0.3825618
MP:0009249	enlarged caput epididymis	1	0.01215633	0.001070678	0.8492995	0.06087656	1
MP:0009250	abnormal appendicular skeleton morphology	579	0	0	1.142542e-113	5.329358e-267	7.532565e-06
MP:0009251	enlarged endometrial glands	5	1	0.08570884	0.2067213	0.8694087	0.009658384
MP:0009252	absent urinary bladder	4	0.6807237	1.183498e-15	0.002264686	0.002223487	0.3638067
MP:0009253	abnormal sympathetic neuron physiology	5	4.391493e-10	0.04095991	0.2535311	0.001295598	0.4841008
MP:0009254	disorganized pancreatic islets	30	0.004111502	3.472877e-34	4.975823e-11	4.056826e-10	0.0537177
MP:0009255	degranulated pancreatic beta cells	5	0.07342393	0.0001869088	0.5447216	0.7242572	0.361624
MP:0009256	enlarged corpus epididymis	1	0.01215633	0.001070678	0.8492995	0.06087656	1
MP:0009257	dilated seminiferous tubules	7	0.8987336	0.1419021	0.3442167	0.6598226	0.9624135
MP:0009258	abnormal thymocyte apoptosis	55	3.455888e-115	3.1945e-15	7.115567e-38	2.897221e-60	1.086876e-06
MP:0009262	absent semicircular canal ampulla	1	0.3662177	7.948647e-09	0.770847	0.936322	0.8122343
MP:0009263	abnormal eyelid fusion	24	1.843761e-12	3.977082e-73	6.697736e-06	4.435956e-10	0.205784
MP:0009264	failure of eyelid fusion	20	2.046861e-08	9.227411e-73	2.091982e-05	3.688907e-07	0.4577739
MP:0009265	delayed eyelid fusion	3	8.168644e-07	0.003412533	0.1352905	0.006534117	0.02187754
MP:0009266	abnormal mesendoderm development	14	3.557845e-23	2.352479e-10	0.003812824	1.008974e-05	0.7179806
MP:0009267	abnormal cerebellum fissure morphology	14	2.513831e-07	1.121495e-10	3.286234e-05	4.016569e-07	0.3227151
MP:0009268	absent cerebellum fissure	4	1.291681e-07	0.000495611	0.2692597	9.783749e-07	0.9319606
MP:0009269	decreased fat cell size	51	9.180531e-110	2.69383e-43	1.525263e-41	1.132992e-51	0.5460589
MP:0009270	abnormal guard hair length	4	4.249995e-08	2.142922e-10	0.001521768	0.09493826	0.00704572
MP:0009271	increased guard hair length	1	0.9412582	0.5246082	0.5526167	0.8958141	0.3343108
MP:0009272	decreased guard hair length	3	1.142318e-10	5.028185e-12	0.0006374265	0.02849103	0.008211472
MP:0009273	abnormal hair shaft melanin granule shape	2	0.5016587	0.0004623648	0.03264228	0.0452628	0.3448206
MP:0009274	buphthalmos	6	2.060599e-06	3.068892e-17	1.381904e-09	1.155727e-05	0.05401815
MP:0009275	bruising	8	4.773696e-09	6.248897e-17	0.009153177	6.700301e-05	0.9905429
MP:0009276	ecchymosis	1	0.4542007	0.0001215861	0.8184555	0.3758267	1
MP:0009277	brain tumor	29	1.17839e-24	6.446842e-22	1.134588e-08	6.686888e-12	0.06137045
MP:0009278	abnormal bone marrow cell physiology	47	2.173728e-144	4.206385e-19	1.220698e-20	4.776624e-103	0.0961691
MP:0009280	reduced activated sperm motility	5	1.207467e-08	0.007530921	0.0003063194	0.0654388	0.5395369
MP:0009282	reduced hyperactivated sperm motility	3	0.02665267	0.4363465	0.9713659	0.1193404	0.4297038
MP:0009283	decreased gonadal fat pad weight	38	2.345956e-81	3.505262e-16	5.738288e-29	2.045746e-28	0.0007569638
MP:0009284	abnormal sympathetic neuron innervation pattern	8	0.5708185	1.023922e-23	0.4561036	0.005356997	0.1034333
MP:0009285	increased gonadal fat pad weight	26	8.339578e-33	2.692192e-13	3.025536e-12	8.703472e-17	0.6241323
MP:0009286	increased abdominal fat pad weight	6	0.9997019	1.35891e-05	1.236824e-05	0.1342784	0.3510571
MP:0009287	decreased abdominal fat pad weight	8	2.470114e-29	1.354701e-07	2.86933e-11	8.00644e-08	0.6556976
MP:0009288	increased epididymal fat pad weight	15	1.33469e-23	4.287203e-06	2.044045e-05	4.780682e-11	0.04844017
MP:0009289	decreased epididymal fat pad weight	43	7.474859e-79	1.0306e-30	3.811968e-18	5.909227e-46	0.3512397
MP:0009291	decreased femoral fat pad weight	1	0.05558193	0.7320917	0.6286851	0.002251221	0.5844193
MP:0009292	increased inguinal fat pad weight	16	1.063606e-30	0.0002650025	7.499942e-23	1.00735e-30	0.4699084
MP:0009293	decreased inguinal fat pad weight	21	8.004184e-11	2.422544e-25	6.745598e-10	6.929604e-14	0.7060993
MP:0009294	increased interscapular fat pad weight	11	0.0001334665	1.108573e-12	4.079551e-06	2.241145e-08	0.6140409
MP:0009295	decreased interscapular fat pad weight	11	1.449789e-43	1.766942e-09	4.486838e-18	5.097748e-33	0.4622725
MP:0009296	increased mammary fat pad weight	2	0.9999493	0.5145748	0.1035155	0.9473871	0.1105873
MP:0009297	decreased mammary fat pad weight	1	2.10908e-06	0.000800239	0.007677078	1.879671e-10	1
MP:0009298	increased mesenteric fat pad weight	7	0.01064836	0.5165901	7.912757e-11	0.006460236	0.7831041
MP:0009299	decreased mesenteric fat pad weight	12	1.670003e-33	6.129109e-07	2.843954e-13	2.55943e-10	0.655258
MP:0009300	increased parametrial fat pad weight	5	0.2807797	0.007784003	4.339089e-09	4.534188e-07	0.6863108
MP:0009301	decreased parametrial fat pad weight	3	0.8353449	0.1987172	0.1521176	0.1529171	0.06555703
MP:0009302	increased renal fat pad weight	9	0.907874	0.9266203	0.8456977	0.04848394	0.03249999
MP:0009303	decreased renal fat pad weight	4	2.343674e-17	0.0001576141	6.748119e-11	2.262706e-14	0.9813284
MP:0009304	increased retroperitoneal fat pad weight	16	1.378059e-21	2.355062e-06	1.989373e-11	4.89067e-11	0.2111736
MP:0009305	decreased retroperitoneal fat pad weight	17	0.006499693	2.833633e-16	0.01867408	4.275627e-06	0.9245252
MP:0009307	decreased uterine fat pad weight	3	1.196159e-22	0.004450284	0.0003853147	2.459739e-06	0.9098761
MP:0009308	adenocarcinoma	156	0	2.667633e-25	8.109667e-73	1.467536e-178	0.08210438
MP:0009309	small intestine adenocarcinoma	11	1.553905e-26	0.002912253	0.0005470765	0.0001578641	0.234186
MP:0009310	large intestine adenocarcinoma	14	3.785988e-49	0.9164047	6.535354e-08	1.402255e-29	0.1184159
MP:0009311	duodenum adenocarcinoma	1	0.08540867	0.271842	0.4093108	0.2500529	1
MP:0009312	jejunum adenocarcinoma	1	7.253833e-18	0.9843364	5.900599e-06	0.000666837	0.2355317
MP:0009314	colon adenocarcinoma	13	1.103139e-42	0.9769451	1.076697e-08	6.293205e-24	0.1212909
MP:0009315	rectum adenocarcinoma	1	0.0007990111	1	0.03826761	1.460962e-06	1
MP:0009316	anal adenocarcinoma	1	0.0007990111	1	0.03826761	1.460962e-06	1
MP:0009317	follicular lymphoma	8	3.127005e-15	0.02416007	4.260481e-07	2.088881e-19	0.2777204
MP:0009318	splenic marginal zone lymphoma	4	7.445831e-14	0.5341201	0.02146125	4.125966e-14	0.7669536
MP:0009319	small lymphocytic lymphoma	2	0.4400022	0.7347511	0.064887	0.07395581	0.1102394
MP:0009320	lymphoblastic lymphoma	3	1.107714e-16	4.380539e-05	0.0002144272	1.146667e-06	0.4089204
MP:0009321	increased histiocytic sarcoma incidence	25	3.198451e-33	3.27789e-15	7.807831e-08	1.527501e-18	0.1062916
MP:0009322	increased splenocyte apoptosis	11	3.769683e-14	0.0005230886	7.408481e-06	1.527044e-21	0.07535136
MP:0009323	abnormal spleen development	9	1.003442e-07	2.338534e-10	0.006375564	2.016187e-08	0.03598186
MP:0009324	absent hippocampal fimbria	6	0.04265532	0.0002594963	0.9135341	0.01097435	0.5350308
MP:0009325	necrospermia	8	2.695125e-08	2.495224e-09	1.718447e-08	4.498065e-07	0.2381465
MP:0009326	absent maternal crouching	4	0.9999998	6.639699e-05	0.8572653	0.9828656	0.798885
MP:0009327	abnormal maternal grooming	1	2.598465e-09	1	0.04019739	0.7432789	1
MP:0009328	delayed heart looping	8	3.041704e-15	2.942282e-22	2.176979e-05	2.754719e-15	0.2592228
MP:0009331	absent primitive node	11	3.357014e-31	0.003369576	6.677121e-06	0.2672655	0.5404844
MP:0009332	abnormal splenocyte morphology	57	1.12804e-106	3.778779e-05	1.60283e-61	2.361048e-117	0.2940422
MP:0009333	abnormal splenocyte physiology	80	2.339371e-72	2.451254e-10	1.140569e-61	6.176765e-129	0.0006671967
MP:0009334	abnormal splenocyte proliferation	48	1.581738e-21	0.03924159	5.385566e-20	7.146705e-52	0.0002378677
MP:0009335	decreased splenocyte proliferation	24	4.477669e-23	0.005387337	6.60677e-19	6.854097e-41	0.005655612
MP:0009336	increased splenocyte proliferation	25	0.09923195	0.06044534	2.267258e-07	2.959619e-14	0.004348763
MP:0009337	abnormal splenocyte number	51	1.293696e-91	2.329948e-05	9.255676e-58	1.41015e-108	0.1770907
MP:0009338	increased splenocyte number	22	1.141927e-21	0.0001126505	7.277778e-40	2.15789e-42	0.8374863
MP:0009339	decreased splenocyte number	29	4.084254e-75	0.01464967	3.78891e-22	4.029857e-68	0.03110557
MP:0009340	abnormal splenocyte apoptosis	19	6.621782e-40	0.0003537955	1.641015e-18	3.938988e-50	0.2922265
MP:0009341	decreased splenocyte apoptosis	8	4.730679e-23	0.03310564	2.195073e-19	2.509619e-31	0.497308
MP:0009342	enlarged gallbladder	6	2.761273e-06	1.908344e-07	0.01999911	1.755408e-05	0.8652455
MP:0009343	dilated gallbladder	10	0.02303602	5.169836e-18	0.004143245	1.469331e-06	0.723452
MP:0009345	abnormal trabecular bone thickness	72	6.132548e-105	1.943041e-25	1.112272e-48	2.638838e-77	9.711991e-05
MP:0009346	decreased trabecular bone thickness	34	2.253606e-71	1.473836e-26	6.411184e-31	1.334315e-47	0.003079442
MP:0009347	increased trabecular bone thickness	37	2.201188e-53	1.61087e-05	1.616076e-30	8.125624e-43	0.0004067884
MP:0009348	abnormal urine pH	22	6.114771e-09	3.222501e-20	0.0001544814	2.159483e-05	0.3648505
MP:0009349	increased urine pH	11	5.253901e-06	9.210347e-09	0.08176896	9.678994e-06	0.2681861
MP:0009350	decreased urine pH	11	0.0001659376	1.388471e-13	0.0001221822	0.09724998	0.606659
MP:0009351	thin hair shaft	5	2.39091e-16	0.1760093	0.1235104	7.497665e-15	0.4165416
MP:0009352	impaired spacing of implantation sites	2	0.03843397	1.157795e-06	0.0002021757	0.1966393	0.3332974
MP:0009353	twin decidual capsule	1	7.314496e-07	0.006170312	1	0.5094695	1
MP:0009355	increased liver triglyceride level	76	3.615899e-71	1.958753e-46	8.729087e-33	3.10803e-44	0.07190056
MP:0009356	decreased liver triglyceride level	69	1.730095e-99	1.08063e-49	2.039143e-46	1.471425e-71	0.3187531
MP:0009357	abnormal seizure response to inducing agent	163	3.051897e-54	5.293894e-49	9.110315e-10	4.005356e-19	0.01216806
MP:0009358	environmentally induced seizures	38	9.344884e-08	9.468986e-17	1.374576e-08	8.832447e-18	0.08458711
MP:0009359	endometrium atrophy	2	0.003068893	0.01886431	1.238822e-05	0.001787585	0.5945078
MP:0009360	endometrium inflammation	1	0.4115579	0.001267349	0.0133243	0.006620443	0.308891
MP:0009361	abnormal primordial ovarian follicle morphology	20	1.862798e-32	0.6516042	3.131937e-08	3.90786e-07	0.0001533412
MP:0009362	abnormal primary ovarian follicle morphology	6	1	0.6535857	0.1323496	0.926251	0.0001784347
MP:0009363	abnormal secondary ovarian follicle morphology	31	4.128259e-10	1.461085e-13	1.154229e-10	4.025885e-26	0.07715973
MP:0009364	abnormal mature ovarian follicle morphology	66	3.29878e-47	8.111114e-09	7.490431e-11	5.080341e-18	0.0006112295
MP:0009365	abnormal theca folliculi	2	0.1792834	0.004998218	0.001842629	0.002197599	0.7696683
MP:0009368	absent theca folliculi	1	0.0004493594	0.0007227235	0.06072417	1.980103e-05	1
MP:0009369	abnormal thecal cell number	7	0.7624733	1.148553e-13	0.0129294	5.773882e-06	0.3519931
MP:0009370	decreased thecal cell number	5	0.9783706	1.498864e-11	0.07614634	0.001592074	0.410937
MP:0009371	increased thecal cell number	2	0.06335557	0.0008883034	0.03877227	0.0003316156	0.4383602
MP:0009372	abnormal cumulus oophorus	4	0.7908352	0.006998724	0.6302267	0.6989377	0.6884501
MP:0009373	abnormal cumulus expansion	13	0.3028	0.3111771	9.410878e-05	0.02842181	0.002619359
MP:0009374	absent cumulus expansion	9	0.9999998	0.3622075	0.004704139	0.6668442	0.04347658
MP:0009375	thin zona pellucida	6	6.054992e-10	0.006784485	0.5971984	6.490021e-07	0.4516091
MP:0009376	abnormal manchette morphology	7	2.30452e-08	8.977805e-08	0.8727146	8.41136e-08	0.8328204
MP:0009377	ectopic manchette	4	0.001760129	3.935619e-08	0.8404833	2.515313e-07	0.968163
MP:0009378	abnormal endoplasmic reticulum morphology	13	4.698745e-48	3.866087e-10	0.0008101895	1.618992e-11	0.4280979
MP:0009379	abnormal foot pigmentation	22	1.427472e-13	5.485604e-22	2.764882e-23	6.816068e-14	0.1583211
MP:0009380	abnormal prostate gland ventral lobe morphology	13	0.07974263	0.0328166	0.3886057	3.225973e-05	0.9874157
MP:0009381	abnormal prostate gland dorsolateral lobe morphology	6	0.2179082	0.1135649	0.0002462511	6.38424e-05	0.8195656
MP:0009382	abnormal cardiac jelly morphology	7	0.005135656	3.33709e-09	0.01174384	0.0006235757	0.009107899
MP:0009384	cardiac valve regurgitation	19	0.6180442	1.220669e-36	0.01630595	0.004951635	0.05008382
MP:0009385	abnormal dermal pigmentation	4	7.76831e-10	0.3023402	0.1892896	0.005566412	0.5160547
MP:0009386	abnormal dermal melanocyte morphology	1	1.11164e-05	0.3016977	0.3219989	0.3738292	0.7862914
MP:0009387	abnormal epidermal pigmentation	5	8.819528e-13	0.0431778	0.09906343	1.524376e-09	0.7942916
MP:0009388	abnormal epidermal melanocyte morphology	2	2.520717e-07	0.002253335	0.008807286	1.340615e-12	1
MP:0009389	abnormal extracutaneous pigmentation	164	1.66787e-103	3.302523e-65	3.740996e-37	6.899228e-53	0.04119867
MP:0009392	retinal gliosis	2	0.004887877	1.840232e-08	0.000268762	0.2029484	0.5896762
MP:0009393	abnormal resting posture	6	3.778161e-13	0.7363932	0.02173745	0.001393132	0.244304
MP:0009394	increased uterine NK cell number	5	4.531203e-18	0.9191591	5.444647e-14	8.569801e-15	0.001229226
MP:0009395	increased nucleated erythrocyte cell number	42	6.973327e-148	2.089226e-08	4.356135e-27	1.030753e-100	0.01126772
MP:0009396	small endometrial glands	1	0.9508384	8.52348e-06	0.0003157966	1.027125e-05	0.2355317
MP:0009397	increased trophoblast giant cell number	18	9.603476e-20	4.280031e-45	0.1212598	8.704385e-12	0.9508668
MP:0009398	abnormal skeletal muscle fiber size	124	4.617464e-81	2.451021e-116	5.908336e-35	2.129504e-62	0.0002108579
MP:0009399	increased skeletal muscle fiber size	32	5.09893e-23	3.80745e-13	5.080276e-07	2.530866e-20	0.005010504
MP:0009400	decreased skeletal muscle fiber size	75	2.432475e-64	4.075611e-80	1.13e-24	1.666087e-41	0.01313043
MP:0009401	increased skeletal muscle fiber diameter	12	0.0004528205	0.0001235697	5.336152e-05	0.03461007	0.06937854
MP:0009402	decreased skeletal muscle fiber diameter	35	1.696654e-40	6.515835e-33	1.419978e-07	3.185194e-23	0.2383386
MP:0009403	increased variability of skeletal muscle fiber size	43	1.194643e-07	1.938387e-26	0.001147515	6.145521e-05	0.1772653
MP:0009404	centrally nucleated skeletal muscle fibers	70	6.463812e-64	7.169659e-39	2.459081e-12	4.171487e-34	0.6769993
MP:0009405	increased skeletal muscle fiber number	5	2.45967e-06	0.9477335	0.1033389	0.01106134	0.2027115
MP:0009406	decreased skeletal muscle fiber number	22	1.081548e-33	0.0007517349	1.153108e-10	1.725228e-10	0.1192942
MP:0009407	increased skeletal muscle fiber density	2	0.9973716	1.384235e-15	0.9610434	0.3143715	0.05398354
MP:0009408	decreased skeletal muscle fiber density	5	9.898757e-05	3.325191e-18	0.0009457533	7.070047e-05	0.01152791
MP:0009409	abnormal skeletal muscle fiber type ratio	33	1.118917e-50	3.318155e-26	2.593059e-11	1.902089e-26	0.0002977687
MP:0009410	abnormal skeletal muscle satellite cell proliferation	9	6.153462e-07	0.122215	0.0002246543	0.00126378	0.2420077
MP:0009411	abnormal skeletal muscle fiber triad morphology	3	0.9999253	0.9092564	0.9995413	0.9999044	0.9577908
MP:0009412	skeletal muscle fiber degeneration	16	4.820722e-19	0.03644573	6.998658e-09	0.0001031586	0.03274826
MP:0009413	skeletal muscle fiber atrophy	21	2.62732e-05	1.214877e-26	0.001495196	5.264722e-07	0.1633918
MP:0009414	skeletal muscle fiber necrosis	21	6.447672e-05	2.675178e-09	0.9914479	3.65417e-05	0.9737197
MP:0009415	skeletal muscle degeneration	23	5.483983e-17	4.708675e-09	3.833814e-11	3.384715e-09	0.01752349
MP:0009416	cardiac muscle degeneration	1	7.882348e-05	0.9443174	0.01250401	1.2427e-09	1
MP:0009417	skeletal muscle atrophy	38	1.200083e-30	3.920495e-38	9.855792e-15	1.636027e-11	0.1482407
MP:0009419	skeletal muscle fibrosis	35	9.169262e-20	5.032633e-26	2.200349e-11	3.639922e-24	0.0673688
MP:0009420	skeletal muscle endomysial fibrosis	6	0.9839998	0.05702366	0.9998845	0.9910764	0.9735176
MP:0009421	increased gastrocnemius weight	4	0.9999924	0.6004128	0.388651	0.09079227	0.01226545
MP:0009422	decreased gastrocnemius weight	6	0.4377036	1.17766e-10	2.774147e-05	0.07722304	0.2475955
MP:0009423	increased extensor digitorum longus weight	1	5.45841e-06	0.007809419	1	0.02743687	1
MP:0009424	decreased extensor digitorum longus weight	3	1.157765e-09	4.484297e-05	0.0001208636	0.0005302773	0.9728873
MP:0009425	increased soleus weight	1	5.45841e-06	0.007809419	1	0.02743687	1
MP:0009426	decreased soleus weight	5	0.0008496416	2.496404e-09	0.000170857	0.01164773	0.8596069
MP:0009427	increased tibialis anterior weight	3	0.02860209	0.1718505	0.6947186	1.491922e-06	0.77155
MP:0009428	decreased tibialis anterior weight	5	3.340904e-15	3.588552e-05	5.113227e-06	0.00339864	0.4367398
MP:0009429	decreased embryo weight	18	5.497679e-37	0.147187	4.229508e-05	3.021477e-09	0.5652787
MP:0009430	increased embryo weight	1	2.911814e-12	0.4553412	0.005815825	0.00296575	1
MP:0009431	decreased fetal weight	60	4.442763e-95	7.611294e-21	1.03068e-27	3.508665e-41	0.5801533
MP:0009432	increased fetal weight	5	6.52132e-07	1.128898e-05	0.0002944712	6.470884e-10	0.7245779
MP:0009433	polyovular ovarian follicle	11	0.999985	0.5067657	0.1113258	0.8404224	0.08139431
MP:0009434	paraparesis	28	1.235167e-16	1.692416e-19	2.247783e-16	1.26077e-12	0.003179968
MP:0009435	abnormal miniature inhibitory postsynaptic currents	20	3.061164e-09	0.07753788	0.0001460153	3.102943e-07	0.3540267
MP:0009436	fragmentation of sleep/wake states	6	8.620244e-06	7.252903e-05	0.0131491	0.002287056	0.2064446
MP:0009438	cricoid and tracheal cartilage fusion	4	0.06446591	0.008055022	0.07048912	1.514381e-08	0.5071018
MP:0009439	myeloid sarcoma	2	0.05173779	4.279094e-06	0.1968165	0.008514569	0.1276589
MP:0009441	delayed skin barrier formation	2	0.6832692	0.9275316	0.009541793	0.7561978	0.1341678
MP:0009442	ovarian teratoma	3	1.056747e-11	0.978594	0.0005266609	9.449797e-06	0.7561057
MP:0009444	ovarian follicular cyst	8	1.984909e-28	0.02884159	1.279258e-05	5.301548e-12	0.5831959
MP:0009445	osteomalacia	7	0.001911787	2.638793e-06	0.01360989	1.68408e-06	0.1322361
MP:0009446	abnormal platelet dense granule physiology	12	8.803823e-22	0.07518323	6.440218e-14	5.067206e-20	0.3748862
MP:0009447	abnormal platelet ATP level	13	2.32806e-19	2.482143e-05	5.89424e-11	3.99567e-20	0.1833101
MP:0009448	decreased platelet ATP level	11	8.711542e-15	2.349679e-06	1.44769e-09	1.317299e-12	0.125123
MP:0009449	increased platelet ATP level	2	1.450401e-07	0.9760927	0.006978129	2.088018e-13	1
MP:0009450	abnormal axon fasciculation	23	6.532078e-05	2.149954e-05	0.06786644	0.0002852166	0.2234804
MP:0009451	abnormal chromosome pairing during meiosis	8	4.333835e-05	0.9864412	0.3091386	0.6108907	0.06329648
MP:0009452	abnormal synaptonemal complex	14	0.005795392	0.8291438	0.3281221	0.5021642	0.002381373
MP:0009453	enhanced contextual conditioning behavior	16	3.92695e-18	1.578853e-05	0.2009829	0.03566512	0.9125968
MP:0009454	impaired contextual conditioning behavior	44	1.729771e-40	3.084205e-16	5.978662e-09	7.688866e-22	0.01513225
MP:0009455	enhanced cued conditioning behavior	7	6.787392e-19	0.001269442	0.9897746	0.8601023	0.905432
MP:0009456	impaired cued conditioning behavior	33	1.507205e-23	3.537614e-09	0.0486228	1.39756e-09	0.7489124
MP:0009457	whorled hair	3	3.480873e-05	2.384763e-11	0.01987576	0.008435014	0.2353075
MP:0009458	abnormal skeletal muscle size	66	1.287732e-43	1.658961e-62	2.372278e-15	1.983507e-15	0.1539124
MP:0009459	skeletal muscle hyperplasia	1	1.068836e-13	0.1768148	0.2059279	0.2517437	0.6162194
MP:0009460	skeletal muscle hypoplasia	2	4.61973e-16	0.0005904139	0.253286	0.0009003121	0.4464895
MP:0009461	skeletal muscle hypertrophy	7	0.2452229	0.8294163	0.6157781	0.1536133	0.8611613
MP:0009462	skeletal muscle hypotrophy	1	0.002143062	0.002206494	0.02406662	0.002011181	0.1692989
MP:0009463	abnormal pituitary infundibular stalk morphology	7	0.7886581	1.285582e-07	0.1665782	0.1012458	0.9166582
MP:0009469	skin hamartoma	3	4.337828e-29	0.3553267	0.0002572127	2.740367e-06	0.893792
MP:0009472	increased urine sulfate level	2	0.9972778	0.4791884	0.8306143	0.8307925	1
MP:0009473	abnormal skin exfoliation	1	3.949584e-14	0.01182993	0.893487	6.777054e-08	1
MP:0009474	thick epidermis stratum spinosum	3	3.238599e-11	0.004433127	3.201483e-08	6.207648e-06	0.8809073
MP:0009475	abnormal nicotine-mediated receptor currents	3	7.669501e-15	0.04744834	0.996422	0.8997587	0.9598537
MP:0009476	enlarged cecum	5	1.682982e-10	2.162548e-06	0.0003592101	0.002757934	0.8590601
MP:0009477	small cecum	5	2.74568e-05	0.0001790583	0.000860315	0.008440124	0.7379428
MP:0009478	coiled cecum	3	0.9999886	3.333444e-06	0.2476853	0.9698242	0.8431287
MP:0009479	abnormal cecum development	2	0.9996277	1.931268e-19	1	0.9579386	0.05398354
MP:0009480	distended cecum	7	8.844286e-12	0.04907938	0.0007897002	0.1999251	0.3549892
MP:0009481	cecum inflammation	16	1.057498e-48	0.01471512	5.390435e-15	1.373061e-35	0.9274926
MP:0009482	ileum inflammation	10	6.070182e-60	0.2492376	1.48409e-10	3.846757e-14	0.3570375
MP:0009483	enlarged ileum	3	0.2992803	0.9143602	0.9633187	0.562466	0.9370309
MP:0009484	ileum hypertrophy	1	0.9643879	0.7535265	0.9584642	0.9969279	1
MP:0009485	distended ileum	9	5.479359e-16	2.421618e-08	4.202689e-05	0.006074308	0.4894774
MP:0009488	abnormal pancreatic islet cell apoptosis	10	5.09445e-21	5.182609e-05	1.136468e-06	6.5913e-12	0.7436745
MP:0009489	abnormal blood vessel endothelium morphology	73	1.045112e-98	1.640861e-44	1.333807e-42	7.041737e-97	0.01300025
MP:0009490	abnormal heart left atrium auricular region morphology	2	0.3851777	0.2559594	0.08434103	0.4803043	0.6342299
MP:0009492	abnormal gallbladder epithelium morphology	1	1.494206e-09	0.05177055	6.803337e-08	0.002584541	1
MP:0009493	abnormal cystic duct morphology	3	0.1477101	5.434615e-21	0.001220538	0.02032757	0.361244
MP:0009494	abnormal biliary ductule morphology	1	0.9953378	3.056625e-10	1	0.9588067	1
MP:0009495	abnormal common bile duct morphology	3	1.72999e-06	0.005454897	1.784458e-09	0.02911605	0.2286811
MP:0009497	abnormal intrahepatic bile duct morphology	5	0.04286914	5.197042e-09	0.9715866	0.003577765	0.9876244
MP:0009498	abnormal extrahepatic bile duct morphology	8	3.947109e-08	1.78484e-09	2.856128e-05	2.913968e-07	0.2991511
MP:0009500	abnormal interlobular bile duct morphology	2	0.3504425	1.576464e-16	0.9944464	0.1264646	1
MP:0009501	abnormal hepatic duct morphology	2	0.005793598	0.894727	0.5825137	0.002264544	0.7967617
MP:0009503	abnormal mammary gland duct morphology	63	3.388635e-94	1.150462e-21	9.5988e-36	1.538598e-55	0.00980861
MP:0009504	abnormal mammary gland epithelium morphology	20	3.128134e-13	1.443445e-05	2.503399e-05	0.0003229269	0.1577444
MP:0009505	abnormal mammary gland lobule morphology	30	2.322057e-34	4.860398e-08	1.391881e-30	2.109111e-18	0.01520375
MP:0009506	abnormal mammary gland alveolus morphology	27	2.34639e-29	1.251093e-05	1.465981e-26	3.034088e-16	0.008724301
MP:0009507	abnormal mammary gland connective tissue morphology	1	0.9621678	0.003530956	0.3856569	0.06617561	0.726318
MP:0009508	mammary gland ductal carcinoma	3	4.668094e-15	0.4069402	0.01737653	0.008329328	0.6293406
MP:0009509	absent rectum	3	0.9999781	1.26656e-24	0.9999949	0.9930083	0.2403624
MP:0009510	cecal atresia	2	0.9996277	1.931268e-19	1	0.9579386	0.05398354
MP:0009511	distended stomach	10	1.468981e-07	0.3648411	0.01357033	0.002019412	0.9417075
MP:0009512	abnormal cerebellar Golgi cell morphology	1	0.9996953	0.8829117	1	0.999381	1
MP:0009514	titubation	1	0.9982283	0.999999	1	0.9948082	1
MP:0009515	gastrointestinal stromal tumor	2	2.031132e-06	0.513871	1.310246e-05	0.1313649	0.0518424
MP:0009517	abnormal salivary gland duct morphology	10	2.273468e-14	1.454528e-28	0.1669292	3.762358e-09	0.0222335
MP:0009520	decreased submandibular gland size	6	0.4027912	3.024712e-29	0.9629245	0.0006818901	0.001152309
MP:0009521	increased submandibular gland size	2	0.002451994	2.235181e-12	2.217196e-12	0.1211744	0.06469083
MP:0009522	submandibular gland hypoplasia	4	0.3058384	2.907219e-29	0.9990248	0.1888182	0.00164755
MP:0009523	submandibular gland hyperplasia	1	9.120994e-09	0.0282954	0.02155812	0.001882544	0.6746492
MP:0009524	absent submandibular gland	4	0.9999481	1.432908e-16	0.8249183	0.8317169	0.2892599
MP:0009525	abnormal submandibular duct morphology	3	0.1915012	2.086427e-32	1	0.491737	0.03717959
MP:0009527	abnormal sublingual duct morphology	5	2.580434e-21	2.492568e-12	0.0004542512	7.196639e-10	0.61951
MP:0009531	increased parotid gland size	1	0.2088391	1	0.5941054	2.43242e-13	1
MP:0009533	absent palatine gland	2	1	4.485499e-12	0.9610434	0.4088053	0.8468146
MP:0009534	absent anterior lingual gland	2	1	4.485499e-12	0.9610434	0.4088053	0.8468146
MP:0009535	abnormal skin sebaceous gland morphology	6	1.159971e-10	1.141435e-12	1.120487e-07	3.678507e-10	0.8088582
MP:0009536	abnormal interstitial cell of Cajal morphology	2	0.0005748386	0.0001586684	0.001874849	0.7132888	0.4295862
MP:0009537	interstitial cells of Cajal hyperplasia	1	2.496788e-08	0.5187106	2.368458e-05	0.3225972	0.2355317
MP:0009538	abnormal synapse morphology	140	4.385057e-59	4.902522e-73	7.241445e-11	2.925112e-33	0.2153132
MP:0009539	abnormal Hassall's corpuscle morphology	4	0.01208059	0.04183158	0.02040352	7.612251e-05	0.0231404
MP:0009540	absent Hassall's corpuscle	3	0.3875306	0.04377531	0.4969369	1.326642e-05	0.0254382
MP:0009541	increased thymocyte apoptosis	33	1.149769e-81	1.323054e-06	1.644994e-15	1.200294e-20	0.04681717
MP:0009542	decreased thymocyte apoptosis	22	3.885446e-33	3.155747e-13	7.705874e-24	4.702736e-40	9.677847e-08
MP:0009543	abnormal thymus corticomedullary boundary morphology	28	1.312846e-62	1.349753e-07	1.386912e-19	4.756756e-28	0.7658326
MP:0009544	abnormal thymus epithelium morphology	16	2.406666e-11	9.042977e-14	6.957845e-18	7.417991e-20	1.964432e-05
MP:0009545	abnormal dermis papillary layer morphology	5	0.9908389	4.176537e-08	0.9966678	0.9995414	0.9882791
MP:0009546	absent gastric milk in neonates	96	1.498318e-70	2.157171e-64	7.533057e-15	4.670428e-34	0.7078993
MP:0009547	elliptocytosis	1	0.0004334395	0.998063	1	0.2435606	1.33778e-06
MP:0009548	abnormal platelet aggregation	71	2.604409e-136	1.457177e-08	2.848181e-63	1.13192e-119	0.0005886208
MP:0009549	decreased platelet aggregation	53	9.562381e-103	4.044854e-06	4.844335e-43	3.13514e-95	0.0001758505
MP:0009550	urinary bladder carcinoma	7	2.218145e-05	0.001519557	4.84598e-06	0.01709632	0.1266799
MP:0009551	urinary bladder transitional cell carcinoma	4	0.3363354	0.1497405	0.3954628	0.1923016	0.3802833
MP:0009552	urinary bladder obstruction	5	0.02056816	0.4519902	0.3181479	0.001423915	0.8050408
MP:0009553	fused lips	1	0.1065648	0.1123981	0.248337	1.456944e-05	1
MP:0009554	abnormal hair follicle melanin granule shape	2	0.8662104	0.6017706	0.02275911	0.998903	0.111108
MP:0009555	abnormal hair follicle melanin granule distribution	6	1.160142e-05	4.940998e-07	3.579029e-05	0.5533831	0.3795448
MP:0009557	decreased platelet ADP level	9	1.69777e-08	7.436071e-08	2.47932e-09	8.58193e-11	0.000341312
MP:0009560	absent epidermis stratum granulosum	8	9.787327e-22	0.0005461585	1.115563e-08	8.213557e-12	0.9141271
MP:0009561	superior cervical ganglion degeneration	2	8.993284e-09	0.06872091	0.03151533	0.0001870268	0.1037166
MP:0009562	abnormal odor adaptation	4	0.002093962	0.004098361	0.4481982	0.02550038	0.7924686
MP:0009563	dyskeratosis	1	1.754171e-13	1	0.5572071	0.0001560321	1
MP:0009564	abnormal meiotic configurations	2	0.8860621	0.9953463	0.8001928	0.7768129	0.5229053
MP:0009566	meiotic nondisjunction	4	0.001798082	0.9994472	0.5185243	0.3487213	0.9596861
MP:0009568	abnormal red blood cell deformability	3	3.958567e-22	0.9999983	0.7465183	3.018804e-11	0.0002654608
MP:0009569	abnormal left lung morphology	24	0.0004909957	3.123546e-06	5.517778e-05	4.998571e-07	0.004879821
MP:0009570	abnormal right lung morphology	36	0.0001260391	1.938819e-46	0.1091494	1.716019e-05	0.3195312
MP:0009571	abnormal right lung accessory lobe morphology	8	0.9983405	8.326768e-13	0.9985529	0.01104855	0.2060589
MP:0009572	abnormal right lung cranial lobe morphology	4	0.6595235	1.825469e-11	1	0.09599882	0.04116631
MP:0009573	abnormal right lung middle lobe morphology	5	0.9996699	4.800819e-21	0.9996668	0.8885534	0.2933703
MP:0009574	abnormal right lung caudal lobe morphology	1	1	2.652335e-09	0.770847	0.8595013	0.8122343
MP:0009575	abnormal pubic symphysis morphology	2	0.9170812	0.1296354	1	0.9702669	0.30398
MP:0009576	oral atresia	4	1.983701e-06	6.383626e-06	0.3309155	1.144594e-05	0.4134112
MP:0009577	abnormal developmental vascular remodeling	52	5.354649e-30	2.726577e-60	1.164409e-19	3.200418e-22	7.248024e-06
MP:0009578	otocephaly	2	0.9940374	0.006697465	0.1965883	0.4088053	1
MP:0009579	acephaly	2	0.7420818	5.043108e-06	0.8693811	0.1731961	1
MP:0009580	increased keratinocyte apoptosis	12	1.957384e-59	0.0187248	4.113095e-09	6.474905e-26	0.9780108
MP:0009581	decreased keratinocyte apoptosis	6	2.771025e-10	0.2087166	1.054898e-05	7.640266e-07	0.03766282
MP:0009582	abnormal keratinocyte proliferation	54	1.566472e-116	5.926264e-30	2.435397e-31	1.143634e-41	0.5466624
MP:0009583	increased keratinocyte proliferation	37	1.412726e-102	3.398538e-29	2.991189e-29	2.004265e-32	0.3968659
MP:0009584	decreased keratinocyte proliferation	18	1.058828e-30	2.432874e-05	1.094233e-08	8.04462e-15	0.7713735
MP:0009585	ectopic bone formation	9	0.008483234	1.025441e-18	0.06274601	4.956125e-09	0.06918054
MP:0009586	increased platelet aggregation	8	3.156766e-13	0.0001913251	5.606043e-24	1.254019e-15	0.1644401
MP:0009588	increased plasma membrane sphingolipid content	1	6.948892e-08	0.008571887	0.0002341954	2.819509e-05	0.7552562
MP:0009589	sphingomyelinosis	1	6.948892e-08	0.008571887	0.0002341954	2.819509e-05	0.7552562
MP:0009590	gonad tumor	56	8.150148e-50	1.264176e-12	5.376342e-17	5.331966e-31	0.003607974
MP:0009591	liver adenocarcinoma	6	3.46589e-06	2.571451e-14	0.0001551071	8.131714e-07	0.4084235
MP:0009592	Leydig cell tumor	4	3.410258e-07	0.6387239	0.0004575404	0.0001519245	0.9133514
MP:0009593	absent chorion	15	1.060075e-30	3.972117e-17	0.005865144	2.120011e-08	0.2769229
MP:0009594	abnormal corneocyte envelope morphology	11	1.015413e-11	0.0009463414	6.118568e-07	0.1812495	0.1120222
MP:0009595	enlarged corneocyte envelope	1	2.90366e-16	0.2639492	0.001369142	0.3434051	0.4410307
MP:0009596	abnormal stratum corneum lipid matrix formation	3	2.124906e-24	0.08550123	1.009658e-07	0.01569822	0.4641521
MP:0009597	impaired stratum corneum desquamation	3	1.368789e-15	0.02325062	0.006556646	0.2306302	0.3367492
MP:0009598	thin epidermis stratum granulosum	2	0.7587565	3.516213e-32	0.9337372	0.1953596	0.9121489
MP:0009599	thick epidermis stratum granulosum	8	0.001916128	0.9187355	5.24136e-06	0.07355683	0.6824774
MP:0009600	hypergranulosis	6	6.782309e-09	0.4868648	3.330102e-07	0.005590753	0.4500513
MP:0009601	epidermis stratum granulosum hyperplasia	2	0.7526683	1.469523e-28	1	0.4588905	0.8496797
MP:0009602	abnormal keratohyalin granule morphology	14	7.615245e-11	1.065206e-14	0.0001054536	3.827603e-06	0.1775684
MP:0009603	absent keratohyalin granules	1	0.2623658	0.7264086	0.008981698	0.3225972	0.001711476
MP:0009605	decreased keratohyalin granule number	10	0.01384252	9.102673e-16	0.2676357	0.114151	0.05230096
MP:0009606	increased keratohyalin granule size	2	1.531745e-06	0.1225403	0.0618689	0.002188768	0.8671359
MP:0009607	decreased keratohyalin granule size	1	4.595735e-06	0.864115	0.1172195	0.09267412	1
MP:0009608	abnormal epidermal lamellar body morphology	7	5.443304e-11	0.005133171	0.005147795	2.52495e-16	0.9905684
MP:0009611	epidermis stratum spinosum hyperplasia	47	2.398823e-56	5.761224e-12	8.065019e-21	2.214432e-26	0.5310671
MP:0009612	thick epidermis suprabasal layer	4	2.733033e-09	0.0002164819	4.856081e-06	0.004087965	0.1956859
MP:0009613	thin epidermis suprabasal layer	1	1.780821e-10	0.961698	0.1877083	0.0019271	0.4577168
MP:0009614	absent epidermis stratum spinosum	1	1	0.07022086	1	0.999381	0.2355317
MP:0009615	abnormal zinc homeostasis	8	0.0003100141	0.2264532	2.558322e-05	0.009744235	0.3138556
MP:0009617	decreased brain zinc level	1	1.877329e-08	0.3448514	0.05800555	0.2120467	1
MP:0009619	abnormal optokinetic reflex	7	0.9965224	0.1944778	0.8856116	0.1151215	0.4922657
MP:0009620	abnormal primary vitreous morphology	12	3.358238e-15	1.700448e-20	1.410755e-07	5.234468e-21	0.561241
MP:0009621	primary vitreous hyperplasia	2	0.8695929	2.214254e-05	0.5998143	0.03403368	0.06778015
MP:0009622	absent inguinal lymph nodes	13	4.584676e-35	0.004732497	1.366199e-10	9.601838e-42	0.5188538
MP:0009623	enlarged inguinal lymph nodes	6	1.034574e-42	0.3406868	7.638137e-12	9.406086e-37	0.04811369
MP:0009624	small inguinal lymph nodes	2	0.02008875	0.1668289	0.02029023	0.0004001776	0.9371125
MP:0009625	abnormal abdominal lymph node morphology	52	5.468591e-62	1.870915e-09	1.770796e-52	1.692951e-73	0.001615416
MP:0009628	absent brachial lymph nodes	9	7.320371e-15	0.02115724	5.874527e-06	1.213979e-15	0.1349037
MP:0009629	small brachial lymph nodes	1	6.594091e-10	2.325589e-08	2.368458e-05	0.03867134	0.2355317
MP:0009630	absent axillary lymph nodes	13	6.813044e-22	0.006832891	1.603091e-05	1.593559e-28	0.6941844
MP:0009631	enlarged axillary lymph nodes	3	3.344325e-21	0.7435423	4.30285e-08	6.848524e-21	0.03294107
MP:0009632	small axillary lymph nodes	1	6.594091e-10	2.325589e-08	2.368458e-05	0.03867134	0.2355317
MP:0009633	absent cervical lymph nodes	9	6.902067e-17	0.2287359	1.474443e-06	2.857551e-28	0.8887731
MP:0009634	absent popliteal lymph nodes	8	1.313144e-06	1.715041e-07	8.292941e-05	2.616299e-08	0.6973521
MP:0009635	enlarged popliteal lymph nodes	1	0.0001074952	0.8412949	1	0.01792414	1
MP:0009636	small popliteal lymph nodes	1	0.623605	1	0.3516038	4.940527e-12	0.01518421
MP:0009637	abnormal pretectal region morphology	7	0.2268844	2.651179e-11	0.3893244	3.24726e-06	0.8132613
MP:0009639	abnormal olivary pretectal nucleus morphology	2	0.1507942	0.6114653	0.8696867	0.07248986	0.8688789
MP:0009640	abnormal renal tubule epithelium morphology	47	2.726463e-24	3.444169e-23	1.588951e-09	2.007307e-11	0.246015
MP:0009641	kidney degeneration	46	2.819371e-55	7.640517e-18	6.075305e-15	5.611024e-42	0.04021767
MP:0009642	abnormal blood homeostasis	2083	0	0	0	0	1.931088e-32
MP:0009643	abnormal urine homeostasis	409	0	7.343486e-191	8.010525e-153	3.973607e-261	1.143482e-08
MP:0009644	uremia	164	6.12071e-137	3.530245e-95	2.208658e-68	1.498743e-89	0.001159556
MP:0009645	crystalluria	10	0.0005077633	0.0002428685	3.387165e-07	0.4663341	0.3355232
MP:0009646	urinary bladder inflammation	9	0.0005607002	5.217532e-05	0.0007789178	0.4579485	0.1808915
MP:0009647	decreased fertilization frequency	15	1.133058e-14	0.0001936946	1.229142e-08	1.519197e-13	0.5774455
MP:0009648	abnormal superovulation	13	0.03215	0.04297469	7.855502e-08	0.009254217	0.005731636
MP:0009649	delayed embryo implantation	1	0.9936036	4.059819e-05	3.659865e-06	0.1834024	0.1720082
MP:0009651	abnormal eyelid development	27	4.099967e-26	8.130936e-66	1.638617e-12	4.808929e-16	0.1780933
MP:0009652	abnormal palatal rugae morphology	8	0.9976626	6.720897e-06	0.5626451	0.245392	0.02479232
MP:0009653	abnormal palate development	109	1.362804e-52	4.901307e-148	2.883459e-08	3.883634e-34	0.0004641965
MP:0009654	abnormal primary palate development	4	0.8835945	1.053559e-41	4.749531e-07	0.0002115721	0.3551947
MP:0009655	abnormal secondary palate development	107	4.424899e-57	4.11988e-145	1.114842e-08	1.541199e-35	0.000368348
MP:0009656	delayed chorioallantoic fusion	5	0.01374611	2.731401e-11	0.007775025	0.0008770719	0.6905105
MP:0009657	failure of chorioallantoic fusion	67	1.125188e-48	1.307186e-46	2.625713e-21	1.040256e-18	0.2165391
MP:0009658	increased placenta apoptosis	7	9.228081e-09	0.007081456	0.008492295	0.001013701	0.005079404
MP:0009660	abnormal induced retinal neovascularization	20	4.956524e-33	1.015711e-08	1.606149e-30	3.712489e-30	0.111889
MP:0009661	abnormal pregnancy	158	2.824983e-95	2.519856e-75	5.102805e-87	1.53854e-71	1.051413e-06
MP:0009662	abnormal uterine receptivity	4	2.698401e-06	0.7831567	0.0001122448	0.08364098	0.03783704
MP:0009664	abnormal luminal closure	2	0.0292576	0.9834956	0.5576945	0.7635494	0.01360921
MP:0009665	abnormal embryo apposition	1	1.311809e-14	0.3230989	9.930776e-06	0.0002188037	0.6338334
MP:0009666	abnormal embryo attachment	2	7.589e-19	0.8010252	3.158285e-05	5.962906e-14	0.7800355
MP:0009669	abnormal postimplantation uterine environment	3	0.2373238	0.2795862	0.6665766	0.9298392	0.004605434
MP:0009671	abnormal uterus physiology	22	0.009077467	2.962819e-07	2.048077e-14	6.908406e-10	1.229739e-06
MP:0009673	increased birth weight	4	1.664305e-33	0.0003021755	5.582623e-08	4.053472e-11	0.0771755
MP:0009674	decreased birth weight	106	5.319814e-129	1.566063e-53	5.006673e-22	1.045282e-56	0.03051079
MP:0009675	orthokeratosis	19	1.150177e-10	1.827598e-09	1.792493e-06	4.287953e-14	0.8090611
MP:0009676	abnormal hemostasis	246	0	2.819827e-38	4.73104e-128	2.117851e-273	9.877226e-12
MP:0009677	abnormal spinal cord dorsal column morphology	16	1.004673e-17	3.29587e-31	1.263657e-19	1.272829e-15	0.4214793
MP:0009678	abnormal spinal cord lateral column morphology	5	0.9997806	1.587956e-10	0.998873	0.971613	0.9970005
MP:0009681	abnormal pyramidal decussation morphology	1	0.498046	1.109201e-09	0.9230908	0.1007809	0.652219
MP:0009682	abnormal anterior corticospinal tract morphology	3	0.998952	2.084654e-08	0.999969	0.8970227	0.9860894
MP:0009683	abnormal lateral corticospinal tract morphology	1	0.001941657	0.6154728	0.7134668	0.0806314	0.4022853
MP:0009684	abnormal spinal cord lateral motor column morphology	6	1.764743e-09	8.898795e-10	0.0001412092	1.622064e-05	0.1892951
MP:0009685	abnormal spinal cord motor column morphology	7	1.683015e-05	4.720725e-15	0.005538518	0.0008212261	0.284409
MP:0009686	abnormal spinal cord medial motor column morphology	3	3.708198e-11	4.806273e-10	1.087194e-05	0.0002450162	0.06738663
MP:0009687	empty decidua capsularis	11	4.323657e-35	8.054301e-09	8.888263e-10	4.455703e-17	0.4930339
MP:0009688	abnormal spinal cord central canal morphology	8	6.010805e-27	9.841109e-10	1.626384e-06	1.649854e-12	0.998097
MP:0009689	abnormal neural tube ventricular layer morphology	4	1.709715e-07	4.757142e-06	0.001788192	0.00327193	0.9531591
MP:0009690	abnormal neural tube mantle layer morphology	1	0.9951255	0.5488258	1	0.886565	1
MP:0009691	abnormal neural tube marginal layer morphology	1	0.0001562	8.055071e-10	0.3455751	0.4534324	0.7053751
MP:0009695	abnormal spinal cord ventral commissure morphology	8	0.9928912	7.047324e-13	0.9681556	0.6842238	0.995657
MP:0009697	abnormal copulation	17	1.106107e-18	0.004262457	4.266531e-11	0.002156446	0.0550083
MP:0009698	heart hemorrhage	60	1.707514e-135	8.499439e-24	3.541558e-58	1.187103e-71	0.0001697923
MP:0009699	hyperchylomicronemia	2	1.057801e-10	4.726501e-10	0.1938838	0.05662342	1
MP:0009701	abnormal birth body size	208	1.06915399983931e-314	2.718684e-89	1.585505e-51	1.572002e-126	0.3092983
MP:0009702	increased birth body size	5	8.767571e-35	1.371851e-05	6.573786e-09	3.558818e-11	0.1440098
MP:0009703	decreased birth body size	207	2.99719600000169e-312	4.785035e-88	1.160481e-50	4.922933e-126	0.2929119
MP:0009704	skin squamous cell carcinoma	18	1.940696e-19	0.0003961862	6.88896e-07	7.565955e-18	0.07947705
MP:0009705	abnormal midgut morphology	3	0.00103632	1.146132e-13	0.6385425	0.9755417	1
MP:0009706	absent midgut	2	0.001469761	8.982178e-11	0.6392192	0.9071759	1
MP:0009707	absent external auditory canal	3	0.0001064208	1.430172e-06	0.1530572	7.31398e-05	0.4651438
MP:0009708	vaginal septum	1	0.4395437	6.202953e-05	0.01604049	0.1296765	1
MP:0009709	hydrometra	1	0.9982283	8.577734e-11	0.770847	0.3225972	1
MP:0009710	anhedonia	2	0.9962766	0.8529317	0.9546465	0.9068139	0.2287658
MP:0009711	abnormal conditioned place preference behavior	30	3.901842e-23	0.0004184218	0.104229	0.0003631573	0.6029322
MP:0009712	impaired conditioned place preference behavior	23	1.899996e-19	0.0188625	0.2778844	0.000472984	0.5638467
MP:0009713	enhanced conditioned place preference behavior	9	2.339167e-22	0.0072445	0.07757714	0.01584206	0.707832
MP:0009714	thin epidermis stratum basale	1	0.5844239	7.434123e-06	0.1503086	0.5714637	0.6825988
MP:0009715	thick epidermis stratum basale	7	1.516572e-07	4.132941e-05	4.543883e-07	4.161818e-07	0.1627794
MP:0009716	abnormal subcommissural organ morphology	3	0.3069535	1.253216e-09	2.770619e-05	0.001273863	0.2120925
MP:0009717	absent subcommissural organ	1	0.8246961	2.072145e-05	3.083323e-07	0.2108217	0.08911155
MP:0009718	absent Purkinje cell layer	9	1.217041e-29	2.14577e-06	8.610399e-05	2.82471e-08	0.9455463
MP:0009719	reduced cerebellar foliation	25	8.722776e-11	2.394085e-06	0.2997791	6.76465e-06	0.7324706
MP:0009721	supernumerary mammary glands	1	1	0.9998923	1	0.977917	0.498173
MP:0009722	abnormal nipple development	5	0.002729981	0.8676908	0.2244747	0.009242743	0.2823526
MP:0009723	supernumerary nipples	1	1	0.9998923	1	0.977917	0.498173
MP:0009724	ectopic nipples	1	1	0.9998923	1	0.977917	0.498173
MP:0009725	absent lens vesicle	3	0.9700028	6.316154e-06	0.4452867	0.1298906	0.005593082
MP:0009727	abnormal navicular morphology	1	1.597063e-05	0.2305501	0.2246218	0.01927655	0.8122343
MP:0009728	abnormal calcaneum morphology	7	0.2534786	0.0005383536	0.003876145	0.8494764	0.1388219
MP:0009729	absent tarsus bones	1	0.06879109	0.1723644	0.7719747	0.4059351	1
MP:0009732	ventricular premature beat	8	0.9543675	2.037354e-27	0.4002466	0.795867	0.06621834
MP:0009733	absent nipple	4	2.697992e-07	0.2552342	0.01842938	0.000131606	0.2981976
MP:0009734	abnormal prostate gland duct morphology	10	5.697691e-14	2.214857e-12	0.4140983	6.837101e-07	0.08995873
MP:0009735	abnormal prostate gland development	12	1.22976e-05	1.728095e-22	0.453743	0.01097264	0.5349971
MP:0009736	abnormal prostate gland branching morphogenesis	9	0.0001433821	4.825626e-25	0.1621676	0.03919518	0.452332
MP:0009737	prostate gland cysts	2	2.302081e-22	0.06506938	7.296999e-07	1.5256e-19	1
MP:0009738	enlarged prostate gland anterior lobe	2	0.09812934	5.421025e-05	0.01156934	0.01818893	0.776477
MP:0009740	small prostate gland dorsolateral lobe	1	0.9794862	0.9655247	0.02326111	0.9948082	0.08911155
MP:0009741	ectopic mammary gland	1	1	0.9998923	1	0.977917	0.498173
MP:0009742	increased corneal stroma thickness	4	1.149314e-16	0.0006480691	0.2092058	0.078723	0.724099
MP:0009743	preaxial polydactyly	34	2.618048e-05	3.120022e-26	0.009100724	7.81433e-09	0.7796159
MP:0009744	postaxial polydactyly	9	0.001992763	1.684205e-22	0.1902349	0.0005276823	0.9819587
MP:0009745	abnormal behavioral response to xenobiotic	253	2.836678e-113	5.838337e-70	1.303498e-20	1.668068e-46	0.02062584
MP:0009746	enhanced behavioral response to xenobiotic	65	6.852023e-56	1.194074e-21	8.495576e-06	1.110072e-27	0.2933736
MP:0009747	impaired behavioral response to xenobiotic	82	2.736365e-27	1.465724e-11	0.0003901604	2.970466e-08	0.8889358
MP:0009748	abnormal behavioral response to addictive substance	82	9.489652e-48	4.174101e-20	1.511445e-09	1.654293e-23	0.5444496
MP:0009749	enhanced behavioral response to addictive substance	44	1.020448e-46	1.736246e-16	2.809342e-06	2.204868e-21	0.3875269
MP:0009750	impaired behavioral response to addictive substance	46	1.965661e-27	3.853218e-07	0.0003508149	1.04033e-12	0.9559244
MP:0009751	enhanced behavioral response to alcohol	13	2.35111e-18	8.821311e-11	0.0007136826	7.029961e-08	0.3771835
MP:0009752	enhanced behavioral response to nicotine	3	1.539654e-18	0.6881415	0.05511781	0.002997899	0.6860918
MP:0009753	enhanced behavioral response to morphine	4	0.8479016	0.001012529	0.5615229	0.6462657	0.6749156
MP:0009754	enhanced behavioral response to cocaine	21	4.908235e-13	0.002791876	0.06806941	2.540663e-07	0.2879057
MP:0009755	impaired behavioral response to alcohol	8	6.229385e-12	0.005762441	0.1760487	1.276627e-05	0.9941836
MP:0009756	impaired behavioral response to nicotine	2	2.666561e-28	0.1622025	0.335038	0.0004102006	1
MP:0009757	impaired behavioral response to morphine	11	0.9484801	0.04791379	0.8956672	0.1306654	0.7011544
MP:0009758	impaired behavioral response to cocaine	15	3.828054e-07	0.8119722	0.3179286	9.233031e-05	0.8180221
MP:0009759	abnormal hair follicle bulge morphology	10	3.561578e-18	4.742442e-15	0.005691736	1.433333e-06	0.007895661
MP:0009760	abnormal mitotic spindle morphology	31	7.642256e-96	1.452887e-09	5.071576e-06	6.113911e-15	0.8381859
MP:0009761	abnormal meiotic spindle morphology	9	6.561144e-44	2.233145e-05	0.7562908	1.514839e-09	0.1036543
MP:0009762	abnormal mitotic spindle assembly checkpoint	7	1.240752e-38	0.5247841	0.00122722	8.754745e-05	0.4620483
MP:0009763	increased sensitivity to induced morbidity/mortality	370	0	3.522969e-100	5.303944e-118	3.751027e-207	4.664211e-10
MP:0009764	decreased sensitivity to induced morbidity/mortality	93	5.269889e-79	7.760232e-20	8.363533e-50	4.70861e-80	3.382059e-05
MP:0009765	abnormal xenobiotic induced morbidity/mortality	161	9.248144e-144	1.267868e-18	2.174089e-46	2.097853e-91	5.219498e-06
MP:0009766	increased sensitivity to xenobiotic induced morbidity/mortality	131	1.386344e-118	1.07309e-12	4.795481e-41	1.111709e-70	6.229362e-05
MP:0009767	decreased sensitivity to xenobiotic induced morbidity/mortality	37	6.261783e-24	1.230092e-07	3.205122e-11	1.483006e-27	0.001403879
MP:0009768	impaired somite development	122	4.550417e-202	1.002319e-108	9.91348e-29	5.447386e-76	0.3360387
MP:0009769	abnormal meiotic spindle assembly checkpoint	2	2.280581e-06	0.8818701	0.3511262	0.01018964	1
MP:0009770	abnormal optic chiasm morphology	10	4.84793e-14	1.507416e-12	0.4771882	0.2093484	0.4039127
MP:0009771	absent optic chiasm	2	0.2367831	3.66105e-07	0.6696407	0.7845433	0.7671544
MP:0009772	abnormal retinal development	36	1.009312e-28	4.837844e-37	5.043085e-05	4.889409e-12	0.3266159
MP:0009773	absent retina	1	0.0001660803	0.2151621	0.01729616	0.01691596	0.1485559
MP:0009774	abnormal behavioral withdrawal response	8	0.9125742	0.08247513	0.8974653	0.9954133	0.007987169
MP:0009775	increased behavioral withdrawal response	1	0.9995742	0.6823298	0.7500295	0.9247693	0.08078425
MP:0009776	decreased behavioral withdrawal response	7	0.6532424	0.05117574	0.8791286	0.9891911	0.02609561
MP:0009777	abnormal behavioral response to anesthetic	12	0.0004601874	0.4239004	0.1951335	0.02016156	0.8377252
MP:0009778	impaired behavioral response to anesthetic	6	0.6489402	0.9308333	0.9613964	0.9060207	0.9903871
MP:0009779	enhanced behavioral response to anesthetic	7	0.5680286	0.03037489	0.239025	0.06486792	0.7323906
MP:0009780	abnormal chondrocyte physiology	24	5.175265e-14	9.242818e-33	1.396339e-05	5.264858e-06	0.336821
MP:0009781	abnormal preimplantation embryo development	283	0	2.845396e-112	3.325421e-74	2.436173e-161	0.005961476
MP:0009782	abnormal basicranium angle	1	7.64628e-09	0.1617153	5.900599e-06	0.2108217	0.498173
MP:0009783	abnormal melanoblast morphology	8	0.307504	2.152651e-15	0.2293952	0.7565079	0.05779878
MP:0009784	abnormal melanoblast migration	3	6.641764e-09	0.01301989	0.005331884	0.4052552	0.3705004
MP:0009785	altered susceptibility to infection induced morbidity/mortality	155	5.738845e-119	9.540683e-17	3.207136e-104	2.882754e-151	1.964869e-23
MP:0009786	decreased susceptibility to infection induced morbidity/mortality	68	7.828482e-29	5.000167e-05	5.291368e-53	1.412932e-54	1.503633e-14
MP:0009787	increased susceptibility to infection induced morbidity/mortality	114	4.363463e-114	1.339557e-11	3.531692e-71	1.493696e-131	6.96722e-18
MP:0009788	increased susceptibility to bacterial infection induced morbidity/mortality	77	3.676025e-91	4.335962e-10	2.047479e-63	1.586257e-113	8.888705e-10
MP:0009789	decreased susceptibility to bacterial infection induced morbidity/mortality	37	1.496563e-08	3.618203e-10	6.236748e-20	5.868879e-21	3.784662e-06
MP:0009790	decreased susceptibility to viral infection induced morbidity/mortality	24	1.232982e-17	0.3568992	7.707698e-21	3.642568e-30	4.115205e-08
MP:0009791	increased susceptibility to viral infection induced morbidity/mortality	27	1.403251e-17	0.001716898	5.909322e-16	6.806092e-33	2.884143e-08
MP:0009793	sebaceous gland hypertrophy	1	0.7744006	3.856416e-05	0.02059921	0.2802023	1
MP:0009794	sebaceous gland hyperplasia	4	0.01675825	4.803956e-05	0.008942831	0.00732614	0.4884708
MP:0009795	epidermal spongiosis	1	0.3715218	0.1405383	0.0004843353	0.009651751	0.01995896
MP:0009796	abnormal base-excision repair	9	2.691382e-46	7.860975e-05	5.556549e-10	1.044377e-19	0.8971379
MP:0009797	abnormal mismatch repair	8	1.841416e-09	0.0003133578	0.6030123	1.582056e-07	0.9677136
MP:0009798	abnormal ophthalmic nerve morphology	2	0.1959807	0.1244778	0.9649412	0.4655135	0.3581558
MP:0009800	abnormal mandibular nerve morphology	6	4.333073e-05	2.627304e-05	1.692619e-06	0.0002938617	0.02699698
MP:0009801	abnormal hair cortex keratinization	3	0.3804539	4.265358e-06	0.005199454	0.4943765	0.3685642
MP:0009804	abnormal interventricular foramen morphology	1	0.9930732	1.824588e-13	0.9128654	0.746	0.498173
MP:0009806	abnormal otic vesicle morphology	36	1.198735e-12	1.197263e-29	0.0002396003	1.578507e-13	0.3853542
MP:0009808	decreased oligodendrocyte number	22	4.233275e-28	1.638015e-05	8.870202e-22	4.206574e-20	0.006242706
MP:0009809	abnormal urine uric acid level	13	3.064284e-16	6.990813e-11	5.289004e-06	0.01496578	0.008393331
MP:0009810	increased urine uric acid level	7	9.455659e-10	2.405957e-09	0.0001446764	0.01577201	0.05344845
MP:0009811	abnormal prostaglandin level	31	4.05175e-45	8.187016e-20	5.527547e-23	8.055216e-28	0.0006865625
MP:0009812	abnormal bradykinin level	2	3.867075e-13	0.1807583	1.638154e-05	6.898535e-07	0.0008730428
MP:0009813	abnormal leukotriene level	5	8.232694e-30	0.0004274807	5.886319e-07	3.362014e-18	0.2387836
MP:0009814	increased prostaglandin level	16	2.557317e-33	8.773086e-08	1.165329e-06	5.130476e-16	0.2059422
MP:0009815	decreased prostaglandin level	17	5.119623e-29	8.08944e-13	1.543347e-14	9.839233e-18	0.05554948
MP:0009816	increased leukotriene level	1	3.940094e-06	0.9004449	0.004617689	1.345806e-07	0.7201944
MP:0009817	decreased leukotriene level	4	1.505304e-25	8.679403e-06	2.742776e-05	2.417928e-12	0.1746522
MP:0009818	abnormal thromboxane level	8	2.802687e-23	3.046635e-06	0.0003465927	3.683647e-15	0.2648423
MP:0009820	abnormal liver vasculature morphology	71	2.661925e-170	9.611721e-21	9.956978e-38	1.113205e-78	0.04684213
MP:0009821	abnormal vestibular aqueduct morphology	1	0.672827	0.02064353	0.9271712	0.8540202	0.09530803
MP:0009823	abnormal sphingomyelin level	4	6.658625e-07	0.0004005087	4.873357e-14	6.155716e-06	0.1058038
MP:0009824	spermatic granuloma	2	0.9990326	0.05169078	0.0009263438	0.125667	0.7360538
MP:0009826	abnormal dermis reticular layer collagen network	2	0.003193015	0.03009917	0.04377599	0.01936711	1
MP:0009827	skin detachment	1	0.8246961	1.824588e-13	0.3832671	0.1282527	0.2355317
MP:0009828	increased tumor latency	24	6.242055e-52	1.437037e-10	1.207962e-12	5.040611e-34	0.001321076
MP:0009829	enlarged eye anterior chamber	6	6.881497e-21	0.01021985	0.5113514	2.401005e-09	0.6035422
MP:0009830	abnormal sperm connecting piece morphology	1	5.853325e-06	7.413629e-07	0.0003762763	0.09837502	0.5844193
MP:0009831	abnormal sperm midpiece morphology	32	1.711498e-79	0.001389351	4.038256e-11	2.442869e-29	0.7480864
MP:0009832	abnormal sperm mitochondrial sheath morphology	21	7.068311e-52	0.001807563	4.717789e-07	6.026905e-24	0.658195
MP:0009833	absent sperm mitochondrial sheath	5	8.765095e-45	0.8201695	0.1612062	1.807157e-05	0.6764888
MP:0009834	abnormal sperm annulus morphology	3	0.000132678	0.6069142	0.1058254	0.002427374	1
MP:0009835	absent sperm annulus	1	0.0006859551	0.1546017	1	0.5135318	1
MP:0009836	abnormal sperm principal piece morphology	9	2.831506e-10	0.2036195	0.04957725	2.673066e-07	0.9735747
MP:0009837	abnormal sperm end piece morphology	1	0.8790765	0.7294166	1	0.9371568	0.2682938
MP:0009838	abnormal sperm axoneme morphology	16	9.884032e-21	0.8877033	3.51034e-05	0.0007860019	0.06464697
MP:0009839	multiflagellated sperm	8	3.926837e-24	4.631483e-12	0.0003123939	0.004584979	0.9289091
MP:0009840	abnormal foam cell morphology	21	6.441771e-49	1.576294e-11	1.325934e-18	2.523009e-23	0.7653663
MP:0009842	abnormal neural crest cell proliferation	5	4.093164e-12	1.11515e-05	4.334626e-12	1.127574e-11	0.9623567
MP:0009843	decreased neural crest cell number	8	9.882689e-07	9.354456e-05	0.7442586	1.500594e-10	0.9858416
MP:0009844	abnormal neural crest cell apoptosis	9	2.607415e-07	0.6696218	0.9855244	0.6833824	0.6643181
MP:0009845	abnormal neural crest cell morphology	36	4.127711e-21	1.782983e-45	3.734439e-16	1.10372e-31	0.2747452
MP:0009846	abnormal neural crest morphology	38	1.22362e-20	3.364513e-51	4.134634e-15	6.435687e-31	0.2795906
MP:0009848	increased horizontal stereotypic behavior	2	0.01589466	0.2742321	0.0849762	1.201808e-11	0.03972837
MP:0009849	increased vertical stereotypic behavior	2	0.04732686	0.007061905	0.006168912	3.705493e-08	0.03880443
MP:0009850	embryonic lethality between implantation and placentation	424	0	1.879985e-160	6.068336e-140	5.298353e-304	0.0008883505
MP:0009851	abnormal Sertoli cell phagocytosis	6	2.128883e-15	8.930971e-06	0.07588735	2.32438e-15	0.01502416
MP:0009852	increased Sertoli cell phagocytosis	1	8.533685e-14	0.9340441	0.5176195	0.0001137709	0.16085
MP:0009853	decreased Sertoli cell phagocytosis	4	0.1095885	9.523527e-09	0.05538622	3.837092e-08	0.01760602
MP:0009854	impaired gastric peristalsis	4	0.006337242	0.04474992	0.03475154	0.03597017	0.8758043
MP:0009856	failure of ejaculation	7	0.45585	0.2052999	0.04986634	0.09173955	0.3733489
MP:0009857	absent kidney cortex	1	0.1189998	0.9048957	0.9558322	0.8172051	0.7232245
MP:0009858	abnormal cellular extravasation	50	1.119089e-103	5.215172e-09	1.101102e-36	4.980508e-82	0.01653695
MP:0009859	eye opacity	7	3.2231e-09	3.330259e-05	3.081773e-07	3.325728e-10	0.1778082
MP:0009860	nephrosclerosis	1	0.9494554	0.0003059936	1	0.1968999	0.1785653
MP:0009861	abnormal pyloric sphincter morphology	6	4.907236e-05	0.2286192	0.1105429	0.002378863	0.9983779
MP:0009862	abnormal aorta elastic tissue morphology	25	5.450419e-11	4.343397e-23	1.298297e-07	4.694869e-11	0.7987057
MP:0009864	abnormal aorta endothelium morphology	4	0.00267846	0.6842466	4.202742e-06	3.335418e-14	0.01557202
MP:0009865	abnormal aorta smooth muscle morphology	13	0.001264308	4.175241e-24	0.03180501	1.6287e-14	0.4962263
MP:0009866	abnormal aorta wall morphology	49	7.356466e-27	2.847751e-63	1.655331e-11	9.601975e-38	0.07114065
MP:0009867	abnormal ascending aorta morphology	24	4.263741e-50	1.150755e-20	1.04811e-10	1.634987e-10	0.08145543
MP:0009868	abnormal descending thoracic aorta morphology	5	0.874459	9.83379e-05	0.0001370121	0.06092251	0.6827699
MP:0009869	abnormal descending aorta morphology	19	3.967366e-13	8.895577e-26	2.1631e-16	2.741767e-16	0.03213311
MP:0009870	abnormal abdominal aorta morphology	9	3.265588e-14	1.953382e-11	1.100222e-10	4.322319e-09	0.008750003
MP:0009871	abnormal aorta tunica adventitia morphology	6	2.23045e-09	4.145238e-18	0.0001282825	5.83153e-08	0.1549543
MP:0009872	abnormal aorta tunica intima morphology	5	0.0008814031	0.356157	3.260719e-07	1.076734e-12	0.04684002
MP:0009873	abnormal aorta tunica media morphology	42	2.92724e-23	9.312992e-52	1.689505e-11	1.807219e-31	0.03512135
MP:0009874	abnormal interdigital cell death	12	0.03845192	2.527345e-13	0.09125597	0.01268625	0.03839127
MP:0009877	exostosis	8	0.0005872883	0.008029351	2.392033e-07	6.586304e-08	0.003700282
MP:0009878	decreased susceptibility to bone fracture	5	0.0226651	0.4362158	5.784038e-08	7.39631e-06	0.3394251
MP:0009879	abnormal arcus anterior morphology	9	3.540248e-06	4.088482e-08	0.02324265	3.61666e-06	0.01203599
MP:0009880	microstomia	2	0.0003264059	0.06989083	0.01800931	0.005257012	0.9509205
MP:0009882	absent palatal shelf	4	2.500305e-05	5.11867e-09	8.696147e-05	0.0001528697	0.070003
MP:0009883	palatal shelf hypoplasia	16	0.2734216	4.678497e-25	0.1827171	0.01655998	0.1222658
MP:0009884	palatal shelf fusion with tongue or mandible	5	0.002574517	1.508151e-17	0.8742953	0.006780115	0.09911884
MP:0009885	abnormal palatal shelf elevation	42	0.004472765	3.317911e-97	0.003247718	2.137644e-16	0.002464242
MP:0009886	failure of palatal shelf elevation	30	0.5620956	1.220335e-57	4.859378e-05	1.885478e-10	0.0004543683
MP:0009887	abnormal palatal shelf fusion at midline	68	6.657469e-37	1.985662e-59	0.001511029	2.319399e-18	0.07031187
MP:0009888	palatal shelves fail to meet at midline	46	1.822541e-24	3.998311e-32	0.0009256403	5.192862e-09	0.1652577
MP:0009889	persistence of medial edge epithelium during palatal shelf fusion	4	0.0003329945	0.0573271	0.09432363	2.719666e-05	1
MP:0009890	cleft secondary palate	144	1.06177e-63	2.294525e-153	2.80182e-15	2.23637e-44	0.0005764917
MP:0009891	abnormal palate bone morphology	50	0.002778498	2.58011e-74	0.004966311	3.253603e-06	0.05630467
MP:0009892	palate bone hypoplasia	3	0.0001833985	0.001614218	0.4120303	0.1066071	0.9559981
MP:0009893	cleft primary palate	2	0.8868073	8.606589e-07	0.3651646	0.04219602	0.6909815
MP:0009894	absent hard palate	3	0.1490765	0.4669498	3.889313e-06	0.05358092	0.009418597
MP:0009895	decreased palatine shelf size	11	0.725154	0.0002195628	0.2639634	0.00558441	0.7441558
MP:0009896	palatine shelf hypoplasia	1	1.23423e-05	3.284561e-10	0.08820478	0.02344513	0.788344
MP:0009897	decreased maxillary shelf size	8	0.9999069	2.424791e-35	0.0007087838	0.4092524	0.007370717
MP:0009898	maxillary shelf hypoplasia	4	0.6921321	2.344904e-12	0.03122361	0.775222	0.03312766
MP:0009899	hyoid bone hypoplasia	7	1.167803e-10	1.015298e-09	0.1992265	0.0005740122	0.1614321
MP:0009900	vomer bone hypoplasia	4	0.001371487	5.650408e-05	0.3813492	0.0579295	0.981693
MP:0009901	abnormal frontonasal prominence morphology	19	1.520474e-07	5.76337e-12	0.02818898	1.057448e-09	0.2563169
MP:0009902	abnormal lateral nasal prominence morphology	5	0.9239191	3.86403e-10	0.1313536	0.0387556	0.006811384
MP:0009903	abnormal medial nasal prominence morphology	9	0.7823383	7.597134e-07	0.06597863	0.9299795	0.2880242
MP:0009904	tongue hypoplasia	6	0.8750852	1.066181e-19	0.004026065	0.04126543	0.0218242
MP:0009905	absent tongue	8	0.0002261912	0.001382947	0.8046622	5.528238e-06	0.9724805
MP:0009906	increased tongue size	2	0.1212124	1.615872e-16	0.2988579	3.012837e-05	0.4295862
MP:0009907	decreased tongue size	19	0.9398125	9.522609e-30	0.003675237	0.00361095	0.02917608
MP:0009908	protruding tongue	11	2.503196e-08	7.251307e-08	0.0004364876	1.431733e-07	0.4494917
MP:0009909	bifid tongue	3	0.998176	9.749844e-12	0.5812084	0.9490975	1
MP:0009910	bifurcated tongue	2	0.9991104	1.69636e-10	0.5539151	0.9392997	1
MP:0009911	increased hyoid bone size	2	2.487427e-08	1.190857e-06	0.8864736	0.03201331	0.9305019
MP:0009912	decreased hyoid bone size	9	2.020401e-09	1.429182e-11	0.5555355	0.0001139206	0.2303439
MP:0009913	abnormal hyoid bone greater horn morphology	6	0.9934382	8.380154e-08	0.6086678	7.305699e-06	0.7622083
MP:0009914	abnormal hyoid bone lesser horn morphology	14	0.9999918	3.915128e-32	0.001454408	0.002926966	0.177291
MP:0009915	absent hyoid bone lesser horns	3	0.9998536	2.367769e-12	1	0.539742	1
MP:0009916	absent hyoid bone greater horns	1	0.9996953	0.5187106	1	0.9948082	1
MP:0009917	abnormal hyoid bone body morphology	6	0.9964018	4.744967e-10	0.009244539	0.001737577	0.8294582
MP:0009918	abnormal stylohyoid ligament morphology	4	0.8919609	3.84275e-20	0.7940355	0.4720273	0.3145734
MP:0009919	abnormal transitional stage T1 B cell morphology	17	2.12172e-71	0.09389192	1.251197e-19	4.085819e-41	0.3094883
MP:0009920	abnormal transitional stage T2 B cell morphology	19	8.451409e-71	0.3486085	4.32519e-17	1.102231e-49	0.1650258
MP:0009922	increased transitional stage T1 B cell number	9	1.031553e-40	0.09917827	6.050164e-16	2.064623e-16	0.09268339
MP:0009923	decreased transitional stage T1 B cell number	9	2.104152e-32	0.3151918	4.589221e-06	6.765502e-28	0.8738079
MP:0009925	increased transitional stage T2 B cell number	2	3.732405e-20	0.2296891	0.03273435	8.744321e-07	0.2643726
MP:0009926	decreased transitional stage T2 B cell number	18	1.056322e-54	0.4439354	1.511379e-16	1.321742e-44	0.2377168
MP:0009928	abnormal pinna hair pigmentation	3	0.003214739	0.007908885	1.20587e-05	0.8234614	0.2104766
MP:0009929	meningomyelocele	8	1.038261e-09	0.007277499	4.516863e-15	3.930848e-11	0.784796
MP:0009931	abnormal skin appearance	440	0	2.869691e-168	1.012649e-142	0	0.0004726545
MP:0009932	skin fibrosis	15	5.53462e-48	1.26325e-14	5.551076e-19	7.297285e-20	0.07478666
MP:0009933	abnormal tail hair pigmentation	3	0.9465617	7.822036e-07	0.0259158	0.9354682	0.07092618
MP:0009934	abnormal hind foot hair pigmentation	1	0.9999736	5.014296e-07	1	0.999381	0.2355317
MP:0009936	abnormal dendritic spine morphology	36	3.680508e-21	1.474574e-26	0.001137748	1.199366e-15	0.6237104
MP:0009937	abnormal neuron differentiation	334	7.973968e-247	6.193971e-232	4.474597e-37	1.059236e-112	0.00928563
MP:0009938	abnormal hippocampus granule cell morphology	4	7.36848e-33	2.869688e-08	0.3288196	0.08710806	0.8737862
MP:0009939	abnormal hippocampus neuron morphology	101	2.486273e-93	8.180049e-43	1.228744e-23	6.980337e-32	0.03998227
MP:0009940	abnormal hippocampus pyramidal cell morphology	58	6.91274e-65	1.314108e-27	6.593951e-19	3.064418e-16	0.5011656
MP:0009941	abnormal olfactory bulb interneuron morphology	5	0.05198013	0.02736252	0.2560447	0.4784741	0.9853978
MP:0009942	abnormal olfactory bulb granule cell morphology	2	0.9999956	0.03151958	1	0.4901675	1
MP:0009943	abnormal olfactory bulb periglomerular cell morphology	3	0.1210523	9.94241e-05	0.1799171	0.1584203	0.9462899
MP:0009944	abnormal olfactory lobe morphology	161	3.54545e-36	5.887217e-112	1.391627e-11	1.080621e-32	0.003682593
MP:0009945	abnormal accessory olfactory bulb morphology	8	0.0213865	1.040609e-13	0.004818104	0.2465307	0.01157007
MP:0009946	abnormal olfactory bulb layer morphology	21	0.001938387	6.86084e-06	0.002100059	0.00696335	0.1354783
MP:0009947	abnormal olfactory bulb external plexiform layer morphology	6	0.0002058464	0.2187123	0.002103575	0.0516648	0.07606276
MP:0009948	abnormal olfactory bulb glomerular layer morphology	12	0.0369374	0.1704122	0.8828905	0.1299156	0.258236
MP:0009949	abnormal olfactory bulb granule cell layer morphology	6	1	0.1830827	0.9999992	0.8289384	0.3966085
MP:0009950	abnormal olfactory bulb internal plexiform layer morphology	2	0.9996277	0.7206877	0.9972973	0.6149029	0.4295862
MP:0009951	abnormal olfactory bulb mitral cell layer morphology	11	5.001213e-05	1.697083e-06	3.04098e-06	0.002525967	0.4426373
MP:0009952	abnormal olfactory bulb subventricular zone morphology	1	0.9930732	0.9655247	0.9827874	0.936322	0.007418096
MP:0009954	abnormal mitral cell morphology	5	1.565629e-07	0.0001431367	1.089471e-05	0.0004146102	0.5598089
MP:0009955	abnormal olfactory bulb tufted cell morphology	1	2.107412e-05	0.9999754	0.04509781	0.4136187	0.7988371
MP:0009956	abnormal cerebellar layer morphology	271	3.241043e-215	3.155249e-180	2.031908e-40	8.208387e-114	0.01931328
MP:0009957	abnormal cerebellum vermis lobule morphology	9	0.6803769	2.755591e-06	0.566115	0.760547	0.3369338
MP:0009958	absent cerebellar granule cells	1	1	0.1087826	1	0.977917	1
MP:0009959	abnormal cerebellar hemisphere morphology	4	0.0004718916	1.231095e-10	0.009656206	0.004285441	0.162955
MP:0009960	abnormal cerebellum anterior lobe morphology	14	0.008437191	3.425449e-15	0.5585069	0.007970509	0.4887931
MP:0009963	abnormal cerebellum hemisphere lobule morphology	2	0.3770347	0.0001961476	0.1390134	0.2423554	0.9362376
MP:0009964	abnormal cerebellum lobule morphology	107	3.451022e-20	2.296624e-72	1.213199e-10	3.337945e-16	0.5437401
MP:0009965	abnormal cerebellum lateral hemisphere morphology	1	0.9930732	1.824588e-13	0.9128654	0.746	0.498173
MP:0009967	abnormal neuron proliferation	116	2.943323e-155	2.635006e-84	1.510173e-10	2.24691e-59	0.7597433
MP:0009968	abnormal cerebellar granule cell proliferation	13	0.0001040233	3.414012e-29	0.005995952	2.237935e-08	0.8102096
MP:0009969	abnormal cerebral cortex pyramidal cell morphology	41	3.217738e-56	3.84319e-21	1.214746e-10	1.452141e-18	0.01087616
MP:0009970	increased hippocampus pyramidal cell number	1	0.2623658	0.07022086	2.163734e-12	0.001677676	0.02789339
MP:0009971	decreased hippocampus pyramidal cell number	15	7.084126e-09	0.1012651	3.076781e-07	0.0003215193	0.1296069
MP:0009972	absent hippocampus pyramidal cells	2	7.46411e-07	0.09187465	0.9930269	0.02262477	0.33537
MP:0009974	decreased cerebral cortex pyramidal cell number	12	1.810007e-14	0.002924961	5.810535e-06	3.535723e-07	0.04640101
MP:0009975	absent cerebral cortex pyramidal cells	2	7.46411e-07	0.09187465	0.9930269	0.02262477	0.33537
MP:0009976	abnormal cerebellar peduncle morphology	2	0.262653	0.9995148	0.9940321	0.1481935	0.6226055
MP:0009977	abnormal cerebellar granule cell migration	15	7.356544e-18	7.984716e-08	5.739809e-07	0.0003144072	0.6701681
MP:0009978	abnormal cerebellum white matter morphology	8	6.049729e-13	0.02614692	0.01583448	1.388099e-06	0.3632767
MP:0009979	abnormal cerebellum deep nucleus morphology	11	3.71535e-12	0.00712111	5.89901e-06	9.077359e-11	0.3866708
MP:0009980	abnormal cerebellum dentate nucleus morphology	3	7.796079e-08	0.9186448	0.0001532181	1.530327e-07	0.8903624
MP:0009983	abnormal cerebellum fastigial nucleus morphology	1	0.02091554	0.9471241	0.02468246	0.1813626	0.003410109
MP:0009988	abnormal cerebellum vermis lobule I morphology	2	0.03439174	0.004649083	0.649668	0.5374195	0.2147009
MP:0009989	abnormal cerebellum vermis lobule II morphology	3	0.4721426	0.1292977	0.9323985	0.7411927	0.4955136
MP:0009990	abnormal cerebellum vermis lobule III morphology	3	0.4721426	0.1292977	0.9323985	0.7411927	0.4955136
MP:0009991	abnormal cerebellum vermis lobule IV morphology	1	0.9999072	0.9933547	1	0.8885926	1
MP:0009992	abnormal cerebellum vermis lobule IX morphology	3	0.3190699	0.001100962	0.6265761	0.3980736	0.2022069
MP:0009993	abnormal cerebellum vermis lobule V morphology	2	0.04881734	0.8648696	0.8546875	0.6786874	0.9510209
MP:0009994	abnormal cerebellum vermis lobule VI morphology	2	0.8571838	0.9987079	1	0.6502319	1
MP:0009995	abnormal cerebellum vermis lobule VII morphology	3	0.004580976	0.9365009	0.899715	0.4853214	0.9627242
MP:0009997	abnormal cerebellum vermis lobule X morphology	3	2.401956e-06	0.0588939	0.3434766	0.2866383	0.1408672
MP:0010008	abnormal Purkinje cell migration	3	0.0004263117	6.824045e-23	0.1318707	0.1399738	0.3661137
MP:0010009	abnormal piriform cortex morphology	3	0.7642807	0.2634119	0.4452867	0.4573078	0.03245028
MP:0010011	ectopic hippocampus pyramidal cells	8	0.9994803	2.977999e-09	5.436579e-06	0.07462799	0.1123092
MP:0010012	ectopic cerebral cortex pyramidal cells	3	0.45667	0.7723113	0.5643183	0.006142856	0.002926143
MP:0010013	cerebral cortex pyramidal cell degeneration	1	0.000152271	0.7066705	0.1645678	0.0449777	1
MP:0010014	hippocampus pyramidal cell degeneration	2	0.9764165	1.088355e-09	0.03798305	0.1125639	0.6495497
MP:0010016	variable depigmentation	8	0.4796176	3.262075e-07	1.628141e-13	8.62055e-07	5.028806e-07
MP:0010017	visceral vascular congestion	54	1.253271e-35	6.611274e-29	6.192056e-19	7.217014e-27	0.0007708761
MP:0010018	pulmonary vascular congestion	36	3.188049e-10	8.853315e-12	7.76961e-10	6.46354e-12	0.348251
MP:0010019	liver vascular congestion	26	2.894194e-32	5.077032e-06	8.529406e-10	4.260834e-19	0.03848271
MP:0010020	spleen vascular congestion	2	7.359453e-08	0.2567145	8.958439e-06	3.558671e-07	0.1307942
MP:0010021	heart vascular congestion	4	2.246807e-05	4.061956e-12	0.04986566	0.002435559	0.2714756
MP:0010022	brain vascular congestion	2	0.9471231	0.7064633	0.0354464	0.8098088	1
MP:0010024	increased total body fat amount	101	3.907594e-71	1.109872e-50	1.182955e-38	1.163755e-39	0.09263497
MP:0010025	decreased total body fat amount	222	0	1.591163e-115	9.419696e-81	1.512674e-137	0.05200082
MP:0010026	decreased liver cholesterol level	27	1.038516e-51	2.453387e-13	8.290562e-24	4.322372e-24	0.6343133
MP:0010027	increased liver cholesterol level	22	1.362078e-23	1.008787e-10	6.781816e-08	5.106811e-13	0.0388895
MP:0010028	aciduria	41	2.467829e-44	9.544721e-26	1.758686e-08	1.011214e-14	0.0700146
MP:0010029	abnormal basicranium morphology	80	1.46652e-78	1.641106e-133	6.562999e-12	2.868244e-35	0.5417048
MP:0010030	abnormal orbit morphology	18	0.8858326	6.057187e-22	0.3292772	0.0006993093	0.975161
MP:0010031	abnormal cranium size	74	8.367263e-44	1.172173e-64	7.479007e-18	2.398296e-28	0.01720685
MP:0010035	increased erythrocyte clearance	8	1.23541e-22	0.9973396	0.006063473	9.968253e-08	0.04446004
MP:0010038	abnormal placenta physiology	26	7.149848e-58	2.889179e-11	1.037823e-08	1.565997e-21	0.03873036
MP:0010039	abnormal trophoblast giant cell proliferation	3	0.137575	0.9647328	0.9655847	0.6011354	1
MP:0010040	abnormal oval cell morphology	3	2.549576e-06	5.894624e-07	0.2208128	0.5952465	0.6833551
MP:0010041	absent oval cells	1	0.04833268	0.4147374	1	0.9279331	1
MP:0010042	abnormal oval cell physiology	6	3.900766e-11	3.632765e-06	0.002151848	5.394871e-06	0.6095512
MP:0010043	abnormal frontonasal suture morphology	5	3.800874e-37	0.002266692	8.098951e-09	3.264311e-35	0.9850546
MP:0010045	increased omental fat pad weight	2	0.9853876	0.9503459	0.9795609	0.9820655	0.3713874
MP:0010047	axonal spheroids	9	2.134946e-22	0.3274763	1.265782e-10	3.423921e-15	0.004248101
MP:0010050	hypermyelination	7	0.0001527514	0.005983205	0.01760756	2.47714e-05	0.6223265
MP:0010052	increased grip strength	21	1.27478e-49	5.807592e-11	0.0002893502	3.547983e-11	0.1059632
MP:0010053	decreased grip strength	179	2.629109e-200	5.368103e-84	3.0318e-37	2.213748e-72	0.02696803
MP:0010054	hepatoblastoma	1	6.594091e-10	2.325589e-08	2.368458e-05	0.03867134	0.2355317
MP:0010055	abnormal sensory neuron physiology	52	7.339739e-92	2.676658e-06	1.280302e-08	4.64919e-23	0.3373595
MP:0010057	abnormal olfactory bulb outer nerve layer morphology	3	1	0.4065291	1	0.9890601	0.7476009
MP:0010059	olfactory bulb hypoplasia	2	2.237995e-05	0.9970696	0.03500091	0.1809261	0.5383513
MP:0010060	abnormal creatine level	8	1.903449e-08	8.489515e-10	2.165719e-09	1.563202e-08	0.3399004
MP:0010061	increased creatine level	5	3.386176e-13	1.478146e-11	3.867218e-08	1.580607e-08	0.4536541
MP:0010062	decreased creatine level	4	0.8772729	0.2932939	0.02493927	0.03915055	0.4695214
MP:0010063	abnormal circulating creatine level	7	1.357897e-10	9.344563e-11	1.064634e-07	3.952272e-08	0.4830394
MP:0010064	increased circulating creatine level	4	2.73786e-13	2.338399e-12	4.537253e-09	1.831622e-08	0.3778297
MP:0010065	decreased circulating creatine level	3	0.6300639	0.2956822	0.5120912	0.1482301	0.784729
MP:0010066	abnormal red blood cell distribution width	70	1.371067e-214	0.01023039	4.832128e-29	8.252737e-137	0.7604574
MP:0010067	increased red blood cell distribution width	68	2.496533e-199	0.005533598	5.253374e-25	1.540094e-126	0.6779524
MP:0010068	decreased red blood cell distribution width	2	1.58025e-18	0.8798163	2.101574e-07	3.536907e-13	1
MP:0010069	increased serotonin level	10	8.407995e-06	0.9945853	0.8825015	0.04686466	0.7523773
MP:0010070	decreased serotonin level	30	1.132903e-36	1.771878e-12	8.737038e-15	1.912101e-20	0.03328981
MP:0010072	increased pruritus	8	1.264453e-12	1.060827e-07	1.337614e-07	0.08425022	0.602628
MP:0010074	stomatocytosis	3	0.0001309324	0.0002387672	0.002293049	2.384507e-05	0.3232291
MP:0010075	abnormal circulating plant sterol level	3	0.003293452	2.605704e-18	0.0001912503	5.943209e-09	0.7969409
MP:0010078	increased circulating plant sterol level	2	1.807578e-06	4.487321e-13	0.005288668	0.006326318	0.7278632
MP:0010079	osteochondroma	4	1.359844e-08	6.96718e-14	1.438629e-06	0.004226618	0.2958792
MP:0010080	abnormal hepatocyte physiology	126	8.688867e-256	2.458572e-79	1.916821e-44	3.382108e-134	0.1179241
MP:0010081	posterior microphthalmia	1	0.1364601	0.0003451558	1	0.002248299	1
MP:0010082	sternebra fusion	11	0.2745	1.809124e-48	0.4371652	0.0009228608	0.9937223
MP:0010084	abnormal long lived plasma cell morphology	2	0.96976	0.9698067	0.004719134	0.2848235	0.01729279
MP:0010086	abnormal circulating fructosamine level	8	6.718334e-62	0.9977153	0.003655161	1.112578e-18	0.7375426
MP:0010087	increased circulating fructosamine level	1	3.752508e-25	0.7601822	0.5565697	0.008201563	1
MP:0010088	decreased circulating fructosamine level	7	4.680044e-41	0.9978632	0.00229032	1.988333e-17	0.613763
MP:0010089	abnormal circulating creatine kinase level	29	9.246699e-20	2.008433e-14	0.005835948	1.641353e-06	0.916592
MP:0010090	increased circulating creatine kinase level	26	2.191845e-11	7.060467e-13	0.004523205	0.0001001844	0.9795284
MP:0010091	decreased circulating creatine kinase level	3	1.74328e-16	0.004434818	0.5288007	0.0002867714	0.09659327
MP:0010092	increased circulating magnesium level	9	1.339671e-28	0.001150262	2.806922e-09	1.811034e-06	0.02986798
MP:0010093	decreased circulating magnesium level	7	0.05318126	4.939798e-10	0.5774212	3.460538e-06	0.805428
MP:0010094	abnormal chromosome stability	117	3.835402e-178	6.929618e-06	7.730069e-13	8.561279e-50	0.3484916
MP:0010095	increased chromosomal stability	4	1.990009e-15	0.4774419	0.1731305	2.734169e-10	1
MP:0010096	abnormal incisor color	9	0.03527689	1.436086e-15	0.0001756165	5.21222e-06	0.06984678
MP:0010097	abnormal retinal blood vessel morphology	9	9.237514e-14	5.22699e-16	7.357747e-07	1.459726e-11	0.1700464
MP:0010098	abnormal retinal blood vessel pattern	4	0.9962649	1.108316e-21	0.03746171	0.800556	0.001980557
MP:0010099	abnormal thoracic cage shape	20	1.227086e-06	8.176695e-22	0.001969745	9.093938e-12	0.1558261
MP:0010101	increased sacral vertebrae number	15	2.393355e-65	0.8461854	7.652949e-12	5.099218e-36	0.3052378
MP:0010102	increased caudal vertebrae number	1	4.488758e-06	0.4598693	0.0844535	0.1184097	0.3435748
MP:0010103	small thoracic cage	33	1.598917e-21	1.545356e-44	0.002176101	1.548502e-10	0.8365982
MP:0010104	enlarged thoracic cage	2	1	0.8751929	0.7828669	0.939745	1
MP:0010105	abnormal sublingual ganglion morphology	1	0.005254905	0.9128044	0.6948436	0.4473193	0.01864501
MP:0010106	abnormal circulating pyruvate kinase level	3	0.9523099	0.3713124	0.9997919	0.9941515	1
MP:0010107	abnormal renal reabsorbtion	40	2.922251e-12	2.61626e-12	2.003068e-05	6.761876e-06	0.423189
MP:0010108	abnormal renal water reabsorbtion	8	0.4847797	0.0004944961	0.1274138	0.007235425	0.2070731
MP:0010109	abnormal renal sodium reabsorbtion	4	0.9153756	0.245163	0.8960429	0.9087974	0.6331726
MP:0010110	abnormal renal phosphate reabsorbtion	5	0.4188899	0.001023516	0.8849628	0.06179394	0.06537827
MP:0010111	abnormal renal calcium reabsorbtion	5	0.008354294	0.003115561	1.280157e-13	0.04466796	0.6499994
MP:0010112	abnormal coccygeal vertebrae morphology	1	0.9982283	8.577734e-11	0.770847	0.3225972	1
MP:0010114	abnormal coccyx morphology	2	0.9999568	8.568679e-09	0.9576473	0.7451737	0.7486531
MP:0010115	abnormal embryonic cloaca morphology	8	0.9829991	2.72452e-11	0.3734504	0.4920969	0.01864401
MP:0010116	abnormal primitive urogenital sinus morphology	7	0.9951484	9.708022e-09	0.5198406	0.4992605	0.008323635
MP:0010117	abnormal lateral plate mesoderm morphology	17	3.900921e-05	1.623634e-17	0.01477505	0.002449251	0.2429149
MP:0010118	abnormal intermediate mesoderm	1	0.3662177	7.948647e-09	0.770847	0.936322	0.8122343
MP:0010119	abnormal bone mineral density	263	3.920674e-218	3.696306e-138	1.662465e-115	2.214045e-150	5.892178e-08
MP:0010122	abnormal bone mineral content	115	1.127149e-96	1.14385e-79	9.451407e-26	6.982291e-40	0.0009482217
MP:0010123	increased bone mineral content	30	7.876358e-25	3.591237e-20	1.597066e-10	9.134148e-08	0.004123028
MP:0010124	decreased bone mineral content	86	7.371165e-77	6.927276e-61	2.183756e-17	2.978565e-34	0.02615507
MP:0010126	abnormal distal visceral endoderm morphology	3	3.309035e-24	0.06771112	2.920616e-06	5.085446e-09	0.9247233
MP:0010127	hypervolemia	3	5.52647e-10	3.142857e-05	0.1259913	0.0001155732	1
MP:0010128	hypovolemia	6	4.035573e-10	0.09716908	0.5209112	4.617486e-05	0.9683839
MP:0010129	increased DN1 thymic pro-T cell number	4	4.853908e-07	6.544862e-06	2.076766e-11	5.123377e-11	0.005587588
MP:0010130	decreased DN1 thymic pro-T cell number	9	1.402637e-29	0.1162979	2.444252e-14	1.228334e-29	5.384663e-05
MP:0010131	increased DN2 thymocyte number	1	0.02062928	0.970214	5.738897e-05	1.562219e-11	0.5704406
MP:0010132	decreased DN2 thymocyte number	8	1.651183e-27	1.563959e-11	9.655759e-08	7.19834e-26	0.04418211
MP:0010133	increased DN3 thymocyte number	10	9.687689e-08	0.0007684352	5.309494e-07	6.082726e-26	6.151887e-06
MP:0010134	decreased DN3 thymocyte number	5	8.454404e-22	1.588859e-15	2.677567e-06	8.177624e-08	0.8614138
MP:0010136	decreased DN4 thymocyte number	12	6.728438e-12	0.0001082622	1.095917e-17	8.291756e-25	7.320725e-07
MP:0010138	arteritis	17	1.331245e-61	0.02605704	3.779399e-11	5.390524e-30	0.7191003
MP:0010139	aortitis	5	0.3044225	1.94432e-08	0.002715825	3.195998e-11	0.4169935
MP:0010140	phlebitis	1	0.0007990111	1	0.03826761	1.460962e-06	1
MP:0010143	enhanced fertility	3	0.1821021	7.555677e-08	0.2940686	0.07181281	0.07939037
MP:0010144	abnormal tumor vascularization	25	2.043115e-07	8.701625e-29	9.673715e-25	1.448199e-23	0.004197576
MP:0010146	umbilical hernia	7	0.9999974	3.463328e-07	0.1649371	0.01387949	0.1658388
MP:0010147	abnormal endocrine pancreas physiology	157	1.693414e-118	1.478839e-96	3.592125e-51	1.132654e-68	5.035011e-06
MP:0010148	abnormal exocrine pancreas physiology	11	1.065654e-17	0.1750846	8.437837e-06	1.065702e-07	0.0001852982
MP:0010149	abnormal synaptic dopamine release	11	8.624873e-12	0.6527258	0.9999942	0.9265857	0.9370565
MP:0010150	abnormal mandibule ramus morphology	26	2.057972e-06	5.440405e-41	0.2367242	1.324507e-10	0.836238
MP:0010151	abnormal spinal cord ependymal layer morphology	2	0.003150776	2.961883e-05	4.287956e-06	0.0394461	0.1471024
MP:0010152	abnormal brain ependyma morphology	16	1.906956e-51	4.047197e-06	1.265507e-06	1.144503e-14	0.3309719
MP:0010154	abnormal gastroesophageal sphincter physiology	1	0.9005029	0.01487587	0.9827874	0.936322	1
MP:0010155	abnormal intestine physiology	262	2.2839779999984e-312	9.508947e-57	5.623696e-135	7.921298e-231	0.000306267
MP:0010156	abnormal small intestinal crypt cell physiology	26	1.111557e-59	2.429161e-17	2.415006e-11	7.103483e-30	0.7525594
MP:0010157	abnormal small intestinal crypt cell proliferation	17	2.407915e-33	1.866247e-22	1.636542e-11	2.041919e-18	0.6969054
MP:0010158	abnormal intestine development	14	8.34818e-22	1.768108e-11	9.627833e-10	3.032919e-21	0.7440882
MP:0010159	abnormal enterocyte differentiation	3	3.270691e-11	0.647841	0.04700297	5.691021e-09	1
MP:0010160	increased oligodendrocyte number	4	9.584061e-08	3.456795e-05	0.4839756	0.3124058	1
MP:0010161	decreased brain cholesterol level	9	2.818381e-33	6.431165e-08	9.31743e-14	4.317699e-32	0.9011575
MP:0010162	increased brain cholesterol level	3	0.01006133	3.542427e-10	0.0007349992	0.009209901	0.5391926
MP:0010163	hemolysis	33	1.296594e-90	0.09407049	7.536378e-12	3.955036e-75	0.7993884
MP:0010165	abnormal response to stress-induced hyperthermia	10	2.224359e-20	8.722357e-09	6.295929e-07	7.584615e-14	0.9521384
MP:0010166	increased response to stress-induced hyperthermia	4	6.099146e-16	0.002398675	8.932967e-08	1.096424e-09	0.836632
MP:0010167	decreased response to stress-induced hyperthermia	6	1.057943e-07	4.605035e-07	0.03992554	2.366404e-06	0.9337999
MP:0010168	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	1	0.8069996	0.9927414	0.1975069	0.02798575	0.3611463
MP:0010169	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	7	2.483809e-08	0.04555894	1.176422e-19	2.987015e-07	0.4947025
MP:0010170	abnormal glial cell apoptosis	10	0.00481055	7.435605e-08	2.451264e-05	0.04909156	0.2023898
MP:0010171	abnormal centroacinar cell of Langerhans morphology	3	0.006618415	1.724556e-11	5.567441e-07	0.0002071856	0.1711655
MP:0010172	abnormal mammary gland epithelium physiology	9	1.159271e-50	1.282015e-07	1.157841e-09	1.583341e-19	0.2986034
MP:0010173	increased mammary gland epithelium proliferation	3	1.241682e-16	0.01219476	0.0005692071	6.170954e-09	1
MP:0010174	decreased mammary gland epithelium proliferation	6	2.915077e-43	0.00549333	3.371992e-06	5.374179e-13	0.2662624
MP:0010175	leptocytosis	7	3.053785e-20	0.5575882	3.043835e-05	7.022709e-11	0.2416286
MP:0010176	dacryocytosis	2	0.003038186	0.01084506	3.976377e-05	3.531751e-07	0.7408111
MP:0010177	acanthocytosis	8	6.573043e-17	0.5316951	3.897817e-07	3.710789e-16	0.6088154
MP:0010178	increased number of Howell-Jolly bodies	12	1.20406e-46	0.1736208	9.291222e-12	4.098262e-42	0.4351776
MP:0010179	rough coat	23	3.189046e-32	8.58277e-09	2.012574e-21	7.387401e-19	0.2200859
MP:0010180	increased susceptibility to weight loss	41	1.455788e-63	3.93454e-18	1.193626e-25	2.687594e-21	0.004798509
MP:0010181	decreased susceptibility to weight loss	8	2.803184e-10	0.4231021	5.434248e-06	0.0003086722	0.9735452
MP:0010182	decreased susceptibility to weight gain	115	1.781495e-277	1.378509e-57	9.483682e-70	2.119844e-126	0.4778443
MP:0010183	abnormal CD4-positive helper T cell morphology	94	1.703166e-111	3.82988e-23	2.081597e-121	4.1421e-154	0.0008180702
MP:0010185	abnormal T follicular helper cell number	11	2.987013e-35	1.672906e-06	2.270239e-20	2.437637e-23	0.9575206
MP:0010186	increased T follicular helper cell number	8	1.074924e-26	0.06092753	5.179103e-14	7.240471e-12	0.842228
MP:0010187	decreased T follicular helper cell number	4	1.979878e-10	1.25157e-07	1.66404e-07	5.045369e-13	0.9779336
MP:0010188	abnormal T follicular helper cell differentiation	1	0.001349864	0.002248265	0.0003157966	0.004004114	0.8122343
MP:0010189	abnormal T follicular helper cell physiology	2	2.435733e-07	0.2961005	0.0005097364	6.426254e-05	0.8282379
MP:0010192	abnormal retinal melanin granule morphology	8	0.8094409	0.3767722	0.009444656	0.001087687	0.5560992
MP:0010193	abnormal choroid melanin granule morphology	9	0.9958061	0.07097017	0.01590995	0.7880369	0.5023465
MP:0010194	absent lymphatic vessels	6	0.9999967	4.299928e-05	0.4579548	0.3848456	0.5340162
MP:0010195	abnormal lymphatic vessel endothelium morphology	6	0.0005113611	1.697321e-21	0.04304598	5.849074e-19	0.3222044
MP:0010196	abnormal lymphatic vessel smooth muscle morphology	4	0.261514	0.4280012	0.008187454	0.2909369	0.7020426
MP:0010198	decreased lymphatic vessel endothelial cell number	5	0.2229872	1.385363e-20	0.1637937	1.476273e-12	0.5070193
MP:0010200	enlarged lymphatic vessel	16	2.078657e-10	1.142728e-06	4.593889e-20	3.742402e-24	0.02415618
MP:0010202	focal dorsal hair loss	7	1.106273e-21	2.024035e-05	0.05643065	6.262138e-05	0.8915176
MP:0010203	focal ventral hair loss	1	0.9930732	0.008215793	0.008981698	0.2108217	0.08911155
MP:0010204	abnormal astrocyte apoptosis	1	0.004017566	0.6327778	0.0693156	0.08035383	0.3273782
MP:0010205	abnormal oligodendrocyte apoptosis	7	0.0001074866	2.843022e-11	0.0291262	0.01268114	0.5648622
MP:0010207	abnormal telomere morphology	23	8.464827e-38	0.5410737	0.004158248	1.107914e-07	0.1730588
MP:0010208	prognathia	2	2.085061e-25	0.002269342	4.80743e-05	0.004925999	0.7451771
MP:0010209	abnormal circulating chemokine level	21	5.345257e-08	2.152718e-10	1.401854e-14	1.288736e-40	2.654758e-05
MP:0010210	abnormal circulating cytokine level	277	0	2.634032e-20	7.935916e-170	0	3.987953e-13
MP:0010211	abnormal acute phase protein level	22	8.404303e-05	1.153771e-13	7.085751e-13	1.194188e-08	0.001135515
MP:0010212	abnormal circulating C-reactive protein level	3	0.9999632	0.556217	0.9588062	0.9903359	0.4221182
MP:0010213	abnormal circulating fibrinogen level	7	0.973387	4.059071e-10	0.4317492	0.1179949	0.2178046
MP:0010214	abnormal circulating serum amyloid protein level	7	1.387627e-12	0.01627648	8.527419e-15	3.703974e-07	0.2016753
MP:0010215	abnormal circulating complement protein level	4	3.302005e-11	0.9845234	6.384345e-10	0.001406898	0.4184572
MP:0010217	abnormal T-helper 17 cell morphology	26	2.976939e-14	3.5284e-14	7.018426e-18	7.96837e-31	0.01364117
MP:0010218	abnormal T-helper 17 cell number	20	3.666436e-14	0.005280267	7.745377e-13	8.013456e-23	0.1186178
MP:0010219	increased T-helper 17 cell number	11	1.36375e-05	0.02011319	2.460692e-05	4.214149e-07	0.08341204
MP:0010220	decreased T-helper 17 cell number	10	2.333663e-09	0.3129467	9.486737e-10	2.820462e-19	0.707682
MP:0010221	abnormal T-helper 17 cell differentiation	11	0.003844448	1.90396e-22	5.439692e-07	4.401807e-15	0.00704294
MP:0010222	abnormal T-helper 17 cell physiology	1	0.3184871	0.06656323	1	0.009250224	1
MP:0010223	abnormal immunoglobulin transcytosis	1	0.9548428	0.009059181	0.1191146	1	0.3882574
MP:0010224	abnormal heart ventricle outflow tract morphology	68	1.22426e-68	1.40465e-68	3.890966e-12	1.079469e-32	0.2060663
MP:0010225	abnormal quadriceps morphology	18	0.003590148	7.104421e-18	5.744472e-06	0.002310104	0.06989612
MP:0010226	increased quadriceps weight	6	0.9999963	0.008528012	0.0008087372	0.5595917	0.06373873
MP:0010227	decreased quadriceps weight	11	1.907759e-05	5.515153e-14	8.878028e-08	0.0001741729	0.3804897
MP:0010228	decreased transitional stage T3 B cell number	4	0.008800932	0.8184339	0.1083357	0.0002935471	0.557527
MP:0010229	increased transitional stage T3 B cell number	1	0.4962879	0.5936006	0.2322041	0.3815484	1
MP:0010231	transverse fur striping	2	1	0.9999993	1	0.9999522	1
MP:0010233	hairless tail	3	0.9999999	0.9366883	0.9921405	0.9904334	0.926355
MP:0010234	abnormal vibrissa follicle morphology	13	1.067667e-28	0.01368853	3.809322e-08	1.67999e-07	0.03109555
MP:0010235	abnormal retina inner limiting membrane morphology	7	0.0001369362	5.214487e-27	0.0001398696	0.005924721	0.3764348
MP:0010236	abnormal retina outer limiting membrane morphology	5	2.045112e-10	0.3028547	0.004486274	0.01461082	0.4028688
MP:0010237	abnormal skeletal muscle weight	24	0.007015673	4.632748e-30	0.003903637	0.02051393	0.4127162
MP:0010238	increased skeletal muscle weight	7	0.9678354	3.816997e-14	0.003162906	0.04280836	0.1367741
MP:0010239	decreased skeletal muscle weight	19	0.002507282	1.201769e-24	0.1778907	0.303083	0.5721975
MP:0010240	decreased skeletal muscle size	56	1.790383e-43	2.426385e-62	5.278406e-13	1.99151e-12	0.1549857
MP:0010241	abnormal aortic arch development	7	3.592641e-28	8.343726e-05	0.4546861	3.983658e-09	0.562122
MP:0010243	increased kidney copper level	2	3.73073e-07	0.1819962	0.7824944	0.02240628	0.03005579
MP:0010246	abnormal intestine copper level	2	0.002854524	0.1515435	0.2413704	0.1737928	0.02070753
MP:0010247	increased intestine copper level	1	0.1347306	0.3575849	0.3886625	0.3864508	0.0146412
MP:0010248	decreased intestine copper level	1	6.302472e-05	0.05654087	0.2232008	0.07813217	1
MP:0010249	lactation failure	18	4.726776e-40	0.01227116	1.076152e-26	8.14965e-21	0.4112394
MP:0010250	absent thymus cortex	2	3.529366e-10	0.6887452	0.0545931	4.998089e-05	1
MP:0010251	subcapsular cataracts	7	0.9986387	2.060977e-07	0.8699448	0.523627	0.3363865
MP:0010252	anterior subcapsular cataracts	4	0.9999973	0.008662569	0.8819561	0.9854781	0.9482681
MP:0010253	posterior subcapsular cataracts	1	0.2918479	4.983733e-08	0.2234231	0.2772816	0.003543936
MP:0010254	nuclear cataracts	21	3.004041e-14	3.484808e-11	1.343391e-16	2.519303e-07	0.01047889
MP:0010255	cortical cataracts	4	0.01827062	3.698909e-11	0.05258579	0.005086351	0.2768411
MP:0010256	anterior cortical cataracts	1	0.9795671	0.04749024	1	0.384922	1
MP:0010258	polar cataracts	7	0.1634009	3.38421e-11	5.064902e-07	0.0005578644	0.04060143
MP:0010259	anterior polar cataracts	6	0.1099961	9.476883e-13	1.099267e-07	0.000273052	0.02751173
MP:0010261	sutural cataracts	2	0.9240748	4.557358e-15	0.0186039	0.2466735	0.7389446
MP:0010262	lamellar cataracts	1	1	1	0.08551872	1	0.1808294
MP:0010263	total cataracts	14	0.002791674	1.067479e-10	0.0110408	0.063696	0.09661763
MP:0010264	increased hepatoma incidence	15	5.442526e-30	8.320632e-05	5.070829e-07	0.0005594279	0.6442644
MP:0010265	decreased hepatoma incidence	1	0.9448504	0.294581	1	0.6259701	0.6237511
MP:0010266	decreased liver tumor incidence	8	1.108274e-06	1.072796e-08	0.8096499	1.415905e-05	0.5768094
MP:0010267	decreased lung tumor incidence	8	5.282656e-22	0.0007183003	1.055367e-08	1.541766e-22	0.3729956
MP:0010268	decreased lymphoma incidence	13	1.660989e-25	2.247718e-07	8.455497e-20	3.271504e-21	0.3249474
MP:0010269	decreased mammary gland tumor incidence	11	7.847949e-64	4.143831e-08	6.818182e-23	4.642043e-21	0.8147206
MP:0010273	increased classified tumor incidence	516	0	4.559864e-136	4.482773e-199	0	1.319117e-06
MP:0010274	increased organ/body region tumor incidence	545	0	1.519977e-173	1.229784e-222	0	4.790523e-07
MP:0010275	increased melanoma incidence	11	3.197326e-11	6.534638e-10	8.519877e-09	0.01691979	0.03946283
MP:0010276	increased intraocular melanoma incidence	1	0.5676165	0.5453221	0.08897535	0.1398156	0.07399826
MP:0010277	increased astrocytoma incidence	3	2.770293e-06	0.4672695	0.002048156	0.0127386	0.727217
MP:0010278	increased glioma incidence	8	2.813326e-07	1.036019e-06	0.01928457	2.610557e-06	0.2122854
MP:0010279	increased gastrointestinal tumor incidence	102	5.831259e-206	9.34414e-26	2.109385e-57	2.396526e-95	0.01543958
MP:0010280	increased skeletal tumor incidence	27	5.231681e-29	1.826191e-41	3.356457e-14	2.223728e-12	0.0124608
MP:0010281	increased nervous system tumor incidence	64	1.429962e-56	1.563524e-25	1.936489e-11	1.028213e-40	0.1577967
MP:0010282	decreased organ/body region tumor incidence	30	3.488625e-95	1.578251e-14	9.225068e-25	7.114275e-54	0.6630004
MP:0010283	decreased classified tumor incidence	19	1.016866e-60	7.030291e-07	9.511101e-22	3.957026e-31	0.4227904
MP:0010285	decreased skin tumor incidence	2	6.843615e-16	0.2793374	0.08825873	0.02984804	1
MP:0010286	increased plasmacytoma incidence	6	1.963756e-24	0.8447419	0.001006612	5.1671e-12	0.002316842
MP:0010287	increased reproductive system tumor incidence	88	5.936796e-98	1.375489e-22	1.331384e-33	2.766632e-55	7.741429e-05
MP:0010288	increased gland tumor incidence	246	0	1.39656e-68	1.337578e-91	3.026721e-235	4.133503e-06
MP:0010289	increased urinary system tumor incidence	19	3.362009e-36	3.239807e-09	1.996454e-09	4.351786e-08	0.1517845
MP:0010290	increased muscle tumor incidence	24	8.208243e-36	1.001599e-25	6.762068e-07	1.371371e-19	0.1562772
MP:0010291	increased cardiovascular system tumor incidence	55	2.758599e-93	5.835429e-39	6.498215e-22	6.921274e-50	0.3472478
MP:0010292	increased alimentary system tumor incidence	115	1.196019e-222	3.850863e-36	6.702412e-60	2.598133e-100	0.04772237
MP:0010293	increased integument system tumor incidence	155	2.078334e-308	2.686903e-83	1.190333e-66	1.116433e-142	0.0369789
MP:0010294	increased kidney tumor incidence	12	9.428502e-39	2.092723e-06	2.040829e-05	9.142712e-11	0.8393931
MP:0010295	increased eye tumor incidence	6	9.230803e-08	0.09580634	1.470944e-06	1.8115e-08	0.03234805
MP:0010296	increased hemolymphoid system tumor incidence	262	0	1.159544e-57	7.123885e-110	0	0.01040494
MP:0010297	increased hepatobiliary system tumor incidence	115	3.030695e-239	1.5221e-34	1.652849e-28	1.476859e-83	0.1277962
MP:0010299	increased mammary gland tumor incidence	89	3.790557e-167	1.360789e-43	7.546068e-42	8.049317e-87	0.04541665
MP:0010300	increased skin tumor incidence	84	1.673971e-181	1.465182e-36	1.233468e-36	4.734766e-78	0.3124506
MP:0010301	increased stomach tumor incidence	24	1.222361e-41	5.420256e-06	4.013323e-11	1.934576e-23	0.08216183
MP:0010306	increased hamartoma incidence	12	2.132148e-51	0.1333274	5.56253e-12	2.161592e-22	0.5648775
MP:0010307	abnormal tumor latency	54	9.904703e-97	2.969461e-06	1.085803e-24	3.90654e-47	0.02904859
MP:0010308	decreased tumor latency	38	4.265083e-79	0.163576	4.770232e-22	3.402585e-27	0.1640138
MP:0010309	increased mesothelioma incidence	5	2.108898e-10	0.009542174	0.001497576	1.179451e-06	0.1873599
MP:0010310	increased Schwannoma incidence	4	1.823894e-07	0.0002767028	0.0002797239	1.38379e-05	0.1962834
MP:0010311	increased meningioma incidence	3	4.89486e-08	0.000236162	0.008045563	0.01903706	0.369031
MP:0010312	increased oligodendroglioma incidence	2	0.4952958	0.670259	0.030692	0.003560289	0.1230314
MP:0010313	increased osteoma incidence	5	8.864623e-16	7.30756e-10	6.62956e-07	0.000128107	0.2287878
MP:0010314	increased neurofibroma incidence	6	1.079281e-12	0.06669419	0.0001230336	7.962754e-06	0.8495273
MP:0010315	increased cholangiocarcinoma incidence	6	0.0001613581	0.3730825	3.017521e-05	1.109579e-05	0.2676757
MP:0010316	increased thyroid tumor incidence	18	2.190244e-17	0.000125538	0.004493646	3.555123e-21	0.1292128
MP:0010318	increased salivary gland tumor incidence	14	2.105267e-31	2.261998e-18	7.590592e-13	1.83366e-15	0.3884921
MP:0010320	increased pituitary gland tumor incidence	35	3.251604e-54	1.276448e-10	3.932503e-12	2.419776e-38	0.2045205
MP:0010321	increased parathyroid gland tumor incidence	4	6.064051e-16	0.2455481	0.001654938	2.798857e-12	0.1910994
MP:0010322	increased cutaneous melanoma incidence	4	0.002672368	0.5007157	0.17274	0.3065178	0.3903505
MP:0010323	retropulsion	12	3.709853e-14	4.400125e-06	0.0002866286	2.612951e-06	0.1937802
MP:0010324	abnormal malleus processus brevis morphology	8	0.9999996	7.384019e-20	0.84566	0.01895891	0.004999258
MP:0010326	malleus hypoplasia	2	3.606156e-07	0.2119711	0.5028625	0.01171234	1
MP:0010328	thin malleus neck	1	3.439713e-06	0.4544414	0.913421	0.03796034	1
MP:0010330	abnormal circulating lipoprotein level	178	2.185535e-191	5.690311e-70	5.637794e-68	4.854916e-110	0.002609914
MP:0010331	abnormal apolipoprotein level	7	1.420709e-53	0.00408539	1.328183e-10	7.41506e-29	0.01171062
MP:0010333	abnormal circulating apolipoprotein E level	4	3.968037e-31	0.07902351	1.617083e-05	2.32802e-12	0.02205009
MP:0010334	pleural effusion	18	5.406862e-34	9.378757e-11	2.749473e-12	3.169804e-24	0.4488072
MP:0010335	fused first branchial arch	9	3.75641e-27	8.594087e-08	0.005994406	2.767153e-14	0.5040024
MP:0010336	increased acute lymphoblastic leukemia incidence	9	1.533025e-44	0.1456118	0.02729275	8.19585e-26	0.9024626
MP:0010337	increased chronic lymphocytic leukemia incidence	1	0.3290063	1	0.3645866	0.2001136	1
MP:0010338	increased desmoid tumor incidence	1	0.006032635	0.2305501	0.008981698	0.1282527	0.2355317
MP:0010343	increased lipoma incidence	4	2.192224e-11	8.618865e-14	0.00039539	4.441495e-05	0.6631169
MP:0010344	increased hibernoma incidence	2	0.09020088	0.001896528	0.4142651	0.02553054	0.2528375
MP:0010345	increased thyroid C-cell carcinoma incidence	3	1.011215e-15	0.007271025	0.02728898	3.531795e-06	0.2613097
MP:0010346	increased thyroid carcinoma incidence	9	0.0002335785	3.186868e-08	0.02601506	5.547803e-10	0.1833315
MP:0010347	osseous metaplasia	3	0.001083502	0.01129341	0.003403493	0.001077178	0.3749926
MP:0010348	increased pancreatic islet cell carcinoma incidence	4	3.088861e-20	0.0731848	9.3736e-07	2.513984e-13	0.2657405
MP:0010349	increased teratocarcinoma incidence	2	3.935569e-08	0.06904617	0.007244339	1.955609e-05	0.7457192
MP:0010350	increased pituitary adenohypophysis tumor incidence	5	3.904319e-28	0.3079696	0.00229914	1.508492e-14	0.4750273
MP:0010351	increased pituitary melanotroph tumor incidence	4	3.858934e-15	0.01531196	0.01122957	4.779941e-08	0.3156568
MP:0010352	gastrointestinal tract polyps	31	4.334846e-60	3.769051e-10	2.592517e-16	2.974906e-19	0.02040437
MP:0010354	increased odontosarcoma incidence	1	2.585769e-05	0.0002997308	0.03446298	0.07308276	1
MP:0010355	abnormal first branchial arch artery morphology	6	0.0007419414	1.346147e-16	0.0001234472	2.413127e-06	0.001948355
MP:0010356	abnormal second branchial arch artery morphology	5	0.0301437	1.156324e-15	6.635714e-07	0.0005750846	0.003174226
MP:0010357	increased prostate gland tumor incidence	30	1.138003e-44	3.766433e-05	5.612901e-18	2.255254e-25	0.006651163
MP:0010358	abnormal free fatty acids level	143	8.874657e-172	8.195758e-72	3.166135e-56	3.947474e-116	0.05231276
MP:0010359	increased liver free fatty acids level	1	0.00851884	1	1	0.2501471	1
MP:0010360	decreased liver free fatty acids level	5	1.233916e-09	0.1584066	0.005246525	0.0009085904	0.2030082
MP:0010361	increased gangliosarcoma incidence	1	7.349229e-05	0.2528496	0.02445157	0.5758676	1
MP:0010362	increased ganglioneuroma incidence	2	0.0001379144	0.6333177	0.2451763	0.7467393	0.9126632
MP:0010363	increased fibrosarcoma incidence	17	2.708456e-22	1.786489e-17	4.92176e-09	2.494295e-15	0.07889832
MP:0010364	increased fibroadenoma incidence	2	8.521929e-07	0.009047759	0.007593697	0.01781979	0.6336529
MP:0010365	increased thymus tumor incidence	99	3.013839e-257	1.763355e-15	2.544517e-51	5.031183e-120	0.0005376588
MP:0010366	increased adrenal cortical tumor incidence	2	0.03883019	4.583883e-09	0.9903918	0.0001939771	0.5698136
MP:0010367	increased spindle cell carcinoma incidence	6	0.00150413	0.9147632	0.2192501	0.001933589	0.49557
MP:0010368	abnormal lymphatic system physiology	14	1.242207e-16	4.918982e-14	2.008806e-08	2.279275e-12	0.7397005
MP:0010369	abnormal thalamus neuron morphology	1	4.64493e-14	0.9624658	0.250726	3.488086e-07	1
MP:0010371	abnormal epiglottis morphology	5	0.9998598	1.036216e-12	0.6837322	0.002176974	0.1062005
MP:0010373	myeloid hyperplasia	37	5.611641e-123	7.508924e-07	1.007407e-40	4.214345e-70	0.1289493
MP:0010375	increased kidney iron level	11	5.812286e-61	0.537562	0.01093562	1.414824e-19	0.3804917
MP:0010376	decreased kidney iron level	1	0.0004888203	1	0.2102142	9.689792e-08	1
MP:0010377	abnormal gut flora balance	15	3.317598e-06	0.8994014	0.6168255	4.253055e-11	0.9292739
MP:0010378	increased respiratory quotient	28	1.390194e-55	4.099565e-23	2.094253e-34	3.277398e-40	0.02361783
MP:0010379	decreased respiratory quotient	37	1.97186e-56	4.262644e-17	2.785878e-17	1.670907e-36	0.07409895
MP:0010380	abnormal inner cell mass apoptosis	27	1.726956e-36	1.944318e-06	8.957446e-08	6.731567e-13	0.05593048
MP:0010382	abnormal dosage compensation, by inactivation of X chromosome	3	0.7525703	0.9861441	0.9898622	0.5602184	0.9683825
MP:0010383	increased adenoma incidence	154	9.522546e-225	2.901629e-63	5.500039e-56	1.375195e-115	0.002774535
MP:0010384	increased renal carcinoma incidence	10	1.575923e-38	1.704304e-06	0.0005541407	2.60021e-09	0.9439922
MP:0010386	abnormal urinary bladder physiology	27	4.671833e-17	3.303511e-06	2.440535e-05	0.01782496	0.1667033
MP:0010387	abnormal Bergmann glial cell morphology	13	1.517617e-26	4.010931e-14	1.243749e-09	9.02213e-13	0.5644756
MP:0010388	abnormal Bergmann glial cell differentiation	2	0.0004092238	0.002034567	0.006223477	0.2964091	0.5474732
MP:0010389	mosaic coat color	2	8.528123e-08	0.3999633	0.0001044997	0.2634988	0.01703161
MP:0010390	increased adrenocortical adenoma incidence	1	8.700358e-12	1	1	0.004668533	1
MP:0010391	increased rhabdomyoma incidence	1	8.375068e-07	0.2432051	1	0.04678733	1
MP:0010392	prolonged QRS complex duration	30	1.393196e-41	6.055433e-17	1.535429e-07	1.175836e-12	0.3346209
MP:0010393	shortened QRS complex duration	2	1.23249e-06	0.02963617	0.3598381	0.02235486	0.6879824
MP:0010394	decreased QRS amplitude	5	0.839862	0.6961543	0.3068184	0.3248013	0.9661985
MP:0010395	abnormal branchial arch development	10	0.1459741	8.441241e-06	7.769716e-05	5.30534e-05	0.498357
MP:0010396	ectopic branchial arch	1	0.4151633	0.05252389	0.05942535	0.01316579	0.6754699
MP:0010397	abnormal otic capsule development	1	0.4151633	0.05252389	0.05942535	0.01316579	0.6754699
MP:0010398	decreased liver glycogen level	16	2.722486e-31	8.48444e-15	8.119914e-06	3.231867e-22	0.0182845
MP:0010399	decreased skeletal muscle glycogen level	4	0.004727381	1.641591e-05	0.6873374	0.06586785	0.2367275
MP:0010400	increased liver glycogen level	13	0.008550486	3.11423e-09	0.2730339	0.02341951	0.1135594
MP:0010401	increased skeletal muscle glycogen level	15	7.810391e-20	1.012975e-18	3.952047e-05	3.327945e-05	0.9574174
MP:0010402	ventricular septal defect	192	2.306072e-287	1.341659e-166	1.285076e-57	7.689608e-112	0.03098459
MP:0010403	atrial septal defect	86	3.009715e-80	6.790994e-48	1.524323e-05	4.258051e-26	0.7688443
MP:0010404	ostium primum atrial septal defect	18	0.9231318	7.222332e-34	0.3861731	0.0001953302	0.5488566
MP:0010405	ostium secundum atrial septal defect	9	3.353673e-05	0.005836416	0.1016655	0.0002874068	0.4559528
MP:0010406	common atrium	21	0.5283846	2.741109e-12	0.05009051	0.06219664	0.7885177
MP:0010408	sinus venosus atrial septal defect	2	0.003616316	4.431981e-23	1	0.4895175	0.9089374
MP:0010412	atrioventricular septal defect	48	1.037862e-41	2.573627e-19	2.032995e-07	5.691436e-12	0.8469108
MP:0010413	complete atrioventricular septal defect	25	7.83346e-44	6.628994e-13	2.165514e-05	0.002481712	0.4859967
MP:0010414	partial atrioventricular septal defect	1	0.9795671	0.04749024	1	0.384922	1
MP:0010417	subarterial ventricular septal defect	1	0.7248003	0.002248265	0.5785484	0.00904338	0.08911155
MP:0010418	perimembraneous ventricular septal defect	52	7.929038e-70	1.90701e-67	5.601769e-10	5.244922e-21	0.01390136
MP:0010419	inlet ventricular septal defect	5	0.1356275	1.111631e-20	0.420324	0.4546905	0.0931067
MP:0010420	muscular ventricular septal defect	28	7.251622e-61	2.135574e-24	0.003598936	2.665467e-08	0.5555459
MP:0010421	ventricular aneurysm	2	0.00443175	9.747869e-07	2.56308e-05	4.215636e-08	0.7254469
MP:0010422	heart right ventricle hypoplasia	9	0.07840839	2.534208e-10	0.03280162	0.003980459	0.6172895
MP:0010423	heart right ventricle aneurysm	1	0.1947878	2.476549e-05	7.842884e-05	5.532163e-05	0.5844193
MP:0010426	abnormal heart and great artery attachment	169	3.292003e-157	6.028914e-137	1.667153e-44	1.248245e-77	0.0519761
MP:0010428	abnormal heart right ventricle outflow tract morphology	47	1.577418e-56	1.421587e-59	4.823317e-05	2.179347e-21	0.6655239
MP:0010431	atrial situs inversus	2	0.9404711	0.8975492	0.4127829	0.6125962	0.6173987
MP:0010432	common ventricle	14	3.385731e-06	4.131363e-21	0.0002149302	5.532918e-05	0.5746374
MP:0010433	double inlet heart left ventricle	2	0.9999831	0.00241368	1	0.3880507	0.7794583
MP:0010436	abnormal coronary sinus morphology	5	8.336207e-06	0.2136851	0.0008260642	0.02830325	0.876144
MP:0010437	absent coronary sinus	3	0.009552934	0.4324465	0.0001142895	0.01195359	0.8736316
MP:0010439	abnormal hepatic vein morphology	3	0.008039979	0.1853988	0.0184637	0.006369204	0.7990842
MP:0010440	anomalous pulmonary venous connection	5	3.054777e-05	0.02434922	0.9951217	0.7356922	0.9305542
MP:0010449	heart right ventricle outflow tract stenosis	18	1.517529e-05	1.718331e-24	0.001338902	1.496831e-07	0.9110927
MP:0010450	atrial septal aneurysm	1	3.328412e-05	0.1968003	0.4916983	0.01044592	0.09701978
MP:0010451	kidney microaneurysm	7	1.918874e-16	6.113646e-17	3.294234e-05	1.959547e-26	0.9688369
MP:0010452	retina microaneurysm	1	0.9729956	9.55657e-06	0.7469781	0.9723926	0.7993345
MP:0010453	abnormal coronary vein morphology	2	0.04508274	0.005900242	1.542034e-06	0.106561	0.2060372
MP:0010454	abnormal truncus arteriosus septation	83	2.931744e-43	1.699276e-115	4.554252e-22	1.570217e-38	0.07247512
MP:0010455	aortopulmonary window	4	4.812451e-17	1.379493e-08	5.281544e-06	2.864579e-06	0.6676453
MP:0010457	pulmonary artery stenosis	8	7.943702e-09	6.384725e-17	1.068933e-07	4.032679e-14	0.8514902
MP:0010458	pulmonary trunk hypoplasia	2	2.171358e-09	1.183976e-05	6.733432e-06	0.006891033	0.6185747
MP:0010459	supravalvar pulmonary trunk stenosis	6	9.758649e-25	0.01931468	0.4632042	3.991452e-10	0.8680346
MP:0010460	pulmonary artery hypoplasia	4	0.08182242	6.313458e-10	0.8685802	7.375207e-07	0.07363644
MP:0010463	aorta stenosis	9	3.015101e-14	5.376332e-21	0.001510952	2.855142e-21	0.2144005
MP:0010464	abnormal aortic arch and aortic arch branch attachment	43	1.211313e-09	5.072552e-77	6.976463e-22	4.737638e-19	0.000530279
MP:0010465	aberrant origin of the right subclavian artery	36	1.114026e-09	1.62135e-63	1.995714e-20	1.751058e-19	0.0548313
MP:0010466	vascular ring	17	0.07096651	8.887285e-10	3.012074e-14	0.0001181624	0.003707489
MP:0010468	abnormal thoracic aorta morphology	108	1.414749e-68	2.352313e-93	3.82199e-26	8.807728e-42	0.000157255
MP:0010469	ascending aorta hypoplasia	3	1.077144e-48	4.603197e-08	0.3730561	9.589352e-07	0.8106106
MP:0010470	ascending aorta dilation	4	0.0001006489	0.0274834	0.05538228	0.0329669	0.1380867
MP:0010471	supravalvar aortic stenosis	1	1	0.007055078	0.1729663	0.4412142	0.339562
MP:0010472	abnormal ascending aorta and coronary artery attachment	4	1.314074e-09	0.035698	7.093871e-05	0.002477626	0.479513
MP:0010473	descending aorta dilation	1	0.0006207319	0.06536931	0.02159501	0.00220781	1
MP:0010476	coronary fistula	7	1.611416e-44	0.3969972	0.001610299	0.0001354156	0.3181677
MP:0010477	coronary artery aneurysm	1	0.9999736	0.5187106	0.054902	0.8595013	0.2355317
MP:0010478	intracranial aneurysm	4	0.9459683	2.337383e-07	0.9936634	0.386712	0.9331549
MP:0010479	brain aneurysm	2	7.756889e-06	2.482651e-05	0.03431538	4.605514e-12	0.6168644
MP:0010480	pulmonary arteriovenous malformation	2	0.1366835	0.0001475042	4.467513e-06	0.00110759	1
MP:0010483	aortic sinus aneurysm	3	1.046982e-06	0.1694438	0.00433796	0.02730526	1
MP:0010484	bicuspid aortic valve	8	1.363089e-14	7.127709e-19	0.8363508	0.001735014	0.874657
MP:0010485	aortic arch hypoplasia	3	0.9996406	6.240015e-29	0.9303527	0.7183928	0.7747967
MP:0010486	absent right subclavian artery	3	0.0006549653	2.516812e-05	5.788774e-05	0.0205919	0.02191722
MP:0010487	abnormal right subclavian artery morphology	38	1.704298e-10	6.127586e-65	1.580429e-23	3.401287e-21	0.03262239
MP:0010488	abnormal left subclavian artery morphology	6	1.651676e-09	0.01207198	3.659201e-12	3.618345e-05	0.08944791
MP:0010489	abnormal heart atrium auricular region morphology	7	0.02567501	0.002617085	0.08455403	0.0953811	0.001613967
MP:0010492	abnormal atrium endocardium morphology	1	0.7248003	4.892357e-05	0.3832671	0.6062543	0.08911155
MP:0010493	abnormal atrium myocardium morphology	2	0.9904512	0.00593509	1	0.9680236	0.2532785
MP:0010498	abnormal interventricular septum muscular part morphology	30	5.438152e-63	1.450249e-24	0.0007718985	5.516018e-09	0.4959099
MP:0010499	abnormal ventricle myocardium morphology	111	5.936905e-225	1.352183e-72	1.382919e-41	7.540972e-93	0.2262486
MP:0010500	myocardium hypoplasia	93	8.350673e-208	4.736985e-51	1.76978e-40	7.510453e-79	0.285272
MP:0010501	atrium myocardium hypoplasia	1	1	4.892357e-05	1	0.999381	0.8122343
MP:0010502	ventricle myocardium hypoplasia	81	1.425272e-192	1.476378e-50	1.648349e-36	8.108444e-80	0.1377506
MP:0010503	myocardial trabeculae hypoplasia	70	1.039264e-158	3.018097e-38	3.187299e-36	2.626467e-64	0.3908902
MP:0010504	abnormal RR interval	11	1.275134e-12	1.388197e-14	3.710674e-10	5.547903e-08	0.4923841
MP:0010505	abnormal T wave	4	1.142431e-12	6.388817e-07	7.889594e-05	0.0005358802	0.2565113
MP:0010506	prolonged RR interval	8	9.616151e-14	9.538863e-16	3.050265e-11	2.418276e-07	0.8856522
MP:0010507	shortened RR interval	1	0.7248003	0.002248265	0.02326111	0.03867134	0.007418096
MP:0010508	abnormal heart electrocardiography waveform feature	78	1.574443e-103	2.439165e-35	5.312407e-16	6.236341e-38	0.5133378
MP:0010509	decreased P wave amplitude	1	1	0.9998923	1	1	1
MP:0010510	absent P wave	2	0.1013751	0.0009483797	0.0877833	0.06424629	0.02365785
MP:0010511	shortened PR interval	1	0.0006000107	0.01487587	0.9827874	0.6062543	0.498173
MP:0010512	absent PR interval	1	1	1.804737e-05	0.6957191	0.4487363	0.6306873
MP:0010514	fragmented QRS complex	1	0.9996953	8.52348e-06	0.2246218	0.746	0.08911155
MP:0010515	abnormal Q wave	1	0.5664139	0.2806125	0.03223571	0.2563045	0.07378476
MP:0010519	atrioventricular block	42	8.775487e-35	3.054817e-29	2.579533e-11	4.436528e-13	0.218024
MP:0010520	sinoatrial block	17	1.057953e-25	2.485035e-08	0.08849936	4.346964e-09	0.09718283
MP:0010521	absent pulmonary artery	3	0.959114	5.966249e-17	1	0.9823529	0.1463336
MP:0010522	calcified aorta	3	0.02143802	0.02587792	2.954e-05	0.004192414	0.06921919
MP:0010526	aortic arch coarctation	3	7.622537e-07	0.01049685	0.01205978	5.188936e-05	1
MP:0010527	bicuspid pulmonary valve	3	1.395407e-11	0.03088508	0.08230982	0.02322153	0.707325
MP:0010530	cerebral arteriovenous malformation	2	3.289126e-12	0.180282	0.0007151644	5.8211e-07	1
MP:0010531	gastrointestinal arteriovenous malformation	1	0.00748721	0.0317779	0.0008137133	0.0008864166	1
MP:0010534	calcified myocardium	1	0.001536245	0.008753536	0.08153932	0.0001244073	1
MP:0010535	myocardial steatosis	1	0.001645586	0.000254372	9.426987e-05	0.1163533	0.04044835
MP:0010536	Ebstein's malformation of tricuspid valve	1	1	1.804737e-05	0.6957191	0.4487363	0.6306873
MP:0010537	tumor regression	8	6.205159e-10	7.381028e-05	4.829411e-07	2.034157e-08	0.985253
MP:0010539	decreased level of surface class II molecules	1	1	0.2279237	0.07186757	0.008740106	1
MP:0010540	long stride length	4	6.634311e-05	0.1235545	0.0009378138	0.2109464	0.164437
MP:0010541	aorta hypoplasia	8	9.002452e-21	1.711215e-17	0.03731402	0.00336116	0.1135253
MP:0010543	aorta tubular hypoplasia	2	0.9764165	8.596338e-05	0.01944535	0.7998565	0.007504665
MP:0010544	interrupted aorta	39	3.884157e-22	2.699046e-26	3.764714e-16	8.214851e-25	0.1530291
MP:0010545	abnormal heart layer morphology	409	0	1.492174e-278	4.405825e-126	0	3.653547e-05
MP:0010546	abnormal subendocardium layer morphology	1	1	0.0001120899	1	0.999381	0.8122343
MP:0010547	abnormal mesocardium morphology	3	0.04628836	2.420727e-07	0.4442214	0.002313417	0.7318795
MP:0010549	absent dorsal mesocardium	2	0.9726718	2.822115e-05	0.4703683	0.08317723	0.3940983
MP:0010551	abnormal coronary vessel morphology	54	4.742783e-82	3.310863e-33	7.997446e-28	1.865375e-36	0.3422874
MP:0010552	abnormal HV interval	3	4.406716e-26	0.001486365	5.164601e-05	3.302554e-10	0.6103073
MP:0010553	prolonged HV interval	2	1.293452e-23	0.0005109921	0.001253962	1.307424e-07	0.4413195
MP:0010554	shortened HV interval	1	0.0002417084	0.5356835	0.008596929	0.0004266501	1
MP:0010556	thin ventricle myocardium compact layer	15	2.729758e-62	3.399577e-15	2.182847e-07	8.652209e-16	0.2863571
MP:0010557	dilated pulmonary artery	3	0.9831557	3.483098e-05	0.0003750363	0.09649158	0.3051062
MP:0010558	sinus venosus hypoplasia	1	1	4.892357e-05	1	0.999381	0.8122343
MP:0010559	heart block	55	1.817444e-68	3.605843e-28	1.195307e-13	4.679581e-21	0.3894754
MP:0010561	absent coronary vessels	3	0.09670171	3.389535e-13	0.8423793	0.1652637	0.980784
MP:0010563	increased heart right ventricle size	95	1.358033e-71	2.024336e-115	1.381718e-12	5.032621e-45	0.1373576
MP:0010564	abnormal fetal ductus arteriosus morphology	25	0.04668363	1.365847e-50	0.003214378	0.006762576	0.0775604
MP:0010565	absent fetal ductus arteriosus	5	0.00149113	4.707695e-06	2.691729e-05	2.865478e-08	0.9125528
MP:0010566	abnormal left posterior bundle morphology	2	0.9999688	2.095629e-38	0.9972973	0.922511	0.6495497
MP:0010567	abnormal right bundle morphology	1	0.9930732	8.577734e-11	0.9128654	0.8595013	0.498173
MP:0010568	abnormal bulbus cordis morphology	1	0.0003007952	0.008472151	0.4610474	0.3150696	1
MP:0010570	prolonged ST segment	3	0.1791868	2.028308e-12	0.03463667	0.3327331	0.2548575
MP:0010572	persistent right dorsal aorta	9	8.025324e-05	1.960713e-15	0.0001287482	7.157229e-12	0.004152689
MP:0010574	aorta dilation	15	1.560957e-12	1.57998e-23	4.902157e-10	3.940948e-12	0.002161501
MP:0010576	premature closure of the ductus arteriosus	1	1	4.892357e-05	1	0.999381	0.8122343
MP:0010577	abnormal heart right ventricle size	108	3.634096e-76	7.085686e-113	2.241251e-13	1.479968e-49	0.1640008
MP:0010578	abnormal heart left ventricle size	100	1.630184e-71	9.223521e-122	2.531243e-21	7.933279e-45	0.2687491
MP:0010579	increased heart left ventricle size	92	1.968743e-81	1.651053e-104	8.629773e-22	4.70355e-48	0.2148653
MP:0010580	decreased heart left ventricle size	7	0.4202871	7.982248e-16	0.02229786	0.04997234	0.6183052
MP:0010581	abnormal atrium myocardial trabeculae morphology	1	1	4.892357e-05	1	0.999381	0.8122343
MP:0010583	abnormal conotruncus morphology	31	1.390478e-55	8.311687e-38	2.624268e-05	1.989906e-22	0.6679552
MP:0010584	abnormal conotruncus septation	6	4.141668e-27	0.002370136	0.0001146284	4.476679e-10	0.8473232
MP:0010585	abnormal conotruncal ridge morphology	27	1.435254e-54	3.088854e-40	4.106692e-05	2.366975e-16	0.653158
MP:0010586	absent conotruncal ridges	3	1.519289e-07	0.2657545	0.0005261279	0.05153712	0.7245481
MP:0010587	conotruncal ridge hypoplasia	11	1.46122e-20	2.747387e-51	0.9865739	0.006376677	0.3162443
MP:0010588	conotruncal ridge hyperplasia	5	6.744124e-17	0.005508263	0.0003894447	4.973387e-14	0.5086912
MP:0010589	common truncal valve	6	5.485788e-24	0.0008141844	0.002242421	0.2241699	0.0003111707
MP:0010591	enlarged aortic valve	7	0.0003723073	7.2422e-11	0.01827437	0.1568797	0.5185459
MP:0010592	abnormal atrioventricular septum morphology	51	2.753155e-44	4.040114e-24	1.428763e-06	6.180023e-12	0.821205
MP:0010593	thick aortic valve cusps	9	0.04141516	6.060121e-13	0.0001798911	9.152431e-06	0.4573867
MP:0010594	thick aortic valve	17	0.001556904	1.776865e-50	1.134738e-06	8.633842e-05	0.7508636
MP:0010595	abnormal aortic valve cusp morphology	20	8.45538e-09	6.176814e-25	0.0009628655	1.007275e-13	0.7554552
MP:0010597	absent aortic valve cusps	1	0.01194802	0.01487587	0.02326111	1.027125e-05	0.2355317
MP:0010598	abnormal aortic valve anulus morphology	1	1.374976e-05	0.0006728322	0.9558743	0.6691332	1
MP:0010600	enlarged pulmonary valve	7	3.020311e-16	2.984572e-06	0.00310572	1.474625e-06	0.7447345
MP:0010601	thick pulmonary valve	17	0.240498	1.286632e-47	0.0005516518	0.02750628	0.9150503
MP:0010602	abnormal pulmonary valve cusp morphology	10	0.008187575	1.988308e-13	0.09765261	5.656341e-06	0.7354725
MP:0010604	absent pulmonary valve cusps	1	0.01194802	0.01487587	0.02326111	1.027125e-05	0.2355317
MP:0010605	thick pulmonary valve cusps	5	0.9986361	1.261696e-15	0.4694172	0.03701166	0.7996931
MP:0010607	common atrioventricular valve	15	4.179229e-10	2.356246e-10	6.245865e-05	0.0004480347	0.2531329
MP:0010610	patent aortic valve	1	0.9410154	1.850401e-07	1	0.08626867	0.3339505
MP:0010611	patent pulmonary valve	1	0.9410154	1.850401e-07	1	0.08626867	0.3339505
MP:0010614	abnormal mitral valve cusp morphology	8	0.4787589	3.795221e-11	0.02101753	0.04542546	0.1685742
MP:0010617	thick mitral valve cusps	6	0.8171093	2.545463e-08	0.06810588	0.03440108	0.07404601
MP:0010618	enlarged mitral valve	6	8.798485e-28	1.658593e-11	1.164968e-05	7.179133e-12	0.5202329
MP:0010620	thick mitral valve	10	0.4855624	6.348824e-16	0.0518864	2.785165e-06	0.02537384
MP:0010622	abnormal tricuspid valve cusp morphology	1	1	1.804737e-05	0.6957191	0.4487363	0.6306873
MP:0010627	enlarged tricuspid valve	4	0.0001171544	6.315714e-10	0.1125611	5.316068e-05	0.11683
MP:0010628	patent tricuspid valve	1	0.9996953	0.0002490035	1	0.1282527	0.02789339
MP:0010629	thick tricuspid valve	4	1.983329e-05	4.212592e-10	0.1534985	4.088444e-08	0.3115603
MP:0010630	abnormal cardiac muscle tissue morphology	306	0	1.046385e-205	9.901893e-87	3.883383e-255	0.0004751672
MP:0010632	cardiac muscle necrosis	7	4.128496e-22	0.133371	0.02478892	8.593245e-07	0.3934448
MP:0010634	increased QRS amplitude	2	9.960633e-08	3.151399e-09	0.1089119	0.001564273	0.3117465
MP:0010635	aorta pulmonary collateral arteries	5	1.885956e-20	0.1815919	0.0006905318	0.0001031459	0.6928752
MP:0010636	bundle branch block	31	7.396898e-38	2.738526e-15	1.104988e-06	6.175916e-12	0.2135159
MP:0010637	sinus bradycardia	5	0.0001455468	0.9967221	0.0003824092	0.00395549	0.4623109
MP:0010639	altered tumor pathology	242	0	9.257117e-110	4.534286e-140	1.258245e-249	2.450781e-08
MP:0010640	ventricular myocardium compact layer hypoplasia	8	9.256156e-06	1.879315e-10	0.001263681	0.2306032	0.9949787
MP:0010641	descending aorta stenosis	1	2.432355e-07	0.02493779	1	0.4407658	1
MP:0010642	absent third branchial arch	3	0.0257339	0.03490614	0.6631304	0.09699399	0.4093056
MP:0010643	absent fourth branchial arch	2	0.08283001	0.01229447	0.5817167	0.5865002	0.3534797
MP:0010644	absent sixth branchial arch	1	0.1947878	0.0002063587	0.6286851	0.9793148	1
MP:0010645	failure of conotruncal ridge closure	2	7.400414e-07	0.0006073174	0.08890943	1.018496e-06	0.1561998
MP:0010646	absent pulmonary vein	2	0.9996277	1.931268e-19	1	0.9579386	0.05398354
MP:0010649	dilated pulmonary trunk	1	0.9996953	0.0002490035	1	0.1282527	0.02789339
MP:0010651	aorticopulmonary septal defect	72	1.95869e-33	7.417701e-91	7.470269e-17	3.344802e-30	0.04754231
MP:0010652	absent aorticopulmonary septum	3	4.144643e-32	0.4692352	0.008555363	0.1499549	0.04506263
MP:0010653	abnormal Wallerian degeneration	3	7.514503e-10	0.1049446	0.6117425	0.002343512	0.1777753
MP:0010654	slow Wallerian degeneration	1	0.06320598	1	1	0.0004987782	1
MP:0010655	absent cardiac jelly	1	0.9508384	0.813613	0.770847	0.936322	0.8122343
MP:0010656	thick myocardium	6	3.150636e-06	1.01517e-06	0.003107365	0.0009132311	0.9554123
MP:0010657	absent pulmonary trunk	1	0.1508481	0.2276447	0.2321885	0.3815255	1
MP:0010658	thoracic aorta aneurysm	8	2.249055e-16	8.089744e-10	2.205999e-05	0.01997661	0.08286908
MP:0010659	abdominal aorta aneurysm	8	3.953996e-13	9.492865e-10	1.343255e-08	6.605166e-08	0.005030805
MP:0010661	ascending aorta aneurysm	6	1.160204e-11	0.0001120485	0.0008977068	0.1270747	0.7897985
MP:0010662	abnormal intersomitic artery morphology	2	0.03835022	0.9586564	0.02483212	2.676514e-06	0.01563902
MP:0010664	abnormal vitelline artery morphology	1	0.06443844	0.03327447	1	0.02696667	1
MP:0010667	abnormal umbilical vein morphology	1	0.9771862	0.0007411124	0.07123754	7.23888e-05	1
MP:0010668	abnormal hepatic portal vein morphology	8	2.839992e-06	0.03393601	1.774374e-08	1.075136e-09	0.3254593
MP:0010669	abnormal activation-induced B cell apoptosis	5	1.137372e-08	2.369872e-06	0.0001893213	3.746867e-12	0.9516128
MP:0010674	increased activation-induced B cell apoptosis	2	0.1134724	0.0002740417	0.02970815	7.140957e-09	0.7368307
MP:0010675	decreased activation-induced B cell apoptosis	3	5.247798e-11	0.001647634	0.001098931	6.024205e-05	1
MP:0010677	decreased activation-induced cell death of T cells	2	9.093074e-07	0.3116926	0.002360899	1.938969e-17	0.9048189
MP:0010678	abnormal skin adnexa morphology	752	0	5.105524e-302	4.330728e-237	0	3.315093e-16
MP:0010680	abnormal skin adnexa physiology	163	2.104352e-180	1.323519e-82	1.406636e-78	1.750583e-105	0.01384129
MP:0010681	abnormal hair follicle bulb morphology	13	1.830838e-17	1.939735e-11	0.03020091	2.703701e-16	0.02351214
MP:0010682	abnormal hair follicle infundibulum morphology	6	2.824575e-19	0.3328343	0.006032654	0.000303286	0.8701391
MP:0010683	dilated hair follicle infundibulum	2	0.06202064	0.3560355	0.004386674	0.05802382	1
MP:0010684	abnormal hair follicle outer root sheath morphology	24	2.099086e-71	1.398779e-16	2.331228e-13	5.263553e-21	0.09621617
MP:0010685	abnormal hair follicle inner root sheath morphology	22	1.670119e-74	4.843529e-09	3.977174e-06	2.342623e-37	0.9921813
MP:0010686	abnormal hair follicle matrix region morphology	4	5.1517e-13	4.47829e-18	0.3194583	6.139899e-05	0.6677241
MP:0010687	absent hair follicle dermal papilla	1	0.0001074952	0.8412949	1	0.01792414	1
MP:0010688	hair follicle outer rooth sheath hyperplasia	5	4.007471e-11	1.702046e-05	0.003625883	0.008379181	0.9489879
MP:0010689	thin hair follicle outer rooth sheath	1	1.679932e-11	0.163831	0.144904	0.0008136812	0.4165969
MP:0010690	thick hair follicle outer rooth sheath	4	1.592503e-06	0.7833686	1.177346e-05	2.81021e-11	0.04083506
MP:0010693	thin hair follicle inner rooth sheath	1	1.102892e-08	0.9972714	0.07796389	1.313292e-08	0.1227811
MP:0010695	abnormal blood pressure regulation	7	0.0007051077	2.325271e-15	1.722859e-05	5.991616e-07	0.05179271
MP:0010697	abnormal systemic arterial blood pressure regulation	5	2.688276e-07	7.463157e-08	0.000809047	3.399709e-08	0.2755575
MP:0010698	abnormal impulsive behavior control	6	0.6453989	5.576886e-09	0.9842563	0.2673166	0.3769088
MP:0010699	dilated hair follicles	4	0.03388287	0.07555855	8.920808e-05	2.784556e-05	0.806441
MP:0010701	fusion of atlas and odontoid process	11	7.190996e-05	0.002198832	0.007605023	0.0002237444	0.9894701
MP:0010702	split cervical atlas	4	1.962504e-07	0.003354921	2.698529e-06	5.026097e-12	0.7125642
MP:0010703	split cervical axis	4	1.962504e-07	0.003354921	2.698529e-06	5.026097e-12	0.7125642
MP:0010705	absent metoptic pilar	2	0.8761668	0.02933584	0.1156364	0.5140891	0.3196039
MP:0010706	ventral rotation of lens	5	1.352491e-11	1.85968e-07	1.559817e-11	0.002647792	0.6259185
MP:0010707	decreased ventral retina size	2	2.67791e-18	6.308279e-08	8.429106e-05	0.1659431	1
MP:0010709	absent anterior chamber	1	0.9930732	0.008215793	0.9128654	0.4587774	1
MP:0010710	absent sclera	4	2.515481e-07	0.0005083579	0.0001914147	0.08032478	0.7784694
MP:0010711	persistent hyperplastic primary vitreous	10	4.299129e-19	1.785737e-07	1.249717e-07	8.376023e-21	0.5710547
MP:0010713	corneal-lenticular stalk	3	0.8262355	1.611428e-05	0.02335082	0.01430429	0.04003126
MP:0010714	iris coloboma	9	0.01563088	2.759317e-13	1.891432e-08	1.30013e-08	0.56759
MP:0010715	retina coloboma	6	4.911624e-11	4.738241e-13	1.741121e-11	6.32268e-05	0.2671922
MP:0010716	optic disc coloboma	5	9.006013e-10	1.807284e-11	0.0005066385	0.04318079	0.7861523
MP:0010717	optic nerve coloboma	3	3.771742e-07	1.638444e-09	4.192847e-05	0.07014335	0.5836042
MP:0010719	ciliary body coloboma	1	2.438437e-07	0.2305501	1.386651e-06	0.03867134	0.8122343
MP:0010720	absent sublingual duct	1	2.426927e-21	4.892357e-05	5.900599e-06	0.01927655	1
MP:0010721	short sublingual duct	2	0.8761668	0.02933584	0.1156364	0.5140891	0.3196039
MP:0010722	persistent cervical thymus	3	0.07015815	0.2507386	0.05646239	5.46236e-08	0.4804738
MP:0010723	paternal effect	1	0.2741696	0.04873951	0.4422462	0.7393667	0.1667558
MP:0010724	thick interventricular septum	32	1.794791e-42	3.632533e-38	1.081684e-07	3.262597e-41	0.8935359
MP:0010725	thin interventricular septum	24	8.65689e-37	2.747768e-15	8.557026e-18	2.133052e-15	0.01010301
MP:0010727	increased glioblastoma incidence	6	0.0003433563	0.1169934	0.05997264	0.01618341	0.5962511
MP:0010728	fusion of atlas and occipital bones	11	0.002491147	1.171556e-15	4.471329e-08	1.667875e-10	0.02256788
MP:0010729	absent arcus anterior	5	0.007793305	0.002675893	0.09051772	0.002548371	0.8240983
MP:0010730	absent odontoid process	2	0.4027235	3.371927e-06	0.08771777	0.9247435	0.6174339
MP:0010731	absent ventral tubercle of atlas	1	0.9917053	0.793057	0.128367	0.0004744903	0.6628606
MP:0010732	abnormal node of Ranvier morphology	3	2.046211e-15	0.0003133077	1.095093e-08	9.678831e-07	0.7232369
MP:0010733	abnormal axon initial segment morphology	3	0.0110809	1.91504e-13	0.9922348	0.101974	0.03079046
MP:0010734	abnormal paranode morphology	6	5.525293e-10	1.592197e-09	0.01346577	2.645694e-05	0.1183348
MP:0010735	abnormal paranodal axoglial junction morphology	5	0.00301612	1.050465e-09	0.02396424	2.579176e-05	0.1028019
MP:0010736	abnormal extraembryonic ectoderm morphology	21	4.94821e-57	9.886089e-14	2.370963e-18	4.747436e-16	0.01695969
MP:0010738	abnormal internode morphology	5	2.222234e-12	4.382968e-09	0.1709065	6.545724e-05	0.7540615
MP:0010739	abnormal axolemma morphology	2	6.564127e-07	5.931261e-06	0.1200054	3.33958e-05	0.6546015
MP:0010740	abnormal dendritic cell chemotaxis	6	6.530965e-22	0.3619165	5.457759e-08	6.546567e-15	0.002831276
MP:0010741	abnormal melanocyte proliferation	1	0.9998051	0.6825753	1	0.9974875	1
MP:0010742	increased Schwann cell number	7	8.101306e-11	6.390196e-05	0.02726407	0.0002668566	0.6273333
MP:0010743	delayed suture closure	10	1.440946e-21	2.843356e-26	3.336647e-05	3.256454e-11	0.9356955
MP:0010744	abnormal cervical flexure morphology	1	0.5129706	0.0673791	1.146136e-07	0.6954157	0.6575066
MP:0010745	abnormal pre-Botzinger complex morphology	3	5.271633e-06	0.001745794	0.1797245	4.706616e-05	0.9622195
MP:0010746	abnormal pre-Botzinger complex physiology	12	9.923664e-15	0.0001519762	0.2740117	0.0003043303	0.2597189
MP:0010748	abnormal visual evoked potential	9	0.5553059	4.404449e-10	0.001054852	0.0002663262	0.2564366
MP:0010749	absent visual evoked potential	4	0.9999999	0.0003745536	0.3324142	0.3226345	0.06544168
MP:0010750	increased susceptibility to parasitic infection induced morbidity/mortality	11	1.344361e-17	0.9120796	4.314249e-15	4.907721e-13	0.1133705
MP:0010751	decreased susceptibility to parasitic infection induced morbidity/mortality	7	5.982638e-05	0.8744044	4.29884e-16	0.0003473062	0.001359598
MP:0010752	impaired mucociliary clearance	6	8.224063e-34	0.6680637	0.001299648	1.395244e-07	0.1424606
MP:0010754	abnormal heart left ventricle pressure	43	1.230534e-31	6.739369e-58	5.699937e-13	1.333305e-20	0.3631711
MP:0010755	abnormal heart right ventricle pressure	14	1.385981e-11	0.01697167	0.0009387477	7.107286e-09	0.8862939
MP:0010758	increased right ventricle systolic pressure	4	0.02053162	0.00261531	2.934664e-06	4.384565e-06	0.9056745
MP:0010759	decreased right ventricle systolic pressure	2	0.0008427819	0.9939504	0.9270537	0.9495353	0.09293926
MP:0010760	abnormal macrophage chemotaxis	68	2.157466e-67	3.636272e-29	7.473152e-75	2.703636e-82	2.023579e-07
MP:0010762	abnormal microglial cell activation	14	1.461234e-11	0.4093083	1.734022e-09	5.956198e-27	0.1373355
MP:0010763	abnormal hematopoietic stem cell physiology	38	3.03433e-80	2.775575e-17	1.713943e-23	7.327752e-69	0.3364475
MP:0010766	abnormal NK cell physiology	100	9.78366e-98	6.55034e-06	1.456464e-106	1.638891e-180	2.055914e-31
MP:0010767	abnormal female meiosis I arrest	3	0.006122469	0.89657	0.03967857	0.04876523	0.2066591
MP:0010768	mortality/aging	4052	0	0	0	0	2.569749e-49
MP:0010769	abnormal survival	3791	0	0	0	0	6.053896e-36
MP:0010770	preweaning lethality	3275	0	0	0	0	1.110388e-23
MP:0010771	integument phenotype	1492	0	0	0	0	1.323531e-19
MP:0010772	abnormal pollex morphology	2	0.5900277	0.003670296	0.3719641	0.9760696	0.02645914
MP:0010775	abnormal scaphoid morphology	1	1.93185e-11	0.9397473	0.9657794	0.09370906	0.7508283
MP:0010778	abnormal stomach fundus morphology	2	0.9999064	0.8947966	0.2558892	0.8761505	0.1577097
MP:0010779	abnormal stomach muscularis externa morphology	6	0.9983417	3.557556e-10	0.4155714	0.05786661	0.004272718
MP:0010780	abnormal stomach smooth muscle circular layer morphology	3	0.9972726	8.347252e-10	0.8956538	0.02122236	0.9773189
MP:0010781	pyloric sphincter hypertrophy	4	0.0006140411	0.06661487	0.4183775	0.0089037	0.9927091
MP:0010782	stomach smooth muscle circular layer hypertrophy	1	0.9005029	0.01487587	0.9827874	0.936322	1
MP:0010783	abnormal stomach wall morphology	79	1.287948e-65	1.326465e-33	1.044407e-18	2.914807e-31	0.00075591
MP:0010784	abnormal forestomach morphology	4	1.869133e-05	0.1628003	0.9227701	0.9580731	0.9075022
MP:0010785	abnormal stomach pyloric region morphology	13	3.098644e-20	2.683876e-05	0.0003200492	5.455177e-07	0.9805566
MP:0010786	stomach fundus hypertrophy	1	0.9930732	0.7264086	0.9128654	0.6062543	0.8122343
MP:0010787	gastric cysts	4	0.3970906	0.3440885	0.7603183	0.003748923	0.3739641
MP:0010788	stomach hypoplasia	2	0.5153132	6.878387e-11	0.2861406	0.5011274	0.0244788
MP:0010790	abnormal stomach pyloric antrum morphology	1	6.002391e-41	0.2451823	0.2392139	1.061889e-07	1
MP:0010792	abnormal stomach mucosa morphology	78	1.335817e-67	1.48124e-32	1.063996e-19	1.607815e-32	0.0003816827
MP:0010794	abnormal stomach submucosa morphology	1	0.9508384	0.813613	1	0.936322	0.007418096
MP:0010796	abnormal intermediate gastric gland morphology	1	6.969599e-05	1.792878e-06	0.7263645	0.003223239	0.6526259
MP:0010798	abnormal stomach cardiac region morphology	1	0.001888389	0.8205094	0.09413897	0.01366326	1
MP:0010799	stomach mucosa hyperplasia	11	2.423681e-48	5.734609e-07	3.833631e-14	3.371132e-19	0.02290826
MP:0010800	abnormal submucous nerve plexus morphology	1	0.9005029	0.813613	1	0.746	1
MP:0010801	abnormal myenteric nerve plexus morphology	2	0.0001558267	0.7206877	0.01944535	0.5110735	0.6495497
MP:0010802	abnormal intestinal enteroendocrine cell morphology	9	5.530422e-34	3.058902e-10	3.286201e-10	7.484199e-11	0.6421771
MP:0010803	abnormal stomach enteroendocrine cell morphology	5	7.51431e-06	0.2086506	0.001463466	0.003493216	0.7747241
MP:0010807	abnormal stomach position or orientation	17	0.0003309303	0.7584377	1.685204e-05	0.005703103	0.2644401
MP:0010808	right-sided stomach	14	0.0003363153	0.9122016	0.01945013	0.1189888	0.07864732
MP:0010809	abnormal Clara cell morphology	17	0.0002483043	3.760052e-15	5.53502e-06	3.674968e-12	0.4618671
MP:0010810	increased type II pneumocyte number	18	4.138252e-07	6.213381e-31	3.397582e-13	1.264347e-14	0.635864
MP:0010811	decreased type II pneumocyte number	12	2.062183e-18	1.894428e-21	0.0003256381	1.442798e-14	0.5945637
MP:0010812	absent type II pneumocytes	4	0.998304	2.741837e-06	0.2681368	0.002754071	0.2739189
MP:0010813	abnormal alveolar lamellar body morphology	33	8.472202e-06	2.85869e-30	7.16989e-22	1.785897e-17	0.8422963
MP:0010814	absent alveolar lamellar bodies	11	0.1094856	1.716518e-13	2.444318e-06	9.075556e-05	0.9955531
MP:0010815	enlarged alveolar lamellar bodies	5	0.4616238	0.06968088	6.797193e-05	0.3824109	0.4505394
MP:0010816	decreased type I pneumocyte number	14	2.878293e-08	1.558192e-30	1.42772e-12	1.096471e-07	0.7420575
MP:0010817	absent type I pneumocytes	7	2.349099e-10	1.095303e-10	2.929712e-08	2.026833e-05	0.3105776
MP:0010818	adhesive atelectasis	1	0.001349864	0.3150907	0.001040567	0.4587774	0.2355317
MP:0010819	primary atelectasis	24	9.529147e-20	1.568847e-07	6.807984e-09	5.429562e-23	0.8093005
MP:0010820	abnormal pleura morphology	2	5.433769e-17	5.696248e-05	4.443476e-10	1.097989e-10	0.4147011
MP:0010821	abnormal visceral pleura morphology	1	1.527922e-22	0.1081427	0.4823389	2.823005e-06	1
MP:0010824	absent right lung accessory lobe	2	0.9989528	0.001519169	1	0.6149029	0.8468146
MP:0010825	abnormal lung saccule morphology	38	2.230256e-13	3.132846e-75	1.904451e-08	4.585542e-06	0.5166155
MP:0010826	absent lung saccules	1	0.9999736	8.098066e-49	1	0.3225972	0.498173
MP:0010827	small lung saccule	8	0.8715487	1.472502e-36	0.1084661	0.1240668	0.07997271
MP:0010829	increased bronchioalveolar stem cell number	5	1.202245e-05	0.8663032	0.1472339	6.03619e-12	0.3379598
MP:0010831	partial lethality	250	1.05581828516274e-320	1.237427e-145	4.032386e-88	6.853576e-160	0.0011334
MP:0010832	lethality during fetal growth through weaning	2114	0	0	0	0	3.532115e-19
MP:0010833	abnormal memory T cell morphology	74	1.518184e-68	3.063464e-29	1.629611e-93	4.290747e-124	5.326593e-22
MP:0010834	abnormal CD4-positive, alpha-beta memory T cell morphology	14	1.060485e-18	6.90333e-11	4.681247e-09	3.505606e-22	0.2958921
MP:0010835	increased CD4-positive, alpha-beta memory T cell number	8	1.581853e-19	0.04514536	8.856498e-07	1.184237e-23	0.3429243
MP:0010836	decreased CD4-positive, alpha-beta memory T cell number	6	0.00042295	2.227106e-12	0.0004549754	0.0002641773	0.4033219
MP:0010837	abnormal CD8-positive, alpha-beta memory T cell morphology	12	2.699909e-22	7.986707e-11	9.253001e-12	3.178041e-15	4.40734e-05
MP:0010838	increased CD8-positive, alpha-beta memory T cell number	6	5.448517e-15	0.02919845	2.412555e-06	1.433198e-19	0.2722447
MP:0010839	decreased CD8-positive, alpha-beta memory T cell number	6	1.901455e-09	6.147215e-12	5.751369e-07	0.04713658	4.501741e-06
MP:0010844	increased effector memory CD4-positive, alpha-beta T cell number	2	2.00388e-08	4.726789e-05	0.2869567	1.315524e-05	0.8393429
MP:0010850	increased effector memory CD8-positive, alpha-beta T cell number	2	2.00388e-08	4.726789e-05	0.2869567	1.315524e-05	0.8393429
MP:0010853	abnormal lung position or orientation	32	9.715465e-12	1.425993e-05	4.054707e-07	4.262541e-07	0.08555551
MP:0010854	lung situs inversus	7	3.138756e-15	0.07514531	0.4028435	9.774485e-09	0.722835
MP:0010855	pulmonary hyperemia	1	0.9985613	0.0006091379	0.2470192	0.4840625	0.6459181
MP:0010856	dilated respiratory conducting tubes	24	0.1069225	1.956859e-34	3.292026e-10	2.469815e-13	0.2537359
MP:0010858	pulmonary epithelial necrosis	2	6.248465e-25	0.7234317	2.796716e-06	2.308082e-05	0.1196154
MP:0010859	abnormal anterior commissure pars anterior morphology	4	0.1424019	2.738427e-07	0.3771099	0.3145671	0.05029412
MP:0010860	abnormal anterior commissure pars posterior morphology	9	0.002188429	8.541189e-31	7.431309e-10	0.0008936755	0.2864157
MP:0010861	increased respiratory mucosa goblet cell number	6	0.001110812	1.510256e-07	0.0001467439	0.0002605512	0.5655159
MP:0010862	decreased respiratory mucosa goblet cell number	5	1.879718e-08	1.170194e-07	0.602878	0.00585528	0.8517764
MP:0010863	absent respiratory mucosa goblet cells	2	1.394332e-21	3.363614e-12	0.8583305	1.126864e-05	1
MP:0010864	abnormal enamel knot morphology	1	1	0.1617153	0.5785484	0.6062543	0.498173
MP:0010865	prenatal growth retardation	566	0	4.3596579999988e-312	5.932944e-203	0	0.09089319
MP:0010866	abnormal prenatal body size	716	0	0	3.204548e-230	0	2.16247e-06
MP:0010867	abnormal bone trabecula morphology	87	1.782136e-100	9.972654e-41	9.508306e-63	1.918406e-55	0.00171505
MP:0010868	increased bone trabecula number	33	3.326181e-48	2.101751e-09	1.425023e-37	3.57039e-27	0.386574
MP:0010869	decreased bone trabecula number	43	8.892662e-84	8.484502e-27	5.748746e-37	4.900851e-43	0.005900769
MP:0010870	absent bone trabeculae	5	0.9828225	0.002964325	0.4494765	0.4471961	0.3040969
MP:0010871	abnormal trabecular bone mass	32	1.876045e-33	9.955184e-25	9.723273e-21	8.01121e-25	0.01119735
MP:0010872	increased trabecular bone mass	17	2.719489e-22	2.776467e-21	1.020854e-15	7.001225e-10	0.1971232
MP:0010873	decreased trabecular bone mass	15	3.985018e-13	1.587809e-06	4.295402e-07	1.277463e-17	0.009201802
MP:0010874	abnormal bone volume	107	5.961462e-119	7.415694e-60	2.8949e-77	1.268399e-79	0.02591001
MP:0010875	increased bone volume	52	4.263433e-80	6.875615e-11	4.514255e-51	5.228765e-43	0.1847122
MP:0010876	decreased bone volume	57	2.150635e-68	2.499234e-53	1.611573e-38	4.753898e-47	0.0534521
MP:0010877	abnormal trabecular bone volume	63	2.309924e-89	3.724873e-43	4.751092e-38	3.65486e-55	0.1405037
MP:0010878	increased trabecular bone volume	30	7.842556e-55	4.725501e-11	1.801153e-29	1.500965e-30	0.4347008
MP:0010879	decreased trabecular bone volume	33	5.302879e-50	8.249994e-33	3.562149e-17	3.043467e-30	0.09605607
MP:0010881	esophagus hypoplasia	2	0.3076212	7.2909e-05	0.8705277	0.002397898	0.1493313
MP:0010882	trachea hypoplasia	1	0.8246961	1.324959e-06	1	0.03867134	0.498173
MP:0010883	trachea stenosis	4	0.9999776	3.451589e-24	0.1683284	0.06397096	0.7366943
MP:0010884	esophagus stenosis	2	0.3076212	7.2909e-05	0.8705277	0.002397898	0.1493313
MP:0010885	absent trachea	4	0.9999994	1.626618e-12	0.9702609	0.06064584	0.1916326
MP:0010887	pale lung	6	7.475726e-20	5.733462e-16	1.643894e-07	7.748868e-05	0.1604481
MP:0010889	small alveolar lamellar bodies	4	0.1858251	0.0005473308	1.19896e-05	0.000802058	0.4722554
MP:0010890	decreased alveolar lamellar body number	10	0.02030398	1.903303e-15	2.700884e-10	8.831874e-11	0.2679871
MP:0010891	increased alveolar lamellar body number	4	0.6141725	0.3725925	0.08982102	0.5772683	0.6777776
MP:0010892	increased oligodendrocyte progenitor number	3	0.8030584	1.718537e-09	0.001270319	0.8053197	0.03915067
MP:0010893	abnormal posterior commissure morphology	2	0.9582025	0.07306891	0.4247468	0.07387328	1
MP:0010894	pulmonary alveolar edema	5	4.449099e-24	0.06160644	0.002503639	2.283153e-08	0.265452
MP:0010895	increased lung compliance	15	6.413869e-12	2.457952e-07	2.359144e-12	3.562198e-05	0.3252517
MP:0010896	decreased lung compliance	7	1.280749e-16	2.002983e-08	2.380711e-07	4.963083e-06	0.7717328
MP:0010897	abnormal bronchiole epithelium morphology	26	5.071074e-07	1.715291e-35	1.168059e-10	2.491077e-15	0.5008115
MP:0010898	abnormal pulmonary alveolus epithelium morphology	79	1.512006e-41	2.695287e-100	4.009231e-48	2.044388e-60	0.8197657
MP:0010899	abnormal pulmonary alveolar system morphology	254	5.061964e-307	4.192931e-230	1.811086e-109	3.517676e-200	0.2319366
MP:0010900	abnormal pulmonary interalveolar septum morphology	55	3.605183e-47	2.718986e-53	4.197469e-28	1.549736e-40	0.4922015
MP:0010901	abnormal pulmonary alveolar parenchyma morphology	88	3.299215e-45	2.947253e-112	2.147845e-52	1.603987e-72	0.6604872
MP:0010902	abnormal pulmonary alveolar sac morphology	12	6.125074e-15	3.320435e-16	9.060609e-11	2.081497e-12	0.6809961
MP:0010903	abnormal pulmonary alveolus wall morphology	20	7.717678e-32	4.557581e-18	1.330878e-18	1.896073e-22	0.04105931
MP:0010904	abnormal alveolar pore morphology	3	0.03872001	0.1314796	0.03008713	0.02211592	0.6043669
MP:0010905	absent alveolar pores	1	0.2470631	0.07840333	0.4838158	0.001516576	1
MP:0010906	abnormal lung bud morphology	9	0.1860888	3.045414e-09	0.9983698	0.9962457	0.6193506
MP:0010907	absent lung buds	4	0.3921208	0.01989701	0.9548876	0.9999654	0.4887645
MP:0010908	dilated pulmonary alveolar ducts	7	0.521967	0.001176145	8.948409e-05	0.3702676	0.1722772
MP:0010909	pulmonary alveolar hemorrhage	14	6.080575e-23	1.263363e-07	0.001082267	4.302299e-09	0.0002945655
MP:0010910	bronchiolar epithelial hyperplasia	3	3.376583e-08	2.60282e-09	1.591604e-06	2.116946e-05	0.4803925
MP:0010911	abnormal pulmonary acinus morphology	246	5.483441e-306	3.24664e-215	2.933204e-111	1.096923e-197	0.290092
MP:0010912	herniated liver	4	0.9999957	3.399766e-12	0.8677441	0.6453177	0.6744864
MP:0010913	abnormal neuroendocrine cell morphology	20	3.337672e-07	6.62604e-09	2.305237e-07	0.0003175204	0.9900233
MP:0010914	abnormal solitary pulmonary neuroendocrine cell morphology	8	0.8132832	0.01630488	0.07233046	0.930844	0.988553
MP:0010915	increased solitary pulmonary neuroendocrine cell number	5	0.2470287	0.08049848	0.05122881	0.9789793	0.96466
MP:0010916	decreased solitary pulmonary neuroendocrine cell number	2	0.9997709	1.856633e-05	0.2372386	0.6860886	0.8721909
MP:0010917	absent solitary pulmonary neuroendocrine cells	1	0.9984822	0.01413363	1	0.831762	1
MP:0010918	abnormal pulmonary neuroendocrine body morphology	8	0.0002292595	4.517234e-07	7.551769e-11	0.0002193213	0.2294243
MP:0010919	increased number of pulmonary neuroendocrine bodies	3	0.1898365	1.457751e-10	3.038262e-09	0.1151053	0.8695369
MP:0010920	decreased number of pulmonary neuroendocrine bodies	1	0.9984822	0.01413363	1	0.831762	1
MP:0010921	absent pulmonary neuroendocrine bodies	1	0.9984822	0.01413363	1	0.831762	1
MP:0010922	alveolitis	10	0.7812314	7.190428e-16	0.0002106349	0.007397227	0.0005130154
MP:0010923	calcified pulmonary alveolus	3	0.923092	2.289921e-28	0.892262	0.9318153	0.7030759
MP:0010924	abnormal osteoid morphology	8	1.261609e-07	0.001246049	0.001902045	7.249604e-05	0.1000866
MP:0010925	abnormal osteoid volume	4	4.712628e-07	2.394744e-05	9.54475e-05	8.73694e-06	0.4756907
MP:0010926	increased osteoid volume	2	0.005240046	5.541046e-05	0.0005158214	0.00286615	0.526335
MP:0010927	decreased osteoid volume	2	1.979901e-06	0.08023817	0.05032481	0.0003610693	0.5563666
MP:0010928	abnormal osteoid thickness	5	1.917057e-10	0.07080656	0.1192313	0.004953139	0.4273814
MP:0010929	increased osteoid thickness	4	3.94078e-05	0.02229194	0.06979392	0.05246319	0.3570307
MP:0010930	decreased osteoid thickness	1	5.25086e-11	1	1	0.003151524	1
MP:0010931	abnormal trabecular bone connectivity density	17	7.624887e-14	6.068354e-06	3.425909e-05	7.916452e-13	0.002052544
MP:0010932	increased trabecular bone connectivity density	7	1.323129e-06	0.03195784	0.08311723	2.915083e-05	0.691511
MP:0010933	decreased trabecular bone connectivity density	10	6.493785e-09	3.036674e-05	6.668193e-05	3.828787e-09	0.0001799631
MP:0010934	increased subcutaneous adipose tissue amount	3	0.999998	0.2959542	4.056169e-12	0.4192465	0.07233041
MP:0010935	increased airway resistance	9	0.0003061844	7.034419e-08	1.12667e-05	0.002219073	0.9241402
MP:0010936	decreased airway resistance	7	0.05801305	1.365359e-15	2.557597e-06	0.01537141	0.1536303
MP:0010937	increased total lung capacity	3	0.00028235	0.09930204	2.287186e-05	0.00741352	0.02477673
MP:0010938	decreased total lung capacity	3	2.742863e-30	0.29307	5.082829e-12	8.801058e-11	0.8903541
MP:0010939	abnormal mandibular prominence morphology	6	7.523031e-05	4.035418e-14	5.519605e-07	0.0001841148	0.4763693
MP:0010940	abnormal maxillary prominence morphology	13	0.6927298	1.143681e-17	0.2772177	0.003402071	0.6025698
MP:0010941	abnormal foramen magnum morphology	8	3.427584e-34	8.481895e-11	0.1176261	2.919089e-09	0.8958389
MP:0010942	abnormal respiratory epithelium morphology	164	2.605659e-114	2.392049e-122	2.782294e-77	4.963229e-100	0.283343
MP:0010943	abnormal bronchus epithelium morphology	14	3.422747e-07	5.24897e-23	1.285281e-07	3.971282e-11	0.00442239
MP:0010944	respiratory epithelium hypertrophy	1	3.439007e-05	0.422662	0.002677473	4.172874e-10	1
MP:0010945	lung epithelium hyperplasia	4	4.013591e-14	1.655041e-14	1.42405e-06	0.0003481642	0.5550684
MP:0010947	abnormal single-strand DNA break repair	4	6.280615e-10	0.1188401	0.1438156	2.229858e-05	0.4392358
MP:0010948	abnormal double-strand DNA break repair	25	2.692502e-33	0.5202408	0.05815258	7.475478e-07	0.3712033
MP:0010949	decreased Clara cell number	8	0.02988303	1.321768e-15	3.397978e-05	1.897275e-07	0.7630873
MP:0010950	abnormal lung hysteresivity	5	6.071661e-08	0.01109074	0.0004233324	0.0671565	0.8878913
MP:0010951	abnormal lipid oxidation	24	2.337687e-44	1.778128e-40	5.619913e-11	1.385802e-29	0.8821499
MP:0010952	abnormal fatty acid beta-oxidation	7	2.560339e-07	3.911708e-06	0.007700073	2.191093e-09	0.976955
MP:0010953	abnormal fatty acid oxidation	22	1.386939e-40	9.819189e-41	7.541238e-11	4.373676e-28	0.9110711
MP:0010954	abnormal cellular respiration	116	4.352664e-121	1.096915e-21	2.843949e-23	3.265733e-70	0.2237118
MP:0010955	abnormal respiratory electron transport chain	66	8.219639e-58	5.226651e-07	3.527978e-09	2.827016e-26	0.0465338
MP:0010956	abnormal mitochondrial ATP synthesis coupled electron transport	33	3.126445e-27	6.355332e-05	6.644138e-11	1.946815e-19	0.07534748
MP:0010957	abnormal aerobic respiration	30	1.32984e-29	6.238213e-09	4.110777e-08	1.863064e-18	0.2010815
MP:0010958	abnormal tricarboxylic acid cycle	8	4.606116e-08	0.1505575	0.1996208	0.0008491154	0.9756986
MP:0010959	abnormal oxidative phosphorylation	35	3.502154e-29	7.473205e-05	1.603041e-10	3.373263e-20	0.08747159
MP:0010960	abnormal compact bone mass	13	4.17168e-12	7.364198e-05	1.41048e-11	8.78395e-09	0.0002246368
MP:0010961	increased compact bone mass	4	3.359429e-12	0.5902618	2.289306e-06	0.0002093388	0.1177195
MP:0010962	decreased compact bone mass	9	0.0007216773	1.275205e-06	7.034424e-07	6.641584e-06	0.0003862554
MP:0010963	abnormal compact bone volume	10	2.461914e-06	1.036108e-05	1.327715e-06	0.009076349	0.3723317
MP:0010964	increased compact bone volume	7	7.901669e-16	5.349452e-06	3.228373e-08	0.0002965557	0.33585
MP:0010965	decreased compact bone volume	3	0.9999927	0.1100963	0.3382214	0.7776356	0.5625908
MP:0010966	abnormal compact bone area	16	2.499548e-26	1.004229e-10	1.765749e-09	1.183213e-18	0.1389731
MP:0010967	increased compact bone area	9	2.148346e-09	0.003367221	4.510963e-08	0.0006792232	0.05499009
MP:0010968	decreased compact bone area	9	1.98908e-16	6.300161e-10	0.0004543885	2.722524e-17	0.5054456
MP:0010969	absent compact bone	1	0.6481597	0.001422937	0.1677005	0.347682	0.05934321
MP:0010970	abnormal compact bone lamellar structure	4	1.099821e-10	9.340096e-19	0.0003740062	1.516717e-05	0.3371735
MP:0010971	abnormal periosteum morphology	4	3.299776e-18	0.0007719726	1.63477e-08	5.211547e-07	0.7978396
MP:0010973	increased periosteum thickness	1	9.118635e-13	0.4128127	0.001040567	3.238663e-06	1
MP:0010975	abnormal lung lobe morphology	34	0.006042969	9.375626e-54	2.982604e-05	0.0002109345	0.2138064
MP:0010976	small lung lobe	11	0.5658884	1.677864e-15	0.02354412	0.6233101	0.3361538
MP:0010977	fused right lung lobes	5	0.0035325	3.226091e-05	0.390755	0.9734893	0.6174722
MP:0010978	absent ureteric bud	13	0.09160314	1.070225e-08	0.06894516	7.735036e-07	0.9016731
MP:0010979	small ureteric bud	4	0.006672175	6.908731e-27	0.000289621	0.006822088	0.09930429
MP:0010980	ectopic ureteric bud	12	0.01568731	9.539877e-25	0.001676713	4.74708e-08	0.64803
MP:0010981	abnormal branching involved in ureteric bud morphogenesis	61	4.813468e-26	3.956137e-84	1.109871e-12	1.50386e-20	0.01726484
MP:0010982	abnormal ureteric bud elongation	21	0.0005242343	1.137371e-35	0.005206074	9.027544e-07	0.3272151
MP:0010983	abnormal ureteric bud invasion	16	0.002942261	4.54669e-26	0.02764993	1.0844e-05	0.7596898
MP:0010984	abnormal metanephric mesenchyme morphology	35	3.822494e-09	1.110496e-56	2.204952e-05	8.288069e-07	0.4001021
MP:0010985	abnormal kidney mesenchyme morphology	39	3.612294e-05	6.52326e-57	0.0001754892	5.913719e-06	0.3008697
MP:0010986	abnormal mesonephric mesenchyme morphology	3	0.9942439	8.536578e-09	0.9985006	0.8181631	0.9880091
MP:0010987	abnormal nephrogenic mesenchyme morphogenesis	7	1.06402e-09	3.065235e-06	0.8555297	0.0003772751	0.2704866
MP:0010988	abnormal bronchial cartilage morphology	7	3.57368e-17	1.133175e-15	3.328976e-05	2.054348e-17	0.6539269
MP:0010989	fused bronchial cartilage rings	2	5.881812e-08	0.8778073	0.188949	1.499628e-16	1
MP:0010992	increased surfactant secretion	2	2.656056e-06	0.0001091364	0.008144325	1.491045e-06	0.8402278
MP:0010993	decreased surfactant secretion	13	0.03154524	1.857944e-11	1.436812e-07	4.68652e-07	0.2407843
MP:0010994	aerophagia	5	0.196412	1.340018e-07	0.9990069	0.9979528	0.9186309
MP:0010995	abnormal lung alveolus development	45	1.283678e-50	7.703202e-68	9.253004e-24	8.856454e-30	0.696027
MP:0010996	increased aorta wall thickness	7	3.482884e-30	2.044811e-07	3.42938e-05	2.945431e-08	1
MP:0010997	decreased aorta wall thickness	5	0.0001428277	2.139579e-05	0.1610667	0.4049044	0.7678278
MP:0010998	pulmonary alveolar proteinosis	7	1.136478e-06	4.557055e-21	2.778915e-07	3.93623e-08	0.9998189
MP:0011001	absence of AMPA-mediated synaptic currents	1	1	0.813613	1	0.936322	1
MP:0011002	enhanced AMPA-mediated synaptic currents	5	0.9612076	0.01290345	0.5559298	0.8970233	0.8343713
MP:0011003	reduced AMPA-mediated synaptic currents	16	1.392521e-21	1.941714e-08	0.1464382	0.03301113	0.9824725
MP:0011004	abnormal epidermal stem cell morphology	4	1.059181e-08	7.982633e-09	0.215821	0.000169493	0.5901298
MP:0011009	increased circulating glutamate dehydrogenase level	5	2.931521e-07	0.0167692	0.01952092	0.01070806	0.03040117
MP:0011011	impaired lung lobe morphogenesis	5	0.8514976	3.02523e-11	0.508563	0.9954655	0.590826
MP:0011012	bronchiectasis	2	0.9999998	6.04302e-20	0.9997038	0.5110735	0.9647485
MP:0011013	bronchiolectasis	1	0.9996953	3.351959e-31	1	0.8595013	0.8122343
MP:0011014	decreased core body temperature	19	9.549471e-14	4.040885e-08	0.001464624	2.769334e-08	0.04318367
MP:0011015	decreased body surface temperature	5	1.041218e-11	0.03744181	0.0166351	4.732999e-11	0.9848492
MP:0011016	increased core body temperature	9	4.240024e-25	0.0007058813	3.058328e-14	3.035842e-23	0.9898795
MP:0011018	pulmonary hyaline membrane formation	6	5.987402e-24	0.004619955	0.01638791	2.476491e-07	0.8254721
MP:0011019	abnormal adaptive thermogenesis	63	2.79767e-86	3.373282e-57	6.433552e-40	3.679704e-66	0.2365223
MP:0011020	abnormal circadian temperature homeostasis	16	8.631312e-07	2.158637e-08	1.042214e-09	1.307456e-06	0.8398049
MP:0011021	abnormal circadian regulation of heart rate	7	0.00503789	0.0002988674	0.02680985	0.006719851	0.5532163
MP:0011022	abnormal circadian regulation of systemic arterial blood pressure	4	0.002755693	1.374949e-06	0.01446597	6.091376e-05	0.2137881
MP:0011024	abnormal branching involved in lung morphogenesis	34	0.5782472	1.428308e-67	2.109721e-05	1.614214e-08	0.3119911
MP:0011025	abnormal branching involved in trachea morphogenesis	4	0.9999219	3.860681e-17	0.9999288	0.9044821	0.3769236
MP:0011026	impaired branching involved in trachea morphogenesis	3	0.9997897	1.109543e-22	0.9977583	0.7618069	0.9853521
MP:0011028	impaired branching involved in bronchus morphogenesis	11	0.9999918	1.107924e-19	1	0.9344659	0.402318
MP:0011030	impaired branching involved in preterminal bronchiole morphogenesis	2	0.2373348	0.0002458195	0.0298199	0.0008393513	0.04648351
MP:0011031	abnormal branching involved in terminal bronchiole morphogenesis	11	1.827282e-06	7.836322e-44	6.664867e-11	4.190119e-05	0.04764205
MP:0011032	impaired branching involved in terminal bronchiole morphogenesis	9	2.332379e-05	3.887266e-39	3.55632e-08	0.002041659	0.02356133
MP:0011034	impaired branching involved in respiratory bronchiole morphogenesis	3	0.9999995	7.570623e-06	0.6664692	0.176434	0.525767
MP:0011038	impaired branching involved in alveolar sac morphogenesis	1	0.9641222	0.1445276	1	0.6709231	0.7847776
MP:0011039	abnormal vestibuloocular dark reflex	5	0.2304842	0.9615871	0.8472246	0.1326196	0.3039833
MP:0011040	abnormal vestibuloocular light reflex	2	0.7043274	0.7279976	0.9206614	0.5767334	1
MP:0011041	abnormal vertical vestibuloocular reflex	1	1	0.9843364	1	0.999381	0.498173
MP:0011042	abnormal horizontal vestibuloocular reflex	2	0.01509428	0.1216155	0.1960055	0.001034779	0.4739444
MP:0011043	abnormal lung elastance	7	2.098442e-14	1.439481e-23	0.0001261815	3.581033e-11	0.9105963
MP:0011044	increased lung elastance	3	1.041584e-10	0.004609832	0.0006456324	0.0001799647	0.8702458
MP:0011045	decreased lung elastance	4	1.33043e-06	1.131874e-23	0.01681076	3.262865e-08	0.8590597
MP:0011047	increased lung tissue damping	2	4.425599e-20	0.4503326	0.0002278401	4.351515e-06	1
MP:0011049	impaired adaptive thermogenesis	46	6.974656e-52	8.28094e-46	4.439339e-29	1.342411e-43	0.06504968
MP:0011050	abnormal respiratory motile cilium morphology	13	5.800605e-43	1.086157e-05	0.001148688	6.81765e-15	0.9853277
MP:0011053	decreased respiratory motile cilia number	4	1.122614e-14	1.384795e-15	0.7547044	0.003445778	0.5931079
MP:0011054	absent respiratory motile cilia	2	0.01159916	2.158986e-16	0.8573805	0.01903476	0.4590139
MP:0011055	abnormal respiratory motile cilium physiology	13	0.009460604	0.9506252	0.4937509	0.6831075	0.0853693
MP:0011056	abnormal brain ependyma motile cilium morphology	11	1.463471e-44	3.514099e-07	9.828723e-08	4.409496e-11	0.2686346
MP:0011057	absent brain ependyma motile cilia	2	1.124675e-39	0.01273206	0.5022295	8.357127e-09	0.3038873
MP:0011058	abnormal spinal cord motile cilium morphology	1	0.8246961	2.072145e-05	3.083323e-07	0.2108217	0.08911155
MP:0011059	abnormal ependyma motile cilium morphology	14	1.445052e-67	1.01739e-06	8.10131e-09	3.300353e-13	0.246922
MP:0011060	abnormal kinocilium morphology	12	1.100637e-12	0.0002239142	4.882451e-09	0.0008796391	0.0008779451
MP:0011061	abnormal inner hair cell kinocilium morphology	5	6.643469e-06	0.9273993	1.123371e-06	0.1983235	0.06258181
MP:0011062	abnormal outer hair cell kinocilium morphology	6	2.694502e-07	0.0002756503	7.859239e-06	0.00433554	0.2041393
MP:0011063	absent inner hair cell kinocilia	1	0.9999736	0.9843364	0.008981698	0.8595013	0.08911155
MP:0011064	abnormal vestibular hair cell kinocilium morphology	1	0.9508384	0.813613	1	0.936322	0.007418096
MP:0011065	abnormal kidney epithelial cell primary cilium morphology	19	3.58411e-21	3.024051e-09	0.1042415	0.06765307	0.9259647
MP:0011066	abnormal renal tubule epithelial cell primary cilium morphology	15	2.050857e-07	5.877881e-11	0.7813666	0.5498231	0.8844977
MP:0011067	abnormal somatostatin level	1	0.001639319	0.3716489	1	0.3239201	1
MP:0011069	abnormal brain ependyma motile cilium physiology	2	0.9999999	0.002305326	0.0002813035	0.6992114	0.1192403
MP:0011071	absent Clara cells	4	0.9908439	8.874356e-07	0.9948175	0.9537193	0.9151397
MP:0011072	abnormal macrophage cytokine production	9	1.026518e-15	0.4758404	3.171641e-06	2.775302e-13	0.4774479
MP:0011073	abnormal macrophage apoptosis	19	2.843366e-29	5.246451e-09	3.601428e-12	2.641062e-23	0.04255727
MP:0011074	abnormal macrophage nitric oxide production	11	5.163747e-09	1.731047e-12	8.094384e-10	8.110049e-09	0.5851913
MP:0011075	abnormal macrophage activation involved in immune response	9	1.889547e-19	2.526191e-08	7.122104e-10	1.008917e-22	0.3047343
MP:0011076	increased macrophage nitric oxide production	3	0.1341892	5.372958e-06	3.375131e-05	0.01699009	0.7731174
MP:0011077	decreased macrophage nitric oxide production	8	6.314334e-10	4.093786e-08	3.506808e-06	4.697004e-08	0.4631094
MP:0011078	increased macrophage cytokine production	3	0.0002547802	0.9714906	0.0002488423	0.0001912033	0.6874759
MP:0011079	decreased macrophage cytokine production	5	1.034414e-13	0.03705737	0.001280118	3.292226e-11	0.3259376
MP:0011080	increased macrophage apoptosis	8	2.707972e-15	1.898157e-09	3.5346e-10	8.406612e-13	0.01466561
MP:0011081	decreased macrophage apoptosis	11	9.429541e-16	0.01456204	0.0002588473	3.016945e-12	0.4511125
MP:0011082	abnormal gastrointestinal motility	56	5.348432e-41	4.461612e-36	2.774851e-11	2.298215e-16	0.3514629
MP:0011083	complete lethality at weaning	61	1.968532e-24	3.290783e-18	2.222783e-07	9.596237e-21	0.3726271
MP:0011084	partial lethality at weaning	44	2.872264e-55	1.237949e-17	2.830858e-07	2.256568e-28	0.1341003
MP:0011085	complete postnatal lethality	591	0	4.036047e-286	6.652118e-121	2.400594e-249	1.778717e-09
MP:0011086	partial postnatal lethality	722	0	0	8.631014e-169	0	9.294405e-07
MP:0011087	complete neonatal lethality	629	0	0	2.304997e-109	1.018981e-266	4.271396e-05
MP:0011088	partial neonatal lethality	344	0	6.142574e-294	4.314083e-82	3.678539e-192	0.013194
MP:0011089	complete perinatal lethality	294	8.928578e-255	3.460528e-278	2.182385e-59	9.351969e-142	0.0001506097
MP:0011090	partial perinatal lethality	309	1.165372e-272	2.529059e-151	5.557503e-93	1.318822e-192	2.924414e-05
MP:0011091	complete prenatal lethality	359	0	3.563263e-173	3.463154e-118	1.316383e-262	3.65299e-05
MP:0011092	complete embryonic lethality	352	0	1.169611e-130	5.763911e-130	7.213141e-233	0.004728951
MP:0011093	complete embryonic lethality at implantation	21	2.616768e-35	7.945191e-08	0.0001307008	3.90881e-06	0.03927556
MP:0011094	complete embryonic lethality before implantation	135	0	1.627666e-16	2.676019e-35	5.227489e-89	0.2926587
MP:0011095	complete embryonic lethality between implantation and placentation	38	4.277249e-147	3.907927e-13	3.574053e-16	6.962899e-67	0.1403721
MP:0011096	complete embryonic lethality between implantation and somite formation	267	0	5.113101e-115	3.257846e-104	9.160178e-187	0.0216037
MP:0011097	complete embryonic lethality between somite formation and embryo turning	91	1.248999e-234	3.758844e-27	6.232574e-46	9.819266e-65	0.02685172
MP:0011098	complete embryonic lethality during organogenesis	702	0	0	4.823974e-238	0	0.003761273
MP:0011099	complete lethality throughout fetal growth and development	295	0	5.387653e-201	3.08268e-108	1.282943e-296	1.694285e-05
MP:0011100	complete preweaning lethality	152	6.017966e-225	6.322289e-53	1.608852e-63	8.565857e-69	0.1261077
MP:0011101	partial prenatal lethality	378	0	4.151322e-214	5.246916e-129	3.016072e-256	0.3114331
MP:0011102	partial embryonic lethality	49	2.998879e-65	3.226732e-18	8.829808e-09	5.185181e-23	0.06217646
MP:0011103	partial embryonic lethality at implantation	5	1.415191e-12	0.01869762	1.999282e-06	5.828393e-06	0.7750401
MP:0011104	partial embryonic lethality before implantation	20	4.707183e-56	1.561046e-21	0.02468392	1.310591e-22	0.1402377
MP:0011105	partial embryonic lethality between implantation and placentation	10	3.537307e-29	0.003826112	0.0006822183	0.003617711	0.8918712
MP:0011106	partial embryonic lethality between implantation and somite formation	29	2.575867e-29	2.716174e-24	7.433408e-07	5.532717e-13	0.009323288
MP:0011107	partial embryonic lethality between somite formation and embryo turning	23	1.930269e-27	1.126598e-11	0.0006077275	2.150165e-10	0.09852067
MP:0011108	partial embryonic lethality during organogenesis	299	0	3.710624e-168	6.834901e-122	1.198241e-230	6.815112e-07
MP:0011109	partial lethality throughout fetal growth and development	229	0	3.272959e-154	1.923996e-79	1.107141e-187	0.2288047
MP:0011110	partial preweaning lethality	160	2.25675e-240	8.117722e-72	2.421907e-51	4.427171e-144	0.1346754
MP:0011111	complete lethality during fetal growth through weaning	14	8.163586e-25	3.078231e-31	6.680765e-10	4.375558e-10	0.06187323
MP:0011112	partial lethality during fetal growth through weaning	10	2.995679e-16	1.097355e-09	0.0003626749	1.630385e-13	0.6318732
MP:0011114	abnormal airway basal cell differentiation	1	1	0.9329748	1	0.999381	0.8122343
MP:0011115	airway basal cell hyperplasia	1	1	0.9329748	1	0.999381	0.8122343
MP:0011116	absent Reichert's membrane	2	0.9998994	3.132417e-05	0.1663528	0.5574644	0.1119844
MP:0011117	abnormal susceptibility to weight gain	202	6.850868e-284	9.027384e-69	1.075158e-62	6.49467e-130	0.01649239
MP:0011118	abnormal susceptibility to weight loss	49	1.212984e-71	8.998792e-16	5.604935e-30	8.480912e-24	0.03942167
MP:0011121	decreased primordial ovarian follicle number	7	4.738405e-11	0.9063077	5.242665e-05	4.536989e-05	0.2933922
MP:0011122	absent primordial ovarian follicles	1	0.9564166	0.9836555	1	0.6443265	0.3916907
MP:0011125	decreased primary ovarian follicle number	5	5.00905e-05	0.6817043	0.1614071	3.104951e-05	0.1102945
MP:0011127	abnormal secondary ovarian follicle number	9	0.0003060089	3.039956e-08	4.153324e-06	4.02361e-11	0.8576287
MP:0011128	increased secondary ovarian follicle number	3	3.089472e-09	0.5963073	0.005196018	1.279857e-06	0.8193373
MP:0011129	decreased secondary ovarian follicle number	6	0.6490596	6.02281e-11	0.0001680881	2.331421e-06	0.7961443
MP:0011131	abnormal lung endothelial cell physiology	9	2.239953e-56	0.001531218	2.714733e-09	6.04651e-13	0.4631315
MP:0011134	decreased lung endothelial cell migration	1	0.0006629825	0.5284659	6.801192e-07	0.0004176958	0.09419908
MP:0011138	abnormal lung endothelial cell proliferation	6	3.616251e-28	0.01110132	0.02795919	4.104423e-05	0.5103297
MP:0011139	increased lung endothelial cell proliferation	5	1.014324e-27	0.1060178	0.08729219	0.003645942	0.4287239
MP:0011140	decreased lung endothelial cell proliferation	1	0.04868976	0.0005197978	0.03902796	2.813412e-05	1
MP:0011141	increased lung endothelial cell apoptosis	2	1.390788e-09	0.001806505	1.06272e-05	2.585233e-14	1
MP:0011142	abnormal lung-associated mesenchyme development	4	0.0006979306	4.018132e-07	0.06177524	6.071443e-06	0.0802779
MP:0011143	thick lung-associated mesenchyme	23	8.334391e-17	5.186434e-56	7.405522e-09	1.54049e-12	0.6112359
MP:0011144	thin lung-associated mesenchyme	3	8.809677e-22	5.019833e-13	0.5105388	1.380268e-10	0.9056408
MP:0011145	abnormal mesenchymal cell differentiation involved in lung development	3	0.3343805	0.408519	0.3265766	0.7462949	0.2622759
MP:0011146	abnormal mesenchymal cell proliferation involved in lung development	15	5.20273e-06	3.871657e-08	0.000340773	2.3187e-22	0.3980907
MP:0011147	increased mesenchymal cell proliferation involved in lung development	4	0.01364342	0.7131644	0.6782704	7.913902e-06	0.3144994
MP:0011148	decreased mesenchymal cell proliferation involved in lung development	10	1.755944e-06	3.951131e-11	1.444176e-06	9.834374e-18	0.4851293
MP:0011149	abnormal hippocampus stratum lacunosum morphology	1	0.4684289	0.04169029	0.1636485	0.01819494	0.6934666
MP:0011150	abnormal hippocampus stratum oriens morphology	2	1.046906e-12	0.3280908	0.8921321	0.7291681	1
MP:0011153	thick hippocampus stratum oriens	1	0.8641733	0.1881215	1	0.5971927	1
MP:0011154	thick hippocampus stratum radiatum	2	1.590058e-11	0.138961	0.001102198	2.932366e-08	0.3670654
MP:0011155	absent hippocampus stratum oriens	1	1.56693e-21	0.6842931	0.4150762	0.7974846	1
MP:0011156	abnormal hypodermis fat layer morphology	96	3.519821e-116	2.981529e-53	6.390501e-45	3.982841e-60	0.02394251
MP:0011157	abnormal hypodermis muscle layer morphology	2	0.07973305	7.051345e-27	1	0.5030741	0.5852254
MP:0011158	absent hypodermis muscle layer	1	0.9996953	3.351959e-31	1	0.8595013	0.8122343
MP:0011159	abnormal epidermal-dermal junction morphology	8	4.379546e-47	1.51213e-10	0.002295672	8.577404e-08	0.1150071
MP:0011160	dermal-epidermal separation	7	8.659999e-48	7.387687e-11	0.003530691	4.018535e-06	0.1080793
MP:0011163	increased wet-to-dry lung weight ratio	4	0.8311064	3.721478e-38	0.9780687	0.2593241	0.7193732
MP:0011164	panniculitis	1	0.04237524	1	1	0.01720678	1
MP:0011165	abnormal tooth root development	3	6.969428e-06	1.857801e-12	6.140455e-08	1.727743e-10	0.9595331
MP:0011166	absent molar root	1	9.120572e-10	0.8546663	0.03499953	3.048714e-10	1
MP:0011167	abnormal adipose tissue development	8	1.067825e-33	1.246754e-07	0.0002761714	5.759045e-09	0.6553196
MP:0011168	abnormal fat cell differentiation	6	8.041807e-09	0.001399911	1.101234e-07	1.505042e-05	0.9703773
MP:0011169	abnormal white fat cell differentation	2	0.0002399677	0.002716489	0.000185103	0.007560825	1
MP:0011171	increased number of Heinz bodies	5	8.531508e-24	0.8860634	0.1229157	3.158005e-21	0.9651017
MP:0011172	abnormal otic pit morphology	3	0.03650749	0.005149379	3.872727e-08	0.03355136	0.8837124
MP:0011174	lipodystrophy	6	1.985075e-09	1.540093e-07	6.616082e-14	5.587136e-11	0.5181783
MP:0011175	platyspondylia	3	8.762629e-05	0.00316312	0.1437203	0.1189784	0.984446
MP:0011176	abnormal erythroblast morphology	32	2.483797e-62	0.3332549	0.0006501938	3.948253e-45	0.03557837
MP:0011177	abnormal erythroblast number	27	6.59185e-48	0.07157716	4.644365e-05	8.335501e-33	0.02919294
MP:0011178	increased erythroblast number	20	6.145765e-28	0.1128759	1.215385e-07	6.242466e-29	0.07472152
MP:0011179	decreased erythroblast number	6	1.141527e-05	0.05499807	0.9124721	0.1773584	0.065235
MP:0011180	abnormal hematopoietic cell number	1493	0	0	0	0	3.436629e-45
MP:0011181	increased hematopoietic cell number	958	0	7.99446e-218	0	0	4.585155e-38
MP:0011182	decreased hematopoietic cell number	1146	0	1.721894e-257	0	0	2.722216e-30
MP:0011183	abnormal primitive endoderm morphology	9	0.03244611	5.562432e-42	0.9051616	1.438777e-05	0.333579
MP:0011184	absent embryonic epiblast	10	1.6906e-30	1.334821e-06	0.1879058	3.906834e-11	0.6996478
MP:0011185	absent primitive endoderm	3	0.1692517	8.27914e-27	0.7522976	0.003323741	0.5911552
MP:0011186	abnormal visceral endoderm morphology	56	9.204377e-90	6.075553e-56	1.893079e-28	8.665586e-31	0.01358044
MP:0011187	abnormal parietal endoderm morphology	24	2.93319e-50	5.965098e-44	8.305484e-17	2.308131e-22	0.7748902
MP:0011188	increased erythrocyte protoporphyrin level	9	1.510498e-23	0.8574207	0.003483266	1.021316e-09	0.03104234
MP:0011189	small embryonic epiblast	7	0.199237	6.612195e-12	0.4551541	0.1763974	0.8997108
MP:0011190	thick embryonic epiblast	4	1.610647e-15	8.260495e-10	0.000572059	0.0002810992	0.7286838
MP:0011191	increased embryonic epiblast cell apoptosis	8	0.0009073021	0.09392159	0.02670451	0.03104886	0.5074201
MP:0011192	decreased embryonic epiblast cell proliferation	4	3.094928e-05	0.5074282	9.904328e-05	1.761319e-06	0.1469482
MP:0011193	embryonic epiblast cell degeneration	2	0.4623327	0.1134699	1.386068e-10	0.7666439	0.02206494
MP:0011194	abnormal hair follicle physiology	9	7.05144e-05	1.989631e-13	0.0004981366	0.1261287	0.001867743
MP:0011195	increased hair follicle apoptosis	6	0.0001792817	5.528545e-19	0.02596842	0.2355237	0.01861214
MP:0011197	abnormal proamniotic cavity morphology	23	1.194112e-49	1.61477e-17	2.743411e-10	2.084528e-21	0.1251457
MP:0011198	absent proamniotic cavity	11	1.005276e-65	0.008564419	4.007277e-05	2.000767e-26	0.9942979
MP:0011199	abnormal amniotic cavity morphology	13	4.32229e-25	3.944253e-10	0.007339078	0.00604961	0.6550282
MP:0011200	abnormal extraembryonic coelom morphology	10	2.684357e-15	1.340469e-40	0.2564603	0.0001231308	0.7825328
MP:0011201	abnormal visceral yolk sac cavity morphology	5	0.6039957	6.924164e-09	0.1992764	0.006864056	0.07797304
MP:0011202	abnormal ectoplacental cavity morphology	8	6.23268e-23	4.538454e-13	0.4042735	1.410869e-05	0.955838
MP:0011203	abnormal parietal yolk sac morphology	141	1.837678e-219	5.276944e-107	1.443445e-34	1.029869e-87	0.2217085
MP:0011204	abnormal visceral yolk sac blood island morphology	31	4.508526e-69	4.801798e-19	1.576196e-28	4.145827e-55	0.1729711
MP:0011205	excessive folding of visceral yolk sac	18	5.612348e-36	4.177419e-11	4.860755e-18	8.789174e-21	0.0001419161
MP:0011206	absent visceral yolk sac	3	2.975193e-11	5.154869e-06	0.007748715	0.01628134	0.7988293
MP:0011207	absent ectoplacental cavity	6	2.841933e-10	9.121589e-11	0.6355337	0.000295334	0.9358466
MP:0011208	small proamniotic cavity	6	4.335824e-09	8.889194e-06	1.668803e-05	0.0001007694	0.07489314
MP:0011209	absent extraembryonic coelom	2	0.1194149	0.0005236106	0.1074993	0.4733098	0.6413165
MP:0011210	abnormal temporomandibular joint morphology	5	0.766028	3.436588e-22	0.9999742	0.0004104033	0.3088857
MP:0011213	abnormal brain copper level	5	1.041596e-09	0.003600165	0.2574282	3.036402e-06	0.1584914
MP:0011214	increased brain copper level	2	3.312987e-10	0.06792645	0.5403002	0.002662481	0.6895894
MP:0011215	decreased brain copper level	4	0.0004300703	0.005033594	0.06760516	7.588728e-05	0.1530567
MP:0011221	decreased intestinal calcium absorption	4	0.1037615	0.05909525	0.02180405	0.002943317	0.08187988
MP:0011223	dilated lymph node medullary sinus	1	3.638001e-05	0.2353925	0.00215206	0.05460293	1
MP:0011224	abnormal lymph node medullary cord morphology	6	7.925113e-44	0.903779	1.344846e-06	2.594416e-23	0.7950487
MP:0011225	lymph node medullary cord hyperplasia	2	3.942302e-08	0.751027	0.5500503	3.314335e-09	0.1766023
MP:0011226	abnormal thiamin level	1	0.9494554	0.0003059936	1	0.1968999	0.1785653
MP:0011227	abnormal vitamin B12 level	3	0.0009661389	0.1321236	0.9194979	0.4538428	0.2641267
MP:0011228	abnormal vitamin D level	18	0.8959308	2.047797e-21	0.001663398	0.1634438	0.2738493
MP:0011229	abnormal vitamin C level	6	1.846766e-05	0.004373408	0.1139423	0.001509757	0.5115707
MP:0011230	abnormal folic acid level	2	0.9580105	0.3638869	0.03812393	0.4907644	5.510153e-05
MP:0011231	abnormal vitamin E level	4	0.1355897	0.4052678	0.0001028991	0.0001287623	0.02184677
MP:0011232	abnormal vitamin A level	15	4.623452e-16	1.618075e-18	5.074511e-05	4.132388e-06	4.064797e-05
MP:0011233	abnormal vitamin A metabolism	10	0.8846167	4.994073e-06	0.9639513	0.5697933	0.0008605747
MP:0011234	abnormal retinol level	9	7.881174e-08	5.892762e-10	0.002618212	0.03006679	1.207022e-05
MP:0011237	decreased blood oxygen capacity	2	0.1410975	3.86032e-09	0.6875818	0.2813496	0.3180649
MP:0011241	abnormal fetal derived definitive erythrocyte cell number	7	1.32127e-36	0.0003451062	7.012355e-05	1.616664e-29	0.4317
MP:0011242	increased fetal derived definitive erythrocyte cell number	1	0.000428119	0.01340791	8.562057e-07	7.362636e-06	0.6079867
MP:0011243	decreased fetal derived definitive erythrocyte cell number	5	6.679123e-30	0.00140082	0.02299649	9.648519e-19	0.3860445
MP:0011246	abnormal fetal liver hematopoietic progenitor cell morphology	3	0.002300137	2.025666e-07	0.7800554	0.549164	0.2336581
MP:0011249	abdominal situs inversus	2	0.9861336	0.9774992	0.8010353	0.3790895	0.8288602
MP:0011250	abdominal situs ambiguus	5	0.9951891	0.9995041	0.9167423	0.9873825	0.3300089
MP:0011251	bronchial situs inversus	1	0.01933566	0.1505586	0.7799979	0.06113187	1
MP:0011252	situs inversus totalis	8	0.6371961	0.08891871	0.9609883	0.5751145	0.01414197
MP:0011253	situs inversus with levocardia	4	0.5075382	0.9276846	0.003854487	0.5506932	0.2438148
MP:0011254	superior-inferior ventricles	2	0.9996277	0.5771493	0.907263	0.6149029	0.8468146
MP:0011255	abnormal anterior visceral endoderm cell migration	12	1.743942e-10	0.1346415	0.0006118244	9.186947e-07	0.08595914
MP:0011256	abnormal neural fold morphology	89	1.413586e-98	1.756179e-104	2.117989e-28	1.12613e-62	0.002147608
MP:0011257	abnormal head fold morphology	4	1.110527e-13	7.589168e-05	3.391635e-11	0.005107868	0.3097534
MP:0011259	abnormal cephalic neural fold morphology	55	4.181257e-43	5.837807e-75	1.593711e-19	3.729841e-41	0.002501771
MP:0011260	abnormal head mesenchyme morphology	32	6.084288e-45	5.561195e-13	1.405465e-05	6.074476e-13	0.8726455
MP:0011261	abnormal limb mesenchyme morphology	7	0.01798059	0.001619176	0.1432308	0.001800937	0.6079751
MP:0011262	abnormal branchial arch mesenchyme morphology	2	0.8854834	0.9981436	0.7707692	0.07037842	0.6063518
MP:0011263	abnormal spleen mesenchyme morphology	4	0.01497869	6.698618e-13	0.2738195	3.246318e-07	0.05370883
MP:0011264	abnormal cardiac mesenchyme morphology	2	0.000797459	0.2498476	0.1852408	0.02534186	0.4800891
MP:0011265	abnormal pancreas mesenchyme morphology	1	0.9999736	0.8829117	1	0.746	1
MP:0011266	abnormal frontonasal mesenchyme morphology	1	0.9996953	4.892357e-05	0.9827874	0.936322	0.8122343
MP:0011267	abnormal excitatory postsynaptic current amplitude	17	1.337626e-15	2.834901e-24	0.9950154	0.05631693	0.9172908
MP:0011268	biphasic excitatory postsynaptic current amplitude	3	1.234047e-05	1.483909e-39	0.9979319	0.44942	0.9215317
MP:0011269	increased excitatory postsynaptic current amplitude	3	3.389744e-09	0.005309657	0.3961047	0.00464525	1
MP:0011270	decreased excitatory postsynaptic current amplitude	13	2.838796e-13	1.571025e-29	0.9886662	0.08337486	0.7005341
MP:0011272	short excitatory postsynaptic current rise time	3	1.234047e-05	1.483909e-39	0.9979319	0.44942	0.9215317
MP:0011274	short excitatory postsynaptic current decay time	1	7.674891e-05	0.3143497	1	0.003819137	0.1075989
MP:0011276	increased tail pigmentation	6	3.090598e-11	0.07597736	2.368751e-07	7.806961e-12	0.9835419
MP:0011277	decreased tail pigmentation	15	0.003071613	4.842655e-08	2.9512e-07	0.01511908	0.0117588
MP:0011278	increased ear pigmentation	5	3.225488e-10	0.06807694	3.552769e-07	1.974552e-11	0.9809574
MP:0011279	decreased ear pigmentation	12	0.0004815437	3.431959e-06	8.667859e-09	0.004186463	0.01921671
MP:0011282	increased podocyte apoptosis	3	1.209144e-08	0.3785463	0.01619828	4.919819e-07	0.1132632
MP:0011284	abnormal circulating erythropoietin level	12	1.138906e-17	6.468756e-06	0.000610198	2.80895e-28	0.5194871
MP:0011285	increased circulating erythropoietin level	11	7.772123e-18	0.08839824	0.005665388	3.253586e-28	0.7322916
MP:0011286	decreased circulating erythropoietin level	3	0.008054017	5.492509e-11	0.01277156	0.002631192	0.6142538
MP:0011289	abnormal nephron number	23	0.008916988	3.610336e-48	2.492555e-07	0.0001414716	0.005477096
MP:0011290	decreased nephron number	22	0.01959657	1.843224e-47	3.627994e-05	7.440147e-05	0.009657621
MP:0011291	nephron necrosis	1	1	0.4128127	1	0.8595013	1
MP:0011292	absent nephron	3	0.04621135	3.716369e-08	0.1350095	0.001597493	0.514757
MP:0011293	dilated nephron	2	0.01555565	2.865103e-08	0.711544	0.4747627	0.6419399
MP:0011294	renal glomerulus hypertrophy	33	2.118961e-41	4.933049e-14	3.11876e-41	1.641196e-28	0.0008077271
MP:0011295	abnormal tubuloglomerular feedback response	3	0.0008853961	6.250307e-06	0.09164928	0.002589456	0.5404117
MP:0011296	decreased tubuloglomerular feedback response	2	0.008551148	0.01053714	0.03413018	0.01354115	0.3461311
MP:0011297	absent tubuloglomerular feedback response	1	0.02432494	9.640864e-06	0.8410566	0.05397814	1
MP:0011298	ureter hypoplasia	5	2.77265e-07	9.915701e-21	0.01940035	0.006186402	0.7188879
MP:0011299	abnormal macula densa morphology	2	0.927438	0.284066	0.8562319	0.9342647	1
MP:0011300	abnormal juxtaglomerular cell morphology	5	0.9997801	6.349367e-07	0.001550758	0.9551616	0.3674244
MP:0011301	juxtaglomerular cell hyperplasia	2	1	0.009193234	0.07416116	0.9555007	0.05905438
MP:0011302	abnormal extraglomerular mesangial cell morphology	1	0.9982283	0.813613	1	0.977917	1
MP:0011303	absent kidney papilla	2	0.9999648	0.0675188	0.9039483	0.3975297	0.05228664
MP:0011304	kidney papillary atrophy	9	6.599163e-08	3.953616e-14	1.990197e-05	0.01591995	0.04587928
MP:0011305	dilated kidney calyx	9	0.999463	0.05433831	0.4953782	0.2314555	0.00291648
MP:0011306	absent kidney pelvis	4	0.6919257	0.6163004	0.1422044	0.0006826142	0.4013663
MP:0011307	kidney medulla cysts	15	8.857972e-17	6.929786e-06	1.28436e-06	3.361514e-05	0.007246298
MP:0011308	kidney corticomedullary cysts	5	1	5.830792e-06	0.5271852	0.9672163	0.01716158
MP:0011309	abnormal kidney arterial blood vessel morphology	15	0.0009505082	2.820963e-17	0.0008348973	0.0812773	0.01739512
MP:0011310	abnormal kidney capillary morphology	62	1.065892e-63	2.6605e-37	5.757977e-47	1.654139e-57	0.07231503
MP:0011311	abnormal kidney venous blood vessel morphology	3	0.9702283	0.007378469	0.5447313	0.03958363	1
MP:0011312	abnormal kidney afferent arteriole morphology	6	2.112805e-16	2.556237e-07	0.0002451671	0.005688963	0.2246228
MP:0011313	abnormal kidney efferent arteriole morphology	1	1.308349e-06	0.0003136487	1.008212e-06	0.006352072	0.4259408
MP:0011316	abnormal kidney interlobular artery morphology	5	0.0162059	2.006361e-09	8.226497e-06	0.3415283	0.02906399
MP:0011317	abnormal renal artery morphology	3	0.9881584	0.0006391215	0.9983332	0.318224	0.2873859
MP:0011318	abnormal right renal artery morphology	2	0.999804	0.006186961	0.9965432	0.8415988	0.9604909
MP:0011320	abnormal glomerular capillary morphology	60	4.78363e-65	2.048646e-38	8.672153e-49	6.098561e-59	0.0455863
MP:0011321	abnormal peritubular capillary morphology	5	9.917959e-06	2.44264e-06	0.002829483	0.002146878	0.3143234
MP:0011323	abnormal renal vein morphology	2	0.3819989	0.333013	0.05557029	0.001132352	1
MP:0011327	abnormal left renal vein morphology	1	0.2418396	0.3846538	0.4798694	0.001431243	1
MP:0011331	abnormal papillary duct morphology	5	0.9965522	0.002789733	0.9998076	0.9112926	0.1809706
MP:0011332	abnormal kidney outer medulla morphology	4	0.2028946	0.9645273	0.9948	0.5976829	0.5503376
MP:0011333	abnormal kidney inner medulla morphology	9	0.6276518	1.347913e-06	0.3536498	0.8645719	0.137236
MP:0011334	abnormal nephrogenic zone morphology	16	1.62895e-14	1.77971e-26	2.328217e-08	8.876973e-08	0.03295052
MP:0011336	abnormal kidney pelvis urothelium morphology	3	4.536441e-09	0.245332	5.499769e-05	8.900253e-05	0.538396
MP:0011338	abnormal mesangial matrix morphology	51	1.036929e-64	5.81675e-25	2.52751e-43	1.42002e-42	0.001003651
MP:0011339	abnormal glomerular mesangium morphology	77	3.705569e-103	7.529596e-29	5.953001e-72	7.964002e-78	0.002268008
MP:0011341	abnormal loop of Henle descending limb morphology	1	0.913736	0.9311385	0.8814681	0.7435166	0.5844193
MP:0011344	abnormal loop of Henle ascending limb thick segment morphology	6	2.491989e-14	0.1861793	0.01275134	0.02338282	0.6354958
MP:0011345	truncated loop of Henle	2	0.7309875	1.187198e-19	0.8634183	0.006330369	0.8100629
MP:0011346	renal tubule atrophy	30	6.571734e-30	0.001752041	0.0001321585	2.036437e-13	0.02604867
MP:0011347	abnormal kidney medullary ray morphology	2	0.05148915	2.446043e-10	9.421446e-05	0.01615573	0.0173438
MP:0011348	abnormal renal glomerulus basement membrane morphology	50	3.565777e-94	1.549885e-23	9.484621e-35	1.214763e-58	0.5262471
MP:0011349	abnormal renal glomerulus basement membrane thickness	39	2.700439e-69	5.095959e-31	4.595935e-34	2.490692e-43	0.3097712
MP:0011350	abnormal proximal convoluted tubule brush border morphology	11	0.4892234	2.094068e-05	1.767688e-08	0.5254051	0.2721313
MP:0011351	absent proximal convoluted tubule brush border	1	0.9641222	0.1445276	1	0.6709231	0.7847776
MP:0011352	proximal convoluted tubule brush border loss	9	0.03133542	2.340652e-06	5.720923e-10	0.2460065	0.1493222
MP:0011353	expanded mesangial matrix	49	3.786689e-53	3.83475e-26	2.760562e-41	2.161235e-37	0.001450194
MP:0011354	absent renal glomerulus	2	2.806381e-07	0.004772647	0.3466685	0.2769632	1
MP:0011359	decreased glomerular capillary number	8	2.187992e-05	1.407822e-07	0.0003598679	0.0709937	0.5526945
MP:0011360	kidney cortex hypoplasia	5	0.9986637	4.920702e-07	0.999992	0.9999994	0.8722405
MP:0011361	pelvic kidney	3	0.5586909	0.6444832	0.978893	0.6670708	0.3144748
MP:0011362	ectopic adrenal gland	2	0.9999831	3.545663e-15	0.9693124	0.3880507	0.5454475
MP:0011363	renal glomerulus atrophy	15	3.058256e-05	1.132475e-15	0.0618597	0.0003664165	0.9664463
MP:0011364	abnormal metanephros morphology	28	1.80444e-23	7.834704e-45	1.351729e-07	4.05842e-06	0.4368821
MP:0011365	small metanephros	7	2.128034e-25	4.752793e-25	4.703906e-05	0.001286772	0.6246534
MP:0011366	absent metanephros	12	0.4882949	2.37048e-16	0.08821778	0.005741909	0.5547354
MP:0011367	abnormal kidney apoptosis	71	8.784883e-78	2.979537e-49	3.664788e-29	4.579099e-32	0.4821428
MP:0011368	increased kidney apoptosis	62	8.194533e-72	2.361414e-43	7.455405e-24	1.911922e-29	0.8299575
MP:0011369	increased renal glomerulus apoptosis	14	3.01001e-16	5.449539e-10	2.506385e-23	2.249303e-13	0.03885792
MP:0011370	increased mesangial cell apoptosis	2	0.3510744	9.507803e-07	0.001412413	0.07473645	0.7774561
MP:0011371	decreased kidney apoptosis	9	4.364124e-08	1.275605e-07	3.921033e-07	0.0002472525	0.01524531
MP:0011372	decreased renal tubule apoptosis	7	3.494755e-08	9.485284e-10	8.968022e-10	2.940434e-05	0.00295652
MP:0011376	abnormal kidney corticomedullary boundary morphology	12	0.4287364	1.606304e-08	0.1174632	0.001040802	0.001468069
MP:0011377	renal glomerulus fibrosis	16	5.287682e-12	7.44809e-06	9.628437e-05	1.575164e-08	0.07315177
MP:0011378	abnormal kidney outer medulla inner stripe morphology	2	0.9920218	0.9503857	0.9977926	0.9999944	0.9061915
MP:0011379	abnormal kidney outer medulla outer stripe morphology	1	1.142526e-15	0.6277595	0.04370225	4.762351e-16	1
MP:0011380	enlarged brain ventricle	97	8.45044e-83	4.648571e-110	1.452855e-13	1.787887e-45	0.06439771
MP:0011382	abnormal kidney lobule morphology	1	0.3662177	7.948647e-09	0.770847	0.936322	0.8122343
MP:0011383	abnormal kidney capsule morphology	1	0.9996953	0.813613	0.5785484	0.8595013	0.08911155
MP:0011384	abnormal progesterone level	45	8.279173e-14	5.58911e-35	5.715427e-18	1.51002e-14	0.002209138
MP:0011385	abnormal testosterone level	75	1.253105e-23	3.317165e-38	1.031585e-25	6.309887e-25	0.01012765
MP:0011386	increased metanephric mesenchyme apoptosis	20	0.918722	1.502247e-28	0.04122636	0.08294148	0.6593874
MP:0011387	absent metanephric mesenchyme	6	0.4687329	7.899237e-34	5.31652e-05	0.08210121	0.5400962
MP:0011388	absent heart	12	5.882942e-23	2.690381e-16	0.04990958	4.519059e-06	0.7685714
MP:0011389	absent optic disc	4	0.987853	2.00493e-13	0.7791606	0.05872302	1
MP:0011390	abnormal fetal cardiomyocyte physiology	50	5.739437e-76	1.582554e-33	6.616601e-15	1.288778e-56	0.03268214
MP:0011392	increased fetal cardiomyocyte apoptosis	3	3.364188e-13	0.3401392	0.07172596	1.656413e-09	0.7711312
MP:0011394	increased fetal cardiomyocyte proliferation	4	4.459758e-21	0.0002187124	0.000305306	5.465677e-24	0.5910615
MP:0011395	decreased fetal cardiomyocyte proliferation	6	3.310234e-35	8.748713e-13	0.05555209	1.119215e-12	0.05187324
MP:0011396	abnormal sleep behavior	51	2.332079e-21	1.256045e-12	4.591627e-09	1.326994e-20	0.4379608
MP:0011400	complete lethality	20	2.196556e-26	1.102787e-14	2.894623e-13	5.181375e-14	0.2767884
MP:0011401	abnormal vascular smooth muscle development	1	0.819143	0.7360682	0.0004116363	0.0002877162	0.002126837
MP:0011402	renal cast	41	2.443423e-57	5.885511e-19	4.320359e-27	3.334782e-36	0.01448348
MP:0011403	pyelonephritis	5	0.0003905145	0.5757286	0.5716642	0.3153629	0.2469583
MP:0011404	pyelitis	1	0.4724575	0.584296	0.8802533	0.740619	0.582671
MP:0011405	tubulointerstitial nephritis	21	2.852863e-27	0.006112577	0.0003470815	5.19818e-15	0.2266173
MP:0011406	abnormal retrotrapezoid nucleus morphology	3	0.001210529	0.0386834	0.1314836	0.0005343656	0.9833422
MP:0011407	absent nephrogenic zone	4	4.364821e-06	0.0008210289	0.000714389	1.802465e-05	0.2734948
MP:0011408	renal tubule hypertrophy	4	0.6630625	2.023644e-06	0.03549023	0.001814017	0.09370123
MP:0011409	increased renal glomerulus basement membrane thickness	37	1.275853e-56	1.117645e-32	4.919826e-32	8.658294e-38	0.3787869
MP:0011410	ectopic testis	3	0.03675397	6.854574e-13	0.6611755	0.1585804	0.8304075
MP:0011411	abnormal gonadal ridge morphology	9	6.379307e-07	0.0001234561	0.6515341	0.0008109392	0.3665655
MP:0011412	gonadal ridge hypoplasia	3	0.9999075	0.001076395	0.9820532	0.003366458	0.9880091
MP:0011413	colorless urine	7	4.618284e-14	0.3918693	2.092884e-05	0.003998335	0.7591891
MP:0011414	erythruria	2	3.65406e-07	0.9764714	0.667234	8.344712e-06	1
MP:0011415	abnormal aldosterone level	37	6.979458e-47	2.547915e-48	8.194505e-10	2.215382e-20	0.01282871
MP:0011417	abnormal renal transport	26	5.925932e-06	3.86599e-11	2.462241e-09	3.524561e-08	0.4287305
MP:0011418	leukocyturia	3	0.97129	5.06535e-10	3.445412e-06	0.00401127	0.6363236
MP:0011419	erythrocyturia	1	0.0005379173	0.008280559	0.001325481	5.105107e-09	1
MP:0011422	kidney medulla atrophy	10	1.049398e-14	0.000302671	0.1724264	1.448873e-05	0.07033165
MP:0011423	kidney cortex atrophy	14	3.571706e-35	4.131857e-10	0.0006411882	2.276153e-17	0.001321632
MP:0011424	decreased urine uric acid level	6	2.632339e-08	0.002928254	0.007760289	0.2655308	0.04290245
MP:0011425	abnormal kidney interstitium morphology	57	9.918429e-36	4.722418e-12	2.244451e-12	3.510561e-26	0.06640581
MP:0011426	abnormal ureter smooth muscle morphology	9	0.9993395	0.000359033	0.9820878	0.3198269	0.8424172
MP:0011427	mesangial cell hyperplasia	36	6.734269e-34	3.821456e-08	1.405312e-25	3.103643e-41	0.04704962
MP:0011428	mesangial cell hypoplasia	3	2.592979e-09	0.0002706614	0.3874347	2.162797e-13	0.5009285
MP:0011429	absent mesangial cell	3	4.427025e-20	4.992415e-08	1.805935e-07	6.054223e-35	0.8521107
MP:0011430	mesangiolysis	14	1.707175e-06	2.760996e-13	1.101955e-07	0.0004812295	0.002369494
MP:0011431	increased urine flow rate	2	0.02690586	1.049384e-09	0.0004237988	0.9916416	0.1347244
MP:0011432	decreased urine flow rate	4	0.9824951	5.171125e-09	0.3979237	0.589185	0.4584843
MP:0011433	glomerular capillary congestion	1	0.0006629825	0.5284659	6.801192e-07	0.0004176958	0.09419908
MP:0011434	abnormal urine magnesium level	10	1.171939e-22	1.641702e-10	1.149647e-06	2.76114e-08	0.8159678
MP:0011435	increased urine magnesium level	9	2.211886e-20	3.054877e-08	0.06416	2.489738e-07	0.8811753
MP:0011436	decreased urine magnesium level	1	0.0008383883	0.0004208295	3.541616e-13	0.02457024	0.4082343
MP:0011437	glomerulus hemorrhage	5	1.679942e-08	3.937122e-05	0.02745592	3.127158e-05	0.4634936
MP:0011438	absent kidney medulla	2	0.01380836	7.562273e-09	0.7759375	0.0915131	0.7467584
MP:0011439	abnormal kidney cell proliferation	40	1.016199e-53	6.900054e-32	1.39381e-21	4.507093e-49	0.4794976
MP:0011440	increased kidney cell proliferation	27	6.326224e-46	0.006215248	1.443554e-19	2.303157e-32	0.2299132
MP:0011441	decreased kidney cell proliferation	13	1.775717e-11	4.935554e-50	0.0001116356	1.579212e-18	0.8504379
MP:0011442	abnormal renal sodium ion transport	7	0.2880504	5.04806e-09	0.001356088	0.0002010709	0.2687576
MP:0011443	abnormal renal water transport	11	5.898541e-06	0.003803646	0.00184058	3.643124e-06	0.4800721
MP:0011445	abnormal renal protein reabsorption	5	6.618158e-06	0.9016397	0.4931369	0.0527973	0.9809267
MP:0011447	abnormal renal glucose reabsorption	4	1.437684e-06	0.573077	0.1721149	0.1164511	0.2075232
MP:0011448	decreased dopaminergic neuron number	23	2.018883e-15	8.725697e-05	0.7784568	0.0114173	0.9848866
MP:0011450	ectopic dopaminergic neuron	1	0.9379559	0.1876644	0.5480092	0.1801954	0.7998004
MP:0011451	increased susceptibility to dopaminergic neuron neurotoxicity	13	0.0001661495	0.08273114	0.0006835194	1.142451e-06	0.9502662
MP:0011452	decreased susceptibility to dopaminergic neuron neurotoxicity	13	4.848021e-16	0.4443686	4.718448e-12	9.138815e-07	0.636416
MP:0011453	abnormal glomerular capillary endothelium morphology	22	1.712687e-45	2.72007e-17	1.206289e-19	1.24382e-44	0.2915059
MP:0011454	abnormal glomerular endothelium fenestra morphology	10	1.528454e-18	1.186171e-15	4.020817e-10	1.131504e-06	0.1827296
MP:0011455	absent glomerular endothelium fenestra	7	2.578871e-17	1.186319e-20	4.786101e-10	1.409437e-08	0.4621767
MP:0011457	abnormal metanephric ureteric bud development	5	0.0576728	0.0004232848	1.950783e-07	0.000163778	0.01218388
MP:0011458	abnormal urine chloride ion level	19	7.177044e-14	9.776789e-23	3.145986e-07	3.491815e-13	0.1165073
MP:0011459	increased urine chloride ion level	11	2.426561e-19	2.732033e-09	0.0005130216	3.278176e-05	0.287218
MP:0011460	decreased urine chloride ion level	8	0.3858307	3.026547e-16	8.471655e-05	1.81509e-10	0.1429264
MP:0011462	increased urine bicarbonate level	3	5.978117e-07	0.03230809	0.9990648	0.4288225	0.8953354
MP:0011464	bilirubinuria	1	0.1265954	4.01145e-06	0.01481529	0.007624591	0.6460395
MP:0011465	abnormal urine urea nitrogen level	11	1.476663e-06	8.056191e-10	2.035857e-12	5.579263e-05	0.4170837
MP:0011466	increased urine urea nitrogen level	3	4.440756e-06	0.0006068924	2.473864e-05	0.6656824	0.8604916
MP:0011467	decreased urine urea nitrogen level	7	0.01228494	7.568268e-08	2.832303e-13	7.510971e-07	0.173698
MP:0011468	abnormal urine amino acid level	37	5.355469e-20	7.519824e-21	9.960912e-08	3.145229e-05	0.08279531
MP:0011469	abnormal urine creatinine level	13	0.1418007	7.406406e-06	0.0002618639	0.008784103	0.127321
MP:0011470	increased urine creatinine level	4	0.03411372	0.9594028	0.9184503	0.5521022	0.1339718
MP:0011471	decreased urine creatinine level	9	0.5201036	1.003119e-09	1.593528e-06	0.002231736	0.3106706
MP:0011473	increased urine glycosaminoglycan level	8	3.278919e-25	0.02901824	0.2604694	1.213139e-07	0.0524223
MP:0011475	abnormal glycosaminoglycan level	9	4.636135e-34	0.05999426	0.1928452	4.67392e-11	0.07359569
MP:0011476	abnormal urine nucleotide level	3	0.9979876	0.2052137	0.8837457	0.3360925	0.04353049
MP:0011477	abnormal urine nucleoside level	6	1.255972e-05	0.03204102	2.663688e-05	0.04755074	0.1736347
MP:0011478	abnormal urine catecholamine level	10	5.589666e-11	1.617334e-07	0.0055505	5.743057e-10	0.5304961
MP:0011479	abnormal catecholamine level	131	1.726831e-37	7.238505e-32	2.038896e-10	2.704461e-32	0.6787638
MP:0011480	impaired ureteric peristalsis	5	0.01221215	4.513666e-11	0.5528591	0.0791455	0.3969485
MP:0011481	anterior iris synechia	12	0.03457535	2.023719e-21	3.714402e-06	2.916615e-05	0.8321359
MP:0011483	renal glomerular synechia	9	0.0001566	2.677337e-07	0.001727438	1.316192e-11	0.2463014
MP:0011484	abnormal ureter urothelium morphology	3	3.139524e-06	1.616147e-12	6.176236e-08	0.007703856	0.8774765
MP:0011485	abnormal urethra urothelium morphology	1	3.1199e-06	1.220147e-06	1	0.1510882	1
MP:0011486	ectopic ureter	7	0.02185251	2.785764e-05	0.01439679	2.97312e-08	0.8765582
MP:0011487	abnormal ureteropelvic junction morphology	5	0.9982026	0.008662772	0.02347173	0.0007913023	0.1993544
MP:0011488	abnormal ureterovesical junction morphology	5	0.9998571	0.2243678	0.9980875	0.9570177	0.9935089
MP:0011489	ureteropelvic junction atresia	1	0.9996953	0.9655247	1	0.9948082	1
MP:0011490	ureteropelvic junction stenosis	2	0.9999688	0.001519169	0.06993206	0.1125639	0.4295862
MP:0011491	ureteropelvic junction obstruction	3	0.7417724	0.3597044	0.1059414	0.001073447	0.2053335
MP:0011492	ureterovesical junction obstruction	3	0.9999856	0.8530845	0.9989706	0.9975335	0.9773731
MP:0011493	double ureter	9	5.984964e-11	4.589396e-15	0.8909703	0.01461601	0.96305
MP:0011495	abnormal head shape	73	3.925439e-37	1.467461e-110	8.442358e-12	3.086112e-20	0.1204072
MP:0011496	abnormal head size	95	3.679223e-94	5.493604e-44	5.813238e-19	5.054482e-60	0.9072355
MP:0011498	abnormal glomerular capsule parietal layer morphology	6	0.0005703083	1.002795e-05	4.036051e-07	0.0004106703	0.009327028
MP:0011499	abnormal glomerular capsule space morphology	28	0.08560588	1.426317e-33	0.0105503	0.001325176	0.5114829
MP:0011500	decreased glomerular capsule space	2	0.9028822	0.136837	0.0005973251	0.01428727	0.008643418
MP:0011501	increased glomerular capsule space	25	0.01742602	1.641995e-34	0.05448123	0.001439101	0.7374737
MP:0011502	parietal capsular epithelium metaplasia	2	0.5179326	0.009702612	0.0001000286	1.831374e-07	0.03299227
MP:0011503	distended jejunum	3	0.7600432	2.233371e-09	5.203486e-05	0.004420393	0.1618809
MP:0011504	abnormal limb long bone morphology	279	3.477151e-103	2.27566e-216	7.747183e-34	2.62817e-78	0.0005891542
MP:0011505	camptomelia	5	1	4.782387e-17	0.01777013	0.09713423	0.118032
MP:0011506	glomerular crescent	21	5.947944e-27	0.008846416	3.184972e-17	3.199616e-26	0.004963646
MP:0011507	kidney thrombosis	10	2.087936e-05	3.99851e-05	2.061265e-06	4.698922e-08	0.7085125
MP:0011508	glomerular capillary thrombosis	8	5.792226e-11	1.139555e-05	4.227758e-09	1.819376e-10	0.4826477
MP:0011509	dilated glomerular capillary	11	5.574162e-09	2.815994e-10	0.0003283204	6.610559e-09	0.091198
MP:0011510	biventricular, discordant atrioventricular connection	2	0.9996277	0.5771493	0.907263	0.6149029	0.8468146
MP:0011511	biventricular, ambiguous atrioventricular connection	1	0.9930732	0.9655247	0.770847	0.8595013	0.8122343
MP:0011512	mesangial cell interposition	6	1.258678e-10	0.1047015	4.532382e-19	2.359085e-12	0.6222274
MP:0011513	abnormal vertebral artery morphology	4	0.7789234	2.402466e-15	0.7488522	0.2987923	0.8661614
MP:0011514	skin hemorrhage	18	1.343741e-37	9.518909e-11	4.774471e-10	1.046341e-31	0.1995732
MP:0011515	purpura	3	7.971573e-11	0.2615939	4.037682e-07	8.532552e-13	0.1957152
MP:0011516	aspartylglucosaminuria	1	1	0.9979726	0.770847	0.9948082	0.8122343
MP:0011517	hyperoxaluria	2	6.977564e-06	0.01632258	2.880853e-05	0.134099	0.7771526
MP:0011518	abnormal cell chemotaxis	126	3.745082e-177	1.491884e-39	5.36205e-93	1.141939e-204	1.866711e-12
MP:0011519	abnormal placenta labyrinth size	49	8.566613e-124	2.971326e-32	2.155376e-48	1.841981e-63	0.0820678
MP:0011520	increased placental labyrinth size	5	4.55018e-15	0.2874533	1.078616e-08	3.798042e-06	0.001400082
MP:0011521	decreased placental labyrinth size	44	1.563257e-110	1.387891e-34	1.825824e-41	3.06733e-59	0.4251908
MP:0011522	abnormal placental labyrinth villi morphology	4	4.958967e-06	0.9649047	9.129967e-06	0.06520102	0.06384436
MP:0011523	thin placenta labyrinth	15	3.442952e-37	2.819446e-19	1.081278e-14	6.028261e-10	0.5657068
MP:0011524	thick placenta labyrinth	3	1.098278e-19	0.4695312	1.054019e-06	0.0007763721	0.01312689
MP:0011525	abnormal placenta intervillous maternal lacunae morphology	7	6.03266e-32	1.877945e-12	7.135224e-15	1.090973e-19	0.2852705
MP:0011526	abnormal placenta fetal blood space morphology	3	5.94589e-26	0.05068421	6.437737e-15	2.288554e-16	0.08652572
MP:0011527	disorganized placental labyrinth	9	3.129986e-08	0.09662741	0.03579439	1.902176e-07	0.3302648
MP:0011528	abnormal placental labyrinth villi branching morphogenesis	1	0.001103327	0.9278255	0.04339603	0.05404699	1
MP:0011529	increased placenta intervillous maternal lacunae size	3	1.170061e-05	9.085989e-11	4.07967e-10	3.258919e-05	0.03683399
MP:0011531	abnormal syncytiotrophoblast morphology	3	0.0002050388	0.9395836	5.403174e-05	0.1709153	0.04243723
MP:0011532	decreased urine major urinary protein level	3	0.5260838	0.9669893	0.5250496	0.4442701	0.8787671
MP:0011533	increased urine major urinary protein level	1	1	0.9999856	1	0.9948082	0.498173
MP:0011534	granular kidney	7	0.01962794	0.01045556	0.0136594	8.908272e-05	0.6471061
MP:0011535	increased urination frequency	2	0.8806265	2.950245e-07	0.9544331	0.9760959	1
MP:0011537	uraturia	3	1.547637e-21	4.821294e-07	0.6729242	0.000325175	0.3982016
MP:0011538	abnormal urine hormone level	4	1.994403e-11	5.940103e-05	0.8469586	0.01429643	0.0008817957
MP:0011541	decreased urine aldosterone level	3	2.177478e-05	5.396853e-07	0.9226993	0.09995317	1.488009e-05
MP:0011543	increased urine antidiuretic hormone level	2	8.673172e-11	0.002089386	0.8298132	0.1360634	0.3805214
MP:0011546	increased urine progesterone level	1	0.2510445	0.1952237	0.486795	1	0.03147484
MP:0011550	decreased urine corticosterone level	1	0.2510445	0.1952237	0.486795	1	0.03147484
MP:0011553	increased urine deoxycorticosterone level	1	0.2510445	0.1952237	0.486795	1	0.03147484
MP:0011555	increased urine microglobulin level	5	0.3740549	0.003792169	0.307297	0.03369317	0.5413135
MP:0011556	increased urine beta2-microglobulin level	2	0.9999953	0.9265148	0.6949599	0.9914353	0.8573662
MP:0011559	increased urine insulin level	1	0.9997258	0.7468457	0.823537	0.9784657	1
MP:0011561	renal glomerulus lipidosis	2	1.620098e-08	0.8513744	0.07904402	0.002617607	1
MP:0011562	abnormal urine prostaglandin level	6	1.80204e-11	0.1466286	0.1436444	1.182887e-05	0.2125012
MP:0011563	increased urine prostaglandin level	4	0.0009004145	0.4174562	0.7654801	0.07625004	0.08800326
MP:0011564	decreased urine prostaglandin level	3	1.658241e-05	0.2634849	0.03383691	0.00024491	0.3069139
MP:0011565	kidney papillary hypoplasia	9	0.9644087	0.0001187012	0.1479996	0.7899794	0.03563712
MP:0011567	increased renal glomerulus lobularity	4	1.836396e-10	0.7606303	0.01054591	2.033766e-06	0.8947971
MP:0011568	decreased foot pigmentation	2	0.04333717	2.516835e-08	0.9964642	0.9977738	0.4103492
MP:0011569	abnormal azygos vein morphology	5	0.2247073	0.356415	0.0001168705	0.07440329	0.4302667
MP:0011572	abnormal aorta bulb morphology	7	0.02284018	1.469126e-09	0.4872822	0.09035013	0.3125857
MP:0011575	dilated aorta bulb	2	0.5231342	1.995871e-07	0.3772135	0.125849	0.6054446
MP:0011576	absent cervical atlas	3	0.311985	4.768339e-26	0.03409538	0.001818621	1
MP:0011577	abnormal lipoprotein lipase activity	9	4.522867e-22	6.387169e-13	1.760754e-09	0.001041124	0.002670889
MP:0011578	increased lipoprotein lipase activity	3	0.0001932989	0.3459773	0.1325013	0.6851798	0.005234667
MP:0011579	decreased lipoprotein lipase activity	6	1.414514e-19	3.646123e-15	7.852668e-10	0.0001151864	0.06370201
MP:0011580	abnormal triglyceride lipase activity	4	0.000104498	2.796256e-14	5.825948e-06	0.00111368	0.07483314
MP:0011581	increased triglyceride lipase activity	1	0.06074024	1	0.005161348	1	1
MP:0011582	decreased triglyceride lipase activity	3	0.0003338518	3.669579e-15	7.263939e-05	0.0006081765	0.06360737
MP:0011583	abnormal alkaline phosphatase activity	2	5.070746e-05	0.0003158342	0.0035337	6.035718e-05	0.1415504
MP:0011584	increased alkaline phosphatase activity	1	0.04081623	0.4128127	0.0003157966	0.004004114	0.08911155
MP:0011585	decreased alkaline phosphatase activity	1	6.969599e-05	1.792878e-06	0.7263645	0.003223239	0.6526259
MP:0011588	decreased ornithine carbamoyltransferase activity	1	1	0.5474854	0.9292173	1	1
MP:0011591	decreased hormone-sensitive lipase activity	1	0.9997672	4.552006e-06	0.04603531	0.000133565	0.1491728
MP:0011592	abnormal catalase activity	3	2.064701e-10	0.3094146	0.01151886	0.0008787065	0.5956601
MP:0011593	increased catalase activity	1	0.9563108	0.9836034	1	0.1794215	0.08919761
MP:0011594	decreased catalase activity	1	0.9563108	0.9836034	1	0.1794215	0.08919761
MP:0011597	decreased purine-nucleoside phosphorylase activity	1	1	1	1	0.108684	1
MP:0011599	increased phosphatidylcholine-sterol O-acyltransferase activity	2	2.544087e-05	0.1234064	0.001554767	0.18027	1
MP:0011601	abnormal glutathione peroxidase activity	4	1.471073e-12	8.32531e-07	0.0008244877	7.56086e-05	0.4334786
MP:0011602	increased glutathione peroxidase activity	1	0.9502312	0.0003850002	0.6976729	0.4519068	0.01897532
MP:0011603	decreased glutathione peroxidase activity	3	2.074803e-17	0.0002806476	0.0001042779	1.344614e-05	1
MP:0011606	decreased glucokinase activity	2	0.3133608	0.003887315	0.825439	0.3572931	1
MP:0011609	decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	1	7.294801e-08	0.9411137	0.2024267	2.939329e-05	1
MP:0011610	abnormal primordial germ cell apoptosis	6	1.020288e-08	3.907473e-21	0.9278354	0.06111024	0.7185766
MP:0011611	abnormal circulating ghrelin level	7	0.007130399	0.9891357	0.8700076	0.264779	0.1014309
MP:0011612	increased circulating ghrelin level	5	0.004751958	0.9943192	0.6841809	0.2485207	0.03432665
MP:0011613	decreased circulating ghrelin level	2	0.365597	0.6628564	0.9520047	0.506524	0.8610538
MP:0011615	submucous cleft palate	1	7.23987e-08	1.310999e-15	1	0.01043992	0.296257
MP:0011617	abnormal habituation	5	1.492192e-13	0.3775115	0.0008100715	1.279847e-10	0.1615392
MP:0011620	abnormal habituation to a new environment	3	0.00384358	0.4340135	7.47807e-05	0.0005618363	0.1122882
MP:0011621	abnormal habituation to a novel object	1	0.1404243	0.7815633	1	0.123435	0.6064659
MP:0011625	cystolithiasis	8	3.067554e-05	4.216076e-05	0.4080709	0.9277359	0.7255882
MP:0011626	orotic acid urinary bladder stones	1	1	0.5474854	0.9292173	1	1
MP:0011627	decreased skin pigmentation	3	0.9605358	0.2109756	0.06361714	0.9997993	0.179787
MP:0011628	increased mitochondria number	4	0.1228771	0.01955115	0.9247764	0.2878742	0.06463796
MP:0011629	decreased mitochondria number	8	3.012681e-15	0.0002554101	0.003650757	9.15049e-17	0.8118059
MP:0011630	increased mitochondria size	25	2.755801e-60	4.299838e-10	1.074405e-19	7.072826e-37	0.01513833
MP:0011631	decreased mitochondria size	4	0.9996658	0.8609992	0.9796691	0.9684077	0.07442513
MP:0011632	dilated mitochondria	9	3.226923e-28	0.002719824	0.0001828478	1.303251e-06	0.0004240113
MP:0011633	abnormal mitochondrial shape	8	9.754456e-15	0.04498017	4.95877e-07	1.111319e-10	0.2207437
MP:0011635	abnormal mitochondrial crista morphology	26	7.688127e-52	0.00490562	7.145225e-09	2.945023e-25	0.001103269
MP:0011636	disorganized mitochondrial cristae	6	3.681626e-11	8.896653e-05	0.3175564	0.0002110724	0.2746972
MP:0011637	abnormal mitochondrial matrix morphology	1	0.9999736	0.07022086	2.368458e-05	0.07280409	0.02789339
MP:0011638	abnormal mitochondrial chromosome morphology	17	3.976638e-17	0.0001427259	0.001365109	2.087418e-16	0.3855736
MP:0011639	decreased mitochondrial DNA content	11	1.906318e-13	0.3977984	0.09234871	1.090287e-10	0.1233106
MP:0011640	abnormal aorta collagen fibril morphology	1	0.9442586	0.959598	1.329959e-06	0.004881465	1
MP:0011641	abnormal pulmonary collagen fibril morphology	1	0.9780158	1.310216e-06	1	0.9091759	1
MP:0011642	abnormal bone collagen fibril morphology	4	0.1184912	0.0002444662	0.9514781	0.5830753	0.5414797
MP:0011643	abnormal tendon collagen fibril morphology	3	5.594398e-05	2.944949e-15	0.9686845	0.1368726	0.777639
MP:0011644	abnormal oviduct epithelium motile cilium morphology	3	4.198267e-31	0.02415586	0.0007999165	0.004596487	0.2832412
MP:0011645	absent oviduct epithelium motile cilium	1	2.327337e-09	0.00530088	0.1495125	0.004879008	0.0531146
MP:0011648	thick heart valve cusps	14	0.1774096	6.708841e-20	0.001623859	5.624106e-06	0.1529348
MP:0011649	immotile respiratory cilia	6	0.9999108	0.9934631	0.9924913	0.987838	0.05176005
MP:0011654	increased urine histidine level	1	0.1420581	0.1163076	0.0265342	0.08396718	0.1486527
MP:0011655	abnormal systemic artery morphology	220	5.766913e-168	1.594147e-156	1.034744e-63	1.548915e-137	6.420376e-07
MP:0011659	interrupted aortic arch, type b	2	5.810057e-10	0.3221804	0.05226034	0.01363419	0.6580647
MP:0011660	ectopia cordis	1	0.9996953	0.5187106	1	0.9948082	1
MP:0011661	persistent truncus arteriosus type i	1	2.022276e-08	0.03459105	3.765649e-06	1.916057e-05	1
MP:0011662	persistent truncus arteriosus type ii	1	2.022276e-08	0.03459105	3.765649e-06	1.916057e-05	1
MP:0011665	d-loop transposition of the great arteries	7	3.181948e-18	0.01226251	0.06027591	0.03241333	0.7281494
MP:0011666	double outlet right ventricle, ventricular defect committed to aorta	3	0.006164352	0.9998736	0.8253285	0.9980074	0.09661039
MP:0011667	double outlet right ventricle with atrioventricular septal defect	6	0.9999987	0.1076044	0.9892183	0.822836	0.8803991
MP:0011668	double outlet right ventricle, Taussig bing type	2	6.932927e-13	0.002228505	0.7722685	0.4064916	0.3232402
MP:0011673	unbalanced complete common atrioventricular canal	1	0.03438893	0.04889574	2.96555e-05	0.6240751	1
MP:0011674	multiple major aortopulmonary collateral arteries	2	6.992225e-21	0.9994194	0.8877088	7.179914e-05	0.5935721
MP:0011681	atrium cysts	1	2.022276e-08	0.03459105	3.765649e-06	1.916057e-05	1
MP:0011682	renal glomerulus cysts	15	3.682602e-32	1.876381e-09	0.005341426	1.629648e-08	0.3273139
MP:0011683	dual inferior vena cava	6	4.802363e-09	0.863756	5.038878e-06	0.009433179	0.340864
MP:0011684	coronary-cameral fistula to right ventricle	1	2.514814e-13	0.1261252	0.09629129	0.03456845	1
MP:0011686	increased epidermal stem cell number	2	1.518602e-08	0.5616947	0.3440906	0.0005613754	0.5747654
MP:0011689	absent neutrophils	1	7.91993e-08	0.9938493	2.498256e-09	3.121819e-05	0.02789339
MP:0011696	absent mast cells	5	1.663436e-16	0.4016434	3.256571e-14	0.002423659	0.117466
MP:0011697	vacuolated lens	20	0.0003823112	3.871704e-25	1.47025e-25	1.508891e-06	0.009580724
MP:0011698	abnormal brown adipose tissue physiology	10	3.800085e-27	0.02242759	3.639001e-07	1.0014e-16	0.2589825
MP:0011699	abnormal brown adipose tissue thermogenesis	4	4.300331e-14	0.6935578	0.001320696	5.174905e-05	0.9123232
MP:0011701	decreased cumulus expansion	1	0.0001941504	0.5707737	0.0639237	0.2865442	1
MP:0011702	abnormal fibroblast proliferation	120	3.62431099999999e-310	5.943245e-21	1.450289e-28	2.140784e-119	0.4199663
MP:0011703	increased fibroblast proliferation	24	7.200981e-86	1.152655e-06	4.132276e-08	6.468199e-44	0.8315946
MP:0011704	decreased fibroblast proliferation	98	1.178148e-238	7.378846e-17	3.796422e-22	3.502261e-88	0.2775547
MP:0011705	absent fibroblast proliferation	9	4.204295e-30	0.7971425	0.0003030813	1.277377e-09	0.05136095
MP:0011706	abnormal fibroblast migration	36	8.312546e-43	1.47335e-41	3.738503e-26	2.119264e-64	0.6563829
MP:0011707	impaired fibroblast cell migration	9	6.911279e-23	0.008815724	7.984401e-09	4.165423e-37	0.4473764
MP:0011708	decreased fibroblast cell migration	33	2.912455e-41	4.432511e-39	3.444234e-27	9.508845e-68	0.6355275
MP:0011709	increased fibroblast cell migration	2	0.999157	1.55481e-05	0.2994052	0.3422897	0.7757298
MP:0011710	enhanced osteoblast differentiation	2	0.6226378	0.001519169	0.1210609	0.8701658	0.9647485
MP:0011711	impaired osteoblast differentiation	3	0.2319161	2.620632e-10	0.5124294	0.2534703	0.9379293
MP:0011719	abnormal natural killer cell mediated cytotoxicity	61	8.11213e-62	2.153853e-05	5.598005e-72	3.259691e-119	2.812332e-22
MP:0011722	abnormal ossification involved in bone maturation	1	3.800431e-10	0.1556365	1.303925e-05	0.0432448	1
MP:0011723	ectopic neuron	65	1.240419e-44	1.392036e-74	7.767363e-17	7.042577e-32	0.0002590763
MP:0011724	ectopic cortical neuron	6	5.467874e-17	1.7575e-16	0.007034087	1.972146e-11	0.4294877
MP:0011727	ectopic ovary	1	1	2.652335e-09	0.770847	0.8595013	0.8122343
MP:0011731	decreased myelin sheath thickness	2	0.199519	0.003131553	1	0.8850272	1
MP:0011732	decreased somite size	37	1.397571e-20	1.248824e-19	0.0001091742	1.635653e-11	0.6694201
MP:0011733	fused somites	16	6.278799e-11	9.7241e-12	6.300338e-05	4.583719e-09	0.2721366
MP:0011734	abnormal urine ammonia level	4	0.001230377	2.516891e-16	0.9835982	0.0001873421	0.1925832
MP:0011735	increased urine ammonia level	2	0.8570555	0.006840384	0.9771317	0.6824572	0.2052101
MP:0011736	decreased urine ammonia level	2	8.721223e-06	1.334978e-16	0.9166936	2.988896e-06	0.4037573
MP:0011737	hypodipsia	1	2.033974e-18	0.04515471	0.701407	0.006142341	1
MP:0011738	anasarca	2	0.9994771	0.9750619	1	0.9167555	0.7937142
MP:0011739	abnormal Boettcher cell morphology	1	0.9996953	0.04353317	0.054902	0.936322	0.498173
MP:0011740	abnormal urine nitrite level	7	3.295034e-13	0.0001137564	1.575758e-10	2.677273e-05	0.4252194
MP:0011741	increased urine nitrite level	3	0.0006432207	0.1215721	0.0001717928	0.117879	0.1064642
MP:0011742	decreased urine nitrite level	4	8.388294e-12	5.186652e-05	1.031905e-07	8.837624e-06	0.9199981
MP:0011743	abnormal Golgi apparatus morphology	1	8.885418e-06	0.2415598	7.916486e-05	6.560886e-05	0.131346
MP:0011744	abnormal kidney epithelial cell primary cilium physiology	1	1.150047e-16	0.2762569	0.0001112282	0.04962712	1
MP:0011745	isolation of the left subclavian artery	1	0.8246961	0.9329748	0.3832671	0.936322	0.02789339
MP:0011746	spleen fibrosis	5	9.37795e-24	0.032713	3.171749e-13	1.02526e-11	0.5196314
MP:0011747	myelofibrosis	6	2.437949e-16	0.5609322	3.215267e-11	1.588312e-07	0.0258603
MP:0011748	intestinal fibrosis	3	0.7044706	0.229356	0.5641498	0.001384251	0.002412087
MP:0011749	perivascular fibrosis	4	0.002791681	0.009165143	0.6475868	0.1531713	1
MP:0011750	abnormal seminiferous tubule epithelium morphology	82	1.738036e-52	2.296884e-11	1.70463e-30	3.061944e-23	0.001346845
MP:0011751	abnormal X-Y chromosome synapsis during male meiosis	4	0.7232554	0.9999074	0.6316567	0.0008521052	0.8698686
MP:0011753	decreased podocyte number	8	9.124239e-16	0.0131569	0.008878864	2.617776e-09	0.401774
MP:0011754	abnormal kidney collecting duct intercalated cell morphology	1	0.7248003	4.892357e-05	0.3832671	0.8595013	0.0003482699
MP:0011757	abnormal kidney collecting duct principal cell morphology	1	0.0285936	0.1895162	0.3548467	2.026355e-05	1
MP:0011758	renal ischemia	1	1.308349e-06	0.0003136487	1.008212e-06	0.006352072	0.4259408
MP:0011759	absent Rathke's pouch	7	0.1946023	0.2991684	0.112422	0.002364457	0.1599903
MP:0011760	abnormal ureteric bud tip morphology	5	1.999479e-05	6.627656e-12	9.858873e-07	6.980746e-07	0.3630447
MP:0011761	abnormal ureteric bud trunk morphology	1	9.89145e-06	0.09293501	0.0004944267	0.0002444115	0.4529742
MP:0011762	renal/urinary system inflammation	189	5.502599e-286	6.53153e-39	5.887452e-132	9.179924e-212	9.488735e-09
MP:0011763	urethritis	2	0.0001475983	7.302384e-06	1	0.03964718	1
MP:0011765	oroticaciduria	4	1.861252e-28	0.1474111	0.0613949	0.001986181	0.9726241
MP:0011766	abnormal urinary bladder mucosa morphology	1	0.6719125	0.1747096	1	0.2265993	1
MP:0011767	ureterocele	2	1.312584e-38	3.323873e-08	0.04496652	0.0004805164	0.1525354
MP:0011769	urinary bladder fibrosis	1	0.9794862	0.9655247	0.02326111	0.9948082	0.08911155
MP:0011770	increased urine selenium level	2	0.8894436	9.483426e-07	0.007200403	0.02422198	0.2225858
MP:0011772	genital tubercle hypoplasia	3	0.9448969	5.591503e-16	0.9740641	0.9566973	0.6034166
MP:0011773	abnormal urinary bladder blood vessel morphology	1	0.9794862	0.9655247	0.02326111	0.9948082	0.08911155
MP:0011774	abnormal urinary bladder detrusor smooth muscle morphology	2	0.9993391	0.03190286	1	0.9975857	0.5067435
MP:0011775	rectal atresia	1	7.314496e-07	0.006170312	1	0.5094695	1
MP:0011777	abnormal male prostatic urethra morphology	1	0.6288708	0.1526919	1	0.8314017	1
MP:0011780	abnormal female urethra morphology	2	0.000494594	6.375479e-06	0.9817442	0.03514003	1
MP:0011783	abnormal ureteral orifice morphology	2	0.6703891	0.002320772	0.8056055	0.1922734	1
MP:0011784	abnormal urinary bladder neck morphology	1	0.6288708	0.1526919	1	0.8314017	1
MP:0011789	increased urethra carcinoma incidence	1	0.004017566	0.6327778	0.0693156	0.08035383	0.3273782
MP:0011792	abnormal urethral gland morphology	2	4.826194e-17	1.288937e-08	2.809064e-06	0.0004656242	0.3070187
MP:0011797	blind ureter	5	0.5939715	9.370588e-08	0.3340739	0.04308679	0.9344187
MP:0011799	increased urinary bladder weight	2	0.6008538	0.1910158	1	0.9959326	1
MP:0011801	urethra obstruction	1	0.6288708	0.1526919	1	0.8314017	1
MP:0011802	seminal vesiculitis	1	0.6288708	0.1526919	1	0.8314017	1
MP:0011803	double kidney pelvis	1	0.0003994016	0.3886302	0.1413571	5.987441e-09	1
MP:0011804	increased cell migration	3	3.051326e-11	0.0006140387	0.01192594	0.0003469764	0.8988412
MP:0011805	decreased cell migration	34	2.064778e-43	2.415504e-38	8.658729e-31	2.912051e-70	0.5178218
MP:0011808	abnormal myoblast differentiation	1	7.349229e-05	0.2528496	0.02445157	0.5758676	1
MP:0011816	decreased pre-pro B cell number	1	0.9814612	4.683724e-05	0.3380292	0.4428175	0.701259
MP:0011818	abnormal pancreatic beta cell proliferation	5	1.627079e-07	1.885977e-07	2.434015e-05	2.397844e-08	0.6400832
MP:0011819	increased pancreatic beta cell proliferation	2	1.639932e-05	0.0001931681	0.0001017051	4.441953e-10	0.7734943
MP:0011820	decreased pancreatic beta cell proliferation	4	7.468015e-10	0.0002982714	0.0006651968	3.966627e-07	0.6826441
MP:0011826	increased lymphocyte chemotaxis	1	1.852494e-26	0.7860741	0.003784301	4.499546e-06	1
MP:0011827	impaired neuron differentiation	4	0.0002054319	7.98966e-05	0.8015906	0.006410007	0.7571478
MP:0011828	urinary bladder cysts	1	1	0.3642343	0.687584	0.06370262	1
MP:0011829	vesicovaginal fistula	1	1	0.3642343	0.687584	0.06370262	1
MP:0011833	abnormal cremaster muscle morphology	1	0.9930732	0.3150907	0.008981698	0.6062543	0.498173
MP:0011834	abnormal clitoral gland morphology	1	3.1199e-06	1.220147e-06	1	0.1510882	1
MP:0011843	abnormal kidney collecting duct epithelium morphology	10	0.2095147	2.125005e-18	0.3350338	0.001941436	1.392784e-05
MP:0011844	kidney collecting duct atrophy	2	3.41576e-13	0.1039027	0.2802449	0.2460449	1
MP:0011846	decreased kidney collecting duct number	5	2.029153e-11	4.080383e-16	1.366218e-09	0.001284352	0.2892216
MP:0011850	absent clitoral bone	1	3.1199e-06	1.220147e-06	1	0.1510882	1
MP:0011854	cerebral edema	6	0.0005115619	2.747598e-18	2.230929e-07	0.0003966604	0.4470693
MP:0011855	abnormal glomerular filtration barrier morphology	1	1.308349e-06	0.0003136487	1.008212e-06	0.006352072	0.4259408
MP:0011856	abnormal glomerular filtration barrier function	6	2.291432e-06	0.01342268	1.005566e-05	7.312973e-07	0.2945561
MP:0011857	short kidney papilla	1	0.01194802	0.00437481	0.2246218	0.03867134	0.2355317
MP:0011858	elongated kidney papilla	2	0.7045562	0.0002873696	0.1965883	0.3143715	0.2456392
MP:0011859	decreased renal glomerulus basement membrane thickness	1	0.01194802	0.00437481	0.2246218	0.03867134	0.2355317
MP:0011860	abnormal peritubular capillary endothelium morphology	2	3.455941e-05	0.0001790313	0.1316359	0.002613061	0.3373699
MP:0011861	increased cranium height	1	0.9996953	3.351959e-31	1	0.8595013	0.8122343
MP:0011862	decreased cranium length	1	0.1947878	0.9993019	0.8814681	0.3473939	0.5844193
MP:0011868	podocyte microvillus transformation	7	2.269957e-08	2.164186e-08	3.993284e-08	4.771831e-11	0.4036441
MP:0011869	detached podocyte	3	4.401294e-20	0.4015507	5.977711e-05	7.696956e-05	0.4511815
MP:0011870	abnormal podocyte polarity	1	0.1628608	0.03431722	0.002937057	0.1408839	0.2521755
MP:0011871	podocyte hypertrophy	4	0.102253	0.5491985	0.0003094508	0.2369765	0.002002806
MP:0011873	enlarged uterine horn	1	0.01211823	9.685072e-08	4.269221e-05	2.882946e-07	0.7894491
MP:0011877	absent liver	2	3.922906e-10	0.7592517	0.02711294	1.354932e-07	0.512927
MP:0011881	distended duodenum	1	1.354016e-25	0.9357302	1	0.0001445506	1
MP:0011883	absent diaphragm	2	0.9998762	1.939142e-05	0.07522649	0.02063323	0.09001936
MP:0011888	abnormal circulating total protein level	41	1.396983e-92	4.303828e-08	5.590266e-13	2.550899e-25	0.03405237
MP:0011889	abnormal circulating ferritin level	10	3.933423e-05	2.774968e-05	0.008465095	2.280289e-05	0.6259087
MP:0011890	increased circulating ferritin level	8	0.0006149885	0.001159098	0.001464976	0.0002952819	0.5952571
MP:0011891	decreased circulating ferritin level	2	0.008887227	0.001438957	0.9553931	0.01338169	0.722095
MP:0011895	abnormal circulating unsaturated transferrin level	6	0.6976255	4.569169e-10	0.2237035	0.01474238	0.2114183
MP:0011896	increased circulating unsaturated transferrin level	3	0.6338109	7.077581e-05	0.007770357	0.2237668	0.05723012
MP:0011897	decreased circulating unsaturated transferrin level	3	0.680558	8.907682e-07	0.9742962	0.01487859	0.7947483
MP:0011898	abnormal platelet cell number	197	0	3.303621e-40	1.220714e-113	0	0.002106561
MP:0011901	abnormal hematopoietic stem cell proliferation	6	1.011984e-10	0.00086318	5.865272e-07	6.636525e-13	0.2210013
MP:0011902	increased hematopoietic stem cell proliferation	4	8.083442e-05	0.02808242	2.282704e-05	4.970771e-11	0.5036012
MP:0011903	decreased hematopoietic stem cell proliferation	2	3.525543e-08	0.004868008	0.00528754	0.001135372	0.1520892
MP:0011904	abnormal Schwann cell physiology	5	0.00139407	3.654453e-05	0.04967358	4.35122e-05	0.5801403
MP:0011906	increased Schwann cell proliferation	4	0.6456817	0.0009927489	0.4465943	0.001629744	0.4131058
MP:0011911	abnormal pancreatic endocrine progenitor cell physiology	1	0.7338375	0.6948788	0.4218103	0.4306829	1
MP:0011913	abnormal reticulocyte cell number	96	3.605823e-302	4.052308e-15	7.725609e-47	4.755292e-213	0.6802901
MP:0011918	abnormal PQ interval	6	8.439303e-21	2.166974e-16	0.9456399	0.001069778	0.1767946
MP:0011919	abnormal R wave	2	0.9940374	0.0002873696	0.5642112	0.7998565	0.6495497
MP:0011922	abnormal circulating osteocalcin level	2	0.004752531	0.05557218	3.269099e-05	0.3745429	0.01305581
MP:0011923	abnormal bladder urine volume	2	1.068361e-08	0.4513452	0.05278452	0.1628059	1
MP:0011926	abnormal cardiac valve physiology	20	0.4237133	1.12284e-35	0.01311319	0.003916191	0.0495656
MP:0011929	abnormal aortic valve flow	1	0.01815389	0.5284495	0.3264595	0.3047446	0.5631992
MP:0011932	abnormal endocrine pancreas development	18	0.01001335	4.374649e-16	8.005654e-07	2.109564e-08	0.06285644
MP:0011935	abnormal pancreatic bud formation	3	9.74603e-18	0.0002823846	8.053724e-06	6.853935e-27	0.9202444
MP:0011939	increased food intake	132	5.556633e-110	2.83088e-40	9.431243e-39	2.899822e-43	0.4041189
MP:0011940	decreased food intake	72	7.607822e-62	2.765553e-18	2.912038e-14	3.173298e-25	0.3871818
MP:0011941	increased fluid intake	80	7.513497e-50	7.81518e-48	4.392472e-32	1.803434e-34	0.002164357
MP:0011942	decreased fluid intake	27	3.507252e-27	0.1476699	0.05501252	2.756625e-10	0.0870946
MP:0011943	abnormal circadian feeding behavior	2	0.01562972	5.813542e-06	0.4739303	0.01259098	0.5953932
MP:0011945	increased eating frequency	1	0.9939639	0.1413066	0.8603996	0.8724082	0.5554604
MP:0011947	abnormal fluid intake	102	3.114693e-82	4.8659e-40	5.267358e-29	6.142742e-42	0.002349471
MP:0011951	increased cardiac stroke volume	7	5.307861e-20	0.002471274	0.306851	5.180028e-10	0.9925238
MP:0011952	decreased cardiac stroke volume	12	2.513529e-24	5.32388e-06	0.09393166	2.156982e-06	0.76384
MP:0011953	prolonged PQ interval	5	4.243331e-06	1.628064e-18	0.9326309	0.2554799	0.1147987
MP:0011954	shortened PQ interval	1	1.121245e-34	0.9308131	0.8201511	1.050476e-09	1
MP:0011956	abnormal compensatory feeding amount	18	2.004987e-21	3.790036e-08	0.01435867	0.0008665257	0.4888482
MP:0011957	decreased compensatory feeding amount	14	1.196964e-22	3.591541e-05	0.7542212	0.004705945	0.8409428
MP:0011958	increased compensatory feeding amount	4	0.1063846	3.075161e-05	1.019011e-07	0.04053603	0.05039039
MP:0011961	abnormal cornea thickness	19	0.01535126	9.754916e-32	9.241352e-05	0.0001656573	0.6358564
MP:0011962	increased cornea thickness	1	0.9930732	0.008215793	0.9128654	0.4587774	1
MP:0011963	abnormal total retina thickness	16	3.451414e-19	6.705581e-19	0.1639992	0.0002880857	0.4929626
MP:0011964	increased total retina thickness	6	0.9001118	1.176654e-18	0.9416731	0.7627017	0.5960013
MP:0011965	decreased total retina thickness	10	2.451822e-35	0.0002682565	0.00473334	1.221142e-07	0.4404421
MP:0011966	abnormal auditory brainstem response waveform shape	34	2.608859e-31	3.760328e-18	0.001601197	7.819603e-14	0.203903
MP:0011967	increased or absent threshold for auditory brainstem response	163	1.711173e-176	4.908906e-78	1.854411e-25	6.95313e-72	0.005565389
MP:0011968	decreased threshold for auditory brainstem response	3	0.9999954	0.6567334	0.5524935	0.9831317	0.5123573
MP:0011969	abnormal circulating triglyceride level	275	0	3.346887e-119	2.131628e-96	4.308869e-210	0.0005708727
MP:0011971	increased circulating lactate dehydrogenase level	5	9.868085e-17	0.0001944384	0.0001077792	3.091549e-25	0.04168877
MP:0011973	abnormal circulating glycerol level	29	1.633189e-28	3.825635e-06	3.792713e-15	3.251399e-13	0.0005076745
MP:0011975	neuronal cytoplasmic inclusions	3	1.105833e-05	0.08532844	5.87009e-10	0.287575	0.01749034
MP:0011977	abnormal sodium ion homeostasis	90	5.088825e-72	1.87575e-50	3.924291e-22	1.337973e-31	0.004510681
MP:0011978	abnormal potassium ion homeostasis	69	1.034654e-27	1.230664e-62	4.318523e-12	5.945716e-20	2.214904e-05
MP:0011987	abnormal GABAergic neuron physiology	1	0.02261012	0.04353317	6.505246e-08	3.121819e-05	0.08911155
MP:0011996	abnormal retinal inner nuclear layer thickness	38	2.340237e-12	7.864222e-17	2.600021e-13	6.362286e-21	0.02639766
MP:0011997	abnormal retinal outer nuclear layer thickness	83	3.008892e-81	1.115546e-11	1.166022e-29	2.271958e-41	0.02869815
MP:0011998	decreased embryonic cilium length	5	1.96675e-09	1.317709e-11	0.01699506	0.000571671	0.01170407
MP:0011999	abnormal tail length	108	2.692684e-62	3.576105e-90	6.737612e-24	7.152878e-44	0.02949608
MP:0012004	abnormal septum pellucidum morphology	1	0.03582201	0.214571	0.1147639	0.001639201	1
MP:0012007	abnormal chloride level	58	8.860763e-35	1.137515e-39	8.602314e-12	6.688086e-15	0.01036637
MP:0012008	delayed parturition	6	0.9825893	1.811178e-05	0.576712	0.3747989	0.04364904
MP:0012009	early parturition	4	1	4.8103e-14	0.9984363	0.9996418	0.4091664
MP:0012010	parturition failure	6	0.04103274	1.298125e-05	1.293479e-07	1.024504e-06	0.03854867
MP:0012014	abnormal olfactory neuron innervation pattern	12	1	6.931319e-20	0.0609162	0.1025544	0.0001089755
MP:0012018	abnormal oviduct physiology	4	1.298402e-08	2.464477e-07	0.1765506	0.05459122	0.2107667
MP:0012027	abnormal embryonic cilium location or orientation	6	0.0520954	3.017528e-12	0.008462081	0.02841255	0.7581062
MP:0012028	abnormal visceral endoderm physiology	13	1.366562e-10	0.2600458	0.002646811	1.025431e-06	0.03141794
MP:0012029	abnormal electroretinogram waveform feature	6	0.02693092	4.380657e-06	0.115513	0.002626243	0.5043253
MP:0012051	spasticity	2	0.2935089	3.463711e-05	0.7864923	0.1458924	0.5126977
MP:0012055	abnormal phrenic nerve innervation pattern to diaphragm	9	4.42882e-13	3.112898e-14	0.01487379	0.09431923	0.773783
MP:0012057	abnormal mural trophectoderm morphology	87	9.96812e-135	2.377528e-76	2.767343e-19	1.381831e-53	0.5324497
MP:0012058	abnormal morula morphology	1	0.6095025	0.01008448	0.7028883	0.1820511	1
MP:0012059	thick diaphragm muscle	2	0.2688344	0.7146396	0.4383626	2.476135e-05	0.406015
MP:0012060	diaphragm muscle hyperplasia	1	0.2920226	0.7564167	1	1.325329e-06	1
MP:0012061	abnormal central tendon morphology	3	0.9987995	1.35908e-19	0.9951147	0.7010909	0.9535877
MP:0012062	small tail bud	10	9.532555e-11	5.323307e-13	0.08968343	0.05781524	0.6071751
MP:0012063	absent tail bud	2	2.143985e-08	0.2787469	0.008601726	1.006546e-05	0.07132012
MP:0012075	impaired mammary gland growth during pregnancy	1	0.9124092	0.03057499	0.1653555	2.134821e-06	0.01905956
MP:0012076	abnormal agouti pigmentation	29	2.255787e-21	0.002996383	6.034191e-06	6.7053e-15	0.6662929
MP:0012081	absent heart tube	9	1.283399e-14	2.870584e-11	0.0002023379	0.05538626	0.6319337
MP:0012082	delayed heart development	14	2.057104e-24	3.914401e-17	1.269545e-18	1.657557e-21	0.1457191
MP:0012083	absent foregut	7	9.306204e-12	2.694158e-10	0.00722376	1.374885e-06	0.1242554
MP:0012084	truncated foregut	4	0.05754372	5.416687e-07	0.01997312	0.4068921	0.4788837
MP:0012085	midface hypoplasia	5	0.4868498	3.837537e-43	0.1770504	0.2828893	0.8171042
MP:0012086	absent hindgut	3	1.31323e-06	0.9701105	0.004289655	0.01505485	0.5280895
MP:0012087	absent midbrain	14	8.801218e-17	2.196573e-07	5.622377e-09	4.55903e-05	0.5213723
MP:0012088	abnormal midbrain size	24	1.529185e-28	0.03834585	0.004541117	0.000161977	0.9172591
MP:0012089	decreased midbrain size	18	9.890416e-30	0.1944833	0.005319754	0.0009735269	0.9836365
MP:0012090	midbrain hypoplasia	4	2.374596e-10	0.9818187	0.04155514	0.03704426	0.5935499
MP:0012091	increased midbrain size	7	0.8420046	0.3349735	0.9895639	0.9807401	0.6992956
MP:0012092	diencephalon hypoplasia	1	0.09492681	0.000274454	0.0006382511	0.003639315	0.7430814
MP:0012093	absent nodal flow	4	2.338209e-05	0.1482954	0.1783932	0.06181927	0.006531266
MP:0012094	abnormal Reichert's membrane thickness	8	0.003043737	1.928187e-16	3.494229e-10	0.0003604358	0.2926476
MP:0012095	increased Reichert's membrane thickness	4	5.085919e-06	0.001078084	1.982331e-06	0.002178161	0.2106418
MP:0012096	decreased Reichert's membrane thickness	3	0.7548638	6.824116e-20	5.993515e-06	0.01300564	0.8744139
MP:0012097	abnormal spongiotrophoblast size	27	9.33423e-91	1.41483e-09	1.183424e-08	3.569211e-42	0.9551053
MP:0012098	increased spongiotrophoblast size	9	6.698273e-24	0.06126427	0.0701549	4.187368e-11	0.9426849
MP:0012099	decreased spongiotrophoblast size	18	4.96586e-71	1.112685e-10	2.088206e-09	3.566002e-34	0.8429392
MP:0012100	absent spongiotrophoblast	4	0.0001501388	0.004119609	0.06420695	1.848812e-05	0.1843402
MP:0012101	acoria	3	0.002204997	1.297775e-07	0.01255787	0.0086607	0.9005258
MP:0012102	absent trophectoderm	7	0.05887965	5.16534e-06	5.068378e-09	0.0001263184	0.03524041
MP:0012103	abnormal embryonic disc morphology	65	2.453397e-71	4.06339e-70	2.183226e-24	1.449645e-26	0.02254413
MP:0012104	small amniotic cavity	4	1.891255e-17	0.007339079	0.01754399	0.1021567	0.9099328
MP:0012105	delayed gastrulation	4	2.006597e-11	0.6606036	0.006002315	0.09668844	0.4259918
MP:0012106	impaired exercise endurance	40	7.604215e-36	2.220402e-40	4.45738e-10	2.585326e-20	0.3074413
MP:0012107	enhanced exercise endurance	9	5.246098e-32	0.0003838797	1.141401e-08	5.682464e-20	0.2825853
MP:0012108	increased trophoblast glycogen cell number	2	8.209643e-09	0.7807612	0.224678	0.1190576	0.5997695
MP:0012109	decreased trophoblast glycogen cell number	7	1.897328e-32	4.807461e-05	3.374091e-15	1.070934e-13	0.9499968
MP:0012110	increased hair follicle number	3	0.0001253151	2.445688e-12	0.001930077	0.0620375	0.1990038
MP:0012111	failure of morula compaction	6	2.815957e-54	0.0001749042	2.912531e-06	9.390777e-07	0.787237
MP:0012113	decreased inner cell mass proliferation	18	6.463922e-26	2.294062e-15	7.711824e-06	2.415984e-05	0.601632
MP:0012114	absent inner cell mass proliferation	43	7.525012e-93	0.1336208	2.386153e-19	1.037299e-16	0.499978
MP:0012115	abnormal trophectoderm cell proliferation	7	1.917839e-20	2.849932e-05	0.04654284	0.002931483	0.993764
MP:0012117	decreased trophectoderm cell proliferation	3	4.045516e-09	1.043889e-08	0.02086983	0.003945581	1
MP:0012118	absent trophectoderm cell proliferation	4	2.653125e-13	0.7872503	0.4855648	0.1472118	0.8997055
MP:0012119	increased trophectoderm apoptosis	6	1.164444e-11	0.00599432	1.134911e-05	0.004790268	0.9091725
MP:0012120	trophectoderm cell degeneration	2	4.448601e-16	0.3107369	0.0001739723	0.1148726	0.8657453
MP:0012123	abnormal bronchoconstrictive response	6	0.0004529641	0.9332891	3.654916e-05	0.08567331	0.05192334
MP:0012124	increased bronchoconstrictive response	3	1.216537e-09	0.1333965	9.641585e-05	2.303705e-05	0.2593752
MP:0012125	decreased bronchoconstrictive response	3	0.8826313	0.9987969	0.02487085	0.9850549	0.07778622
MP:0012126	abnormal placenta hemotrichorial membrane morphology	4	0.9998848	0.0001156894	1.036097e-07	0.002520252	0.3585988
MP:0012127	absent placenta hemotrichorial membrane	3	0.999997	0.2053438	5.860987e-05	0.2489626	0.2162546
MP:0012128	abnormal blastocyst formation	28	1.040831e-40	1.432379e-21	9.690486e-09	1.567307e-19	0.008016526
MP:0012129	failure of blastocyst formation	27	4.681379e-40	3.637801e-22	6.163973e-09	9.282146e-19	0.007016898
MP:0012131	small visceral yolk sac	6	5.993329e-34	0.0008755537	9.78225e-07	1.362359e-24	0.4946047
MP:0012132	abnormal midbrain-hindbrain boundary morphology	21	1.106916e-14	1.296453e-37	1.929799e-09	2.121169e-14	0.9902356
MP:0012133	absent midbrain-hindbrain boundary	9	1.926144e-05	4.088485e-30	0.1831439	0.005310203	0.9589868
MP:0012134	absent umbilical cord	5	0.0001594929	3.740748e-07	0.001825583	2.283344e-06	0.01136564
MP:0012135	embryonic-extraembryonic boundary constriction	18	9.956111e-10	1.390183e-08	2.375259e-06	4.394466e-05	0.6475947
MP:0012136	absent forebrain	14	5.489187e-24	4.887179e-11	1.61616e-07	1.364828e-10	0.6669899
MP:0012137	abnormal forebrain size	57	6.442658e-54	8.32612e-12	4.34818e-08	2.71547e-23	0.187075
MP:0012138	decreased forebrain size	54	3.167222e-62	1.135858e-13	4.592376e-10	4.192395e-28	0.04359062
MP:0012139	increased forebrain size	6	0.00798504	0.04902532	0.1560075	0.009391944	0.9871283
MP:0012141	absent hindbrain	1	6.594091e-10	2.325589e-08	2.368458e-05	0.03867134	0.2355317
MP:0012142	absent amniotic cavity	2	0.2903136	0.01053232	0.907263	0.9795184	0.4295862
MP:0012155	abnormal optic pit morphology	4	4.518381e-05	0.0450625	0.0001557568	0.01922622	0.5531131
MP:0012156	rostral-caudal axis duplication	13	3.140213e-08	2.751963e-15	0.001963151	4.07509e-05	0.3737435
MP:0012157	rostral body truncation	23	2.603644e-18	8.407195e-19	7.894984e-12	1.287002e-14	0.0010993
MP:0012158	absent visceral endoderm	1	0.009959619	5.830197e-08	0.8841568	0.004074135	1
MP:0012159	absent anterior visceral endoderm	9	1.948962e-14	7.300937e-05	3.983568e-06	3.480637e-07	0.1747094
MP:0012160	expanded anterior visceral endoderm	2	2.804754e-09	0.003924439	0.00014578	0.03966411	0.8892704
MP:0012161	absent distal visceral endoderm	1	4.168152e-14	0.6405929	0.04326895	0.0009746326	0.7297547
MP:0012162	absent parietal endoderm	1	0.009959619	5.830197e-08	0.8841568	0.004074135	1
MP:0012163	abnormal dental mesenchyme morphology	2	8.329533e-10	3.24056e-07	0.004741016	0.001930204	0.5983915
MP:0012165	absent neural folds	4	0.01204321	2.406494e-06	0.0600356	0.154673	0.7487703
MP:0012167	abnormal epigenetic regulation of gene expression	74	3.158671e-107	2.123186e-17	5.188772e-12	6.672277e-12	0.02353164
MP:0012168	abnormal optic placode morphology	9	0.3306433	3.083911e-16	0.6592127	3.648969e-05	0.005391214
MP:0012169	optic placode degeneration	1	0.9996953	0.0002490035	1	0.1282527	0.02789339
MP:0012170	absent optic placodes	5	0.1408033	1.210609e-06	0.4432001	0.007119364	0.01323703
MP:0012171	oligohydramnios	1	0.1189998	0.9048957	0.9558322	0.8172051	0.7232245
MP:0012172	abnormal amniotic fluid composition	6	1.389934e-07	2.535368e-07	0.02417784	0.0002322328	0.9827755
MP:0012173	short rostral-caudal axis	16	1.173881e-57	1.771281e-10	1.05713e-10	2.016134e-20	0.9486182
MP:0012174	flat head	2	6.296771e-06	0.07736046	0.7015112	0.1305449	1
MP:0012175	flat face	4	2.50552e-06	4.392599e-08	0.003414909	0.0736211	0.9479395
MP:0012176	abnormal head development	42	1.189229e-52	1.803779e-16	5.119306e-06	4.074143e-16	0.97942
MP:0012177	delayed head development	1	2.060291e-30	0.9942286	0.00634996	0.04421041	1
MP:0012178	absent frontonasal prominence	1	0.9982283	0.8829117	0.5785484	0.9948082	0.498173
MP:0012179	abnormal splanchnic mesoderm morphology	3	3.855551e-05	0.5699463	0.9676124	0.09453689	0.6709857
MP:0012180	abnormal somatic mesoderm morphology	2	0.00139495	0.7566308	1	5.723219e-10	1
MP:0012181	increased somite number	5	6.428327e-09	1.863871e-20	0.0002084125	7.787714e-08	0.1146338
MP:0012182	abnormal presomitic mesoderm morphology	3	0.9991458	1.312284e-08	0.006446998	0.05161376	0.929021
MP:0012183	decreased paraxial mesoderm size	8	2.015472e-20	0.184507	0.0003081401	0.001192006	0.01658899
MP:0012184	absent paraxial mesoderm	8	0.05701681	7.258964e-16	0.0001612039	0.0309669	0.7631645
MP:0012224	abnormal sterol level	403	0	2.058098e-155	6.191578e-122	1.81335e-220	1.692194e-05
MP:0012226	increased sterol level	227	5.286512e-237	2.87293e-83	4.081684e-69	1.172198e-103	0.0004232388
MP:0012260	encephalomeningocele	8	3.380211e-35	0.9961126	0.004106791	8.378485e-08	0.6665924
